UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 40-F

[X] Registration statement pursuant to Section 12 of the Securities Exchange Act of 1934

or

[    ] Annual report pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934

 

For the fiscal year ended __________    Commission File Number __________

Village Farms International, Inc.

(Exact name of Registrant as specified in its charter)

 

[British Columbia], Canada   2833   N/A

(Province or other jurisdiction of

incorporation or organization)

 

(Primary Standard Industrial

Classification Code Number)

 

(I.R.S. Employer Identification

Number)

4700-80 th Street

Delta, British Columbia V4K 3N3

Canada

(407) 936-1190

(Address and telephone number of Registrant’s principal executive offices)

CT Corporation

111 Eighth Avenue

New York, New York 10011

(212) 894-8940

(Name, address (including zip code) and telephone number

(including area code) of agent for service in the United States)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

 

Title of each class   Name of each exchange on which registered
Common Shares, no par value   The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None

For annual reports, indicate by check mark the information filed with this Form:

 

[    ] Annual information form   [    ] Audited annual financial statements


Indicate the number of outstanding shares of each of the issuer’s classes of capital or common stock as of the close of the period covered by the annual report: N/A

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. N/A

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.

[ X ] Emerging growth company

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 13(a) of the Exchange Act. [    ]

 

The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.


 

EXPLANATORY NOTE

Village Farms International, Inc. (the “Company”, the “Registrant”) is a Canadian issuer eligible to file its registration statement pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on Form 40-F pursuant to the multi-jurisdictional disclosure system of the Exchange Act. The Company is a “foreign private issuer” as defined in Rule 3b-4 under the Exchange Act. Equity securities of the Company are accordingly exempt from Sections 14(a), 14(b), 14(c), 14(f) and 16 of the Exchange Act pursuant to Rule 3a12-3.

FORWARD LOOKING STATEMENTS

This Registration Statement and the Exhibits incorporated by reference into this Registration Statement of the Registrant contain forward-looking statements that reflect management’s expectations with respect to future events, the Registrant’s financial performance and business prospects. All statements other than statements of historical fact are forward-looking statements. Forward-looking statements include, but are not limited to, future developments; use of funds; and the business and operations of the Registrant. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “proposed” “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved”, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Registrant to be materially different from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of continued development, marketing and sales as well as those factors discussed under the heading “Risk Factors” in the Registrant’s Annual Information Form for the year ended December 31, 2017, included as Exhibit 99.10 to this Registration Statement, and those discussed under the heading “Risks and Uncertainties” in the Registrant’s management’s discussion and analysis for the three months ended September 30, 2018 included as Exhibit 99.55 to this Registration Statement. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Although the management and officers of the Registrant believe that the expectations reflected in such forward-looking statements are based upon reasonable assumptions and have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Registrant’s forward-looking statements contained in the Exhibits incorporated by reference into this Registration Statement are made as of the respective dates set forth in such Exhibits. In preparing this Registration Statement, the Registrant has not updated such forward-looking statements to reflect any change in circumstances or in management’s beliefs, expectations or opinions that may have occurred prior to the date


hereof. Nor does the Registrant assume any obligation to update such forward-looking statements in the future. Accordingly, for the reasons set forth above, the forward-looking statements in the Exhibits incorporated by reference into this Registration Statement should not be unduly relied upon.

DIFFERENCES IN UNITED STATES AND CANADIAN REPORTING PRACTICES

The Registrant is permitted, under a multijurisdictional disclosure system adopted by the United States, to prepare this report in accordance with Canadian disclosure requirements, which are different from those of the United States. The Registrant currently prepares its financial statements, which are filed with this report on Form 40-F in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and the audit is subject to Canadian auditing and auditor independence standards.

PRINCIPAL DOCUMENTS

In accordance with General Instruction B.(1) of Form 40-F, the Registrant hereby incorporates by reference Exhibits 99.01 through 99.66, inclusive, as set forth in the Exhibit Index attached hereto.

In accordance with General Instruction D.(9) of Form 40-F, the Registrant has filed the written consent of certain experts named in the foregoing Exhibits as Exhibit 99.49, Exhibits 99.58 to 99.62 and Exhibit 99.65, as set forth in the Exhibit Index attached hereto.

TAX MATTERS

Purchasing, holding, or disposing of securities of the Registrant may have tax consequences under the laws of the United States and Canada that are not described in this registration statement on Form 40-F.

DESCRIPTION OF COMMON SHARES

The required disclosure is included under the heading “Capital Structure” in the Registrant’s Annual Information Form for the fiscal year ended December 31, 2017, attached hereto as Exhibit 99.10.

OFF-BALANCE SHEET ARRANGEMENTS

The Registrant does not have any off-balance sheet arrangements.

CURRENCY

Unless otherwise indicated, all dollar amounts in this Registration Statement on Form 40-F are in Canadian dollars. The exchange rate of Canadian dollars into United States dollars, on December 31, 2017, based upon the daily exchange rate as quoted by the Bank of Canada was Cdn.$1.00 = U.S.$0.7965.


CONTRACTUAL OBLIGATIONS

The following table lists, as of December 31, 2017, information with respect to the Registrant’s known contractual obligations (in thousands):

 

     Payments due by period  

Contractual Obligations

   Total      Less than
1 year
     1-3 years      3-5 years      More than
5 years
 

Long-term debt, net of fees

   $ 38,380      $ 2,620      $ 6,785      $ 28,805      $ 170  

Trade payables

   $ 12,952      $ 12,952      $      $      $  

Accrued liabilities

   $ 3,793      $ 3,793      $      $      $  

Obligation under capital lease

   $ 251      $ 72      $ 179      $      $  

Other liabilities

   $ 1,097      $      $ 1,097      $      $  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 56,473      $ 19,437      $ 8,061      $ 28,805      $ 170  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

UNDERTAKING

Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.

CONSENT TO SERVICE OF PROCESS

The Registrant has concurrently filed a Form F-X in connection with the class of securities to which this Registration Statement relates.

Any change to the name or address of the Registrant’s agent for service shall be communicated promptly to the Commission by amendment to the Form F-X referencing the file number of the Registrant.


SIGNATURES

Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

  VILLAGE FARMS INTERNATIONAL, INC.
By:  

/s/ Michael D. DeGiglio

  Name:   Michael D. DeGiglio
  Title:   Chief Executive Officer

Date: January 18, 2019

 


EXHIBIT INDEX

The following documents are being filed with the Commission as Exhibits to this Registration Statement:

 

Exhibit   

Description

99.01   

Disclosure under Early Warning Requirement dated January  11, 2018

99.02   

News Release dated January 11, 2018

99.03   

News Release dated January 12, 2018

99.04   

News Release dated January 24, 2018

99.05   

News Release dated March 5, 2018

99.06   

News Release dated March 14, 2018

99.07   

News Release dated March 19, 2018


99.08   

Certification of Annual Filings Full Certificate by CEO dated April 2, 2018

99.09   

Certification of Annual Filings Full Certificate by CFO dated April 2, 2018

99.10   

Annual Information Form dated April 2, 2018

99.11   

Consolidated Financial Statements for the year ended December  31, 2017 and December 31, 2016

99.12   

Management’s Discussion and Analysis for the year ended December 31, 2017

99.13   

News Release dated April 2, 2018

99.14   

Notice of Intention to Distribute Securities dated April  2, 2018

99.15   

Notice of the Meeting and Record Date dated April 6, 2018

99.16   

News Release dated April 12, 2018

99.17   

News Release dated April 30, 2018

99.18   

News Release dated May 10, 2018

99.19   

Certification of Interim Filings Full Certificate by CEO dated May 14, 2018

99.20   

Certification of Interim Filings Full Certificate by CFO dated May 14, 2018

99.21   

Interim Consolidated Financial Statements for the three and six months ended March 31, 2018 and March 31, 2017

99.22   

Management’s Discussion and Analysis for the three months ended March 31, 2018

99.23   

News Release dated May 14, 2018

99.24   

Form of Proxy - Annual General and Special Meeting to be held on June 14, 2018

99.25    Noticed of Meeting and Management Information Circular dated May 16, 2018
99.26   

Notice of Meeting dated May 16, 2018

99.27   

News Release dated May 18, 2018

99.28   

News Release dated May 24, 2018

99.29   

News Release dated June 14, 2018

99.30   

Report of Voting Results dated June 14, 2018

99.31   

Notice of Intention to Distribute Securities dated June  20, 2018

99.32   

News Release dated June 27, 2018

99.33   

Disclosure under Early Warning Requirement dated June 29, 2018

99.34   

News Release dated June 29, 2018

99.35   

News Release dated July 30, 2018

99.36   

News Release dated August 8, 2018

99.37   

News Release dated August 14, 2018

99.38   

Certification of Interim Filings Full Certificate by CEO dated August 15, 2018

99.39   

Certification of Interim Filings Full Certificate by CFO dated August 15, 2018

99.40   

Interim Consolidated Financial Statements for the three and six months ended June 30, 2018 and June 30, 2017

99.41   

Management’s Discussion and Analysis for the three months ended June 30, 2018

99.42   

News Release dated August 21, 2018

99.43   

News Release dated August 23, 2018

99.44   

News Release dated September 6, 2018

99.45   

News Release dated September 24, 2018

99.46   

Material Change Report dated September 25, 2018

99.47   

News Release dated September 25, 2018

99.48   

Underwriting Agreement dated September 27, 2018

99.49   

Consent of PricewaterhouseCoopers LLP dated October 4, 2018

99.50   

Final short form prospectus - English

99.51   

News Release dated October 12, 2018

99.52   

News Release dated October 15, 2018

99.53   

News Release dated November 7, 2018

99.54   

Interim Consolidated Financial Statements for the three and nine months ended September 30, 2018 and September 30, 2017

99.55   

Management’s Discussion and Analysis for the three months ended September 30, 2018

99.56   

News Release dated November 12, 2018

99.57   

Certification of Interim Filings Full Certificate by CFO dated November 12, 2018

99.58   

Certification of Interim Filings Full Certificate by CEO dated November 12, 2018

99.59   

Consent letter of issuer’s legal counsel

99.60   

Consent letter of underwriters’ legal counsel

99.61   

Consent letter of issuer’s legal counsel

99.62   

Consent letter of underwriters’ legal counsel

99.63   

News Release dated December 10, 2018

99.64   

News Release dated December 13, 2018

99.65   

Consent of PricewaterhouseCoopers LLP dated January 18, 2019

99.66   

News Release dated December 20, 2018

Exhibit 99.01

FORM 62-103F1

REQUIRED DISCLOSURE UNDER THE EARLY WARNING REQUIREMENTS

Item 1 – Security and Reporting Issuer

1.1 State the designation of securities to which this report relates and the name and address of the head office of the issuer of the securities.

Common shares

Village Farms International, Inc.

4700 – 80th Street

Delta, British Columbia

V4K 3N3

1.2 State the name of the market in which the transaction or other occurrence that triggered the requirement to file this report took place.

The transactions took place through exchange facilities on January 11, 2018.

Item 2 – Identity of the Acquiror

2.1 State the name and address of the acquiror.

Mastronardi Holdings Limited (“ MHL ”)

2100 Road 4 East

Kingsville, Ontario

N9Y 2E5

2.2 State the date of the transaction or other occurrence that triggered the requirement to file this report and briefly describe the transaction or other occurrence.

A disposition of common shares occurred through exchange facilities at a price of Cdn.$7.90 per common share for an aggregate sale price of Cdn.$41,454,460.00.

2.3 State the names of any joint actors.

Not applicable.

Item 3 – Interest in Securities of the Reporting Issuer

3.1 State the designation and number or principal amount of securities acquired or disposed of that triggered the requirement to file the report and the change in the acquiror’s securityholding percentage in the class of securities.

Disposition of 5,247,400 common shares on January 11, 2018, representing an aggregate of approximately 12.48% of the issued and outstanding common shares.


3.2 State whether the acquiror acquired or disposed ownership of, or acquired or ceased to have control over, the securities that triggered the requirement to file the report.

MHL disposed of ownership of the common shares.

3.3 If the transaction involved a securities lending arrangement, state that fact.

Not applicable.

3.4 State the designation and number or principal amount of securities and the acquiror’s securityholding percentage in the class of securities, immediately before and after the transaction or other occurrence that triggered the requirement to file this report.

Immediately before the dispositions, MHL owned 5,247,400 common shares representing approximately 12.48% of the issued and outstanding common shares. Following the disposition, MHL no longer holds any common shares of Village Farms.

3.5 State the designation and number or principal amount of securities and the acquiror’s securityholding percentage in the class of securities referred to in Item 3.4 over which

(a) the acquiror, either alone or together with any joint actors, has ownership and control,

See Item 3.4.

(b) the acquiror, either alone or together with any joint actors, has ownership but control is held by persons or companies other than the acquiror or any joint actor, and

Nil.

(c) the acquiror, either alone or together with any joint actors, has exclusive or shared control but does not have ownership.

Nil.

3.6 If the acquiror or any of its joint actors has an interest in, or right or obligation associated with, a related financial instrument involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the related financial instrument and its impact on the acquiror’s securityholdings.

Not applicable.

3.7 If the acquiror or any of its joint actors is a party to a securities lending arrangement involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the arrangement including the duration of the arrangement, the number or principal amount of securities involved and any right to recall the securities or identical securities that have been transferred or lent under the arrangement.

Not applicable.

 

2


State if the securities lending arrangement is subject to the exception provided in section 5.7 of NI 62-104.

Not applicable.

3.8 If the acquiror or any of its joint actors is a party to an agreement, arrangement or understanding that has the effect of altering, directly or indirectly, the acquiror’s economic exposure to the security of the class of securities to which this report relates, describe the material terms of the agreement, arrangement or understanding.

Not applicable.

Item 4 – Consideration Paid

4.1 State the value, in Canadian dollars, of any consideration paid or received per security and in total.

The disposition occurred through exchange facilities at a price of Cdn.$7.90 per common share for an aggregate sale price of Cdn.$41,454,460.00

4.2 In the case of a transaction or other occurrence that did not take place on a stock exchange or other market that represents a published market for the securities, including an issuance from treasury, disclose the nature and value, in Canadian dollars, of the consideration paid or received by the acquiror.

Not applicable.

4.3 If the securities were acquired or disposed of other than by purchase or sale, describe the method of acquisition or disposition.

Not applicable.

Item 5 – Purpose of the Transaction

State the purpose or purposes of the acquiror and any joint actors for the acquisition or disposition of securities of the reporting issuer. Describe any plans or future intentions which the acquiror and any joint actors may have which relate to or would result in any of the following:

(a) the acquisition of additional securities of the reporting issuer, or the disposition of securities of the reporting issuer;

(b) a corporate transaction, such as a merger, reorganization or liquidation, involving the reporting issuer or any of its subsidiaries;

(c) a sale or transfer of a material amount of the assets of the reporting issuer or any of its subsidiaries;

 

3


(d) a change in the board of directors or management of the reporting issuer, including any plans or intentions to change the number or term of directors or to fill any existing vacancy on the board;

(e) a material change in the present capitalization or dividend policy of the reporting issuer;

(f) a material change in the reporting issuer’s business or corporate structure;

(g) a change in the reporting issuer’s charter, bylaws or similar instruments or another action which might impede the acquisition of control of the reporting issuer by any person or company;

(h) a class of securities of the reporting issuer being delisted from, or ceasing to be authorized to be quoted on, a marketplace;

(i) the issuer ceasing to be a reporting issuer in any jurisdiction of Canada;

(j) a solicitation of proxies from securityholders;

(k) an action similar to any of those enumerated above.

Not applicable.

Item 6 – Agreements, Arrangements, Commitments or Understandings With Respect to Securities of the Reporting Issuer

Describe the material terms of any agreements, arrangements, commitments or understandings between the acquiror and a joint actor and among those persons and any person with respect to securities of the class of securities to which this report relates, including but not limited to the transfer or the voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. Include such information for any of the securities that are pledged or otherwise subject to a contingency, the occurrence of which would give another person voting power or investment power over such securities, except that disclosure of standard default and similar provisions contained in loan agreements need not be included.

In connection with the disposition, MHL has agreed to a 60 day lockup period during which MHL and those associated with it will not trade, dispose or deal with any common shares of Village Farms International, Inc. unless the prior written consent of the buyer is obtained by MHL or MHL tenders common shares to an unsolicited takeover bid.

Item 7 – Change in Material Fact

If applicable, describe any change in a material fact set out in a previous report filed by the acquiror under the early warning requirements or Part 4 in respect of the reporting issuer’s securities.

Not applicable.

 

4


Item 8 – Exemption

If the acquiror relies on an exemption from requirements in securities legislation applicable to formal bids for the transaction, state the exemption being relied on and describe the facts supporting that reliance.

Not applicable.

Item 9 – Certification

Certificate

I, as the acquiror, certify, or I, as the agent filing the report on behalf of an acquiror, certify to the best of my knowledge, information and belief, that the statements made in this report are true and complete in every respect.

Date: January 11, 2018

 

MASTRONARDI HOLDINGS LIMITED
By:  

“Steve Attridge”

  Name: Steve Attridge
  Title: Chief Financial Officer

 

5

Exhibit 99.02

FOR IMMEDIATE RELEASE

MASTRONARDI HOLDINGS LIMITED REDUCES HOLDINGS OF VILLAGE FARMS

INTERNATIONAL, INC.

KINGSVILLE, ONTARIO – January  11, 2018 – Mastronardi Holdings Limited (“MHL”) announces that today it disposed of 5,247,400 common shares of Village Farms International, Inc. (“Village Farms”), representing an aggregate of approximately 12.48% of the issued and outstanding common shares. Following the disposition, MHL no longer holds any common shares of Village Farms. The disposition occurred through exchange facilities at a price of Cdn.$7.90 per common share for an aggregate sale price of Cdn.$41,454,460.00.

MHL is located at 2100 Road 4 East, Kingsville, Ontario, Canada, N9Y 2E5. For further information, or to obtain a copy of the early warning report to be filed by MHL, please contact Steve Attridge at 519-326-1491. Village Farms is listed on the Toronto Stock Exchange under the symbol “VFF” and its head office is located at 4700 – 80th Street, Delta, British Columbia, Canada, V4K 3N3.

* * *

Exhibit 99.03

Village Farms International Advises of Disposition of Shares by Unrelated Third Party

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

Vancouver, BC, January  12, 2018 – Village Farms International, Inc. (“ Village Farms ” or the “ Company ”) (TSX: VFF) (OTCQX: VFFIF) today announced that on January 11, 2018 Mastronardi Holdings Limited (“ MHL ”), an unrelated third party, through exchange facilities disposed of 5,247,400 common shares of Village Farms, representing the entirety of its remaining position such that MHL no longer holds any common shares of Village Farms. The disposition follows on dispositions by MHL of 210,600 common shares and 2,275,000 Village Farms common shares on December 4, 2017 and December 21, 2017 respectively. Immediately prior to the disposition on December 4, 2017, MHL owned 7,733,000 common shares representing approximately 18.40% of the issued and outstanding common shares of Village Farms.

“MHL, owners of Mastronardi Produce, originally acquired its 7,733,000 million share position in March 2016 when Village Farms was focused exclusively on its produce business,” said Michael DeGiglio, Chief Executive Officer, Village Farms International, Inc. “As we expand on our existing North American produce business and diversify into cannabis production in Canada through our joint venture, Pure Sunfarms Corp., we are pleased to transition MHL’s ownership to institutional investors who recognize Village Farms’ significant opportunities in the Canadian cannabis industry as one of the largest and most experienced greenhouse growers in the country.”

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.

Cautionary Language

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements concerning: (i) the Offering; (ii) the use of the proceeds of the Offering; (iii) results of the completion of the Offering; and (iv) the Company’s financial position in the future. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors” set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2016, and for the three and nine months ended September 30, 2017, which are available electronically at www.sedar.com . Actual results may differ materially from any forward-looking statements. Although the Company believes that its forward-looking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward- looking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/January2018/12/c3624.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 12-JAN-18

Exhibit 99.04

Village Farms International, Inc. Named to 2018 OTCQX Best 50

/NOT FOR DISTRIBUTION OVER THE UNITED STATES WIRE SERVICES/

VANCOUVER, Jan. 24, 2018 /CNW/ - Village Farms International, Inc. (Village Farms) (TSX:VFF) (OTCQX:VFFIF), is pleased to announce it has been named to the 2018 OTCQX ® Best 50,aranking of top performing companies traded on the OTCQX Best Market last year.

The OTCQX Best 50 is an annual ranking of the top 50 U.S .and international companies traded on the OTCQX market. The ranking is calculated based on an equal weighting of one-year total return and average daily dollar volume growth in the previous calendar year. Companies in the 2018 OTCQX Best 50 were ranked based on their performance in 2017.

“Our ranking as the fourth best performing company traded on the OTCQX in 2017 – up from17th prior year – reflects our position as one of the largest vertically integrated greenhouse growers In North America alongside our ability to leverage our 30 years of experience to capitalize on new opportunities that will drive future profitability and generate long-term shareholder value, “said Michael DeGiglio, CEO, Village Farms International. “We would once again like to acknowledge the OTCQX for its continued support, providing a liquid and efficient market for our many US shareholders.”

For the complete 2018 OTCQX Best 50 ranking, visit http://bit.ly/OTCQX-best50-2018

The OTCQX Best Market offers transparent and efficient trading of established, investor-focused U.S. and global companies. To qualify for the OTCQX market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and have a professional third-party sponsor introduction. The companies found on OTCQX are distinguished by the integrity of their operations and diligence with which they convey their qualifications.

About Village Farms International, Inc.

Village Farms is one of the largest producers, marketers, and distributors of premium-quality, greenhouse-grown fruits and vegetables in North America. The food our farmers grow, along with other greenhouse farmers under exclusive arrangements are all grown in environmentally friendly, soil-less, glass greenhouses. The Village Farms ® brand of fruits and vegetables is marketed and distributed primarily to local retail grocer sand dedicated fresh food distributors throughout the United States and Canada. Since its inception, Village Farms has been guided by sustainability principles that enable us to grow food 365 days a year that not only feeds the growing population but is healthier for people and the planet. Village Farms is Good for the Earth ® and good for you.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/January2018/24/c4374.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 08:00e 24-JAN-18

 

Exhibit 99.05

Village Farms International and Emerald Health Therapeutics Announce Cannabis Cultivation License for 1.1 Million ft2 Delta 3 Greenhouse Operation

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES/

– Unmatched Experience and Expertise and Optimized Facility Design Will Support Continuous Production and

Consistent Quality and Supply –

VANCOUVER, March 5, 2018 /CNW/ – Village Farms International, Inc. (Village Farms) (TSX:VFF) (OTCQX:VFFIF) and Emerald Health Therapeutics, Inc. (Emerald) (TSXV: EHT; OTCQX: EMHTF) today announced that Health Canada has issued a Cultivation Licence for their co-owned Delta 3 greenhouse operation (the “Joint Venture”) under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”). This optimally-designed 1.1 million ft 2 cannabis growing facility is located in one of the best growing climates in Canada in Delta, BC, and is conservatively projected to produce 75,000 kg of quality cannabis annually at full production.

Village Farms and Emerald aim for the Joint Venture to be one of the most consistent and reliable suppliers of quality cannabis products to wholesalers, distributors and retailers across Canada and internationally, with the goal to be the low-cost cannabis Canadian producer at an all-in production cost of less than $1.00 per gram at full production.

The Joint Venture will immediately begin cultivating cannabis in the Delta 3 greenhouse following the transfer of existing starter plants from Emerald and expects to receive its Sales License under ACMPR by July 1, 2018.

“Growing any agricultural crop on a large scale and repeatedly delivering expected quantities and consistent quality, with full regulatory compliance, at a competitive price is an extremely challenging proposition for even the most experienced agricultural producers. The goal is for the Joint Venture to set the standard in this regard in the Canadian cannabis industry and establish itself as a preferred supplier for both the short- and long-terms,” said Michael DeGiglio, CEO, Village Farms International. “In addition to production ramp-up, in 2018 the Joint Venture will focus on product development and developing its marketing strategy to become a vertically integrated leader in the Canadian cannabis market.”

“Our Joint Venture is well positioned to be a leading supplier in the imminent legal adult-use Canadian cannabis market, with potentially significant benefit to each of our companies and our shareholders,” said Avtar Dhillon, MD, Executive Chairman of Emerald. “With Emerald’s in-depth cannabis expertise, Village Farms’ know-how based on innumerable crop cycles over 30-years of large-scale greenhouse growing, and working with global agricultural leaders and high-tech facilities and systems experts, we configured this greenhouse for continuous weekly harvesting year-round, maximum operating efficiencies, and flexibility to adapt to an evolving market. We are accomplishing this on a very capital-efficient basis.”


The Joint Venture is converting the Delta 3 greenhouse operation to cannabis production with meticulous attention to the growing environment and systems, processing areas, and production ramp up, with a particular focus on management of climate and contaminants, optimizing yield, maximizing efficiencies, and achieving continuous year-round production. Key elements of the design, conversion, and operations include:

 

   

Growing system with automation proven in different crops to provide optimal efficiencies;

 

   

Industry-leading HVAC systems reflecting hundreds of aggregate years of climate management experience, with technically advanced data systems;

 

   

High-tech light deprivation and light supplementation systems with individual control of over 15 growing zones within the 1.1 million ft 2 footprint;

 

   

Fully automated 90,000 square feet nursery capable of supplying Delta 3 (as well as the 1.1 million ft 2 Delta 2 facility should the Joint Venture exercise its option to purchase that facility, as described below);

 

   

State of the art drying, trimming and packaging areas;

 

   

Core upgrades to facility infrastructure;

 

   

Use of an established labour force and proprietary labour tracking systems; and,

 

   

Secure supply of low-cost electricity from BC Hydro sufficient to power Delta 3 at full production (and, if required, to power the Delta 2 facility at full production).

Conversion of the first 250,000 ft 2 section of the 1.1 million ft 2 Delta 3 greenhouse to cannabis production is substantially complete and is expected to commence production in April 2018. Senior growing and operational personnel, including the established team transferred from Village Farms, are in place for production ramp-up. Conversion of the remainder of the 1.1 million ft 2 is underway and the entire facility is expected to be in production in 2019.

The Joint Venture holds options on two additional state-of-the-art greenhouses owned by Village Farms (Delta 2 and Delta 1, with 1.1 million ft 2 and 2.6 million ft 2 of growing capacity, respectively). Exercising these options would expand the Joint Venture’s production facility to 4.8 million ft 2 and make it one of the largest cannabis producers in Canada.

About Emerald Health Therapeutics

Emerald Health Therapeutics, Inc. (TSXV: EMH; OTCQX: EMHTF) operates through Emerald Health Therapeutics Canada Inc. (“EHTC”), a wholly owned subsidiary and Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations. Through EHTC, Emerald is authorized to produce and sell dried cannabis and cannabis oil for medical purposes. It operates an indoor facility in Victoria, BC, and is building a 500,000 ft 2 greenhouse on 32 acres in Metro Vancouver, with expansion potential to 1 million ft 2 to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald owns 50% of a Joint Venture with Village Farms International, Inc. that is converting an existing 1.1 million ft 2 greenhouse in Delta, BC to grow cannabis. Emerald’s team is highly experienced in life sciences, product development and large-scale agribusiness. Emerald is part of the Emerald Health Group , which is broadly focused on developing pharmaceutical, botanical and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

About Village Farms International, Inc.

Village Farms is one of the largest producers, marketers, and distributors of premium-quality, greenhouse-grown fruits and vegetables in North America. The food our farmers grow, along with other greenhouse farmers under exclusive arrangements are all grown in environmentally friendly, soil-less, glass greenhouses. The Village Farms ® brand of fruits and vegetables is marketed and distributed primarily to local retail grocers and dedicated fresh food distributors throughout the United States and Canada. Since its inception, Village Farms has been guided by sustainability principles that enable us to grow food 365 days a year that not only feeds the growing population but is healthier for people and the planet. Village Farms is Good for the Earth® and good for you.


Cautionary Language

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements concerning: (i) the Offering; (ii) the use of the proceeds of the Offering; (iii) results of the completion of the Offering; and (iv) the Company’s financial position in the future. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by such statements. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors” set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2016, and for the three and nine months ended September 30, 2017, which are available electronically at www.sedar.com. Actual results may differ materially from any forward looking statements. Although the Company believes that its forward-looking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward- looking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2018/05/c2840.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 08:00e 05-MAR-18

Exhibit 99.06

Village Farms International to Host Fourth Quarter 2017 Financial Results Conference Call on Tuesday, March 20, 2018 at 11:00 a.m. ET (8:00 a.m. PT)

VANCOUVER, March 14, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTC: VFFIF) today announced it will host a conference call to discuss its fourth quarter 2017 financial results and provide an update on its cannabis joint venture in Canada on Tuesday, March  20, 2018 at 11:00 a.m. ET (8:00 a.m. PT) . Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2p3jsyq .

The Company expects to report its fourth quarter 2017 financial results via news release after markets close on Monday, March 19, 2018.

Conference Call Archive Access Information

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 8267239 followed by the pound key. The telephone replay will be available until Tuesday, March 27, 2018 at midnight (ET). The conference call will also be archived on Village Farm’s web site at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2018/14/c1239.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 14-MAR-18

Exhibit 99.07

Village Farms International Reschedules Fourth Quarter and Year End 2017 Financial Results Conference Call to April 2, 2018 at 11:00 a.m. ET (8:00 a.m. PT)

VANCOUVER, March 19, 2018 /CNW/ Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTC: VFFIF) today announced it has reschedule its fourth quarter 2017 and year end financial results conference call to Monday, April  2, 2018 at 11:00 a.m. ET (8:00 a.m. PT) . Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2p3jsyq .

The Company expects to report its fourth quarter and year end 2017 financial results via news release at approximately 7:00 a.m. ET on Monday, April 2, 2018.

The change in scheduling was made to allow for more time to finalize the 2017 financial statements for the Company’s cannabis joint venture, Pure Sunfarms Corp.

Conference Call Archive Access Information

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 8267239 followed by the pound key. The telephone replay will be available until April 9, 2018 at midnight (ET). The conference call will also be archived on Village Farm’s web site at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2018/19/c6557.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 10:08e 19-MAR-18

Exhibit 99.08

Form 52-109F1

Certification of Annual Filings

Full Certificate

I, Michael A. DeGiglio, the Chief Executive Officer of Village Farms International, Inc. certify the following:

 

1.

Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the “annual filings”) of Village Farms International, Inc. (the “issuer”) for the financial year ended December 31, 2017.

 

2.

No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the annual filings.

 

3.

Fair presentation: Based on my knowledge, having exercised reasonable diligence, the annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the annual filings.

 

4.

Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (“DC&P”) and internal control over financial reporting (“ICFR”), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.

Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the financial year end

(a) designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the annual filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

(b) designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework.

 

5.2

N/A


5.3

N/A

 

6.

Evaluation : The issuer’s other certifying officer(s) and I have

 

  (a)

evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer’s DC&P at the financial year end and the issuer has disclosed in its annual MD&A our conclusions about the effectiveness of DC&P at the financial year end based on that evaluation; and

 

  (b)

evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer’s ICFR at the financial year end and the issuer has disclosed in its annual MD&A

 

  (i)

our conclusions about the effectiveness of ICFR at the financial year end based on that evaluation; and

 

  (ii)

N/A

 

7.

Reporting changes in ICFR: The issuer has disclosed in its annual MD&A any change in the issuer’s ICFR that occurred during the period beginning on October 1, 2017 and ended on December 31, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

8.

Reporting to the issuer’s auditors and board of directors or audit committee: The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of ICFR, to the issuer’s auditors, and the board of directors or the audit committee of the board of directors any fraud that involves management or other employees who have a significant role in the issuer’s ICFR.

Date: April 2, 2018

“Michael A. DeGiglio”

Michael A. DeGiglio

Chief Executive Officer

Village Farms International, Inc.

Exhibit 99.09

Form 52-109F1

Certification of Annual Filings

Full Certificate

I, Stephen C. Ruffini, the Chief Financial Officer of Village Farms International, Inc. certify the following:

 

1.

Review: I have reviewed the AIF, if any, annual financial statements and annual MD&A, including, for greater certainty, all documents and information that are incorporated by reference in the AIF (together, the “annual filings”) of Village Farms International, Inc. (the “issuer”) for the financial year ended December 31, 2017.

 

2.

No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the annual filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, for the period covered by the annual filings.

 

3.

Fair presentation: Based on my knowledge, having exercised reasonable diligence, the annual financial statements together with the other financial information included in the annual filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the annual filings.

 

4.

Responsibility: The issuer’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (“DC&P”) and internal control over financial reporting (“ICFR”), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings, for the issuer.

 

5.

Design: Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer(s) and I have, as at the financial year end

(a) designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the annual filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

(b) designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework: The control framework the issuer’s other certifying officer(s) and I used to design the issuer’s ICFR is the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework.

 

5.2

N/A

 

5.3

N/A


6.

Evaluation : The issuer’s other certifying officer(s) and I have

 

  (a)

evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer’s DC&P at the financial year end and the issuer has disclosed in its annual MD&A our conclusions about the effectiveness of DC&P at the financial year end based on that evaluation; and

 

  (b)

evaluated, or caused to be evaluated under our supervision, the effectiveness of the issuer’s ICFR at the financial year end and the issuer has disclosed in its annual MD&A

 

  (i)

our conclusions about the effectiveness of ICFR at the financial year end based on that evaluation; and

 

  (ii)

N/A

 

7.

Reporting changes in ICFR: The issuer has disclosed in its annual MD&A any change in the issuer’s ICFR that occurred during the period beginning on October 1, 2017 and ended on December 31, 2017 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

8.

Reporting to the issuer’s auditors and board of directors or audit committee: The issuer’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of ICFR, to the issuer’s auditors, and the board of directors or the audit committee of the board of directors any fraud that involves management or other employees who have a significant role in the issuer’s ICFR.

Date: April 2, 2018

“Stephen C. Ruffini”

Stephen C. Ruffini

Chief Financial Officer

Village Farms International, Inc.

Exhibit 99.10

 

LOGO

Village Farms International, Inc.

4700–80th Street

Delta, British Columbia

V4K 3N3

Annual Information Form

For the Year Ended December 31, 2017

April 2, 2018


TABLE OF CONTENTS

 

INTERPRETATION

     1

Glossary of Terms

     1

Interpretation

     3

Market and Industry Data

     3

Intercorporate Relationships

     3

GENERAL DEVELOPMENT OF THE COMPANY

     4

History

     4

Tomato Suspension Agreement – Mexico

     5

Refinancing

     5

Purchase of Maxim Power (B.C.) Inc.

     6

Formation of Pure Sunfarms Corp.

     6

INDUSTRY OVERVIEW

     8

Greenhouse Vegetable Industry Overview

     8

Cannabis Industry Overview

     9

DESCRIPTION OF THE BUSINESS

     11

Overview

     11

Core Operating Principle

     11

Greenhouse Facilities and Products

     12

Sales, Marketing and Distribution

     12

Production and Packaging Process

     14

Product Development and Specialization

     14

Product Pricing

     14

Intellectual Property

     15

Competition

     15

Employees

     15

Capital Expenditures

     15

Energy Management Strategy

     16

Foreign Exchange Strategy

     16

Environmental and Regulatory Matters

     16

British Columbia Vegetable Marketing Commission

     17

Agency and Producer Licenses

     17

Quota

     17

CAPITAL STRUCTURE

     18

Common Shares

     18

Special Shares

     18

Preferred Shares

     18

Warrants

     18

Retained Interest of Michael DeGiglio

     19

Book Entry System

     19

Financial Year End

     19

CREDIT FACILITIES

     19

Credit Facilities

     19

RISK FACTORS

     20

Risks Relating to the Company

     20

Risks Relating to the Joint Venture

     25

Risks Related to Tax

     30

 

- i -


DIVIDENDS

     31

Dividend Policy

     31

Historical Distributions

     31

MARKET FOR SECURITIES

     31

Trading Price and Volume

     31

DIRECTORS AND MANAGEMENT

     32

Board Committees

     33

Cease Trade Orders or Bankruptcies

     34

Penalties or Sanctions

     34

Personal Bankruptcies

     34

Conflicts of Interest

     35

LEGAL PROCEEDINGS AND REGULATORY ACTIONS

     35

TRANSFER AGENT AND REGISTRAR

     35

EXPERTS

     35

MATERIAL CONTRACTS

     35

AUDIT COMMITTEE INFORMATION

     36

Charter of the Audit Committee

     36

Composition of the Audit Committee

     36

Prior Approval Policies and Procedures

     36

External Auditor Service Fees

     36

ADDITIONAL INFORMATION

     36

 

- ii -


FORWARD-LOOKING STATEMENTS

Certain statements contained in this annual information form constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this annual information form include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable rates when required.

Although the forward-looking statements contained in this annual information form are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this annual information form and management’s discussion and analysis.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this annual information form relate only to events or information as of the date on which the statements are made in this annual information form. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.


INTERPRETATION

Glossary of Terms

“ACMPR” means the Access to Cannabis for Medical Purposes Regulations;

“APDI means Agro Power Development, Inc., a Delaware corporation;

Bank ” means the Canadian chartered bank referred to under “Credit Facilities”;

BCVMC ” means the British Columbia Vegetable Marketing Commission;

Business ” means the businesses carried on by the Company and its subsidiaries;

CBCA ” means the Canada Business Corporations Act , as amended;

CDS ” means CDS Clearing and Depository Services Inc.;

CDS Participant ” means a participant in the CDS depository service;

Combination Transaction ” means the combination transaction which closed on October 18, 2006 whereby the businesses of Hot House Growers Inc. and Village Farms were combined;

Company ” means Village Farms International, Inc. and, as the context requires, Village Farms International, Inc. together with its subsidiaries;

Compensation Plan ” means the share based compensation plan of the Company adopted on December 31, 2009;

Common Shares ” means the common shares in the capital of the Company;

Conversion ” means the plan of arrangement carried out under the CBCA and completed on December 31, 2009 whereby, among other things, the Fund was terminated and the ordinary unitholders of the Fund received Common Shares of the Company on a one for one basis;

Credit Facilities ” means the Term Loan, the Operating Loan and the VFCE Loan;

CSA ” has the meaning ascribed thereto under “General Development of the Company”;

Delta 1 Greenhouse ” has the meaning ascribed thereto under “General Development of the Company”;

Delta 2 Greenhouse ” has the meaning ascribed thereto under “General Development of the Company”;

Delta 3 Greenhouse ” has the meaning ascribed thereto under “General Development of the Company”;

“Emerald” means Emerald Health Therapeutics, Inc.;

Emerald Contribution ” has the meaning ascribed thereto under “General Development of the Company”;

EBITDA ” means earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long term debt, and unrealized gains on the changes in the value of derivative instruments and non-controlling interest;

Federal Court ” has the meaning ascribed thereto under “Industry Overview”;

Forward-looking statements ” has the meaning ascribed thereto under “Forward-Looking Statements”;

 

- 1 -


Fund ” means Village Farms Income Fund, which was terminated on December 31, 2009 as part of the Conversion;

IRS ” means the Internal Revenue Service;

Joint Venture ” has the meaning ascribed thereto under “General Development of the Company”;

Joint Venture Agreement ” has the meaning ascribed thereto under “General Development of the Company”;

License ” has the meaning ascribed thereto under “Risk Factors”;

Management ” means the management of the Company and its subsidiaries who operate the Business;

Material Decisions ” has the meaning ascribed thereto under “General Development of the Company”;

MMPR ” has the meaning ascribed thereto under “Industry Overview”;

Operating Loan ” has the meaning ascribed thereto under “Credit Facilities”;

Offeree ” has the meaning ascribed thereto under “General Development of the Company”;

Offeror ” has the meaning ascribed thereto under “General Development of the Company”;

PACA license ” means a license issued by the United States Department of Agriculture, established by the Perishable Agricultural Commodities Act; this license is required for any business selling fresh and frozen fruits and vegetables.

Preferred Shares ” the preferred shares in the capital of the Company;

Prime Rate ” means the floating annual rate of interest (based on a 365/366 day year) established and recorded by the Bank from time to time as a reference rate for purposes of determining rates of interest it will charge on loans denominated in Canadian dollars;

“Pure Sunfarms” means Pure Sunfarms Corp.;

QA ” has the meaning ascribed thereto under “General Development of the Company”;

RPIC ” has the meaning ascribed thereto under “General Development of the Company”;

SPIC ” has the meaning ascribed thereto under “General Development of the Company”;

Staff Notice ” has the meaning ascribed thereto under “General Development of the Company”;

Securityholders’ Agreement ” means the agreement that was entered into on the completion of the Combination Transaction between, among others, the Fund, VF Opco and Michael A. DeGiglio as amended and restated on December 31, 2009 by, among others, the Company, VF Opco and Michael A. DeGiglio;

Special Shares ” means the special voting shares in the capital of the Company;

Term Loan ” has the meaning ascribed thereto under “Credit Facilities”;

TSX ” means Toronto Stock Exchange;

Units ” means the former ordinary units of the Fund, which were cancelled on December 31, 2009 in connection with the Conversion;

 

- 2 -


U.S. Holdings ” means VF U.S. Holdings Inc., a Delaware corporation;

VF Canada GP ” means Village Farms Canada GP Inc., a corporation incorporated under the laws of Canada that is the general partner of VF Canada LP;

VF Canada LP ” means Village Farms Canada Limited Partnership;

VFCE ” means VF Clean Energy, Inc.;

VFCE Loan ” has the meaning ascribed thereto under “Credit Facilities”;

VFLP ” means Village Farms, L.P.;

VF Opco ” means VF Operations Canada Inc., a corporation incorporated under the laws of Canada; and

Village Farms ” means, collectively, APDI and its subsidiary entities, as these entities existed prior to the completion of the Combination Transaction.

Words importing the singular number only include the plural and vice versa and words importing any gender include all genders. All dollar amounts set forth in this annual information form are in United States dollars, except where otherwise indicated.

Interpretation

Unless otherwise noted or the context otherwise requires: (i) the term “cannabis” has the meaning given to the term “marihuana” under the ACMPR; and (ii) the term “Licensed Producer” means a person licensed by Health Canada under Section 35 of the ACMPR.

Market and Industry Data

Unless otherwise indicated, information contained in this annual information form concerning the Company’s industry and the markets in which it operates or seeks to operate is based on information from third party sources, industry reports and publications, websites and other publicly available information, and management studies and estimates. Unless otherwise indicated, the Company’s estimates are derived from publicly available information released by third party sources as well as data from the Company’s own internal research, and include assumptions which the Company believes to be reasonable based on management’s knowledge of the Company’s industry and markets. The Company’s internal research and assumptions have not been verified by any independent source, and the Company has not independently verified any third party information. While the Company believes that such third party information to be generally reliable, such information and estimates are inherently imprecise. In addition, projections, assumptions and estimates of the Company’s future performance or the future performance of the industry and markets in which the Company operates are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in this annual information form under “Risk Factors”.

STRUCTURE OF THE COMPANY

The Company is a corporation incorporated under the CBCA. The head and registered office of the Company and each of its Canadian subsidiaries is located at 4700 80th Street, Delta, British Columbia, V4K 3N3.

Intercorporate Relationships

The following chart illustrates the structure of the Company and its subsidiaries (including jurisdiction of establishment/incorporation and percentage of voting securities owned) as of December 31, 2017 and April 2, 2018.

 

- 3 -


LOGO

GENERAL DEVELOPMENT OF THE COMPANY

History

The Company’s predecessor, the Fund, completed its initial public offering as an income trust on December 23, 2003. The Company converted from an income trust to a publicly-traded company on December 31, 2009 as part of the Conversion. In connection with the Conversion, the Company changed its name to Village Farms International, Inc.

As of the date hereof, the Company has 42,447,613 Common Shares and no Special Shares issued and outstanding.

The Company’s premium product is grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas and is marketed and distributed under its Village Farms ® brand name and other brand names, primarily to retail supermarkets and dedicated fresh food distribution companies. The Company also markets and distributes produce under exclusive arrangements for other greenhouse producers primarily located in British Columbia, central Mexico and the north eastern part of the United States. The Company markets and distributes its products throughout the United States and Canada. It currently operates four distribution centres located across the United States and Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates three main goals – environmental health, economic profitability and social and economic equality

 

- 4 -


Certain of the Company’s subsidiaries have operated vegetable producing greenhouses in British Columbia since 1989 and in Texas since 1995.

Tomato Suspension Agreement – Mexico

On June 22, 2012, a group of U.S. tomato growers, including VFLP, petitioned the U.S. Department of Commerce to withdraw their petition and requested termination of the 1996 Tomato Suspension Agreement (“ 1996 Agreement ”) with Mexico. The basis of the petition was that Mexican tomato growers were ‘dumping’ tomatoes into the U.S. market which is a violation of U.S. regulations. Dumping is defined as an importer who is selling product in the U.S. market for less than their costs. Mexican producers claimed they were not dumping and were adhering to the 1996 Agreement, but U.S. tomato producers who represented more than 85% of all U.S. tomato production (the threshold for U.S. Department of Commerce intervention) stipulated that the 1996 Agreement was outdated, it should be terminated and an investigation into Mexican tomato dumping should ensue. Due to the high volume of Mexican imports of produce, in particular tomatoes (field, shade and greenhouse), the issue was raised at the highest levels of both countries governments.

Negotiations for a revised agreement began and resulted in a new agreement (the “ Suspension Agreement ”) which became effective on March 4, 2013. All signatories have agreed that they will not sell product at prices below the established reference prices in the new Suspension Agreement. The Suspension Agreement has two reference price periods: October 23 – June 30 (“winter”) and July 1 – October 22 (“summer”), and distinguishes between “Open Field/Adapted Environment” and “Controlled Environment”, although “specialty” tomatoes is a separate category from the growing environments. Each environment and category has different reference prices depending on the period and the packaging.

While VFLP and some other U.S. greenhouse growers would have preferred that there was a definitive definition of “greenhouse” – the definition of “Controlled Environment” uses the Certified Greenhouse Growers Association definition which essentially is a modern glass greenhouse.

All signatories must ensure that they and/or their initial U.S. selling agent adhere to the Suspension Agreement and must hold a valid and effective PACA license. It is a violation of the Suspension Agreement to sell at a new price below the minimum reference price and doing so could result in financial fines or loss of the seller’s or importer’s PACA license, which is required to buy or sell produce in the United States. Additionally, the Mexican government is requiring Mexican growers to formally register with the Mexican authorities in order to export to the U.S., and failing to do so will result in the denial of export rights.

The net result of the Suspension Agreement is positive for the Company as it has curtailed the ongoing issue of mislabeling Mexican field tomatoes as greenhouse tomatoes and sets a minimum floor price for selling to U.S. importers or retailers, if they buy directly. In the long run, the Company believes that the Suspension Agreement should slow down the rapid growth of tomato production in Mexico as real economics – selling for a profit – is brought to bear on Mexican growers. If the market price for U.S. tomatoes drops below the reference price, Mexican growers would be unable to export to the United States.

Refinancing

The Company completed a refinancing of its Term Loan and Operating Loan in 2013, and subsequent amendments to each facility in 2016. The Company’s Term Loan is with a lender that understands and appreciates the cyclical nature of agriculture and in particular the hydroponic greenhouse industry. The March 2016 amendment extended the maturity date on the Term Loan to May 1, 2021 and changed the amortization of principal to be spread over 15 years from the previous 14 years on a lower outstanding principal balance. This amendment provided the Company with greater flexibility in satisfying its debt services covenant under its Operating Loan due to lower annual principal payments.

 

- 5 -


In addition, the Company agreed to an amendment with the Bank which extends the term of its Operating Loan to May 31, 2021. The Operating Loan is a revolving facility of up to CA$13,000,000 is based on up to 90% of the Company’s accounts receivable. The Operating Loan is subject to a debt service coverage ratio that changes over rolling 12-month periods.

Purchase of Maxim Power (B.C.) Inc.

On July 17, 2014, the Company purchased Maxim Power (B.C.) Inc., a wholly-owned subsidiary of Maxim Power Corp., for approximately CA$5.2 million, which included a closing adjustment of CA$0.7 million for working capital. Maxim Power (B.C.) Inc. is a 7 megawatt power generation facility that is located on existing Village Farms property. The Company subsequently changed the name of this acquired company to VF Clean Energy, Inc. The facility that Village Farms acquired as part of the acquisition continues generating power under an existing long term power purchase agreement with British Columbia Hydro and Power Authority and improves the sustainability profile of Village Farms’ greenhouse operations in Delta, B.C.

Formation of Pure Sunfarms Corp.

In June 2017, the Company entered into a joint venture (the “Joint Venture”) with Emerald for the objective of seeking to achieve large-scale, low-cost, high quality cannabis production. The Joint Venture was formed by way of a corporation named “Pure Sunfarms Corp.”, which is 50% owned by the Company and 50% owned by Emerald, and has the purpose of carrying on the business of the Joint Venture. Under the terms of the agreement governing the Joint Venture (the “Joint Venture Agreement”), the Company initially contributed rights to a 1.1 million square foot greenhouse facility in Delta, British Columbia (the “Delta 3 Greenhouse”) which the Joint Venture will seek to convert to ACMPR compliant production and, if permitted by applicable laws, production for the nontherapeutic adult-use cannabis market under the proposed Cannabis Act (the “Cannabis Act”). Under the terms of the Joint Venture Agreement Emerald is contributing an aggregate of $20 million (the “Emerald Contribution”). On the formation of the Joint Venture, $2 million of the Emerald Contribution was contributed to Pure Sunfarms.

The Joint Venture Agreement includes a list of material decisions (the “Material Decisions”), including, among others the decision to no longer pursue any cultivation or distribution license which Pure Sunfarms was pursuing, a decision to fundamentally change the purpose or operations of Pure Sunfarms, any proposed response to investigations, audits or inspections by governmental authorities in relation to the licenses, any proposed response to proposed corrective action, voluntary or involuntary, in relation to the licenses, any proposed response to a governmental authority in connection with a threatened or actual suspension or cancellation of the licences and approval of the annual operating and capital budgets for Pure Sunfarms. Material Decisions require the affirmative vote of a majority of the votes cast at a board of directors meeting, at which a quorum is present. The board of directors of Pure Sunfarms currently consists of six directors – three appointed by Emerald and three appointed by the Company. If either Emerald or the Company’s ownership interest in Pure Sunfarms falls below 35%, such entity will lose one of the board of director members appointed by it. Voting rights will also be lost if a party is in default of its obligations under the Joint Venture Agreement or in the case of a decision in respect of which a party has a conflict of interest. The Joint Venture Agreement includes customary events of default and remedies for the non-defaulting party (including a dilution mechanism). The Joint Venture Agreement also includes restrictions against transfer of the shares of Pure Sunfarms, rights of first refusal, drag along rights and a buy-sell provision (the “Buy-Sell”). The Buy-Sell can only be exercised by Emerald or the Company (the “Offeror”) on or after the second anniversary of the formation of the Joint Venture if it is not in default of its obligations under the Joint Venture Agreement and: (a) the operating or capital budget for Pure Sunfarms for a subject year has not been approved by the board of directors by March 1 of such year; or (b) the board of directors is deadlocked with respect to a Material Decision. The recipient of the buy-sell notice (the “Offeree”) has 60 days to determine whether to sell its shares at the price offered in Pure Sunfarms to the Offeror or to purchase the Offeror’s shares in Pure Sunfarms at that price.

Subject to certain carve-outs in favour of Emerald, each of Emerald and the Company have committed to being the exclusive joint venture partner of the other party for all greenhouse-grown cannabis activities in Canada. It is a requirement of the Joint Venture Agreement that, should the option on the Delta 2 Greenhouse, an additional 1.1 million square foot greenhouse facility in Delta, British Columbia (the “Delta 2 Greenhouse”), or the Delta 1 Greenhouse, an additional 2.6 million square foot greenhouse facility in Delta, British Columbia (the “Delta 1 Greenhouse”), be exercised by the Joint Venture, the Delta 2 Greenhouse or the Delta 1 Greenhouse, as the case may be, would be contributed to the Joint Venture by the Company on an unencumbered basis.

 

- 6 -


On September 15, 2017, Emerald Health Botanicals Inc., a Licensed Producer under the ACMPR (License No. 10MM0005/2017), submitted an application to Health Canada for the expansion of its facilities to include a second cultivation site. The application for the second site was made in the name of Emerald Health Farms Inc., a wholly-owned and controlled subsidiary of Emerald Health Botanicals Inc., for the Delta 3 Greenhouse, located at 4431-80th Street, Delta, British Columbia. The application was subsequently accepted for review by Health Canada on September 18, 2017. The application for the second site named a senior person in charge (“SPIC”), a responsible person in charge (“RPIC”) and an alternate responsible person in charge (“A/RPIC”) as required by the ACMPR. A quality assurance person (“QA”), who will be responsible for assuring the quality of the product that is cultivated at the site, is yet to be appointed for this second site. Security clearances for each of the SPIC, RPIC, and A/RPIC were also submitted to Health Canada as required by the ACMPR. The application sought to obtain approval for the possession, production, sale, shipping, transportation, delivery and destruction of dried cannabis, cannabis plants, seeds and fresh marihuana, with an expected production capacity of 18,750 kilograms of dried cannabis annually. There is no intent to engage in the production and sale of cannabis oil at this time. On March 2, 2018 a cultivation license was issued by Health Canada under the ACMPR in respect of the Delta 3 Greenhouse. Upon receipt of the cultivation license, Emerald Health Farms changed its name to Pure Sunfarms Canada Corp. The Joint Venture hopes to receive a sales license under the ACMPR by July 1, 2018. Once the sales license has been issued in the name of Pure Sunfarms Canada Corp., the Joint Venture intends to exercise its irrevocable option to buy the shares of Pure Sunfarms Canada Corp. for $1.00 in order to possess the issued producer license and lawfully operate the facility.

Subsequent to acceptance by Health Canada to review the application, the Joint Venture commenced physical conversion of the Delta 3 Greenhouse and expects to complete conversion of the first 250,000 square foot quadrant by April 2018, at which time the Joint Venture is expected to commence production. Subject to the receipt of a sales license from Health Canada, and subject to inspection and approval by Health Canada, it expects to begin selling dried cannabis on or before July 2018 and to have all four quadrants of the Delta 3 Greenhouse commercially producing in the first quarter of 2019. The Joint Venture conservatively forecasts annual production from the Delta 3 Greenhouse to be a minimum of 75,000 kilograms of dried cannabis, which it expects to achieve in 2020.

On October 26, 2017, the Canadian Securities Administrators (the “CSA”) issued CSA Staff Notice 51-352 – Issuers with U.S. Marijuana-Related Activities (the “Staff Notice”) which sets out, among other things, certain disclosure expectations of the CSA regarding issuers who have direct, indirect or ancillary involvement in the U.S. cannabis industry. The Staff Notice was issued resulting from concerns regarding the lack of a uniform national framework for cannabis regulation in the United States, which currently has a conflict between state and federal law relating to cannabis, with certain U.S. states permitting the use and sale of cannabis, notwithstanding that cannabis continues to be listed as a controlled substance under U.S. federal law. The Company and the Joint Venture do not have, and do not intend to engage in, any direct, indirect or ancillary involvement in the U.S. cannabis industry (as described in the Staff Notice) until it is federally legal to do so.

Potential Future Developments

The Company is constantly exploring and evaluating whether to produce certain higher margin alternative crops, as well as whether to market and distribute other fresh produce grown by third parties to the Company’s retail customer base.

At this time the Company has no plans to grow cannabis at its U.S. facilities or to participate in any cannabis business activity or investment in the U.S. until such time that it is federally legal to do so in the U.S.. The Company intends to provide further updates with respect to these matters should relevant additional information become available. See “Forward Looking Statements”.

 

- 7 -


INDUSTRY OVERVIEW

Greenhouse Vegetable Industry Overview

The North American Industry

The greenhouse vegetable industry in North America has experienced rapid growth over the past 20 years, particularly in the western regions of the United States, southwest British Columbia and southern Ontario in Canada, and concentrated areas in Mexico.

Mexico is the largest producer of greenhouse tomatoes, accounting for 57% of North American greenhouse vegetable sales, followed by Canada and the United States. Based on figures from 2016, greenhouse tomatoes accounted for over 45% tomato volume sold at retail stores in the United States. It is estimated that retail sales represent over 50% of the total fresh tomato market, including both field and hothouse grown. The balance of fresh tomato sales are to the food service industry, which is primarily serviced by field tomato producers.

The following table illustrates estimated greenhouse tomato area and production for the U.S., Mexico and Canada in 2016 (the most recent date for which this information is available):

 

Item    United
States
     Canada      Mexico 1      Total
North
America
 

Greenhouse tomato production (millions of pounds)

     645        609        2,400        4,312  

Greenhouse tomato area (hectares)

     680        591        14,000        15,271  

Conversion: 1 hectare = 2.471 acres

           

 

1  

The figures for Mexico include all protected crop most of which is a shadehouse rather than a greenhouse and is based on management estimates.

Sources: The State of the N. American Hothouse Vergetable Industry, by Dr. Roberta Cook, March 2018; Greenhouse Consultants; and Perishables Group Freshfact, Nielsen Business Media, Inc.

Greenhouse Industry — United States

The majority of greenhouse vegetable producers in the United States are located in the southwestern and western states, where the growing conditions are more ideal for winter growing operations and in some areas year-round production. New greenhouse facilities have recently been completed in the Midwest region of the United States and more are planned for this area. These facilities will have lights to allow them to produce in the winter months. Producing in the winter months is advantageous as produce prices are generally higher, although with increasing Mexican production, seasonal fluctuations are decreasing. The majority of greenhouse tomatoes produced in the United States are used for domestic consumption. In addition, the United States imports a significant portion of its supply of greenhouse tomatoes from Canada and Mexico to meet domestic demand, it is estimated that Mexican greenhouse vegetables comprise between 40 to 60% of consumption in the United States. Producers in the United States benefit from high yields, consistent product quality, year-round supply and closer proximity to its customers.

Greenhouse Industry — Canada

Among the North American greenhouse vegetable producers, Canada is the largest supplier from April to October of each year. Several factors, including climatic advantages (cooler summer temperatures) and the proximity of greenhouse producers to consumer markets, contribute to Canada’s favourable positioning relative to the United States during that time period. The primary markets for greenhouse produce grown in British Columbia include the west and northwest regions of the United States, as well as western Canada, while the primary markets for Ontario produce include the east and central regions of the United States, as well as eastern Canada.

 

- 8 -


The strengths of the Canadian greenhouse vegetable industry include its high yields and consistent product quality. The main weakness of the Canadian greenhouse industry relates to its lack of production during the historically higher priced winter months. However, because of the high volume of tomatoes produced in Canada during the April to October growing season, profits generated during this time period generally are sufficient to sustain producers through the full year.

Greenhouse Industry — Mexico

Although Mexico was the last to enter the greenhouse tomato industry in North America, it has more greenhouse tomato acreage than the United States and Canada combined. It should be noted there is no formal definition of a “greenhouse” and a significant portion of the greenhouse acreage in Mexico is very low-tech, employing shade field structures. The product from the shade facilities is in some instances marketed as greenhouse-grown, which until the recent update on the Suspension Agreement between the United States and Mexico (as described above) was not in violation of any regulations, but for the State of California regulations, which has a definition of greenhouse for produce sold within the state. Average yields and product quality in Mexico are comparatively low, due to the wide range of greenhouse technologies. Currently, Mexican producers tend to grow and market during the winter months as they have sufficient light levels to grow and cooler temperatures during these months, although the trend towards more sophisticated greenhouses is permitting a longer growing season, as well as increased yields.

Management believes that Mexico’s industry, however, is often challenged by high heating costs, less experienced management, less developed infrastructure, higher distribution costs, inconsistent product quality and the lack of an experienced sales and marketing organization. Over the last several years, the greenhouse industry in Mexico has continued to make significant advances with respect to its growing expertise and ability to extend its growing season, which continues to put pressure on produce pricing.

Pricing

Prices for vegetables fluctuate depending upon availability of supply and consumer demand. Greenhouse vegetable producers typically command a higher price for their products compared to field producers, as a result of the vegetables’ consistent quality, taste, appearance and year-round availability. This higher price, combined with higher production yields for greenhouse produce, typically offset the higher costs associated with greenhouse production relative to field production. Production costs for greenhouse grown produce are generally higher due to greater energy, labour, infrastructure, technological requirements and more intense crop yields per acre. As the fresh produce market share of big box retailers increases, pricing is moving towards more contract pricing for six, nine or even twelve month periods reducing some of the traditional seasonal pricing. Contract pricing does not provide volume guaranties. Average pricing over the last five years has continued to slowly decrease in large part due to the increasing supply of greenhouse tomatoes.

Cannabis Industry Overview

Legal History of Medical Cannabis in Canada

The Marihuana for Medical Purposes Regulations (“ MMPR ”) established a legal regime for licensing producers and permitting the sale of dried cannabis to registered patients pursuant to a medical document provided by a health care practitioner. The overarching purposes of the MMPR was to ensure that Canadians with a medical need could access quality-controlled cannabis grown under secure and sanitary conditions. The MMPR were repealed on August 24, 2016 and were replaced by the ACMPR as a result of a decision by the Federal Court of Canada (the “ Federal Court ”) in Allard v. Canada. The Federal Court held that requiring individuals to obtain cannabis only from Licensed Producers violated liberty and security rights protected by section 7 of the Canadian Charter of Rights and Freedoms . The Federal Court found that individuals who require cannabis for medical purposes did not have “reasonable access” under the MMPR regime. Accordingly, the ACMPR contemplates both access to medical cannabis through a Licensed Producer or through personal production exemptions, thereby giving patients reasonable access to, and choice of, cannabis product.

 

- 9 -


Current Applicable Regulatory Regime

The ACMPR are the current governing regulations regarding the production, sale and distribution of cannabis products, including cannabis oil, in Canada. The ACMPR provide for three possible alternatives for Canadian residents who have been authorized by their health care practitioner to access cannabis for medical purposes:

 

   

they can continue to access quality-controlled cannabis by registering with Licensed Producers;

 

   

they can register with Health Canada to produce a limited amount of cannabis for their own medical purposes (starting materials must be obtained from a Licensed Producer); or

 

   

they can designate someone else who is registered with Health Canada to produce cannabis on their behalf (starting materials must be obtained from a Licensed Producer).

The ACMPR sets out, among other things, the authorized activities and general responsibilities of Licensed Producers, including:

 

   

the requirement to obtain and maintain a licence from Health Canada prior to commencing any activities;

 

   

calculating the quantity of cannabis, other than dried cannabis, that is equivalent to a given quantity of dried cannabis;

 

   

security measures relating to facilities and personnel;

 

   

Good Product Practices (“GPPs”)

 

   

packaging, shipping, labelling, import and export and record-keeping requirements; and

 

   

patient registration and ordering requirements.

Authorized activities under the ACMPR include the production and sale of starting materials (i.e., cannabis seeds and plants) to those individuals who have registered to produce a limited amount of cannabis for their own medical purposes, or to have it produced by a designated person, and the ability to sell an interim supply of fresh or dried cannabis or cannabis oil to registered persons while they wait for their plants to grow. Licences and licence applications under the ACMPR consolidate the MMPR licence requirements for the production and sale of dried cannabis, the requirements for supplemental licences under the exemption in section 56 of the Controlled Drugs and Substances Act (Canada), and the new requirements for the sale of cannabis seeds and plants.

Expected Legalization of Recreational Cannabis in Canada: The Cannabis Act

In connection with the current Government of Canada’s platform advocating for the legalization and regulation of recreational cannabis in order to dismantle the illegal market and restrict access by under-age individuals, on April 13, 2017, the Government of Canada released Bill C-45 which, if implemented, would enact the Cannabis Act. The Cannabis Act would provide a licensing and permitting scheme for the production, testing, packaging, labelling, sending, delivery, transportation, sale, possession and disposal of cannabis for non-medicinal (i.e., recreational) use, to be implemented by regulations made under the Cannabis Act.

The Government of Canada has advised that it intends to bring the Cannabis Act into force no later than July, 2018. The provincial and territorial governments have indicated that there must be a sufficient period of time between Royal Assent (i.e. approval by Parliament) of the Cannabis Act and the date that the law comes into force, and that a minimum of 8 to 12 weeks is necessary for an orderly transition. The Government of Canada has indicated that it would prioritize an orderly transition to the new legal framework, and provide for this 8-12 week period of time. Given this time frame, it is expected that recreational cannabis will not be available through authorized provincial/territorial retailers until at least August 2018.

The Cannabis Act proposes to maintain separate access to cannabis for medical purposes, including providing that import and export licences and permits will only be issued in respect of cannabis for medical or scientific purposes.

On October 3, 2017, the Parliamentary Standing Committee on Health proposed amendments to the Cannabis Act including, among other things, an amendment that would permit cannabis edibles and concentrates to be sold, to come into force no later than 12 months after the Cannabis Act comes into force.

 

- 10 -


On November 10, 2017, the Government of Canada proposed that federal tax on cannabis for recreational purposes should not exceed $1 per gram or 10% of the producer’s price, whichever is higher, with retail sales taxes levied on top of that amount.

While the Cannabis Act provides for the regulation of the commercial production of cannabis for recreational purposes and related matters by the federal government, it proposes that the provinces and territories of Canada will have authority to regulate other aspects of recreational cannabis (similar to what is currently the case for liquor and tobacco products), such as sale and distribution, minimum age requirements, places where cannabis can be consumed, and a range of other matters. To date, the Governments of Ontario, Manitoba, Alberta, New Brunswick, Québec and British Columbia have announced partial regulatory regimes for the distribution and sale of cannabis for recreational purposes within those provinces. Other provinces, namely Prince Edward Island and Nova Scotia, and the Yukon territory, have engaged in public consultation but have yet to announce a proposed approach to the sale and distribution model for recreational cannabis in their respective jurisdictions.

On November 22, 2017, Health Canada also launched public consultations (together with consultation proposals) on the proposed regulatory approach for the proposed Cannabis Act. The consultations were open until January 20, 2018, and on March 19, 2018, Health Canada published a Summary of Comments Received during the Public Consultation. This Summary document provides direction on the packaging and labelling provisions of the proposed regulations under the Cannabis Act to help licensed producers, provinces and territories and others prepare for the coming into force of the proposed Act. Regulations under the Cannabis Act (if it is approved by Parliament) are expected to be published in final form (i.e. without an opportunity for further consultation) shortly following Royal Assent of the Cannabis Act and before its coming into force.

DESCRIPTION OF THE BUSINESS

Overview

The Company is one of the largest and longest operating vertically integrated greenhouse growers in North America. The Company’s vegetables are grown hydroponically (without the use of soil) in a glass enclosed, high technology environment using sophisticated computer systems to control irrigation, fertilizers, carbon dioxide, light, temperature, ventilation, humidity and other climatic factors. The Company’s tomatoes are produced by plants that have been selected for their taste, quality and other characteristics and are not genetically modified. The Company owns and currently operates a total of six produce greenhouse facilities, four in Texas and two in British Columbia. The Company operates an industry leading sales, distribution and marketing organization. In particular, the Company’s strategy focuses on forging strong customer relationships by servicing retailers on a year-round basis, and maintaining the highest standards of food safety.

At this time, the Company is leasing a third British Columbia facility to Pure Sunfarms which received its cultivation license on March 2, 2018. Pure Sunfarms has the right to continue to lease the facility from the Company or purchase it for $1.

The Company, through its subsidiary VFCE, owns and operates a 7 megawatt power plant that generates electricity.

Core Operating Principle

The Company’s core operating principle is to deliver fairness and satisfaction in its customer brand promise. Management strives to operate the business for optimal success by endeavoring to be:

 

   

a leading supplier of greenhouse grown produce in North America;

 

   

a producer of the highest quality product which adheres to the highest food safety standards;

 

   

a low cost producer;

 

   

a daily supplier to customers;

 

- 11 -


   

a provider of excellence in customer service and logistics;

 

   

enhancing investor value; and

 

   

an employer with a dynamic environment in which employees can grow and prosper.

Greenhouse Facilities and Products

All of the Company’s greenhouses use state of the art hydroponic technology and produce a combined estimated 90 to 100 million pounds of premium quality greenhouse tomatoes and cucumbers annually. All of the greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company continually evaluates its production facilities and has devised a planting strategy that optimizes its product mix.

The following table outlines the Company’s operating greenhouse facilities.

 

            Growing Area       

Greenhouse Facility

   Square
Feet
     Square
Metres
     Acres     

Products Grown

Marfa, TX (2 greenhouses)

     2,527,312        234,795        60      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Fort Davis, TX (1 greenhouse)

     1,684,874        156,530        40      Specialty tomatoes

Monahans, TX (1 greenhouse)
(Permian Basin facility)

     1,272,294        118,200        30      Tomatoes on-the-vine, long English cucumbers

Delta, BC (2 greenhouses)

     3,664,390        340,433        85      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Delta, BC (1 greenhouse)

     1,077,758        100,172        25     

Leased to Pure Sunfarms for cultivation of cannabis

  

 

 

    

 

 

    

 

 

    

Total

     10,226,628        950,085        240     

The Company embraces sustainable agriculture and environmentally friendly growing practices by:

 

   

utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their products virtually free of chemical agents. This process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies;

 

   

capturing rainwater from some of its greenhouse roofs for irrigation purposes;

 

   

recycling water and nutrients during the production process;

 

   

growing plants in natural medium including coconut fibre and rock wool as opposed to growing in the soil and depleting nutrients; and

 

   

using dedicated environmental control computer systems which monitor and control almost all aspects of the growing environment thereby maximizing the efficient use of energy.

Sales, Marketing and Distribution

The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed

 

- 12 -


provider to be the sole grower in North America) and cucumbers at its facilities. The Company, from its supply partners, also distributes and purchases premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.

The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.

With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the year ended December 31, 2017, the Company had an on-time delivery record of 98.5%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.

The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:

Year-Round Supplier . Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing.

Quality and Food Safety . Sales are made directly to retailers which ensures control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs ® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs ® .

Quality Packaging and Presentation . Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf.

Exclusive Varieties . The Company expands its product profile to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand.

Direct Sale to Retail Customers . Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fred Meyer, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Market Basket, Publix Super Markets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC.

Excellence in Customer Service and Logistics . Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres.

The Company markets, sells and distributes all of its products, including products sold under exclusive marketing arrangements with its U.S., Canadian and Mexican greenhouse operations.

 

- 13 -


Production and Packaging Process

The production process for the Company’s west Texas facilities (Marfa and Fort Davis) starts in the spring. Raw materials purchased by the Company for its greenhouse operations include seeds, fertilizers and growing media purchased from several different suppliers. From May to June, the seeds purchased by the Company are grown by an independent third party contractor, which has specialized equipment and growing space, until the plants are approximately four to six weeks old, at which time they are transported to the Company’s Texas facilities. None of the Company’s plants or products are genetically modified. June through September, planting occurs in the greenhouses. From this point on, until the end of the season, plants are pruned to ensure that the optimal number of tomatoes are grown on each plant. Harvesting commences in September/October and generally continues until June of the following year.

The Company’s newest facility in Monahans, Texas, completed in December 2011, is based on the Company’s proprietary GATES ® technology which is a state of the art technology that allows for a 12-month per year production. The greenhouse is fully enclosed and uses a proprietary system to cool the greenhouse even in the hot summer months. This facility grows cucumbers and tomatoes and is constantly planting and replanting to ensure a consistent level of production year-round, although as with any greenhouse summer production is higher due to longer daylight hours.

The production process in Canada for tomatoes is similar to the Company’s west Texas operations, although the timing for growing the seeds, planting, and harvesting occur at different times during the year. Specifically, from October to December, the seeds purchased by the Company’s Canadian operations are grown by an independent third party contractor. In December, planting occurs in the Company’s greenhouses. Harvesting commences in March and generally continues until late November of each year.

The tomatoes and cucumbers are vine-ripened and hand-picked for optimum taste and quality, at all of the Company’s facilities. Once harvested, products are sorted by grade and weight and packed for distribution to customers. The Company offers a variety of packaging for its tomatoes that are product and customer specific.

Product Development and Specialization

The Company is engaged in ongoing testing of new technologies and advanced growing systems, including test trials of new tomato varieties to determine whether they improve product quality, taste and production yields, or lower the cost of production. The Company tests these tomato varieties for their maturation period, resistance to disease, the size and quality of the tomatoes as well as the tomatoes’ shelf life and adaptability to seasonal changes in light. If a new variety shows promising characteristics, the Company will conduct a commercial trial where the new variety is planted on a larger scale, with performance results compared to the Company’s existing tomato varieties.

The Company launched its first exclusive tomato varieties in select retail accounts in late 2012. The initial reception, of one in particular – Mini San Marzano – has been well received and the Company has been expanding its production space to meet increasing retailer and consumer demand. Since 2012, the Company has entered into additional exclusive seed agreements in addition to Mini San Marzano with the latest in 2017 for an initial launch in the first quarter of 2018. While none of the other exclusive tomato seed agreements has had the same success as Mini San Marzano, they have added to the uniqueness of the Company’s product offerings, which has resulted in new retail business.

Product Pricing

Prices for the Company’s products have historically followed a seasonal trend of higher prices during the first and fourth quarters of the calendar year and lower prices in the summer months. This historical trend is rapidly changing with the ever-increasing supply of Mexican production, which due to Mexican climate conditions is concentrated in the winter months, as well the increasing influence of big box retailers who operate off partial to full year pricing contracts. Going forward, assuming these trends continue, pricing is likely to become less seasonal than it has been in the past. The Company’s goal is to exceed industry average prices by continuing to develop long-term customer relationships, providing a favourable product mix, developing exclusive varieties and delivering logistic efficiencies.

 

- 14 -


Intellectual Property

The Company owns and has registered many trademarks and service marks in the United States as well as some in Canada and other jurisdictions. The following is a list of the key trademarks registered in the United States, the Company’s primary distribution market: Village Farms ® , Delectable TOV ® , Baby Beefs ® , From Our House To Your Home ® , Hydrobites ® , Mini Sensations ® , Sinfully Sweet Campari ® , Savory Roma ® , Lip-Smackn’ Grape ® , Heavenly Villagio Marzano ® , Cherry No. 9 ® , Cabernet Estate Reserve ® , BC Grown Logo ® , Texas Grown Logo ® , Good for the Earth ® , Village Farms Greenhouse Grown ® , Scrumptious Mini ® , and Sweet Bells ® .

Competition

The market for premium greenhouse grown produce is highly competitive. In addition to other domestic and foreign greenhouse producers, the Company competes with producers of field grown tomatoes that generally have prices substantially below those of greenhouse-grown tomatoes. Competition from producers in Mexico has increased due to increased acreage and improved yields due to the use of improved technology as well as a result of the North American Free Trade Agreement. Newly elected U.S. President has stated his intent to “renegotiate” NAFTA but as of the date of this filing no specifics have been announced. See “General Development of the Company” for further information on Mexican tomato supplies.

The Company’s greenhouse vegetable competitors are located primarily in the United States, Canada and Mexico. Four of the larger North American greenhouse producers/distributors competing with the Company are Mastronardi Produce Ltd., Windset Farms Inc., Houweling Nurseries Ltd and Mucci Farms Ltd.

Offsetting the competitive pressures faced by the Company are substantial barriers to entry in North America related to the sizeable initial capital outlay requirements of a modern greenhouse, significant ramp up time, the need for operational expertise and capable sales, marketing and distribution abilities.

Employees

The Company has approximately 1,000 employees and contract workers, the majority of whom are employed in the Company’s greenhouse operations. None of the employees are covered by a collective bargaining agreement. In the opinion of Management, the Company enjoys a good working relationship with its employees.

Capital Expenditures

During the year ended December 31, 2017, the Company spent approximately $1.7 million on capital assets (2016—$2.2 million). During the year ended December 31, 2017, the capital expenditures were used for improvements to existing facilities, distribution centres or information technology systems or hardware.

For the foreseeable future, Management estimates that average annual maintenance capital expenditures on its tomato greenhouse facilities will be approximately $2.0-$3.0 million per year. This amount will consist mainly of technological upgrades, ongoing repairs of growing systems and improvements to existing facilities. In addition to maintenance capital expenditures, the Company incurs ongoing repair and maintenance costs which are expensed as incurred and therefore not included in capital expenditures. These expenses averaged $2.2 million per year during the last three fiscal years.

During 2018, Management anticipates capital investment spending for its produce facilities to be between $2.0 million and $3.0 million. The Company may make additional equity contributions to Pure Sunfarms of cash in the next twelve months depending on the final completion timeline for the Delta 3 Greenhouse and whether or not Pure Sunfarms obtains financing.

 

- 15 -


Energy Management Strategy

The Company employs the following energy management strategy:

when feasible, contract for forward purchases of natural gas at favourable rates. At this time, due to the expectation of low natural gas pricing for the foreseeable future, no forward purchase contracts are in place;

develop techniques to reduce the use of natural gas. The Company has installed energy screens in all of its U.S. greenhouse facilities and most of its Canadian greenhouse facilities and has experienced a substantial reduction in gas usage;

continue to investigate methods to extract food grade CO2 from the landfill gas at the Delta, BC greenhouse facilities;

continue to investigate alternate fuels, such as biomass or woodwaste; and

continue to investigate the concept of closed greenhouses and the use of geothermal energy.

Foreign Exchange Strategy

The Company’s reporting currency is the U.S. dollar to more accurately represent the economic environment in which it operates.

For the 2018 fiscal year, it is expected that approximately 80% of the Company’s costs will be incurred in U.S. dollars, and approximately 85% of its revenues will be earned in U.S. dollars. As a result, Management believes that the Company is benefiting from a “matching” of revenues and expenses by currency. The Company also has the ability to enter into foreign exchange contracts and foreign exchange options for the purchase of Canadian dollars in order to reduce the risks of exchange rate fluctuations affecting the level of Canadian dollars needed for Canadian operations, as well as the purchase of Euros affecting both its Canadian and U.S. operations.

Environmental and Regulatory Matters

Greenhouse operations in the United States are subject to numerous environmental laws and regulations, including the Food Quality Protection Act of 1996 , the Clean Air Act , the Clean Water Act , the Resource Conservation and Recovery Act , the Federal Insecticide , Fungicide and Rodenticide Act , the Toxic Substances Control Act and the Comprehensive Environmental Response, Compensation and Liability Act .

The Company’s U.S. greenhouse operations are subject to regulations enforced by, among others, the U.S. Food and Drug Administration (“ FDA ”) and the United States Department of Agriculture (“ USDA ”). The FDA enforces statutory standards regarding the branding and safety of food products and determines the safety of food substances in the United States. The USDA sets standards for raw produce and governs its inspection and certification. Under the Perishable Agricultural and Commodities Act , the USDA exercises broad control over the marketing of produce in domestic and foreign commerce, sets standards of fair conduct as to representations, sales, delivery, shipment and payment for goods, and regulates the licensing of produce merchants and brokers. The Company’s U.S. growing operations are also subject to oversight by the U.S. Environmental Protection Agency regarding the use of fertilizers and pesticides protection.

Similar to the U.S. regulatory requirements described above, the Company’s Canadian operations are subject to various general commercial regulations, including those relating to food safety, packaging and labelling, occupational health and safety, phyto sanitary certificates for cross border shipments, product source and re call capability, and anti bioterrorism measures for cross border shipments.

 

- 16 -


The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.

The Natural Products Marketing (BC) Act (the “ Act ”) and certain federal orders issued under the Agricultural Products Act (Canada) give the British Columbia provincial government the authority to regulate the marketing and production of specific agricultural products. The British Columbia Marketing Board (“ BCMB ”) was created in 1935 to supervise and regulate marketing boards and commissions created under the Act. Independent of government, the BCMB’s primary mandate today is to administer the regulated marketing legislation in the public interest. The BCMB has three principal responsibilities: supervising all marketing boards and commissions; hearing appeals from organizations or persons who are dissatisfied or aggrieved by a decision of a marketing board or commission; and acting as a signatory to federal provincial agreements that govern the marketing of some regulated products.

British Columbia Vegetable Marketing Commission

The BCVMC has responsibility for promoting and regulating the production, transportation, packing, storage and marketing of regulated vegetables in British Columbia. It also requires greenhouse growers to market through agencies licensed by the BCVMC to encourage the orderly distribution of regulated products. The BCVMC has the right to regulate the time and place at which, and to designate the agency through which, a regulated product must be produced, packed, stored, transported or marketed, and can also determine the manner of distribution, the quantity and the quality, grade or class of these products. It can also (but in the case of greenhouse tomatoes and bell peppers currently does not) set the prices at which a regulated product or a grade or class of it may be bought or sold in British Columbia.

Agency and Producer Licenses

The BCVMC issues licenses to agencies and producers in British Columbia on an annual basis by way of general orders passed by the BCVMC. Licensed agencies are authorized to purchase greenhouse vegetables from licensed producers and to market those vegetables within British Columbia and for interprovincial or export trade. The Company, through one its Canadian subsidiaries, has been authorized to buy and sell produce grown in British Columbia since February 6, 2007.

Licensed producers, such as VF Canada LP, operate the facilities in which greenhouse vegetables are produced and must be a member of an agency licensed by the BCVMC. Only producers licensed by the BCVMC can sell their products to an agency licensed by the BCVMC.

Quota

Each year, VF Canada LP is allocated a quota by the BCVMC to plant a specified number of square metres of its greenhouses with a particular crop. There are no restrictions on the amount of product that VF Canada LP can produce in its allocated quota area. The table below summarizes VF Canada LP’s allocations since 2016 at the start of each year:

 

(square metres)    2018      2017      2016  

Tomatoes on-the-vine

     89,082        165,082        165,082  

Beef tomatoes

     68,110        98,784        98,784  

Specialty tomatoes

     170,377        176,694        176,694  
  

 

 

    

 

 

    

 

 

 

Total

     327,569        440,560        440,560  
  

 

 

    

 

 

    

 

 

 

VF Canada LP retains the right to be allocated the same amount of quota for each subsequent crop year. However, VF Canada LP can, and often does, apply for changes in specific quota allocations to optimize product mix and improve financial returns.

 

- 17 -


CAPITAL STRUCTURE

Common Shares

The Company is authorized to issue an unlimited number of Common Shares. Each Common Share entitles the holder thereof to receive notice of and to attend all meetings of shareholders of the Company and to one vote per Common Share at such meetings (other than meetings at which only the holders of another class of shares are entitled to vote separately as a class). The Common Shares entitle the holders thereof to receive, in any year, dividends on the Common Shares as and when declared by the board of directors of the Company, provided that payment of such dividends is not prohibited under law and after payment of any applicable amounts to which holders of any Preferred Shares may be entitled. In the event of the liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, after payment of or other proper provision for all of the liabilities of the Company and the payment of any amounts payable to holders of the Preferred Shares, the holders of the Common Shares will be entitled to share pro rata in all remaining property or assets of the Company.

The ability of a beneficial owner of Common Shares to pledge such Common Shares or otherwise take action with respect to such shareholder’s interest in such Common Shares (other than through a CDS Participant) may be limited due to the lack of a physical Common Share certificate.

The Company has the option to terminate the registration of the Common Shares through the book entry system in which case definitive certificates for the Common Shares in fully registered form would be issued to beneficial owners of such Common Shares or their nominees.

Special Shares

The holders of Special Shares are entitled to one vote for each Special Share held at all meetings of shareholders of the Company other than meetings at which only the holders of another class of shares are entitled to vote separately as a class; provided that in no event shall the votes attached to the Special Shares exceed 45% of the votes otherwise attached to the Common Shares and Special Shares then outstanding. In certain circumstances, the holders of Special Shares will not be entitled to vote separately as a class and will not be entitled to dissent. The holders of Special Shares will not be entitled to share in any distribution of the property or assets of the Company upon the dissolution, liquidation or winding-up of the Company, whether voluntary or involuntary, or in the event of any other distribution of assets of the Company among its shareholders for the purpose of winding-up its affairs. The provisions of the Special Shares cannot be modified by the Company without first obtaining, by separate affirmative vote, two-thirds of the votes cast at a meeting of the holders of the shares of such class.

The holders of Special Shares are not entitled to receive any dividends. The Company has redeemed all of the Special Shares that were previously issued and outstanding.

Preferred Shares

The Company is authorized to issue an unlimited number of Preferred Shares. The Company’s board of directors will fix the number of Preferred Shares, as well as the designation, rights, privileges, restrictions and conditions for each series of Preferred Shares that may be issued, subject to the Company filing the applicable articles of amendment under the CBCA. Preferred Shares will have preference over Common Shares with respect to the payment of dividends and in the distribution of assets in the event of the liquidation, dissolution or winding-up of the Company, be it voluntary or involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of winding-up its affairs. Preferred Shares will have no right to vote on shareholder matters, subject to certain exceptions. No changes to the provisions of the Preferred Shares may be made without the approval of the holders of the Preferred Shares.

Warrants

In conjunction with the formation of Pure Sunfarms on June 27, 2017 the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Each such warrant entitles the holder to purchase one Common Share at an exercise price of CA$2.07. Each such warrant is exercisable up to June 6, 2020.

 

- 18 -


Retained Interest of Michael DeGiglio

Pursuant to the terms of the Securityholders’ Agreement, the Company has granted to its Chief Executive Officer, Michael DeGiglio certain pre-emptive rights, as well as “demand” and “piggy back” registration rights, which will enable Mr. DeGiglio to require the Company to file a prospectus (in the case of a demand registration) and otherwise assist with a public offering of Common Shares, subject to certain limitations. In the event of a “piggy back” offering, the Company’s financing requirements are to take priority. Subject to the approval of the TSX, in the event that the Company decides to issue equity securities or securities convertible into or exchangeable for equity securities of the Company other than to officers, employees, consultants or directors of the Company or any subsidiary of the Company pursuant to a bona fide incentive compensation plan, the Securityholders’ Agreement provides, among other things, Michael DeGiglio with pre-emptive rights to purchase such number of newly issued equity securities in order to maintain his pro rata ownership interest in the Company.

Book Entry System

Registration of interests in and transfers of the Common Shares are made only through the book entry system administered by CDS. Common Shares must be purchased, transferred and surrendered for redemption through a shareholder’s applicable CDS Participant. All rights of shareholders must be exercised through, and all payments or other property to which such shareholder is entitled will be made or delivered by, CDS or the CDS Participant through which the shareholder holds such Common Shares. Upon the purchase of any Common Shares, a shareholder will typically receive only a customer confirmation from their applicable CDS Participant through which the Common Shares were purchased.

Financial Year End

The fiscal year end of the Company is December 31.

CREDIT FACILITIES

Credit Facilities

On March 28, 2013, the Company entered into a new term facility among VF Canada LP (the “ Borrower ”), certain affiliates of the Borrower, as guarantors, and Farm Credit Canada (the “ Term Loan ”). On March 24, 2016, the Term Loan was amended. The following summary describes the current provisions of the Term Loan. The Term Loan matures on May 1, 2021. The current balance of the Term Loan is US$36,694,544. Subject to acceleration upon an event of default, the outstanding balance of the Term Loan will be payable by way of monthly instalments of principal and interest based on an amortization period of 15 years, with the balance of the term loans and all unpaid accrued interest to be paid in full at maturity. The Term Loan is subject to annual financial covenants as well as other positive and negative covenants typical for this type of loan. The Term Loan is a LIBOR borrowing plus a margin based on the prevailing coverage ratio at each reporting date. The interest rate as at the date of this annual information form was 6.28698% per annum.

In addition to the Term Loan described above, the Company also has an operating credit facility with a Canadian chartered bank (the “ Bank ”). This revolving operating loan of up to CA$13,000,000 is at variable interest rates with a maturity date of October 12, 2021 (the “ Operating Loan ”). The borrowing base is based on 90% of current accounts receivable less priority claims. No amount was drawn on the Operating Loan as at December 31, 2017 (December 31, 2016 – $nil) which is available to a maximum of CA$13,000,000, less two outstanding letters of credit of US$320,000 and CA$38,500. Interest on amounts borrowed is calculated by way of Prime Rate, US Prime Rate, Base Rate or LIBOR plus a margin. It is the Company’s choice on how it will borrow, and all undrawn funds are charged a stand-by fee of 0.375% per annum. As of the date of this annual information form, the outstanding balance of the Operating Loan is $3,000,000.

 

- 19 -


On September 26, 2014, the Company’s subsidiary, VFCE, entered into a loan agreement with the Bank (the “ VFCE Loan ”). The VFCE Loan is a non-revolving fixed rate loan of CA$3.0 million, has a maturity date of June 30, 2023, a fixed interest rate of 4.98% per annum, and monthly payments of CA$36,000 which commenced in January 2015. As of the date of this annual information form, the outstanding balance of the VFCE Loan is approximately $1.85 million.

As security for the borrowings, the Company has provided, among other things, promissory notes, a first mortgage on one of the greenhouse properties, and general security agreements over its assets. The borrowings are subject to certain positive and negative covenants customary for loans on terms similar to the Credit Facilities. The Company and certain of its direct and indirect subsidiaries, including APDI, have provided full recourse guarantees of the Credit Facilities and have granted security therefore. As at December 31, 2017, and through April 2, 2018, the Company was in compliance with all covenants.

RISK FACTORS

The risks and uncertainties described below are not the only risks and uncertainties facing the Company. Additional risks and uncertainties not currently known to Management or that Management currently deems immaterial also may impair the operations of the Company. If any of the following risks actually occur, the Company’s business, results of operations and financial condition, could be adversely affected.

Risks Relating to the Company

Product Pricing

The greenhouse vegetable industry is highly competitive and sensitive to changes in the price of greenhouse tomatoes, bell peppers and cucumbers. The price of greenhouse produce is affected by many factors including supply and demand, negotiations between buyers and sellers, quality and general economic conditions, all of which could have a material adverse effect on the financial condition of the Company. Demand for the Company’s products is subject to fluctuations resulting from adverse changes in general economic conditions, evolving consumer preferences, nutritional and health-related concerns and public reaction to food spoilage or food contamination issues. General supply of tomatoes, bell peppers and cucumbers is subject to fluctuations relating to weather, insects, plant disease and changes in greenhouse acreage. There can be no assurance that consumption will increase or that present consumption levels will be maintained. If consumer demands for greenhouse produce decreases, the Company’s financial condition and results of operations may be materially adversely affected.

Maintain Profitability

The Company’s ability to continue to generate comparable net earnings is based, in part, on its ability to maintain its low cost structure to sustain its EBITDA margins. These margins are dependent upon the Company’s ability to continue to profitably sell produce and to be the supplier of choice to its customers. The failure to develop and successfully adapt new products at favourable margins or an increase in cost of goods or operating costs could have a material adverse effect on the financial condition, results of operations, and cash available.

A principal objective of the Company is to pursue operational efficiencies. Profitability depends in significant measure on its ability to, among other things, successfully manage, identify and implement operational efficiencies. There can be no assurance that the Company will be successful in managing its cost control and productivity improvement measures.

Risks Inherent in the Agricultural Business

The Company’s revenue involves the growing of greenhouse produce, an agricultural product. As such, the Company is subject to the risks inherent in the agricultural business, such as weather, insects, plant and seed diseases and similar agricultural risks. Although the Company grows its products in climate-controlled greenhouses, carefully monitors the growing conditions within its greenhouses and retains experienced production personnel, there can be no assurance that natural elements will not have a material adverse effect on the production of its products.

 

- 20 -


Natural Catastrophes

The Company’s operations may be adversely affected by severe weather including wind, snow, hail and rain, which may result in its operations having reduced harvest yields due to lower light levels, or a more catastrophic event as occurred at the Company’s Marfa, Texas facilities on May 31, 2012, when it lost all three of its operating greenhouses to a short but powerful hail storm. Although the Company anticipates and factors in certain periods of lower than optimal light levels, extended periods of severe or unusual light levels may adversely impact its financial results due to higher costs and missed sales opportunities arising from reduced production yields.

The Company’s business operations, some of which are located on the British Columbia coast, are located in an area that is geologically active and considered to be at risk from earthquakes. The Company’s earthquake deductible is 10% of the Company’s loss caused by the earthquake, subject to a maximum deductible of CA$5,000,000.

Climate change over time is predicted to lead to changes in the frequency of storm events as well as their severity. The Company is unable to predict the impact of climate change on its business.

While the Company maintains insurance coverage, it cannot predict that all potential insurable risks have been foreseen or that adequate coverage is maintained against known risks.

Retail Consolidation

The Company’s top ten customers for the years ended December 31, 2017 and 2016 accounted for approximately 62% and 63%, respectively, of total revenues. As a result of continuing retail consolidation, the Company’s U.S. retail customers grow larger and become more sophisticated enabling them to demand lower pricing, special packaging or varieties as well as increased promotional programs. If the Company is unable to use its scale, marketing expertise and market leadership position to respond to these trends, it may have a material adverse effect on its financial condition and results of operations.

Covenant Risk

Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach or default that might otherwise result there from. If the Company defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, or (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its Common Shares. See also “Risk Factors—Dependence Upon Credit Facilities”.

Dependence Upon Credit Facilities

The Company is subject to fluctuations in its working capital on a month to month basis. Consistent with its past practice, the Company may draw down on revolving credit facilities available under its Operating Loan. There can be no assurance that the Company will continue to have access to appropriate credit facilities on reasonable terms and conditions, if at all. An inability to draw down upon credit facilities could have a material adverse effect on the Company’s business, financial condition and results of operations.

 

- 21 -


Competition

The greenhouse vegetable industry in North America is highly competitive. The Company faces competition from numerous greenhouse operators throughout North America and, to a lesser extent, Europe. Some of the Company’s competitors have strong economic resources and are well established as suppliers to the markets in which the Company’s products are sold. Accordingly, such competitors may be better able to withstand volatility within the industry and challenging economic times due to retaining greater operating and financial flexibility than the Company. There can be no assurance that the Company will be able to compete successfully against its current or future competitors or that such competition will not have a material adverse effect on the Company’s financial condition and results of operations and the amount of cash available for distribution to shareholders.

Transportation Disruptions

Due to the perishable and premium nature of the Company’s products, the Company depends on fast and efficient road transportation to distribute its product. Any prolonged disruption of this transportation network could have an adverse effect on the Company’s financial condition and results of operations.

Labour

The Company’s operations are labour intensive, particularly during peak harvest months. In Canada, most of the Company’s labour is supplied by contract labour suppliers on short-term contracts and workers hired through the Seasonal Agriculture Workers Program. There can be no assurance that the Company will be able to source sufficient skilled labourers in the future. In the case of the facilities in west Texas, a portion of the Company’s labour is documented workers in Mexico who cross the U.S. border on a daily basis into Texas. There can be no assurance that the Company would not be impacted by any decision relating to control of the U.S./Mexico border. In the case of the facility in Monahans, Texas it is situated in the middle of the Texas oil and gas patch and finding and retaining farm workers at affordable rates is an ongoing challenge. Any shortage of such labour could restrict the ability of the Company to operate its greenhouses and to distribute its product to its customers.

Efforts by labour unions to organize the Company’s employees could divert management attention away from regular day-to-day operations and increase the Company’s operating expenses. Labour unions may make attempts to organize the Company’s non-unionized employees. Management is not aware of any activities relating to union organizations at any of its greenhouse facilities. Management cannot predict which, if any, groups of employees may seek union representation in the future or the outcome of any collective bargaining. If the Company is unable to negotiate acceptable collective bargaining agreements, it may have to wait through “cooling off” periods, which are often followed by union initiated work stoppages, including strikes. Depending on the type and duration of any work stoppage, the Company’s operating expenses could increase significantly, which could have a material adverse effect on its financial condition, results of operations and cash flows.

Risks Associated with Cross-Border Trade

The Company’s Canadian and U.S. product is actively sold cross-border. Markets in the United States and other countries may be affected from time to time by trade rulings and the imposition of customs, duties and other tariffs. There can be no assurance that the Company’s financial condition and results of operations will not be materially adversely affected by trade rulings and the imposition of customs duties or other tariffs in the future. Furthermore, there is no assurance that further trade actions will not be initiated by U.S. producers of greenhouse or field grown vegetables. Any prolonged disruption in the flow of the Company’s product across the U.S.-Canada border could have an adverse effect on the Company’s financial condition and results of operations.

 

- 22 -


Key Executives

The Company depends heavily on each member of its management team and the departure of a member of management could cause its operating results to suffer. The future success of the Company will depend on, among other things, its ability to keep the services of these key executives and to hire other highly qualified employees at all levels. The Company will compete with other potential employers for employees, and it may not be successful in hiring and retaining the services of executives and other employees that it requires. The loss of the services of, or the Company’s inability to hire, executives or key employees could hinder its business operations and growth.

Uninsured and Underinsured Losses

The Company maintains at all times insurance coverage in respect of potential liabilities of the Company and the accidental loss of value of the assets of the Company from risks, in those amounts, with those insurers, and on those terms as Management considers appropriate to purchase and which is readily available, taking into account all relevant factors including the practices of owners of similar assets and operations, as well as costs.

Not all risks are covered by insurance or the insurance may have high deductibles, and no assurance can be given that insurance will be consistently available or will be consistently available on an economically feasible basis, or that the amounts of insurance will at all times be sufficient to cover each and every loss or claim that may occur involving the assets or operations of the Company and loss payments may not be as timely and responsive as the Company’s working capital needs require. In particular, damage caused by an accidental or natural disaster to any or all of the Company’s key production facilities may result in significant replacement costs and loss of business that may not be fully recoverable or is subject to a high deductible (such as an earthquake in British Columbia) under any insurance policy.

The Company does not carry crop loss or cyber security insurance.

Governmental Regulations

The Company’s operations are governed by a broad range of federal, state, provincial and local environmental, health and safety laws and regulations, permits, approvals, and common law and other requirements that impose obligations relating to, among other things: worker health and safety; the release of substances into the natural environment; the production, processing, preparation, handling, storage, transportation, disposal, and management of substances (including liquid and solid, non hazardous and hazardous wastes and hazardous materials); and the prevention and remediation of environmental impacts such as the contamination of soil and water (including groundwater). Failure by the Company to comply with applicable laws, rules, regulations and policies may subject the Company to civil or regulatory proceedings, including fines, injunctions, administrative orders or seizures, which may have a material adverse effect on the Company’s financial condition and results of operations. Also, as a result of the above requirements, the Company’s operations and ownership, management and control of property carry an inherent risk of environmental liability (including potential civil actions, compliance or remediation orders, fines and other penalties), including with respect to the disposal of waste and the ownership, management, control or use of transport vehicles and real estate. Compliance with all such laws and future changes to them is material to the Company. The Company has incurred and will continue to incur significant capital and operating expenditures to comply with such laws. Future discovery of previously unknown environmental issues, including contamination of property underlying or in the vicinity of the Company’s present or former properties or manufacturing facilities, could require the Company to incur material unforeseen expenses. All of these risks and related potential expenses may have a material adverse effect on the Company’s financial condition and results of operations.

Product Liability

As a producer of food products, the Company is subject to potential product liabilities connected with its operations and the marketing and distribution of vegetable products, including liabilities and expenses associated with contaminated or unsafe product. There can be no assurance that the insurance against all such potential liabilities maintained by the Company will be adequate in all cases. In addition, even if a product liability claim was not successful or was not fully pursued, the negative publicity surrounding any such assertion could harm the Company’s reputation with its customers. The consequences of any of the foregoing events may have a material adverse effect on the Company’s financial condition and results of operations.

 

- 23 -


Cyber Security

Cyber security has become an increasingly problematic issue for issuers and businesses in Canada and around the world, including the Company. Cyber-attacks against organizations of all sizes are increasing in sophistication and are often focused on financial fraud, compromising sensitive data for inappropriate use or disrupting business operations. A cyber incident is considered to be any adverse event that threatens the confidentiality, integrity or availability of the Company’s information resources. More specifically, a cyber-incident is an intentional attack or an unintentional event that can include gaining unauthorized access to information systems to disrupt operations, corrupt data or steal confidential information. As the Company’s reliance on technology has increased, so have the risks posed to its systems. The Company’s primary risks that could directly result from the occurrence of a cyber-incident include operational interruption, damage to its reputation, damage to the Company’s business relationships, disclosure of confidential information regarding its employees and third parties with whom the Company interacts, and may result in negative consequences, including remediation costs, loss of revenue, additional regulatory scrutiny and litigation. The Company has implemented processes, procedures and controls to help mitigate these risks, but these measures, as well as its increased awareness of a risk of a cyber-incident, do not guarantee that its financial results will not be negatively impacted by such an incident.

Vulnerability to Rising Energy Costs

The Company’s greenhouse operations consume considerable energy for heat and carbon dioxide production, and are vulnerable to rising energy costs. Energy costs have shown volatility, which has and may continue to adversely impact the Company’s cost structure. Should the cost of energy rise, and should the Company face difficulties in sustaining price increases to offset the impact of increasing fuel costs, gross profit margins could be adversely impacted. See “Description of the Business — Energy Management Strategy”.

Risks of Regulatory Change

The Company is subject to extensive laws and regulations with respect to the production, handling, distribution, packaging and labelling of its products. Such laws, rules, regulations and policies are administered by various federal, state, provincial, regional and local health agencies and other governmental authorities. Changes to any of these laws and regulations could have a significant impact on the Company. There can be no assurance that the Company will be able to cost effectively comply with future laws and regulations. Failure by the Company to comply with applicable laws and regulations may subject the Company to civil or regulatory proceedings, including fines, injunctions, recalls or seizures, which may have a material adverse effect on the Company’s financial condition and results of operations. In addition, the Company voluntarily submits to guidelines set by certain private industry associations. Failure to comply with such guidelines or to adopt more stringent guidelines set by such associations in the future may result in lower sales in certain retail markets and may adversely affect the Company’s financial condition and results of operations. Among the regulations to which the Company is subject are those administered by the BCVMC. The BCVMC grants each licensed producer that it regulates an annual quota to produce specified products in a given year. The BCVMC also has the authority to set the prices at which a regulated product may be bought or sold in British Columbia. There can be no assurance that the BCVMC will not alter its quota allocation policy or that the BCVMC will not introduce pricing restrictions in a manner that could adversely affect the Company’s financial condition and results of operations. There can be no assurance that a modification of the current regulatory schemes will not have an adverse effect on the Company’s financial condition, results of operations.

Environmental, Health and Safety Risk

The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate.

 

- 24 -


Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect operational results and profitability.

Foreign Exchange Exposure

The Company estimates that approximately 85% of its sales will be recorded in U.S. dollars; as such it is necessary to convert U.S. dollars to Canadian dollars and Euros to pay for some of its production and overhead costs. Any foreign currency hedge arrangements that the Company has entered into may not protect it against any losses which may occur as a result of a fluctuation in the U.S./Canadian dollar or U.S./Euro exchange rates. As a result, such fluctuations may have an adverse impact on the Company’s financial results and the amount of free cash flow available for distribution to shareholders.

Technological Advances

It is possible that more economical or efficient greenhouse production technology than what is currently used by the Company will be developed, thereby potentially adversely affecting the Company’s competitive position.

Accounting Estimates

The Company will be required to make accounting estimates and judgments in the ordinary course of business. Such accounting estimates and judgments will affect the reported amounts of its assets and liabilities at the date of the financial statements and the reported amounts of its operating results during the periods presented. Additionally, the Company will be required to interpret the accounting rules in existence as of the date of the financial statements when the accounting rules are not specific to a particular event or transaction. If the underlying estimates are ultimately proven to be incorrect, or if auditors or regulators subsequently interpret the Company’s application of accounting rules differently, subsequent adjustments could have a material adverse effect on its operating results for the period or periods in which the change is identified. The Company historically carried its land at historical cost. As at December 31, 2016, the Company has changed its policy so that land is now measured at fair value. The land will be revalued every three years. Subsequent adjustments to land value or changes in other accounting estimates could require the Company to restate its financial statements. A restatement of the Company’s financial statements could result in a material change in the price of the Common Shares.

Growth

The Company may not be able to successfully manage its growth. The Company’s growth strategy will place significant demands on its financial, operational and management resources. In order to continue its growth, it will need to add administrative, management and other personnel, and make additional investments in operations and systems. The Company may not be able to locate and train qualified personnel, or do so on a timely basis, or expand its operations and systems to the extent, and in the time, required.

Risks Relating to the Joint Venture

Reliance on Licenses

The Joint Venture’s ability to grow, store and sell cannabis in Canada is solely dependent on its ability to obtain licenses to cultivate and sell cannabis under the ACMPR (a “ License ”) for each of the greenhouses at which it proposes to grow cannabis. Moreover, the introduction of the Cannabis Act, expected to become law in the summer of 2018, is expected to change the licensing requirements required to operate a cannabis cultivation facility, sell cannabis as well as how to conduct additional licensed activities. Under the Cannabis Act, the Joint Venture and the Company may be required to obtain discreet licenses for each licensable activity including cultivation, processing, testing, sale and distribution. Once obtained, each License is subject to ongoing compliance and reporting requirements. Failure to comply with the requirements of a License or any failure to maintain such License would have a material adverse

 

- 25 -


impact on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company. Although the Company believes the Joint Venture will obtain any required Licenses and meet the requirements for extension of any License, there can be no guarantee that any License will be granted, extended or renewed, or if it is extended or renewed, that it will be extended or renewed on the same or similar terms. Should a License not be granted, extended or renewed or should it be renewed on different terms, the business, prospects, financial condition, results of the operation and cash flows of the Joint Venture and the Company would be materially adversely affected. In addition, should Health Canada have concerns about the change of shareholder status of Pure Sunfarms Canada Corp. upon the Joint Venture exercising its option to buy the shares of Pure Sunfarms Canada Corp., such that the Licenses cannot be lawfully possessed by the Joint Venture, the business, prospects, financial condition, results of the operation and cash flows of the Joint Venture and the Company would be materially adversely affected.

Regulatory Risks

The activities of the Joint Venture are subject to regulation by governmental authorities, particularly under the ACMPR. Achievement of the Joint Venture’s business objectives are contingent, in part, upon compliance with regulatory requirements enacted by governmental authorities and obtaining all regulatory approvals, where necessary, for the sale of its products. Neither the Company nor the Joint Venture can predict the time required to secure all appropriate regulatory approvals for the Joint Venture or its products, or the extent of testing and documentation that may be required by governmental authorities. Any delays in obtaining, or failure to obtain, regulatory approvals would significantly delay the development of products and could have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

The commercial cannabis industry is a new industry in Canada and the Company anticipates that regulations governing the industry will be subject to change. In addition, the proposed Cannabis Act is not yet in force and the regulations to the Cannabis Act have not yet been published. The operations of the Joint Venture will be subject to a variety of laws, regulations, guidelines and policies relating to the manufacture, processing, import, export, management, packaging/labelling, advertising, sale, transportation, storage and disposal of cannabis but also laws and regulations relating to drugs, controlled substances, health and safety, land use, the conduct of operations and the protection of the environment. Any changes to such laws, regulations, guidelines and policies may have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Additionally, although neither the Company nor the Joint Venture has any cannabis-related operations in the United States, as certain members of the Company’s management team are located in the United States, the Company and the Joint Venture may be subject to risks with respect to changes in cannabis regulation and enforcement in the United States. Any changes in the United States regulatory regime, or the scope and extent of the enforcement thereof, could have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Unfavourable Publicity or Consumer Perception

The Company believes the cannabis industry is highly dependent upon consumer perception regarding the safety, efficacy and quality of the cannabis produced. Consumer perception of the Joint Venture’s products can be significantly influenced by scientific research or findings, regulatory investigations, litigation, media attention and other publicity regarding the consumption of cannabis products. There can be no assurance that future scientific research, findings, regulatory proceedings, litigation, media attention or other research findings or publicity will be favourable to the cannabis market or any particular product, or consistent with earlier publicity. Future research reports, findings, regulatory proceedings, litigation, media attention or other publicity that are perceived as less favourable than, or that question, earlier research reports, findings or publicity could have a material adverse effect on the demand for the Joint Venture’s products and the business, prospects, results of operations, financial condition and cash flows of the Joint Venture and the Company. The Joint Venture’s dependence upon consumer perceptions means that adverse scientific research reports, findings, regulatory proceedings, litigation, media attention or other publicity, whether or not accurate or with merit, could have a material adverse effect on the Joint Venture, the demand for the Joint Venture’s products, and the business, prospects, results of operations, financial condition and cash flows of the Joint Venture and the Company. Further, adverse publicity reports or other media attention regarding the safety, efficacy and quality of cannabis in general, or the Joint Venture’s products specifically, or associating the consumption

 

- 26 -


of cannabis with illness or other negative effects or events, could have such a material adverse effect on the Joint Venture and the Company. Such adverse publicity reports or other media attention could arise even if the adverse effects associated with such products resulted from consumers’ failure to consume such products appropriately or as directed. Such adverse publicity reports or other media attention may also impact the Company’s reputation.

Competition

The Joint Venture may face increased competition from other Licensed Producers as the cannabis industry matures. Increased competition from larger and/or better-financed competitors could have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company. In addition, there may be pressure for industry consolidation creating larger companies with increased scope. To date, Health Canada has only issued a limited number of licenses under the ACMPR. However, there are a very large number of pending applications for licenses. If demand for cannabis production increases, the Company expects competition to increase, as current and future competitors will begin to offer an increasing number of diversified products. A significant increase in the number of licenses granted could have a material adverse impact on the operations of the Joint Venture. The Joint Venture will require continued investment in research and development, marketing, sales and client support efforts to remain competitive. The Joint Venture and the Company may not have sufficient resources to meet such investment needs which could materially adversely affect the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Risks Inherent in an Agricultural Business

The Joint Venture’s business involves the growing of cannabis, an agricultural product. Such business will be subject to the risks inherent in any agricultural business, such as insects, plant diseases, shortage of qualified labour and similar agricultural risks. Although the Joint Venture will be growing in a controlled environment with climate controlled systems in place, there can be no assurance that natural elements or labour issues will not have a material adverse effect on any such future production, the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Risks Related to the Joint Venture

The Company’s future cash flows, earnings, results of operations and financial condition will in part depend on the Company retaining its ownership interest in the Joint Venture. Under the Joint Venture Agreement, either the Company or Emerald may exercise the Buy-Sell effective on or after June 6, 2019 in certain circumstances, which could result in the Company having to either sell all of its interest in the Joint Venture or acquire all of Emerald’s interest in the Joint Venture. In addition, any dilution of the Company’s interest in the Joint Venture would adversely affect the amount of revenue the Company can derive from the Joint Venture.

The success of the Joint Venture depends on the Company and Emerald maintaining a cooperative working relationship. Since each of Emerald and the Company control half of the board of directors of the Joint Venture, the Company relies on Emerald as an equal partner in the Joint Venture. Any strain on, or breakdown of, the working relationship between the Company and Emerald could adversely affect the governance and operations of the Joint Venture. Since the Buy-Sell becomes effective on or after June 6, 2019 and upon a deadlock of the board of directors of the Joint Venture with respect to Material Decisions or the inability of the board of directors of the Joint Venture to pass an annual budget within a specified timeframe, any breakdown in the relationship between Emerald and the Company may ultimately result in the exercise of the Buy-Sell provision. If the Company is required to sell its interest in the Joint Venture pursuant to the Buy-Sell, this would result in a material adverse effect on the Company’s business, prospects, financial condition, results of operations and cash flows.

 

- 27 -


Reliance on a Single Facility

To date, the Joint Venture’s activities and resources have been primarily focused on the Delta 3 Greenhouse. The Joint Venture expects to continue the focus on this facility for the foreseeable future. Adverse changes or developments affecting the existing facility could have a material adverse effect on the Joint Venture’s ability to continue producing cannabis and the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Conversion of Facility

While the Delta 3 Greenhouse facility received its initial cultivation license on March 2, 2018, it continues to convert the remaining sections of the Delta 3 Greenhouse facility which are subject to additional Health Canada regulatory approvals. There is also no guarantee that Health Canada will approve the entire Delta 3 Greenhouse for cultivation in a timely fashion, or at all. Additionally, the Joint Venture has commenced the Health Canada sales license process, which is crucial for the Joint Venture to be able to sell cannabis under the ACMPR. The delay or denial of such approvals would have a material adverse impact on the business of the Joint Venture and the Company, and may result in the Joint Venture not meeting anticipated or future demand when it arises.

Limited Operating History in the Cannabis Industry

The Joint Venture has yet to generate a profit from its operations. The Joint Venture is therefore subject to many of the risks common to early-stage enterprises, including limitations with respect to personnel, financial, and other resources and lack of significant revenues. There is no assurance that the Company will be successful in achieving a return on shareholders’ investment from the operations of the Joint Venture and the likelihood of success must be considered in light of the early stage of operations.

Failure to Realize Growth Strategy

There are risks associated with the Company’s growth strategy, and such strategies may not succeed, as they can be adversely affected by a variety of factors, including some that are discussed elsewhere in these risk factors as well as delays in obtaining, or conditions imposed by, regulatory approvals and quality control and health concerns. As a result, there is a risk that the Company may not have the capacity to meet customer demand or to meet future demand when it arises. If the Company cannot manage growth in the cannabis industry effectively it may have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Research and Development and Product Obsolescence

Rapidly changing markets, technology, emerging industry standards and frequent introduction of new products characterize the Joint Venture’s business. The introduction of new products embodying new technologies, including new manufacturing processes, and the emergence of new industry standards may render the Joint Venture’s cannabis products obsolete, less competitive or less marketable. The process of developing the Joint Venture’s products is complex and requires significant continuing costs, development efforts and third party commitments. The Joint Venture’s failure to develop new technologies and products and the obsolescence of existing technologies could adversely affect the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company. The Joint Venture may be unable to anticipate changes in its potential customer requirements that could make the Joint Venture’s existing technology obsolete. The Joint Venture’s success will depend, in part, on its ability to continue to enhance its existing technologies, develop new technology that addresses the increasing sophistication and varied needs of the market, and respond to technological advances and emerging industry standards and practices on a timely and cost-effective basis. The development of the Joint Venture’s proprietary technology entails significant technical and business risks. The Joint Venture may not be successful in using its new technologies or exploiting its niche markets effectively or adapting its businesses to evolving customer or medical requirements or preferences or emerging industry standards. This may have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

 

- 28 -


Product Liability

As the Joint Venture’s products are designed to be ingested by humans, the Joint Venture and the Company face a risk of exposure to product liability claims, regulatory action and litigation if its products are alleged to have caused significant loss or injury. In addition, the sale of the Joint Venture’s cannabis products involves the risk of injury to consumers due to tampering by unauthorized third parties or product contamination. Previously unknown adverse reactions resulting from human consumption of the Joint Venture’s cannabis products alone or in combination with other medications or substances could occur. The Joint Venture may be subject to various product liability claims, including, among others, that the Joint Venture’s products caused injury or illness and that the Joint Venture provided inadequate instructions for use or inadequate warnings concerning possible side effects or interactions with other substances. A product liability claim or regulatory action against the Joint Venture could result in increased costs, could adversely affect the Joint Venture’s and the Company’s reputation with its clients and consumers generally, and could have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company. There can be no assurance that the Joint Venture will be able to obtain or maintain product liability insurance on acceptable terms or with adequate coverage against potential liabilities. Such insurance is expensive and may not be available in the future on acceptable terms, or at all. The inability to obtain sufficient insurance coverage on reasonable terms or to otherwise protect against potential product liability claims could prevent or inhibit the commercialization of the Joint Venture’s potential products.

Product Recalls

Manufacturers of products are sometimes subject to the recall or return of their products for a variety of reasons, including product defects, such as contamination, unintended harmful side effects or interactions with other substances, packaging safety and inadequate or inaccurate labelling disclosure. If any of the Joint Venture’s cannabis products are recalled due to an alleged product defect or for any other reason, the Joint Venture could be required to incur the unexpected expense of the recall and any legal proceedings that might arise in connection with the recall. The Joint Venture may lose a significant amount of sales and may not be able to replace those sales at an acceptable margin or at all. In addition, a product recall may require significant management attention. Although the Joint Venture will put in place detailed procedures for testing its cannabis products before production of cannabis products begin, there can be no assurance that any quality, potency or contamination problems will be detected in time to avoid unforeseen product recalls, regulatory action or lawsuits. A recall for any of the foregoing reasons could lead to decreased demand for the Joint Venture’s products and could have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company. Additionally, product recalls may lead to increased scrutiny of the Joint Venture’s operations by Health Canada or other regulatory agencies, requiring further management attention and potential legal fees and other expenses.

Fluctuating Prices of Raw Materials

The Joint Venture’s revenues will in large part be derived from the production, sale and distribution of cannabis. The price of production, sale and distribution of cannabis will fluctuate widely due to, among other factors, how young the cannabis industry is and the impact of numerous factors beyond the control of the Joint Venture and the Company including international, economic and political trends, expectations of inflation, currency exchange fluctuations, interest rates, global or regional consumptive patterns, speculative activities and increased production due to new production and distribution developments and improved production and distribution methods. The effect of these factors on the price of product produced by the Joint Venture and, therefore, the economic viability of the Joint Venture’s business, cannot accurately be predicted. This may have a material adverse effect on the business, prospects, financial condition, results of operations and cash flows of the Joint Venture and the Company.

Environmental Regulations and Risks

The Joint Venture’s operations are subject to environmental regulation in the various jurisdictions in which it operates. These regulations mandate, among other things, the maintenance of air and water quality standards and land reclamation. They also set forth limitations on the generation, transportation, storage and disposal of solid and hazardous waste. Environmental legislation is evolving in a manner which will require stricter standards and enforcement, increased fines and penalties for non-compliance, more stringent environmental assessments of proposed projects and a heightened degree of responsibility for companies and their officers, directors and employees. There is

 

- 29 -


no assurance that future changes in environmental regulation, if any, will not adversely affect the Joint Venture’s operations. Government approvals and permits are currently, and may in the future be, required in connection with the Joint Venture’s operations. To the extent such approvals are required and not obtained, the Joint Venture may be curtailed or prohibited from its proposed production of cannabis or from proceeding with the development of its operations as currently proposed. Failure to comply with applicable laws, regulations and permitting requirements may result in enforcement actions thereunder, including orders issued by regulatory or judicial authorities causing operations to cease or be curtailed, and may include corrective measures requiring capital expenditures, installation of additional equipment, or remedial actions. The Joint Venture and the Company may be required to compensate those suffering loss or damage by reason of the Joint Venture’s operations and may have civil or criminal fines or penalties imposed for violations of applicable laws or regulations. Amendments to current laws, regulations and permits governing the production of cannabis, or more stringent implementation thereof, could have a material adverse impact on the Joint Venture and the Company, and cause increases in expenses, capital expenditures or production costs or reduction in levels of production or require abandonment or delays in development.

Risks Related to Tax

Potential U.S. Permanent Establishment of VF Canada GP and VF Canada LP

Under the Canada U.S. Tax Convention, a Canadian resident will be subject to U.S. income taxation with respect to the business profits of such Canadian resident attributable to a permanent establishment (“ PE ”) of such Canadian resident located in the United States. A Canadian resident generally will be treated as maintaining a PE in the United States if, among other situations, an agent of the Canadian resident (other than an independent agent acting in the ordinary course of its business) has, and habitually exercises in the United States, authority to conclude contracts in the name of the Canadian resident.

Due to the cross border activity of certain employees of the Company, the United States may deem VF Canada GP and VF Canada LP to maintain a U.S. permanent establishment. In the event that such a U.S. permanent establishment is deemed to exist, VF Canada GP and VF Canada LP generally will be required to file U.S. federal income tax returns and will be subject to U.S. federal income tax with respect to the business profits allocable to such permanent establishment.

Advances by VF Opco to U.S. Holdings

In connection with the completion of the Combination Transaction, VF Opco loaned approximately CA$20,000,000 to U.S. Holdings (the “ Advances ”). As at December 31, 2017, CA$9,500,000 of the Advances remained outstanding. U.S. Holdings has claimed interest deductions with respect to the interest paid on the Advances in computing its income for U.S. federal income tax purposes. There can be no assurance that the IRS will not assert that any portion of the advances was equity in the U.S. borrower for U.S. federal income tax purposes. If the IRS were successful in this assertion, payments made by U.S. Holdings on such Advances would be treated as non-deductible distributions paid by U.S. Holdings to VF Opco and subject to U.S. federal withholding taxes. The Company anticipates that the amount of any such withholding taxes, net of positive tax consequences that may arise from related circumstances, will not be material. In addition, the deductibility of interest paid or accrued may be subject to various limitations. The Company anticipates that the amount of interest charged on such Advances that might otherwise be claimed as a deduction, will not be material.

Transfer Pricing

Pursuant to an annual sales agreement, VF Opco has agreed to sell some of its inventory to VFLP for resale in the United States, as well as VFLP has agreed to sell some of its inventory to VF Opco for resale in Canada. VF Opco and VFLP take the position that the amounts charged by VF Opco and VFLP for such inventory represent the fair market value of the goods sold. The IRS or the Canada Revenue Agency have and may, in the future, challenge the pricing as being in excess of fair market value. If the IRS or the Canada Revenue Agency were successful in challenging the pricing, VFLP’s U.S. or Canadian taxable income could be increased. The consequences being a higher overall effective tax rate, as well as the potential for higher tax payments.

 

- 30 -


U.S. Real Property Holding Corporation

If U.S. Holdings is, or has been within the prior five years, a United States real property holding corporation as defined under section 897 of the Internal Revenue Code, any portion of a distribution by U.S. Holdings to VF Opco which is treated as a gain for U.S. federal income tax purpose would be subject to United States federal income and withholding taxes.

DIVIDENDS

Dividend Policy

The Company has no current plans to pay dividends as it is growth focused. The amount of any dividends payable by the Company will be at the discretion of the board of directors of the Company and may vary depending on, among other things, the Company’s earnings, financial requirements for the Company’s operations, growth opportunities, debt covenants, the satisfaction of the solvency tests imposed by the CBCA for declaration and payment of dividends and the conditions existing from time to time.

Historical Distributions

The Company has not paid any cash dividends or distributions on any class of the Company’s securities for any of the three most recently completed financial years.

MARKET FOR SECURITIES

Trading Price and Volume

The Common Shares are listed and posted for trading on the TSX under the symbol “VFF”. The following table sets forth the trading price range and trading volume of the Common Shares for the most recently completed financial year, as reported by the TSX:

 

                     Month        High            Low        Volume  

2017

   January    1.59    1.32      658,856  
   February    1.80    1.50      647,180  
   March    1.85    1.58      364,122  
   April    1.99    1.77      331,347  
   May    1.98    1.60      137,863  
   June    2.84    1.74      1,093,619  
   July    2.21    1.88      382,950  
   August    2.14    1.87      415,464  
   September    2.90    1.87      960,869  
   October    4.15    2.62      3,089,304  
   November    6.25    3.55      4,309,894  
   December    7.93    5.41      6,190,748  

 

- 31 -


DIRECTORS AND MANAGEMENT

The following table sets forth the name, position with the Company, municipality of residence, principal occupation during the five preceding years, period of service for each of the directors and executive officers of the Company and the number of Common Shares beneficially owned by him/her, directly or indirectly, or over which he/she exercises control or direction:

 

Name and Municipality
of Residence (1)

 

Position

 

Principal Occupation
During the Past Five
Years (1)

 

Service as a
Director/Executive
Officer

 

No. of
Common Shares
Beneficially Owned (2)

Michael A. DeGiglio
Florida, USA
  Director, and Chief Executive Officer   Chief Executive Officer of the Company   Director and Executive Officer since October 18, 2006   9,821,649
John P. Henry (3)
Florida, USA
  Director   Retired senior executive   Director since October 18, 2006   35,000
David Holewinski (3),(4)
Michigan, USA
  Director   Management Consultant   Director since June 21, 2011   145,000
John R. McLernon (4)
British Columbia, Canada
  Chair of the Board Directors   Honorary Chairman and Co-Founder of Colliers International   Director since January 18, 2005   106,500
Stephen C. Ruffini
Florida, USA
  Director, Executive Vice President and Chief Financial Officer   Chief Financial Officer of the Company   Director since 2014 and Executive Officer since January 5, 2009   500,000
Christopher C.
Woodward (3)(4)
British Columbia, Canada
  Director   President, Woodcorp Investments Ltd. (private investment company)   Director since November 10, 2003   165,000
Dr. Roberta Cook
California, USA
  Director   Marketing Consultant   Director since January 4, 2016   20,000

 

(1)

The information as to municipality of residence and principal occupation, not being within the knowledge of the Company, has been furnished by the respective directors and executive officers individually.

(2)

The directors and executive officers of the Company beneficially own, directly or indirectly, or exercise control or direction over an aggregate of 10,793,149 Common Shares, representing approximately 25.4% of the issued and outstanding Common Shares. The information as to Common Shares beneficially owned or over which a director or executive officer exercises control or direction, not being within the knowledge of the Company, has been furnished by the director or executive officer individually.

(3)

Member of the Audit Committee of the Company.

(4)

Member of the Compensation and Corporate Governance Committee of the Company.

Each of the directors of the Company holds office for a term expiring at the close of the next annual meeting of shareholders or until his/her successor is appointed, unless his or her office is earlier vacated.

The following are brief profiles of the directors and executive officers of the Company:

Michael A. DeGiglio, Director and Chief Executive Officer of the Company . Mr. DeGiglio is a founder of Village Farms International through preceding companies and has served as its Chief Executive Officer since its inception in 1989. Mr. DeGiglio joined EcoScience Corporation (NASDAQ) a bio-technology company, in November 1992 upon its acquisition of Agro-Dynamics Inc., a company Mr. DeGiglio founded in 1984 and served as President since its inception. Additional, he served as President and Chief Executive Officer of EcoScience from 1995 until its merger with Village Farms in 1999. Prior to commencing his business career in 1983, Mr. DeGiglio served on active duty in the United States Navy from 1976 through 1983, and in the Naval Air reserves from 1983 through 2001, retiring at the rank of Captain. Throughout his Naval career, Captain DeGiglio held multiple Department head positions, successfully completed a tour as Commanding Officer of a jet squadron, performed multiple tours overseas, accumulated over 5,000 hours of military flight time, and completed numerous senior management and military courses. Mr. DeGiglio received a Bachelor of Science degree in Aeronautical Science from Embry Riddle Aeronautical University (ERAU) in Daytona Beach, Florida. He has served as the former Chairman of the Presidential Advisory Board of ERAU.

 

- 32 -


John P. Henry, Director of the Company . Mr. Henry has served as a director of the Company since 2006. From 1981 to 2000, Mr. Henry was employed by Ocean Spray Cranberries, Inc. (“ Ocean Spray ”), retiring as Senior Vice-President of Grower Relations and Chief Financial Officer in 2000. Ocean Spray grew from $400 million to $1.3 billion in revenues during his tenure. Mr. Henry also served as a Director of Nantucket Allserve Inc., a majority owned subsidiary of Ocean Spray. From 1980 to 1981 he was Chief Financial Officer of Castle Toy Co, Inc. prior to this; Mr. Henry was employed by Laventhol and Horwath providing auditing, consulting and tax services to large public and private companies. He received a Bachelor of Science degree in Business Administration and Master in Taxation degrees from Bryant College in Smithfield, Rhode Island. Mr. Henry is a non-practicing Certified Professional Accountant in the State of Rhode Island.

David Holewinski, Director of the Company . Mr. Holewinski is a Management Consultant. He served as a director of Agro Power Development Inc. (“ APDI ”) from 2004 until October 2006. Between 1995 and 2000, Mr. Holewinski also served as Senior Vice President of Business Development for APDI. Mr. Holewinski has co-founded two biotechnology companies, a company with cyber technology and also co-founded a company with novel precast concrete technology for the construction industry. Between 1983 and 1988, Mr. Holewinski was a Manager of Business Development for ConAgra Foods, Inc. Mr. Holewinski has a Bachelor of Arts degree from Pennsylvania State University and a Master of Business Administration degree from Harvard University.

John R. McLernon, Chairman and Director of the Company . Mr. McLernon is President of McLernon Consultants Ltd. He is Honorary Chairman and Co-Founder of Colliers International (“ Colliers ”), a global commercial real estate services company operating from 485 offices in 65 countries. He served as Chairman and Chief Executive Officer of Colliers from 1977 to 2002 and as Chairman until December 2004. Mr. McLernon also serves as a director of several public and private companies as well as major nonprofit organizations.

Stephen C. Ruffini, Director and Chief Financial Officer of the Company . Mr. Ruffini joined Village Farms in January 2009. Mr. Ruffini came to Village Farms from Performing Brands, Inc. where he served as Chief Operating Officer and Chief Financial Officer. Mr. Ruffini has 25 years of extensive financial, operations, investor relations and mergers and acquisitions experience with leading international companies, including Hit Entertainment plc, Lyrick Corporation and Arthur Andersen LLP. Mr. Ruffini is a Certified Public Accountant who holds an M.B.A. from the University of Texas, in Austin, Texas and a B.B.A. in Finance from the Southern Methodist University in Dallas, Texas.

Christopher C. Woodward, Director of the Company . Mr. Woodward is a member of the Audit Committee and Compensation Committee. Mr. Woodward serves as a chair or director of a number of private, public companies and charitable institutions. These include the P.A. Woodward Medical Foundation, Brentwood College and the Sea to Sky Gondola Corp. He serves as the current Chair Vancouver Coastal Health Authority, Chair of the Keg Royalty Trust and Director of the Great Western Brewery. Mr. Woodward received his Bachelor of Arts (Economics) degree from the University of Western Ontario.

Dr.  Roberta Cook, Director of the Company . On July 1, 2016, Dr. Cook retired from her 31-year position as a Cooperative Extension Marketing Economist in the Department of Agricultural and Resource Economics (ARE) at the University of California, Davis. She is currently an Emerita faculty member, and consults on a broad range of fresh produce marketing issues. She has a PhD in Agricultural Economics from Michigan State University. She serves on the board of directors of Ocean Mist Farms, and has been a board member of Naturipe Farms and Sunkist, as well as numerous other advisory boards in the produce industry. For nearly a decade, Dr. Cook was Faculty Director of the California Agribusiness Executive Seminar co-sponsored by University of California, Davis and Wells Fargo Bank. In 2011, The Packer honoured her as one of the top 25 produce industry leaders.

Board Committees

The board of directors of the Company currently has an audit committee and a compensation and corporate governance committee.

 

- 33 -


Audit Committee of the Company . This committee is comprised of John P. Henry, Christopher C. Woodward and David Holewinski, each independent directors of the Company, and is responsible for maintaining management’s accounting and financial reporting practices and procedures, the adequacy of internal accounting controls and procedures, the quality and integrity of the Company’s financial statements and related financial public disclosure and for liaising with the external auditors of the Company. The chairperson of the audit committee of the Company is John P. Henry.

Compensation and Corporate Governance Committee of the Company . This committee is comprised of John R. McLernon, David Holewinski and Christopher C. Woodward, who are all independent directors and is responsible for assisting the board in determining compensation of senior management as well as reviewing the adequacy and form of directors’ compensation. The committee reviews annually the Chief Executive Officer’s goals and objectives for the upcoming year and each year performs an appraisal of the Chief Executive Officer’s performance. This committee also administers and makes recommendations regarding the operation of the Compensation Plan and other incentive plans of the Company. The committee is responsible for developing the Company’s approach to corporate governance issues, advising the board in filling vacancies on the board and periodically reviewing the compensation and effectiveness of the board and the contribution of individual directors. The chairperson of the compensation and corporate governance committee of the Company is John R. McLernon.

Cease Trade Orders or Bankruptcies

To the knowledge of the directors of the Company, no director or officer of the Company and no personal holding company of any such persons is, as at the date hereof, or was within ten years prior to the date hereof, a director, chief executive officer or chief financial officer of any company that (a) was subject to an order that was issued while the director or executive officer was acting in the capacity as director, chief executive officer or chief financial officer, or (b) was subject to an order that was issued after the director or executive officer ceased to be a director, chief executive officer or chief financial officer and which resulted from an event that occurred while that person was acting in the capacity as director, chief executive officer or chief financial officer. For the purposes of this paragraph, “order” means a cease trade order, an order similar to a cease trade order or an order that denied the relevant company access to any exemption under securities legislation, in each case, that was in effect for a period of more than 30 consecutive days.

John R. McLernon was a director of Syscan International Inc. (“ Syscan ”), a public company whose shares were listed on the TSX Venture Exchange. Mr. McLernon resigned as a director of Syscan within the year preceding Syscan making an assignment to a trustee pursuant to the Bankruptcy and Insolvency Act (Canada) in December 2008.

Stephen C. Ruffini was Chief Operating Officer and Chief Financial Officer of Performing Brands, Inc., which filed for Chapter 7 bankruptcy protection on December 19, 2008, in the North District of Texas – Dallas division.

Penalties or Sanctions

To the knowledge of the directors of the Company, no director or officer of the Company, no shareholder holding a sufficient number of securities of the Company to affect materially the control of the Company and no personal holding company of any such persons has been subject to (a) any penalties or sanctions imposed by a court relating to securities legislation or by a securities regulatory authority or has entered into a settlement agreement with a securities authority, or (b) any other penalties or sanctions imposed by a court or regulatory body that would likely be considered important to a reasonable investor in making an investment decision.

Personal Bankruptcies

To the knowledge of the directors of the Company, no director or officer of the Company, no shareholder holding a sufficient number of the Company’s securities to affect materially the control of the Company, and no personal holding company of any such persons has, during the ten years prior to the date hereof, become bankrupt, made a proposal under any legislation relating to bankruptcy or insolvency, or was subject to or instituted any proceedings, arrangement or compromise with creditors, or had a receiver, receiver manager or trustee appointed to hold such persons assets.

 

- 34 -


Conflicts of Interest

To the knowledge of the directors of the Company, there are no existing or potential material conflicts of interest among the Company and a director or officer of the Company.

LEGAL PROCEEDINGS AND REGULATORY ACTIONS

The Company is not involved in any legal proceedings which would have a material effect on the Company. To the knowledge of Management, no legal proceedings of a material nature involving the Company are contemplated by any other party. There have not been any (a) penalties or sections imposed against the Company by a court relating to securities legislation or by a securities regulatory authority during the most recently completed financial year, (b) other penalties or sanctions imposed by a court or regulatory body against the Company that would likely be considered important to a reasonable investor in making an investment decision, and (c) settlement agreements the Company entered into before a court relating to securities legislation or with a securities regulatory authority during the most recently completed financial year.

TRANSFER AGENT AND REGISTRAR

The transfer agent and registrar for the Common Shares is Computershare Investor Services Inc. at its principal offices in Vancouver, British Columbia or Toronto, Ontario.

EXPERTS

The consolidated financial statements of the Company as at December 31, 2017 and December 31, 2016, which comprise the consolidated statements of financial position as at December 31, 2017 and 2016 and the consolidated statements of income and comprehensive income, changes in shareholders’ equity and cash flows for the years then ended, and the related notes, have been audited by PricewaterhouseCoopers LLP, Chartered Professional Accountants, in Vancouver, British Columbia. PricewaterhouseCoopers LLP has advised the Company that it is independent within the meaning of the Code of Professional Conduct of the Chartered Professional Accountants of British Columbia.

MATERIAL CONTRACTS

The only contracts entered into, other than in the ordinary course of business, that are material and that were entered into within the most recently completed financial year, or before the most recently completed financial year but are still in effect, are as follows:

 

  (a)

the Term Loan;

 

  (b)

the Operating Loan

 

  (c)

the Securityholders’ Agreement; and

 

  (d)

Joint Venture Agreement

The material contracts are described elsewhere in this annual information form.

 

- 35 -


AUDIT COMMITTEE INFORMATION

Charter of the Audit Committee

The terms of reference of the audit committee of the Company (the “ Audit Committee ”) are attached as Schedule A to this Annual Information Form.

Composition of the Audit Committee

The Audit Committee presently consists of John P. Henry (Chair), David Holewinski and Christopher C. Woodward. The education and experience of each member is described under “Directors and Management”.

Each member of the Audit Committee is independent and financially literate, as such terms are defined in National Instrument 52 110 — Audit Committees .

Prior Approval Policies and Procedures

All non-audit services to be provided to the Company by the external auditors must either be approved explicitly in advance by the Audit Committee, or by Management pursuant to certain pre approval policies and procedures established by the Audit Committee that are detailed as to the particular services that may be pre-approved.

The Audit Committee may delegate to one or more members of the Audit Committee the authority to grant such pre approvals. The decisions of such member(s) regarding approval of non-audit services shall be reported by such member(s) to the full Audit Committee at its first scheduled meeting following such pre approval.

External Auditor Service Fees

The following table sets forth, by category, the fees billed in Canadian dollars by PricewaterhouseCoopers LLP, the Company’s auditors, for the periods ended December 31, 2017 and 2016:

 

Fee Category

   2017      2016  

Audit fees

   $ 238,500      $ 222,620  

Audit-related fees

     31,540        9,500  

Tax fees

     73,632        66,824  
  

 

 

    

 

 

 

Total

   $ 343,672      $ 298,944  
  

 

 

    

 

 

 

Audit fees ” and “ Audit–related fees ” include all fees paid to PricewaterhouseCoopers LLP for the audit of the annual consolidated financial statements, review of the interim financial statements, conversion to International Financial Reporting Standards and other services in connection with regulatory filings.

Tax fees ” include all fees paid to PricewaterhouseCoopers LLP for tax compliance, tax advice and tax planning, and advisory services.

ADDITIONAL INFORMATION

Additional information relating to the Company may be found on SEDAR at www.sedar.com . Additional information, including directors’ and officers’ remuneration and indebtedness, principal holders of the Company’s securities and securities authorized for issuance under equity compensation plans, as applicable, is contained in the Company’s management information circular for its most recent annual meeting of shareholders that involves the election of directors. Additional financial information is provided in the Company’s audited consolidated financial statements and management’s discussion and analysis for the Company’s most recently completed financial year.

 

- 36 -


SCHEDULE A

VILLAGE FARMS INTERNATIONAL, INC. (together with its subsidiaries, as the context requires, the “Company”)

AUDIT COMMITTEE CHARTER

December 31, 2009

The Company wishes to adopt certain procedures specified in this Charter.

 

1.

PURPOSE

The Audit Committee (the “Committee”) is a standing committee of the board of directors of the Company (the “Board”). The primary function of the Committee is to assist the Board in fulfilling its oversight responsibilities with respect to monitoring the Company’s accounting and financial reporting and practices and procedures; the adequacy of the Company’s internal accounting controls and procedures; and for reviewing the quality and integrity of financial statements and other financial information provided by the Company to securityholders and others, and approving the interim financial statements and the related management’s discussion and analysis as delegated by the Board.

 

2.

STRUCTURE AND OPERATIONS

The Committee shall be comprised of three or more members of the Board, who all satisfy the “independence” and “financial literacy” requirements of National Instrument 52-110 – Audit Committees (“NI 52-110”), as amended. No member of the Committee shall be an officer or employee of the Company, or any affiliate of the Company.

For the purposes of this Charter, a member of the Committee is “independent” if the member has no direct or indirect material relationship with the Company, as more fully defined in NI 52-110, and a member of the Committee is “financially literate” if he or she has the ability to read and understand a set of financial statements that present a breadth and level of complexity of the accounting issues that can reasonably be expected to be raised by the financial statements of the Company.

The members of the Committee shall be annually appointed by the Board and shall serve until such member’s successor is duly elected and qualified or until such member’s earlier resignation or removal. The members of the Committee may be removed, with or without cause, by a majority of the Board. Unless a chairperson (a “Committee Chair”) is elected by the full Board, the members of the Committee shall designate a Committee Chair by the majority vote of the full Committee membership. The Committee Chair shall be entitled to vote to resolve any ties. The Committee Chair will chair all regular sessions of the Committee and set the agendas for Committee meetings.

 

3.

MEETINGS

The Committee shall meet at least quarterly or more frequently as circumstances dictate. As part of its goal to foster open communication, the Committee shall periodically meet with management of the Company and the external auditors to discuss any matters that the Committee or each of these groups believes should be discussed. The Committee may meet privately with the auditors, outside counsel of its choosing and the Chief Financial Officer of the Company, as necessary. In addition, the Committee may meet with the external auditors and management of the Company quarterly to review the Company’s financial statements in a manner consistent with that outlined in Section 4 of this Charter.

The Committee may invite to its meetings any directors of the Company, management of the Company and such other persons as it deems appropriate in order to carry out its responsibilities. The Committee may exclude from its meetings any persons it deems appropriate in order to carry out its responsibilities.

 

A-1


A majority of the Committee members, but not less than two, will constitute a quorum. A majority of members present at any meeting at which a quorum is present may act on behalf of the Committee. The Committee may meet by telephone or videoconference and may take action by unanimous written consent with respect to matters that may be acted upon without a formal meeting.

The Committee Chair shall designate a person who need not be a member thereof to act as Secretary, who shall record the proceedings of the meetings. The agenda of each meeting will be prepared by the Secretary and, whenever reasonably practicable, circulated to each member prior to each meeting. The Committee shall maintain minutes or other records of meetings and activities of the Committee.

 

4.

RESPONSIBILITIES, DUTIES, AUTHORITY

The following functions shall be the common recurring activities of the Committee in carrying out its responsibilities outlined in Section 1 of this Charter. These functions should serve as a guide with the understanding that the Committee may carry out additional functions and adopt additional policies and procedures as may be appropriate in light of changing business, legislative, regulatory, legal and other conditions. The Committee shall also carry out any other responsibilities and duties delegated to it by the Board from time to time related to the purposes of this Committee outlined in Section 1.

The Committee in discharging its oversight role is empowered to investigate any matter of interest or concern that the Committee deems appropriate. In this regard, the Committee shall have the authority to retain outside counsel, accounting, or other advisors for this purpose, including authority to approve the fees payable to such advisors and other terms of retention.

The Committee shall be given full access to the Board, management of the Company, employees of the Company, directly and indirectly responsible for financial reporting, and independent accountants, as necessary, to carry out these responsibilities. While acting within the scope of this stated purpose, the Committee shall have all the authority of the Board.

Notwithstanding the foregoing, the Committee is not responsible for certifying the financial statements of the Company or guaranteeing the external auditors’ report. The fundamental responsibility for the financial statements and disclosures rests with management of the Company.

The Committee, through discussions with management of the Company and the external auditors, shall satisfy itself that management of the Company has established appropriate and cost-effective systems of internal control to safeguard assets from loss and unauthorized use, manage significant business risks and ensure accurate and timely financial reporting, and as otherwise contemplated by National Instrument 52-109—Certification and Disclosure in Issuers’ Annual and Interim Filings, as amended.

 

5.

DOCUMENT REPORTS/REVIEWS

Annual Financial Statements and Management’s Discussion and Analysis

The Committee shall review with management of the Company and the external auditors prior to their public dissemination:

 

  (a)

the annual audited consolidated financial statements of the Company;

 

  (b)

the annual Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Company (“MD&A”);

 

  (c)

the results of external auditor’s examination of the annual consolidated financial statements and their report;

 

  (d)

any significant changes that were required in the external audit plan;

 

A-2


  (e)

any significant issues raised with management of the Company during the course of the audit, including any restrictions on the scope of activities or access to information; and

 

  (f)

those matters related to the conduct of the audit that are required to be discussed under generally accepted auditing standards applicable to the Company.

Following completion of the matters contemplated above, the Committee shall make a recommendation to the Board with respect to the approval of the annual financial statements and annual MD&A with such changes contemplated and further recommended by the Committee as the Committee considers necessary.

Interim Financial Statements and Interim MD&A

The Committee shall review with management of the Company prior to their public dissemination, the interim unaudited consolidated financial statements of the Company and the interim MD&A. The Committee shall approve the interim financial statements and interim MD&A, as the Board has delegated this function to the Committee. The Committee shall have the authority to determine whether to request the Company’s external auditors to undertake a review engagement in respect of the interim unaudited consolidated financial statements from time to time, including in conjunction with a public offering of securities by the Company.

Press Releases

The Committee shall review with management of the Company, prior to their public dissemination, the annual and interim earnings press releases (paying particular attention to the use of any “pro forma” or “adjusted” non-GAAP information) as well as financial information and earnings guidance provided to analysts and rating agencies.

Reports and Regulatory Returns

The Committee shall review and discuss with management of the Company, and the external auditors to the extent the Committee deems appropriate, such reports and regulatory returns of the Company as may be specified by law.

Other Financial Information

The Committee shall review the financial information included in any prospectus, annual information form or information circular of the Company with the management of the Company and the external auditors, both together and separately, prior to their public dissemination, and shall make a recommendation to the Board with respect to the approval of such prospectus, annual information form or information circular with such changes contemplated and further recommended as the Committee considers necessary. The Committee shall review each annual information form of the Company to ensure the completeness and veracity of the mandated disclosure (as required by Form 52-110F1) about the Committee.

Charter

The Committee shall review and update this Charter periodically, as conditions warrant.

 

6.

FINANCIAL REPORTING PROCESSES

Establishment and Assessment of Procedures

The Committee shall satisfy itself that adequate procedures are in place for the review of the Company’s public disclosure of financial information extracted or derived from the financial statements of the Company and periodically assess the adequacy of these procedures annually.

 

A-3


Application of GAAP

The Committee shall assure itself that the external auditors are satisfied that the accounting estimates and judgments made by management of the Company, and their selection of accounting principles reflect an appropriate application of generally accepted accounting principles.

Practices and Policies

The Committee shall review with management of the Company and the external auditors, together and separately, the principal accounting practices and policies of the Company.

 

7.

EXTERNAL AUDITORS

Oversight and Responsibility

The Committee is directly responsible for overseeing the work of the external auditors engaged for the purpose of preparing or issuing an auditor’s report or performing other audit, review or attest services for the Company, including the resolution of disagreements between management of the Company and the external auditors regarding financial reporting.

Reporting

The external auditors shall report directly to the Committee and are ultimately accountable to the Committee.

Performance and Review

The Committee shall annually review the performance of the external auditors and recommend to the Board the nomination of the external auditors (and the compensation of the external auditors) or approve any discharge of the external auditors when circumstances warrant, for the purpose of preparing or issuing an auditor’s report or performing other audit, review or attest services for the Company.

Annual Audit Plan

The Committee shall review with the external auditors and management of the Company, the overall scope of the annual audit plan and the resources the external auditors will devote to the audit. The Committee shall annually review and approve the fees to be paid to the external auditors with respect to the annual audit, and shall recommend to the Board the fees to be paid to the external auditors.

Non-Audit Services

“Non-audit services” means all services performed by the external auditors other than audit services. All “non- audit” services to be provided to the Company by the external auditors must either be approved explicitly in advance by the Committee, or by management pursuant to certain pre-approval policies and procedures established by the Committee that are detailed as to the particular services that may be pre-approved.

The Committee may delegate to one or more members of the Committee the authority to grant such pre-approvals. The decisions of such member(s) regarding approval of “non-audit” services shall be reported by such member(s) to the full Committee at its first scheduled meeting following such pre-approval. Notwithstanding the foregoing, pre-approval is not necessary for certain de minimis “non-audit” services performed by the external auditors, as specified in Section 2.4 of NI 52-110.

 

A-4


Independence Review

The Committee shall review and assess the qualifications, performance and independence of the external auditors, including the requirements relating to such independence of the law governing the Company. At least annually, the Committee shall receive from and review with the external auditors, their written statement delineating all relationships with the Company and, if necessary, recommend that the Board take appropriate action to satisfy itself of the external auditors’ independence and accountability to the Committee.

 

8.

REPORTING

Reports to the Board

In addition to such specific reports contemplated elsewhere in this Charter, the Committee shall report regularly to the full Board regarding such matters, including:

any issues that arise with respect to the quality or integrity of the financial statements of the Company, compliance with legal or regulatory requirements by the Company, or the performance and independence of the external auditors of the Company;

proceedings at meetings of the Committee; and

such other matters as are relevant to the Committee’s discharge of its responsibilities.

Recommendations

In addition to such specific recommendations contemplated elsewhere in this Charter, the Committee shall provide such recommendations as the Committee may deem appropriate. The report to the Board may take the form of an oral report by the Committee Chair or any other member of the Committee designated by the Committee to make such report.

Reports to the Compensation and Corporate Governance Committee

The Committee shall provide reports or otherwise communicate with the Compensation and Corporate Governance Committee of the Company, as appropriate.

 

9.

WHISTLE-BLOWING

Procedures

The Committee shall establish procedures for:

the receipt, retention and treatment of complaints received by the Company regarding accounting, internal accounting controls, or auditing matters; and

the confidential, anonymous submission by employees of the Company of concerns regarding questionable accounting or auditing matters.

Such procedures will be reflected in the Code of Ethics and Whistleblower Policy of the Company and its subsidiaries, as amended from time to time.

GENERAL

Access to Counsel

The Committee may review, periodically, with outside counsel of its choosing, any legal matter that could have a significant impact on the financial statements of the Company.

 

A-5


Hiring of Partners and Employees of External Auditors

The Committee shall annually review and approve the Company’s hiring policies regarding partners, employees and former partners and employees of the present and former external auditors of the Company.

General

The Committee shall perform such other duties and exercise such powers as may, from time to time, be assigned or vested in the Committee by the Board, and such other functions as may be required of an audit committee by law, regulations or applicable stock exchange rules.

 

A-6

Exhibit 99.11

Village Farms International, Inc.

Consolidated Financial Statements

Years Ended December 31, 2017 and 2016


April 2, 2018

Independent Auditor’s Report

To the Shareholders of

Village Farms International, Inc.

We have audited the accompanying consolidated financial statements of Village Farms International, Inc. and its subsidiaries, which comprise the consolidated statements of financial position as at December 31, 2017 and 2016 and the consolidated statements of changes in shareholders’ equity, income (loss) and comprehensive income and cash flows for the years then ended, and the related notes, which comprise a summary of significant accounting policies and other explanatory information.

Management’s responsibility for the consolidated financial statements

Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

Auditor’s responsibility

Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with Canadian generally accepted auditing standards. Those standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.

We believe that the audit evidence we have obtained in our audits is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of Village Farms International, Inc. and its subsidiaries as at December 31, 2017 and 2016, and their financial performance and their cash flows for the years then ended in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board.

(Signed) “PricewaterhouseCoopers LLP”

Chartered Professional Accountants

Vancouver, Canada


Village Farms International, Inc.

Consolidated Statements of Financial Position

(In thousands of United States dollars)

 

     December 31, 2017     December 31, 2016  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 7,091     $ 5,373  

Trade receivables

     11,259       10,187  

Other receivables

     1,982       263  

Inventories (note 5)

     17,309       16,108  

Income taxes recoverable

     246       246  

Prepaid expenses and deposits

     564       676  

Biological asset (note 6)

     4,405       4,446  
  

 

 

   

 

 

 

Total current assets

     42,856       37,299  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment (note 7)

     81,754       96,135  

Investment in joint venture (note 8)

     15,727       —    

Other assets (note 9)

     2,004       1,531  
  

 

 

   

 

 

 

Total assets

   $ 142,341     $ 134,965  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 12,952     $ 12,711  

Accrued liabilities

     3,793       3,586  

Current maturities of long-term debt (note 10)

     2,620       3,291  

Current maturities of capital lease obligations

     72       33  
  

 

 

   

 

 

 

Total current liabilities

     19,437       19,621  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt (note 10)

     35,760       41,929  

Long-term maturities of capital lease obligations

     179       87  

Deferred tax liability (note 17)

     4,825       4,987  

Deferred compensation

     1,097       954  
  

 

 

   

 

 

 

Total liabilities

     61,298       67,578  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital (note 20)

     36,115       24,954  

Contributed surplus

     1,726       1,392  

Revaluation surplus (note 7)

     4,321       6,132  

Accumulated other comprehensive loss

     (391     (541

Retained earnings

     39,272       35,450  
  

 

 

   

 

 

 

Total shareholders’ equity

     81,043       67,387  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 142,341     $ 134,965  
  

 

 

   

 

 

 

Subsequent event (note 24)

    

The accompanying notes are an integral part of these consolidated financial statements

 

1


Village Farms International, Inc.

Consolidated Statements of Changes in Shareholders’ Equity

For the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except for shares outstanding)

 

    Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    Revaluation
Surplus
    Accumulated Other
Comprehensive
Loss
    Retained
Earnings
    Total
Shareholders’
Equity
 

Balance at January 1, 2016

    38,807,345     $ 24,903     $ 1,197     $ —       $ (602   $ 37,433     $ 62,931  

Shares issued on exercise of stock options

    75,600       51       —         —         —         —         51  

Share-based compensation (note 23)

    —         —         195       —         —         —         195  

Cumulative translation adjustment

    —         —         —         —         61       —         61  

Gain on revaluation of land, net of tax (note 7)

    —         —         —         6,132       —         —         6,132  

Net loss

    —         —         —         —         —         (1,983     (1,983
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2016

    38,882,945     $ 24,954     $ 1,392     $ 6,132     $ (541   $ 35,450     $ 67,387  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at January 1, 2017

    38,882,945       24,954       1,392       6,132       (541     35,450       67,387  

Shares issued pursuant to public offering, net of issuance costs

    2,500,000       9,769       —         —         —         —         9,769  

Shares issued on exercise of stock options (note 23)

    91,667       59       —         —         —         —         59  

Issuance of warrants for common shares (note 8)

    —         —         148       —         —         —         148  

Share-based compensation (note 23)

    768,000       1,333       186       —         —         —         1,519  

Cumulative translation adjustment

    —         —         —         —         150       —         150  

Reclassification of previously recorded revaluation gain of land, net of tax (note 7)

    —         —         —         (1,811     —         —         (1,811

Net income

    —         —         —         —         —         3,822       3,822  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Balance at December 31, 2017

    42,242,612     $ 36,115     $ 1,726     $ 4,321     $ (391   $ 39,272     $ 81,043  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

2


Village Farms International, Inc.

Consolidated Statements of Income (Loss) and Comprehensive Income

For the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share data)

 

     2017     2016  

Sales (note 19)

   $ 158,406     $ 155,502  

Cost of sales (note 15)

     (144,433     (140,778

Change in biological asset (note 6)

     265       (1,501

Selling, general and administrative expenses (note 15)

     (15,413     (13,720
  

 

 

   

 

 

 

Loss from operations

     (1,175     (497

Interest expense

     2,695       2,514  

Foreign exchange loss

     (26     86  

Other income

     (46     (22

Share of loss from joint venture (note 8)

     255       —    

(Gain) loss on disposal of assets (note 8)

     (8,013     12  
  

 

 

   

 

 

 

Income (loss) before income taxes

     3,960       (3,087

Provision for (recovery of) income taxes (note 16)

     138       (1,104
  

 

 

   

 

 

 

Net income (loss)

   $ 3,822     $ (1,983
  

 

 

   

 

 

 

Basic income (loss) per share (note 21)

   $ 0.10     $ (0.05
  

 

 

   

 

 

 

Diluted income (loss) per share (note 21)

   $ 0.10     $ (0.05
  

 

 

   

 

 

 

Other comprehensive income:

    

Foreign currency translation adjustment

     150       61  

Gain on revaluation of land, net of tax (note 7)

     (1,811     6,132  
  

 

 

   

 

 

 

Comprehensive income

   $ 2,161     $ 4,210  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

3


Village Farms International, Inc.

Consolidated Statements of Cash Flows

For the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars)

 

     2017     2016  

Cash flows from operating activities:

    

Net income (loss)

   $ 3,822     $ (1,983

Adjustments to reconcile net income (loss) to net cash

    

provided by operating activities:

    

Depreciation and amortization

     7,586       8,164  

Amortization of deferred charges

     73       120  

(Gain) loss on disposal of assets

     (8,013     12  

Share of loss from joint venture (note 8)

     255       —    

Interest paid

     2,614       2,351  

Share-based compensation

     1,519       195  

Deferred income taxes

     109       (1,261

Change in biological asset

     (265     1,501  

Changes in non-cash working capital items (note 18)

     (4,417     (433
  

 

 

   

 

 

 

Net cash provided by operating activities

     3,283       8,666  
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property, plant and equipment

     (1,696     (2,193
  

 

 

   

 

 

 

Net cash used in investing activities

     (1,696     (2,193
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from borrowings

     7,306       4,000  

Repayments on borrowings

     (14,320     (7,718

Interest paid on long-term debt

     (2,614     (2,351

Proceeds from issuance of common stock pursuant to public offering, net

     9,769       —    

Proceeds from exercise of stock options

     59       51  

Payments on capital lease obligations

     (59     (41
  

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     141       (6,059
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (10     2  
  

 

 

   

 

 

 

Increase in cash and cash equivalents

     1,718       416  

Cash and cash equivalents, beginning of year

     5,373       4,957  
  

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $ 7,091     $ 5,373  
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Income taxes (recovered) paid

   $ (25   $ 1,082  
  

 

 

   

 

 

 

Supplemental disclosure of non-cash information:

    

Purchases of capital expenditures by financing capital lease

   $ 190     $ 126  
  

 

 

   

 

 

 

Purchases of capital expenditures by use of accounts payable

     —       $ 385  
  

 

 

   

 

 

 

Issuance of warrants

   $ 148       —    
  

 

 

   

 

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

 

4


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

1

NATURE OF OPERATIONS

Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act . VFF’s principal operating subsidiaries as at December 31, 2017 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc (“VFCE”). The address of the registered office of VFF is 4700 80 th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), which is recorded as Investment in Joint Venture (note 8).

The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also traded in the United States on the OTCQX ® Best Market under the symbol VFFIF.

The Company, through its subsidiaries VFCLP and VFLP, owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. In addition, the Company’s joint venture, Pure Sunfarms, is in the start up stage of becoming a producer and supplier of cannabis products to be sold to wholesalers, distributors and retailers across Canada and internationally.

 

2

BASIS OF PRESENTATION

Basis of Presentation

These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) applicable to the preparation of consolidated financial statements as issued by the International Accounting Standards Board (“IASB”) and interpretations of the International Financial Reporting Interpretations Committee (“IFRIC”).    

The policies applied in these consolidated financial statements are based on IFRS issued and outstanding as of December 31, 2017. The consolidated financial statements were approved by the Board of Directors of the Company for issue on March 16, 2018. Management does not have the authority to amend the consolidated financial statements after the statements have been issued, without the approval by the Board of Directors of the Company. The preparation of consolidated financial statements in conformity with IFRS requires the use of certain critical accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the consolidated financial statements are disclosed in note 3.

Basis of Measurement

The consolidated annual financial statements have been prepared on the historical cost basis except for the following material items on the consolidated statements of financial position:

 

   

biological assets are measured at fair value less costs to sell;

 

   

land is valued at fair market value; and

 

   

available-for-sale financial assets are measured at fair value.

Functional and Presentation Currency

These consolidated financial statements are presented in United States dollars (“U.S. dollars”), which is the Company’s functional currency. VFCE’s functional currency is Canadian dollars and conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates . All financial information presented in U.S. dollars has been rounded to the nearest thousands, except per share amounts.

 

3

SIGNIFICANT ACCOUNTING POLICIES, JUDGMENTS AND ESTIMATION UNCERTAINTY

The significant accounting policies set out below have been applied consistently to all periods presented in these consolidated financial statements.

 

5


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Consolidation

The consolidated financial statements of the Company consolidate the accounts of VFF and its subsidiaries. All intercompany transactions, balances and unrealized gains and losses from intercompany transactions are eliminated on consolidation.    

Joint Venture

A joint venture is a contractual arrangement whereby the Company and other parties undertake an economic activity through a jointly controlled entity. Joint control exists when strategic, financial and operating policy decisions relating to the activities require the unanimous consent of the parties sharing control. Joint ventures are accounted for using the equity method and are recognized initially at cost. The Company recognizes its share of the post-acquisition income and expenses and equity movement in the venture. If the cumulative losses exceed the carrying amount of the equity investment, they are first applied to any additional advances that are receivable from the joint venture to the extent of the total amount receivable. Additional losses are recognized only to the extent that there exists a legal or constructive obligation.

Segment Reporting

Operating segments are reported in a manner consistent with internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer (“CEO”). Based on the aggregation criteria in IFRS 8, Operating Segments , the Company has identified two operating segments, the Produce Business and the Energy Business.

Foreign Currency Translation

The integrated foreign operations of the Company’s monetary assets and liabilities are translated into U.S. dollars at year-end exchange rates and other assets and liabilities are translated at historical rates. Revenues, expenses and cash flows are translated at monthly average exchange rates. Gains and losses on translation are charged to income. Transactions denominated in foreign currencies are translated at the rate prevailing at the transaction date. All financial information presented in U.S. dollars has been rounded to the nearest thousand.

Financial Instruments

Financial assets and liabilities are recognized when the Company becomes party to the contractual provisions of the financial instrument. Financial assets are derecognized when the rights to receive cash flows from the assets have expired or have been transferred and the Company has transferred substantially all risks and rewards of ownership. Financial liabilities are derecognized when the obligation specified in the contract is discharged, cancelled or expired.

Financial assets and liabilities are offset and the net amount is reported on the consolidated statements of financial position when there is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a net basis or realize the asset and settle the liability simultaneously.

At initial recognition, the Company classifies its financial instruments in the following categories depending on the purpose for which the instruments were acquired:

(i) Financial assets and liabilities carried at fair value through profit or loss:

A financial asset or liability is classified in this category if acquired principally for the purpose of selling or repurchasing in the short-term. Derivatives are also included in this category unless they are designated as hedges.

Financial instruments in this category are recognized initially and subsequently at fair value. Transaction costs are expensed as incurred in the consolidated statements of income (loss). Gains and losses arising from changes in fair value are presented in the consolidated statements of income (loss) within gain or loss on derivatives in the period in which they arise. Financial assets and liabilities carried at fair value through profit or loss are classified as current except for the portion expected to be realized or paid beyond twelve months of the consolidated statements of financial position date, which is classified as non-current.

(ii) Available-for-sale investments:

Available-for-sale investments are non-derivatives that are either designated in this category or not classified in any of the other categories. The Company currently has no available-for-sale investments on its consolidated statements of financial position. Available-for-sale investments are recognized initially at fair value plus transaction costs and are subsequently carried at fair value.

 

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Gains or losses arising from changes in fair value are recognized in other comprehensive income. Available-for-sale investments are classified as non-current, unless the investment matures within twelve months, or management expects to dispose of them within twelve months.

(iii) Loans and receivables:

Loans and receivables are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. The Company’s loans and receivables comprise trade receivables, other receivables, and cash and cash equivalents, and are included in current assets due to their short-term nature. Loans and receivables are initially recognized at the amount expected to be received less, when material, a discount to reduce the loans and receivables to fair value. Subsequently, loans and receivables are measured at amortized cost using the effective interest method less a provision for impairment.

(iv) Financial liabilities at amortized cost:

Financial liabilities at amortized cost include trade payables, accrued liabilities, obligations under capital leases and long-term debt. Trade payables and accrued liabilities are initially recognized at the amount required to be paid less, when material, a discount to reduce the payables to fair value. Subsequently, trade payables and accrued liabilities are measured at amortized cost using the effective interest method. Long-term debt is recognized initially at fair value, net of transaction costs incurred which are amortized over the term of the loans. Financial liabilities are classified as current liabilities if payment is due within twelve months. Otherwise, they are presented as non-current liabilities.

(v) Derivative financial instruments:

The Company has used derivatives in the form of interest rate swaps to manage risks related to some of its variable rate long-term debt. Derivatives are classified as carried at fair value through profit or loss, are included on the consolidated statements of financial position within liabilities, and are classified as current or non-current based on the contractual terms specific to the instrument. Gains and losses on re-measurement are included in the consolidated statements of income (loss). The Company currently has no derivatives on its consolidated statements of financial position.

Impairment of Financial Assets

At each reporting date, the Company assesses whether there is objective evidence that a financial asset is impaired. The criteria used to determine if objective evidence of an impairment loss exists include:

 

  (i)

significant financial difficulty of the obligor;

 

  (ii)

delinquencies in interest or principal payments; and

 

  (iii)

it becomes probable that the borrower will enter bankruptcy or other financial reorganization.

If such evidence exists, the Company recognizes an impairment loss as follows:

 

  i)

Financial assets carried at amortized cost: The loss is the difference between the amortized cost of the loan or receivable and the present value of the estimated future cash flows, discounted using the instrument’s original effective interest rate. The carrying amount of the asset is reduced by this amount either directly or indirectly through the use of an allowance account.

 

  ii)

Available-for-sale financial assets: The impairment loss is the difference between the original cost of the asset and its fair value at the measurement date, less any impairment losses previously recognized in the consolidated statements of income (loss). This amount represents the cumulative loss in accumulated other comprehensive income that is reclassified to net income.

Impairment losses on financial assets carried at amortized cost are reversed in subsequent periods if the amount of the loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognized. Impairment losses on available-for-sale equity instruments are not reversed.

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Cash and Cash Equivalents

Cash and cash equivalents consist of cash deposits held with banks, and other highly liquid short-term interest bearing securities with maturities at the date of purchase of three months or less.

Trade Receivables

Trade receivables are measured at amortized cost, net of allowance for uncollectible amounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time accounts are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off receivables when they become uncollectible, and payments subsequently received on such receivables are credited to bad debt expense.

Inventories

Inventories refer to deferred crop costs and other supplies and packaging which are incurred to date on current production and are not defined as a biological asset. Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year. Growing crops are accounted for in accordance with the Company’s policy on biological assets. Cost of sales is based on estimated costs over the crop cycle allocated to both actual and estimated future yields at each period-end date.

The carrying value of agricultural produce is its fair value less costs to sell and complete at the date of harvest and is presented with biological asset on the consolidated statements of financial position. Supplies and packaging are recorded at the lower of cost or replacement cost. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.

Biological Asset

Biological asset consists of the Company’s produce on the vines at year-end. Measurement of the biological asset begins        six weeks prior to harvest as management at this point has visibility on production and expected sales. Costs related to the crop prior to this point are presented in deferred crop costs (inventories). The produce on the vine is measured at fair value less costs to sell and costs to complete, with any change therein recognized in income. Costs to sell include all costs that would be necessary to sell the assets, including finishing and transportation costs.

Property, Plant and Equipment

Recognition and measurement

Property, plant and equipment are stated at cost less accumulated depreciation and impairment losses, except for land. Land has historically been stated at cost, and is now stated at fair values and will be revalued every three years by an independent external appraiser. Any revaluation gains or losses arising from changes in the fair market value of land is recognized in other comprehensive income on the consolidated statements of income (loss) and revaluation surplus on the statements of financial position.

Property, plant and equipment costs include expenditures that are directly attributable to the acquisition of the asset. The cost of self-constructed assets includes the cost of materials and direct labour, any other costs directly attributable to bringing the assets to a working condition for their intended use, the costs of dismantling and removing the items and restoring the site on which they are located, and borrowing costs.

When parts of an item of property, plant and equipment have different useful lives, they are accounted for as separate items (major components) of property, plant and equipment.

The gain or loss on disposal of an item of property, plant and equipment is determined by comparing the proceeds from disposal with the carrying amount of the property, plant and equipment, and is presented net within gain/loss on disposal of assets in the consolidated statements of income (loss).

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Depreciation

Depreciation is based on the cost of an asset less its residual value. Significant components of individual assets are assessed, and if a component has a useful life that is different from the remainder of that asset, that component is depreciated separately.

Depreciation expense is recognized on a straight-line basis over the estimated useful lives of each component of an item of property, plant and equipment. Leased assets are depreciated over the shorter of the lease term and their useful lives unless it is reasonably certain that the Company will obtain ownership by the end of the lease term. Land is not depreciated. The estimated useful lives of the class of assets for the current and comparative periods are as follows:

 

Classification

   Estimated Useful Lives  

Leasehold and land improvements

     5-20 years  

Greenhouses and other buildings

     4-30 years  

Greenhouse equipment

     3-30 years  

Machinery and equipment

     3-12 years  

Construction in process reflects the cost of assets under construction, which are not depreciated until placed into service.

Impairment of Non-Financial Assets

Property, plant and equipment and intangible assets are tested for impairment when events or changes in circumstances indicate that the carrying amount may not be recoverable. For the purpose of testing impairment, assets are grouped at the lowest levels for which there are separately identifiable cash flows (cash-generating units or “CGUs”). An impairment loss is recognized for the amount, if any, by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell and value in use (being the present value of the expected future cash flows of the relevant asset or CGUs).

Leased Assets

Leases where the Company assumes substantially all the risks and rewards of ownership are classified as finance leases. Upon initial recognition, the leased asset is measured at an amount equal to the lower of its fair value and the present value of the minimum lease payments. Subsequent to initial recognition, the asset is accounted for in accordance with the accounting policy applicable to that asset. Other leases are operating leases and rent expenses are recognized in the Company’s consolidated statements of income (loss).

Borrowing Costs

Borrowing costs attributable to the acquisition, construction or production of qualifying assets are added to the cost of those assets, until such time as the assets are substantially ready for their intended use. All other borrowing costs are recognized initially at fair value. Borrowings are subsequently carried at amortized cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognized in the consolidated statements of income (loss) over the year of the borrowings using the effective interest method.

Revenue Recognition

Revenue from the sale of produce in the course of ordinary activities is measured at the fair value of the consideration received or receivable, net of returns, trade discounts and volume rebates. Revenue from the production and sale of power is measured at the fair value of the consideration received or receivable. Revenue is recognized when persuasive evidence exists that the significant risks and rewards of ownership have been transferred to the customer, recovery of the consideration is probable, the associated costs and possible return of goods can be estimated reliably, there is no continuing management involvement with the goods, and the amount of revenue can be measured reliably. If it is probable that discounts will be granted and the amount can be measured reliably, then the discount is recognized as a reduction of revenue as the sales are recognized. The timing of the transfer of risks and rewards occurs at the time the produce has been successfully delivered, the risk of loss has passed to the customer, and collectability is reasonably assured.

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Income Taxes

The tax expense for the year comprises current and deferred tax. Tax is recognized in the consolidated statements of income (loss), except to the extent that it relates to items recognized in other comprehensive income or directly in equity.

The current income tax charge is calculated on the basis of the tax laws enacted or substantively enacted at the consolidated statements of financial position dates in the relevant tax jurisdiction. Management periodically evaluates positions taken in tax returns with respect to situations in which applicable tax regulation is subject to interpretation. It establishes provisions where appropriate on the basis of the amounts expected to be paid to the tax authorities.

Deferred income tax is recognized, using the liability method, on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts. Deferred income tax is determined using tax rates (and laws) that have been enacted or substantively enacted at the consolidated statements of financial position dates and are expected to apply when the related deferred income tax asset is realized or the deferred income tax liability is settled.

Deferred income tax assets are recognized only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilized. Offsetting of deferred income tax assets and liabilities occurs only when the deferred income tax assets and liabilities relate to income taxes levied by the same taxation authority on either the same taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.

Share-Based Compensation

The Company grants stock options and performance-based restricted share units (“RSUs”) to certain employees and directors.

Stock options generally vest over three years (33% per year following the grant date) and expire after ten years. Each tranche in an award is considered a separate award with its own vesting period. The fair value of each tranche is measured at the date of grant using the Black-Scholes option pricing model. Compensation expense is recognized over the tranche’s vesting period by increasing contributed surplus based on the number of awards expected to vest. The number of awards expected to vest is reviewed at least annually, with any impact recognized immediately.

The RSUs granted are expected to be settled using the Company’s own equity and issued from treasury. The equity-settled share-based compensation is measured at the fair value of the Company’s common shares as at the grant date in accordance with the terms of the RSU Plan. The fair value determined at the grant date is charged to income on a straight-line basis over the vesting period or when performance based vesting conditions are met, based on the estimate of the number of RSUs that will eventually vest and be converted to common shares, with a corresponding increase in equity.

Provisions

Provisions, where applicable, are recognized in accrued liabilities when the Company has a present legal or constructive obligation as a result of past events, it is more likely than not that an outflow of resources will be required to settle the obligation, and the amount can be reliably estimated. Provisions are measured at management’s best estimate of the expenditure required to settle the obligation at the end of the reporting period, and are discounted to present value where the effect is material.

Income Per Share

Basic income per share are computed using the weighted average number of common shares outstanding during the period. The treasury stock method is used for the calculation of diluted income per share. Under this method, the weighted average number of common shares outstanding assumes that the proceeds to be received on the exercise of dilutive share options are applied to repurchase common shares at the average market price for the period. Share options are dilutive when the average market price of the common shares during the period exceeds the exercise price of the options.

Significant Accounting Judgments and Estimation Uncertainties

The preparation of the consolidated financial statements in conformity with IFRS requires management to make judgments, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets, liabilities, income, and expenses. These estimates and judgments have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.

 

10


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Critical accounting estimates and judgments

i) Estimated useful lives of property, plant and equipment

Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.

ii) Financial instruments

The Company’s over-the-counter derivative includes an interest rate swap used to economically hedge exposure to variable cash flows associated with interest payments on the Company’s borrowings. Management utilizes a third party to value the derivative at each reporting period; the estimates and assumptions used by the third party are based on available market data which includes market yields and counterparty credit spreads.

iii) Biological asset

The fair value of the biological asset is derived using a discounted cash flow model. Management estimates the sales price of produce on the vine by utilizing actual sales prices for the first six weeks of the next year, and estimates the costs to sell and complete by projecting yields and crop, packaging, and transportation costs. The estimated costs are subject to fluctuations based on the timing of prevailing growing conditions and market conditions.

iv) Inventories and cost of sales

Cost of sales is based upon incurred costs, and estimated costs to be incurred, of each crop allocated to both actual and estimated future yields over each crop cycle. The estimates of future yields are reviewed at each reporting period for accuracy. However, numerous factors such as weather, diseases and prevailing market conditions can impact the estimation of pricing, costs, and future yields. The estimated costs to be incurred are based on references to historical costs and updated for discussions with suppliers and senior management. Inventories include the actual cost of the crop not yet defined as a biological asset, packaging supplies, and purchased produce, less the amounts that have been expensed in cost of sales.    

v) Income taxes and deferred income tax assets or liabilities

Management uses judgment and estimates in determining the appropriate rates and amounts in recording deferred taxes, giving consideration to timing and probability. Actual taxes could vary significantly from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities. The recognition of deferred income tax assets is subject to judgment and estimation over whether these amounts can be realized. Management estimates, at this time, that the hail storm insurance proceeds received are not currently taxable, but if certain conditions are not met, a portion could become taxable in the future.

 

4

CHANGES IN ACCOUNTING POLICIES

The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.

IFRS 9, Financial Instruments, addresses classification and measurement of financial assets and financial liabilities, and replaces the multiple category and measurement models in IAS 39, Financial Instruments-Recognition and Measurement . The new Standard limits the number of categories for classification of financial assets to two: amortized cost and fair value through profit or loss. The requirements for financial liabilities are largely in line with IAS 39. IFRS 9 also replaces the models for measuring equity instruments. Equity instruments are either recognized at fair value through profit or loss or at fair value through other comprehensive income. The ability to recognize unquoted equity instruments at cost under IAS 39 is eliminated. The standard is effective for annual periods beginning on or after January 1, 2018. IFRS 9 is not expected to have a material impact on amounts recorded on the consolidated financial statements of the Company.

 

11


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15, issued in May 2014, establishes the requirements for recognizing revenue that apply to all contracts with customers, except for contracts that are within the scope of the Standards on leases, insurance contracts, and financial instruments. IFRS 15 is effective for annual periods beginning on or after January 1, 2018, with early adoption permitted. Management has evaluated the impact of IFRS 15 and does not expect it to have a material impact on the consolidated financial statements of the Company.

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the company also applies IFRS 15. Management is currently assessing the impact on the Company’s consolidated financial statements along with the timing of adoption of IFRS 16. Management expects that

IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

IAS 16, Property, Plant and Equipment, allows for a policy choice for subsequent measurement of property, plant and equipment to be based on historical cost or fair value. The Company has historically carried its land at historical cost. As at December 31, 2016, the Company has changed its policy so that land is initially measured at historical cost but subsequently measured at fair value. Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to the year ended December 31, 2016 only.

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated balance sheet date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture.

 

5

INVENTORIES

 

     December 31, 2017      December 31, 2016  

Deferred crop costs

   $ 19,070      $ 17,847  

Purchased produce inventory

     396        689  

Biological asset adjustment (note 6)

     (2,212      (2,516

Spare parts inventory

     55        88  
  

 

 

    

 

 

 
   $ 17,309      $ 16,108  
  

 

 

    

 

 

 

The cost of inventories recognized as expense and included in cost of sales for the year ended December 31, 2017 amounted to $120,509 (2016 - $118,395). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the consolidated statements of financial position.

 

12


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

6

BIOLOGICAL ASSET

Information about the biological asset presented on the consolidated statements of financial position and in the consolidated statements of income (loss) is as follows:

 

    December 31,
2017
    December 31,
2016
 

Estimated sales value - biological asset Less

  $ 7,937     $ 8,196  

Estimated remaining costs to complete

    3,043       3,257  

Estimated selling costs

    489       493  
 

 

 

   

 

 

 

Fair value of biological asset less costs to sell

    4,405       4,446  

Less actual costs (note 5)

    2,212       2,516  
 

 

 

   

 

 

 

Increase in fair value of biological asset over cost

    2,193       1,930  

Fair value over cost of harvested and sold biological asset - beginning of year

    1,928       3,431  
 

 

 

   

 

 

 

Change in biological asset

  $ 265     $ (1,501
 

 

 

   

 

 

 

 

7

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of the following:

 

    Land     Leasehold
and land
improve-
ments
    Buildings     Machinery
and
Equipment
    Construction
in process
    Total  

Year ended December 31, 2016

         

Opening net book value

  $ 5,027     $ 1,464     $ 53,229     $ 33,868     $ 697     $ 94,285  

Additions/transfers

    (360     360       —         —         2,564       2,564  

Additions-Capital Lease

      —         —         140         140  

Land revaluation

    7,197       —         —         —           7,197  

Placed in service

    —         —         581       2,385       (2,966     —    

Disposals

    —         —         —         (276     —         (276

Accum deprec on disposal

    —         —         —         264       —         264  

Depreciation expense

    —         (132     (3,306     (4,726     —         (8,164

Foreign currency translation adjustment

    —         —         13       112       —         125  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

  $ 11,864     $ 1,692     $ 50,517     $ 31,767     $ 295     $ 96,135  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2016

 

Cost

  $ 11,864     $ 3,820     $ 82,937     $ 65,563     $ 295     $ 164,479  

Accumulated depreciation

    —         (2,128     (32,420     (33,796     —         (68,344
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

  $ 11,864     $ 1,692     $ 50,517     $ 31,767     $ 295     $ 96,135  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Year ended December 31, 2017

 

         

Opening net book value

  $ 11,864     $ 1,692     $ 50,517     $ 31,767     $ 295     $ 96,135  

Additions/transfers

    —         —         (416     789       1,412       1,785  

Additions-Capital Lease

    —         —         —         191       —         191  

Placed in service

    —         —         —         1,071       (1,164     (93

Disposals

    (2,752     —         (5,524     (4,694     (75     (13,045

Accum deprec on disposal

    —         —         1,601       2,521       —         4,122  

Depreciation expense

    —         (95     (2,858     (4,633     —         (7,586

Foreign currency translation adjustment

    —         —         24       221       —         245  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

  $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2017

 

       

Cost

  $ 9,112     $ 3,820     $ 77,029     $ 63,237     $ 468     $ 153,666  

Accumulated depreciation

    —         (2,223     (33,685     (36,004     —         (71,912
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

  $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

13


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. During the year ended December 31, 2016, the Company changed its policy from the cost method to revalue land used in production at fair market value every three years using an external revaluation method performed by an independent appraiser. During the year ended December 31, 2016, land was determined to have increased in value from $4.7 million historical cost to $11.9 million fair market value, resulting in a land revaluation gain of $7.2 million. The gain of $7.2 million had a tax impact to deferred taxes of $1.1 million, resulting in net revaluation surplus in shareholders’ equity on the statements of financial position of $6.1 million. As at December 31, 2017, land, greenhouse buildings, and greenhouse equipment at Delta 3 were contributed as the Company’s investment in the joint venture transaction (note 8). The revaluation surplus related to Delta 3 of $1.8 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the consolidated statements of income (loss).

 

8

INVESTMENT IN JOINT VENTURE

On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms Corp. (“Pure Sunfarms”), a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to pursue large-scale cannabis production in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.

In conjunction with the formation of Pure Sunfarms, Village Farms contributed the rights to lease and purchase the Delta 3 land and greenhouse facility to the joint venture. The contribution of the rights has been accounted for as a reduction of the land and greenhouse facility in exchange for the investment in Pure Sunfarms Corp. It was determined that the land and greenhouse facility had a fair value of $14.9 million (CA$20 million) at the date of contribution. The fair value of the land was determined through an appraisal performed by an independent valuator. The fair value of the greenhouse was determined using the replacement cost model adjusted for the age of the greenhouse. This was a non-cash transaction. The Company recognized a gain of $8.0 million on the contribution of the land and greenhouse. The Company had previously recorded a fair value increase on the Delta 3 land (2016 - $2.1 million), which was recorded in accumulated other comprehensive income, net of taxes of $1.8 million. As a result of the contribution of the Delta 3 land, this amount has been recycled to the consolidated statements of income (loss), and has been included in the gain noted above.

As part of the transaction, Village Farms incurred related transaction costs of $1.1 million (CA$1.4 million), which have been added to the amount of the investment in Pure Sunfarms Corp. in accordance with IAS 28. Included in these costs are 300,000 common share purchase warrants valued at $148 (CA$192), issued to an affiliate of a Canadian financial institution as partial consideration for services related to the joint venture agreement. As at December 31, 2017, the Investment in Joint Venture of $15.7 million is recorded in the consolidated statement of financial position. For the year ended December 31, 2017, the Company’s share of net loss from joint venture totaled $255 (CA$325), which is recorded in the consolidated statement of income.

The Company’s share of the joint venture consists of the following (in $000’s of USD):

 

Balance, beginning of year

   $ —    

Investments in joint venture

     14,882  

Transaction costs

     1,100  

Share of loss for the year

     (255
  

 

 

 

Balance, end of year

   $ 15,727  
  

 

 

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD) :

 

Current assets

  

Cash and cash equivalents

   $ 2,907  

Other current assets

     475  

Non-current assets

     23,144  

Current liabilities

     (1,171

Non-current liabilities

     —    
  

 

 

 

Net assets

   $ 25,355  
  

 

 

 

Reconciliation of net assets:

  

Net loss for the year

   $ (645

Contributions from joint venture partners

     26,000  
  

 

 

 

Net assets

   $ 25,355  
  

 

 

 

 

14


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

     (in $000’s of CAD)  

Revenue

   $ —    

Selling, general and administrative expenses

     (880

Other expense

     (4

Recovery of income taxes

     239  
  

 

 

 

Net loss for the year

   $ (645
  

 

 

 

 

9

OTHER ASSETS

The following table summarizes the components of other assets:

 

     December 31, 2017      December 31, 2016  

Patronage stock

   $ 437      $ 437  

Note receivable (note 13)

     70        101  

Security deposits

     538        103  

Cash surrender value - insurance

     924        840  

Other

     35        50  
  

 

 

    

 

 

 

Total

   $ 2,004      $ 1,531  
  

 

 

    

 

 

 

 

10

DEBT

 

     December 31, 2017      December 31, 2016  

Long-term debt:

     

Opening balance

   $ 45,534      $ 49,187  

Proceeds from long-term debt

     306        —    

Repayment of debt

     (7,320      (3,718

Foreign currency translation

     120        65  
  

 

 

    

 

 

 

Closing balance

   $ 38,640      $ 45,534  
  

 

 

    

 

 

 

Current portion

   $ 2,620      $ 3,291  

Non-current portion

     36,020        42,243  

Less: Unamortized deferred transaction costs

     (260      (314
  

 

 

    

 

 

 
   $ 38,380      $ 45,220  
  

 

 

    

 

 

 

Credit Facilities

The Company has a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan was amended in March 2016 and has a maturity date of May 1, 2021 and a balance of $36,695 as at December 31, 2017. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on May 1, 2021. Monthly principal payments were $347 through May 1, 2016, and $253 effective June 1, 2016. As at December 31, 2017, borrowings under the FCC Loan agreement are subject to an interest rate of 5.88483% (December 31, 2016 - 5.38094%) which is determined based on the Company’s Debt to EBITDA ratio and the applicable LIBOR rate. Beginning January 1, 2018, the Company has a principal payment holiday until April 2018.

The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023, fixed interest rate of 4.98%, and monthly payments of CA$36. As at December 31, 2017, the balance was US$1,658 (December 31, 2016 - US$1,806). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. Any drawings on the issued Letters of Guarantee must be covered by the Company within one business day notice by the bank . The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at December 31, 2017, the balance was US$192 (December 31, 2016 - $nil) .

 

15


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The Company has a line of credit agreement with a Canadian Chartered Bank ( “Operating Loan”). The revolving Operating Loan was amended in May 2016 and has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021, and is subject to margin requirements stipulated by the bank. As at December 31, 2017, $nil was drawn on this facility (December 31, 2016 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling $320 and CA$38.

The Amendments to the Company’s FCC Loan and Operating Loan have been accounted for as modifications of the existing debt in accordance with IAS 39, Financial Instruments: Recognition and Measurement .

The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at December 31, 2017 and 2016, the Company was in compliance with all covenants on its Credit Facilities.

Accrued interest payable on the credit facilities and loans as at December 30, 2017 was $193 (December 31, 2016 - $202) and these amounts are included in accrued liabilities in the consolidated statements of financial position.

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the greenhouse properties, and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at December 31, 2017 was $120,815 (December 31, 2016 - $130,700).

Transaction costs incurred in connection with these financing activities are deferred and amortized over the terms of the related financing agreement. Total deferred financing costs, net of accumulated amortization, are netted against long-term debt on the consolidated statements of financial position, and total $260 as at December 31, 2017 (December 31, 2016 - $314).

The aggregate annual maturities of long-term debt for the next five years and thereafter are as follows:

 

2018

   $ 2,620  

2019

     3,394  

2020

     3,391  

2021

     1,616  

2022

     27,448  

Thereafter

     171  
  

 

 

 
   $ 38,640  
  

 

 

 

 

11

COMMITMENTS

Operating Leases

The Company has entered into certain operating lease commitments for land, office space and equipment through 2022. The future minimum lease payments for the next five years and thereafter are as follows:

 

2018

   $ 1,285  

2019

     940  

2020

     459  

2021

     468  

2022

     248  

Thereafter

     3  
  

 

 

 
   $ 3,403  
  

 

 

 

The Company made payments of $1,682 during the year ended December 31, 2017 (2016 - $1,595). Payments include common area amounts and fees paid to the lessors.

 

16


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

12

FINANCIAL INSTRUMENTS

The following table summarizes the carrying and fair value of the Company’s financial instruments:

 

     December 31, 2017      December 31, 2016  

Cash and cash equivalents

   $ 7,091      $ 5,373  

Trade receivables

   $ 11,259      $ 10,187  

Other financial assets

   $ 2,491      $ 1,047  

Other financial liabilities

   $  56,718      $  62,591  

Interest income, expense and gains and losses from loans, receivables and other financial liabilities are recognized in the consolidated statements of income (loss). The following table summarizes interest income and expense for the years ended December 31:

 

     2017      2016  

Interest income earned on cash and cash equivalents

   $ —        $ —    

Interest expense from other financial liabilities

   $  2,695      $  2,514  

Financial assets and liabilities are recognized on the consolidated statements of financial position at fair value in a hierarchy that is based on significance of the inputs used in making the measurements. The levels in the hierarchy are:

 

   

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

   

Level 2 - Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices)

 

   

Level 3 - Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).

Management of financial risks

The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at December 31, 2017 and 2016. The Company uses financial instruments only for risk management purposes, not for generating trading profit.

i) Credit risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables and other receivables. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 16.0% and 14.8% of the balance of trade receivables as at December 31, 2017 (2016 - three customers represented 12.0%, 11.8%, and 10.1%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales. The maximum amount of credit risk exposure is limited to the carrying amount of the balances on the consolidated financial statements.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At December 31, 2017, the allowance for doubtful accounts balance was $50 (2016 - $50). The Company has not recorded bad debt expense during the year ended December 31, 2017 (2016 - $nil).

At December 31, 2017, 89.4% (2016 - 87.4%) of trade receivables were outstanding less than 30 days, 7.4% (2016 - 9.5%) were outstanding for between 30 and 90 days and the remaining 3.2% (2016 - 3.1%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

 

17


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

ii) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the year ended December 31, 2017 would have been lower by $201. This represents $201 in increased interest expense (2016 - $227).

iii) Foreign exchange risk

At December 31, 2017, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7966 (2016 – US$0.7437). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain consolidated statements of financial position items at December 31, 2017 and December 31, 2016 with the net foreign exchange gain or loss directly impacting net income (loss) for the years.

 

     December 31,
2017
     December 31,
2016
 

Financial assets

     

Cash and cash equivalents

   $ 287      $ 93  

Trade receivables

     349        222  

Financial liabilities

     

Trade payables and accrued liabilities

     (371      (229

Loan payable

     (232      (240
  

 

 

    

 

 

 

Net foreign exchange gain (loss)

   $ 33      $ (154
  

 

 

    

 

 

 

iv) Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at December 31, 2017:

 

Financial liabilities

   Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt, net of fees

   $ 38,380      $ 2,620      $ 6,785      $ 28,805      $ 170  

Trade payables

     12,952        12,952        —          —          —    

Accrued liabilities

     3,793        3,793        —          —          —    

Obligation under capital lease

     251        72        179        —          —    

Other liabilities

     1,097        —          1,097        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 56,473      $ 19,437      $ 8,061      $ 28,805      $ 170  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at December 31, 2017, the Company has an operating loan of up to CA$13,000, less outstanding letters of credit totaling $333 and CA$38.

v) Fair values

The carrying amount of short-term financial instruments, less provisions for impairment if applicable, is consistent with the fair value of such instruments. The Company’s debt bears a variable interest rate tied to market rates and therefore its carrying value approximates its fair value.    

 

13

RELATED PARTY TRANSACTIONS AND BALANCES

As at December 31, 2017, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $411 primarily for consulting services and reimbursement of expenses which occurred in the year. These amounts were non-interest bearing and were due on demand. These amounts are included in other receivables in the December 31, 2017 consolidated statement of financial position.

 

18


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Included in other assets as at December 31, 2017, is a $70 (2016—$101) promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company.    

 

14

COMPENSATION OF KEY MANAGEMENT

Key management includes the Company’s officers and senior vice presidents:

 

     Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 

Salaries and other employee benefits

   $ 1,778      $ 1,887  

Share-based payments

     1,104        91  
  

 

 

    

 

 

 
   $  2,882      $  1,978  
  

 

 

    

 

 

 

 

15

EXPENSES BY NATURE

 

The following table outlines the Company’s significant expenses by nature:

 

Cost of sales    Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 

Purchased produce

   $  41,978      $  41,207  

Raw materials and consumables used

     40,365        38,884  

Depreciation and amortization

     7,447        7,991  

Transportation and storage

     19,999        18,510  

Employee compensation and benefits

     34,644        34,186  
  

 

 

    

 

 

 
   $ 144,433      $ 140,778  
  

 

 

    

 

 

 

 

Selling, general and administrative expenses    Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 

Employee benefits - salaries and short-term benefits

   $  8,422      $  7,928  

Employee benefits - share-based payments

     1,519        195  

Marketing

     617        1,122  

Professional services

     1,705        1,302  

Office expenses

     1,671        1,538  

Other

     1,479        1,635  
  

 

 

    

 

 

 
   $  15,413      $  13,720  
  

 

 

    

 

 

 

 

Employee compensation and benefits    Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 

Salaries and short-term employee benefits

   $  43,066      $  42,114  

Share-based compensation

     1,519        195  
  

 

 

    

 

 

 
   $ 44,585      $ 42,309  
  

 

 

    

 

 

 

 

16

INCOME TAX EXPENSE

The provision for (recovery of) income taxes consists of the following components:

 

     Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 
Current    $ 29      $ 157  
Deferred      109        (1,261
  

 

 

    

 

 

 

Provision for (recovery of) income taxes

   $  138      $ (1,104
  

 

 

    

 

 

 

 

19


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The provision for (recovery of) income taxes reflected in the consolidated statements of income (loss) for the years ended December 31, 2017 and December 31, 2016 differs from the amounts computed at the federal statutory tax rates. The principal differences between the statutory income tax (recovery) and the effective provision for (recovery of) income taxes are summarized as follows:

 

     Year Ended
December 31, 2017
     Year Ended
December 31, 2016
 

Income (loss) before income taxes

   $  3,960      $  (3,087
  

 

 

    

 

 

 

Tax (recovery) calculated at domestic tax rates applicable in the respective countries

     674        (1,196

Non-deductible items

     422        75  

True up of prior year income tax estimates

     —          (219

Tax rate differences on deferred taxes

     (482      —    

State tax adjustments

     (36      30  

Foreign exchange on translation

     132        100  

Unrealized foreign exchange

     116        97  

Differences attributed to joint venture capital transactions

     (698      —    

Share of losses from joint venture

     66     

Other

     (56      9  
  

 

 

    

 

 

 

Provision for (recovery of) income taxes

   $ 138      $ (1,104
  

 

 

    

 

 

 

The statutory tax rate in effect for the year ended December 31, 2017 was 26.0% (2016 - 26.0%) in Canada and 23.0% (2016 - 35.0%) in the United States.

As a result of the US tax reform, the US federal tax rate was substantively enacted on December 22, 2017 and a reduced federal tax rate will be effective from January 1, 2018 in accordance with the Tax Cuts and Jobs Act of 2017. Accordingly, the relevant deferred tax balances have been remeasured with the new rate. As additional interpretations and regulatory guidance becomes available, the Company will continue to assess the impact of the new legislation.

The weighted average applicable tax rate was 3.5% tax benefit for 2017 (2016 - 35.8%).

 

17

DEFERRED INCOME TAXES

The deferred tax assets and liabilities presented on the consolidated statements of financial position are net amounts corresponding to their reporting jurisdiction. The deferred tax assets and liabilities presented in the note disclosure are grouped based on asset and liability classification without consideration of their corresponding reporting jurisdiction.

The amounts in the consolidated statements of financial position reconcile to the amounts disclosed in this note as follows:

 

     December 31, 2017      December 31, 2016  

Deferred tax assets

   $ 7,606      $ 11,957  

Deferred tax liabilities

     (12,431      (16,944
  

 

 

    

 

 

 
   $ (4,825    $ (4,987
  

 

 

    

 

 

 

 

Deferred tax assets:

   Tax losses/
other
credits
    LT Debt/
Interest
    Inventory     Intangibles     Other     Total  

At January 1, 2016

   $ 7,364     $ 3,385     $ 406     $ 416     $ 404     $ 11,975  

Credited /(charged) to statement of loss

     49       (195     112       (17     33       (18
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2016

   $ 7,413     $  3,190     $ 518     $ 399     $ 437     $  11,957  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Credited to statement of income

     (2,289     (968     (144     (399     (551     (4,351
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2017

   $  5,124     $  2,222     $  374     $  —       $ (114   $  7,606  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

20


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

     Accelerated
tax
depreciation
    Biological
asset
    Revaluation
Surplus
    Joint
Venture
Shares
    Total  

Deferred tax liabilities:

          

At January 1, 2016

   $ (15,959   $ (1,200   $ —       $ —       $ (17,159

Credited to statement of loss

     754       526       —         —         1,280  

Charged to statements of other comprehensive income

     —         —         (1,065     —         (1,065
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2016

   $ (15,205   $ (674   $ (1,065   $ —       $ (16,944

Credited/(charged) to statement of income

     6,179       214       —         (2,151     4,242  

Credited to statement of other comprehensive income

     —         —         271       —         271  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At December 31, 2017

   $ (9,026   $ (460   $ (794   $ (2,151   $ (12,431
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The analysis of deferred tax assets and deferred tax liabilities is as follows:

 

     December 31, 2017     December 31, 2016  
     Canada     U.S.     Canada     U.S.  

Deferred tax assets:

        

Expected to be recovered in more than 12 months

     $ 747       $ 5,753       $ 1,914       $ 8,651  

Expected to be recovered within 12 months

     388       718       225       1,167  

Deferred tax liabilities:

        

Expected to be settled in more than 12 months

     (4,606     (6,569     (4,202     (10,846

Expected to be settled within 12 months

     (40     (1,216     (27     (1,869
  

 

 

   

 

 

   

 

 

   

 

 

 

Deferred tax liabilities, net of assets

     $ (3,511)       $ (1,314)       $ (2,090)       $ (2,897)  
  

 

 

   

 

 

   

 

 

   

 

 

 

Non-capital and farm losses expire as follows:

 

     Canada      U.S.      Total  
2021    $ —        $ 7,338      $ 7,338  
2022      —          5,043        5,043  
2023      —          3,993        3,993  
2027      28        —          28  
2028      4        —          4  
2029      27        —          27  
2030      8        —          8  
2031      424        —          424  
2032      4        14,895        14,899  
2033      4        —          4  
2034      5        11,665        11,670  
2035      358        7,445        7,803  
2036      106        3,619        3,725  
2037      146        4,445        4,591  
  

 

 

    

 

 

    

 

 

 
   $  1,114      $  58,443      $  59,557  
  

 

 

    

 

 

    

 

 

 

Deferred income tax assets are recognized for tax loss carry-forwards to the extent that the realization of the related tax benefit through future profits is probable.

 

21


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

18

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

     For the Years Ended December 31,  
     2017      2016  

Trade receivables

   $ (1,059    $ (1,037

Inventories

     (1,197      (2,805

Inventories reclassified to biological asset

     306        132  

Other receivables

     (1,642      161  

Income taxes recoverable

     —          (246

Prepaid expenses and deposits

     41        (379

Trade payables

     394        3,484  

Accrued liabilities and income taxes

     (955      291  

Other assets, net of other liabilities

     (305      (34
  

 

 

    

 

 

 
   $ (4,417    $ (433
  

 

 

    

 

 

 

 

19

SEGMENT AND GEOGRAPHIC INFORMATION

The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer.

The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:

 

     For the Years Ended December 31,  
     2017      2016  

Sales

     

Produce - U.S.

   $ 132,464      $ 131,187  

Produce - Canada

     24,020        22,177  

Energy - Canada

     1,922        2,138  
  

 

 

    

 

 

 
   $  158,406      $  155,502  
  

 

 

    

 

 

 

The Company’s property, plant and equipment, net of accumulated depreciation, are located as follows:

 

     December 31,
2017
     December 31,
2016
 

United States

   $ 46,922      $ 51,459  

Canada

     31,183        40,976  

Energy - Canada

     3,649        3,700  
  

 

 

    

 

 

 
   $ 81,754      $ 96,135  
  

 

 

    

 

 

 

The depreciation and amortization charges for the year ended December 31, 2017 in the Produce business were $6,791 (2016 - $7,616) and $795 (2016 - $548) in the Energy business.

 

20

SHARE CAPITAL AND EQUITY

The following is a summary of share capital:

 

     The VFF Common Shares  
     # of Shares      Amount  

Share capital - January 1, 2016

     38,807,345      $ 24,903  

Shares issued on exercise of options - 2016

     75,600        51  
  

 

 

    

 

 

 

Share capital - December 31, 2016

     38,882,945        24,954  
  

 

 

    

 

 

 

Shares issued pursuant to public offering, net

     2,500,000        9,769  

Share-based compensation - 2017

     768,000        1,333  

Shares issued on exercise of options - 2017

     91,667        59  
  

 

 

    

 

 

 

Share capital - December 31, 2017

     42,242,612      $  36,115  
  

 

 

    

 

 

 

 

22


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

VFF is authorized to issue an unlimited number of common shares and preferred shares, issuable in series. These shares have no par value.

(i) Common shares:

The common shares entitle the holders thereof to one vote per share at all shareholder meetings of VFF. The holders of the common shares are entitled to receive any dividend declared by VFF on the common shares. Subject to the rights, privileges, restrictions and conditions attached to any other class of shares of VFF, the holders of the common shares are entitled to receive, pro rata, the remaining property or assets of VFF upon its dissolution, liquidation or wind-up.

(ii) Preferred shares:

The preferred shares may be issued in one or more series, with such rights and conditions as may be determined by resolution of the directors of VFF who shall determine the designation, rights, privileges, conditions and restrictions to be attached to the preferred shares of such series. There are no voting rights attached to the preferred shares except as prescribed by law. In the event of the liquidation, dissolution or wind-up of VFF, or any other distribution of assets of VFF among its shareholders for the purpose of winding up its affairs, the holders of the preferred shares of each series are entitled to receive, among other things, with priority over the common shares and any other shares ranking junior to the preferred shares of VFF, an amount equal to any cumulative dividends, whether or not declared, or declared thereon but unpaid and no more. The preferred shares for each series are also entitled to such other preferences over the common shares and any other shares ranking junior to the preferred shares as may be determined as to their respective series authorized to be issued. The preferred shares of each series shall be on a parity basis with the preferred shares of every other series with respect to payment of dividends and return of capital. There are no preferred shares currently issued and outstanding.

 

21

INCOME PER SHARE

Basic income per share is calculated by dividing the net income attributable to owners of the Company by the weighted average number of common shares in issue during the year excluding common shares purchased by the Company and held as treasury shares.

 

     For the Years Ended December 31,  
     2017      2016  

Net income (loss) attributable to owners of the Company

   $ 3,822      $ (1,983

Weighted average number of common shares outstanding (thousands)

     39,144        38,883  
  

 

 

    

 

 

 

Basic income (loss) per share

   $ 0.10      $ (0.05
  

 

 

    

 

 

 

Diluted income per share is calculated by adjusting the weighted average number of common shares outstanding to assume conversion of all dilutive potential common shares. The Company’s share options are potentially dilutive to common shares. A calculation is done to determine the number of shares that could have been acquired at fair value (determined as the average market share price of the Company’s shares for the year) based on the monetary value of the subscription rights attached to outstanding share options. The number of shares calculated above is compared with the number of shares that would have been issued assuming the exercise of the share options. If dilutive effect is less than zero, then issuance is anti-dilutive and is excluded from dilutive income per share calculation.

 

    For the Years Ended December 31,  
    2017     2016  

Net income (loss) attributable to owners of the Company

  $ 3,822     $ (1,983

Weighted average number of common shares outstanding (thousands)

    39,144       38,883  

Adjustment for:

   

Share options (thousands)

    1,164       293 61  
 

 

 

   

 

 

 

Weighted average number of common shares outstanding for diluted income per share (thousands)

    40,308       39,176  
 

 

 

   

 

 

 

Diluted income (loss) per share

  $ 0.10     $ (0.05
 

 

 

   

 

 

 

 

22

CAPITAL DISCLOSURES

The Company’s objectives when managing capital are to safeguard its assets and maintain a competitive cost structure, continue as a going concern and provide returns to its shareholders. In addition, the Company works with all relevant stakeholders to ensure the safety of its operations and employees and remain in compliance with all environmental regulations.

 

23


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The Company’s main objectives when managing capital are:

 

   

to structure the repayment of obligations in line with the expected lives of the Company’s principal revenue generating assets;

 

   

to ensure the Company has access to capital to fund contractual obligations as they become due and to ensure adequate cash levels to withstand the impact of unfavorable economic conditions;

 

   

to maintain the Company’s credit ratings to facilitate access to capital markets at competitive interest rates; and

 

   

to access capital markets to fund its growth initiatives.

The Company’s capital comprises net debt and equity:

 

     December 31,
2017
     December 31,
2016
 

Total bank debt

   $  38,640      $  45,534  

Less cash and cash equivalents

     (7,091      (5,373
  

 

 

    

 

 

 

Net debt

     31,549        40,161  

Total equity

     81,043        67,387  
  

 

 

    

 

 

 
     $ 112,592      $ 107,548  
  

 

 

    

 

 

 

It is the Company’s intention to meet its obligations through the collection of current accounts receivable and cash. As at December 31, 2017, the Company has an operating loan up to CA$13,000, less $333 and CA$38 outstanding letters of credit (as at December 31, 2016, $nil was outstanding on the operating loan, and $333 and CA$38 outstanding on the letters of credit). As at December 31, 2017, the operating loan borrowing base was CA$10,400 based on a percentage of the Company’s outstanding accounts receivable less the issued letters of credit. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

 

23

SHARE-BASED COMPENSATION PLAN

The Company has a share-based compensation plan. The maximum number of common shares that can be issued upon the exercise of options granted is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options vest at a rate of 33% per year, beginning one year following the grant date of the options. Share-based compensation expense for the year ended December 31, 2017 of $1,519 (2016—$195) was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.

The following table presents the assumptions used to establish the fair value assigned to the options issued using the Black-Scholes valuation model:

 

     December 2017     June 2016     March 2016     November 2015  

Expected volatility

     52.7     51.9     52.5     53.3

Dividend

     $nil       $nil       $nil       $nil  

Risk-free interest rate

     2.05     1.26     1.52     1.39

Expected life

     6.5 years       6.5 years       6.5 years       6.5 years  

Fair value

     $3.1869       $0.795       $0.738       $0.421  

Expected volatility was based on three years of historical data.

 

24


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The following table summarizes stock options of 320,000 granted during the year. In addition, for the year ended

December 31, 2017, there were 91,667 stock options exercised and 6,666 stock options forfeited.

 

     For the Years Ended December 31,  
     2017      2016  
     Stock options      Weighted
average grant
date fair value
     Stock options      Weighted average
exercise price
 

Beginning of year

     2,116,065      CA$ 1.19        1,899,999      CA$ 1.14  

Granted

     165,000      CA$ 2.20        250,000      CA$ 1.43  

Granted

     155,000      CA$ 6.00        50,000      CA$ 1.55  

Exercised

     (16,667    CA$ 0.83        (25,000    CA$ 1.24  

Exercised

     (25,000    CA$ 1.10        (50,600    CA$ 0.70  

Exercised

     (50,000    CA$ 0.70        —          —    

Forfeitures

     (6,666    CA$ 1.48        (8,334    CA$ 1.48  
  

 

 

    

 

 

    

 

 

    

 

 

 

End of year

     2,337,732      CA$ 1.59        2,116,065      CA$ 1.19  
  

 

 

    

 

 

    

 

 

    

 

 

 

The following table summarizes stock options outstanding and granted as at December 31, 2017:

 

Exercise price

   Number
outstanding
     Remaining
contractual
life (years)
     Number of
exercisable
options
 

CA$0.70

     149,399        2.0        149,399  

CA$1.24

     565,000        3.4        565,000  

CA$1.27

     150,000        4.2        150,000  

CA$0.85

     100,000        5.2        100,000  

CA$1.10

     215,000        5.7        215,000  

CA$1.48

     360,000        6.2        360,000  

CA$0.94

     100,000        7.2        66,667  

CA$0.83

     28,333        7.8        13,334  

CA$0.80

     50,000        7.9        33,334  

CA$1.43

     250,000        8.3        83,338  

CA$1.55

     50,000        8.5        16,667  

CA$2.20

     165,000        9.5        Nil  

CA$6.00

     155,000        10.0        Nil  
  

 

 

       
     2,337,732        
  

 

 

       

Share options outstanding at the end of the year have the following expiry dates and exercise prices:

 

     Exercise price
in CA$ per
share
     December 31,
2017
     December 31,
2016
 

Expiry date - January 13, 2020

     0.70        149,399        199,399  

Expiry date - May 20, 2021

     1.24        565,000        565,000  

Expiry date - March 13, 2022

     1.27        150,000        150,000  

Expiry date - March 13, 2023

     0.85        100,000        100,000  

Expiry date - September 26, 2023

     1.10        215,000        240,000  

Expiry date - March 18, 2024

     1.48        360,000        366,666  

Expiry date - March 19, 2025

     0.94        100,000        100,000  

Expiry date - October 6, 2025

     0.83        28,333        45,000  

Expiry date - November 16, 2025

     0.80        50,000        50,000  

Expiry date - March 29, 2026

     1.43        250,000        250,000  

Expiry date - June 30, 2026

     1.55        50,000        50,000  

Expiry date - June 14, 2027

     2.20        165,000        —    

Expiry date - December 22, 2027

     6.00        155,000        —    
     

 

 

    

 

 

 
        2,337,732        2,116,065  
     

 

 

    

 

 

 

During 2017, 906,000 performance-based restricted share units were issued to Village Farms employees involved with the recently formed joint venture with Pure Sunfarms, Corp. Once a performance target is met and the shares units are deemed earned and vested, compensation expense based was recorded based on the fair value of the share units on grant date and is included in selling, general and administrative expenses in the consolidated statement of income. There were 128,000 performance-based restricted share units outstanding, which had not yet vested as at December 31, 2017.

 

25


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Consolidated Financial Statements for the Years Ended December 31, 2017 and 2016

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The following table summarizes 906,000 performance-based restricted share units were issued during the year.

 

     2017  
     Performance-
based restricted
share units
     Weighted average
grant date fair
value in CA$
 

Beginning of year

     —       

Issued

     885,000      CA$ 2.20  

Issued

     21,000      CA$ 6.00  

Exercised

     (768,000    CA$ 2.20  

Expired

     (10,000    CA$ 2.20  
  

 

 

    

 

 

 

Outstanding at end of year

     128,000      CA$ 2.82  
  

 

 

    

 

 

 

Exercisable at end of year

     —       
  

 

 

    

24 SUBSEQUENT EVENT

On March 5, 2018 the Company, and joint venture partner Emerald, announced that Health Canada had issued a Cultivation Licence to Pure Sunfarms under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

 

26

Exhibit 99.12

Village Farms International, Inc.

Management’s Discussion and Analysis

Year Ended December 31, 2017

April 2, 2018


Village Farms International, Inc.

 

 

Management’s Discussion and Analysis

Information is presented in thousands of United States dollars (“U.S. dollars”) unless otherwise noted.

Introduction

This management’s discussion and analysis (“MD&A”) should be read in conjunction with the annual consolidated financial statements and accompanying notes of Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”), for the year ended December 31, 2017 (the “Consolidated Financial Statements”). The information provided in this MD&A is current to April 2, 2018 unless otherwise noted.

VFF is a corporation existing under the Canada Business Corporations Act . The Company’s principal operating subsidiaries at December 31, 2017 were Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”) and VF Clean Energy, Inc. (“VFCE”). On June 6, 2017 VFF entered into a shareholders’ agreement in respect of the operation and governance of Pure Sunfarms Corp. (“Pure Sunfarms”) in which VFF owns a 50% interest.

Basis of Presentation

The annual data included in the MD&A is presented in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.

The preparation of annual financial data requires the use of certain accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the annual financial data, are disclosed in note 3 of the Consolidated Financial Statements.

Segment Reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the CEO. Based on the aggregation criteria in IFRS 8, Operating Segments , the operating segments of the Company are treated as two reporting segments.

Functional and Presentation Currency

The financial data is presented in U.S. dollars, which is the Company’s functional currency. All financial information presented in U.S. dollars has been rounded to the nearest thousand.

Business Overview

Management believes that the Company is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America. These premium products are grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas. The Company also markets and distributes premium tomatoes, peppers and cucumbers produced under exclusive arrangements with other greenhouse producers. The Company primarily markets and distributes under its Village Farms ® brand name, primarily to retail supermarkets and dedicated fresh food distribution companies throughout the United States and Canada. It currently operates two distribution centres, one located in the United States and one in Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates four main goals – environmental health, economic profitability and social and economic equality. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant from landfill gas that generates electricity and provides thermal heat, in colder months, to one of the Company’s adjacent British Columbia greenhouse facilities and sells electricity to British Columbia Hydro and Power Authority (“BC Hydro”).

The Company embraces sustainable agriculture and environmentally-friendly growing practices by:

 

2


Village Farms International, Inc.

 

 

   

utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their products virtually free of chemical agents. The process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies;

 

   

capturing rainwater from various greenhouse roofs for irrigation purposes;

 

   

capturing landfill gas on a long term contract from the City of Vancouver landfill to generate electricity under a long term contract with BC Hydro and thermal heat for an adjacent greenhouse;

 

   

recycling water and nutrients during the production process;

 

   

growing plants in a natural medium, including coconut fibre and rock wool, as opposed to growing in the soil and depleting nutrients; and

 

   

using dedicated environmental control computer systems which monitor and control virtually all aspects of the growing environment, thereby maximizing the efficient use of energy.

The Company’s assets, as of the reporting date, include six operating produce greenhouses providing approximately 837,094 square metres (or approximately 212 acres) of growing space in Canada and the United States. For the year ended December 31, 2017 the Company had seven operating produce greenhouses. During 2017, the Company granted rights to one of its greenhouses located in Delta, BC (the “Delta 3 Greenhouse”) to Pure Sunfarms. Pure Sunfarms is in the process of converting the Delta 3 Greenhouse into a facility compliant with Access to Cannabis for Medical Purposes Regulations (“ACMPR”) with the object of seeking to achieve large scale low-cost high quality cannabis production. Pure Sunfarms received a cultivation license from Health Canada for the Delta 3 Greenhouse on March 2, 2018.    

All of the Company’s greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company also has marketing agreements with growers in Canada, United States and Mexico that currently operate approximately 572,800 square metres (or approximately 140 acres) of growing area.

The following table outlines the Company’s greenhouse facilities:

 

     Growing Area

Greenhouse Facility

   Square
Feet
     Square
Metres
     Acres     

Products Grown

Marfa, TX (2 greenhouses)

     2,527,312        234,795        60      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Fort Davis, TX (1 greenhouse)

     1,684,874        156,530        40      Specialty tomatoes

Monahans, TX (1 greenhouse)

(Permian Basin facility)

     1,272,294        118,200        30      Tomatoes on-the-vine, long English cucumbers

Delta, BC (2 greenhouses)

     3,664,390        340,433        85      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Pure Sunfarms (1 greenhouse)

     1,077,758        100,127        25      Leased to Pure Sunfarms for cultivation of cannabis
  

 

 

    

 

 

    

 

 

    

Total

     10,226,628        950,085        240     

Marketing

The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed provider to be the sole grower in North America), other speciality tomatoes under exclusive agreements and long English cucumbers at its facilities. The Company also distributes and markets premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.

The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.

 

3


Village Farms International, Inc.

 

 

The Company has distribution capabilities that it believes exceed those of most of its competitors in the North American greenhouse vegetable industry. With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the year ended December 31, 2017, the Company had an on-time delivery record of approximately 98.5%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.

The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:

 

   

Year-Round Supplier. Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing.

 

   

Quality and Food Safety. Sales are made directly to retailers which ensure control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs ® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs ® .

 

   

Quality Packaging and Presentation. Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf.

 

   

Exclusive Varieties. The Company expands its product profile, to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand.

 

   

Direct Sale to Retail Customers. Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including, Associated Grocers, Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fred Meyer, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, Inc., HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Publix Super Markets, Inc., Roundy’s Supermarkets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, United Supermarkets, Unified Western Grocers, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC.

 

   

Excellence in Customer Service and Logistics. Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres.

Investment in Joint Venture

On June 6, 2017, the Company and Emerald Health Botanicals, Inc. (“Emerald”) formed a new corporation named “Pure Sunfarms Corp.”. The Company and Emerald each own 50% of the shares of Pure Sunfarms. VFF contributed rights to one of its 25-acre greenhouse facilities in Delta, British Colombia as its equity contribution and Emerald agreed to contribute CA$20,000,000 to fund the conversion of the facility, of which CA$2,000,000 was contributed in June 2017 and CA$10,000,000 was placed in escrow, with the remaining CA$8,000,000 to be contributed as needed. On March 2, 2018, Health Canada granted a cultivation licence for a portion of the facility. On March 6, CA$10,000,000 was released from escrow to Pure Sunfarms pursuant to the escrow agreement. As of the date of this filing, Emerald has contributed all but CA$2,000,000 of its initial agreed CA$20,000,000 equity contribution. Pure Sunfarms has commenced the cultivation of cannabis in the licensed portion of the facility in order to begin the process of applying and being granted its sales license for the facility, which it hopes to have completed on or before July 1, 2018. Pure Sunfarms also continues the conversion process on the remaining unlicensed portion of the facility.

As part of the formation of Pure Sunfarms, VFF incurred related transaction costs of CA$1,400,000, which have been added to the amount of the investment in accordance with IAS 28, Investments in associates and joint ventures. Included in these costs are 300,000 common share purchase warrants valued at CA$192,000, issued to an affiliate of a Canadian financial institution as partial consideration for services provided in respect of the formation of the Pure Sunfarms. Each such warrant entitles the holder to purchase one common share at an exercise price of CA$2.07. Each such warrant is to be exercised up to June 6, 2020. Additionally, both shareholders of Pure Sunfarms are incurring

 

4


Village Farms International, Inc.

 

 

reimbursable costs and expenditures to support Pure Sunfarms operations, which will be reimbursed by Pure Sunfarms and are considered either capital expenditures or operating expenditures of Pure Sunfarms.

Results of Operations

Consolidated Financial Performance

(In thousands of U.S. dollars, except per share amounts)

 

     For the three months
ended December 31,
 
     2017      2016  

Sales

   $ 36,864      $ 37,308  

Cost of sales

     (31,908      (31,891

Selling, general and administrative expenses

     (4,019      (3,848

Stock compensation expense

     (959      (46

Change in biological asset (1)

     1,082        (157

Income from operations

     1,060        1,366  

Interest expense, net

     (679      (610

Other (expense)

     (81      16  

Share of (loss) from joint venture

     (35      —    

Loss on disposal of assets

     (551      —    

Provision for income taxes

     (321      (287

Net (loss) income

     (607      453  

EBITDA (2)

     2,591        3,501  

Income (Loss) per share/ basic

   ($ 0.02    $ 0.01  

Income (Loss) per share/ diluted

   ($ 0.02    $ 0.01  

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 6 of the Company’s annual consolidated financial statements for the year ended December 31, 2017.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

Results of Operations for the Three Months Ended December 31, 2017 compared to the Three Months Ended December 31, 2016

Sales

Sales for the three months ended December 31, 2017 decreased by ($444), or (1%), to $36,864 from $37,308 for the three months ended December 31, 2016. The decrease in sales is primarily due to a decrease in the Company’s supply partner product volume of (16%) and a decrease in the average selling price of tomatoes from the Company’s facilities of (6%), partially offset by an increase in the Company’s facilities production volume of 3%. The decrease in supply partner revenue is due to the transition from one primary Mexican supply partner to a new primary Mexican supply partner who is in the process of expanding its operations.

The average selling price for tomatoes remained flat for the three months ended December 31, 2017 versus the three months ended December 31, 2016. Cucumber pricing increased by 9% and pepper pricing decreased by (3%) in the fourth quarter of 2017 versus the comparable quarter in 2016.

Cost of Sales

Cost of sales for the three months ended December 31, 2017 was essentially flat at $31,908 from $31,891 for the three months ended December 31, 2016. The Company lowered its cost per pound at its facilities during the quarter by 2% versus the same quarter in 2016. The decrease was due to an increase in the lower cost non-specialty tomato varieties.

 

5


Village Farms International, Inc.

 

 

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $171 to $4,019 for three months ended December 31, 2017 from $3,848 for the three months ended December 31, 2016. The increase is due to higher sales and marketing costs.

Stock Compensation Expense

Stock compensation expense for the three months ended December 31, 2017 was $959 from $46 for the three months ended December 31, 2016. The stock compensation consists of stock grants to executive officers related to the Company’s investment in Pure Sunfarms Corp.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended December 31, 2017 increased by $1,239 to $1,082 from ($157) for the three months ended December 31, 2016. The increase is due to a lower starting biological asset value at October 1, 2017 versus October 1, 2016. The fair value of the biological asset as at December 31, 2017 was $4,405 as compared to $4,446 as at December 31, 2016 due to lower production, offset by higher selling price in January 2018 versus January 2017.

Income from Operations

Income from operations for the three months ended December 31, 2017 decreased ($306) to $1,060 from $1,366 for the three months ended December 31, 2016. The decrease is due to an increase in stock compensation expense of $959, an increase in selling general and administrative expense offset by a higher net change in the fair value of the biological asset for three months ended December 31, 2017 versus the three months ended December 31, 2016.

Interest Expense, net

Interest expense, net, for the three months ended December 31, 2017 increased by ($69), to $679 from $610 for the three months ended December 31, 2016.

Share of (loss) from Joint Venture

The Company’s share of the loss for the three months ended December 31, 2017 is ($35), which consists of travel and other administrative costs.

Provision for Income Taxes

Income tax provision for the three month period ended December 31, 2017 was $321 compared to $287 for the three month period ended December 31, 2016. The income tax provision increased due to a change in the United States future tax rate that caused a reduction in the tax asset value in the United States.

Net (loss) Income

Net income for the three months ended December 31, 2017 decreased by ($1,060) to a net loss of ($607) from net income of $453 for the three months ended December 31, 2016 primarily as a result of an increase in stock compensation in 2017 and loss recognition of ($551).

EBITDA

EBITDA for the three months ended December 31, 2017 decreased by ($910), or (26%), to $2,591 from $3,501 for the three months ended December 31, 2016, primarily as a result of a decrease in sales, a small loss from the joint venture and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.

 

6


Village Farms International, Inc.

 

 

Annual Consolidated Financial Performance

 

     For the year ended December 31,  
(in thousands, except per Share amounts)    2017      2016      2015  

Sales

   $ 158,406      $ 155,502      $ 141,934  

Cost of Sales

     (144,433      (140,778      (128,178

Selling, general and administrative

     (13,894      (13,525      (11,870

Stock compensation expense

     (1,519      (195      176  

Change in biological asset (1)

     265        (1,501      1,922  

(Loss) income from operations

     (1,175      (497      3,632  

Interest expense, net

     2,695        2,514        2,256  

Other income (expense), net

     72        (64      (443

Share of (loss) from joint venture

     (255      —          —    

(Gain) loss on disposal of assets

     (8,013      12        —    

Provision for (Recovery of) income taxes

     138        (1,104      (1,161

Net income (loss)

     3,822        (1,983      2,094  

EBITDA (2)

   $ 7,363      $ 9,385      $ 10,193  

(Loss) earnings per share – basic

   $ 0.10      ($ 0.05    $ 0.05  

(Loss) earnings per share –diluted

   $ 0.10      ($ 0.05    $ 0.05  

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 6 of the Company’s annual consolidated financial statements for the year ended December 31, 2017.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

Results of Operations for the Year Ended December 31, 2017 Compared to the Year Ended December 31, 2016

Net Sales

Net sales for the year ended December 31, 2017 increased $2,904, or 2%, to $158,406 compared to $155,502 for the year ended December 31, 2016. The increase in net sales is due to an increase in supply partner revenues of 4% over the comparable period in 2016, an increase of 4% in the Company’s product volume, partially offset by a decrease of (4%) in the average selling price of the Company’s facilities product for the year ended December 31, 2017 versus the year ended December 31, 2016.

The net price for tomatoes decreased (1%) and pounds sold increased 3% for the year ended December 31, 2017 versus the year ended December 31, 2016. Pepper prices decreased (9%) and pounds sold increased 10% over the comparable period in 2016 and cucumber prices decreased (3%) and pieces decreased (2%) for the year ended December 31, 2017 over the comparable period in 2016.

Cost of Sales

Cost of sales for the year ended December 31, 2017 increased ($3,655), or (3%), to $144,433 from $140,778 for the year ended December 31, 2016. The increase is due to the increase in supply partner cost of sales of 4%, additional freight cost due to 6% more produce being shipped and higher cost from the Company’s facilities due to 4% higher production volume. The cost at the Company’s facilities decreased by (3%) on a per-pound basis versus the same period in 2016.

Change in Biological Asset

The net change in fair value of biological asset for the year ended December 31, 2017 increased $1,766 to $265 from ($1,501) for the year ended December 31, 2016. The increase is due to a lower beginning value on January 1, 2017 versus January 1, 2016.

 

7


Village Farms International, Inc.

 

 

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the year ended December 31, 2017 increased ($369), or (3%), to $13,894 from $13,525 for the year ended December 31, 2016. The increase is due to higher sales and marketing costs.

Stock Compensation Expense

Stock compensation expense for the year ended December 31, 2017 was $1,519 up from $195 for the year ended December 31, 2016, due to the issuance of restricted stock units during the year ended December 31, 2017. The stock compensation consists of stock grants to executive officers related to the Company investment in Pure Sunfarms Corp.

Loss from Operations

Loss from operations for the year ended December 31, 2017 is ($1,175), which was an increased (loss) of ($678) from a loss of ($497) for the year ended December 31, 2016. The decrease in operating results is due to an increase in cost of sales and stock compensation expenses partially offset by an increase in sales and an increase in the change in biological asset.

Interest Expense, net

Interest expense, net, for the year ended December 31, 2017 increased ($180) to $2,695 from $2,514 for the year ended December 31, 2016. The increase is due to an increase in the Company’s long term debt borrowing rate.

Share of (loss) from Joint Venture

The Company’s share of the loss in respect at Pure Sunfarms for the year ended December 31, 2017 is ($255), which consists primarily of travel and other administrative costs.

Provision for (Recovery of) Income Taxes

Income tax provision for the year ended December 31, 2017 was $138 compared to a recovery of ($1,104) for the year ended December 31, 2016. The income tax expense increase is due to a change in the United States future tax rate that caused a reduction in the tax asset value in the United States.

Gain (loss) on Disposal of Assets

For the year December 31, 2017, the Company recognized a gain of $8,013 on the contribution of rights to one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms in exchange for a 50% equity stake in the Pure Sunfarms. See “Investment in Joint Venture” above. For the period ended December 31, 2016, the Company had a loss of ($12).

Net Income (Loss)

Net Income (loss) for the year ended December 31, 2017 improved by $5,805 to a net income of $3,822 from a net loss of ($1,983) for the year ended December 31, 2016. The increase is a result of a gain on assets partially offset by the decrease in income from operations, and an increase in the provision for income taxes.

EBITDA

EBITDA for the year ended December 31, 2017 decreased by ($2,022) to $7,363 from $9,385 for the year ended December 31, 2016, primarily due to a decrease of (4%) in the average selling price of the Company’s produce product. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Earnings to EBITDA”.

 

8


Village Farms International, Inc.

 

 

Results of Operations for the Year Ended December 31, 2016 Compared to the Year Ended December 31, 2015

Sales

Net sales for the year ended December 31, 2016 increased $13,568, or 10%, to $155,502 compared to $141,934 for the year ended December 31, 2015. The increase in net sales is due to an increase in supply partner revenues of 57% over the comparable period in 2015. Company product revenues decreased (3%) for the year ended December 31, 2016 versus the year ended December 31, 2015 due to lower tomato pounds as a result of crop issues primarily relating to TOV and beefsteak varieties at our Canadian facilities.

The net price for all tomato pounds sold increased 2% for the year ended December 31, 2016 versus the year ended December 31, 2015, which was driven by an increase in the volume of higher priced specialty tomatoes sold. Pepper prices decreased (6%) while pepper pounds sold decreased (12%), in 2016, over the comparable period in 2015. Cucumber prices increased 1% and cucumber pieces sold increased 18% for the year ended December 31, 2016 over the comparable period in 2015. The sales of cucumber pieces increased due to a 20% increase in partner suppliers and a 16% increase from the Company’s owned facility. The increase at the Company’s owned facility is due to the impact of supplemental lights on the cucumber area during 2016.

Cost of Sales

Cost of sales for the year ended December 31, 2016 increased $12,600, or 10%, to $140,778 from $128,178 for the year ended December 31, 2015. The increase is due to the increase in supply partner cost of sales of 59% partially offset by a (4%) decrease in cost at the Company’s facilities versus the same period in 2015.

Change in fair value of biological asset, net

The net change in fair value of biological asset for the year ended December 31, 2016 decreased ($3,423) to ($1,501) from $1,922 for the year ended December 31, 2015. The decrease is due to a higher beginning value on January 1, 2016 versus the January 1, 2015 value, lower selling prices in January 2017 versus the same period in 2016 and lower production in January 2017 versus the same period in 2016, due to the cyclical nature of the Companies crop cycle at the Permian Basis facility.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the year ended December 31, 2016 increased $1,674, or 14%, to $13,720 from $12,046 for the year ended December 31, 2015. The increase is due to increases in sales and marketing costs associated with the increase in supply partner revenues.

Income (Loss) from Operations

Income (Loss) from operations for the year ended December 31, 2016 is ($497), which was a decrease of ($4,129) from income from operations of $3,632 for the year ended December 31, 2015. The decrease in operating results is due to a decrease in the change in fair value of biological asset of ($3,423) and an increase in selling and marketing expenses of ($1,674).

Interest Expense, net

Interest expense, net, for the year period ended December 31, 2016 increased ($258) to $2,514 from $2,256 for the year period ended December 31, 2015. The increase is due to an increase in the interest rate on the Company’s long term debt as of May 1, 2016.

Income Taxes

Income tax (recovery) for the year period ended December 31, 2016 was ($1,104) compared to ($1,161) for the year period ended December 31, 2015. The effective tax rate is 36% for the year period ended December 31, 2016 and (124%) for the same period in 2015. For 2015, the U.S. operations effective tax recovery rate was 35% and the Canadian operation had an effective tax rate of 4%, due to the change in exchange rate effective of the debt in Canada issued in U.S dollars.

 

9


Village Farms International, Inc.

 

 

Net (Loss) Income

Net (loss) income for the year period ended December 31, 2016 decreased ($4,077) to a loss of ($1,983) from income of $2,094 for the year period ended December 31, 2015. The decrease is primarily a result of a decrease in the change in biological asset and higher selling, general and administrative expenses.

EBITDA

EBITDA for the year period ended December 31, 2016 decreased ($808), or (8%), to $9,385 from $10,193 for the year period ended December 31, 2015, primarily as a result of lower margins on supply partner volumes and an increase in the selling, general and administrative expenses as compared to the same period in 2015, partially offset by improvements in the cost management at the Company’s owned assets. See the EBITDA calculation in “Non-IFRS Measures - Reconciliation of Net Earnings to EBITDA”.

Selected Statement of Financial Position Data

 

     As at
December 31,
2017
     As at
December 31,
2016
 

Total assets

   $ 142,341      $ 134,965  

Total liabilities

   $ 61,298      $ 67,578  

Shareholders’ equity

   $ 81,043      $ 67,387  

Non-IFRS Measures

References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

 

10


Village Farms International, Inc.

 

 

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:

 

     For the three months ended
December 31,
    For the year ended
December 31,
 
(in thousands of U.S. dollars)    2017     2016      2017     2016     2015  

Net income (loss)

   ($ 607   $ 453      $ 3,822     ($ 1,983   $ 2,094  

Add:

           

Amortization

     1,833       1,917        7,586       8,164       8,285  

Foreign currency exchange loss (gain)

     31       31        (26     86       225  

Interest expense

     679       610        2,695       2,514       2,256  

Income taxes

     321       287        138       (1,104     (1,161

Stock based compensation

     959       46        1,519       195       176  

Change in biological asset

     (1,082     157        (265     1,501       (1,922

Share of loss from joint venture

     35       —          255       —         —    

Share of (loss) from joint venture not related to taxes

     (129     —          (348     —         —    

(Gain) Loss on disposal of assets

     551       —          (8,013     12       240  
  

 

 

   

 

 

    

 

 

   

 

 

   

 

 

 

EBITDA

   $ 2,591     $ 3,501      $ 7,363     $ 9,385     $ 10,193  

Liquidity

Cash flows

The Company expects to provide adequate financing to maintain and improve its property, plant and equipment and to fund working capital needs for the foreseeable future from cash flows from operations, and, if needed, from additional borrowings under the Credit Facilities (as defined below) or other long-term facilities, including capital leases or subordinated debt issuances.

For the three months ended December 31, 2017, cash flows from operating activities before changes in non-cash working capital and change in biological asset totalled $4,142 (2016 – $3,429) and for the year ended December 31, 2017 was $7,965 (2016 - $7,598).

Capital expenditures totalled $525 for the three months ended December 31, 2017 (2016 - $708) and $1,696 for the year ended December 31, 2017 (2016 – $2,193).

The cash provided by (used in) financing activities for the three months ended December 31, 2017 totalled $1,478 (2016 – ($4,426)) and for the year ended December 31, 2017 totalled $141 (2016 – ($6,059)). For the three months ended December 31, 2017, the cash provided by (used in) financing activities primarily consisted of proceeds from issuance of common stock of $9,769 offset by operating loan payments of ($3,000), net term debt payments of ($4,639) and interest payments of ($665) (2016 – debt payments of ($3,797) and interest paid ($643)). For the year ended December 31, 2017, the cash provided by (used in) financing activities primarily consisted of proceeds from issuance of common stock $9,769, offset by net term debt payments of ($7,014) and interest payments of ($2,614) (2016 – operating loan borrowings $4,000, debt payments of ($7,718) and interest paid ($2,351)).

Capital Resources

 

(in thousands of U.S. dollars unless otherwise noted)    Maximum      Outstanding
December 31,
2017
 

Operating Loan

   CA$ 13,000      $ nil  

Term Loan

   $ 36,695      $ 36,695  

VFCE Loan

   CA$ 2,320      CA$ 2,320  

 

11


Village Farms International, Inc.

 

 

The Company is party to a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). This non-revolving variable rate term loan was amended in March 2016 and now has a maturity date of May 1, 2021 and a balance of $36,695 as at December 31, 2017. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on maturity. In December 2017, the Company made a pre-payment on the term loan of $4,000. The Company did not have to make principal payments from January to March 2018. Monthly principal payments of $253 will begin in April 2018. As at December 31, 2017, borrowings under the FCC Loan were subject to an interest rate of 5.884% per annum (December 31, 2017 – 5.380% per annum). The Company’s interest rate on the FCC Loan is determined based on the Company’s Debt to EBITDA ratio on December 31 of the prior year and the current monthly applicable LIBOR rate.

The Company is also party to a variable rate line of credit agreement with a Canadian chartered bank that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank. As at December 31, 2017, $nil was drawn on the Operating Loan (December 31, 2016 – $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit of US$320 and CA$38 (or US$29).

The Company’s subsidiary, VFCE, has a non-revolving fixed rate loan of CA$3.0 million with a maturity date of September 30, 2023, a fixed interest rate of 4.98% per annum, and monthly payments of principal and interest of CA$36. In October 2017, VFCE borrowed an additional CA$250 payable at CA$4 per month plus interest of prime plus 2% per annum. As at December 31, 2017, the outstanding balance was CA$2,320 (US$1,850) (December 31, 2016 - US$1,806).

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at December 31, 2017 was $120,815 (December 31, 2016 – $130,700).

As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therefore. The carrying value of the assets pledged as collateral as at December 31, 2017 was $32,883 (December 31, 2016 - $30,515).

The borrowings are subject to certain positive and negative covenants, which include debt coverage ratios. As at December 31, 2017, the Company was in compliance with all of its covenants.

Accrued interest payable on the Credit Facilities as at December 31, 2017 was $193 (December 31, 2016 – $202) and these amounts are included in accrued liabilities in the interim statements of financial position.

Transaction costs incurred in connection with these financing activities are deferred and amortized over the terms of the related financing agreement. Total deferred financing costs, net of accumulated amortization, are netted against long-term debt on the interim statements of financial position, and total $260 as at December 31, 2017 (December 31, 2016 – $314).

Contractual Obligations and Commitments

Information regarding the Company’s contractual obligations at December 31, 2017 is set forth in the table below:

 

(in thousands of U.S. dollars)    Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $ 38,640      $ 2,620      $ 6,785      $ 29,064      $ 171  

Operating leases

     3,403        1,285        1,399        716        3  

Capital leases

     251        72        179        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 42,294      $ 3,977      $ 8,363      $ 29,780      $ 174  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

12


Village Farms International, Inc.

 

 

Capital Expenditures

During the three month period and year ended December 31, 2017, the Company purchased approximately $520 and $1,691, respectively, of capital assets. Capital expenditures incurred for 2017 were used for replacements or improvements to existing facilities, distribution centres or information technology systems or hardware.

Management continues to review new capital expenditures to support its strategic plan of achieving cost efficiencies through increased productivity. Management may elect, where appropriate, to sell inefficient or non-strategic assets to produce cash to wholly or partially finance new capital expenditures. The Company will also borrow to maintain, improve and replace capital assets when the return on such investments exceeds targeted thresholds for internal rates of return. There can be no assurance, however, that sources of financing will be available, or will be available on terms favourable to the Company, or that these strategic initiatives will achieve adequate cost reduction in actual implementation or in light of the competitive pressures on the cost of raw materials and other factors of production. Management believes that its recurring capital expenditures will be funded and supported from its ongoing operations.

During the three month period and year ended December 31, 2017, the Company incurred $631 and $2,527, respectively, in costs to maintain its capital assets. These expenses are classified as repair and maintenance and are included in cost of sales. Management forecasts approximately $2,500 of annual costs to maintain the Company’s capital assets.

Summary of Quarterly Results

For the three months ended:

 

(in thousands of U.S. Dollars, except per share amounts)

   Dec 31,
2017
    Sept 30,
2017
     Jun 30,
2017
     Mar 31,
2017
    Dec 31,
2016
     Sept 30,
2016
    Jun 30,
2016
    Mar 31,
2016
 

Sales

     36,864       44,735        45,530        31,277     $ 37,308      $ 42,045     $ 44,441     $ 31,708  

Net income (loss)

     (607     294      $ 4,325      ($ 190   $ 453      ($ 1,425   ($ 770   ($ 241

Basic earnings (loss) per share

   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04   ($ 0.02   ($ 0.01

Diluted earnings (loss) per share

   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04   ($ 0.02   ($ 0.01

The Company’s Canadian vegetable growing operations peak production period is in the summer months, with no production during the winter season. As a result, prices for vegetable products from the Company’s Canadian operations have historically followed a seasonal trend of higher prices at the start and end of its crop year, with lower prices in the summer months when the supply of product is greatest. Conversely, the Company’s U.S. vegetable operations winter production allows it to realize higher prices during the October through March period, due to the reduced supply of greenhouse produce in North America during the winter months. The complementary nature of the growing seasons of the Company’s Canadian and U.S. vegetable operations allows the Company to maintain and service its core vegetable retail accounts year round.

Financial Instruments and Risk Management

Risk Management

The Company is exposed to the following risks as a result of holding financial instruments: market risk, credit risk, interest rate risk, foreign exchange risk and liquidity risk. The following is a description of these risks and how they are managed by the Company.

Market Risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market place.

Credit Risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables.

 

13


Village Farms International, Inc.

 

 

The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 16.0% and 14.8%, of the balance of trade receivables as at December 31, 2017 (2016 – three customers, 12.0%, 11.8% and 10.1%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its vegetable sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At December 31, 2017, the allowance for doubtful accounts balance was $50 (2016 – $50). The Company has not recorded bad debt expense during the three month period and year ended December 31, 2017 (2016 – $nil).

At December 31, 2017, 89.4% (December 2016 – 87.4%) of trade receivables were outstanding less than 30 days, 7.4% (December 2016 – 9.5%) were outstanding for between 30 and 90 days and the remaining 3.2% (December 2016 – 3.1%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

The Company has used derivative instruments to reduce market exposure to changes in interest rates. The Company has used derivative instruments only for risk management purposes and not for generating trading profits.

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The following are the contractual maturities of financial liabilities as at December 31, 2017:

 

(in thousands of U.S. dollars)

Financial liabilities

   Contractual
cash flows
     0 to 12
months
     12 to 24
months
     After 24
months
 

Accounts payable and accrued liabilities

   $ 16,745      $ 16,745      $ —        $ —    

Bank debt

     38,640        2,621        3,376        32,643  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 55,385      $ 19,336      $ 3,376      $ 32,643  
  

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash. The Company has available lines of credit of up to CA$13,000 (as at December 31, 2017, $nil was outstanding and US$320 and CA$38 was utilized in the form of outstanding letters of credit). If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach or default that might otherwise result there from. If the Company

 

14


Village Farms International, Inc.

 

 

defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will continue to agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, and (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its common shares. See also “Risk Factors – Dependence Upon Credit Facilities” in the Company’s current Annual Information Form.

Environmental, Health and Safety Risk

The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate. Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect the Company’s operational results and profitability.

The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.

Outlook

Overview

The forward-looking statements contained in this section and elsewhere in this MD&A are not historical facts, but rather, reflect the Company’s current expectations regarding future results or events and are based on information currently available to Management. Certain material factors and assumptions were applied in providing these forward-looking statements. See the “Forward-Looking Statements” section of this MD&A.

On June 6, 2017 the Company announced an initiative into growing cannabis through a joint venture with an existing licensed producer –, pursuant to which the Company would contribute rights to one of its Delta greenhouses and growing knowledge in exchange for a 50% equity position. Emerald is contributing CA$20m for its 50% equity interest. The joint venture is named “Pure Sunfarms Corp.” Pure Sunfarms received its cultivation license for the Delta 3 Greenhouse on March 2, 2018. Pure Sunfarms is in the process of commencing its initial cannabis crop in order to obtain its sales license for the facility on or before July 1, 2018. Pure Sunfarms continues to convert the unlicensed sections of the Company’s Delta 3 greenhouse to grow cannabis and meet the required security standards for licensing under the ACMPR. Management believes that Pure Sunfarms will be successful in obtaining a cultivation and sales license for the remainder of the facility by the end of 2018. Once the entire facility is licensed, it will be one the largest commercial cannabis production facilities in Canada. Management believes it will produce cannabis for CA$1 per gram with margins of at least 50% in late 2019. As such, the Company’s 50% equity interest is capable of generating substantially higher revenue and profits than prior revenues and profits from the tomato crop currently grown in the facility.

 

15


Village Farms International, Inc.

 

 

Management is committed to only conducting activities and growing operations which are federally legal and as such it will not grow, nor invest in any cannabis related business in the U.S. until it is federally legal.

The Company continues to focus on increasing its produce revenues and profits on its core crops – tomatoes, cucumbers and peppers. The Company also continues to actively explore whether to produce certain higher margin alternative crops at the Company’s continuing produce facilities, and continues to consider produce industry consolidation opportunities if an accretive opportunity arises.

In conjunction with its traditional produce business, the Company entered into a new distribution agreement with a Mexican high-end greenhouse grower in Yecapixtla, Morleos, Mexico, who began production with approximately 45 acres in the winter of 2017 and is planning an additional 43 acres of capacity by the end of 2018. The lower cost Mexican produce has the potential to increase the Company’s distribution business allowing the Company to increase its market share with certain retail accounts.

Growth expenditures

The Company expects to spend between $2.5 to $3.0 million on capital expenditures in 2018. These expenditures are to repair and enhance existing growing and packhouse systems either due to obsolesces of the system or to improve operational efficiencies.

The Company may make additional equity contributions to Pure Sunfarms of cash in the next twelve months depending on the final completion timeline for the Delta 3 Greenhouse and whether or not Pure Sunfarms obtains financing.

Disclosure Controls and Procedures

Disclosure controls and procedures have been designed to ensure that information to be disclosed by the Company is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosures. The Chief Executive Officer and Chief Financial Officer have concluded, as of the end of the period covered by the interim and year end filings, that the Company’s disclosure controls and procedures are appropriately designed and operating effectively to provide reasonable assurance that material information relating to the issuer is made known to them by others within the Corporation.

Internal Control over Financial Reporting

NI 52-109 also requires CEOs and CFOs to certify, among other things, that they are responsible for establishing and maintaining internal controls over financial reporting for the issuer, that those internal controls have been designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with IFRS, and that the issuer has disclosed any changes to its internal controls during its most recent period that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

For the year ended December 31, 2017, the Company’s management evaluated the effectiveness of the Company’s internal control over financial reporting, as defined under rules adopted by the CSA. This evaluation was performed under the supervision of, and with the participation of, the Company’s CEO and CFO.

The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

Internal control over financial reporting, no matter how well designed has inherent limitations. Therefore, internal control over financial reporting can provide only reasonable, not absolute, assurance with respect to financial statement preparation and may not prevent or detect all misstatements.

Based on this evaluation, the Company’s CEO and CFO have concluded that, subject to the inherent limitations noted above, the Company’s internal control over financial reporting is effective in providing reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS.

 

16


Village Farms International, Inc.

 

 

There were no changes in the Company’s internal control over financial reporting during the year ended December 31, 2017 that materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Risks and Uncertainties

The Company is subject to various risks and uncertainties which are summarized below, as well as those discussed in this MD&A. Additional details are contained in the Company’s current Annual Information Form dated April 2, 2018 filed on SEDAR, which can be accessed electronically at www.sedar.com .

Risks Relating to the Company

 

   

Product Pricing

 

   

Maintain Profitability

 

   

Risks Inherent in the Agricultural Business

 

   

Natural Catastrophes

 

   

Retail Consolidation

 

   

Covenant Risk

 

   

Dependence Upon Credit Facilities

 

   

Competition

 

   

Transportation Disruptions

 

   

Labour Availability

 

   

Risks Associated with Cross Border Trade

 

   

Governmental Regulations

 

   

Product Liability

 

   

Key Executives

 

   

Uninsured and Underinsured Losses

 

   

Cyber Security

 

   

Vulnerability to Rising Energy Cost

 

   

Risks of Regulatory Change

 

   

Environmental, Health and Safety Risk

 

   

Foreign Exchange Exposure

 

   

Technological Advances

 

   

Accounting Estimates

 

   

Growth

Risks Related to the Joint Venture

 

   

Reliance on Licenses

 

   

Regulatory Risks

 

   

Unfavourable Publicity or Consumer Perception

 

   

Competition

 

   

Risks Inherent in an Agricultural Business

 

   

Risks Related to the Joint Venture

 

   

Reliance on a Single Facility

 

   

Conversion of Facility

 

   

Limited Operating History in the Cannabis Industry

 

   

Failure to Realize Growth Strategy

 

   

Research and Development and Product Obsolescence

 

   

Product Liability

 

   

Product Recalls

 

   

Fluctuating Prices of Raw Materials

 

   

Environmental Regulations and Risks

 

17


Village Farms International, Inc.

 

 

Risks Related to Tax

 

   

Potential U.S. Permanent Establishment of VF Canada GP, VFCLP and VFF

 

   

Advances by VF Operations Canada Inc. to U.S. Holdings

 

   

Transfer Pricing

 

   

U.S. Real Property Holding Corporation

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

Critical Accounting Estimates

Accounts Receivable

Accounts receivable are measured at amortized cost and due within contractual payment terms and are stated at amounts due from customers net of an allowance for doubtful accounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the bad debt expense.

Inventories

Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year and exclude biological assets (see below). Cost of sales is based upon incurred and estimated costs to be incurred from each crop allocated to both actual and estimated future yields over each crop cycle. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.

Biological Assets

Biological assets consist of the Company’s produce on the vines at the period end. The produce on the vine is measured at fair value less costs to sell and complete, with any change therein recognized in profit or loss. Costs to sell include all costs that would be necessary to sell and complete the assets, including finishing and transportation costs.

Income Taxes

The Company utilizes the assets and liability method of accounting for income taxes under which future income tax assets and liabilities are recognized for the estimated future income tax consequences attributable to differences between the financial statement carrying value amount and the tax basis of assets and liabilities. Management uses judgment and estimates in determining the appropriate rates and amounts in recording future taxes, giving consideration to timing and probability. Actual taxes could significantly vary from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities.

Future income tax assets are recognized to the extent that realization is considered more likely than not. The Company considers past results, current trends and outlooks for future years in assessing realization of income tax assets.

 

18


Village Farms International, Inc.

 

 

Impairment of Financial and Non-Financial Assets

At the end of each reporting period, the Company reviews the carrying amounts of its long lived assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. The Company estimates the recoverable amounts of the cash-generating unit (“CGU”) to which the asset belongs.

Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual CGU’s, or otherwise they are allocated to the smallest group of CGU’s for which a reasonable and consistent allocation basis can be identified. Identifiable cash flows are largely independent of the cash flows of other assets and liabilities. This was determined to be the Canadian and U.S. operations.

Recoverable amount is the higher of the fair value less costs to sell and the value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount of the asset or CGU is reduced to its recoverable amount. An impairment loss is recognized immediately in the statement of income.

Where an impairment loss subsequently reverses for assets with a finite useful life, the carrying amount of the asset or CGU is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset or CGU in prior periods. A reversal of an impairment loss is recognized immediately in the statement of income.

Due to the above-noted considerations, which are based on the Company’s best available information, the Company has not recorded any impairment charge on its non-financial assets in the year ended December 31, 2017.

Property, Plant and Equipment – Useful Lives

Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.

Land Revaluation

Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016.

Accounting Standards Issued and Not Applied

The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.

IFRS 9, Financial Instruments, addresses classification and measurement of financial assets and financial liabilities, and replaces the multiple category and measurement models in IAS 39, Financial Instruments-Recognition and Measurement . The new Standard limits the number of categories for classification of financial assets to two: amortized cost and fair value through profit or loss. The requirements for financial liabilities are largely in line with IAS 39. IFRS 9 also replaces the models for measuring equity instruments. Equity instruments are either recognized at fair value through profit or loss or at fair value through other comprehensive income. The ability to recognize unquoted equity instruments at cost under IAS 39 is eliminated. The standard is effective for annual periods beginning on or after January 1, 2018. IFRS 9 is not expected to have a material impact on amounts recorded on the consolidated financial statements of the Company.

 

19


Village Farms International, Inc.

 

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15, issued in May 2014, establishes the requirements for recognizing revenue that apply to all contracts with customers, except for contracts that are within the scope of the Standards on leases, insurance contracts, and financial instruments. IFRS 15 is effective for annual periods beginning on or after January 1, 2018, with early adoption permitted. Management has evaluated the impact of IFRS 15 and does not expect it to have a material impact on the consolidated financial statements of the Company.

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the company also applies IFRS 15. Management is currently assessing the impact on the Company’s consolidated financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

Accounting Standards Adopted in the Year

IAS 16, Property, Plant and Equipment, allows for a policy choice for subsequent measurement of property, plant, and equipment to be based on historical cost or fair value. The Company has historically carried its land at historical cost. As at December 31, 2016, the Company has changed its policy so that land is initially measured at historical cost but subsequently measured at fair value. Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016 only.

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each balance sheet date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.

Related Party Transactions

As at December 31, 2017, included in other assets is a $70 promissory note from an employee of the Company in connection with a relocation agreement. The Company has no other commitments as a result of related party transactions during the year.

Outstanding Share Data

The beneficial interests in the Company are currently divided into interests of three classes, described and designated as “Common Shares”, “Special Shares” and “Preferred Shares”, respectively. An unlimited number of Common Shares, Special Shares and Preferred Shares are issuable pursuant to VFF’s constating documents.

 

20


Village Farms International, Inc.

 

 

On December 21, 2017, VFF issued 2,500,000 Common Shares pursuant to a “bought deal” short form prospectus offering at an issue price of $5.40 per Common Share for gross proceeds of $13,500,000. The offering was conducted by a syndicate of underwriters led by Beacon Securities Limited.

As of the date hereof, VFF has outstanding: (i) 42,447,613 Common Shares carrying the right to one vote at a meeting of voting shareholders of VFF; (ii) nil (0) Special Shares; and (iii) nil (0) Preferred Shares. In conjunction with the formation of Pure Sunfarms Corp., the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Each such warrant entitles the holder to purchase one Common Share at an exercise price of CA$2.07. Each such warrant is exercisable up to June 6, 2020.

For further details on the structure of the Company or the rights attached to each of the above-mentioned securities, please refer to the Company’s current Annual Information Form dated April 2, 2018 which is available electronically at www.sedar.com .

Forward-Looking Statements

Certain statements contained in this MD&A constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this MD&A include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable rates when required.

Although the forward-looking statements contained in this MD&A are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this MD&A and the Company’s annual information form.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this MD&A relate only to events or information as of the date on which the statements are made

 

21


Village Farms International, Inc.

 

 

in this MD&A. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Public Securities Filings

You may access other information about the Company, including its current Annual Information Form and other disclosure documents, reports, statements or other information that it files with the Canadian securities regulatory authorities, through SEDAR at www.sedar.com .

 

22

Exhibit 99.13

VILLAGE FARMS INTERNATIONAL REPORTS YEAR END 2017 FINANCIAL RESULTS AND ANNOUNCES PLAN TO INCREASE PURE SUNFARMS’ 2019 PRODUCTION BY UP TO 30%

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

– Pure Sunfarms to Pursue Accelerated Production Ramp Up Plan for 1.1 Million Ft 2 Delta 3 Greenhouse Following Receipt

of Cultivation License –

– Produce Business Delivers Seventh Quarter of Lower Cost Per Pound at Company Facilities in Last Eight Quarters –

VANCOUVER, April 2, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced its financial results for the fourth quarter and 12-month periods ended December 31, 2017.

(All amounts in U.S. Dollars unless otherwise indicated.)

Highlights for the Year Ended December 31, 2017

(All comparable figures are for the year ended December 31, 2016)

 

   

Sales increased 2% to US$158.4 million from US$155.5 million;

 

   

Net income was US$3.8 million, or US$0.10 per share, compared with a net loss of (US$2.0) million, or (US$0.05) per share;

 

   

EBITDA decreased (22%) to US$7.4 million from US$9.4 million;

 

   

The Company’s newest exclusive tomato variety, Lorabella Blossom TM , won a Produce Business Innovation Award at the New York Produce Show and was selected as one of three finalists for the Gateway Innovation Award at the Viva Fresh Expo in San Antonio; and,

 

   

Successfully completed a “bought deal” short form prospectus offering of 2,500,000 common shares in the capital of the Company at an issue price of CA$5.40 per common share for aggregate gross proceeds of CA$13,500,000, a portion of the proceeds of which were used to repay a portion of the Company’s term loan with a Canadian creditor, which enabled the Company to remove its 1.1 million ft 2 Delta 2 greenhouse facility as collateral against such term loan.

Cannabis Joint Venture (Pure Sunfarms) Update:

 

   

Health Canada issued a cultivation license under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) for Pure Sunfarms’ 1.1 million ft 2 Delta 3 greenhouse operation located in Delta, BC, which is conservatively projected to produce 75,000 kg of quality cannabis annually at full production;

 

   

Following receipt of the cultivation license for the Delta 3 greenhouse, Pure Sunfarms immediately transferred existing starter plants to the greenhouse and initiated the ACMPR sales license application process;

 

   

Conversion of the first 250,000 ft 2 section of the 1.1 million ft 2 Delta 3 greenhouse to cannabis production is substantially complete and senior growing, financial, human resources and operational personnel, including the established team transferred from Village Farms, are in place for production ramp-up; and,

 

   

Conversion of the remainder of the 1.1 million ft 2 Delta 3 greenhouse is underway and on schedule, and Pure Sunfarms is pursuing a strategy to potentially accelerate the production ramp-up through the use of short-term, rental generation equipment to provide incremental electricity to power the supplemental lighting to increase production output during the 2018/2019 winter months when there is insufficient natural sunlight available and prior to the installation of the approved additional 24MW from the local utility. Successful execution of this plan is expected to increase Pure Sunfarms’ production target for 2019 by up to 30% over the current target of approximately 35,000 to 40,000 kg of dried cannabis.


“Since announcing our entry into the Canadian cannabis industry last June, the Pure Sunfarms joint venture has consistently executed on all facets of its plan, culminating with Health Canada’s issuance of the cultivation license for Pure Sunfarms’ 1.1 million ft 2 Delta 3 greenhouse earlier this month,” said Michael DeGiglio, CEO, Village Farms. “Village Farms is always focused on maximizing the return from our assets and, with conversion of the first quadrant of the Delta 3 greenhouse nearing completion, Village Farms has modelled and proposed a strategy to significantly and accretively accelerate the production ramp-up plan for Delta 3, which Pure Sunfarms is now pursuing.”

Mr. DeGiglio added, “With the benefit of Village Farms’ 30-year track record as a proven large-scale, low-cost greenhouse operator, Pure Sunfarms is uniquely positioned to be a leading supplier of quality cannabis products to wholesalers, distributors and private and government retailers across Canada and internationally, with the goal to be the low-cost Canadian producer. Pure Sunfarms’ vision is to be a vertically integrated supplier and is additionally now focused on senior management hires and development of distribution and marketing strategies to this end.”

“I am immensely proud of the considerable contribution that many experienced personnel throughout Village Farms have to made to Pure Sunfarms, while continuing to drive the success of our incumbent produce business. Amidst continuing competition from low-priced, Mexican-grown commodity product, Village Farms remains a vertically integrated supplier of choice to the leading retailers in the U.S. and Canada, with exclusive, premium varieties, including our award-winning Lorabella Blossom TM tomato, and an outstanding reputation for quality and safety. We are actively expanding our supply relationships throughout North America to increase our market share and drive revenue growth. Importantly, our ingrained culture of low-cost production enabled us to lower our cost per pound at Village Farms’ facilities for the seventh quarter in the last eight quarters.

Financial Summary

(in thousands of U.S. Dollars unless otherwise indicated)

Consolidated Financial Performance

(In thousands of U.S. dollars, except per Share amounts)

 

     For the three months ended
December 31,
     For the 12 months ended
December 31,
 
     2017      2016      2017      2016  

Sales

   $ 36,864      $ 37,308      $ 158,406      $ 155,502  

Cost of sales

     (31,908      (31,891      (144,433      (140,778

Selling, general and administrative expenses

     (4,019      (3,848      (13,894      (13,525

Stock compensation expense

     (959      (46      (1,519      (195

Change in biological asset (1)

     1,082        (157      265        (1,501

Loss from operations

     1,060        1,366        (1,175      (497

Interest expense, net

     (679      (610      2,695        2,514  

Other income (expense)

     (81      16        72        (64

Share of loss from joint venture

     (35      —          (255      —    

Gain (loss) on disposal of assets

     (551      —          (8,013      12  

Provision for (recovery of) income taxes

     321        287        138        (1,104

Net income (loss)

     (607      453        3,822        (1,983

EBITDA (2)

     2,591        3,501      $ 7,363      $ 9,385  

Income (Loss) per share/ basic

   ($ 0.02    $ 0.01      $ 0.10      ($ 0.05

Income (Loss) per share/ diluted

   ($ 0.02    $ 0.01      $ 0.10      ($ 0.05

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 6 of the Company’s annual consolidated financial statements for the year ended December 31, 2017.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

Year End 2017 Operational Discussion:

(in thousands of U.S. Dollars unless otherwise indicated)

Net Sales

Net sales for the year ended December 31, 2017 increased $2,904, or 2%, to $158,406 compared to $155,502 for the year ended December 31, 2016. The increase in net sales is due to an increase in supply partner revenues over the comparable period in 2016, an increase of 4% in the Company’s product volume, partially offset by a decrease in the net average selling price for tomatoes of


(1%) for the year ended December 31, 2017 versus the year ended December 31, 2016. Pepper prices decreased (9%) and pounds sold increased 10% over the comparable period in 2016 and cucumber prices decreased (3%) and pieces decreased (2%) for the year ended December 31, 2017 over the comparable period in 2016.

Cost of Sales

Cost of sales for the year ended December 31, 2017 increased ($3,655), or (3%), to $144,433 from $140,778 for the year ended December 31, 2016. The increase is due to the increase in supply partner cost of sales of 4%, additional freight cost due to 6% more produce being shipped and higher costs from the Company’s facilities due to 4% more production volume. The cost at the Company’s facilities decreased by (3%) on a per-pound basis versus the same period in 2016.

Change in Biological Asset

The net change in fair value of biological asset for the year ended December 31, 2017 increased $1,766 to $265 from ($1,501) for the year ended December 31, 2016. The increase is due to a lower beginning value on January 1, 2017 versus January 1, 2016.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the year ended December 31, 2017 increased ($369), or (3%), to $13,894 from $13,525 for the year ended December 31, 2016. The increase is due to higher sales and marketing costs associated with the increase in supply partner revenues.

Stock Compensation Expense

Stock compensation expense for the year ended December 31, 2017 was $1,519, up from $195 for the year ended December 31, 2016, due to the issuance of restricted stock units during the year ended December 31, 2017. The stock compensation consists of stock grants to Company employees and directors related to the cannabis joint venture.

Loss from Operations

Loss from operations for the year ended December 31, 2017 is ($1,175), which was an increased loss of ($678) from a loss of ($497) for the year ended December 31, 2016. The decrease in operating results is due to an increase in cost of sales and stock compensation expenses, partially offset by an increase in sales and an increase in the change in biological asset.

Interest Expense, net

Interest expense, net, for the year ended December 31, 2017 increased ($181) to $2,695 from $2,514 for the year ended December 31, 2016. The increase is due to an increase in the Company’s long-term debt borrowing rate.

Share of (loss) from Joint Venture

The Company’s share of the loss for the year ended December 31, 2017 is ($255), consisting primarily of travel and organizational costs.

Provision for (Recovery of) Income Taxes

Income tax provision for the year ended December 31, 2017 was $138 compared to a recovery of ($1,104) for the year ended December 31, 2016. The income tax expense increase is due to a change in the United States future tax rate that caused a reduction in the tax asset value in the United States.

Gain (loss) on Disposal of Assets

For the year ended December 31, 2017, the Company recognized a gain of $8,013 on the contribution of rights to one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms in exchange for a 50% equity stake in Pure Sunfarms. For the year ended December 31, 2016, the Company had a loss of ($12).


Net Income (Loss)

Net Income (loss) for the year ended December 31, 2017 improved by $5,805 to a net income of $3,822 from a net loss of ($1,983) for the year ended December 31, 2016. The increase is a result of a gain on assets partially offset by the decrease in income from operations, and an increase in the provision for income taxes.

EBITDA

EBITDA for the year ended December 31, 2017 decreased by ($2,022) to $7,363 from $9,385 for the year ended December 31, 2016, primarily due to a decrease in the selling price of the Company’s produce products. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Earnings to EBITDA”.

Fourth Quarter 2017 Operational Discussion:

(in thousands of U.S. Dollars unless otherwise indicated)

Sales

Sales for the three months ended December 31, 2017 decreased by ($444), or (1%), to $36,864 from $37,308 for the three months ended December 31, 2016. The decrease in sales is primarily due to a decrease in the Company’s supply partner product volume which was partially offset by an increase in the Company’s facilities production volume of 3%. The decrease in supply partner product volume is due to the transition from one primary Mexican supply partner to a new primary Mexican supply partner who is in the process of expanding its operations.

The average selling price for tomatoes remained flat for the three months ended December 31, 2017 versus the three months ended December 31, 2016. Cucumber pricing increased by 9% and pepper pricing decreased by (3%) in the fourth quarter of 2017 versus the comparable quarter in 2016.

Cost of Sales

Cost of sales for the three months ended December 31, 2017 was essentially flat at $31,908 from $31,891 for the three months ended December 31, 2016. The Company lowered its cost per pound at its facilities during the quarter by 2% versus the same quarter in 2016. The decrease was due to an increase in the lower cost non-specialty tomato varieties.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by $171, or (4%), to $4,019 for three months ended December 31, 2017 from $3,848 for the three months ended December 31, 2016. The increase is due to higher sales and marketing costs.

Stock Compensation Expense

Stock compensation expense for the three months ended December 31, 2017 was $959 from $46 for the three months ended December 31, 2016. The increase was related to stock grants in the fourth quarter of 2017 to executive officers related to the creation of the cannabis joint venture.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended December 31, 2017 increased by $1,239 to $1,082 from ($157) for the three months ended December 31, 2016. The increase is due to a lower starting biological asset value at October 1, 2017 versus October 1, 2016. The fair value of the biological asset as at December 31, 2017 was $4,405 as compared to $4,446 as at December 31, 2016 due to lower production, offset by higher selling price in January 2018 versus January 2017.

Income from Operations

Income from operations for the three months ended December 31, 2017 decreased ($306) to $1,060 from $1,366 for the three months ended December 31, 2016. The decrease is due to an increase in stock compensation expense, an increase in selling, general and administrative expenses offset by a higher net change in fair value of the biological asset for three months ended December 31, 2017 versus the three months ended December 31, 2016.

Interest Expense, net

Interest expense, net, for the three months ended December 31, 2017 increased by $69, to $679 from $610 for the three months ended December 31, 2016.


Share of (loss) from Joint Venture

The Company’s share of the loss for the three months ended December 31, 2017 is ($35), consisting primarily of travel expenses.

Provision for Income Taxes

Income tax provision for the three month period ended December 31, 2017 was $321 compared to $287 for the three month period ended December 31, 2016. The income tax provision increased due to a change in the United States future tax rate that caused a reduction in the tax asset value in the United States.

Net (loss) Income

Net income for the three months ended December 31, 2017 decreased by ($1,060) to a net loss of ($607) from net income of $453 for the three months ended December 31, 2016 as a result of lower income from operations and a loss on sale of assets of ($551) due to a year-end adjustment related to the contribution of rights to the joint venture.

EBITDA

EBITDA for the three months ended December 31, 2017 decreased by ($910), or (26%), to $2,591 from $3,501 for the three months ended December 31, 2016, primarily as a result of a decrease in sales, a small loss from the joint venture and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.

Non-IFRS Measures

References in this press release to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized change in biological asset, stock compensation, share of loss from joint venture, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income (loss) to EBITDA, as presented by the Company:

 

     For the three months ended
December 31,
     For the 12 months ended
December 31,
 
(in thousands of U.S. dollars)    2017      2016      2017      2016  

Net income (loss)

   ($ 607    $ 453      $ 3,822      ($ 1,983

Add:

           

Amortization

     1,833        1,917        7,587        8,164  

Foreign currency exchange loss (gain)

     31        31        (26      86  

Interest expense

     679        610        2,695        2,514  

Income taxes (recovery)

     321        287        138        (1,104

Stock based compensation

     959        46        1,519        195  

Change in biological asset

     (1,082      157        (265      1,501  

Share of loss from joint venture

     35        —          255        —    

Share of (loss) from joint venture not reelat related to taxes

     (129      —          (348   

(Gain) Loss on disposal of assets

     551        —          (8,013      12  
  

 

 

    

 

 

    

 

 

    

 

 

 

EBITDA

   $ 2,591      $ 3,501      $ 7,363      $ 9,385  


Conference Call

Village Farms’ management team will host a conference call today, Monday, April 2, 2018, at 11:00 a.m. ET (8:00 a.m. PT) to discuss its annual 2017 financial results and provide an update on Pure Sunfarms. Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2p3jsyq .

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 8267239 followed by the pound key. The telephone replay will be available until Monday, April 9, 2018 at midnight (ET). The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.

Cautionary Language

Certain statements contained in this press release form constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt on reasonable terms when required.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.


When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


Village Farms International, Inc.

Consolidated Statements of Financial Position

(In thousands of United States dollars)

 

     December 31, 2017     December 31, 2016  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 7,091     $ 5,373  

Trade receivables

     11,259       10,187  

Other receivables

     1,982       263  

Inventories

     17,309       16,108  

Income taxes receivable

     246       246  

Prepaid expenses and deposits

     564       676  

Biological asset

     4,405       4,446  
  

 

 

   

 

 

 

Total current assets

     42,856       37,299  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment

     81,754       96,135  

Investment in joint venture

     15,727       —    

Other assets

     2,004       1,531  
  

 

 

   

 

 

 

Total assets

   $ 142,341     $ 134,965  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 12,952     $ 12,711  

Accrued liabilities

     3,793       3,586  

Income taxes payable

     —         —    

Current maturities of long-term debt

     2,620       3,291  

Current maturities of capital lease obligations

     72       33  
  

 

 

   

 

 

 

Total current liabilities

     19,437       19,621  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt

     35,760       41,929  

Long-term maturities of capital lease obligations

     179       87  

Deferred tax liability

     4,825       4,987  

Deferred compensation

     1,097       954  
  

 

 

   

 

 

 

Total liabilities

     61,298       67,578  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     36,115       24,954  

Contributed surplus

     1,726       1,392  

Revaluation surplus

     4,321       6,132  

Accumulated other comprehensive loss

     (391     (541

Retained earnings

     39,272       35,450  
  

 

 

   

 

 

 

Total shareholders’ equity

     81,043       67,387  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 142,341     $ 134,965  
  

 

 

   

 

 

 


Village Farms International, Inc.

Consolidated Statements of Income (Loss) and Comprehensive Income

For the Years Ended and Three Months Ended

(In thousands of United States dollars, except per share data)

 

     Years Ended December 31,     Three Months Ended December 31,  
     2017     2016     2017     2016  

Sales

   $ 158,406     $ 155,502     $ 36,864     $ 37,308  

Cost of sales

     (144,433     (140,778     (31,908     (31,891

Change in biological asset

     265       (1,501     1,082       (157

Selling, general and administrative expenses

     (13,894     (13,525     (4,019     (3,848

Stock compensation expense

     (1,519     (195     (959     (46
  

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income from operations

     (1,175     (497     1,060       1,366  

Interest expense

     2,695       2,514       679       610  

Foreign exchange (gain) loss

     (26     86       31       31  

Other income

     (46     (22     50       (15

Share of loss from joint venture

     255       —         35       —    

(Gain) loss on sale of assets

     (8,013     12       551       —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income taxes

     3,960       (3,087     (286     740  

Provision for (recovery of) income taxes

     138       (1,104     321       287  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

   $ 3,822     $ (1,983   $ (607   $ 453  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic income (loss) per share

   $ 0.10     $ (0.05   $ (0.02   $ 0.01  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted income (loss) per share

   $ 0.10     $ (0.05   $ (0.02   $ 0.01  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive income:

        

Foreign currency translation adjustment

     150       61       12       (43

Gain on revaluation of land, net of tax

     (1,811     6,132       —         6,132  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive income (loss)

   $ 2,161     $ 4,210     $ (595   $ 6,542  
  

 

 

   

 

 

   

 

 

   

 

 

 


Village Farms International, Inc.

Consolidated Statements of Cash Flows

For the Years Ended and Three Months Ended

(In thousands of United States dollars)

 

     Years Ended December 31,     Three Months Ended December 31,  
     2017     2016     2017     2016  

Cash flows from operating activities:

        

Net income (loss)

   $ 3,822     $ (1,983   $ (607   $ 453  

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

        

Depreciation and amortization

     7,586       8,164       1,833       1,917  

Amortization of deferred charges

     73       120       19       (41

Loss on sale of assets

     (8,013     12       551       —    

Share of loss from joint venture

     255       —         35       —    

Interest paid

     2,614       2,351       658       643  

Share-based compensation

     1,519       195       959       46  

Deferred income taxes

     109       (1,261     694       411  

Change in biological asset

     (265     1,501       (1,082     157  

Changes in non-cash working capital items

     (4,417     (433     (1,192     1,766  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by operating activities

     3,283       8,666       1,868       5,352  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from investing activities:

        

Purchases of property, plant and equipment

     (1,696     (2,193     (525     (708
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (1,696     (2,193     (525     (708
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows from financing activities:

        

Proceeds from borrowings

     7,306       4,000       193       —    

Repayments on borrowings

     (14,320     (7,718     (7,832     (3,797

Interest paid on long-term debt

     (2,614     (2,351     (658     (643

Proceeds from issuance of common stock pursuant to public offering, net

     9,769       —         9,769       —    

Proceeds from exercise of stock options

     59       51       33       27  

Payments on capital lease obligations

     (59     (41     (19     (13
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) financing activities

     141       (6,059     1,486       (4,426
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (10     2       (23     (4
  

 

 

   

 

 

   

 

 

   

 

 

 

Net increase in cash and cash equivalents

     1,718       416       2,806       214  

Cash and cash equivalents, beginning of year

     5,373       4,957       4,285       5,159  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $ 7,091     $ 5,373     $ 7,091     $ 5,373  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

        

Income taxes (refunded) paid

   $ (25   $ 1,082     $ (61   $ (140
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of non-cash information:

        

Purchases of capital expenditures by financing capital lease

   $ 190     $ 126     $ —       $ —    
  

 

 

   

 

 

   

 

 

   

 

 

 

Purchases of capital expenditures by use of accounts payable

   $ —       $ 385     $ —       $ 132  
  

 

 

   

 

 

   

 

 

   

 

 

 

Issuance of warrants

   $ 148     $ —       $ —       $ —    
  

 

 

   

 

 

   

 

 

   

 

 

 


SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/April2018/02/c6025.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 02-APR-18

Exhibit 99.14

Form 45-102F1

Notice of Intention to Distribute Securities under Section 2.8 of

NI 45-102 Resale of Securities

Reporting issuer

 

1.

Name of reporting issuer: Village Farms International, Inc.

Selling security holder

 

2.

Your name: Michael A. DeGiglio

 

3.

The offices or positions you hold in the reporting issuer: CEO and Director

 

4.

Are you selling securities as a lender, pledgee, mortgagee or other encumbrancer? No

 

5.

Number and class of securities of the reporting issuer you beneficially own: 9,871,649 Common Shares and 400,000 Options.

Distribution

 

6.

Number and class of securities you propose to sell: Up to 150,000 Common Shares

 

7.

Will you sell the securities privately or on an exchange or market? If on an exchange or market, provide the name. Toronto Stock Exchange.

Warning

It is an offence to submit information that, in a material respect and in light of the circumstances in which it is submitted, is misleading or untrue.

Certificate

I certify that

 

  (1)

I have no knowledge of a material fact or material change with respect to the issuer of the securities that has not been generally disclosed; and

 

  (2)

the information given in this form is true and complete.

 

Date April 2, 2018      

Michael A. DeGiglio

Your name(Selling security holder)

     

Michael A. DeGiglio

     

Your signature (or if a company, the

signature of your authorized signatory)


INSTRUCTION:

File this form electronically through SEDAR with the securities regulatory authority or regulator in each jurisdiction where you sell securities and with the Canadian exchange on which the securities are listed. If the securities are being sold on an exchange, the form should be filed in every jurisdiction across Canada.

Notice to selling security holders - collection and use of personal information

The personal information required in this form is collected for and used by the listed securities regulatory authorities or regulators to administer and enforce securities legislation in their jurisdictions. This form is publicly available by authority of National Instrument 45-102 and the securities legislation in each of the jurisdictions. The personal information collected will not be used or disclosed other than for the stated purposes without first obtaining your consent. Corporate filers should seek the consent of any individuals whose personal information appears in this form before filing this form.

If you have questions about the collection and use of your personal information, or the personal information of your authorized signatory, contact any of the securities regulatory authorities or regulators listed below.

British Columbia Securities Commission

P.O. Box 10142, Pacific Centre

701 West Georgia Street

Vancouver, BC V7Y 1L2

Attention: Assistant Manager, Financial Reporting

Telephone: (604) 899-6805 or (800) 373-6393 (in B.C.)

Facsimile: (604) 899-6506

Alberta Securities Commission

Suite 600, 250 – 5 th Street SW

Calgary, AB T2P 0R4

Attention: Information Officer

Telephone: (403) 297-6454

Facsimile: (403) 297-6156

Saskatchewan Financial Services Commission

Securities Division

601 - 1919 Saskatchewan Drive

Regina, SK S4P 4H2

Attention: Deputy Director, Legal/Registration

Telephone: (306) 787-5879

Facsimile: (306) 787-5899

Ontario Securities Commission

20 Queen Street West

22 nd Floor

Toronto, Ontario M5H 3S8

Telephone: (416) 593-8314

 

2


Toll free in Canada: 1-877-785-1555

Facsimile: (416) 593-8122

Public official contact regarding collection of personal information:

Inquiries Officer

Autorité des marchés financiers

Tour de la Bourse

800 square Victoria

C.P. 246, 22e étage

Montréal, Québec H4Z 1G3

Attention: Responsable de l’accès à l’information

Telephone : (514) 395-0337

Toll Free : 1-877-525-0337

Facsimile: (514) 873-6155 (For filing purposes only)

Facsimile: (514) 864-6381 (For privacy requests only)

www.lautorite.qc.ca

New Brunswick Securities Commission

85 Charlotte Street, Suite 300

Saint John, New Brunswick E2L 2J2

Telephone: (506) 658-3060

Toll Free in New Brunswick 1-866-933-2222

Facsimile: (506) 658-3059

Nova Scotia Securities Commission

Suite 400, 5251 Duke Street

Halifax, Nova Scotia B3J 1P3

Attention: Corporate Finance

Telephone: (902) 424-7768

Facsimile: (902) 424-4625

Prince Edward Island Securities Office

95 Rochford Street, 4 th Floor Shaw Building

P.O. Box 2000

Charlottetown, Prince Edward Island C1A 7N8

Telephone: (902) 368-4569

Facsimile: (902) 368-5283

Government of Newfoundland and Labrador

Financial Services Regulation Division

P.O. Box 8700

2nd Floor, West Block

Confederation Building

Prince Philip Drive

St. John’s, NFLD A1B 4J6

Attention: Director of Securities

Telephone: (709) 729-4189

Facsimile: (709) 729-6187

 

3


Government of Yukon

Office of the Yukon Superintendent of Securities

Government of Yukon Department of Community Services

307 Black Street, 1 st Floor

PO Box 2703 (C-6)

Whitehorse, Yukon Y1A 2C6

Telephone: (867) 667-5466

Facsimile: (867) 393-6251

http://www.community.gov.yk.ca/corp/securities_about.html

Government of Northwest Territories

Department of Justice

Securities Registry

1st Floor, Stuart M. Hodgson Building

5009 – 49th Street

Yellowknife, Northwest Territories X1A 2L9

Telephone: (867) 920-3318

Facsimile: (867) 873-0243

Department of Justice, Nunavut Registries Division

P.O. Box 1000, Station 570

1st Floor, Brown Building

Iqaluit, NT X0A 0H0

Attention: Director, Legal Registries Division

Telephone: (867) 975-6590

Facsimile: (867) 975-6194

 

4

Exhibit 99.15

Date: April 6, 2018

To: All Canadian Securities Regulatory Authorities

Subject: VILLAGE FARMS INTERNATIONAL, INC.

Dear Sir/Madam:

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer:

 

Meeting Type:    Annual General and Special Meeting
Record Date for Notice of Meeting:    May 10, 2018
Record Date for Voting (if applicable):    May 10, 2018
Beneficial Ownership Determination Date:    May 10, 2018
Meeting Date:    June 14, 2018
Meeting Location (if available):    Delta, BC
Issuer sending proxy related materials directly to NOBO:    No
Issuer paying for delivery to OBO:    Yes
Notice and Access (NAA) Requirements:   

NAA for Beneficial Holders

   No

NAA for Registered Holders

   No

Voting Security Details:

 

Description    CUSIP Number    ISIN
COMMON    92707Y108    CA92707Y1088

Sincerely,

Computershare

Agent for VILLAGE FARMS INTERNATIONAL, INC.

Exhibit 99.16

Village Farms International to attend and present at 2018 GMP Securities Cannabis Conference

VANCOUVER, April 12, 2018 /CNW/—Village Farms International, Inc. (“Village Farms “or the “Company”) (TSX:VFF) (OTCQX:VFFIF) today announced that the Company’s management team will attend and present at GMP Securities’ 2018 Cannabis Conference on April 19, 2018 at the Ritz-Carlton Hotel in Toronto, Ontario

Village Farm’s management team will also be available for one-on-one meetings during the conference. Interested parties should contact their GMP Securities representative to arrange a meeting with the Company and for further conference registration information

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-daysa year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture(CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario and Mexico.

Cautionary Language

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward looking statements include, but are not limited to, statements concerning:(i) the timing of completion of conversion of the Delta 3 greenhouse to cannabis production; (ii) whether Pure Sunfarms will exercise options to acquire any adjacent greenhouses in order to expand cannabis production; (iii) whether Pure Sunfarms’ business vision will be achieved; and (iv) forecasted annual cannabis production amounts and related production costs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by such statements. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors “set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2017, which are available electronically at www.sedar.com. Actual results may differ materially from any forward looking statements. Although the Company believes that its forward-looking statements contained in this press release a re based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward- looking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.


SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/April2018/12/c8996.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 12-APR-18

 

Exhibit 99.17

VILLAGE FARMS INTERNATIONAL ANNOUNCES PURE SUNFARMS’ CANNABIS SUPPLY AGREEMENT WITH EMERALD HEALTH THERAPEUTICS

– Pure Sunfarms On Track to be One of the Largest Cannabis Growing Operations in Canada and is Advancing its Branding and

Distribution Strategies –

VANCOUVER, April 30, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced the Company’s 50/50 joint venture with Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD), Pure Sunfarms Corp. (“Pure Sunfarms”), has entered into a supply agreement with Emerald. In this agreement, Emerald will purchase 40% of Pure Sunfarms’ production in 2018 and 2019, or approximately 21,000 to 24,000 kilograms using current projected production targets, at a pre-determined price per gram.

Pure Sunfarms has substantially completed conversion of the first 250,000 ft 2 of its existing 1.1 million ft 2 greenhouse in Delta, BC (“Delta 3 greenhouse”) to cannabis production, with the balance of the 1.1 million ft 2 expected to be completed by year end. The Company’s design for the Delta 3 greenhouse is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 individual grow rooms optimized for year-round harvesting (more than 85 harvests annually) and low-cost production. Senior growing, financial, and operational personnel, including the experienced cultivation team transferred from Village Farms, are in place for production ramp-up. Pure Sunfarms is targeting production of dried cannabis of approximately 7,000 to 8,000 kilograms in 2018, 46,000 to 52,000 kilograms in 2019, and more than 75,000 kilograms in 2020 when the facility reaches full production. Health Canada issued a cultivation license for the Delta 3 greenhouse in March.

Pure Sunfarms’ objective is to be a vertically integrated supplier and in addition to production ramp-up is focused on senior management hires, downstream product development, and development of distribution and marketing strategies. With its options on two adjacent operational greenhouse facilities of 1.1 million ft 2 and 2.6 million ft 2 , Pure Sunfarms’ potential production footprint of 4.8 million ft 2 in one contiguous complex would be the largest cannabis cultivation site in Canada and the world.

“Pure Sunfarms’ agreement to supply Emerald with a portion of Pure Sunfarms’ projected production provides a strong initial revenue stream for our shared joint venture, while allowing flexibility to capitalize on other sales opportunities as we continue discussions with multiple parties including provincial governments and other licensed producers,” said Michael DeGiglio, Director, Pure Sunfarms, and CEO, Village Farms. “We are confident Pure Sunfarms’ unmatched experience in large-scale, low-cost agricultural production and fulfilling regular, large-volume supply commitments at consistent quality, alongside extensive cannabis expertise and significant scale, will place it in the top tier of Canadian and international cannabis growers and downstream product developers.”

“As a co-owner of Pure Sunfarms, we are pleased to see the maturing of Pure Sunfarms’ business plan and the rapid conversion of its impressive production facility. We look forward to the significant sales we expect Pure Sunfarms to generate and supporting Pure Sunfarms in the distribution of its production,” said Avtar Dhillon, MD, Executive Chairman of Emerald. “At the same time, Emerald is pleased to secure a significant source of cannabis as we execute our plan to be an important supplier of high-quality cannabis in the anticipated legalized adult-use cannabis market in Canada and develop value-added products supported by unique intellectual property.”

About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. It is building a 500,000 square foot greenhouse in Metro Vancouver to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald also owns 50% of Pure Sunfarms, a joint venture with Village Farms International, Inc., that is converting an existing 1.1 million square foot greenhouse in Delta, BC to grow cannabis. Emerald’s team is highly experienced in life sciences, product development and large-scale agribusiness. Emerald Health Therapeutics is part of the Emerald Health group, which includes multiple companies focused on developing cannabis and cannabinoid products with potential wellness and medical benefits.


About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario and Mexico.

Cautionary Language

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements concerning: (i) the timing of completion of conversion of the Delta 3 greenhouse to cannabis production; (ii) whether Pure Sunfarms will exercise options to acquire any adjacent greenhouses in order to expand cannabis production; (iii) whether Pure Sunfarms’ business vision will be achieved; and (iv) forecasted annual cannabis production amounts and related production costs. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those contemplated by such statements. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors” set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2017, which are available electronically at www.sedar.com. Actual results may differ materially from any forward looking statements. Although the Company believes that its forward-looking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward- looking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/April2018/30/c6429.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, Loderock Advisors, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO:Village Farms International, Inc.

CNW 07: 00e 30-APR-18

Exhibit 99.18

Village Farms International to Host First Quarter 2018 Financial Results Conference Call on Tuesday, May 15, 2018 at 11:00 a.m. ET (8:00 a.m. PT)

VANCOUVER, May 10, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTC: VFFIF) today announced it will host a conference call to discuss its first quarter 2018 financial results, as well as provide an update on its cannabis joint venture in Canada, Pure Sunfarms, on Tuesday, May  15, 2018 at 11:00 a.m. ET (8:00 a.m. PT) . Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2p3jsyq .

The Company expects to report its first quarter 2018 financial results via news release after markets close on Monday, May 14, 2018.

Conference Call Archive Access Information

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 9885703 followed by the pound key. The telephone replay will be available until Tuesday, May 22, 2018 at midnight (ET). The conference call will also be archived on Village Farm’s web site at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2018/10/c1225.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO:Village Farms International, Inc.

CNW 07:00e 10-MAY-18

Exhibit 99.19

Form 52-109F2

Certification of Interim Filings—Full Certificate

I, Michael A. DeGiglio, the Chief Executive Officer of Village Farms International, Inc., certify the following:

 

  4.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended March 31, 2018.

 

  5.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  6.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  7.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  8.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

 

  5.2:

N/A

 

  5.3

N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on April 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: May 14, 2018

“Michael A. DeGiglio”

Michael A. DeGiglio,
Chief Executive Officer
Village Farms International, Inc.

Exhibit 99.20

Form 52-109F2

Certification of Interim Filings—Full Certificate

I, Stephen C. Ruffini, the Chief Financial Officer of Village Farms International, Inc., certify the following:

 

  1.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended March 31, 2018.

 

  2.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  3.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  4.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  5.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

 

  5.2:

N/A

 

  5.3

N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on April 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: May 14, 2018

“Stephen C. Ruffini”

Stephen C. Ruffini,

Chief Financial Officer

Village Farms International, Inc.

Exhibit 99.21

Village Farms International, Inc.

Condensed Consolidated Interim Financial Statements

Three Months Ended March 31, 2018 and 2017

(Unaudited)


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

(Unaudited)

 

     March 31, 2018     December 31, 2017  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 3,869     $ 7,091  

Trade receivables

     9,104       11,259  

Other receivables

     2,257       1,982  

Inventories (note 4)

     19,480       17,309  

Income taxes receivable

     246       246  

Prepaid expenses and deposits

     627       564  

Biological asset (note 5)

     5,999       4,405  
  

 

 

   

 

 

 

Total current assets

     41,582       42,856  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment (note 6)

     80,208       81,754  

Investment in joint venture (note 7)

     15,490       15,727  

Other assets

     1,962       2,004  
  

 

 

   

 

 

 

Total assets

   $ 139,242     $ 142,341  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 8,375     $ 12,952  

Accrued liabilities

     3,619       3,793  

Line of credit

     3,000       —    

Income taxes payable

     38       —    

Current maturities of long-term debt (note 8)

     2,615       2,620  

Current maturities of capital lease obligations

     72       72  
  

 

 

   

 

 

 

Total current liabilities

     17,719       19,437  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt (note 8)

     35,891       35,760  

Long-term maturities of capital lease obligations

     160       179  

Deferred tax liability (note 12)

     4,609       4,825  

Deferred compensation

     1,004       1,097  
  

 

 

   

 

 

 

Total liabilities

     59,383       61,298  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     36,284       36,115  

Contributed surplus

     1,844       1,726  

Revaluation surplus (note 6)

     4,321       4,321  

Accumulated other comprehensive loss

     (446     (391

Retained earnings

     37,856       39,272  
  

 

 

   

 

 

 

Total shareholders’ equity

     79,859       81,043  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 139,242     $ 142,341  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

2


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity

For the Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

     Number of
Common
Shares
     Share
Capital
     Contributed
Surplus
     Revaluation
Surplus
     Accumulated Other
Comprehensive
Loss
    Retained
Earnings
    Total
Shareholders’
Equity
 

Balance at January 1, 2017

     38,882,945      $ 24,954      $ 1,392      $ 6,132      $ (541   $ 35,450     $ 67,387  

Share-based compensation (note 17)

     —          —          41        —          —         —         41  

Cumulative translation adjustment

     —          —          —          —          13       —         13  

Net loss

     —          —          —          —          —         (190     (190
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance at March 31, 2017

     38,882,945      $ 24,954      $ 1,433      $ 6,132      $ (528   $ 35,260     $ 67,251  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance at January 1, 2018 (restated - note 3)

     42,242,612      $ 36,115      $ 1,726      $ 4,321      $ (391   $ 38,999     $ 80,770  

Shares issued on exercise of stock options (note 17)

     205,001        169        —          —          —         —         169  

Share-based compensation (note 17)

     —          —          118        —          —         —         118  

Cumulative translation adjustment

     —          —          —          —          (55     —         (55

Net loss

     —          —          —          —          —         (1,143     (1,143
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

Balance at March 31, 2018

     42,447,613      $ 36,284      $ 1,844      $ 4,321      $ (446   $ 37,856     $ 79,859  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Loss

For the Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share data)

(Unaudited)

 

     Three Months Ended March 31,  
     2018     2017  

Sales (note 14)

   $ 29,490     $ 31,277  

Cost of sales (note 11)

     (25,902     (27,320

Change in biological asset (note 5)

     (659     (645

Selling, general and administrative expenses (note 11)

     (3,475     (3,224
  

 

 

   

 

 

 

(Loss) income from operations

     (546     88  

Interest expense

     598       632  

Foreign exchange (gain) loss

     (7     14  

Other income, net

     (18     (26

Share of loss from joint venture (note 7)

     237       —    

Loss on sale of assets

     —         8  
  

 

 

   

 

 

 

Loss before income taxes

     (1,356     (540

Recovery of income taxes

     (213     (350
  

 

 

   

 

 

 

Net loss

   $ (1,143   $ (190
  

 

 

   

 

 

 

Basic loss per share (note 15)

   $ (0.03   $ (0.00
  

 

 

   

 

 

 

Diluted loss per share (note 15)

   $ (0.03   $ (0.00
  

 

 

   

 

 

 

Other comprehensive loss:

    

Foreign currency translation adjustment

     (55     13  
  

 

 

   

 

 

 

Comprehensive loss

   $ (1,198   $ (177
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

For the Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars)

(Unaudited)

 

     Three Months Ended March 31,  
     2018     2017  

Cash flows used in operating activities:

    

Net loss

   $ (1,143   $ (190

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     1,801       1,951  

Amortization of deferred charges

     —         18  

Loss on sale of assets

     —         8  

Share of loss from joint venture (note 8)

     237       —    

Interest paid

     598       610  

Share-based compensation (note 17)

     118       41  

Deferred income taxes

     (216     (350

Change in biological asset (note 5)

     659       645  

Changes in non-cash working capital items (note 13)

     (7,390     (7,346
  

 

 

   

 

 

 

Net cash used in operating activities

     (5,336     (4,613
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Purchases of property, plant and equipment

     (348     (431
  

 

 

   

 

 

 

Net cash used in investing activities

     (348     (431
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Proceeds from borrowings

     3,000       5,000  

Repayments on borrowings

     (77     (838

Interest paid on long-term debt

     (598     (610

Proceeds from exercise of stock options

     169       —    

Payments on capital lease obligations

     (17     (13
  

 

 

   

 

 

 

Net cash provided by financing activities

     2,477       3,539  
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (15     1  
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (3,222     (1,504

Cash and cash equivalents, beginning of period

     7,091       5,373  
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 3,869     $ 3,869  
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Income taxes paid

   $ —       $ —    
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

1

NATURE OF OPERATIONS

Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act . VFF’s principal operating subsidiaries as at March 31, 2018 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc (“VFCE”). The address of the registered office of VFF is 4700 80 th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), which is recorded as Investment in Joint Venture (note 7).

The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also traded in the United States on the OTCQX ® Best Market under the symbol VFFIF.

The Company, through its subsidiaries VFCLP and VFLP, owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. In addition, the Company’s joint venture, Pure Sunfarms, is in the start up stage of becoming a producer and supplier of cannabis products to be sold to wholesalers, distributors and retailers across Canada and internationally.

 

2

BASIS OF PRESENTATION

Statement of Compliance

The Company’s unaudited condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) and its interpretations, as issued by the International Accounting Standards Board (“IASB”). These condensed consolidated interim financial statements are prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting . They do not include all of the information required for full annual financial statement disclosures, and should be read in conjunction with the Company’s audited annual consolidated financial statements for the year ended December 31, 2017, which were prepared in accordance with IFRS.

Basis of Presentation

The condensed consolidated interim financial statements are prepared on a going concern basis. The accounting policies have been applied consistently in all material respects. These condensed consolidated interim financial statements have been prepared by applying the same accounting policies, assessments of estimates and judgments, and methods of computation as compared with the most recent annual consolidated financial statements.

Basis of Measurement

The condensed consolidated interim financial statements (“interim financial statements”) have been prepared on the historical cost basis except for the following material items in the condensed consolidated interim statement of financial position (“interim statement of financial position”):

 

   

biological assets are measured at fair value less costs to sell;

 

   

land is valued at fair market value; and

 

   

available-for-sale financial assets are measured at fair value.

Functional and Presentation Currency

These interim financial statements are presented in United States dollars (“U.S. dollars”), which is the Company’s primary functional currency. VFCE’s functional currency is Canadian dollars and conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates . All financial information presented in U.S. dollars has been rounded to the nearest thousands, except per share amounts.

 

 

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

3

CHANGES IN ACCOUNTING POLICIES

The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2017. These changes were made in accordance with the applicable transitional provisions.

IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in derecognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.

Following the adoption of IFRS 9, the Company could no longer defer and amortize financing fees that resulted from the refinancing of borrowings in periods prior to January 1, 2018. As a result, the Company has restated the beginning balances noted in the table below to properly account for $260 of financing fees in accordance with IFRS 9. The standard was applied retrospectively therefore approximately $260 of deferred financing costs, net of accumulated amortization, remain netted against long-term debt on the consolidated statement of financial position, as at December 31, 2017.

The following tables show the adjustments recognized for each individual line item. Line items that were not affected by the changes have not been included. As a result, the sub-totals and totals disclosed cannot be recalculated from the numbers provided.

 

     December 31, 2017
As originally
presented
     IFRS 9
Adjustments
     January 1, 2018
Restated
 

Statement of Financial Position (extract)

        

Non-current liabilities

        

Long-term debt

   $ 35,760      $ 260      $ 36,020  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     61,298        260        61,558  
  

 

 

    

 

 

    

 

 

 

Shareholders’ Equity

        

Retained earnings

     39,272        (260      39,012  
  

 

 

    

 

 

    

 

 

 

Total shareholders’ equity

     81,043        (260      80,783  
  

 

 

    

 

 

    

 

 

 

Statements of Income (Loss) and

Comprehensive Income (extract)

        

Interest expense

   $ 2,695      $ 260      $ 2,955  
  

 

 

    

 

 

    

 

 

 

Income (loss) before income taxes

     3,960        (260      3,700  

Provision for (recovery of) income taxes

     138        —          138  
  

 

 

    

 

 

    

 

 

 

Net income (loss)

   $ 3,822      $ (260    $ 3,549  
  

 

 

    

 

 

    

 

 

 

Basic income (loss) per share

   $ 0.10      $ (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

Diluted income (loss) per share

   $ 0.10      $ (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.

The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders they receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and their performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.

The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three months ended March 31, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.

Accounting Standards Issued and Not Applied

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the Company also applies IFRS 15. Management is currently assessing the impact on the Company’s interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated statement of financial position date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.

 

4

INVENTORIES

 

     March 31, 2018      December 31, 2017  

Deferred crop costs

   $ 23,628      $ 19,070  

Purchased produce inventory

     253        396  

Biological asset adjustment (note 5)

     (4,465      (2,212

Spare parts inventory

     64        55  
  

 

 

    

 

 

 
   $ 19,480      $ 17,309  
  

 

 

    

 

 

 

The cost of inventories recognized as expense and included in cost of sales for the three months ended March 31, 2018 amounted to $20,205 (2017 - $21,636). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the interim statement of financial position.

 

5

BIOLOGICAL ASSET

Information about the biological asset presented on the consolidated statements of financial position and in the consolidated statements of income (loss) is as follows:

 

     March 31, 2018      December 31, 2017      March 31, 2017  

Estimated sales value - biological asset

   $ 12,793      $ 7,937      $ 13,477  

Less

        

Estimated remaining costs to complete

     6,127        3,043        6,493  

Estimated selling costs

     667        489        699  
  

 

 

    

 

 

    

 

 

 

Fair value of biological asset less costs to sell

     5,999        4,405        6,285  

Less actual costs

     4,465        2,212        5,000  
  

 

 

    

 

 

    

 

 

 

Increase in fair value of biological asset over cost

     1,534        2,193        1,285  

Fair value over cost of harvested and sold biological asset - beginning of year

     2,193        1,928        1,930  
  

 

 

    

 

 

    

 

 

 

Change in biological asset

   $ (659    $ 265      $ (645
  

 

 

    

 

 

    

 

 

 

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

6

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of the following:

 

     Land      Leasehold
and land
improvements
    Buildings     Machinery
and
Equipment
    Construction
in process
    Total  

At December 31, 2017

 

Cost

   $  9,112      $ 3,820     $ 77,029     $ 63,237     $  468     $ 153,666  

Accumulated depreciation

     —          (2,223     (33,685     (36,004     —         (71,912
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,112      $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Three months ended March 31, 2018

 

   

Opening net book value

   $ 9,112      $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  

Additions (transfers)

     —          —         —         169       270       439  

Placed in service

     —          —         —         —         (91     (91

Depreciation expense

     —          (21     (684     (1,096     —         (1,801

FX translation adjustment

     —          —         (8     (85     —         (93
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

   $ 9,112      $ 1,576     $ 42,652     $ 26,221     $ 647     $ 80,208  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At March 31, 2018

 

       

Cost

   $ 9,112      $ 3,820     $ 77,015     $ 63,267     $ 647     $ 153,861  

Accumulated depreciation

     —          (2,244     (34,363     (37,046     —         (73,653
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,112      $ 1,576     $ 42,652     $ 26,221     $ 647     $ 80,208  
  

 

 

    

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. As at December 31, 2017, land, greenhouse buildings, and greenhouse equipment at Delta 3 were contributed as the Company’s investment in the joint venture transaction (note 7). The revaluation surplus related to Delta 3 of $1.8 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the condensed consolidated interim statements of loss.

 

7

INVESTMENT IN JOINT VENTURE

On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms Corp. (“Pure Sunfarms”), a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to pursue large-scale cannabis production in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.

As at March 31, 2018 the Investment in Joint Venture of $15.5 million (December 31, 2017 - $15.7 million) is recorded in the condensed consolidated interim statement of financial position. For the three months ended March 31, 2018, the Company’s share of net loss from joint venture totaled $237 (CA$302) (2017 - $nil), which is recorded in the condensed consolidated interim statement of loss.

The Company’s share of the joint venture consists of the following (in $000’s of USD):

 

Balance, January 1, 2018

   $ 15,727  

Share of loss

     (237
  

 

 

 

Balance, March 31, 2018

   $ 15,490  
  

 

 

 

 

10


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     March 31, 2018      December 31, 2017  

Current assets

     

Cash and cash equivalents

   $ 8,442      $ 2,907  

Other current assets

     1,110        475  

Non-current assets

     32,811        23,144  

Current liabilities

     (5,612      (1,171
  

 

 

    

 

 

 

Net assets

   $ 36,751      $ 25,355  
  

 

 

    

 

 

 

 

     March 31, 2018      December 31, 2017  

Reconciliation of net assets:

     

Accumulated deficit

   $ (1,249    $ (645

Contributions from joint venture partners

     38,000        26,000  
  

 

 

    

 

 

 

Net assets

   $ 36,751      $ 25,355  
  

 

 

    

 

 

 

 

     Three Months Ended
March 31, 2018
 
     (in $000’s of CAD)  

Revenue

   $ —    

Selling, general and administrative expenses

     (554

Other expense

     (50
  

 

 

 

Net loss

   $ (604
  

 

 

 

 

8

DEBT

 

     March 31, 2018      December 31, 2017  

Long-term debt:

     

Opening balance

   $ 38,380      $ 45,534  

IFRS adjustment for deferred financing fees (note 3)

     260        —    

Proceeds from long-term debt

     —          306  

Repayment of debt

     (85      (7,320

Foreign currency translation

     (49      120  
  

 

 

    

 

 

 

Closing balance

   $ 38,506      $ 38,640  
  

 

 

    

 

 

 

Current portion

   $ 5,615      $ 2,620  

Non-current portion

     35,891        36,020  

Less: Unamortized deferred transaction costs

     —          (260
  

 

 

    

 

 

 
   $ 41,506      $ 38,380  
  

 

 

    

 

 

 

Credit Facilities

The Company has a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan has a maturity date of May 1, 2021 and a balance of $36,695 as at March 31, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on May 1, 2021. As at March 31, 2018, borrowings under the FCC Loan agreement are subject to an interest rate of 6.2869% (December 31, 2017 – 5.88483%) which is determined based on the Company’s Debt to EBITDA ratio and the applicable LIBOR rate.

 

11


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 and fixed interest rate of 4.98%.

As at March 31, 2018, the balance was US$1,726 (December 31, 2017 - US$1,658). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at March 31, 2018, the balance was US$178 (December 31, 2017 - $192) .

The Company has a line of credit agreement with a Canadian Chartered Bank ( “Operating Loan”). The revolving Operating Loan has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021, and is subject to margin requirements stipulated by the bank. As at March 31, 2018, $3,000 was drawn on this facility (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling $261 and CA$38.

The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at March 31, 2018 and December 31, 2017, the Company was in compliance with all covenants on its Credit Facilities.

Accrued interest payable on the credit facilities and loans as at March 31, 2018 was $197 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statement of financial position.

The aggregate annual maturities of long-term debt for the next five years and thereafter are as follows:

 

The remainder of 2018

   $ 2,529  

2019

     3,385  

2020

     3,380  

2021

     28,696  

2022

     352  

Thereafter

     164  
  

 

 

 
     $ 38,506  
  

 

 

 

 

9

FINANCIAL INSTRUMENTS

The following table summarizes the carrying and fair value of the Company’s financial instruments:

 

     March 31, 2018      December 31, 2017  

Cash and cash equivalents

   $ 3,869      $ 7,091  

Trade receivables

   $ 9,104      $  11,259  

Other financial assets

   $ 2,058      $ 2,491  

Other financial liabilities

   $  54,774      $ 56,718  

Interest income, expense and gains and losses from loans, receivables and other financial liabilities are recognized in the condensed consolidated interim statements of loss. The following table summarizes interest income and expense for the three months ended March 31:

 

     2018      2017  

Interest income earned on cash and cash equivalents

   $  —        $  —    

Interest expense from other financial liabilities

   $ 598      $ 632  

Financial assets and liabilities are recognized on the consolidated interim statement of financial position at fair value in a hierarchy that is based on significance of the inputs used in making the measurements. The levels in the hierarchy are:

 

   

Level 1 -  Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

   

Level 2 - Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices)

 

   

Level 3 - Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).

 

12


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

Management of financial risks

The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at March 31, 2018 and December 31, 2017. The Company uses financial instruments only for risk management purposes, not for generating trading profit.

 

  i)

Credit risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables and other receivables. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had one customer that represented more than 10% of the balance of trade receivables, representing 14.0% of the balance of trade receivables as at March 31, 2018 (2017 – three customers represented 14.5%, 12.4% and 10.6%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales. The maximum amount of credit risk exposure is limited to the carrying amount of the balances on the interim financial statements.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At March 31, 2018, the allowance for doubtful accounts balance was $50 (December 31, 2017 - $50). The Company has not recorded bad debt expense during the three months ended March 31, 2018 (2017 - $nil).

At March 31, 2018, 96.7% (December 2017 – 89.4%) of trade receivables were outstanding less than 30 days, 1.6% (December 2017 – 7.4%) were outstanding for between 30 and 90 days and the remaining 1.7% (December 2017 - 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

 

  ii)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the three months ended March 31, 2018 would have been lower by $54. This represents $54 in increased interest expense (2017 - $54).

 

  iii)

Foreign exchange risk

At March 31, 2018, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7750 (December 31, 2017 – US$0.7966). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain consolidated statements of financial position items at March 31, 2018 and December 31, 2017 with the net foreign exchange gain or loss directly impacting net income (loss) for the period.

 

13


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

     March 31, 2018      December 31, 2017  

Financial assets

     

Cash and cash equivalents

   $ 28      $ 287  

Trade receivables

     372        349  

Financial liabilities

     

Trade payables and accrued liabilities

     (294      (371

Loan payable

     (223      (232
  

 

 

    

 

 

 

Net foreign exchange (loss) gain

   $ (117    $ 33  
  

 

 

    

 

 

 

 

  iv)

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at March 31, 2018:

 

Financial liabilities

   Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $  38,506      $ 2,615      $  6,736      $  29,061      $ 94  

Line of credit

     3,000        3,000        —          —          —    

Trade payables

     8,375        8,375        —          —          —    

Accrued liabilities

     3,656        3,656        —          —          —    

Obligation under capital lease

     233        73        160        —          —    

Other liabilities

     1,004        19        985        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 54,774      $  18,467      $ 7,881      $ 29,061      $ 94  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at March 31, 2018, the Company has an operating loan of up to CA$13,000, less an outstanding balance of $3,000 and outstanding letters of credit totaling $261 and CA$38.

 

  v)

Fair values

The carrying amount of short-term financial instruments, less provisions for impairment if applicable, is consistent with the fair value of such instruments. The Company’s debt bears a variable interest rate tied to market rates and therefore its carrying value approximates its fair value.    

 

10

RELATED PARTY TRANSACTIONS AND BALANCES

As at March 31, 2018, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $654 primarily for consulting services and the reimbursement of expenses which occurred in the year. These amounts were non-interest bearing and were due on demand. These amounts are included in other receivables in the interim statement of financial position.

Included in other assets as at March 31, 2018, is a $68 (December 31, 2017—$70) promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company.

 

14


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

11

EXPENSES BY NATURE

The following table outlines the Company’s significant expenses by nature:

 

Cost of sales    Three Months Ended
March 31, 2018
     Three Months Ended
March 31, 2017
 

Purchased produce

   $ 8,186      $ 9,521  

Raw materials and consumables used

     3,435        4,308  

Depreciation and amortization

     1,771        1,915  

Transportation and storage

     4,536        4,367  

Employee compensation and benefits

     7,974        7,209  
  

 

 

    

 

 

 
   $ 25,902      $ 27,320  
  

 

 

    

 

 

 
Selling, general and administrative expenses    Three Months Ended
March 31, 2018
     Three Months Ended
March 31, 2017
 

Employee benefits - salaries and short-term benefits

   $ 2,170      $ 2,115  

Marketing

     86        84  

Professional services

     411        245  

Office expenses

     442        374  

Other

     366        406  
  

 

 

    

 

 

 
   $ 3,475      $ 3,224  
  

 

 

    

 

 

 
Employee compensation and benefits    Three Months Ended
March 31, 2018
     Three Months Ended
March 31, 2017
 

Salaries and short-term employee benefits

   $ 9,728      $ 9,283  

Share-based compensation

     118        41  
  

 

 

    

 

 

 
   $ 9,846      $ 9,324  
  

 

 

    

 

 

 

 

12

DEFERRED INCOME TAX

Income tax expense is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the three months ended March 31, 2018 was 25%, excluding the change in biological asset as reported on the condensed consolidated interim statements of loss, and 30% for the three months ended March 31, 2017.

 

13

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

     Three Months Ended March 31,  
     2018      2017  

Trade receivables

   $ 2,147      $ 467  

Inventories

     (2,173      (2,319

Inventories reclassified to biological asset

     (2,253      (2,484

Other receivables

     58        56  

Prepaid expenses and deposits

     (158      (315

Trade payables

     (4,756      (2,595

Accrued liabilities and income taxes

     44        (174

Other assets, net of other liabilities

     (299      18  
  

 

 

    

 

 

 
   $ (7,390    $ (7,346
  

 

 

    

 

 

 

 

15


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

14

SEGMENT AND GEOGRAPHIC INFORMATION

The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer.

The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:

 

     Three Months Ended March 31,  
     2018      2017  

Sales

     

Produce - U.S.

   $  27,426      $  28,177  

Produce - Canada

     1,539        2,614  

Energy - Canada

     525        486  
  

 

 

    

 

 

 
   $ 29,490      $ 31,277  
  

 

 

    

 

 

 

The Company’s property, plant and equipment, net of accumulated depreciation, are located as follows:

 

     March 31, 2018      December 31, 2017  

United States

   $  45,910      $  46,922  

Canada

     30,886        31,183  

Energy - Canada

     3,412        3,649  
  

 

 

    

 

 

 
   $ 80,208      $ 81,754  
  

 

 

    

 

 

 

The depreciation and amortization charges for the three months ended March 31, 2018 in the Produce business were $1,578 (2017 - $1,765) and $223 (2017 - $186) in the Energy business.

 

15

LOSS PER SHARE

 

     For the Three Months Ended March 31,  
     2018      2017  

Net loss attributable to owners of the Company

   $ (1,143    $ (190

Weighted average number of common shares outstanding (thousands)

     42,372        38,883  
  

 

 

    

 

 

 

Basic loss per share

   $ (0.03    $ (0.00
  

 

 

    

 

 

 

For the three months ended March 31, 2018 and 2017, there were options to purchase 2,132 shares and 2,109 shares, respectively, of the Company’s common stock that were excluded from the diluted loss per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive during the respective periods.

 

     For the Three Months Ended March 31,  
     2018      2017  

Net loss attributable to owners of the Company

   $ (1,143    $ (190

Weighted average number of common shares outstanding (thousands)

     42,372        38,883  

Adjustment for:

     

Share options (thousands)

     —          —    
  

 

 

    

 

 

 

Weighted average number of common shares outstanding for diluted income per share (thousands)

     42,372        38,883  
  

 

 

    

 

 

 

Diluted loss per share

   $ (0.03    $ (0.00
  

 

 

    

 

 

 

 

16


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

16

CAPITAL DISCLOSURES

The Company’s capital comprises net debt and equity:

 

     March 31, 2018      December 31, 2017  

Total bank debt

   $  38,506      $  38,640  

Less cash and cash equivalents

     (3,869      (7,091
  

 

 

    

 

 

 

Net debt

     34,637        31,549  

Total equity

     79,859        81,043  
  

 

 

    

 

 

 
   $ 114,496      $ 112,592  
  

 

 

    

 

 

 

It is the Company’s intention to meet its obligations through the collection of current accounts receivable and cash. As at March 31, 2018, the Company has an available operating loan up to CA$13,000, less $3,000 drawn on the loan and $261 and CA$38 outstanding letters of credit (as at December 31, 2017, $nil was outstanding on the operating loan, and $333 and CA$38 outstanding on the letters of credit). As at March 31, 2018, the operating loan borrowing base was CA$9,426 based on a percentage of the Company’s outstanding accounts receivable less the issued letters of credit. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

 

17

SHARE-BASED COMPENSATION PLAN

The Company has a share-based compensation plan. The maximum number of common shares that can be issued upon the exercise of options granted is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options vest at a rate of 33% per year, beginning one year following the grant date of the options. Share-based compensation expense for the three months ended March 31, 2018 of $118 (2017 - $41) was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.

During 2017, 906,000 performance-based restricted share units were issued to Village Farms employees involved with the recently formed joint venture with Pure Sunfarms, Corp. Once a performance target is met and the shares units are deemed earned and vested, compensation expense was recorded based on the fair value of the share units on grant date and is included in selling, general and administrative expenses in the consolidated statement of loss. There were 128,000 performance-based restricted share units with a weighted average grant date fair value of CA$2.82 outstanding and which had not yet vested as at March 31, 2018 and December 31, 2017.

 

17

Exhibit 99.22

Village Farms International, Inc.

Management’s Discussion and Analysis

Three Months Ended March 31, 2018

May 14, 2018


Village Farms International Inc.

 

Management’s Discussion and Analysis

Information is presented in thousands of United States dollars (“U.S. dollars”) unless otherwise noted.

Introduction

This management’s discussion and analysis (“MD&A”) should be read in conjunction with the condensed consolidated interim financial statements and accompanying notes of Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”), for the three months ended March 31, 2018 (the “Consolidated Financial Statements”). The information provided in this MD&A is current to May 14, 2018 unless otherwise noted.

VFF is a corporation existing under the Canada Business Corporations Act . The Company’s principal operating subsidiaries at March 31, 2018 were Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”) and VF Clean Energy, Inc. (“VFCE”). On June 6, 2017 VFF entered into a shareholders’ agreement in respect of the operation and governance of Pure Sunfarms Corp. (“Pure Sunfarms”) in which VFF owns a 50% interest.

Basis of Presentation

The annual data included in the MD&A is presented in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.

The preparation of annual financial data requires the use of certain accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the annual financial data, are disclosed in note 3 of the Condensed Consolidated Interim Financial Statements.

Segment Reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the CEO. Based on the aggregation criteria in IFRS 8, Operating Segments , the operating segments of the Company are treated as two reporting segments.

Functional and Presentation Currency

The financial data is presented in U.S. dollars, which is the Company’s functional currency. All financial information presented in U.S. dollars has been rounded to the nearest thousand.

Business Overview

Management believes that the Company is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America. These premium products are grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas. The Company also markets and distributes premium tomatoes, peppers and cucumbers produced under exclusive arrangements with other greenhouse producers. The Company primarily markets and distributes under its Village Farms ® brand name, primarily to retail supermarkets and dedicated fresh food distribution companies throughout the United States and Canada. It currently operates two distribution centres, one located in the United States and one in Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates four main goals – environmental health, economic profitability and social and economic equality. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant from landfill gas that generates electricity and provides thermal heat, in colder months, to one of the Company’s adjacent British Columbia greenhouse facilities and sells electricity to British Columbia Hydro and Power Authority (“BC Hydro”).

The Company embraces sustainable agriculture and environmentally-friendly growing practices by:

 

- 2 -


Village Farms International Inc.

 

 

   

utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their products virtually free of chemical agents. The process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies;

 

   

capturing rainwater from various greenhouse roofs for irrigation purposes;

 

   

capturing landfill gas on a long term contract from the City of Vancouver landfill to generate electricity under a long term contract with BC Hydro and thermal heat for an adjacent greenhouse;

 

   

recycling water and nutrients during the production process;

 

   

growing plants in a natural medium, including coconut fibre and rock wool, as opposed to growing in the soil and depleting nutrients; and

 

   

using dedicated environmental control computer systems which monitor and control virtually all aspects of the growing environment, thereby maximizing the efficient use of energy.

The Company’s assets, as of the reporting date, include six operating produce greenhouses providing approximately 849,958 square metres (or approximately 215 acres) of growing space in Canada and the United States. For the three months ended March 31, 2018 the Company had seven operating produce greenhouses. During 2017, the Company granted rights to one of its greenhouses located in Delta, BC (the “Delta 3 Greenhouse”) to Pure Sunfarms. Pure Sunfarms is in the process of converting the Delta 3 Greenhouse into a facility compliant with Access to Cannabis for Medical Purposes Regulations (“ACMPR”) with the object of seeking to achieve large scale low-cost high quality cannabis production. Pure Sunfarms received a cultivation license from Health Canada for the Delta 3 Greenhouse on March 2, 2018.

All of the Company’s greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company also has marketing agreements with growers in Canada, United States and Mexico that currently operate approximately 572,800 square metres (or approximately 140 acres) of growing area.

The following table outlines the Company’s greenhouse facilities:

 

     Growing Area       

Greenhouse Facility

   Square Feet      Square
Metres
     Acres     

Products Grown

Marfa, TX (2 greenhouses)

     2,527,312        234,795        60     

Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Fort Davis, TX (1 greenhouse)

     1,684,874        156,530        40      Specialty tomatoes

Monahans, TX (1 greenhouse)

(Permian Basin facility)

     1,272,294        118,200        30      Tomatoes on-the-vine, long English cucumbers

Delta, BC (2 greenhouses)

     3,664,390        340,433        85     

Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Pure Sunfarms (1 greenhouse)

     1,077,758        100,127        25     

Leased to Pure Sunfarms for cultivation of cannabis

  

 

 

    

 

 

    

 

 

    

Total

     10,226,628        950,085        240     

Marketing

The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed provider to be the sole grower in North America), other speciality tomatoes under exclusive agreements and long English cucumbers at its facilities. The Company also distributes and markets premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.

The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.

 

- 3 -


Village Farms International Inc.

 

 

The Company has distribution capabilities that it believes exceed those of most of its competitors in the North American greenhouse vegetable industry. With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the quarter ended March 31, 2018, the Company had an on-time delivery record of approximately 97.8%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.

The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:

 

   

Year-Round Supplier. Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing.

 

   

Quality and Food Safety. Sales are made directly to retailers which ensure control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs ® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs ® .

 

   

Quality Packaging and Presentation. Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf.

 

   

Exclusive Varieties. The Company expands its product profile, to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand.

 

   

Direct Sale to Retail Customers. Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including, Associated Grocers, Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fred Meyer, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, Inc., HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Publix Super Markets, Inc., Roundy’s Supermarkets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, United Supermarkets, Unified Western Grocers, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC.

 

   

Excellence in Customer Service and Logistics. Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres.

Investment in Joint Venture

On June 6, 2017, the Company and Emerald Health Botanicals, Inc. (“Emerald”) formed a new corporation named “Pure Sunfarms Corp.”. The Company and Emerald each own 50% of the shares of Pure Sunfarms. VFF contributed rights to one of its 25-acre greenhouse facilities in Delta, British Colombia as its equity contribution and Emerald agreed to contribute CA$20,000,000 to fund the conversion of the facility, which was fully funded as of April 2018. Pure Sunfarms has commenced the cultivation of cannabis in the licensed portion of the facility in order to begin the process of applying and being granted its sales license for the facility, which it hopes to receive on or before July 1, 2018. Pure Sunfarms continues the conversion process on the remaining unlicensed portion of the facility.

As part of the formation of Pure Sunfarms, VFF incurred related transaction costs of CA$1,400,000, which have been added to the amount of the investment in accordance with IAS 28, Investments in associates and joint ventures. Included in these costs are 300,000 common share purchase warrants valued at CA$192,000, issued to an affiliate of a Canadian financial institution as partial consideration for services provided in respect of the formation of the Pure Sunfarms. Each such warrant entitles the holder to purchase one common share at an exercise price of CA$2.07. Each such warrant is to be exercised up to June 6, 2020. Additionally, both shareholders of Pure Sunfarms are incurring reimbursable costs and expenditures to support Pure Sunfarms operations, which will be reimbursed by Pure Sunfarms and are considered either capital expenditures or operating expenditures of Pure Sunfarms.

 

- 4 -


Village Farms International Inc.

 

 

Pure Sunfarms has entered into a supply agreement with Emerald. In this agreement, Emerald will purchase 40% of Pure Sunfarms’ production in 2018 and 2019, or approximately 21,000 to 24,000 kilograms using current projected production targets, at a pre-determined price per gram.

Results of Operations

Consolidated Financial Performance

(In thousands of U.S. dollars, except per share amounts)

 

     For the three months
ended March 31,
 
     2018      2017  

Sales

   $ 29,490      $ 31,277  

Cost of sales

     (25,902      (27,320

Selling, general and administrative expenses

     (3,357      (3,183

Stock compensation expense

     (118      (41

Change in biological asset (1)

     (659      (645

(Loss) income from operations

     (546      88  

Interest expense, net

     (598      (632

Other income

     25        4  

Share of loss from joint venture

     (237      —    

Recovery of income taxes

     (213      (350

Net loss

     (1,143      (190

EBITDA (2)

     1,813        2,751  

(Loss) per share – basic

   ($ 0.03    ($ 0.00

(Loss) earnings per share – diluted

   ($ 0.03    ($ 0.00

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s annual consolidated financial statements for the quarter ended March 31, 2018.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

Results of Operations for the Three Months Ended March 31, 2018 compared to the Three Months Ended March 31, 2017

Sales

Sales for the three months ended March 31, 2018 decreased by ($1,787), or (6%), to $29,490 from $31,277 for the three months ended March 31, 2017. The decrease in sales is primarily due to a decrease in the Company’s supply partner product volume of (9%) and a decrease in the Company’s facilities production volume of (5%). The decrease in supply partner revenue is due to the transition from one primary Mexican supply partner to a new primary Mexican supply partner who is in the process of expanding its operations.

The average selling price for tomatoes decreased (4%) for the three months ended March 31, 2018 versus the three months ended March 31, 2017. Cucumber pricing decreased by (1%) and pepper pricing decreased by (20%) in the first quarter of 2018 versus the comparable quarter in 2017.

Cost of Sales

Cost of sales for the three months ended March 31, 2018 decreased by ($1,418), or (5%), to $25,902 from $27,320 for the three months ended March 31, 2017; primarily due to a decrease of ($1,335) in contract sales cost (due to decreased cucumber volume), partially offset by an increase in freight expense of $309.

 

- 5 -


Village Farms International Inc.

 

 

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2018 increased by $174, or 5%, to $3,357 from $3,183 for the three months ended March, 31, 2017. The increase is due to marketing costs, legal fees and consulting fees.

Stock Compensation Expenses

Stock compensation expense for the three months ended March 31, 2018 was $118 from $41 for the three months ended March 31, 2017.

Change in Biological Asset

The net change in fair value of the biological asset remained flat for the three months ended March 31, 2018 at ($659) from ($645) for the three months ended March 31, 2017. The fair value of the biological asset as at March 31, 2018 was $5,999 as compared to $6,285 as at March 31, 2017 due to lower production, offset by higher selling price in early April 2018 versus early April 2017.

Loss from Operations

Loss from operations for the three months ended March 31, 2018 decreased ($634) to ($546) from $88 for the three months ended March 31, 2017. The decrease is due to a decrease in sales and an increase in selling, general and administrative expense for three months ended March 31, 2018 versus the three months ended March 31, 2017.

Interest Expense, net

Interest expense, net, for the three months ended March 31, 2018 decreased by $34, to $598 from $632 for the three months ended March 31, 2017. The decrease is due to lower long term debt versus the prior year.

Share of (loss) from Joint Venture

The Company’s share of the loss for the three months ended March 31, 2018 is ($237), which consists of travel and other administrative costs.

Provision for Income Taxes

Income tax recovery for the three month period ended March 31, 2018 was ($213) compared to ($350) for the three month period ended March 31, 2017. The income tax recovery decreased due to a change in the United States future tax rate.

Net (loss)

Net loss for the three months ended March 31, 2018 increased by ($953) to a net loss of ($1,143) from ($190) for the three months ended March 31, 2017 primarily as a result of a decrease in sales, an increase in selling, general and administrative expenses, the loss from joint venture and a decrease in recovery of income taxes.

EBITDA

EBITDA for the three months ended March 31, 2018 decreased by ($938), or (34%), to $1,813 from $2,751 for the three months ended March 31, 2017, primarily as a result of a decrease in sales, , increased share of loss from Pure Sunfarms and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.

 

- 6 -


Village Farms International Inc.

 

 

Selected Statement of Financial Position Data

 

     As at March 31,      As at March 31,  
     2018      2017  

Total assets

   $ 139,242      $ 135,972  

Total liabilities

   $ 59,383      $ 68,721  

Shareholders’ equity

   $ 79,859      $ 67,251  

Non-IFRS Measures

References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months ended
March 31,
 
     2018      2017  

Net income (loss)

   ($ 1,143    ($ 190

Add:

     

Amortization

     1,801        1,951  

Foreign currency exchange (gain) loss

     (7      14  

Interest expense

     598        632  

Income taxes

     (213      (350

Stock based compensation

     118        41  

Change in biological asset

     659        645  

Loss on disposal of assets

     —          8  
  

 

 

    

 

 

 

EBITDA

   $ 1,813      $ 2,751  

Liquidity

Cash flows

The Company expects to provide adequate financing to maintain and improve its property, plant and equipment and to fund working capital needs for the foreseeable future from cash flows from operations, and, if needed, from additional borrowings under the Credit Facilities (as defined below) or other long-term facilities, including capital leases or subordinated debt issuances.

For the three months ended March 31, 2018, cash flows from operating activities before changes in non-cash working capital and change in biological asset totalled $1,395 (2017 – $2,088).

Capital expenditures totalled $348 for the three months ended March 31, 2018 (2017 - $431).

The cash provided by financing activities for the three months ended March 31, 2018 totalled $2,477 (2017 – $3,539). For the three months ended March 31, 2018, the cash provided by financing activities primarily consisted of operating loan borrowings of $3,000, net term debt payments of ($77), interest payments of ($598) (2017 – operating loan borrowing $5,000, debt payments of ($838) and interest paid ($610)).

 

- 7 -


Village Farms International Inc.

 

 

Capital Resources

 

(in thousands of U.S. dollars unless otherwise noted)    Maximum      Outstanding
March 31, 2018
 

Operating Loan

   CA$ 13,000      $ 3,000  

Term Loan

   $ 36,695      $ 36,695  

VFCE Loan

   CA$ 2,320      CA$ 2,320  

The Company is party to a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). This non-revolving variable rate term loan was amended in March 2016 and now has a maturity date of May 1, 2021 and a balance of $36,695 as at March 31, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on maturity. In December 2017, the Company made a pre-payment on the term loan of $4,000. The Company did not have to make principal payments from January to March 2018. Monthly principal payments of $253 will begin in April 2018. As at March 31, 2018, borrowings under the FCC Loan were subject to an interest rate of 6.2869% per annum (March 31, 2017 – 5.53456% per annum). The Company’s interest rate on the FCC Loan is determined based on the Company’s Debt to EBITDA ratio on December 31 of the prior year and the current monthly applicable LIBOR rate.

The Company is also party to a variable rate line of credit agreement with a Canadian chartered bank that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank. As at March 31, 2018, $3,000 was drawn on the Operating Loan (March 31, 2017 – $5,000), which is available to a maximum of CA$13,000, less outstanding letters of credit of US$261 and CA$38 (or US$29).

The Company’s subsidiary, VFCE, has a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023, a fixed interest rate of 4.98% per annum, and monthly payments of principal and interest of CA$36. In October 2017, VFCE borrowed an additional CA$250 payable at CA$4 per month plus interest of prime plus 2% per annum. As at March 31, 2018, the outstanding balance was CA$2,320 (US$1,726) (March 31, 2017 - US$1,744).

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at March 31, 2018 was $112,016 (March 31, 2017 – $131,883).

As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therefore. The carrying value of the assets pledged as collateral as at March 31, 2018 was $34,634 (March 31, 2017 - $34,192).

The borrowings are subject to certain positive and negative covenants, which include debt coverage ratios. As at March 31, 2018, the Company was in compliance with all of its covenants.

Accrued interest payable on the Credit Facilities as at March 31, 2018 was $197 (March 31, 2017 – $198) and these amounts are included in accrued liabilities in the interim statements of financial position.

 

- 8 -


Village Farms International Inc.

 

 

Contractual Obligations and Commitments

Information regarding the Company’s contractual obligations at March 31, 2018 is set forth in the table below:

 

(in thousands of U.S. dollars)    Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $ 38,506      $ 2,615      $ 6,736      $ 29,061      $ 94  

Line of Credit

   $ 3,000      $ 3,000        —          —          —    

Operating leases

     3,074        1,290        1,181        603        —    

Capital leases

     233        73        160        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 44,813      $ 6,978      $ 8,077      $ 29,664      $ 94  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Capital Expenditures

During the three month period ended March 31, 2018, the Company purchased approximately $348 of capital assets. Capital expenditures incurred for 2018 were used for replacements or improvements to existing facilities, distribution centres or information technology systems or hardware.

Management continues to review new capital expenditures to support its strategic plan of achieving cost efficiencies through increased productivity. Management may elect, where appropriate, to sell inefficient or non-strategic assets to produce cash to wholly or partially finance new capital expenditures. The Company will also borrow to maintain, improve and replace capital assets when the return on such investments exceeds targeted thresholds for internal rates of return. There can be no assurance, however, that sources of financing will be available, or will be available on terms favourable to the Company, or that these strategic initiatives will achieve adequate cost reduction in actual implementation or in light of the competitive pressures on the cost of raw materials and other factors of production. Management believes that its recurring capital expenditures will be funded and supported from its ongoing operations.

During the three month March 31, 2018, the Company incurred $651 in costs to maintain its capital assets. These expenses are classified as repair and maintenance and are included in cost of sales. Management forecasts approximately $2,500 of annual costs to maintain the Company’s capital assets.

Summary of Quarterly Results

For the three months ended:

 

(in thousands of U.S. Dollars, except per share amounts)

   Mar 31,
2018
    Dec 31,
2017
    Sept 30,
2017
     Jun 30,
2017
     Mar 31,
2017
    Dec 31,
2016
     Sept 30,
2016
    Jun 30,
2016
 

Sales

   $ 29,490     $ 36,864     $ 44,735      $ 45,530      $ 31,277     $ 37,308      $ 42,045     $ 44,441  

Net income (loss)

   ($ 1,143   ($ 607   $ 294      $ 4,325      ($ 190   $ 453      ($ 1,425   ($ 770

Basic earnings (loss) per share

   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04   ($ 0.02

Diluted earnings (loss) per share

   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04   ($ 0.02

The Company’s Canadian vegetable growing operations peak production period is in the summer months, with no production during the winter season. As a result, prices for vegetable products from the Company’s Canadian operations have historically followed a seasonal trend of higher prices at the start and end of its crop year, with lower prices in the summer months when the supply of product is greatest. Conversely, the Company’s U.S. vegetable operations winter production allows it to realize higher prices during the October through March period, due to the reduced supply of greenhouse produce in North America during the winter months. The complementary nature of the growing seasons of the Company’s Canadian and U.S. vegetable operations allows the Company to maintain and service its core vegetable retail accounts year round.

 

- 9 -


Village Farms International Inc.

 

 

Financial Instruments and Risk Management

Risk Management

The Company is exposed to the following risks as a result of holding financial instruments: market risk, credit risk, interest rate risk, foreign exchange risk and liquidity risk. The following is a description of these risks and how they are managed by the Company.

Market Risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market place.

Credit Risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables.

The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had one customer that represented more than 10% of the balance of trade receivables, representing 14.0% of the balance of trade receivables as at March 31, 2018 (2017 – three customers, 14.5%, 12.4% and 10.6%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its vegetable sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At March 31, 2018, the allowance for doubtful accounts balance was $50 (2017 – $50). The Company has not recorded bad debt expense during the three month period ended March 31, 2018 (2017 – $nil).

At March 31, 2018, 96.7% (March 2017 – 94.8%) of trade receivables were outstanding less than 30 days, 1.6% (March 2017 – 3.6%) were outstanding for between 30 and 90 days and the remaining 1.7% (March 2017 – 1.6%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

The Company has used derivative instruments to reduce market exposure to changes in interest rates. The Company has used derivative instruments only for risk management purposes and not for generating trading profits.

 

- 10 -


Village Farms International Inc.

 

 

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The following are the contractual maturities of financial liabilities as at March 31, 2018:

 

(in thousands of U.S. dollars)

Financial liabilities

   Contractual
cash flows
     0 to 12
months
     12 to 24
months
     After 24
months
 

Accounts payable and accrued liabilities

   $ 11,994      $ 11,994      $ —        $ —    

Bank debt

     41,506        5,615        3,399        32,492  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 53,500      $ 17,609      $ 3,399      $ 32,492  
  

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash. The Company has available lines of credit of up to CA$13,000 (as at March 31, 2018, $3,000 was outstanding and US$261 and CA$38 was utilized in the form of outstanding letters of credit). If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach or default that might otherwise result there from. If the Company defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will continue to agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, and (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its common shares. See also “Risk Factors—Dependence Upon Credit Facilities” in the Company’s current Annual Information Form.

Environmental, Health and Safety Risk

The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate. Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect the Company’s operational results and profitability.

The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.

 

- 11 -


Village Farms International Inc.

 

 

Overview

The forward-looking statements contained in this section and elsewhere in this MD&A are not historical facts, but rather, reflect the Company’s current expectations regarding future results or events and are based on information currently available to Management. Certain material factors and assumptions were applied in providing these forward-looking statements. See the “Forward-Looking Statements” section of this MD&A.

On June 6, 2017 the Company announced an initiative into growing cannabis through a joint venture with an existing licensed producer –, pursuant to which the Company would contribute rights to one of its Delta greenhouses and growing knowledge in exchange for a 50% equity position. Emerald has contributed CA$20m for its 50% equity interest. The joint venture is named “Pure Sunfarms Corp.” Pure Sunfarms received its cultivation license for the Delta 3 Greenhouse on March 2, 2018. Pure Sunfarms just completed its initial harvest that will be used as part of the supply to provide to Health Canada as part of Pure Sunfarms obtaining its sales license for the facility which it hopes to receive on or before July 1, 2018. Pure Sunfarms continues to convert the unlicensed sections of the Company’s Delta 3 greenhouse to grow cannabis and meet the required security standards for licensing under the ACMPR. Management believes that Pure Sunfarms will be successful in obtaining a cultivation and sales license for the remainder of the facility by the end of 2018. Once the entire facility is licensed, it will be one the largest commercial cannabis production facilities in Canada. Management believes it will produce cannabis for CA$1 per gram with margins of 50% in late 2019. As such, the Company’s 50% equity interest is capable of generating substantially higher revenue and profits than prior revenues and profits from the tomato crop currently grown in the facility.

Pure Sunfarms will need incremental capital to complete the full buildout of the Delta 3 Greenhouse. Presently, it is in discussions with the Company’s current long-term lender to provide traditional term debt to Pure Sunfarms. Depending on the timing of any debt funding, the two shareholder’s may have to contribute additional equity or short-term debt to Pure Sunfarms to complete the full build out prior to the end of 2018.

Management is committed to only conducting activities and growing operations which are federally legal and as such it will not grow, nor invest in any cannabis related business in the U.S. until it is federally legal.

The Company continues to focus on increasing its produce revenues and profits on its core crops – tomatoes, cucumbers and peppers. The Company also continues to actively explore whether to produce certain higher margin alternative crops at the Company’s continuing produce facilities, and continues to consider produce industry consolidation opportunities if an accretive opportunity arises.

Growth expenditures

The Company expects to spend between $2.5 to $3.0 million on capital expenditures in 2018. These expenditures are to repair and enhance existing growing and packhouse systems either due to obsolesces of the system or to improve operational efficiencies.

The Company may make additional equity contributions to Pure Sunfarms of cash in the next twelve months depending on the final completion timeline for the Delta 3 Greenhouse and whether or not Pure Sunfarms obtains financing.

Disclosure Controls and Procedures

Disclosure controls and procedures have been designed to ensure that information to be disclosed by the Company is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosures. The Chief Executive Officer and Chief Financial Officer have concluded, as of the end of the period covered by the interim and year end filings, that the Company’s disclosure controls and procedures are appropriately designed and operating effectively to provide reasonable assurance that material information relating to the issuer is made known to them by others within the Corporation.

Internal Control over Financial Reporting

Internal control over financial reporting is a process designed to provide reasonable assurance that all assets are safeguarded, transactions are appropriately authorized and to facilitate the preparation of relevant, reliable and timely information. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute,

 

- 12 -


Village Farms International Inc.

 

 

assurance that the objective of the control system is met. Management has assessed the effectiveness of the Company’s internal control over financial reporting as defined by National Instrument 52-109, Certification of Disclosure in Issuers’ Annual and Interim Filings. Management has concluded that their internal control over financial reporting was effective as of March 31, 2018. There were no material changes in the Company’s internal control over financial reporting that occurred during the three months ended March 31, 2018 that had materially affected, or is reasonably likely to affect the Company’s internal controls over financial reporting.

Risks and Uncertainties

The Company is subject to various risks and uncertainties which are summarized below, as well as those discussed in this MD&A. Additional details are contained in the Company’s current Annual Information Form dated April 2, 2018 filed on SEDAR, which can be accessed electronically at www.sedar.com .

Risks Relating to the Company

 

   

Product Pricing

 

   

Maintain Profitability

 

   

Risks Inherent in the Agricultural Business

 

   

Natural Catastrophes

 

   

Retail Consolidation

 

   

Covenant Risk

 

   

Dependence Upon Credit Facilities

 

   

Competition

 

   

Transportation Disruptions

 

   

Labour Availability

 

   

Risks Associated with Cross Border Trade

 

   

Governmental Regulations

 

   

Product Liability

 

   

Key Executives

 

   

Uninsured and Underinsured Losses

 

   

Cyber Security

 

   

Vulnerability to Rising Energy Cost

 

   

Risks of Regulatory Change

 

   

Environmental, Health and Safety Risk

 

   

Foreign Exchange Exposure

 

   

Technological Advances

 

   

Accounting Estimates

 

   

Growth

Risks Related to the Joint Venture

 

   

Reliance on Licenses

 

   

Regulatory Risks

 

   

Unfavourable Publicity or Consumer Perception

 

   

Competition

 

   

Risks Inherent in an Agricultural Business

 

   

Risks Related to the Joint Venture

 

   

Reliance on a Single Facility

 

   

Conversion of Facility

 

   

Limited Operating History in the Cannabis Industry

 

   

Failure to Realize Growth Strategy

 

   

Research and Development and Product Obsolescence

 

   

Product Liability

 

   

Product Recalls

 

   

Fluctuating Prices of Raw Materials

 

   

Environmental Regulations and Risks

 

- 13 -


Village Farms International Inc.

 

 

Risks Related to Tax

 

   

Potential U.S. Permanent Establishment of VF Canada GP, VFCLP and VFF

 

   

Advances by VF Operations Canada Inc. to U.S. Holdings

 

   

Transfer Pricing

 

   

U.S. Real Property Holding Corporation

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

Critical Accounting Estimates

Accounts Receivable

Accounts receivable are measured at amortized cost and due within contractual payment terms and are stated at amounts due from customers net of an allowance for doubtful accounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the bad debt expense.

Inventories

Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year and exclude biological assets (see below). Cost of sales is based upon incurred and estimated costs to be incurred from each crop allocated to both actual and estimated future yields over each crop cycle. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.

Biological Assets

Biological assets consist of the Company’s produce on the vines at the period end. The produce on the vine is measured at fair value less costs to sell and complete, with any change therein recognized in profit or loss. Costs to sell include all costs that would be necessary to sell and complete the assets, including finishing and transportation costs.

Income Taxes

The Company utilizes the assets and liability method of accounting for income taxes under which future income tax assets and liabilities are recognized for the estimated future income tax consequences attributable to differences between the financial statement carrying value amount and the tax basis of assets and liabilities. Management uses judgment and estimates in determining the appropriate rates and amounts in recording future taxes, giving consideration to timing and probability. Actual taxes could significantly vary from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities.

Future income tax assets are recognized to the extent that realization is considered more likely than not. The Company considers past results, current trends and outlooks for future years in assessing realization of income tax assets.

Impairment of Financial and Non-Financial Assets

At the end of each reporting period, the Company reviews the carrying amounts of its long lived assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. The Company estimates the recoverable amounts of the cash-generating unit (“CGU”) to which the asset belongs.

 

- 14 -


Village Farms International Inc.

 

 

Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual CGU’s, or otherwise they are allocated to the smallest group of CGU’s for which a reasonable and consistent allocation basis can be identified. Identifiable cash flows are largely independent of the cash flows of other assets and liabilities. This was determined to be the Canadian and U.S. operations.

Recoverable amount is the higher of the fair value less costs to sell and the value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount of the asset or CGU is reduced to its recoverable amount. An impairment loss is recognized immediately in the statement of income.

Where an impairment loss subsequently reverses for assets with a finite useful life, the carrying amount of the asset or CGU is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset or CGU in prior periods. A reversal of an impairment loss is recognized immediately in the statement of income.

Due to the above-noted considerations, which are based on the Company’s best available information, the Company has not recorded any impairment charge on its non-financial assets in the three months ended March 31, 2018.

Property, Plant and Equipment – Useful Lives

Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.

Land Revaluation

Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016.

Accounting Standards Issued and Not Applied

The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the company also applies IFRS 15. Management is currently assessing the impact on the Company’s consolidated interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

 

- 15 -


Village Farms International Inc.

 

 

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated balance sheet date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Accounting Standards Adopted in the Year

IFRS 9 Financial Instruments replaced the current IAS 39 Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduced a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in derecognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. The Company’s adoption of IFRS 9, effective January 1, 2018, had no material impact on the condensed consolidated financial statements of the Company.

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of products with standard shipping terms and discounts. Substantially all of the Company’s revenue transactions consist of a single performance obligation to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders we receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and our performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the three months ended March 31, 2018.

 

- 16 -


Village Farms International Inc.

 

 

Related Party Transactions

As at March 31, 2018, included in other assets is a $68 promissory note from an employee of the Company in connection with a relocation agreement. The Company has no other commitments as a result of related party transactions during the year.

Outstanding Share Data

The beneficial interests in the Company are currently divided into interests of three classes, described and designated as “Common Shares”, “Special Shares” and “Preferred Shares”, respectively. An unlimited number of Common Shares, Special Shares and Preferred Shares are issuable pursuant to VFF’s constating documents.

On December 21, 2017, VFF issued 2,500,000 Common Shares pursuant to a “bought deal” short form prospectus offering at an issue price of $5.40 per Common Share for gross proceeds of $13,500,000. The offering was conducted by a syndicate of underwriters led by Beacon Securities Limited.

As of the date hereof, VFF has outstanding: (i) 42,485,946 Common Shares carrying the right to one vote at a meeting of voting shareholders of VFF; (ii) nil (0) Special Shares; and (iii) nil (0) Preferred Shares. In conjunction with the formation of Pure Sunfarms Corp., the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Each such warrant entitles the holder to purchase one Common Share at an exercise price of CA$2.07. Each such warrant is exercisable up to June 6, 2020.

For further details on the structure of the Company or the rights attached to each of the above-mentioned securities, please refer to the Company’s current Annual Information Form dated April 2, 2018 which is available electronically at www.sedar.com .

Forward-Looking Statements

Certain statements contained in this MD&A constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this MD&A include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable rates when required.

 

- 17 -


Village Farms International Inc.

 

 

Although the forward-looking statements contained in this MD&A are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this MD&A and the Company’s annual information form.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this MD&A relate only to events or information as of the date on which the statements are made in this MD&A. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Public Securities Filings

You may access other information about the Company, including its current Annual Information Form and other disclosure documents, reports, statements or other information that it files with the Canadian securities regulatory authorities, through SEDAR at www.sedar.com .

 

- 18 -

Exhibit 99.23

VILLAGE FARMS INTERNATIONAL REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND ANNOUNCES COMMENCEMENT OF COMMERCIAL-SCALE GROWING AT DELTA 3 GREENHOUSE

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

VANCOUVER, May 14, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced its financial results for the first quarter ended March 31, 2018.

(All amounts in U.S. Dollars unless otherwise indicated.)

Highlights for the First Quarter Ended March 31, 2018

(All comparable figures are for the first quarter ended March 31, 2017)

 

   

Sales of US$29.5 million, a decrease of (6%) from US$31.3 million;

 

   

Net loss was US($1.1) million, or US($0.03) per share, compared with a net loss of US($0.2) million, or US($0.00) per share; and,

 

   

EBITDA of US$1.8 million, a decrease of US($1.0), or (34)%, from US$2.8 million.

Cannabis Joint Venture (Pure Sunfarms) Update

 

   

Pure Sunfarms completed its initial cannabis harvest at the Delta 3 greenhouse, a portion of which will be submitted for testing under Health Canada’s sales licensing process and the remainder of which will be inventoried for sale when Pure Sunfarms receives its sales license;

 

   

Pure Sunfarms received an amendment to its cultivation license for the Delta 3 greenhouse from Health Canada, permitting Pure Sunfarms to initiate commercial scale growing, which commenced today. As previously announced, senior growing, financial, human resources and operational personnel, including the established team transferred from Village Farms, as well as multiple new management hires are in place for production ramp-up, and the search for a CEO is well underway;

 

   

Pure Sunfarms finalized a contract for the short-term rental of the requisite generating equipment to power supplemental lighting during the 2018/2019 winter months, while the installation of the approved additional 24MW by the local utility is in process. The power generation equipment will enable Pure Sunfarms to increase production throughout the 2018/2019 winter months, thereby accelerating the production ramp-up at the Delta 3 facility, such that Pure Sunfarms now conservatively projects production of approximately 7,000 to 8,000 kilograms in 2018 and 46,000 to 52,000 kilograms in 2019.

 

   

Pure Sunfarms entered into its first supply agreement, with Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD), under which Emerald will purchase 40% of Pure Sunfarms’ production in 2018 and 2019, or approximately 21,000 to 24,000 kilograms using current projected production targets, at a pre-determined price per gram. Pure Sunfarms is currently in discussions with multiple parties, including provincial governments and other licensed producers, in pursuit of additional supply agreements.

“The start today of commercial-scale cannabis production at the Delta 3 facility is the most significant milestone for Pure Sunfarms to date,” said Michael DeGiglio, CEO, Village Farms. “And we are thrilled to definitively move forward with the accelerated production plan, which significantly increases Pure Sunfarms conservative production targets to as much as 60,000 kilograms or more of dried cannabis through the end of 2019. This accelerated plan will enable Pure Sunfarms to more fully capitalize on the expected near-term shortfall of supply when adult use of cannabis is legalized in Canada.”

“In addition, Pure Sunfarms’ first supply agreement provides a strong initial revenue stream, while allowing the flexibility to pursue opportunities with government purchasers, as well as the significant near-term demand we are seeing from other licensed producers. With the advantage of Village Farms’ decades of experience designing, building and operating large-scale greenhouse facilities and Emerald’s deep cannabis expertise, I am more than confident in Pure Sunfarms’ ability to steadily ramp up production in the 17 grow rooms within the 1.1 million square foot Delta 3 facility and consistently deliver high-quality and fulfill large-volume supply commitments.”

 


“In our produce business, while volumes from our Ontario partners were on target, our first quarter results were impacted by lower yields at our Texas facilities, lower volumes from our Mexican supply partner, and slightly lower volumes at our Delta, BC operations, as we have not yet fully replaced the capacity from the transfer of the Delta 3 facility to Pure Sunfarms. This capacity will be fully replaced by the Fall of this year. As a result, we were unable to benefit from favourable spot market pricing as our full production was committed to contracted-price retail customers. On the cost side, we experienced an approximately 25% increase in pound-for-pound freight costs due to new US regulation as of December requiring freight companies to install Electronic Logging Devices. This initial surge in freight costs, which impacted transportation costs in the US across all industries, have since subsided to single digit year-on-year increases.”

Financial Summary

(in thousands of U.S. Dollars unless otherwise indicated)

Consolidated Financial Performance

(In thousands of U.S. dollars, except per Share amounts)

 

     For the three months
ended March 31,
 
     2018      2017  

Sales

   $ 29,490      $ 31,277  

Cost of sales

     (25,902      (27,320

Selling, general and administrative expenses

     (3,357      (3,183

Stock compensation expense

     (118      (41

Change in biological asset (1)

     (659      (645

(Loss) income from operations

     (546      88  

Interest expense, net

     (598      (632

Other income (expense)

     25        4  

Share of loss from joint venture

     (237      —    

Provision for (recovery of) income taxes

     (213      (350

Net income (loss)

     (1,143      (190

EBITDA (2)

     1,813        2,751  

Income (Loss) per share/ basic

   ($ 0.03    ($ 0.00

Income (Loss) per share/ diluted

   ($ 0.03    ($ 0.00

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s condensed consolidated interim financial statements for the quarter ended March 31, 2018.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

First Quarter 2018 Operational Discussion:

(in thousands of U.S. Dollars unless otherwise indicated)

Sales

Sales for the three months ended March 31, 2018 decreased by ($1,787), or (6%), to $29,490 from $31,277 for the three months ended March 31, 2017. The decrease in sales is primarily due to a decrease in the Company’s supply partner product volume of (9%) and a decrease in the Company’s facilities production volume of (5%). The decrease in supply partner revenue is due to the transition from one primary Mexican supply partner to a new primary Mexican supply partner who is in the process of expanding its operations.

The average selling price for tomatoes decreased (4%) for the three months ended March 31, 2018 versus the three months ended March 31, 2017. Cucumber pricing decreased by (1%) and pepper pricing decreased by (20%) in the first quarter of 2018 versus the comparable quarter in 2017.


Cost of Sales

Cost of sales for the three months ended March 31, 2018 decreased by ($1,418), or (5%), to $25,902 from $27,320 for the three months ended March 31, 2017; primarily due to a decrease of ($1,335) in contract sales cost (due to decreased volume), partially offset by an increase in freight expense of $309.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2018 increased by $174, or 5%, to $3,357 from $3,183 for the three months ended March, 31, 2017. The increase is due to marketing costs, legal fees and consulting fees.

Stock Compensation Expenses

Stock compensation expense for the three months ended March 31, 2018 was $118 from $41 for the three months ended March 31, 2017.

Change in Biological Asset

The net change in fair value of the biological asset remained flat for the three months ended March 31, 2018 at ($659) from ($645) for the three months ended March 31, 2017. The fair value of the biological asset as at March 31, 2018 was $5,999 as compared to $6,285 as at March 31, 2017 due to lower production, offset by higher selling price in early April 2018 versus early April 2017.

Loss from Operations

Loss from operations for the three months ended March 31, 2018 decreased ($634) to ($546) from $88 for the three months ended March 31, 2017. The decrease is due to a decrease in sales and an increase in selling, general and administrative expense for three months ended March 31, 2018 versus the three months ended March 31, 2017.

Interest Expense, net

Interest expense, net, for the three months ended March 31, 2018 decreased by ($34), to $598 from $632 for the three months ended March 31, 2017. The decrease is due to lower long term debt versus the prior year.

Share of (loss) from Joint Venture

The Company’s share of the loss for the three months ended March 31, 2018 was ($237), which consists of travel and other administrative costs.

Provision for Income Taxes

Income tax recovery for the three month period ended March 31, 2018 was ($213) compared to ($350) for the three month period ended March 31, 2017. The income tax recovery decreased due to a change in the United States future tax rate.

Net (loss)

Net loss for the three months ended March 31, 2018 increased by ($953) to a net loss of ($1,143) from ($190) for the three months ended March 31, 2017, primarily as a result of a decrease in sales, an increase in selling, general and administrative expenses, the loss from joint venture and a decrease in the recovery of income taxes.

EBITDA

EBITDA for the three months ended March 31, 2018 decreased by ($938), or (34%), to $1,813 from $2,751 for the three months ended March 31, 2017, primarily as a result of a decrease in sales, its share of loss from Pure Sunfarms and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.


Non-IFRS Measures

References in this press release to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized change in biological asset, stock compensation, share of loss from joint venture, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.    

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income (loss) to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months ended
March 31,
 
     2018      2017  

Net income (loss)

   ($ 1,143    ($ 190

Add:

     

Amortization

     1,801        1,951  

Foreign currency exchange (loss) gain

     (7      14  

Interest expense

     598        632  

Income taxes (recovery)

     (213      (350

Stock based compensation

     118        41  

Change in biological asset

     659        645  

(Gain) Loss on disposal of assets

            8  
  

 

 

    

 

 

 

EBITDA

   $ 1,813      $ 2,751  

Conference Call

Village Farms’ management team will host a conference call tomorrow, Tuesday, May 15, 2018, at 11:00 a.m. ET (8:00 a.m. PT) to discuss its first quarter 2018 financial results and provide an update on Pure Sunfarms. Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2jWvIPf .

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 9885703 followed by the pound key. The telephone replay will be available until Tuesday, May 22, 2018 at midnight (ET). The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.


Cautionary Language

Certain statements contained in this press release form constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt on reasonable terms when required.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

(Unaudited)

 

     March 31, 2018     December 31, 2017  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 3,869     $ 7,091  

Trade receivables

     9,104       11,259  

Other receivables

     2,257       1,982  

Inventories

     19,480       17,309  

Income taxes receivable

     246       246  

Prepaid expenses and deposits

     627       564  

Biological asset

     5,999       4,405  
  

 

 

   

 

 

 

Total current assets

     41,582       42,856  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment

     80,208       81,754  

Investment in joint venture

     15,490       15,727  

Other assets

     1,962       2,004  
  

 

 

   

 

 

 

Total assets

   $  139,242     $  142,341  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 8,375     $ 12,952  

Accrued liabilities

     3,619       3,793  

Line of credit

     3,000       —    

Income taxes payable

     38       —    

Current maturities of long-term debt

     2,615       2,620  

Current maturities of capital lease obligations

     72       72  
  

 

 

   

 

 

 

Total current liabilities

     17,719       19,437  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt

     35,891       35,760  

Long-term maturities of capital lease obligations

     160       179  

Deferred tax liability

     4,609       4,825  

Deferred compensation

     1,004       1,097  
  

 

 

   

 

 

 

Total liabilities

     59,383       61,298  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     36,284       36,115  

Contributed surplus

     1,844       1,726  

Revaluation surplus

     4,321       4,321  

Accumulated other comprehensive loss

     (446     (391

Retained earnings

     37,856       39,272  
  

 

 

   

 

 

 

Total shareholders’ equity

     79,859       81,043  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $  139,242     $  142,341  
  

 

 

   

 

 

 


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Income (Loss) and Comprehensive Income

For the Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars, except per share data)    

(Unaudited)    

 

     Three Months Ended March 31,  
     2018     2017  

Sales

   $ 29,490     $ 31,277  

Cost of sales

     (25,902     (27,320

Change in biological asset

     (659     (645

Selling, general and administrative expenses

     (3,357     (3,183

Stock compensation expense

     (118     (41
  

 

 

   

 

 

 

(Loss) income from operations

     (546     88  

Interest expense

     598       632  

Foreign exchange (gain) loss

     (7     14  

Other income

     (18     (26

Share of loss from joint venture

     237       —    

Loss on sale of assets

     —         8  
  

 

 

   

 

 

 

Loss before income taxes

     (1,356     (540

Recovery of income taxes

     (213     (350
  

 

 

   

 

 

 

Net loss

   $ (1,143   $ (190
  

 

 

   

 

 

 

Basic loss per share

   $ (0.03   $ (0.00
  

 

 

   

 

 

 

Diluted loss per share

   $ (0.03   $ (0.00
  

 

 

   

 

 

 

Other comprehensive income:

    

Foreign currency translation adjustment

     (55     13  
  

 

 

   

 

 

 

Comprehensive loss

   $ (1,198   $ (177
  

 

 

   

 

 

 


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

For the Three Months Ended March 31, 2018 and 2017

(In thousands of United States dollars)

(Unaudited)

 

     Three Months Ended March 31,  
     2018     2017  

Cash flows used in operating activities:

    

Net loss

   $ (1,143   $ (190

Adjustments to reconcile net loss to net cash used in operating activities:

    

Depreciation and amortization

     1,801       1,951  

Amortization of deferred charges

     —         18  

Loss on sale of assets

     —         8  

Share of loss from joint venture

     237       —    

Interest paid

     598       610  

Share-based compensation

     118       41  

Deferred income taxes

     (216     (350

Change in biological asset

     659       645  

Changes in non-cash working capital items

     (7,390     (7,346
  

 

 

   

 

 

 

Net cash used in operating activities

     (5,336     (4,613
  

 

 

   

 

 

 

Cash flows used in investing activities:

    

Purchases of property, plant and equipment

     (348     (431
  

 

 

   

 

 

 

Net cash used in investing activities

     (348     (431
  

 

 

   

 

 

 

Cash flows provided by financing activities:

    

Proceeds from borrowings

     3,000       5,000  

Repayments on borrowings

     (77     (838

Interest paid on long-term debt

     (598     (610

Proceeds from exercise of stock options

     169       —    

Payments on capital lease obligations

     (17     (13
  

 

 

   

 

 

 

Net cash provided by financing activities

     2,477       3,539  
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     (15     1  
  

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (3,222     (1,504

Cash and cash equivalents, beginning of year

     7,091       5,373  
  

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $ 3,869     $ 3,869  
  

 

 

   

 

 

 

Supplemental cash flow information:

    

Income taxes paid

   $ —       $ —    
  

 

 

   

 

 

 


SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2018/14/c8618.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 17:00e 14-MAY-18

Exhibit 99.24

VILLAGE FARMS INTERNATIONAL, INC.

 

      Security Class
      Holder Account Number

Form of Proxy - Annual and Special Meeting of Shareholders to be held on June 14, 2018

This Form of Proxy is solicited by and on behalf of Management.

Notes to proxy

 

1.

Every holder has the right to appoint some other person or company of their choice, who need not be a holder, to attend and act on their behalf at the meeting or any adjournment or postponement thereof. If you wish to appoint a person or company other than the persons whose names are printed herein, please insert the name of your chosen proxyholder in the space provided (see reverse).

 

2.

If the securities are registered in the name of more than one owner (for example, joint ownership, trustees, executors, etc.), then all those registered should sign this proxy. If you are voting on behalf of a corporation or another individual you must sign this proxy with signing capacity stated, and you may be required to provide documentation evidencing your power to sign this proxy.

 

3.

This proxy should be signed in the exact manner as the name(s) appear(s) on the proxy.

 

4.

If this proxy is not dated, it will be deemed to bear the date on which it is mailed by Management to the holder.

 

5.

The securities represented by this proxy will be voted as directed by the holder, however, if such a direction is not made in respect of any matter, this proxy will be voted as recommended by Management.

 

6.

The securities represented by this proxy will be voted in favour or withheld from voting or voted against each of the matters described herein, as applicable, in accordance with the instructions of the holder, on any ballot that may be called for and, if the holder has specified a choice with respect to any matter to be acted on, the securities will be voted accordingly.

 

7.

This proxy confers discretionary authority in respect of amendments or variations to matters identified in the Notice of Meeting or other matters that may properly come before the meeting or any adjournment or postponement thereof.

 

8.

This proxy should be read in conjunction with the accompanying documentation provided by Management.

Proxies submitted must be received by 10:00 AM, Pacific Time on June 12, 2018.

VOTE USING THE TELEPHONE OR INTERNET 24 HOURS A DAY 7 DAYS A WEEK!

 

To Vote Using the Telephone         To Vote Using the Internet

•  Call the number listed BELOW from a touch tone telephone.

  

            

  

•  Go to the following web site:

www.investorvote.com

1-866-732-VOTE (8683) Toll Free      

Smartphone?

Scan the QR code to vote now.


If you vote by telephone or the Internet, DO NOT mail back this proxy.

Voting by mail may be the only method for securities held in the name of a corporation or securities being voted on behalf of another individual.

Voting by mail or by Internet are the only methods by which a holder may appoint a person as proxyholder other than the Management nominees named on the reverse of this proxy. Instead of mailing this proxy, you may choose one of the two voting methods outlined above to vote this proxy.

To vote by telephone or the Internet, you will need to provide your CONTROL NUMBER listed below.

CONTROL NUMBER

Appointment of Proxyholder

 

I/We being holder(s) of common shares of Village Farms International, Inc. hereby appoint : John R. McLernon, or failing him, Stephen C. Ruffini, or failing him, Michael A. DeGiglio,    OR   

Print the name of the person you are appointing if this person is someone other than the Chairman of the Meeting.

    

as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the shareholder in accordance with the following direction (or if no directions have been given, as the proxyholder sees fit) and all other matters that may properly come before the Annual and Special Meeting of Shareholders of Village Farms International, Inc. to be held at Village Farms, 4700 - 80th Street, Delta, British Columbia, V4K 3N3, on June 27, 2017 at 10:00 AM (Pacific Time) and at any adjournment or postponement thereof.

VOTING RECOMMENDATIONS ARE INDICATED BY HIGHLIGHTED TEXT OVER THE BOXES.

 

 

    For    

 

    Withhold    

1.   Appointment of Auditors

   
Appointment of PricewaterhouseCoopers LLP as auditors of Village Farms International, Inc. for the ensuing year and authorizing the directors to fix their remuneration.    

 

  For   Withhold   For        Withhold   For   Withhold

2.  Election of Directors

               
01. Michael A. DeGiglio        02. John P. Henry          ☐ 03. John R. McLerron    
04. Christopher C. Woodward        05. David Holewinski          ☐ 06. Stephen C. Ruffini    
07. Roberta Cook                


3.  The Ordinary Resolution Approving the Renewal of the Company’s Compensation Plan

   For    Against
The ordinary resolution that the Compensation Plan, in the form attached as Appendix C to the Management Information Circular of the Company dated May 10, 2018.      

 

 

 

Authorized Signature(s) - This section must be completed for your instructions to be executed.    Signature(s)    Date
     
I/We authorize you to act in accordance with my/our instructions set out above. I/We hereby revoke any proxy previously given with respect to the Meeting. If no voting instructions are indicated above, this Proxy will be voted as recommended by Management.         DD/MM/YY

 

 

 

Interim Financial Statements - Mark this box if you would like to receive Interim Financial Statements and accompanying Management’s Discussion and Analysis by mail.      Annual Financial Statements - Mark this box if you would NOT like to receive the Annual Financial Statements and accompanying Management’s Discussion and Analysis by mail.   

If you are not mailing back your proxy, you may register online to receive the above financial report(s) by mail at www.computershare.com/mailinglist.

 

H G G Q                2 5 2 9 2 6    A R 2

Exhibit 99.25

VILLAGE FARMS INTERNATIONAL, INC.

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

TO BE HELD ON JUNE 14, 2018

AND MANAGEMENT INFORMATION CIRCULAR

May 10, 2018

 


TABLE OF CONTENTS

 

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

     3  

SOLICITATION OF PROXIES AND VOTING INSTRUCTIONS

     4  

    

 

Solicitation of Proxies

     4  

    

 

Registered Owners

     4  

    

 

Non-Registered Owners

     5  

COMMON SHARES

     6  

PRINCIPAL HOLDERS OF VOTING SECURITIES

     6  

MATTERS TO BE CONSIDERED AT THE MEETING

     7  

    

 

Financial Statements

     7  

    

 

Appointment of Auditor

     7  

    

 

Election of Directors

     7  

    

 

Approval of the Compensation Plan Renewal

     10  

SHARE-BASED COMPENSATION PLAN

     11  

    

 

Background

     11  

    

 

“Rolling” Maximum Reserve

     11  

    

 

Types of Awards

     11  

    

 

Burn Rate Chart

     12  

    

 

Other Terms

     12  

COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS

     14  

    

 

Compensation Discussion and Analysis

     14  

    

 

Programs and Objectives and Reward Philosophy

     14  

    

 

Compensation of Named Executive Officers

     19  

    

 

Compensation of Directors

     25  

    

 

Composition of the Compensation and Corporate Governance Committee

     26  

INDEBTEDNESS

     27  

AUDIT COMMITTEE

     27  

INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS

     27  

STATEMENT OF CORPORATE GOVERNANCE PRACTICES

     27  

SHAREHOLDER PROPOSALS FOR NEXT YEAR’S ANNUAL MEETING

     31  

ADDITIONAL INFORMATION

     32  

DIRECTORS’ APPROVAL

     32  

APPENDIX A

     33  

APPENDIX B

     41  

APPENDIX C

     55  


VILLAGE FARMS INTERNATIONAL, INC.

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual and special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Village Farms International, Inc. (“Village Farms” or the “Company”) will be held at 10:00 a.m., Pacific time, on the 14 th day of June, 2018 at Village Farms, 4700—80 th Street, Delta, British Columbia, V4K 3N3, for the following purposes:

 

1.

to receive the consolidated financial statements of the Company for the fiscal year ended December 31, 2017 together with the report of the auditors thereon;

 

2.

to appoint the auditor and authorize the directors of the Company (the “Directors”) to fix the remuneration of the auditor for the ensuing year;

 

3.

to elect the Directors for the ensuing year;

 

4.

to consider, and if thought advisable, pass an ordinary resolution to approve the renewal of the Company’s Compensation Plan, as more particularly described in the accompanying management information circular (the “Information Circular”); and

 

5.

to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

The accompanying Information Circular provides additional information relating to the matters to be dealt with at the Meeting and is deemed to form part of this notice. The Board of Directors has fixed May 10, 2018 as the record date for the Meeting (the “Record Date”). Only Shareholders of record at the close of business on the Record Date are entitled to vote at the Meeting or any adjournment or postponement thereof.

DATED at Delta, British Columbia this 10 th day of May, 2018.

 

By Order of the Board of Directors
By:  

(signed) “John R. McLernon”

       Chairman of the Board of Directors

If you are a Shareholder and you are not able to attend the Meeting in person, please exercise your right to vote either by (a) signing and returning the enclosed form of proxy to Computershare Investor Services Inc. at 100 University Avenue 8 th Floor, Toronto, Ontario, M5J 2Y1 so as to arrive not later than 10:00 a.m., Pacific time, on June 12, 2018 or, if the Meeting is adjourned, 48 hours (excluding Saturdays, Sundays and holidays) prior to the commencement of the reconvened meeting, or (b) completing the request for voting instructions in accordance with the directions provided.


THIS PAGE INTENTIONALLY LEFT BLANK


VILLAGE FARMS INTERNATIONAL, INC.

MANAGEMENT INFORMATION CIRCULAR

DATED MAY 10, 2018

SOLICITATION OF PROXIES AND VOTING INSTRUCTIONS

Solicitation of Proxies

The information contained in this management information circular (the “Information Circular”) is furnished in connection with the solicitation of proxies from registered owners of common shares (the “Common Shares”) of Village Farms International, Inc. (“Village Farms” or the “Company”) (and of voting instructions in the case of non-registered owners of Common Shares) to be used at the annual and special meeting (the “Meeting”) of holders of Common Shares (“Shareholders”) of the Company to be held at 10:00 a.m., Pacific time, on the 14 th day of June, 2018 at 4700 – 80 th Street, Delta, British Columbia, V4K 3N3, and at all adjournments or postponements of the Meeting, for the purposes set forth in the accompanying notice of meeting (the “Notice of Meeting”). It is expected that the solicitation will be made primarily by mail, but proxies and voting instructions may also be solicited personally by management of the Company. The solicitation of proxies and voting instructions by this Information Circular is being made by or on behalf of management of the Company. The total cost of the solicitation of proxies will be borne by the Company. The information contained in this Information Circular is given as at the close of business on May 10, 2018, except where otherwise noted.

Registered Owners

Appointment of Proxies

The individuals named in the form of proxy are representatives of management of the Company and are officers or directors of the Company or its affiliates. A Shareholder has the right to appoint someone else, who need not be a Shareholder, to represent that Shareholder at the Meeting, by inserting that other person’s name in the blank space in the form of proxy.

To be valid, proxies must be deposited with Computershare Investor Services Inc. (“Computershare”) at 100 University Avenue 8 th  Floor, Toronto, Ontario, M5J 2Y1, so as to arrive not later than 10:00 a.m., Pacific time, on June 12, 2018 or, if the Meeting is adjourned, 48 hours (excluding Saturdays, Sundays and holidays) prior to the commencement of any reconvened meeting.

Revocation

A Shareholder who has submitted a proxy may revoke it by:

 

  A.

completing and signing a form of proxy bearing a later date and depositing it with Computershare as described above;

 

  B.

depositing a document that is signed by that Shareholder (or by someone that the Shareholder has properly authorized to act on that Shareholder’s behalf) (i) at the registered office of the Company at any time up to the last business day preceding the day of the Meeting, or any adjournment of the Meeting, at which the proxy is to be used, or (ii) with the chairperson of the Meeting, prior to the commencement of the Meeting, on the day of the Meeting or any adjournment of the Meeting;

 

4


  C.

electronically transmitting the revocation in a manner permitted by law, provided that the revocation is received (i) at the registered office of the Company at any time up to and including the last business day preceding the day of the Meeting, or any adjournment of the Meeting, at which the proxy is to be used, or (ii) by the chair of the Meeting, prior to the commencement of the Meeting, on the day of the Meeting or any adjournment of the Meeting; or

 

  D.

following any other procedure that is permitted by law.

Voting of Proxies

In connection with any ballot that may be called for, the management representatives designated in the enclosed form of proxy will vote or withhold from voting the Common Shares in accordance with the instructions of the Shareholder as indicated on the proxy and, if the Shareholder specifies a choice with respect to any matter to be acted upon, the Common Shares will be voted accordingly. In the absence of any direction, your Common Shares will be voted by the management representatives FOR the appointment of the auditor, FOR the election of each director of the Company and FOR the renewal of the Company’s Compensation Plan (as defined below) as indicated under those headings in this Information Circular.

The management representatives designated in the enclosed form of proxy have discretionary authority with respect to amendments to or variations of matters identified in the Notice of Meeting and with respect to other matters that may properly come before the Meeting. At the date of this Information Circular, the management of the Company knew of no such amendments, variations or other matters.

Non-Registered Owners

Shareholders who do not hold their Common Shares in their own name are referred to as non-registered owners. If your Common Shares are registered in the name of a depository (such as CDS Clearing and Depository Services Inc. (“CDS”)) or an intermediary (such as a bank, trust company, securities dealer or broker, or trustee or administrator of a self-administered Registered Retirement Savings Plan, Registered Retirement Income Fund, Registered Education Savings Plan or similar plan), you are a non-registered owner.

Currently, most issued and outstanding Common Shares are in a book-based system administered by CDS. Consequently, most of the Common Shares are currently registered under the name of “CDS & Co.” (the registration name for CDS). CDS also acts as nominee for brokerage firms through which beneficial holders hold their Common Shares. Common Shares held by CDS can only be voted upon the instructions of the beneficial holder of the Common Shares.

Only registered owners of Common Shares, or the persons they appoint as their proxies, are permitted to attend and vote at the Meeting. If you are a non-registered owner, you are entitled to direct how the Common Shares beneficially owned by you are to be voted or you may obtain a form of legal proxy that will entitle you to attend and vote at the Meeting.

In accordance with Canadian securities law, the Company has mailed copies of its 2017 Audited Consolidated Financial Statements to requesting shareholders and has distributed copies of the Notice of Meeting and this Information Circular (collectively, the “Meeting Materials”) to the intermediaries for onward distribution to non-registered shareholders who have not waived their right to receive them. Typically, intermediaries will use a service company (such as Broadridge Financial Solutions, Inc.) to forward the Notice of Meeting and this Information Circular to non-registered shareholders.

If you are a non-registered shareholder and have not waived your right to receive the Meeting Materials, you will receive either a request for voting instructions or a form of proxy with your Meeting Materials. The purpose of these documents is to permit you to direct the voting of the Common Shares you beneficially own. You should follow the procedures set out below, depending on which type of document you receive.

 

5


Request for Voting Instructions.

If you do not wish to attend the Meeting (or have another person attend and vote on your behalf), you should complete the enclosed request for voting instructions in accordance with the directions provided. You may revoke your voting instructions at any time by written notice to your intermediary, except that the intermediary is not required to honour the revocation unless it is received at least seven (7) days before the Meeting.

If you wish to attend the Meeting and vote in person (or have another person attend and vote on your behalf), you must complete the enclosed request for voting instructions in accordance with the directions provided and a form of proxy will be sent to you giving you (or the other person) the right to attend and vote at the Meeting. You (or the other person) must register with the Company’s transfer agent, Computershare, when you arrive at the Meeting.

or

Form of Proxy.

The form of proxy has been signed by the intermediary (typically by a facsimile, stamped signature) and completed to indicate the number of Common Shares beneficially owned by you. Otherwise, the form of proxy is incomplete.

If you do not wish to attend the Meeting, you should complete the form of proxy in accordance with the instructions set out in the section titled “Registered Owners” above.

If you wish to attend the Meeting and vote in person, you must strike out the names of the persons named in the proxy and insert your name in the blank space provided. To be valid, proxies must be deposited with Computershare at 100 University Avenue 8 th Floor, Toronto, Ontario, M5J 2Y1 not later than 10:00 a.m., Pacific time, on June 12, 2018 or, if the Meeting is adjourned, 48 hours (excluding Saturdays, Sundays and holidays) prior to the commencement of any reconvened meeting. You must register with the Company’s transfer agent, Computershare, when you arrive at the Meeting.

You should follow the instructions on the document that you have received and contact your intermediary promptly if you need assistance.

COMMON SHARES

At the close of business on May 10, 2018, the Company had outstanding 42,485,946 Common Shares, each of which carries the right to one vote at a meeting of the Shareholders of the Company, which represent all the outstanding voting shares of the Company. Each Shareholder of record at the close of business on May 10, 2018, the record date established for the Meeting, will be entitled to vote on all matters proposed to come before the Meeting on the basis of one vote for each Common Share.

PRINCIPAL HOLDERS OF VOTING SECURITIES

To the knowledge of the directors and officers of the Company, the following are the only persons or companies who beneficially own, directly or indirectly, or exercise control or direction over, more than 10% of the outstanding Common Shares of the Company:

 

6



NAME
   NUMBER OF COMMON
SHARES OWNED OR
CONTROLLED 
     PERCENTAGE OF THE
OUTSTANDING COMMON
SHARES
 

MICHAEL A. DEGIGLIO

     9,671,649      22.8

MATTERS TO BE CONSIDERED AT THE MEETING

Financial Statements

The consolidated financial statements of the Company for the fiscal year ended December 31, 2017, together with the report of the auditors thereon, were mailed to requesting Shareholders separately from this Information Circular. These financial statements are also available electronically on SEDAR at www.sedar.com.

Appointment of Auditor

The management representatives designated in the enclosed form of proxy (or voting instruction form) intend to vote FOR the reappointment of PricewaterhouseCoopers LLP as auditor of the Company to hold office until the next annual general meeting of Shareholders and to authorize the board of directors of the Company (the “Board”) to fix the remuneration of the auditor for the ensuing year. PricewaterhouseCoopers LLP has served as auditor of the Company and its predecessor, Village Farms Income Fund (the “Fund”), since its inception on November 10, 2003. The reappointment of PricewaterhouseCoopers LLP as auditor of the Company must be confirmed by a resolution of a majority of the votes cast by Shareholders at the Meeting.

Election of Directors

The Board currently consists of seven directors. Management proposes to nominate the persons listed below for election as directors. The Company’s articles of arrangement provide that the number of directors of the Company will be a minimum of three and a maximum of ten. Shareholders will vote on each individual director separately.

Accordingly, the number of directors to be elected at the Meeting is seven. The management representatives designated in the enclosed form of proxy (or voting instruction form) intend to vote FOR the election as directors of each of the proposed nominees whose names are set out below. All nominees are now directors and have been directors since the dates indicated below. Management does not contemplate that any of the proposed nominees will be unable to serve as a director but, if that should occur for any reason before the Meeting, the management representatives designated in the enclosed form of proxy (or voting instruction form) reserve the right to vote for another nominee at their discretion. The Company adopted a majority voting policy in April 2013, which was amended on May 10, 2017, pursuant to which directors who are not elected by at least a majority (50% +1) of the votes cast with respect to his or her election in an uncontested election are required to tender their resignation, absent exceptional circumstances. Each director elected will hold office until the next annual meeting of Shareholders or until his/her successor is elected or appointed, unless his/her office is vacated earlier in accordance with the Company’s articles of arrangement and applicable law.

 

7


The following table sets forth the names of, and certain additional information for, the seven persons nominated for election as directors.

 

Name and Province or State
and Country of Residence 1

  

Position with the Company

  

Principal
Occupation

  

Director
Since 5

  

Ownership or Control Over
Common Shares 2

Michael A. DeGiglio
Florida, USA
   Director and Chief Executive Officer    Chief Executive Officer of the Company    October 18, 2006    9,671,649
John P. Henry 3
Florida, USA
   Director    Retired Senior Executive    October 18, 2006    35,000
John R. McLernon 4
British Columbia, Canada
   Chair of the Board of Directors    Honourary Chairman and Co-Founder of the Colliers Macaulay Nicolls Group Inc.    January 18, 2005    106,500
Christopher C. Woodward 3,4
British Columbia, Canada
   Director    President, Woodcorp Investments Ltd.    November 10, 2003    165,000
David Holewinski 3,4
Michigan, USA
   Director    Management Consultant    June 21, 2011    145,000

Stephen C. Ruffini

Florida, USA

   Director and Chief Financial Officer    Chief Financial Officer of the Company    March 19, 2014    500,000

Dr. Roberta Cook

California, USA

   Director    Marketing Consultant    January 4, 2016    20,000

 

1

The information as to residence and principal occupation, where not within the knowledge of the Company, has been furnished by the respective individuals listed in the table above.

2

The information as to Common Shares beneficially owned or over which a director exercises control or direction, not being within the knowledge of the Company, has been furnished by the respective directors.

3

Member of the audit committee of the Company (the “Audit Committee”).

4

Member of the compensation and corporate governance committee of the Company (the “Compensation and Corporate Governance Committee”).

5

Prior to December 31, 2009, the Company was a subsidiary of the Fund. Accordingly, the dates presented in this column include the period of time during which each individual served as a director of the Company while it was a subsidiary of the Fund, or alternatively, as a trustee of the Fund.

Biographies of Directors

The following are brief profiles of the directors of the Company.

Michael  A. DeGiglio , Director and Chief Executive Officer of the Company. Mr. DeGiglio is a founder of Village Farms International through predecessor companies and has served as its Chief Executive Officer since its inception in 1989. Mr. DeGiglio joined EcoScience Corporation (NASDAQ) a bio-technology company, in November 1992 upon its acquisition of Agro-Dynamics Inc., a company Mr. DeGiglio founded in 1984 and where he served as President since its inception. Additionally, he served as President and Chief Executive Officer of EcoScience from 1995 until its merger with Village Farms in 1999. Prior to commencing his business career in 1983, Mr. DeGiglio served on active duty in the United States Navy from 1976 through 1983, and in the Naval Air reserves from 1983 through 2001, retiring at the rank of Captain. Throughout his Naval career, Captain DeGiglio held multiple Department head positions, successfully completed a tour as Commanding Officer of a jet squadron, performed multiple tours overseas, accumulated over 5,000 hours of military flight time, and completed numerous senior management and military courses. Mr. DeGiglio received a Bachelor of Science degree in Aeronautical Science from Embry Riddle Aeronautical University (ERAU) in Daytona Beach, Florida. He has served as the former Chairman of the Presidential Advisory Board of ERAU.

 

8


John P. Henry , Director of the Company. Mr. Henry has served as a director of the Company since 2006. From 1981 to 2000, Mr. Henry was employed by Ocean Spray Cranberries, Inc. (“Ocean Spray”), retiring as Senior Vice-President of Grower Relations and Chief Financial Officer in 2000. Ocean Spray grew from $400 million to $1.3 billion in revenues during his tenure. Mr. Henry also served as a Director of Nantucket Allserve Inc., a majority owned subsidiary of Ocean Spray. From 1980 to 1981, he was Chief Financial Officer of Castle Toy Co, Inc., and prior to that, Mr. Henry was employed by Laventhol and Horwath providing auditing, consulting and tax services to large public and private companies. He received a Bachelor of Science degree in Business Administration and a Masters in Taxation degrees from Bryant College in Smithfield, Rhode Island. Mr. Henry is a non-practicing Certified Professional Accountant in the State of Rhode Island.

John R. McLernon , Chairman and Director of the Company. Mr. McLernon is President of McLernon Consultants Ltd. He is Honourary Chairman and Co-Founder of Colliers International (“Colliers”), a global commercial real estate services company operating from 485 offices in 65 countries. He served as Chairman and Chief Executive Officer of Colliers from 1977 to 2002 and as Chairman until December 2004. Mr. McLernon also serves as a director of several public and private companies as well as major nonprofit organizations, and is Chairman of A&W Revenue Royalties Income Fund and City Office REIT, Inc.

Christopher  C. Woodward , Director of the Company. Mr. Woodward serves as chair or director of a number of private and public companies as well as charitable institutions. These include the P.A. Woodward Medical Foundation, Brentwood College, the Sea to Sky Gondola Corp. and Great Western Brewery. He is currently Chair of the Vancouver Coastal Health Authority and Chair of the Keg Royalty Trust. Mr. Woodward received his Bachelor of Arts (Economics) degree from the University of Western Ontario.

David Holewinski , Director of the Company. Mr. Holewinski is a Management Consultant. He served as a director of Agro Power Development Inc. (“APDI”) from 2004 until October 2006. Between 1995 and 2000, Mr. Holewinski served as Senior Vice President of Business Development for APDI. Mr. Holewinski has co-founded two biotechnology companies, co-founded a company with computer and internet security, as well as co-founded a company with novel precast concrete technology for the construction industry. Between 1983 and 1988, Mr. Holewinski was a Manager of Business Development for ConAgra Foods, Inc. Mr. Holewinski has a Bachelor of Arts degree from Pennsylvania State University and a Master of Business Administration degree from Harvard University.

 

9


Stephen C. Ruffini , Director and Chief Financial Officer of the Company. Mr. Ruffini joined Village Farms Income Fund in January 2009. He joined the Board of Directors of Village Farms International, Inc. in March 2014. From 2001 to 2005, Mr. Ruffini was a Director and Chief Financial Officer of HIT Entertainment, Ltd., which was the preeminent young children’s entertainment company listed on the London Stock Exchange. From 2006 to 2008, he was the Chief Financial Officer of Performing Brands, which was a publicly listed U.S. company in the beverage industry. He was a Tax Manager with Arthur Andersen from 1984 to 1993. Mr. Ruffini has a Masters of Business Administration degree from the University of Texas and a Bachelor of Business Administration degree from Southern Methodist University.

Dr.  Roberta Cook , Director of the Company. On July 1, 2016, Dr. Cook retired from her 31-year position as a Cooperative Extension Marketing Economist in the Department of Agricultural and Resource Economics (ARE) at the University of California, Davis. She is currently an Emerita faculty member, and consults on a broad range of fresh produce marketing issues. She has a PhD in Agricultural Economics from Michigan State University. She serves on the board of directors of Ocean Mist Farms, and has been a board member of Naturipe Farms and Sunkist, as well as numerous other advisory boards in the produce industry. For nearly a decade, Dr. Cook was Faculty Director of the California Agribusiness Executive Seminar co-sponsored by University of California, Davis and Wells Fargo Bank. In 2011, The Packer honoured her as one of the top 25 produce industry leaders.

Corporate Cease Trade Orders, Bankruptcies and Court Proceedings

Mr. McLernon was a director of Syscan International Inc. (“Syscan”), a public company whose shares were listed on the TSX Venture Exchange. Mr. McLernon resigned as a director of Syscan within the year preceding Syscan making an assignment to a trustee pursuant to the Bankruptcy and Insolvency Act (Canada) in December 2008.

On March 12, 1998, the United States District Judge for the Central District of California entered a Final Consent Judgment of Permanent Injunction, Disgorgement, and Civil Penalty against Mr. Holewinski relating to allegations of insider trading in the securities of Chantal Pharmaceutical Corporation. Mr. Holewinski, without admitting or denying the allegations, consented to a Judgment that permanently enjoined him from future violations of the antifraud provisions of the federal securities laws and ordered Mr. Holewinski to disgorge losses avoided in the amount of US$28,162, plus prejudgment interest in the amount of US$4,921 and to pay a civil penalty in the amount of US$28,162.

Mr. Ruffini was an officer of Performing Brands, Inc. (“Performing”), a public company whose shares were listed on NASDAQ. Performing filed a voluntary petition in the U.S. Bankruptcy Court (North Texas District) under Chapter 7 of the United States Bankruptcy Code, in December 2008.

Approval of the Compensation Plan Renewal

The Shareholders will be asked to consider, and if thought advisable, pass an ordinary resolution (the “Compensation Plan Resolution”), the full text of which is set forth in Appendix C to this Information Circular, approving the renewal of the Company’s Compensation Plan, as defined below.

Reference should be made to the full text of the Compensation Plan attached hereto as Appendix B. The TSX requires that the Compensation Plan be approved by the Shareholders on a periodic basis. The full text of the Compensation Plan Resolution, approving the renewal of the Compensation Plan and unallocated Options and share-based awards, is attached hereto as Appendix C. This approval will be effective for three years from the date of the Meeting. If approval is not obtained at the Meeting, Options and share-based awards which have not been allocated as of June 14, 2018 and Options and share-based awards which are outstanding as of June 14, 2018 and are subsequently cancelled, terminated or exercised will not be available for a new grant of Options or share-based awards. Previously awarded Options and share–based awards will not be affected by the approval or disapproval of the Compensation Plan Resolution. To be effective, the Compensation Plan Resolution must be approved by at least 50% of the votes cast in person or by proxy by the Shareholders at the Meeting. A summary of the Compensation Plan is below under “Share-Based Compensation Plan”.

 

10


The management representatives designated in the enclosed form of proxy intend to vote FOR the renewal of the Compensation Plan and approval of the unallocated share-based awards and Options, unless the Shareholder has specified in his or her proxy that his or her Shares are to be voted against the Compensation Plan Resolution.

SHARE-BASED COMPENSATION PLAN

Background

The Company adopted a compensation plan (the “Compensation Plan”), effective January 1, 2010, on completion of its conversion into a corporation, in order to attract and retain directors, officers, employees and service providers to the Company and to motivate them to advance the interests of the Company by affording them with the opportunity to acquire an equity interest in the Company. The Compensation Plan has been drafted to comply with the policies of the Toronto Stock Exchange (the “TSX”) as they exist at the date of this Information Circular. The Compensation Plan was most recently approved by the Shareholders on June 24, 2015. The following information is intended as a summary of the Compensation Plan.

“Rolling” Maximum Reserve

The TSX permits the adoption of a “rolling” type of share-based compensation plan whereby the number of shares available for issuance under the plan will not be greater than a rolling maximum percentage of the outstanding shares. The Compensation Plan provides that the number of Common Shares reserved for issuance upon the exercise or redemption of awards granted under the Compensation Plan is a rolling maximum of ten percent (10%) of the outstanding Common Shares at any point in time. Currently, the Company has 42,485,946 Common Shares outstanding. Therefore, up to 4,248,595 Common Shares may be reserved for issuance under the Compensation Plan. The purpose of adopting a “rolling” type of share based compensation plan is to ensure that a sufficient number of Common Shares remain issuable under the Compensation Plan to meet the overall objective of the Compensation Plan. Any exercise, redemption, expiry or lapse of awards will make new grants available under the Compensation Plan effectively resulting in a “re-loading” of the number of awards available to be granted. The Compensation Plan must be approved by shareholders every three years.

Types of Awards

The Compensation Plan is an omnibus share-based compensation plan, pursuant to which the Company is authorized to award Options, stock appreciation rights, deferred share units, restricted share units, restricted stock and other share-based awards, which may be settled in shares issued from the treasury or in cash. To date, only Options have been awarded under the Compensation Plan. As of December 31, 2017, Options to purchase 2,337,732 Common Shares were outstanding, and 128,000 Performance-based restricted share units were outstanding, which together represented approximately 5.8% of the issued and outstanding Common Shares as at such date. As of December 31, 2017, the Company had 1,758,529 Common Shares available for future grants under the Compensation Plan, which represented approximately 4.2% of the issued and outstanding Common Shares as at such date.

An Option is a right to purchase a Common Share for a fixed exercise price. A stock appreciation right is a right to either a cash payment or the issuance of Common Shares with a market price equal in value to the difference between the exercise price and the fair market value of a Common Share. A stock appreciation right may be granted in relation to an option or on a stand-alone basis. A deferred share unit is a right to a Common Share or a cash payment equal to the fair market value of a Common Share redeemable only after the participant has ceased to hold all positions with the Company and its affiliates. A restricted share unit is a right to a Common Share or a

 

11


cash payment equal to the fair market value of a Common Share redeemable after the passage of time, the achievement of performance targets or both. A restricted share unit is a Common Share issued to a participant subject to conditions which may include the passage of time, the achievement of performance targets or both. Any voting rights and entitlements to dividends in respect of restricted shares will be determined by the Board on the date of grant and will be set out in the applicable award agreement. Other share based awards are awards which provide for the issuance of a Common Share or a payment equal to the fair market value of a Common Share on such terms and conditions as the Company determines.

When dividends are paid on the Common Shares, an additional number of restricted share units and deferred share units, as the case may be, will be credited to the eligible holder thereof. The additional units credited will be determined as the amount of the dividend multiplied by the number of restricted share units or deferred share units, as the case may be, credited to the eligible holder thereof at the dividend payment date, and divided by the market price of a Common Share on the dividend payment date.

Burn Rate Chart

 

     2017
    2016     2015  

# of Awards Granted in the Fiscal Year

     1,216,000       300,000       195,000  

Weighted Average Number of Shares Outstanding for the Fiscal Year

     40,308,000       39,176,000       38,868,000  

Burn Rate for Compensation Plan

     3.0     0.8     0.5

Other Terms

The Compensation Plan authorizes the Board (or a committee of the Board if so authorized by the Board) to grant awards to “Eligible Persons”. Eligible Persons are directors, officers, employees, consultants, management company employees and any other service providers of the Company or its affiliates.

The aggregate number of Common Shares issued to insiders of the Company within any one (1) year period under the Compensation Plan, together with any other security based compensation arrangement, cannot exceed 10% of the outstanding Common Shares. In addition, the aggregate number of Common Shares issuable to insiders of the Company at any time under the Compensation Plan, together with any other security based compensation arrangement, cannot exceed ten percent (10%) of the outstanding Common Shares. There are otherwise no limits on the maximum number of awards that may be issued to any single Eligible Person.

The date of grant, the number of Common Shares, the term, the vesting period and any other terms and conditions of awards granted pursuant to the Compensation Plan are determined by the Board, subject to the express provisions of the Compensation Plan.

The exercise price of an Option and a stock appreciation right will be the closing price of the Common Shares on the TSX for the trading day immediately preceding the date of the grant. There is no exercise price for other awards. The purchase price for restricted stock will generally be nil, although past service may be treated as consideration for the grant of restricted stock.

 

12


Unless otherwise specified by the Board at the time an Option is granted under the Compensation Plan, (i) the term of the Option will be ten (10) years from the date of the grant (which is the maximum allowable term under the Compensation Plan), unless the expiry of the term falls during a blackout (or within ten (10) days following the end of a blackout) from trading in the securities of the Company imposed on certain persons including the optionee pursuant to any policies of the Company; and where such a blackout applies, the expiry of the term of the Option shall automatically be extended to ten (10) business days following the end of the blackout; and (ii) the Option will vest as to one-third ( 1 3 ) on each of the first three anniversaries of the date of grant.

Subject to the terms of the award agreement and the discretion of the Company to accelerate the vesting of an award, or extend the term of an award (but not to later that the original expiry date of the awards), awards will terminate immediately upon the holder ceasing to be an Eligible Person, provided however, in the event of: (i) death, the vested award continues to be exercisable or redeemable for a period up to six (6) months from the date of death, or (ii) termination without cause or resignation, the vested award continues to be exercisable or redeemable for a period up to ninety (90) days from the date of termination. No award is exercisable following expiry of the term.

For stock appreciation rights, the market appreciation is the fair market value of a Common Share, based on the closing price on the date prior to the exercise date, minus the exercise price. Stock appreciation rights can be granted in relation to an Option either at the date of grant or at a later date.

For stock appreciation rights which are granted in relation to an Option, the vesting, term and other terms and conditions will be the same as for the related Option and the exercise of the stock appreciation right will result in a cancellation of the related Option and vice versa.

For stock appreciation rights which are not granted in relation to an Option and for all other awards, the vesting, redemption and expiry terms will be set out in the award agreement and the terms and conditions of the award will be as set out in the award agreement, or as otherwise set out in the Compensation Plan.

Performance-based restricted share units vest as certain performance related events are achieved. Once the Participant is vested, the Participant may elect to receive the vested units in the form of Common Shares. If the performance related event does not occur or does not occur in the time provided in the grant, the Performance-based restricted share units expire and will be cancelled.

In the event an offer is made for the Common Shares which would result in the offeror exercising control of the Company within the meaning of applicable securities laws, the Board may, in its discretion, provide that any Options then outstanding which are not otherwise exercisable may be exercised, in whole or in part, so as to allow the optionee to tender the Common Shares received upon such an exercise.

Awards are non-assignable. No financial assistance is provided to any Eligible Person to facilitate the purchase of Common Shares under the Compensation Plan.

The Compensation Plan contains a formal amendment procedure. The Board may amend certain terms of the Compensation Plan without requiring the approval of the Company shareholders, subject to those provisions of applicable law and regulatory requirements (including the rules, regulations and policies of the TSX), if any, that require the approval of Shareholders. Amendments not requiring shareholder approval include, without limitation: altering, extending or accelerating Option vesting terms and conditions; amending the termination provisions of an Option; accelerating the expiry date of an Option; determining adjustments pursuant to the provisions of the Compensation Plan concerning corporate changes; amending the definitions contained in the Compensation Plan; amending or modifying the mechanics of exercising or redeeming awards; amending provisions relating to the administration of the Compensation Plan; making “housekeeping” amendments, such as those necessary to cure errors or ambiguities contained in the Compensation Plan; effecting amendments necessary to comply with the provisions of applicable laws; and suspending or terminating the Compensation Plan.

 

13


The Compensation Plan specifically provides that the following amendments require shareholder approval: increasing the number of Common Shares issuable under the Compensation Plan, except by operation of the “rolling” maximum reserve; amending the Compensation Plan which amendment could result in the aggregate number of Common Shares issued to insiders within any one year period or issuable to insiders at any time under the Compensation Plan, together with any other security based compensation arrangement, exceeding 10% of the outstanding Common Shares; extending the term of any award beyond the expiry of the original term of the award; reducing the exercise price of an Option or cancelling and replacing Options with Options having a lower exercise price; amending the class of Eligible Persons which would have the potential of broadening or increasing participation in the Compensation Plan by insiders; amending the formal amendment procedures; and making any amendments required to be approved by the Company’s shareholders under applicable law.

COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS

Compensation Discussion and Analysis

This Compensation Discussion and Analysis (“CD&A”) describes the major elements of the Company’s compensation program for the Named Executive Officers (defined below, in the Summary Compensation Table). This CD&A also discusses the objectives, philosophy and decisions underlying the compensation of the Named Executive Officers. This CD&A should be read together with the executive compensation tables and related footnotes found later in this Information Circular.

The Compensation and Corporate Governance Committee is responsible for decisions respecting compensation of the Company’s senior executives. The Compensation and Corporate Governance Committee is composed entirely of independent directors and reviews and approves executive compensation programs and specific compensation arrangements for the executive officers of the Company. The Compensation and Corporate Governance Committee reports to the Board, and all compensation decisions with respect to the Chief Executive Officer are reviewed and approved by the entire Board, without participation by the Chief Executive Officer or the President.

The principal elements of the Company’s executive compensation program for 2015, 2016 and 2017 were:

 

   

Base salary;

 

   

Annual, performance-based cash incentives (“Bonus”);

 

   

Long-term equity incentives, including Options and Performance-based restricted share units; and

 

   

Severance pay arrangements for certain Named Executive Officers as set forth in their employment agreements.

The Board of Directors fully understands the need to continuously and rigorously manage risk. Risk assessment and analysis is an integral part of Board and committee meetings and decisions, including compensation.

Programs and Objectives and Reward Philosophy

The Compensation and Corporate Governance Committee is guided by the following key objectives and reward philosophies in the design and implementation of the Company’s executive compensation program:

 

   

Competitive Pay. Competitive compensation programs are required to attract and retain a high-performing executive team.

 

14


   

Pay for performance. The Company’s compensation program is designed to motivate its executive officers to drive the Company’s business and financial results and to reward near-term performance. The “at risk” portion of total compensation (i.e., the incentive programs under which the amount of compensation realized by the executive is not guaranteed, and increases with higher levels of performance) should be a significant component of an executive’s compensation.

 

   

Alignment with shareholders. The interests of the Company’s executives must be aligned with the interests of the Company’s shareholders. The Company’s compensation program should motivate and reward its executives to drive performance which leads to the enhancement of long-term shareholder value.

Key Considerations

In applying these program objectives and reward philosophies, the Compensation and Corporate Governance Committee takes into account the key considerations discussed below:

Competitive Market Assessment. The Company periodically conducts a competitive market assessment for each of the primary elements of the Company’s executive compensation program. In setting executive compensation levels, the Compensation and Corporate Governance Committee reviews market data from the following sources:

 

   

Peer Group Information. The Compensation and Corporate Governance Committee considers information from the management information circular of “peer group” public companies. The peer group is composed primarily of food and related companies of similar size in terms of number of employees or revenue in Canada and the United States. The peer group was selected by the Compensation and Corporate Governance Committee in 2014 based on input from Towers Watson, an independent consulting firm retained by the Compensation and Corporate Governance Committee and from management. Compensation at the peer group companies is considered by the Compensation and Corporate Governance Committee, but compensation is not benchmarked to any particular level. The following companies were included in the Company’s peer group:

 

Alico Inc.

Boulder Foods Corp.

Calavo Growers, Inc.

  

Annie’s Inc.

Bridgford Foods Corp.

Coffee Holding Company

Diamond Foods, Inc.

   Farmer Brothers Co.

Golden Enterprises Inc.

   Inventure Foods, Inc.

John B Sanfilippo & Son

Lifeway Foods Inc.

  

Legumex Walker Inc.

Limoneira Foods Inc.

Omega Protein

   Rogers Sugar Inc.

SunOpta, Inc.

   Ten Peaks Coffee

 

   

The Company’s Financial and Strategic Objectives . Each year, the Company’s management team develops an annual operating plan or budget for review and approval by the Board. The Compensation and Corporate Governance Committee uses the financial plan in the development of compensation plans and performance goals for the Company’s Named Executive Officers for the next year.

 

15


Additional Information and Considerations

The Role of the Compensation and Corporate Governance Committee and Its Use of Advisors . A summary of the role of the Compensation and Corporate Governance Committee is found in the section entitled “Composition of the Compensation and Corporate Governance Committee” in this Information Circular. For more information on the role and responsibilities of the Compensation and Corporate Governance Committee, we encourage you to review the Compensation and Corporate Governance Committee charter, which is available on the Company’s website at www.villagefarms.com .

The Compensation and Corporate Governance Committee charter permits the Compensation and Corporate Governance Committee to engage independent outside advisors to assist it in the fulfillment of its responsibilities. The Compensation and Corporate Governance Committee may engage an independent executive compensation consultant for information, advice and counsel. The consultant may assist the Compensation and Corporate Governance Committee by providing an independent review of:

 

   

The Company’s executive compensation policies, practices and designs;

 

   

The mix of compensation established for the Company’s Named Executive Officers as compared to external benchmarks;

 

   

Market trends and competitive practices in executive compensation; and

 

   

The specific compensation package for Mr. DeGiglio and other Named Executive Officers.

Executive Compensation Related Fees

In 2014, the Compensation and Corporate Governance Committee engaged Towers Watson as its independent compensation and benefit consultant. The Compensation and Corporate Governance Committee directly retained and instructed Towers Watson and Towers Watson reported directly to the Compensation and Corporate Governance Committee. In 2014, Towers Watson charged approximately $16,000 for its advice to the Compensation and Corporate Governance Committee. The Compensation and Corporate Governance Committee previously retained Towers Watson for a similar study in 2009. The Compensation and Corporate Governance Committee did not engage a compensation and benefit consultant in 2015, 2016 or 2017.

 

16


The Role of Executive Management in the Process of Determining Executive Compensation

Mr. Ruffini, the Company’s Chief Financial Officer, is responsible for administering the Company’s executive compensation programs and provides information and analysis on various aspects of the Company’s executive compensation plans, including financial analysis relevant to the process of establishing performance targets for the Company’s annual cash incentive plan and the cost of long-term equity incentive plans. Mr. DeGiglio makes recommendations to the Compensation and Corporate Governance Committee regarding executive compensation decisions for the other Named Executive Officers.

Hedging

The Company does not currently have any policies in place that would prevent Named Executive Officers or directors from purchasing financial instruments that might be designed to hedge or offset a decrease in market value of equity securities granted as compensation or held by Named Executive Officers or directors.

Elements of Compensation

The compensation program is comprised of salary, benefits and short term and long term compensation incentives based on the achievement of corporate and individual objectives. The key components of the short term compensation program are salary and the short term annual bonus incentive program. The long term compensation program is comprised of Options and Performance-based restricted share units.

Base Salary and Benefits

Base salaries for executives are based on positions with equivalent responsibilities in the peer company group. However, the Compensation and Corporate Governance Committee took into account the substantial holdings of Common Shares of Mr. DeGiglio at the time his 2017 base salary was determined. The Compensation and Corporate Governance Committee reviews annually and approves any changes in base salary for the Chief Executive Officer and considers and, if thought fit, approves changes in base salaries recommended by the Chief Executive Officer for the other Named Executive Officers.

The Company provides a comprehensive benefit program to senior management. The program provides all employees (including senior management) with medical and dental benefits and life insurance coverage. The Company is responsible for all costs associated with the benefit program; however, senior management is responsible for the co-payments under the Company benefits plan.

Short Term Incentive Plan Bonus

The Company uses annual cash bonus plans to motivate and reward individual executives for the direct contribution which they make to the Company. Overall, senior management is responsible for achieving the annual business plan.

The executive is required to be employed through December 31 of the respective calendar year in order to earn a bonus. Each Named Executive Officer can earn 20% to 80% of their base salary depending on their position, subject to reduction at the Compensation and Corporate Governance Committee’s discretion.

In determining the bonus plan for 2017, the Compensation and Corporate Governance Committee took into account the industry in which the Company operates, as well as the performance of the Company and its subsidiaries over the past three years. The Compensation and Corporate Governance Committee also took into account the contributions of the individual executives and board members towards the implementation of special projects, such as the formation, implementation and execution of the Company’s cannabis initiative. The Compensation and Corporate Governance Committee determined the amount of the incentive award for the Chief Executive Officer and determined the amount of the incentive award for the other Named Executive Officers based on the recommendations made by the Chief Executive Officer. Due to missing the Company’s financial performance target during 2017, no cash bonuses were paid for the calendar year 2017.

 

17


In administering the annual incentive bonus plan, the Compensation and Corporate Governance Committee may, in its judgment, vary incentive awards payable to executives to award exceptional performance or for other reasons determined by that committee.

Performance-Based Restricted Share Units

In determining the 2017 incentive plans for Named Executive Officers and other key employees of the Company, the Compensation and Corporate Governance Committee issued Performance-based restricted share units to individuals who were involved in designing, creating, implementing and executing the Company’s new cannabis strategy. The Company’s cannabis strategy involved identifying and partnering with an existing public Licensed Producer who was willing to enter into a joint venture with the Company pursuant to the terms put forth by the Company, which involved forming an new entity, contributing one of the Company’s existing greenhouse facilities, converting it to grow cannabis, obtaining the necessary governmental licenses to cultivate and sell cannabis in Canada and growing a large scale high-quality low cost cannabis crop. The Company’s existing produce business was not generating sufficient cash to create a cash bonus incentive plan. Accordingly Performance-based restricted share units were granted.

Retirement Savings

The Company sponsors a retirement savings plan that is qualified under section 401(k) of the United States Internal Revenue Code and provides that participating employees are eligible to make contributions of 1% to 15% of their total salaries, subject to prescribed limits. The Company matches up to 25% of the first 6% of employee contributions.

The Company also sponsors a nonqualified deferred compensation plan for its named executive officers and executives under section 409A of the United States Internal Revenue Code and provides that participating employees are eligible to defer up to 80% of their salaries and annual cash bonuses on an annual basis. The Company may match up to 25% of the first 4% of employee salary deferrals. Since the summer of 2012 due to the under performance of the Company, the Company suspended the Company match on the nonqualified deferred compensation plan.

Performance Graph

The following graph shows the total cumulative return on a $100 investment made on December 31, 2012 in Common Shares, with the cumulative total return of the S&P/TSX Composite Total Return Index, for the period commencing on December 31, 2012 and ending on December 31, 2017, assuming reinvestment of all dividends, for which there were none.

 

18


LOGO

As a reflection of the Company’s 2017 produce performance, no cash bonus was declared for the Executives for the 2017 calendar year. The Company believes that its EBITDA performance and its historical pre-2017 share performance were closely aligned, as reflected in the Company’s share performance and bonus payments over the five year period (2012-2016). In June 2017, subsequent to the announcement of the conversion of a portion of the Company’s Canadian assets to a cannabis growing facility, the Company’s share performance was much higher than it has been historically and no longer reflects the Company’s produce EBITDA performance. Rather it is more closely associated with the anticipation by the equity markets of higher future year EBITDA performance related to a higher margin product in the form of cannabis. Recognizing that the traditional cash bonus plan was not the optimal form of incentive compensation for the new crop strategy, the Company awarded Performance-based restricted share units and Options to certain Named Executive Officers who are working on the cannabis venture. As a result of granting the Performance-based restricted share units, in 2017, some of the Named Executive Officers received higher compensation in 2017 than in prior years. A similar trend is also reflected in the Company’s significantly improved 2017 stock performance.    

Compensation of Named Executive Officers

The Summary Compensation Table below provides a summary of compensation earned by each person who held the position of Chief Executive Officer and Chief Financial Officer of the Company in 2017 and the next three most highly compensated executive officers of the Company (collectively, the “Named Executive Officers”).

 

19


SUMMARY COMPENSATION TABLE

(in United States dollars)

 

Name and Principal Position

   Year      Salary      Share-
Based
Awards (1)
     Option-
Based

Awards (2)
     Non-Equity Incentive
Plan Compensation
     Pension
Value
     All Other
Compensation
       
   Annual
Incentive
Plans
    Long-Term
Incentive
Plans
    Total
Compensation
 

Michael A. DeGiglio

     2017      $ 575,000      $ 495,865        —          —         —          —        $ 25,498 (3)      $ 1,096,363  

Chief Executive

     2016      $ 575,000        —        $ 73,800        —         —          —        $ 117,827 (3)      $ 766,627  

Officer

     2015      $ 575,000        —        $ 53,900        260,167 (3)        —          —        $ 29,630 (3)      $ 918,697  

Stephen C. Ruffini

     2017      $ 350,000      $ 495,865        —          —         —          —        $ 3,500 (4)      $ 849,364  

Executive Vice President and

     2016      $ 350,000        —          —          —         —          —        $ 3,500 (4)      $ 353,500  

Chief Financial Officer

     2015      $ 350,921        —          —          —         —          —        $ 25,571 (4)      $ 376,492  

Paul Selina

     2017      $ 208,000      $ 99,173      $ 61,804        —         —          —        $ 3,120 (5)      $ 372,097  

Vice President of Applied

     2016      $ 208,000        —          —          —         —          —        $ 3,120 (5)      $ 211,120  

Research

     2015      $ 207,333        —          —          —         —          —        $ 3,110 (5)      $ 210,443  

Michael Minerva

                        

Senior Vice President Grower

     2017      $ 236,900        —        $ 61,804        —         —          —        $ 1,777 (6)      $ 300,481  

Relations &

     2016      $ 236,900        —          —          —         —          —        $ 1,777 (6)      $ 238,677  

Supply Development

     2015      $ 236,900        —          —          —         —          —        $ 1,777 (6)      $ 238,677  

Douglas Kling

Senior Vice President

     2017      $ 295,000        —          —          —         —          —        $ 2,950 (7)      $ 297,950  

and Chief Marketing

     2016      $ 295,000        —          —          —         —          —        $ 2,950 (7)      $ 297,950  

Officer

     2015      $ 272,883        —          —          —         —          —        $ 2,729 (7)      $ 275,612  

 

(1)

The amounts listed in this column represent the grant date fair value of the Performance-based restricted share units granted to Named Executive Officers in June 2017, some of which have vested based on the execution of a cannabis joint venture agreement and have been settled in Common Shares and some of which are still unvested and will only vest if certain performance events are achieved. The grant date fair value is calculated based on the number of Performance-based restricted share units granted multiplied by the price of the Common Shares on the date of grant.

(2)

The amounts listed in this column represent the grant date fair value of the Options granted to Named Executive Officers as calculated using the Black-Scholes option pricing model using the following assumptions for 2017 (which are the same method and assumptions used to calculate the accounting fair value) – expected volatility – 52.7%, risk free rate – 2.05%, expected life – 6.5 years – resulting in a fair value of $3.09/Option for Messrs. Selina and Minerva. For 2016 – expected volatility – 52.5%, risk free rate – 1.52%, expected life – 6.5 years – resulting in a fair value of $0.738/Option for Mr. DeGiglio. For 2015—expected volatility – 59.6%, risk free rate – 1.47%, expected life – 6.5 years – resulting in a fair value of $0.539/Option for DeGiglio.

(3)

Mr. DeGiglio received a $24,000 auto allowance and $1,498 in employer 401(k) matches during 2017, a $24,000 auto allowance, $1,498 in employer 401(k) matches and $2,932 in disability insurance during fiscal 2016 and a $24,000 auto allowance, $2,698 in employer 401(k) matches and $2,932 in disability insurance during fiscal 2015. In addition, in prior years, Mr. DeGiglio voluntarily took a lower salary than he was entitled to pursuant to his employment agreement, as well as agreed to voluntarily forego his 2012 bonus payment. In 2015, due to improvements in the Company’s operations, the Board approved payments to Mr. DeGiglio of $260,167 to compensate him for his reduced compensation in prior years. Additionally, Mr. DeGiglio received a distribution from the Company’s 409(a) deferral plan of $90,895 in 2016, which represents prior year wages that Mr. DeGiglio deferred into a future period pursuant to the executive deferral plan.

(4)

Mr. Ruffini received $3,500, $3,500 and $3,646 in employer 401(k) matches during fiscal 2017, 2016 and 2015, respectively. Additionally, Mr. Ruffini received a distribution from the Company’s 409(a) deferral plan of $21,925, in 2015, which represents prior year wages that Mr. Ruffini deferred into a future period pursuant to the executive deferral plan.    

(5)

Mr. Selina received $3,120, $3,120 and $3,110 in employer 401(k) matches during fiscal 2017, 2016 and 2015, respectively.

(6)

Mr. Minerva received $1,777, $1,777 and $1,777 in employer 401(k) matches during fiscal 2017, 2016 and 2015, respectively.

(7)

Mr. Kling received $2,950, $2,950 and $2,729 in employer 401(k) matches during fiscal 2017, 2016 and 2015, respectively.

 

20


Option-Based Awards

The following table sets out the Option and Performance-based restricted share unit awards outstanding for the Named Executive Officers as at December 31, 2017.

 

     Option-based Awards      Share-based Awards  

Name

   Number of
Common
Shares
Underlying
Unexercised
Options
     Option
Exercise
Price
(C$)
     Option Expiration
Date
     Value of
Unexercised
In-The-Money
Options (US$) (1)
     Number of Units
of Shares that
have not Vested
     Market Value of
Share-based
Awards that
have not vested
(US$) (2)
     Market Value of
Share-based
Vested Awards
that have not
paid out or
distributed
(US$)
 

Michael A. DeGiglio

     100,000      $ 1.27        March 14, 2022      $ 507,772           

Michael A. DeGiglio

     100,000      $ 1.48        March 18, 2024      $ 491,032           

Michael A. DeGiglio

     100,000      $ 0.94        March 19, 2025      $ 534,077           

Michael A. DeGiglio

     100,000      $ 1.43        March 29, 2026      $ 495,018           

Stephen C. Ruffini

     99,399      $ 0.70        January 13, 2020      $ 549,883           

Stephen C. Ruffini

     50,000      $ 1.24        May 20, 2021      $ 255,082           

Stephen C. Ruffini

     50,000      $ 1.27        March 13, 2022      $ 253,886           

Stephen C. Ruffini

     100,000      $ 0.85        March 14, 2023      $ 541,251           

Stephen C. Ruffini

     75,000      $ 1.48        March 18, 2024      $ 368,274           

Douglas Kling

     50,000      $ 0.70        January 13, 2020      $ 284,575           

Michael Minerva

     100,000      $ 1.24        May 20, 2021      $ 510,163           

Michael Minerva

     20,000      $ 6.00        December 22, 2027      $ 26,146           

Paul Selina

     50,000      $ 1.24        May 20, 2021      $ 255,082        40,000      $ 243,603     

Paul Selina

     20,000      $ 6.00        December 22, 2027      $ 26,146           

 

(1)

The value is calculated by multiplying the number of outstanding Options by the difference between the exercise price of the Options and the closing price of the Common Shares on the TSX on December 29, 2017, which was C$7.64. The value was converted into United States dollars based on the Bank of Canada closing exchange rate on December 29, 2017 of $0.79713.

(2)

The value is calculated by multiplying the number of outstanding share-based awards by the closing price of the Common Shares on the TSX on December 29, 2017, which was C$7.64. The value was converted into United States dollars based on the Bank of Canada closing exchange rate on December 29, 2017 of $0.79713.

The number of Options and Performance-based restricted share units granted in 2017 to the Named Executive Officers was determined by the Compensation and Corporate Governance Committee.

 

21


Incentive Plan Awards

The following table sets out the value of all incentive plan awards that vested during 2017.

 

Named

   Option-Based
Awards – Value
Vested During 2017
($) (1)
     Share-Based Awards –
Value Vested During 2017
($) (1)
     Non-Equity Incentive Plan
Compensation – Value
earned during 2017

($) (1)
 

Michael A. DeGiglio

   $ 34,183      $ 495,865        —    

Stephen C. Ruffini

   $ 4,117      $ 495,865        —    

Paul Selina

     —        $ 33,058        —    

Michael Minerva

     —          —          —    

Doug Kling

     —          —          —    

 

(1)

The value is calculated using the closing price of the Common Shares on the TSX on the vesting date. The value was converted into United States dollars based on the Bank of Canada closing exchange rate on the vesting date.

Security-Based Compensation Arrangements

The following table sets forth certain information relating to the Compensation Plan as at December 31, 2017.

 

Plan Category

   Name of Plan    Number of Common
Shares to be Issued

Upon Exercise of
Outstanding Options,
Warrants and Rights
     Weighted-
Average

Exercise Price of
Outstanding
Options,
Warrants and
Rights
     Number of Securities
Remaining for
Future Issuance
Under Equity
Compensation Plans
 

Equity compensation plans approved by shareholders

   Share-Based

Compensation

Plan

     2,465,732      C$ 1.59        1,758,529  

Equity compensation plans not approved by shareholders

        —          —          —    
     

 

 

    

 

 

    

 

 

 

Total:

        2,465,732      C$ 1.59        1,758,529  
     

 

 

    

 

 

    

 

 

 

Termination and Change of Control Benefits

Mr. DeGiglio entered into an employment agreement with Village Farms, L.P., the material terms of which are summarized below:

Michael A. DeGiglio . Village Farms, L.P. entered into an employment agreement with Mr. DeGiglio, dated as of January 1, 2017, for his services as Chief Executive Officer and President of the Company and its affiliates. The agreement is for a term of three years and provides for, among other things, an annual salary of US$575,000. The agreement provides standard confidentiality, non-solicitation and non-competition covenants in favour of Village Farms, L.P. and its parent and affiliates, which apply during the term of each agreement and for a specific period

 

22


of time following the termination of the agreement. Mr. DeGiglio’s employment contract provides, among other things, that (i) if it is not renewed by the Company for an additional three year term, is terminated by the Company without cause, or is terminated by Mr. DeGiglio for good reason (as defined in his employment agreement, including a change in control), he will be paid severance compensation at his then-current base salary when it would be payable to him if his employment had continued for another three years from the effective date of termination, and (ii) if Mr. DeGiglio’s employment is terminated due to death or disability, he shall continue to receive salary payments at his then-current salary (or to Mr. DeGiglio’s heirs in the case of his death), reimbursed for expenses incurred prior to such death or disability and benefits shall continue in the event of disability, and to the extent then applicable to heirs of Mr. DeGiglio in the event of his death, until the remaining months of the current term or twelve months, whichever is greater. Mr. DeGiglio is subject to a three year non-competition and non-solicitation obligation in respect of employees who were employed with the Company within the year preceding the termination of his employment, customers and suppliers of the Company, as well as a confidentiality obligation. If Mr. DeGiglio breaches these obligations, the Company is entitled to injunctive and equitable relief.

Any modification or renewal of the above-noted employment agreement will be subject to the prior review of the Compensation and Corporate Governance Committee.

Stephen C. Ruffini. Village Farms, L.P. has entered into an employment agreement with Mr. Ruffini, dated as of April 1, 2017, for his services as Executive Vice President and Chief Financial Officer of the Company and its subsidiaries. The agreement with Village Farms, L.P. outlines Mr. Ruffini’s day-to-day executive activities. The agreement is for a term of three years and provides for, among other things, an annual salary of US$350,000. The agreement provides standard confidentiality, non-solicitation and non-competition covenants in favour of Village Farms, L.P., which apply during the term of the agreement and for a specific period of time following the termination of the agreement. Mr. Ruffini’s employment agreement provides, among other things, that (i) if it is not renewed by the Company for an additional three year term, is terminated by the Company without cause, or is terminated by Mr. Ruffini for good reason (as defined in his employment agreement, including change in control), he will be paid severance compensation at his then-current base salary when it would be payable to him if his employment had continued for eighteen months from the effective date of termination, and (ii) if Mr. Ruffini’s employment is terminated due to death or disability, he shall continue to receive salary payments at his then-current salary (or to Mr. Ruffini’s heirs in the case of his death), reimbursed for expenses incurred prior to such death or disability and benefits shall continue in the event of disability, and to the extent then applicable to heirs of Mr. Ruffini in the event of his death, until the remaining months of the current term or twelve months, whichever is greater.

Douglas Kling. Village Farms, L.P. has entered into an employment agreement with Mr. Kling, dated as of January 1, 2012, for his services as Senior Vice President and Chief Marketing Officer of the Company and its subsidiaries. The agreement with Village Farms, L.P. outlines Mr. Kling’s day-to-day executive activities. The agreement provides for, among other things, an annual salary of US$255,000, which will be reviewed annually. In subsequent years, Mr. Kling received increases in his annual salary base to his current annual salary of US$295,000. The agreement provides standard confidentiality, non-solicitation and non-competition covenants in favour of Village Farms, L.P., which apply during the term of the agreement and for a specific period of time following the termination of the agreement. Mr. Kling’s employment agreement provides, among other things, that if Mr. Kling is terminated by the Company without cause or he resigns for good reason (as defined in his employment agreement, including change in control), he will be paid severance compensation at his then-current base salary when it would be payable to him if his employment had continued for eighteen months from the effective date of termination.

Paul Selina. Village Farms, L.P. has entered into an employment agreement with Mr. Selina, dated as of January 1, 2011, for his services as Vice President of Applied Research of the Company and its subsidiaries. The agreement with Village Farms, L.P. outlines Mr. Selina’s day-to-day executive activities. The agreement provides for, among other things, an annual salary of US$180,000, which will be reviewed annually. In subsequent years, Mr. Selina received increases in his annual salary base to his current annual salary of US$208,000. The agreement provides

 

23


standard confidentiality, non-solicitation and non-competition covenants in favour of Village Farms, L.P., which apply during the term of the agreement and for a specific period of time following the termination of the agreement. Mr. Selina’s employment agreement provides, among other things, that if Mr. Selina is terminated by the Company without cause or he resigns for good reason, he will be paid severance compensation at his then-current base salary when it would be payable to him if his employment had continued for twelve months from the effective date of termination.    

Michael Minerva. Village Farms, L.P. has entered into an employment agreement with Mr. Minerva, dated as of October 1, 2012, for his services as Vice President Grower Relations and Supply Development of the Company and its subsidiaries. The agreement with Village Farms, L.P. outlines Mr. Minerva’s day-to-day executive activities. The agreement provides for, among other things, an annual salary of US$230,000, which will be reviewed annually. In 2014, Mr. Minerva received an increase in his annual salary to his current salary of US$236,900. The agreement provides standard confidentiality, non-solicitation and non-competition covenants in favour of Village Farms, L.P., which apply during the term of the agreement and for a specific period of time following the termination of the agreement. Mr. Minerva’s employment agreement provides, among other things, that if Mr. Minerva is terminated by the Company without cause or he resigns for good reason (as defined in his employment agreement, including change in control), he will be paid severance compensation at his then-current base salary when it would be payable to him if his employment had continued for twelve months from the effective date of termination.

The following table outlines the incremental values that would have been paid to the Named Executive Officers if they had separated from the Company on December 31, 2017.

 

Name

  

Separation Terms

  

Payment in the event of:
Death or Disability

Michael A. DeGiglio
Chief Executive Officer and President
   3 x base salary = US$1,725,000 for non-renewal of Agreement, Termination without Cause, Resignation for Good Reason or Change in Control.   

The greater of:

 

1)  The end of the contract term – December 31, 2019 or

 

2)  12-months (US$575,000)

Stephen C. Ruffini
Executive Vice President and Chief Financial Officer
   1.5 x base salary = US$525,000 for non-renewal of Agreement, Termination without Cause, Resignation for Good Reason or Change in Control.   

The greater of:

 

1)  The end of the contract term – March 31, 2020 or

 

2)  12-months (US$350,000)

Douglas Kling
Senior Vice President and Chief Marketing Officer
   1.5x base salary = US$442,500 for Termination without Cause, Resignation for Good Reason or Change in Control.    None
Paul Selina
Vice President of Applied Research
   1.0x base salary = US$208,000 for
Termination without Cause or Resignation
for Good Reason.
   None
Michael Minerva
Senior Vice President Grower Relations & Supply Development
   1.0x base salary = US$236,900 for Termination without Cause, Resignation for Good Reason or Change in Control.    None

 

24


Compensation of Directors

DIRECTOR COMPENSATION TABLE

(in United States dollars)

 

Name

   Fees
Earned
     Share-
Based
Awards (3)
     Option-
Based
Awards
     Non-Equity
Incentive
Plan
Compensation
     Pension
Value
     All Other
Compensation
     Total  

John R. McLernon (1)

   $ 33,871      $ 49,586        —          —          —          —        $ 83,457  

Christopher C. Woodward (1)

   $ 28,612      $ 49,586        —          —          —          —        $ 78,198  

John P. Henry (2)

   $ 30,403      $ 49,586        —          —          —          —        $ 79,989  

Dave Holewinski (2)

   $ 29,190      $ 49,586        —          —          —          —        $ 78,776  

Roberta Cook (2)

   $ 19,162      $ 49,586        —          —          —          —        $ 68,748  

 

(1)  

Paid in Canadian dollars. The US dollar amount shown was converted monthly at the average exchange rate for each month as posted by the Bank of Canada.

(2)  

Paid in US dollars.

(3)

The amounts listed in this column represent the grant date fair value of the Performance-based restricted share units granted to Directors and converted to US dollars. The grant date fair value is calculated based on the number of Performance-based restricted share units granted multiplied by the price of the Common Shares on the date of grant. The Performance-based restricted share unit performance criteria for vesting for the Directors was based on the execution of a cannabis joint venture agreement.

Each non-management director of the Company receives a retainer of C$18,000 per year, payable in monthly installments of C$1,500, plus C$1,500 per meeting and C$750 per teleconference. The Chairman receives an additional annual fee of C$10,000 payable in monthly installments. The Audit Committee Chairman receives an additional C$5,000 per year, payable monthly. The Compensation Committee Chairman receives an additional C$3,000 per year, payable monthly. The Audit Committee members receive an annual fee of C$6,000, payable monthly, plus C$1,000 per meeting and C$500 per teleconference. The Compensation Committee members receive an annual fee of C$3,000, payable monthly, plus C$1,000 per meeting and C$500 per teleconference. Directors are also entitled to be reimbursed for reasonable out of pocket expenses incurred by them in connection with their services as directors. Directors of the Company are also eligible to participate in the Compensation Plan. Options were granted to non-management directors in 2016. In 2017, the non-management directors were each granted 30,000 Performance-based restricted share units. Vesting for the Performance-based restricted share units occurred on execution of the cannabis joint venture shareholder agreement. Ms. Cook elected to receive only 20,000 of her vested 30,000 Units and voluntarily forfeited the remaining 10,000 units.

Option-Based Awards

The following table sets out the option-based awards outstanding for the non-management Directors as at December 31, 2017. As at December 31, 2017, the Company did not have any share-based awards outstanding to non-management Directors.

 

25


     Option-Based Awards  

Name

   Number of
Common
Shares
Underlying
Unexercised
Options
     Option
Exercise
Price
(C$)
   Option Expiration
Date
   Value of
Unexercised
In-The-Money
Options (US$) (1)
 

John R. McLernon

     25,000      $1.48    March 18, 2024    $ 122,758  

John R. McLernon

     25,000      $1.43    March 29, 2026    $ 123,754  

Christopher C. Woodward

     25,000      $1.48    March 18, 2024    $ 122,758  

Christopher C. Woodward

     25,000      $1.43    March 29, 2026    $ 123,754  

John P. Henry

     25,000      $1.48    March 18, 2024    $ 122,758  

John P. Henry

     25,000      $1.43    March 29, 2026    $ 123,754  

Dave Holewinski

     25,000      $1.48    March 18, 2024    $ 122,758  

Dave Holewinski

     25,000      $1.43    March 29, 2026    $ 123,754  

Roberta Cook

     25,000      $1.43    March 29, 2026    $ 123,754  

 

(1)

The value is calculated by multiplying the number of outstanding Options by the difference between the exercise price of the Options and the closing price of the Common Shares on the TSX on December 29, 2017, which was C$7.64. The value was converted into United States dollars based on the Bank of Canada closing exchange rate on December 29, 2017 of $0.79713.

Incentive Plan Awards

The following table sets out the value of all incentive plan awards that vested during 2017.

 

Named

   Option-Based
Awards – Value

Vested During 2017
($)(1)
     Share-Based Awards –
Value Vested During 2017
($) (1)
     Non-Equity Incentive Plan
Compensation – Value
earned during  2017

($) (1)
 

John R. McLernon

   $ 7,174      $ 49,586        —    

Christopher C. Woodward

   $ 7,174      $ 49,586        —    

John P. Henry

   $ 7,174      $ 49,586        —    

Dave Holewinski

   $ 7,174      $ 49.586        —    

Roberta Cook

   $ 2,432      $ 49,586        —    

 

(1)

The value is calculated using the closing price of the Common Shares on the TSX on the option vesting date and using the grant date value for the Performance-based restricted share units, which vested in 2017. The value was converted into United States dollars based on the Bank of Canada closing exchange rate on the vesting date for options and the grant date for Performance-based restricted share units.

Composition of the Compensation and Corporate Governance Committee

The Board established the Compensation and Corporate Governance Committee to discharge the Board’s responsibilities relating to setting the compensation of its directors and shaping the Company’s approach to corporate governance and recommending to the Board corporate governance practices to be followed by the Company. Since June 2013, the committee was comprised of three directors, namely John R. McLernon, Christopher C. Woodward and Dave Holewinski. Each of these directors is independent.

 

26


John McLernon has served on the Compensation Committee of A&W Income Trust and has served on the Compensation Committee of BC Rail, BC Lottery and Colliers International.    

Christopher Woodward serves on the Compensation Committee for The Keg Royalties Income Fund and the Vancouver Coastal Health Authority.

INDEBTEDNESS

None of the current, former or proposed nominee directors or executive officers of the Company or its subsidiary entities, nor any known associate of such director or executive officer, is, or has been at any time during the past fiscal year, indebted to the Company, its subsidiary entities, associates or affiliates. None of such persons’ indebtedness to another entity is, or has been, the subject of a guarantee, support agreement, letter of credit or other similar arrangement, undertaking or understanding provided by the Company, its subsidiary entities, associates or affiliates.

Aggregate Indebtedness

(in United States dollars unless otherwise noted)

 

Purpose    To the Company or its Subsidiaries     To Another Entity  

Common Share purchases

   $ —       $ —    

Other

   $ 67,667 (1)      $ —    

 

(1)

Village Farms, L.P. advanced a loan of $379,000 to an employee of Village Farms, L.P. on June 18, 2007, in connection with the relocation of this employee at the request of Village Farms, L.P. The $379,000 promissory note is non-interest bearing and has a current balance of $67,667.

AUDIT COMMITTEE

Information regarding the Company’s audit committee can be found in the Company’s Annual Information Form (“AIF”) for the financial year ended December 31, 2017. Each member of the Audit Committee is independent and financially literate, as such terms are defined in National Instrument 52-110 Audit Committees . A copy of the AIF can be obtained by contacting the Company at 4700-80 th Street, Delta, British Columbia, V4K 3N3, or is also available electronically on SEDAR at www.sedar.com .

INTEREST OF MANAGEMENT AND OTHERS IN MATERIAL TRANSACTIONS

None of the principal holders of Common Shares or any director or officer of the Company and its subsidiaries, or any associate or affiliate of any of the foregoing persons, has or had any material interest in any transaction since January 1, 2017 or any proposed transaction that materially affected, or will materially affect, the Company or any of its affiliates.

STATEMENT OF CORPORATE GOVERNANCE PRACTICES

The following table describes the Company’s governance practices. Where applicable, reference is made to the governance practices of the Company’s predecessor, the Fund. For convenience, these are organized by reference to the requirements set out in National Instrument 58-101 Disclosure of Corporate Governance Practices (“NI 58-101”).

 

27


Form 58-101F1 Required Disclosure

  

Comments Regarding the Company’s Corporate Governance Practices

1. Board of Directors   

A majority of the Board is independent.

 

The independent directors are as follows:

 

•  John R. McLernon

 

•  Christopher C. Woodward

 

•  John P. Henry

 

•  David Holewinski

 

•  Dr. Roberta Cook

  

The following directors are not independent:

 

•  Michael A. DeGiglio

 

•  Stephen C. Ruffini

   The Board has determined that Mr. DeGiglio and Mr. Ruffini are not independent by virtue of their employment as executive officers of the Company.
   The chairman of the board from January 1, 2017 to December 31, 2017 was John R. McLernon. Mr. McLernon is an independent director.
  

Mr. McLernon presently serves as a trustee or director, as the case may be, of two other reporting issuers, namely A&W Revenue Royalties Income Fund and City Office REIT, Inc.

 

Mr. Woodward presently serves as a trustee of one other reporting issuer, namely The Keg Royalties Income Fund.

  

The attendance record of each director or Board meetings and teleconferences held from January 1, 2017 to May 10, 2018 was as follows:

 

•  John R. McLernon: 13 of 13 meetings

 

•  Christopher C. Woodward: 11 of 13 meetings

 

•  John P. Henry: 13 of 13 meetings

 

•  Michael A. DeGiglio: 13 of 13 meetings

 

•  David Holewinski: 13 of 13 meetings

 

•  Stephen Ruffini: 13 of 13 meetings

 

•  Dr. Roberta Cook: 11 of 13 meetings

 

28


  

The independent directors held 4 separate meetings or teleconferences from January 1, 2017 to May 10, 2018 at which non-independent directors and members of management did not attend.

 

The Chairman’s role is to facilitate open and candid discussion among the independent directors.

2. Board Mandate    The Board has a written mandate (the “Board Mandate”), which is attached hereto as Appendix A.
3. Position Descriptions   

The written position descriptions for the chair of the Board and for the chair of each Board committee are set out in the Board Mandate.

 

The written position description for the Chief Executive Officer of the Company is set out in the Compensation and Corporate Governance Committee charter.

4. Orientation and Continuing Education    Orientation materials relating to the Company’s business and affairs are provided to new directors regarding the role of the Board and its committees including materials with respect to the Board Mandate and the mandate of each committee of the Board. Education of the directors is continuing so that they maintain and enhance their understanding of their responsibilities and the Company’s business. On an annual basis, the directors meet at one of the Company’s facilities, receive a tour of such facility and are provided an opportunity to ask questions.
5. Ethical Business Conduct    A Code of Ethics and Whistleblower Policy (the “Code”) applicable to all employees, officers and directors was implemented by the Fund in 2006 and was adopted by the Board upon completion of the conversion transaction on December 31, 2009 and is available electronically on SEDAR at www.sedar.com . To facilitate compliance with the Code, the Code includes mandatory procedures with respect to the reporting of conflicts of interest.
  

Since the beginning of the most recently completed financial year, no reports have been filed pertaining to any conduct of a director or executive officer that constitutes a departure from the Code. The Code includes requirements with respect to the avoidance of self-dealing conflicts of interests. The Code provides for a complaint procedure which allows employees to report (anonymously, if they wish) any conduct that does not comply with the Code.

 

Through the Code, the Board encourages and promotes a culture of ethical business conduct in which it can monitor compliance with the Code.

6. Nomination of Directors    The Compensation and Corporate Governance Committee is responsible for the nomination of directors. The Compensation and Corporate Governance Committee is composed of three directors, all of whom are independent. The Compensation and Corporate Governance Committee examines the size, composition and structure of the Board and makes recommendations with respect to individuals qualified for appointment to the Board.

 

29


   The Board aspires to the highest standards of governance and is committed to ensuring that its practices are consistent with those considered to be the most beneficial to shareholders. Accordingly, the Board has approved a policy that in an uncontested election of directors, any nominee who is not elected by at least a majority (50% + 1) of the votes cast with respect to his or her election will tender his or her resignation immediately. The Compensation and Corporate Governance Committee will consider the offer of resignation and, absent exceptional circumstances, will recommend that the Board accept the resignation. The Board will promptly accept the resignation absent exceptional circumstances, and will make its decision and announce its decision and the reasons for its decision in a press release no later than 90 days after the date of the applicable Shareholders’ meeting.
7. Compensation    On an annual basis, the Compensation and Corporate Governance Committee, composed entirely of independent directors, reviews and recommends to the Board, for approval, the remuneration of directors. For further particular, please see “Compensation of Directors and Executive Officers – Compensation Discussion and Analysis”.
8. Other Board Committees    The Company does not have any standing committees other than the Audit Committee and the Compensation and Corporate Governance Committee, as discussed herein.
9. Assessments    The mandate of the Compensation and Corporate Governance Committee provides that the committee is responsible for assessing the composition of the Board, the effectiveness of the Board and its committees and the contribution of individual directors. The objective of these assessments is to ensure the continuous efficiency of the Board and its committees in performing their duties and to promote continuous improvement. Along with any issue that it deems significant, during the assessment of the Board or a committee, the committee takes into account the mandate or applicable rules, and during the assessment of each director, it takes into account the applicable position descriptions as well as the skills and abilities that each director should in principle contribute to the Board.

10. Director Term Limits and Other

      Mechanisms of Board Renewal

   The Company does not impose term limits on its directors as it takes the view that term limits are an arbitrary mechanism for removing directors which can result in valuable, experienced directors being forced to leave the Board solely because of length of service. Instead, the Company believes that directors should be assessed based on their ability to continue to make a meaningful contribution.

 

30


11. Diversity   

The Compensation and Corporate Governance Committee believes that having a diverse Board and senior management team offers a depth of perspective and enhances Board and management operations. The Compensation and Corporate Governance Committee identifies candidates to the Board and management of the Company that possess skills with the greatest ability to strengthen the Board and management.

 

The Compensation and Corporate Governance Committee does not specifically define diversity, but values diversity of experience, perspective, education, race, gender and national origin as part of its overall evaluation of director nominees for election or re-election as well as candidates for management positions. Recommendations concerning director nominees are, foremost, based on merit and performance.

 

The Board does not support fixed percentages for any selection criteria, as the composition of the Board and management is based on the numerous factors established by the selection criteria and it is ultimately the skills, experience, character and behavioral qualities that are most important to determining the value which an individual could bring to the Board or management of the Company.

 

At the senior management level, no executive officer of the Company and its subsidiaries (0%) is female. There is currently one female director (14%). The Company does not have a formal policy on the representation of women on the Board or senior management of the Company. The Board does not believe that a formal diversity policy will necessarily result in the identification or selection of the best candidates. As such, the Company does not see any meaningful value in adopting a formal policy in this respect at this time as it does not believe that it would further enhance gender diversity beyond the current recruitment and selection process carried out by the Compensation and Corporate Governance Committee. However, the Board is mindful of the benefit of diversity on the Board and management of the Company and the need to maximize the effectiveness of the Board and management and their respective decision-making abilities. Due to the size of the Company, its activities, and its number of employees, the Company has not yet set measurable objectives for achieving gender diversity. The Company will consider establishing measureable objectives as it develops.

SHAREHOLDER PROPOSALS FOR NEXT YEAR’S ANNUAL MEETING

The Canada Business Corporations Act permits certain eligible shareholders of the Company to submit shareholder proposals to the Company, which proposals may be included in a management information circular relating to an annual meeting of shareholders. The final date by which the Company must receive shareholder proposals for the annual meeting of shareholders to be held in 2019 is February 9, 2019.

 

31


ADDITIONAL INFORMATION

Financial information for the financial year ended December 31, 2017 is provided in the Company’s comparative consolidated financial statements and management’s discussion and analysis (“MD&A”). Shareholders who wish to request copies of the annual and interim financial statements and MD&A should contact the Company at 4700-80 th Street, Delta, British Columbia, V4K 3N3.

The financial statements and MD&A, the AIF and other information relating to the Company are available electronically on SEDAR at www.sedar.com.

DIRECTORS’ APPROVAL

The contents of this Information Circular and its sending to Shareholders of the Company have been approved by the directors of the Company.

DATED at Delta, British Columbia this 10 th day of May, 2018.

 

By Order of the Board of Directors
By:  

(signed) “John R. McLernon”

  Chairman of the Board of Directors

 

32


APPENDIX A

VILLAGE FARMS INTERNATIONAL, INC. (the “Company”)

MANDATE OF THE BOARD OF DIRECTORS

The purpose of this document is to summarize the governance and management roles and responsibilities of the board of directors of the Company (the “Board”).

 

1.

ACCOUNTABILITY

The Board is responsible to shareholders.

 

2.

ROLE

The role of the Board is to focus on governance and stewardship of the business carried on by the Company as a whole. The Board will review strategy, assign responsibility for achievement of that strategy, and monitor performance against those objectives. In fulfilling this role, the Board will regularly review the strategic plans developed by management so that they continue to be responsive to the changing business environment in which the Company operates.

 

3.

RESPONSIBILITIES

In order that the Board fulfills its role, the Board will:

 

  (a)

Define Shareholder Expectations

 

   

Satisfy itself that there is effective communication between the Board and the Company’s shareholders, other stakeholders, and the public.

 

   

Determine, from time to time, the appropriate criteria against which to evaluate performance, and set corporate strategic goals and objectives within this context.

 

  (b)

Establish Strategic Goals, Performance Objectives, Operational Policies and Identify Principal Risks

The Board will review and approve broad strategic corporate objectives and establish corporate values against which the performance of the Company will be measured. In this regard, the Board will, at least annually:

 

   

Approve long-term strategies;

 

   

Review and approve management of the Company’s strategic and operational plans so that they are consistent with long-term goals;

 

   

Approve strategic and operational policies within which management of the Company will operate;

 

   

Identify the principal risks of the Company and ensure implementation of appropriate systems to manage these risks;

 

33


   

Set targets against which to measure corporate and executive performance of the Company;

 

   

Satisfy itself that a portion of executive compensation is linked appropriately to Company performance; and

 

   

Satisfy itself that a process is in place with respect to the appointment, development, evaluation and succession of senior management of the Company.

 

  (c)

Delegate Management Authority to the Chief Executive Officer

 

   

Ensure that the Board delegates to the Chief Executive Officer the authority to manage and supervise the business of the Company and decisions regarding the ordinary course of business and operations.

 

   

Determine what, if any, executive limitations may be required in the exercise of the authority delegated to management.

 

  (d)

Monitor Corporate Performance

 

   

Understand, assess and monitor the principal risks of all aspects of the businesses in which the Company is engaged.

 

   

Monitor performance of the Company against both short-term and long-term strategic plans and annual performance targets, and monitor compliance with Board policies and the effectiveness of risk management practices.

 

   

Ensure that the boards of directors of the Company’s subsidiaries monitor compliance by management of its subsidiaries with internal controls and effective management information systems.

 

  (e)

Develop Board Processes

 

   

Develop an approach relating to the conduct of the Board’s business and the fulfillment of the Board’s responsibilities.

 

   

Develop the Board’s approach to corporate governance through the Board’s Compensation and Corporate Governance Committee.

 

4.

QUALIFICATIONS OF DIRECTORS

Directors are expected to have the highest personal and professional ethics and values and be committed to advancing the best interests of the Company and its shareholders. They are also expected to possess skills and competencies in areas that are relevant to the Company’s activities and that enhance the ability of the Board to effectively oversee the business and affairs of the Company.

A majority of the Board must be independent. Independent shall have the meaning, as the context requires, given to it in National Instrument 52-110 Audit Committees , as may be amended from time to time. The chairperson of the Board (the “Chair of the Board”) must be an independent director. The

 

34


Chair of the Board should act as the effective leader of the Board and ensure that the Board’s agenda will enable it to successfully carry out its duties. The position description for the Chair of the Board is attached hereto as Schedule A.

Each director must have an understanding of the Company’s principal operational and financial objectives, plans and strategies, financial position and performance as well as the performance of the Company relative to its principal competitors. Directors must have sufficient time to carry out their duties and not assume responsibilities that would materially interfere with, or be incompatible with, Board membership. Directors, who experience a significant change in their personal circumstances, including a change in their principal occupation, are expected to advise the chairperson of the Compensation and Corporate Governance Committee (the “Committee Chair”) and, if determined appropriate by the Board on the recommendation of the Compensation and Corporate Governance Committee, resign from the Board.

 

5.

MEETINGS

The Board has meetings at least once in each quarter, with additional meetings held when required. Additional meetings may be called by the Chair of the Board or any two directors on proper notice. Board meetings may be held by telephonic means.

The Chair of the Board is primarily responsible for the agenda. Prior to each Board meeting, the Chair of the Board will discuss agenda items for the meeting with the Chief Executive Officer of the Company, and other members of the Board. Any director may propose the inclusion of items on the agenda, request the presence of, or a report by any member of senior management of the Company, or at any Board meeting raise subjects that are not on the agenda for that meeting.

The Audit Committee of the Company has meetings quarterly, with additional meetings held when required. The Compensation and Corporate Governance Committee of the Company has meetings as often as it deems necessary. Meeting frequency and agendas for the standing committees may change from time to time, however, depending on opportunities or risks faced by the Company and its subsidiaries. The committee chairperson or any two members of a committee may call a committee meeting, request that an item be included on the committee’s agenda or raise subjects that are not on the agenda for that meeting.

Audit Committee meetings can also be called by the Company’s auditor or the Chief Financial Officer of the Company. Notice of the place, day and time of each Board or committee meeting must be served on each director or manager at least 48 hours prior to the meeting. Directors or committee members, however, may waive notice of any meeting. Attendance of a director, in person or by telephone, at a Board meeting shall constitute a waiver of notice of that meeting except, with respect to Board meetings, in circumstances described in the By-laws of the Company (the “By-laws”). The notice needs to state the purpose or purposes for which the meeting of directors or managers is being held.

Procedures for Board Meetings

 

   

Subject to the Company’s By-laws, procedures for Board meetings are determined by the Chair of the Board unless otherwise determined by a resolution of the Board.

 

   

Subject to the Company’s By-laws, procedures for committee meetings are determined by the committee chairperson unless otherwise determined by a resolution of the committee or the Board.

 

   

A quorum for any Board or committee meeting shall be as required by the constating documents of the Company.

 

35


6.

DIRECTORS’ RESPONSIBILITIES

 

  (a)

Attendance and Participation

 

   

Each director is expected to attend all meetings of the Board and any committee of which he or she is a member. A director who is unable to attend a meeting in person may participate by telephone or teleconference. The Board or any committee may also take action from time to time by unanimous written consent.

 

   

In advance of each Board or committee meeting, members will receive the proposed agenda and other materials necessary to the directors’ understanding of the matters to be considered. Directors are expected to spend the time needed to review the materials in advance of such meetings and to actively participate in such meetings.

 

  (b)

Service on Other Boards and Audit Committee

 

   

The Board does not believe that its members should be prohibited from serving on the boards of other public companies so long as these commitments do not materially interfere and are compatible with their ability to fulfill their duties as a member of the Board. Directors must advise the Chair of the Board in advance of accepting an invitation to serve on the board of another public company and, as a general rule, directors are not allowed to join a board of another public company on which two or more other directors of the Company serve.

 

  (c)

Access to Independent Advisors

 

   

The Board and any committee may at any time retain outside financial, legal or other advisors at the expense of the Company and have the authority to determine the advisors’ fees and other retention terms. Any director may, subject to the approval of the Chair of the Board, retain an outside advisor at the expense of the Company.

 

7.

EVALUATION OF BOARD, DIRECTORS AND COMMITTEES

The Compensation and Corporate Governance Committee, in consultation with the Chair of the Board, will ensure that an appropriate system is in place to evaluate and perform an annual evaluation of the effectiveness of the Board as a whole as well as the committees of the Board, and the boards of directors or managers and board committees of the Company’s subsidiaries, to ensure they are fulfilling their respective responsibilities and duties. In connection with these evaluations, each director will be requested to provide his or her assessment of the effectiveness of the Board and each committee as well as the performance of individual directors. These evaluations should take into account the competencies and skills each director is expected to bring to his or her particular role on the Board or on a committee, as well as any other relevant facts. The position description for a committee chairperson is attached hereto as Schedule B.

 

36


8.

MANAGEMENT

 

  (a)

Management’s Role

 

   

The primary responsibility of management of the Company is to safeguard the Company’s assets and to create wealth for shareholders. When performance is found to be inadequate, the Board has the responsibility to bring about appropriate change.

 

   

Management of the Company is under the direction of its Chief Executive Officer. The Board shall take such steps as it deems necessary to satisfy itself as to the integrity of the Chief Executive Officer and other executive officers of the Company and that such individuals create a culture of integrity throughout the Company.

 

  (b)

Management’s Relationship to the Board

 

   

Senior management of the Company, primarily through the Chief Executive Officer, reports to and is accountable to the Board.

 

   

Business plans are developed to ensure the compatibility of shareholder, Board and management views on the Company and the Company’s subsidiaries’ strategic direction, performance targets and utilization of shareholders’ equity. A special meeting of the Board is held each year to review the strategic initiatives and the business plan submitted by senior management of the Company.

 

  (c)

Board Access to Management

 

   

Information provided by management to directors is critical to their effectiveness. In addition to the reports presented to the Board at its regular and special meetings, the Board is also kept informed on a timely basis by management of the Company with respect to developments and key decisions taken by management in pursuing the Company’s business plan. The directors periodically assess the quality, completeness and timeliness of information provided by management to the Board.

 

  (d)

Management Performance Review and Rewards

 

   

The Corporate Governance and Compensation and Corporate Governance Committee of the Company annually reviews the position description of the Chief Executive Officer and establishes objectives against which his or her performance is reviewed, with his or her compensation or level being assessed against these agreed objectives. Similar reviews and assessments are undertaken for other members of senior management in consultation with the Chief Executive Officer.

 

   

The compensation plans of the Company are based on maintaining a direct link between management rewards and the wealth created for shareholders.

 

37


9.

COMMUNICATION AND DISCLOSURE POLICIES

The Company has adopted a Disclosure and Insider Trading Policy, which summarizes its policies and practices regarding disclosure of material information to investors, analysts and the media. The purpose of this policy is to ensure that the Company’s communications with the investment community are timely, consistent and in compliance with all applicable securities legislation. The Disclosure and Insider Trading Policy is reviewed annually by the Board and is available on the Company’s website.

The Company endeavors to keep its shareholders informed of its progress through a comprehensive annual report, annual information form, quarterly interim reports and periodic press releases. It also maintains a website that provides summary information about the Company and ready access to its published reports, press releases, statutory filings and supplementary information provided to analysts and investors. Directors and management meet with the Company’s shareholders at the annual meeting and are available to respond to questions at that time.

The Company also maintains an investor relations program to respond to inquiries in a timely manner. Management meets on a regular basis with investment analysts, financial advisors and interested members of the public to ensure that accurate information is available to investors, including quarterly conference calls to discuss the Company’s financial results. The Company also endeavors to ensure that the media is kept informed of developments as they occur, and have an opportunity to meet and discuss these developments with the Company’s designated spokespersons.

 

10.

CODE OF ETHICS AND WHISTLEBLOWER POLICY

The Board expects all directors, managers, officers and employees of the Company and its subsidiaries to conduct themselves in accordance with the highest ethical standards and to adhere to the Company’s Code of Ethics and Whistleblower Policy (the “Code”). Any waiver of the Code for officers, directors or managers may only be made by the Board or the Compensation and Corporate Governance Committee and will be disclosed to shareholders by the Company to the extent required by law, regulation or stock exchange requirement.

 

11.

PROHIBITION ON PERSONAL LOANS

The Company will not, either directly or indirectly, including through its subsidiaries, extend or maintain credit, arrange for the extension of credit, or renew an extension of credit, in the form of a personal loan to or for any director or executive officer.

 

12.

FEEDBACK

The Board welcomes input and comments from shareholders of the Company. Input or comments for the Board or its committees should be directed to the Company Secretary at:

Board of Directors of Village Farms International, Inc.

c/o Stephen C. Ruffini, Company Secretary

Village Farms International, Inc.

4700 - 80 th Street

Delta, British Columbia

V4K 3N3

 

38


SCHEDULE A

Position Description of Chairperson of the Board (the “Chair of the Board”)

The Chair of the Board of the Company is principally responsible for overseeing the operations and affairs of the Board. In fulfilling his or her responsibilities, the Chair of the Board will:

 

  (a)

provide leadership to foster the effectiveness of the Board;

 

  (b)

ensure there is an effective relationship between the Board and senior management of the Company;

 

  (c)

ensure that the appropriate committee structure is in place and assist the Compensation and Corporate Governance Committee in making recommendations for appointments to such committees;

 

  (d)

in consultation with the other members of the Board and the Chief Executive Officer of the Company, prepare the agenda for each meeting of the Board;

 

  (e)

ensure that all directors receive the information required for the proper performance of their duties, including information relevant to each meeting of the Board;

 

  (f)

chair Board meetings, including stimulating debate, providing adequate time for discussion of issues, facilitating consensus, encouraging full participation and discussion by individual directors and confirming that clarity regarding decision-making is reached and accurately recorded;

 

  (g)

together with the Compensation and Corporate Governance Committee, ensure that an appropriate system is in place to evaluate the performance of the Board as a whole, the Board’s committees and individual directors, and make recommendations to the Compensation and Corporate Governance Committee for changes when appropriate;

 

  (h)

work with the Chief Executive Officer of the Company and other members of senior management to monitor progress on strategic planning, policy implementation and succession planning; and

 

  (i)

provide additional services required by the Board.

 

39


SCHEDULE B

Position Description of a Committee Chairperson (a “Committee Chair”)

A Committee Chair is principally responsible for overseeing the operations and affairs of his or her particular committee. In fulfilling his or her responsibilities, a Committee Chair will:

 

  (a)

provide leadership to foster the effectiveness of the committee;

 

  (b)

ensure there is an effective relationship between the Board and the committee;

 

  (c)

ensure that the appropriate charter is in effect and assist the Compensation and Corporate Governance Committee in making recommendations for amendments to the charter;

 

  (d)

in consultation with the other members of the committee and Board, where appropriate, prepare the agenda for each meeting of the committee;

 

  (e)

ensure that all committee members receive the information required for the proper performance of their duties, including information relevant to each meeting of the committee;

 

  (f)

chair committee meetings, including stimulating debate, providing adequate time for discussion of issues, facilitating consensus, encouraging full participation and discussion by individual members and confirming that clarity regarding decision-making is reached and accurately recorded; and

 

  (g)

together with the Compensation and Corporate Governance Committee, ensure that an appropriate system is in place to evaluate the performance of the committee as a whole, the committee’s individual members, and make recommendations to the Compensation and Corporate Governance Committee for changes when appropriate; and provide additional services required by the Board.


APPENDIX B

COMPENSATION PLAN

VILLAGE FARMS INTERNATIONAL, INC.

SHARE-BASED COMPENSATION PLAN

ARTICLE 1

purpose

1.1 Purpose . The purpose of this share-based compensation plan of the Corporation is to advance the interests of the Corporation and its Affiliates by encouraging Eligible Persons to increase their proprietary interest in the Corporation and to remain associated with the Corporation, rewarding significant performance achievements and providing Eligible Persons with additional incentive in their efforts on behalf of the Corporation and its Affiliates.

1.2 Effective Date . The effective date of the Plan is December 31, 2009.

ARTICLE 2

DEFINED TERMS

2.1 Definitions . The following terms used herein shall have the following meanings:

 

  (a)

Affiliate ” means an entity which is an “affiliate” of the Corporation for the purposes of National Instrument 45-106 Prospectus and Registration Exemptions as amended or replaced from time to time;

 

  (b)

Award ” means an Option, Stock Appreciation Right, Restricted Share Unit, Deferred Share Unit, Restricted Stock or other Share-Based Award granted pursuant to the Plan;

 

  (c)

Award Shares ” has the meaning set out in Section 0;

 

  (d)

Black-Out Period ” means a time when, pursuant to any policies of the Corporation, any securities of the Corporation may not be traded by certain persons as designated by the Corporation, including any holder of an Award;

 

  (e)

Board ” means the board of directors of the Corporation or, if established and duly authorized to act in respect of the Plan, a committee of the board of directors of the Corporation;

 

  (f)

Business Day ” means any day, other than a Saturday or a Sunday, on which the Exchange is open for trading;

 

  (g)

Code ” means the U.S. Internal Revenue Code of 1986, as amended or replaced from time to time;

 

  (h)

Consultant ” means an individual or Consultant Company, other than a Director, Officer, Employee or Management Company Employee that:


  (i)

s engaged to provide on an ongoing bona fide basis, consulting, technical, management or other services to the Corporation or an Affiliate, other than services provided in relation to a distribution of securities;

 

  (ii)

provides the services under a written contract with the Corporation or an Affiliate; and

 

  (iii)

spends or will spend a significant amount of time on the affairs and business of the Corporation or an Affiliate;

 

  (i)

Consultant Company ” means for an individual consultant, a company or partnership of which the individual is an employee, shareholder or partner;

 

  (j)

Corporation ” means Village Farms International Inc., a corporation incorporated under the laws of Canada, and any successor corporation;

 

  (k)

Deferred Share Units ” has the meaning set out in Section 0;

 

  (l)

Director ” means a member of the board of directors of the Corporation or of any of its Affiliates;

 

  (m)

Eligible Person ” means any Director, Officer, Employee or Consultant of the Corporation or any Affiliate determined by the Board as eligible for participation in the Plan;

 

  (n)

Employee ” means an individual who is considered an employee of the Corporation or its Affiliates for the purposes of applicable income tax legislation;

 

  (o)

Exchange ” means the TSX or, if the Shares are not then issued and posted for trading on the TSX, on such stock exchange in Canada on which such Shares are listed and posted for trading as may be selected for such purpose by the Board;

 

  (p)

Fixed Term ” means the period of time during which the Options must be exercised pursuant to the terms of the Plan;

 

  (q)

Insider ” has the meaning given under applicable securities legislation, as amended or replaced from time to time, and also includes associates and affiliates of such an insider;

 

  (r)

Management Company Employee ” means an individual employed by a person providing management services to the Corporation, who is required for the ongoing successful operation of the business enterprise of the Corporation;

 

  (s)

Market Price ” means the closing price of the Shares on the Exchange on the date immediately preceding the applicable date rounded up to the nearest cent. In the event that such Shares are not then listed and posted for trading on any Exchange, the Market Price in respect thereof shall be the fair market value of such Shares as determined by the reasonable application by the Board of a reasonable valuation method in compliance with Section 409A of the Code and that is acceptable to the Canada Revenue Agency;


  (t)

Offer ” has the meaning set out in Section 0;

 

  (u)

Officer ” means a senior officer of the Corporation or its Affiliates;

 

  (v)

Option ” means an option granted to purchase Shares for the Option Price under the terms of the Plan;

 

  (w)

Option Price ” means the price per share at which Shares may be purchased under the Option and based on which the SAR Amount is determined, as the same may be adjusted from time to time in accordance with 0 hereof;

 

  (x)

Other Awards ” has the meaning set out in Section 0;

 

  (y)

Participant ” means an Eligible Person who holds an Award under the terms of the Plan;

 

  (z)

Plan ” means this share-based compensation plan;

 

  (aa)

Restricted Share Units ” has the meaning set out in Section 0;

 

  (bb)

Restricted Stock ” has the meaning set out in Section 0;

 

  (cc)

SAR  Amount ” has the meaning set out in Section 0;

 

  (dd)

Separation from Service ” means with respect to a US Participant a “separation from service” with the Company within the meaning of, and that satisfies the requirements of, Section 409A of the Code, including Treasury Regulation §1.409A-1(h); provided that it shall only include a circumstance where the employee dies, retires or otherwise has a termination of employment;

 

  (ee)

Shares ” mean the common shares of the Corporation as currently constituted or, in the event of an adjustment as contemplated by 0, such other shares or securities to which a Participant may be entitled or on which the value of an Award may be based, as a result of such adjustment;

 

  (ff)

Specified Employee ” has the meaning set forth in Section 409A(a)(2)(B) of the Code;

 

  (gg)

Stock Appreciation Rights ” has the meaning set out in Section 0;

 

  (hh)

Termination Date ” means the date a Participant ceases to be an Eligible Person and does not include any period of statutory, contractual or reasonable notice or any period of salary continuance or deemed employment;


  (ii)

Treasury Regulations ” means the United States Treasury Regulations promulgated under the Code;

 

  (jj)

TSX ” means the Toronto Stock Exchange; and

 

  (kk)

U.S. Participant ” means any Eligible Person that is subject to tax under the laws of the United States.

ARTICLE 3

ADMINISTRATION OF PLAN

3.1 General . This Plan shall be administered by the Board which shall have the power, subject to the specific provisions of the Plan:

 

  (a)

to establish policies and to adopt rules and regulations for carrying out the purposes, provisions and administration of the Plan;

 

  (b)

to interpret and construe the Plan and to determine all questions arising out of the Plan and any Award granted pursuant to the Plan, where every such interpretation, construction or determination made by the Board shall be final, binding and conclusive for all purposes;

 

  (c)

to determine the Eligible Persons to whom Awards are granted and to grant Awards;

 

  (d)

to determine the number of Awards;

 

  (e)

to determine the Option Prices provided that the Option Price shall not be less than the Market Price;

 

  (f)

to determine the time or times when Awards will be granted and exercisable or redeemable;

 

  (g)

to determine if the Shares that are subject to an Award will be subject to any restrictions upon the exercise or redemption of such Award; and

 

  (h)

to prescribe the form of the instruments relating to the grant, exercise, redemption and other terms of Awards.

The power described in this Section 0 shall be exercised in accordance with applicable securities laws and rules and policies of the Exchange.

3.2 Award Agreement . Each Participant shall execute an award agreement in the form determined by the Board from time to time. In the event of any inconsistency between the terms of any award agreement and this Plan, the terms of this Plan shall govern.


3.3 Section  409A . This Plan is intended to comply with the applicable requirements of Section 409A of the Code and shall be administered in accordance with Section 409A of the Code. All Awards under the Plan shall be structured in a manner consistent with the requirements of Section 409A of the Code to the extent subject thereto and payments with respect thereto shall only be made in a manner and upon an event permitted under Section 409A. To the extent required under Section 409A, payments to a U.S. Participant who is a Specified Employee upon his or her Separation from Service shall be postponed and subject to a 6 month delay and shall be paid on the first business day of the seventh month following Separation from Service, or if such U.S. Participant dies during the postponement period prior to the payment of postponed amount, the amounts withheld on account of Section 409A of the Code shall be paid to the personal representative of such U.S. Participant’s estate within 60 days after the date of such U.S. Participant’s death. Except where otherwise expressly provided, to the extent that any provision of the Plan would cause a conflict with the requirements of Section 409A of the Code, or would cause the administration of the Plan to fail to satisfy the requirements of Section 409A of the Code, such provision shall be deemed null and void to the extent permitted by applicable law.

ARTICLE 4

SHARES SUBJECT TO THE PLAN

4.1 10% Rolling Plan . Subject to adjustment as provided in 0, the Shares to be offered under the Plan shall consist of the Corporation’s authorized but unissued Shares. The aggregate number of Shares to be delivered upon the exercise or redemption of all Awards granted under the Plan shall not exceed the greater of ten percent (10%) of the issued and outstanding Shares at the time of granting of Awards (on a non-diluted basis) or such other number or percentage as may be approved by the Exchange and the shareholders of the Corporation from time to time.

4.2 Awards to Insiders . Under no circumstances shall this Plan, together with all other security-based compensation arrangements of the Corporation, result, at any time, in:

the number of Shares issuable to Insiders exceeding ten percent (10%) of the issued and outstanding Shares (on a non-diluted basis); or

the issuance to Insiders, within a one-year period, of a number of Shares exceeding ten percent (10%) of the issued and outstanding Shares (on a non-diluted basis).

4.3 Exercise or Redemption of Awards . Any exercise of Options or redemption of Awards will make new grants available under the Plan effectively resulting in a re-loading of the number of Shares available to grant under the Plan.

4.4 Awards That Expire or Terminate . If any Award granted hereunder shall expire or terminate for any reason without having been exercised or redeemed in full, the Shares underlying the Award shall again be available for the purpose of the Plan.

4.5 Restrictions on Exercise or Redemption . Notwithstanding any of the provisions contained in the Plan or any Award, the Corporation’s obligation to issue Shares to a Participant pursuant to the exercise or redemption of an Award shall be subject to:

 

  (a)

completion of such registration or other qualification of such Shares or obtaining approval of the Exchange or such regulatory authority as the Corporation shall determine to be necessary or advisable in connection with the authorization, issuance or sale thereof;

 

  (b)

the admission of such Shares to listing on the Exchange; and


  (c)

the receipt from the Participant of such representations, agreements and undertakings, including as to future dealings in such Shares as the Corporation or its counsel determines to be necessary or advisable in order to safeguard against the violation of the securities laws of any jurisdiction.

In this connection, the Corporation shall, to the extent necessary, take all reasonable steps to obtain such approvals, registrations and qualifications as may be necessary for the issuance of such Shares in compliance with applicable securities laws and for the listing of such Shares on the Exchange. If any Shares cannot be issued to any Participant for any reason including, without limitation, the failure to obtain necessary shareholder, regulatory or stock exchange approval, then the obligation of the Corporation to issue such Shares shall terminate and any amounts paid by the Participant to the Corporation to exercise or redeem an Award shall be returned to the Participant.

4.6 Non-Assignable . An Award is personal to the Participant and is non-assignable and non-transferable. Where an Award is granted to a company wholly-owned by a Participant, such company must agree, at the time of the grant, not to effect or permit any transfer of ownership of the Award or shares of such company, nor issue any additional shares to any individual or entity for so long as the Award remain outstanding to the credit of that company, except with the prior written consent of the Corporation and any required consent of the Exchange and any other applicable regulatory authority.

ARTICLE 5

ELIGIBILITY AND CEASING TO BE AN ELIGIBLE PERSON

5.1 Eligible Persons . Awards may only be granted to Eligible Persons.

5.2 Compliance with Laws . Notwithstanding any provision contained in this Plan, no Participant may exercise or redeem any Award granted under this Plan and no Shares may be issued upon exercise or redemption of an Award unless such exercise or redemption and issuance are in compliance with all applicable securities laws or other legislation of the jurisdiction of residence of such person. Unless the potential Participant is a resident of Canada, the Corporation may require, as a condition of the grant of an Award, that the potential Participant provide a written acknowledgement that the grant of the Award does not violate any such laws.

5.3 Termination Date . Subject to Section 0, Section 0 and any express resolution passed by the Board, all Awards, and all rights to acquire Shares pursuant thereto, granted to an Eligible Person shall expire and terminate immediately upon the Participant’s Termination Date.

5.4 Circumstances When Options and Stock Appreciation Rights are Exercisable . If, before the expiry of an Option or Stock Appreciation Right in accordance with the terms thereof, a Participant ceases to be an Eligible Person for any reason whatsoever, other than termination by the Corporation for cause (in which case all unexercised Options and Stock Appreciation Rights (vested or unvested) shall cease immediately), such Options and Stock Appreciation Rights may be exercised, subject to:

 

  (i)

the terms set out in the award agreement;

 

  (ii)

any determination made by the Board to accelerate the vesting of or to extend the expiry of an Option or Stock Appreciation Right; and

 

  (iii)

any other terms of the Plan


  (b)

if the Participant is deceased, by the heirs of the Participant or by legal personal representative(s) of the estate of the Participant at any time within six (6) months following the death of the Participant; or

 

  (c)

by the Participant at any time within ninety (90) days following the Termination Date.

But, in any case, the exercise of the Option or Share Appreciation Right must be: (i) prior to the expiry of the Fixed Term of the Option or the expiry of the Stock Appreciation Right with the terms thereof, and (ii) only to the extent that the Option or Share Appreciation Right was vested and the Participant was otherwise entitled to exercise the Option or Share Appreciation Right at the Termination Date.

5.5 Another Listed Category . Awards shall not be affected in the event the Participant ceases to fall within a listed category contained in the definition of an “ Eligible Person ” hereunder where such Participant falls within another listed category of such definition.

ARTICLE 6

CERTAIN ADJUSTMENTS

6.1 Offer for Shares . If a bona fide offer (“ Offer ”) for Shares is made to the Participant or to shareholders generally or to a class of shareholders which includes the Participant, which Offer, if accepted in whole or in part, would result in the offeror exercising control over the Corporation within the meaning of subsection 1(3) of the Securities Act (Ontario) (as amended from time to time), then the Board may, in its discretion, notify each Participant of the Offer, with full particulars thereof, whereupon, the Board may in its discretion, provide that notwithstanding the terms of the Award, such Award (other than a Deferred Share Unit) may be exercised in whole or in part by the Participant so as to permit the Participant to tender the Shares received upon such exercise (the “ Award Shares ”) pursuant to the Offer.

6.2 Changes in Shares . In the event of any stock dividend, stock split, combination or exchange of shares, merger, amalgamation, acquisition, divestiture, consolidation, spin-off or other distribution (other than normal cash dividends) of the Corporation’s assets to shareholders, or any other change in the capital of the Corporation affecting Shares, the Board will make such proportionate adjustments, if any, as the Board in its discretion may deem appropriate, in compliance with Section 409A of the Code, to reflect such change, with respect to (i) the number or kind of shares or other securities reserved for issuance pursuant to this Plan; (ii) the number or kind of shares or other securities subject to unexercised or unredeemed Awards previously granted; and (iii) the Option Price, if applicable, of Awards.

6.3 No Fractional Shares . The Corporation will not issue fractional Shares in satisfaction of any of its obligations hereunder.

6.4 Accelerated Exercise or Redemption of Awards . Notwithstanding any other provisions of the Plan, the Board may at any time give written notice to all Participants advising that their respective Awards (other a than Deferred Share Unit) are all immediately exercisable or redeemable and may be exercised or redeemed only within 30 days of such written notice or such other period as determined by the Board and not thereafter and that all rights of the Participants under any Awards (other than a Deferred Share Unit) not exercised or redeemed within such period will terminate all the expiration of such period; provided that with respect to any U.S. Participant, the acceleration of the time or schedule of any payment of compensation under the Plan that is subject to Section 409A of the Code is prohibited, except as provided in the Treasury Regulations and administrative guidance promulgated under Section 409A of the Code.


ARTICLE 7

OPTIONS

7.1 Grant of Options . The Board may grant Options to Eligible Persons.

7.2 Option Exercise Term . Options shall be for a Fixed Term and exercisable from time to time as determined in the discretion of the Board at the time of grant, provided that, subject to Section 0, no Option shall have a term exceeding ten (10) years (or such shorter period as is permitted by the Exchange from time to time).

7.3 Black-Out Period . Except where not permitted by the Exchange, where an Option would expire during a Black-Out Period or within ten (10) Business Days following the end of a Black-Out Period, the term of such Option shall be extended to the date which is ten (10) Business Days following the end of such Black-Out Period.

7.4 Terms of Options . Subject to this Article, the number of Shares subject to each Option, the Option Price, the expiration date of each Option, the extent to which each Option is exercisable from time to time during the term of the Option and other terms and conditions relating to each such Option shall be determined by the Board; provided, however, if no specific determination is made by the Board with respect to any of the following matters, each Option shall, subject to any other specific provisions of the Plan, contain the following terms and conditions:

 

  (a)

the Fixed Term shall be ten (10) years from the date the Option is granted to the Participant; and

 

  (b)

the Option shall vest in installments, with 1 3 of such Option exercisable in whole or in part on or after the first anniversary following the grant of the Option, and a further 1 3 vesting and becoming exercisable on each of the second and third anniversaries following the grant of the Option.

7.5 Restrictions on Option Price . The Option Price shall in no circumstances be lower than the greatest of: (i) the price permitted by the Exchange; (ii) the price permitted by any other regulatory body having jurisdiction; or (iii) the Market Price.

7.6 Exercise of Options . Subject to the provisions of the Plan and award agreement, an Option may be exercised from time to time by delivery to the Corporation at its principal office of a written notice of exercise addressed to the Secretary or the Chief Financial Officer of the Corporation in a form approved by the Board from time to time and accompanied by payment in full of the Option Price for the Shares to be purchased. Upon receipt of payment in full and subject to the terms of this Plan, the number of Shares in respect of which the Option is exercised will be duly issued to the Participant as fully paid and non-assessable. Upon the exercise of any Option with a related Stock Appreciation Right, the corresponding portion of the related Stock Appreciation Right shall be surrendered to the Corporation and cancelled.

ARTICLE 8

STOCK APPRECIATION RIGHTS

8.1 Grants of Share Appreciation Rights . The Board may grant rights (“ Stock Appreciation Rights ”) to Eligible Persons either on a stand-alone basis or in relation to any Option. Where a Stock Appreciation Right is granted in relation to an Option, it shall be a right in respect of the same number of Shares and shall have the same Option Price as the Option. Where a Stock Appreciation Right is granted on a stand-alone basis, the Board shall designate the number of Shares in respect of which the Stock Appreciation Right is granted and shall designate the Option Price, which shall be not less than the Market Price on the date of grant.


8.2 Stock Appreciation Rights . A Stock Appreciation Right is the right to the excess, if any, of:

 

  (a)

the Market Price of a Share on the date such Stock Appreciation Right is exercised over

 

  (b)

the Option Price

multiplied by the number of Shares in respect of which the Stock Appreciation Right is being exercised, less any amount required to be withheld by applicable law (the “ SAR Amount ”).

8.3 Terms of Stock Appreciation Rights Granted in Connection with an Option . Stock Appreciation Rights granted in relation to an Option shall be exercisable only at the same time, by the same persons and to the same extent, that the related Option is exercisable. Upon exercise of any Stock Appreciation Right related to an Option, the corresponding portion of the related Option shall be surrendered to the Corporation and cancelled. In the sole discretion of the Corporation, the Corporation may elect to satisfy the exercise of a Stock Appreciation Right by issuing to the Participant Shares which have a Market Price as at the date of exercise of the Stock Appreciation Right, equal to the SAR Amount.

8.4 Terms of Stock Appreciation Rights Granted on a Stand Alone Basis . Stock Appreciation Rights granted on a stand-alone basis shall be granted on such terms as shall be determined by the Board and set out in the award agreement, provided that the Option Price shall not be less than the Market Price on the date of grant.

8.5 Exercise of Stand Alone Stock Appreciation Rights . Subject to the provisions of the Plan and award agreement, a Stock Appreciation Right may be exercised from time to time by delivery to the Corporation at its principal office of a written notice of exercise addressed to the Secretary or the Chief Financial Officer of the Corporation. Upon receipt of the notice and subject to the terms of this Plan, the Corporation shall within ten (10) business days pay to the Participant the SAR Amount or issue to the Participant a number of Shares (disregarding fractions) having an aggregate value, based on Market Price at the date of exercise, equal to the SAR Amount or any combination of payment and issuance of Shares.

ARTICLE 9

RESTRICTED SHARE UNITS

9.1 Grants of Restricted Share Units . The Board may grant rights (“ Restricted Share Units ”) to Eligible Persons. The Board shall designate the number of Restricted Share Units granted.

9.2 Restricted Share Units . A Restricted Share Unit is the right to receive one Share issued from treasury for each Restricted Share Unit redeemed or, at the election of the Corporation, a payment equal to the number of Restricted Share Units redeemed, multiplied by the Market Price on the date of vesting or any combination of payment and issuance of Shares. When dividends are paid on the Shares an additional number of Restricted Share Units will be credited to the Participant determined as the amount of the dividend multiplied by the number of Restricted Share Units credited to the Participant at the dividend payment date divided by the Market Price on the dividend payment date.


9.3 Terms of Restricted Share Units . Restricted Share Units shall be granted on such terms as shall be determined by the Board and set out in the award agreement.

9.4 Redemption of Restricted Share Units . Subject to the provisions of the Plan and award agreement, a Restricted Share Unit shall be redeemed and paid (or Shares issued) on, or as soon as practical following, the date the Restricted Share Unit vests, but in any event not later than the earlier of: (i) December 31 of the third year following the year in respect of which they were granted; and (ii) March 15 of the calendar year following the calendar year in which such Restricted Share Units are no longer subject to a substantial risk of forfeiture.

ARTICLE 10

DEFERRED SHARE UNITS

10.1 Grants of Deferred Share Units . The Board may grant rights (“ Deferred Share Units ”) to Eligible Persons, other than Consultants. The Board shall designate the number of Deferred Share Units granted.

10.2 Deferred Share Units . A Deferred Share Unit is the right to receive one Share issued from treasury for each Deferred Share Unit redeemed or, at the election of the Corporation, a payment equal to the number of Deferred Share Units redeemed, multiplied by the Market Price on the date of redemption or any combination of payment and issuance of Shares. When dividends are paid on the Shares an additional number of Deferred Share Units will be credited to the Participant determined as the amount of the dividend multiplied by the number of Deferred Share Units credited to the Participant at the dividend payment date divided by the Market Price on the dividend payment date.

10.3 Terms of Deferred Share Units . Deferred Share Units shall be granted on such terms as shall be determined by the Board and set out in the award agreement.

10.4 Redemption of Deferred Share Units . Subject to the provisions of the Plan and award agreement, a Deferred Share Unit held by a Participant other than a U.S. Participant may be redeemed from time to time by delivery to the Corporation at its principal office of a written notice of redemption addressed to the Secretary or the Chief Financial Officer of the Corporation in a form approved by the Board from time to time, provided that Deferred Share Units may not be redeemed earlier that the date the Participant ceases to hold all positions with the Corporation and may not be redeemed later than December 15 of the year following the year in which the Participant ceased to hold all positions with the Corporation. Upon receipt of the notice and subject to the terms of this Plan, the Deferred Share Unit shall be redeemed.

10.5 Redemption of Deferred Share Units Held by U.S. Participants . Notwithstanding anything to the contrary in this Plan, with respect to any U.S. Participants, all Deferred Share Units shall be redeemed and paid (or Shares issued) within thirty days of such U.S. Participant’s Separation from Service; provided that in the event that a U.S. Participant is a Specified Employee such payment shall be made (or Shares issued) at the time described in Section 0 hereof, provided that notwithstanding Section 0 hereof such payment shall not be made later than the end of the first calendar year commencing after the year in which the Separation from Service occurred. Any cash payment shall be based on the Market Price of a Share on the date of such U.S. Participant’s Separation from Service.


ARTICLE 11

RESTRICTED STOCK

11.1 Grants of Restricted Stock . The Board may grant shares (“ Restricted Stock ”) to Eligible Persons.

11.2 Restricted Stock . Restricted Stock is a Share which vests based on the achievement of performance targets, the passage of time or both.

11.3 Terms of Restricted Stock . Restricted Stock shall be granted on such terms as shall be determined by the Board and set out in the award agreement.

11.4 Lapse of Restrictions . Subject to the provisions of the Plan and award agreement, Restricted Stock may be sold, transferred or otherwise dealt with, only when all restrictions have lapsed.

ARTICLE 12

OTHER AWARDS

12.1 Grants of Other Awards . The Board may grant other share-based awards (“ Other Awards ”) to Eligible Persons. Other Awards shall be granted on such terms as shall be determined by the Board and set out in the award agreement and will be subject to the approval of the TSX.

ARTICLE 13

AMENDMENT PROCEDURE

13.1 Amendment Procedure . The Corporation retains the right to amend or terminate the terms and conditions of the Plan by resolution of the Board. If required, any amendments shall be subject to the prior consent of any applicable regulatory bodies, including the Exchange. Any amendment to the Plan shall take effect with respect to all outstanding Awards on the date of, and all Awards granted after, the effective date of such amendment, provided that in the event any amendment materially and adversely effects any outstanding Options it may apply to such outstanding Awards only with the mutual consent of the Corporation and the Participants to whom such Awards have been granted. The Board shall have the power and authority to approve amendments relating to the Plan or to Awards, without further approval of the shareholders of the Corporation, including the following non-exhaustive list of such amendments:

 

  (a)

altering, extending or accelerating the terms and conditions of vesting of any Awards;

 

  (b)

amending the termination provisions of an Award, which amendment shall include determining that any provisions of 0 concerning the effect of the Participant ceasing to be an Eligible Person shall not apply for any reason acceptable to the Board;

 

  (c)

accelerating the expiry of the Fixed Term of any Option;

 

  (d)

determining adjustments pursuant to 0 hereof;


  (e)

amending the definitions contained within the Plan, including but not limited to the definition of “Eligible Person” under the Plan except as provided in Section (e);

 

  (f)

amending or modifying the mechanics of exercise or redemption of the Awards as set forth in the Plan;

 

  (g)

effecting amendments of a “housekeeping” nature including, without limiting the generality of the foregoing, any amendment for the purpose of curing any ambiguity, error, inconsistency or omission in or from the Plan;

 

  (h)

effecting amendments necessary to comply with the provisions of applicable laws (including, without limitation, the rules, regulations and policies of the Exchange);

 

  (i)

effecting amendments respecting the administration of the Plan;

 

  (j)

effecting amendments necessary to suspend or terminate the Plan;

provided that no amendment shall be made with respect to any Award of a U.S. Participant if such amendment would cause such Award to be subject to tax under Section 409A of the Code.

13.2 Shareholder Approval . Notwithstanding the foregoing, approval of the shareholders of the Corporation shall be required for the following types of amendments:

 

  (a)

increasing the number of Shares issuable under the Plan, except such increase by operation of Section 0 and in the event of an adjustment contemplated by 0;

 

  (b)

amending the Plan which amendment could result in the aggregate number of Shares of the Corporation issued to Insiders within any one (1) year period under the Plan together with any other security-based compensation arrangement, or issuable to Insiders at any time under the Plan together with any other security-based compensation arrangement, exceeding ten percent (10%) of the issued and outstanding Shares;

 

  (c)

extending the Fixed Term of an Option;

 

  (d)

reducing the Option Price of an Option or cancelling an Option and replacing such Option with a lower Option Price under such replacement Option, except as permitted pursuant to 0;

 

  (e)

amending the listed categories contained in the definition of “Eligible Persons” hereunder which would have the potential of broadening or increasing participation in the Plan by Insiders;

 

  (f)

extending the term (fixed or otherwise) of an Option held by an Insider beyond the expiry of the original Fixed Term of the Option;

 

  (g)

amending Section 0 hereof and this Section 0; and


  (h)

making any amendments required to be approved by shareholders under applicable law (including, without limitation, pursuant to the rules, regulations and policies of the Exchange).

Where required by the policies of the Exchange, the shareholder approval required by this Section 0 shall be by the majority vote of the shareholders of the Corporation excluding any votes cast by Insiders who are entitled to participate as Eligible Persons under the Plan or who will specifically benefit from the proposed amendment.

13.3 Conflict . In the event of any conflict between Sections 0 and Section 0, the latter shall prevail to the extent of the conflict.

ARTICLE 14

GENERAL

14.1 No Rights as Shareholder . The holder of an Award, other than Restricted Stock, shall not have any rights as a Shareholder of the Corporation with respect to any Shares covered by such Award until such holder shall have exercised or redeemed such Award and been issued Shares in accordance with the terms of the Plan (including tender of payment in full of the Option Price of the Shares in respect of which an Option is being exercised) and the Corporation shall issue such Shares to the Participant in accordance with the terms of the Plan in those circumstances.

14.2 No Rights Conferred .

Nothing contained in this Plan or any Award shall confer upon any Participant any right with respect continuance as a Director, Officer, Employee, Consultant or Management Company Employee of the Corporation or its Affiliates, or interfere in any way with the right of the Corporation or its Affiliates to terminate the Participant’s employment at any time.

Nothing contained in this Plan or any Award shall confer on any Participant who is not a Director, Officer, Employee, Consultant or Management Company Employee any right to continue providing ongoing services to the Corporation or its Affiliates or affect in any way the right of the Corporation or its Affiliates to determine to terminate his, her or its contract at any time.

14.3 Tax Consequences . It is the responsibility of the Participant to complete and file any tax returns which may be required under any applicable tax laws within the periods specified in those laws as a result of the Participant’s participation in the Plan. The Corporation shall not be responsible for any tax consequences to the Participant as a result of the Participant’s participation in the Plan. The Corporation shall make any withholdings or deductions in respect of taxes as required by law or the interpretation or administration thereof. The Corporation shall be entitled to make arrangements to sell a sufficient number of Shares to be issued pursuant to the exercise of an Award to fund the payment and remittance of such taxes that are required to be deducted or withheld and any associated costs.

14.4 No Representation . The Corporation makes no representation or warranty as to the future market value of any Shares issued in accordance with the provisions of the Plan.

14.5 Governing Law . This Plan shall be governed by and construed in accordance with the laws of the Province of Ontario and the laws of Canada applicable therein.


14.6 Severance . If any provision of this Plan or any agreement entered into pursuant to this Plan contravenes any law or any order, policy, by-law or regulation of any regulatory body or Exchange having authority over the Corporation or this Plan then such provision shall be deemed to be amended to the extent required to bring such provision into compliance therewith.

ARTICLE 15

SHAREHOLDER AND REGULATORY APPROVAL

This Plan shall be subject to the approval of the shareholders of the Corporation to be given by a resolution passed at a meeting of the shareholders of the Corporation, and to acceptance by the Exchange and any other relevant regulatory authority. Any Awards granted hereunder prior to such approval and acceptance shall be conditional upon such approval and acceptance being given, and no such Awards may be exercised unless and until such approval and acceptance is given.


APPENDIX C

Renewal of the Company’s Compensation Plan

“Be it resolved as an ordinary resolution that:

 

  (b)

the Compensation Plan, in the form attached as Appendix B to the Management Information Circular of the Company dated May 10, 2018, is hereby renewed, approved and adopted;

 

  (c)

all unallocated share-based awards under the Compensation Plan be and are hereby approved, and the Company shall have the ability to continue granting share-based awards, including options, under the Compensation Plan until June 14, 2021, the date that is three (3) years from the date on which approval of shareholders of the Company is being sought; and

 

  (d)

any one or more directors or officers of the Company are hereby authorized, for and on behalf of the Company, to take, or cause to be taken, any and all such acts and things and to execute and deliver, under the corporate seal of the Company or otherwise, all such deeds, instruments, notices, consents, acknowledgments, certificates, assurances and other documents (including any documents required under applicable laws or regulatory policies) as any such director or officer in his or her sole discretion may determine to be necessary or desirable to give effect to the foregoing resolution, such determination to be conclusively evidenced by the taking of any such action or such director’s or officer’s execution and delivery of any such deed, instrument, notice, consent, acknowledgement, certificate, assurance or other document.”

Exhibit 99.26

VILLAGE FARMS INTERNATIONAL, INC.

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

NOTICE IS HEREBY GIVEN that the annual and special meeting (the “Meeting”) of the holders (the “Shareholders”) of common shares (the “Common Shares”) of Village Farms International, Inc. (“Village Farms” or the “Company”) will be held at 10:00 a.m., Pacific time, on the 14th day of June, 2018 at Village Farms, 4700 - 80th Street, Delta, British Columbia, V4K 3N3, for the following purposes:

 

  1.

to receive the consolidated financial statements of the Company for the fiscal year ended December 31, 2017 together with the report of the auditors thereon;

 

  2.

to appoint the auditor and authorize the directors of the Company (the “Directors”) to fix the remuneration of the auditor for the ensuing year;

 

  3.

to elect the Directors for the ensuing year;

 

  4.

to consider, and if thought advisable, pass an ordinary resolution to approve the renewal of the Company’s Compensation Plan, as more particularly described in the accompanying management information circular (the “Information Circular”); and

 

  5.

to transact such other business as may properly come before the Meeting or any adjournment or postponement thereof.

The accompanying Information Circular provides additional information relating to the matters to be dealt with at the Meeting and is deemed to form part of this notice. The Board of Directors has fixed May 10, 2018 as the record date for the Meeting (the “Record Date”). Only Shareholders of record at the close of business on the Record Date are entitled to vote at the Meeting or any adjournment or postponement thereof.

DATED at Delta, British Columbia this 10th day of May, 2018.

 

By Order of the Board of Directors
By:   (signed) “John R. McLernon”
  Chairman of the Board of Directors

If you are a Shareholder and you are not able to attend the Meeting in person, please exercise your right to vote either by (a) signing and returning the enclosed form of proxy to Computershare Investor Services Inc. at 100 University Avenue 8th Floor, Toronto, Ontario, M5J 2YI so as to arrive not later than 10:00 a.m., Pacific time, on June 12, 2018 or, if the Meeting is adjourned, 48 hours (excluding Saturdays, Sundays and holidays) prior to the commencement of the reconvened meeting, or (b) completing the request for voting instructions in accordance with the directions provided.

Exhibit 99.27

VILLAGE FARMS INTERNATIONAL ANNOUNCES CAD$10 MILLION PRIVATE PLACEMENT OF COMMON SHARES

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

VANCOUVER, May 18, 2018 /CNW/– Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced that it has agreed to issue, on a private placement basis, 1,886,793 common shares of the Company to certain accredited investors at a price of CAD$5.30 per common share for total gross proceeds of approximately CAD$10,000,000 (the “Offering”). The net proceeds of the Offering will be used, if required, to contribute capital to Pure Sunfarms Corp., the Company’s 50%-owned joint venture for large-scale, low-cost, high quality cannabis production in Canada, as it continues conversion of, and ramps up commercial production at, its 1.1 million square foot Delta 3 greenhouse, as well as for general working capital purposes.

The closing of the Offering is expected to occur on or about May 24, 2018 and is subject to receipt of all regulatory approvals, including the approval of the Toronto Stock Exchange.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”,


“likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2018/18/c7221.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 17:02e 18-MAY-18

Exhibit 99.28

VILLAGE FARMS INTERNATIONAL COMPLETES CAD$10 MILLION PRIVATE PLACEMENT OF COMMON SHARES

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

VANCOUVER, May 24, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced that it has closed its previously announced private placement of 1,886,793 common shares of the Company to certain accredited investors at a price of CAD$5.30 per common share for total gross proceeds of approximately CAD$10,000,000 (the “Offering”). The net proceeds of the Offering will be used, if required, to contribute capital to Pure Sunfarms Corp., the Company’s 50%-owned joint venture for large-scale, low-cost, high quality cannabis production in Canada, as it continues conversion of, and ramps up commercial production at, its 1.1 million square foot Delta 3 greenhouse, as well as for general working capital purposes.

Upon closing of the Offering today, there were 44,372,739 issued and outstanding common shares of the Company.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, and these securities will not be offered or sold in any jurisdiction in which their offer or sale would be unlawful. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “1933 Act”), or any state securities laws of the United States. Accordingly, these securities will not be offered or sold to persons within the United States unless an exemption from the registration requirements of the 1933 Act and applicable state securities laws is available.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or


involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/May2018/24/c2537.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 11:30e 24-MAY-18

Exhibit 99.29

June 14, 2018

TRADING SYMBOL: The Toronto Stock Exchange/OTCQX:

                                         Village Farms International, Inc. – VFF/VFFIF

Village Farms International Announces Election of Directors and Approval of the Renewal of the Company’s Compensation Plan

Vancouver, B.C., June  14, 2018 – Village Farms International, Inc. (the “Company”) (TSX:VFF) (OTC:VFFIF) announced today that all of the director nominees listed in the management information circular dated May 10, 2018 (the “Circular”) were elected as directors of the Company at the annual and special meeting of shareholders held earlier today (the “Meeting”). The results of the vote for each nominee director are set out below:

 

Nominee

   Proxy Votes For      Proxy % For     Proxy Votes
Withheld
     Proxy %
Withheld
 

John R. McLernon

     18,704,239        99.78     41,350        0.22

Christopher C. Woodward

     18,704,229        99.78     41,360        0.22

John P. Henry

     18,677,639        99.64     67,950        0.36

David Holewinski

     18,677,499        99.64     68,090        0.36

Michael A. DeGiglio

     18,715,390        99.84     30,199        0.16

Stephen C. Ruffini

     18,705,635        99.79     39,954        0.21

Roberta Cook

     18,713,444        99.83     32,145        0.17

In addition, the ordinary resolution to approve the renewal of the Company’s Compensation Plan was approved at the Meeting.    

Final voting results of all matters voted on at the Meeting will be made available on SEDAR at www.sedar.com .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in B.C., Ontario and Mexico.

For further information

Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190 ext. 340.

Exhibit 99.30

VILLAGE FARMS INTERNATIONAL, INC.

Report of Voting Results

(Section 11.3 of National Instrument 51-102)

This report describes the matters requiring shareholder approval and the outcome of the shareholder votes at the Annual and Special Meeting of Shareholders of Village Farms International, Inc. (the “ Corporation ”) held in Delta, British Columbia on June 14, 2018 (the “ Meeting ”).

 

Shares voted:

     23,425,034  

Number of shares issued and outstanding (as of the record date):

     42,485,946  

Percentage of shares voted:

     55.14

The following is a summary of the votes cast by the shareholders represented by proxy at the Meeting.

 

   

Appointment of Auditor

PricewaterhouseCoopers LLP was appointed auditor of the Corporation to hold office until the next Annual Meeting of Shareholders and the directors were authorized to fix the auditor’s remuneration.

 

Votes For     % For     Votes Withheld     % Withheld  
  23,268,338       99.33     156,696       0.67

 

   

Election of Directors

The following persons were elected as directors of the Corporation to hold office until the next Annual Meeting of Shareholders or until his or her successor is elected or appointed.

 

Nominee

   Votes For      % For     Votes Withheld      % Withheld
 

John R. McLernon

     18,704,239        99.78     41,350        0.22

Christopher C. Woodward

     18,704,229        99.78     41,360        0.22

John P. Henry

     18,677,639        99.64     67,950        0.36

David Holewinski

     18,677,499        99.64     68,090        0.36

Michael A. DeGiglio

     18,715,390        99.84     30,199        0.16

Stephen C. Ruffini

     18,705,635        99.79     39,954        0.21

Roberta Cook

     18,713,444        99.83     32,145        0.17


   

Approval of the Renewal of the Company’s Compensation Plan

The ordinary resolution to approve the renewal of the Company’s Compensation Plan, as more particularly described in the management information circular of the Corporation dated May 10, 2018 (the “ Circular ”), was approved as follows:

 

Votes For     % For     Votes Against     % Against  
  15,487,025       82.62     3,258,564       17.38

Date: June 14, 2018

VILLAGE FARMS INTERNATIONAL, INC.

 

By:  

“Stephen C. Ruffini”

  Name: Stephen C. Ruffini
  Title: EVP & CFO

Exhibit 99.31

Form 45-102F1

Notice of Intention to Distribute Securities under Section 2.8 of

NI 45-102 Resale of Securities

Reporting issuer

 

1.

Name of reporting issuer: Village Farms International, Inc.

Selling security holder

 

2.

Your name: Michael A. DeGiglio

 

3.

The offices or positions you hold in the reporting issuer: CEO and Director

 

4.

Are you selling securities as a lender, pledgee, mortgagee or other encumbrancer? No

 

5.

Number and class of securities of the reporting issuer you beneficially own: 9,671,649 Common Shares, 400,000 Options and 410,000 Performance Share Units

Distribution

 

6.

Number and class of securities you propose to sell: Up to 250,000 Common Shares

 

7.

Will you sell the securities privately or on an exchange or market? If on an exchange or market, provide the name. Toronto Stock Exchange.

Warning

It is an offence to submit information that, in a material respect and in light of the circumstances in which it is submitted, is misleading or untrue.

Certificate

I certify that

 

  (1)

I have no knowledge of a material fact or material change with respect to the issuer of the securities that has not been generally disclosed; and

 

  (2)

the information given in this form is true and complete.

 

Date June 20, 2018      

Michael A. DeGiglio

Your name (Selling security holder)

                              

Michael A. DeGiglio

Your signature (or if a company, the

signature of your authorized signatory)


INSTRUCTION:

File this form electronically through SEDAR with the securities regulatory authority or regulator in each jurisdiction where you sell securities and with the Canadian exchange on which the securities are listed. If the securities are being sold on an exchange, the form should be filed in every jurisdiction across Canada.

Notice to selling security holders - collection and use of personal information

The personal information required in this form is collected for and used by the listed securities regulatory authorities or regulators to administer and enforce securities legislation in their jurisdictions. This form is publicly available by authority of National Instrument 45-102 and the securities legislation in each of the jurisdictions. The personal information collected will not be used or disclosed other than for the stated purposes without first obtaining your consent. Corporate filers should seek the consent of any individuals whose personal information appears in this form before filing this form.

If you have questions about the collection and use of your personal information, or the personal information of your authorized signatory, contact any of the securities regulatory authorities or regulators listed below.

British Columbia Securities Commission

P.O. Box 10142, Pacific Centre

701 West Georgia Street

Vancouver, BC V7Y 1L2

Attention: Assistant Manager, Financial Reporting

Telephone: (604) 899-6805 or (800) 373-6393 (in B.C.)

Facsimile: (604) 899-6506

Alberta Securities Commission

Suite 600, 250 – 5 th Street SW

Calgary, AB T2P 0R4

Attention: Information Officer

Telephone: (403) 297-6454

Facsimile: (403) 297-6156

Saskatchewan Financial Services Commission

Securities Division

601 - 1919 Saskatchewan Drive

Regina, SK S4P 4H2

Attention: Deputy Director, Legal/Registration

Telephone: (306) 787-5879

Facsimile: (306) 787-5899

 

2


Ontario Securities Commission

20 Queen Street West

22 nd Floor

Toronto, Ontario M5H 3S8

Telephone: (416) 593-8314

Toll free in Canada: 1-877-785-1555

Facsimile: (416) 593-8122

Public official contact regarding collection of personal information:

Inquiries Officer

Autorité des marchés financiers

Tour de la Bourse

800 square Victoria

C.P. 246, 22e étage

Montréal, Québec H4Z 1G3

Attention: Responsable de l’accès à l’information

Telephone : (514) 395-0337

Toll Free : 1-877-525-0337

Facsimile: (514) 873-6155 (For filing purposes only)

Facsimile: (514) 864-6381 (For privacy requests only)

www.lautorite.qc.ca

New Brunswick Securities Commission

85 Charlotte Street, Suite 300

Saint John, New Brunswick E2L 2J2

Telephone: (506) 658-3060

Toll Free in New Brunswick 1-866-933-2222

Facsimile: (506) 658-3059

Nova Scotia Securities Commission

Suite 400, 5251 Duke Street

Halifax, Nova Scotia B3J 1P3

Attention: Corporate Finance

Telephone: (902) 424-7768

Facsimile: (902) 424-4625

Prince Edward Island Securities Office

95 Rochford Street, 4 th Floor Shaw Building

P.O. Box 2000

Charlottetown, Prince Edward Island C1A 7N8

Telephone: (902) 368-4569

Facsimile: (902) 368-5283

 

3


Government of Newfoundland and Labrador

Financial Services Regulation Division

P.O. Box 8700

2nd Floor, West Block

Confederation Building

Prince Philip Drive

St. John’s, NFLD A1B 4J6

Attention: Director of Securities

Telephone: (709) 729-4189

Facsimile: (709) 729-6187

Government of Yukon

Office of the Yukon Superintendent of Securities

Government of Yukon Department of Community Services

307 Black Street, 1 st Floor

PO Box 2703 (C-6)

Whitehorse, Yukon Y1A 2C6

Telephone: (867) 667-5466

Facsimile: (867) 393-6251

http://www.community.gov.yk.ca/corp/securities_about.html

Government of Northwest Territories

Department of Justice

Securities Registry

1st Floor, Stuart M. Hodgson Building

5009 – 49th Street

Yellowknife, Northwest Territories X1A 2L9

Telephone: (867) 920-3318

Facsimile: (867) 873-0243

Department of Justice, Nunavut Legal Registries Division

P.O. Box 1000, Station 570

1st Floor, Brown Building

Iqaluit, NT X0A 0H0

Attention: Director, Legal Registries Division

Telephone: (867) 975-6590

Facsimile: (867) 975-6194

 

4

Exhibit 99.32

Village Farms International Announces Amendment to Pure Sunfarms’ Cultivation License, Substantially Expanding Cannabis Production Area to 225,000 Square Feet

VANCOUVER, June 27, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) and Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada an amendment to its cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to substantially expand its cannabis production to 225,000 square feet of the 1.1-million square foot Delta 3 production facility.

In mid-May, Pure Sunfarms initiated commercial-scale production on 130,000 square feet at the Delta 3 greenhouse, which is now fully utilized, with harvesting expected to begin in August. Planting in the newly-licensed area will commence this week and is expected to be completed by the end of July. Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted to cannabis production by year end.

The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging. The greenhouse is designed to cultivate more than 200,000 cannabis plants concurrently.

“We are thrilled to expand Pure Sunfarms’ production area to 225,000 square feet,” said Michael DeGiglio, Director, Pure Sunfarms and CEO of Village Farms. “Leveraging Village Farms’ deep experience designing greenhouse operations globally for high-value crops, Pure Sunfarms has developed the Delta 3 greenhouse to optimize operating conditions for the highest quality and yield with continuous year-round harvesting. We are not surprised to see our first commercial-scale crop thriving in this environment and remain firmly on track for our production targets in 2018 and beyond.”

“The Delta 3 production facility is maturing at an outstanding pace thanks to our senior cultivation, financial, and operational teams. We are making great strides to achieve large-volume, high-quality, low-cost cannabis production and anticipate receiving our sales license before the onset of recreational sales on October 17th,” said Chris Wagner, Director, Pure Sunfarms, and CEO of Emerald Health Therapeutics. “With the Canadian government’s historic legalization of adult-use cannabis, we are focused on meeting the needs of both medical and recreational consumers in this new era of cannabis regulation.


About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the anticipated legal Canadian adult-use cannabis market starting in 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group , which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual


results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/June2018/27/c7150.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, l awrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 27-JUN-18

Exhibit 99.33

FORM 62-103F1

REQUIRED DISCLOSURE UNDER THE EARLY WARNING REQUIREMENTS

State if the report is filed to amend information disclosed in an earlier report. Indicate the date of the report that is being amended.

Update to Early Warning Report filed on October 20, 2006 by Michael A. DeGiglio.

Item 1 – Security and Reporting Issuer

 

1.1

State the designation of securities to which this report relates and the name and address of the head office of the issuer of the securities.

This report relates to common shares (“Common Shares”) of Village Farms International, Inc. (“Village Farms”).

Village Farms’ address is:

4700 - 80th Street

Delta, British Columbia

V4K 3N3

 

1.2

State the name of the market in which the transaction or other occurrence that triggered the requirement to file this report took place.

Toronto Stock Exchange

Item 2 – Identity of the Acquiror

 

2.1

State the name and address of the acquiror.

Michael A. DeGiglio

c/o Village Farms International, Inc.

4700 - 80th Street

Delta, British Columbia

V4K 3N3

 

2.2

State the date of the transaction or other occurrence that triggered the requirement to file this report and briefly describe the transaction or other occurrence.

On June 28 and 29, 2018, Mr. DeGiglio disposed of 180,000 Common Shares at an average price of $6.37 per Common Share for an aggregate disposition price of $1,146,464 (the “Disposition”).

 

2.3

State the names of any joint actors.

Not applicable.


Item 3 – Interest in Securities of the Reporting Issuer

 

3.1

State the designation and number or principal amount of securities acquired or disposed of that triggered the requirement to file the report and the change in the acquiror’s securityholding percentage in the class of securities.

Mr. DeGiglio disposed of 180,000 Common Shares, representing approximately 0.4% of the issued and outstanding Common Shares.

 

3.2

State whether the acquiror acquired or disposed ownership of, or acquired or ceased to have control over, the securities that triggered the requirement to file the report.

Mr. DeGiglio disposed of ownership and control of 180,000 Common Shares.

 

3.3

If the transaction involved a securities lending arrangement, state that fact.

Not applicable.

 

3.4

State the designation and number or principal amount of securities and the acquiror’s securityholding percentage in the class of securities, immediately before and after the transaction or other occurrence that triggered the requirement to file this report.

Prior to the Disposition, Mr. DeGiglio beneficially owned 9,671,649 Common Shares, representing approximately 21.7% of the issued and outstanding Common Shares.

After the Disposition, Mr. DeGiglio beneficially owns 9,491,649 Common Shares, representing approximately 21.3% of the issued and outstanding Common Shares.

 

3.5

State the designation and number or principal amount of securities and the acquiror’s securityholding percentage in the class of securities referred to in Item 3.4 over which

(a) the acquiror, either alone or together with any joint actors, has ownership and

control,

Mr. DeGiglio has beneficial ownership and control over all of the Common Shares referred to in Item 3.4 above.

(b) the acquiror, either alone or together with any joint actors, has ownership but control is held by persons or companies other than the acquiror or any joint actor, and

Not applicable.

(c) the acquiror, either alone or together with any joint actors, has exclusive or shared control but does not have ownership.

Not applicable.


3.6

If the acquiror or any of its joint actors has an interest in, or right or obligation associated with, a related financial instrument involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the related financial instrument and its impact on the acquiror’s securityholdings.

Not applicable.

 

3.7

If the acquiror or any of its joint actors is a party to a securities lending arrangement involving a security of the class of securities in respect of which disclosure is required under this item, describe the material terms of the arrangement including the duration of the arrangement, the number or principal amount of securities involved and any right to recall the securities or identical securities that have been transferred or lent under the arrangement.

State if the securities lending arrangement is subject to the exception provided in section 5.7 of NI 62-104.

Not applicable.

 

3.8

If the acquiror or any of its joint actors is a party to an agreement, arrangement or understanding that has the effect of altering, directly or indirectly, the acquiror’s economic exposure to the security of the class of securities to which this report relates, describe the material terms of the agreement, arrangement or understanding.

Not applicable.

Item 4 – Consideration Paid

 

4.1

State the value, in Canadian dollars, of any consideration paid or received per security and in total.

The consideration received for the Disposition was $6.37 per Common Share, representing total consideration of $1,146,464.

 

4.2

In the case of a transaction or other occurrence that did not take place on a stock exchange or other market that represents a published market for the securities, including an issuance from treasury, disclose the nature and value, in Canadian dollars, of the consideration paid or received by the acquiror.

Not applicable.

 

4.3

If the securities were acquired or disposed of other than by purchase or sale, describe the method of acquisition or disposition.

Not applicable.


Item 5 – Purpose of the Transaction

State the purpose or purposes of the acquiror and any joint actors for the acquisition or disposition of securities of the reporting issuer. Describe any plans or future intentions which the acquiror and any joint actors may have which relate to or would result in any of the following:

(a) the acquisition of additional securities of the reporting issuer, or the disposition of securities of the reporting issuer;

(b) a corporate transaction, such as a merger, reorganization or liquidation, involving the reporting issuer or any of its subsidiaries;

(c) a sale or transfer of a material amount of the assets of the reporting issuer or any of its subsidiaries;

(d) a change in the board of directors or management of the reporting issuer, including any plans or intentions to change the number or term of directors or to fill any existing vacancy on the board;

(e) a material change in the present capitalization or dividend policy of the reporting issuer;

(f) a material change in the reporting issuer’s business or corporate structure;

(g) a change in the reporting issuer’s charter, bylaws or similar instruments or another action which might impede the acquisition of control of the reporting issuer by any person or company;

(h) a class of securities of the reporting issuer being delisted from, or ceasing to be authorized to be quoted on, a marketplace;

(i) the issuer ceasing to be a reporting issuer in any jurisdiction of Canada;

(j) a solicitation of proxies from securityholders;

(k) an action similar to any of those enumerated above.

The purpose of the Disposition was to monetize a de minimus percentage of Michael DeGiglio’s shareholdings in Village Farms for personal reasons. Following the Disposition, Michael DeGiglio has beneficial ownership of approximately 21.3% of the issued and outstanding Common Shares and has no immediate plans to acquire or dispose of any additional Common Shares. In the future, Michael DeGiglio may from time to time acquire or dispose ownership of, or control or direction over, additional Common Shares for investment purposes.


Item 6 – Agreements, Arrangements, Commitments or Understandings With Respect to Securities of the Reporting Issuer

Describe the material terms of any agreements, arrangements, commitments or understandings between the acquiror and a joint actor and among those persons and any person with respect to securities of the class of securities to which this report relates, including but not limited to the transfer or the voting of any of the securities, finder’s fees, joint ventures, loan or option arrangements, guarantees of profits, division of profits or loss, or the giving or withholding of proxies. Include such information for any of the securities that are pledged or otherwise subject to a contingency, the occurrence of which would give another person voting power or investment power over such securities, except that disclosure of standard default and similar provisions contained in loan agreements need not be included.

Not applicable.

Item 7 – Change in Material Fact

If applicable, describe any change in a material fact set out in a previous report filed by the acquiror under the early warning requirements or Part 4 in respect of the reporting issuer’s securities.

Not applicable.

Item 8 – Exemption

If the acquiror relies on an exemption from requirements in securities legislation applicable to formal bids for the transaction, state the exemption being relied on and describe the facts supporting that reliance.

Not applicable.

Item 9 – Certification

Certificate

I, as the acquiror, certify, or I, as the agent filing the report on behalf of an acquiror, certify to the best of my knowledge, information and belief, that the statements made in this report are true and complete in every respect.

Date June 29, 2018

 

“Michael A. DeGiglio”
Signature
Michael A. DeGiglio
Name/Title

Exhibit 99.34

Michael DeGiglio Disposes of 180,000 Common Shares of Village Farms International, Inc.

Early Warning Press Release

TORONTO, June 29, 2018 /CNW/—Michael A. DeGiglio (the Chief Executive Officer and a director of Village Farms International, Inc. (“Village Farms”) (TSX:VFF) (OTC:VFFIF)), yesterday and today sold 180,000 common shares of Village Farms (“Common Shares”) through the facilities of the Toronto Stock Exchange at an average price of $6.37 per Common Share, for an aggregate disposition price of $1,146,464 (the “ Disposition ”).

Following the Disposition, Mr. DeGiglio beneficially owns approximately 21.3% of the issued and outstanding Common Shares. Mr. DeGiglio also holds fully vested options for a total of 366,667 Village Farms Common Shares. Prior to the Disposition, Mr. DeGiglio held beneficial ownership of approximately 21.7% of the issued and outstanding Common Shares. Mr. DeGiglio disposed of the Common Shares in order to monetize a de minimus percentage of his shareholdings in Village Farms for personal reasons, including his intention to provide seed funding for a proposed charitable foundation. Mr. DeGiglio has no other immediate plans to acquire or dispose of any additional Common Shares. In the future, Mr. DeGiglio may from time to time acquire or dispose ownership of, or control or direction over, additional Common Shares for investment purposes.

This press release is being issued pursuant to the requirements of National Instrument 62-103 - The Early Warning System and Related Take-Over Bid and Insider Reporting Issues of the Canadian Securities Administrators. An early warning report with additional information in respect of the foregoing matter will be filed and available on the SEDAR profile of Village Farms at www.sedar.com. To obtain a copy of the early warning report, you may contact Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., at (407) 936-1190, ext. 340.

Village Farms’ head office is located at 4700 - 80th Street, Delta, British Columbia, V4K 3N3.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/June 2018/29/c2763.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936- 1190,ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 17:08e 29-JUN-18

Exhibit 99.35

Village Farms International’s Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse

— Pure Sunfarms’ Delta 3 Greenhouse Facility Becomes One of the Largest Canadian Cannabis Growing Operations Licensed to Sell Product, With Significant Production and Sales Ramp Expected Through 2018 and Beyond —

VANCOUVER, July 30, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) and Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, has received its cannabis sales license from Health Canada. Pure Sunfarms is now permitted to immediately begin selling product from its expanding inventory of high-quality dried cannabis, including to Emerald Health Therapeutics, under their previously announced supply agreement, as well as to address significant demand from other licensed producers. This sales license also positions Pure Sunfarms to secure supply agreements with provincial government distributors for the imminent legal adult-use marketplace.

“Pure Sunfarms continues to achieve its milestones on or ahead of schedule, and has transformed the Delta 3 facility from growing and selling tomatoes to growing and selling cannabis in just seven months,” said Michael DeGiglio, CEO, Village Farms. “Pure Sunfarms’ near-term objective is to maximize the profitability of its expanding production capacity during what is expected to be an initial period of short supply when adult cannabis use becomes legal in Canada on October 17, 2018. Pure Sunfarms will become a vertically integrated supplier and, with this sales license in place, will aggressively move forward with its product development and branding strategies.”

“Pure Sunfarms is moving at remarkable speed to become a significant cannabis supplier and, with our high operational quality standards, we achieved a very rapid turnaround on this license. We greatly appreciate Health Canada’s timely responses to all of our submissions,” said Chris Wagner, CEO, Emerald Health Therapeutics. “With access to established wholesale and provincial agreements and the prospect of similar additional agreements in the near-term, Pure Sunfarms is well prepared for a rapid sales ramp-up in the coming quarters. This will drive value for both Village Farms and Emerald, as joint venture partners.”

Pure Sunfarms initiated commercial-scale cannabis production in May of this year and is currently utilizing 225,000 square feet of its 1.1-million square foot Delta 3 greenhouse facility in Delta, BC, with the expectation that the full 1.1 million square feet will be converted for cannabis production by the end of 2018, on schedule and on budget. Upon completion of the conversion, Pure Sunfarms’ Delta 3 facility will be one of the single largest cannabis growing facilities in the world.


About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is a Licensed Producer under Canada’s Access to Cannabis for Medical Purposes Regulations and produces and sells dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot (25 acres) greenhouse in Delta, BC, and is in commercial production. It also wholly owns Agro-Biotech, a Montreal-based licensed cannabis grower with a 75,000 square foot indoor facility, and is planning to add a 500,000 square foot wholly owned greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group , which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that provide wellness and medical benefits to people through interacting with the human body’s endocannabinoid system.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or


implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/July2018/30/c6404.html

%SEDAR: 00029410E

For further information: Contact Information: Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 30-JUL-18

Exhibit 99.36

Village Farms International to Host Second Quarter 2018 Conference Call on Wednesday, August 15, 2018 at 11:00 a.m. ET (8:00 a.m. PT)

VANCOUVER, August  8, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTC: VFFIF) today announced it will host a conference call to discuss its second quarter 2018 financial results, as well as provide an update on its cannabis joint venture, Pure Sunfarms, on Wednesday, August  15, 2018 at 11:00 a.m. ET (8:00 a.m. PT) . Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2ALoIA0 .

The Company expects to report its second quarter 2018 financial results via news release after markets close on Tuesday, August 14, 2018.

Conference Call Archive Access Information

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 4590879 followed by the pound key. The telephone replay will be available until Wednesday, August 22, 2018 at midnight (ET). The conference call will also be archived on Village Farm’s web site at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/August2018/08/c6395.html

%SEDAR: 00029410E

For further information: Lawrence Chamberlain, Investor Relations, LodeRock Advisors, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 08-AUG-18

Exhibit 99.37

VILLAGE FARMS INTERNATIONAL REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS RAPIDLY EXPANDING CANNABIS PRODUCTION

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

VANCOUVER, August 14, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced its financial results for the second quarter ended June 30, 2018.

(All amounts in U.S. Dollars unless otherwise indicated.)

Highlights for the Second Quarter Ended June 30, 2018

(All comparable figures are for the second quarter ended June 30, 2017)

 

   

Sales of US$42.0 million, a decrease of (8%) from US$45.5 million;

 

   

Net loss was US($2.3) million, or US($0.05) per share, compared with net income of US$4.3 million, or US$0.11 per share;

 

   

EBITDA of US($1.3) million, compared with US$1.3 million,

 

   

Closed a private placement of 1,886,793 common shares of the Company at a price of CAD$5.30 per common share for total gross proceeds of approximately CAD$10,000,000, the net proceeds of which will be used to contribute capital to Pure Sunfarms Corp., the Company’s 50% owned joint venture for large-scale, low-cost, high quality cannabis production in Canada, as it continues conversion of, and ramps up commercial production at, its 1.1 million square foot Delta 3 greenhouse, as well as for general working capital purposes; and,

 

   

Extended its exclusive produce distribution agreement with Leamington, Ontario-based Great Northern Hydroponics, for an additional three years.

Highlights for Village Farms’ Cannabis Joint Venture, Pure Sunfarms

 

   

Since May of this year, Pure Sunfarms has received from Health Canada two successive amendments to the cultivation license for its Delta 3 greenhouse, enabling it to expand its cannabis production area to 225,000 square feet of the 1.1-million square foot facility. The entire 225,000 square feet is in production and Pure Sunfarms expects to have the entire 1.1 million square foot Delta 3 facility converted for cannabis production by the end of this year, with the majority of that in production, and to be in production on the entire 1.1 million square feet in the first quarter of 2019.

 

   

On July 30, 2018, Pure Sunfarms received its cannabis sales license from Health Canada, permitting it to immediately begin selling product from its expanding inventory of high-quality dried cannabis, The sales license positions Pure Sunfarms to secure additional supply agreements with other licensed producers, as well as with provincial government distributors for the imminent legal adult-use marketplace. Pure Sunfarms has since completed its first sale of cannabis.

“Less than 12 months after submitting its application for a cultivation license, Pure Sunfarms is growing, harvesting, and, now, selling high-quality cannabis, as demand for product increases ahead of imminent adult-use legalization on October 17,” said Michael DeGiglio, CEO, Village Farms. “Pure Sunfarms has completed multiple harvests and both quality and yield are exceeding expectations. The Delta 3 greenhouse, optimized for


efficient, continual year-round production, is operating as designed. Everyday, the operation is benefitting from the deep experience of the growing team, the existing skilled labour force and the specific knowledge and advantage that comes with having operated this large-scale greenhouse for two decades. With each new flower room planted out, with each harvest, I am more confident in Pure Sunfarms’ ability to become a premier, vertically integrated supplier to the Canadian cannabis market, with the advantage of being the low-cost producer.”

Mr. DeGiglio added, “Pure Sunfarms is on firmly track to begin generating positive cash flow for Village Farms as early as the first quarter of 2019. We are proud to be able to drive what we believe will be meaningful, long-term value for our shareholders with minimal capital investment, minimal dilution and using only our existing internal management team and staff at Village Farms to support our investment.”

Mr. DeGiglio added, “In our incumbent produce business, as expected we saw lower production volumes, as we have not yet fully replaced the capacity from the transfer of the Delta 3 facility to Pure Sunfarms due to the transition of new Mexican partner grower who is continuously expanding their acreage through 2020. Our 2018 U.S. production is lower than 2018 due to several factors, including planned maintenance at our Monahans facility, record temperatures in Texas, and weather-related damage to a portion of one of our facilities. Profitability this year continues to be impacted by significantly higher freight costs of $0.8m, as the entire U.S. economy struggles with limited trucking capacity in the wake of new regulations. Our produce business continues to focus on maximizing margins through exclusive, higher-margin varieties and low-cost production as we provide the highest quality and safest produce to the leading grocers across the U.S. and Canada. I am very pleased that we have extended our exclusive distribution agreement with Great Northern Hydroponics, an Ontario-based, world-class grower of premium produce, for another three years.”    

Financial Summary

(in thousands of U.S. Dollars unless otherwise indicated)

 

     For the three months
ended June 30,
     For the six months
ended June 30,
 
     2018      2017      2018      2017  

Sales

   $ 42,039      $ 45,530      $ 71,529      $ 76,807  

Cost of sales

     (41,150      (42,805      (67,053      (70,125

Selling, general and administrative expenses

     (3,688      (3,425      (7,045      (6,608

Stock compensation expense

     (138      (428      (256      (469

Change in biological asset (1)

     856        (701      197        (1,346

(Loss) income from operations

     (2,081      (1,829      (2,628      (1,741

Interest expense, net

     691        695        1,289        1,327  

Other income

     (5      (28      (30      (40

Gain on sale of assets

     —          8,572        —          8,564  

Share of (loss) from joint venture

     (104      —          (341      —    

(Recovery of) provision for income taxes

     (589      1,751        (802      1,401  

Net (loss) income

     (2,282      4,325        (3,426      4,135  

EBITDA (2)

     (1,316      1,264        496        4,015  

(Loss) earnings per share – basic

   ($ 0.05    $ 0.11      ($ 0.08    $ 0.11  

(Loss) earnings per share –diluted

   ($ 0.05    $ 0.11      ($ 0.08    $ 0.10  

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s annual consolidated financial statements for the three and six months ended June 30, 2018.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.


Second Quarter 2018 Operational Discussion:

(in thousands of U.S. Dollars unless otherwise indicated)

Sales

Sales for the three months ended June 30, 2018 decreased by ($3,491), or (8%), to $42,039 from $45,530 for the three months ended June 30, 2017. The decrease in sales is primarily due to a decrease in production from the Company’s facilities of (13%), of which (8%) is due to the contribution of the Delta 3 greenhouse to Pure Sunfarms. The Company’s Texas facilities produced (8%) less tomatoes, partially offset by and an increase from the remaining two Delta facilities for the three months ended June 30, 2018 versus the same period in 2017.

The average selling price for tomatoes increased 1% for the three months ended June 30, 2018 versus the three months ended June 30, 2017. Cucumber pricing decreased by (6%) and pepper pricing increased by 4% in the second quarter of 2018 versus the comparable quarter in 2017.

Cost of Sales

Cost of sales for the three months ended June 30, 2018 decreased by ($1,655), or (4%), to $41,150 from $42,805 for the three months ended June 30, 2017; primarily due a decrease from the Delta 3 facility ($1,524) and a decrease of ($970) in contract sales cost, due to decreased cucumber volumes, partially offset by an increase in freight expense of $571 and labor costs at the Company’s facilities due to a shortage of labor at the Company’s Texas facilities due to increase economic activity in the Permian Basin and another increase in the B.C. minimum wage in 2018.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended June 30, 2018 increased by $263, or 8%, to $3,688 from $3,425 for the three months ended June 30, 2017. The increase is due to public company costs such as investor relations, legal and listing fees.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended June 30, 2018 increased by $1,557 to a gain of $856 from a loss of ($701) for the three months ended June 30, 2017. The increase in the change in value is primarily due to a higher average selling price of the biological asset in July 2018 versus the same period in 2017. The fair value of the biological asset as at June 30, 2018 was $6,920 as compared to $6,756 as at June 30, 2017 due to higher selling prices in July 2018 versus July 2017.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the three months ended June 30, 2018 was ($104), which consists of salaries and other administrative costs, offset by the Company’s share of the JV’s biological asset of $161, as the joint venture had buds on the plant and dried bud in inventory on June 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on plant and in inventory on June 30, 2018.


Gain on Sale of Assets

No gains were recognized in 2018. The Company recognized for the three month period ended June 30, 2017 a gain of $8,572 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms Corp. in exchange for a 50% equity stake in the corporation.

(Recovery of) Provision for Income Taxes

Income tax recovery for the three month period ended June 30, 2018 was ($589) compared to an income tax provision of $1,751 for the three month period ended June 30, 2017. The change is primarily due to a gain of $8,572 recognized on the contribution of one of the Company’s Delta greenhouse facilities in exchange for its 50% equity interest in Pure Sunfarms 2017.

Net (Loss) Income

Net loss for the three months ended June 30, 2018 was ($2,282) compared to net income of $4,325 for the three months ended June 30, 2017 primarily as a result of the gain recognized in the second quarter of 2017 on the contribution of the Delta 3 facility of $8,572, offset by the gain on the change in biological asset an increase in recovery of income taxes during the second quarter of 2018.

EBITDA

EBITDA for the three months ended June 30, 2018 decreased by ($2,580), to ($1,316) from $1,264 for the three months ended June 30, 2017, primarily as a result of a decrease in sales caused by production shortfalls in Texas, share of loss from Pure Sunfarms and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures - Reconciliation of Net Income to EBITDA”.

Non-IFRS Measures

References in this press release to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized change in biological asset, stock compensation, share of loss from joint venture, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income (loss) to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months
ended June 30,
     For the six months
ended June 30,
 
     2018      2017      2018      2017  

Net (loss) income

   ($ 2,282    $ 4,325      ($ 3,426    $ 4,135  

Add:

           

Amortization

     1,722        1,949        3,523        3,900  

Foreign currency exchange loss (gain)

     21        (13      14        1  

Interest expense

     691        695        1,289        1,327  

Income taxes (recovery)

     (589      1,751        (802      1,401  

Stock based compensation

     138        428        256        469  

Change in biological asset

     (856      701        (197      1,346  

Change in biological asset in JV

     (161      —          (161      —    

Gain on disposal of assets

     —          (8,572      —          (8,564
  

 

 

    

 

 

    

 

 

    

 

 

 

EBITDA

   ($ 1,316    $ 1,264        496        4,015  


Conference Call

Village Farms’ management team will host a conference call tomorrow, Wednesday, August 15, 2018, at 11:00 a.m. ET (8:00 a.m. PT) to discuss its second quarter 2018 financial results and provide an update on Pure Sunfarms. Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at http://bit.ly/2ALoIA0 .

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 4590879 followed by the pound key. The telephone replay will be available until                     Wednesday, August 22, 2018 at midnight (ET). The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario and Mexico.

Cautionary Language

Certain statements contained in this press release form constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign


exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt on reasonable terms when required.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

(Unaudited)

 

     June 30, 2018     December 31, 2017  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 12,933     $ 7,091  

Trade receivables

     14,470       11,259  

Other receivables

     1,879       1,982  

Inventories

     18,567       17,309  

Income taxes receivable

     246       246  

Prepaid expenses and deposits

     1,031       564  

Biological asset

     6,920       4,405  
  

 

 

   

 

 

 

Total current assets

     56,046       42,856  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment

     79,516       81,754  

Investment in joint venture

     15,386       15,727  

Other assets

     1,996       2,004  
  

 

 

   

 

 

 

Total assets

   $  152,944     $  142,341  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 10,780     $ 12,952  

Accrued liabilities

     6,656       3,793  

Line of credit

     7,000       —    

Current maturities of long-term debt

     3,440       2,620  

Current maturities of capital lease obligations

     57       72  
  

 

 

   

 

 

 

Total current liabilities

     27,933       19,437  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt

     34,203       35,760  

Long-term maturities of capital lease obligations

     160       179  

Deferred tax liability

     4,006       4,825  

Deferred compensation

     1,100       1,097  
  

 

 

   

 

 

 

Total liabilities

     67,402       61,298  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     44,133       36,115  

Contributed surplus

     1,982       1,726  

Revaluation surplus

     4,321       4,321  

Accumulated other comprehensive loss

     (480     (391

Retained earnings

     35,586       39,272  
  

 

 

   

 

 

 

Total shareholders’ equity

     85,542       81,043  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 152,944     $ 142,341  
  

 

 

   

 

 

 


Village Farms International, Inc.

Condensed Consolidated Interim Statements of (Loss) Income and Comprehensive Income

For the Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share data)

(Unaudited)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2018     2017     2018     2017  

Sales

   $ 42,039     $ 45,530     $ 71,529     $ 76,807  

Cost of sales

     (41,150     (42,805     (67,053     (70,125

Change in biological asset

     856       (701     197       (1,346

Selling, general and administrative expenses

     (3,688     (3,425     (7,045     (6,608

Stock compensation expense

     (138     (428     (256     (469
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (2,081     (1,829     (2,628     (1,741

Interest expense

     691       695       1,289       1,327  

Foreign exchange loss (gain)

     21       (13     14       1  

Other income

     (26     (15     (44     (41

Share of loss from joint venture

     104       —         341       —    

Gain on sale of assets

     —         (8,572     —         (8,564
  

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income taxes

     (2,871     6,076       (4,228     5,536  

(Recovery of) provision for income taxes

     (589     1,751       (802     1,401  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

   $ (2,282   $ 4,325     $ (3,426   $ 4,135  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic (loss) income per share

   $ (0.05   $ 0.11     $ (0.08   $ 0.11  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (loss) income per share

   $ (0.05   $ 0.11     $ (0.08   $ 0.10  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss) income:

        

Foreign currency translation adjustment

     (34     60       (89     73  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss) income

   $ (2,316   $ 4,385     $ (3,515   $ 4,208  
  

 

 

   

 

 

   

 

 

   

 

 

 


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

For the Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars)

(Unaudited)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2018     2017     2017     2016  

Cash flows used in operating activities:

        

Net loss

   $  (2,282   $ 4,325     $  (3,426   $ 4,135  

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation and amortization

     1,722       1,949       3,523       3,900  

Amortization of deferred charges

     —         18       —         36  

Loss on sale of assets

     —         (8,572     —         (8,564

Share of loss from joint venture

     104       —         341       —    

Interest paid

     691       670       1,289       1,280  

Share-based compensation

     138       428       256       469  

Deferred income taxes

     (604     1,751       (819     1,401  

Change in biological asset

     (856     701       (197     1,346  

Changes in non-cash working capital items

     932       1,269       (6,458     (6,077
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (155     2,539       (5,491     (2,074
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows used in investing activities:

        

Purchases of property, plant and equipment

     (1,092     (562     (1,440     (993
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (1,092     (562     (1,440     (993
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by financing activities:

        

Proceeds from borrowings

     4,000       1,000       7,000       6,000  

Repayments on borrowings

     (840     (818     (917     (1,656

Interest paid on long-term debt

     (691     (670     (1,289     (1,280

Proceeds from issuance of common stock pursuant to private placement, net

     7,755       —         7,755       —    

Proceeds from exercise of stock options

     94       26       263       26  

Payments on capital lease obligations

     (17     (9     (34     (22
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     10,301       (471     12,778       3,068  
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     10       3       (5     4  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     9,064       1,509       5,842       5  

Cash and cash equivalents, beginning of year

     3,869       3,869       7,091       5,373  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $  12,933     $ 5,378     $  12,933     $ 5,378  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

        

Income taxes paid

   $ —       $ 286     $ —       $ 1,148  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of non-cash information:

        

Purchases of capital expenditures by financing capital lease

   $ —       $ 126     $ —       $ 126  
  

 

 

   

 

 

   

 

 

   

 

 

 

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/August2018/14/c8635.html

%SEDAR: 00029410E

For further information : Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 18:28e 14-AUG-18

Exhibit 99.38

Form 52-109F2

Certification of Interim Filings - Full Certificate

I, Michael A. DeGiglio, the Chief Executive Officer of Village Farms International, Inc., certify the following:

 

  1.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended June 30, 2018.

 

  2.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  3.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  4.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  5.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

5.2: N/A

5.3 N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on April 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: August 14, 2018

         “Michael A. DeGiglio”

Michael A. DeGiglio,
Chief Executive Officer
Village Farms International, Inc.

Exhibit 99.39

Form 52-109F2

Certification of Interim Filings - Full Certificate

I, Stephen C. Ruffini, the Chief Financial Officer of Village Farms International, Inc., certify the following:

 

  1.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended June 30, 2018.

 

  2.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  3.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  4.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  5.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

5.2: N/A

5.3 N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on April 1, 2018 and ended on June 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

 

Date: August 14, 2018

        “Stephen C. Ruffini”

Stephen C. Ruffini,
Chief Financial Officer
Village Farms International, Inc.

Exhibit 99.40

Village Farms International, Inc.

Condensed Consolidated Interim Financial Statements

Three and Six Months Ended June 30, 2018 and 2017

(Unaudited)


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

(Unaudited)

 

     June 30, 2018     December 31, 2017  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 12,933     $ 7,091  

Trade receivables

     14,470       11,259  

Other receivables

     1,879       1,982  

Inventories

     18,567       17,309  

Income taxes receivable

     246       246  

Prepaid expenses and deposits

     1,031       564  

Biological asset

     6,920       4,405  
  

 

 

   

 

 

 

Total current assets

     56,046       42,856  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment

     79,516       81,754  

Investment in joint venture

     15,386       15,727  

Other assets

     1,996       2,004  
  

 

 

   

 

 

 

Total assets

   $  152,944     $  142,341  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 10,780     $ 12,952  

Accrued liabilities

     6,656       3,793  

Line of credit

     7,000        

Current maturities of long-term debt

     3,440       2,620  

Current maturities of capital lease obligations

     57       72  
  

 

 

   

 

 

 

Total current liabilities

     27,933       19,437  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt

     34,203       35,760  

Long-term maturities of capital lease obligations

     160       179  

Deferred tax liability

     4,006       4,825  

Deferred compensation

     1,100       1,097  
  

 

 

   

 

 

 

Total liabilities

     67,402       61,298  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     44,133       36,115  

Contributed surplus

     1,982       1,726  

Revaluation surplus

     4,321       4,321  

Accumulated other comprehensive loss

     (480     (391

Retained earnings

     35,586       39,272  
  

 

 

   

 

 

 

Total shareholders’ equity

     85,542       81,043  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $ 152,944     $ 142,341  
  

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

2


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity

For the Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

     Number of
Common
Shares
     Share
Capital
     Contributed
Surplus
     Revaluation
Surplus
    Accumulated Other
Comprehensive
Loss
    Retained
Earnings
    Total
Shareholders’
Equity
 

Balance at January 1, 2017

     38,882,945      $ 24,954      $ 1,392      $ 6,132     $ (541   $ 35,450       67,387  

Shares issued on exercise of stock options (note 17)

     33,334        26        —          —         —         —         26  

Issuance of common stock shares

     230,000        —          —          —         —         —         —    

Issuance of warrants for common shares

     —          —          148        —         —         —         148  

Share-based compensation (note 17)

     —          398        71        —         —         —         469  

Cumulative translation adjustment

     —          —          —          —         73       —         73  

Reclassification of previously recorded revaluation gain of land, net of tax (note 6)

     —          —          —          (1,811     —         —         (1,811

Net income

     —          —          —          —         —         4,135       4,135  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at June 30, 2017

     39,146,279        25,378        1,611        4,321       (468     39,585       70,427  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at January 1, 2018 (restated—note 3)

     42,242,612        36,115        1,726        4,321       (391     39,012       80,783  

Shares issued on exercise of stock options (note 17)

     342,733        263        —          —         —         —         263  

Shares issued pursuant to private placement of common stock shares, net of issuance costs

     1,886,793        7,755        —          —         —         —         7,755  

Share-based compensation (note 17)

     —          —          256        —         —         —         256  

Cumulative translation adjustment

     —          —          —          —         (89     —         (89

Net loss

     —          —          —          —         —         (3,426     (3,426
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at June 30, 2017

     44,472,138      $  44,133      $ 1,982      $ 4,321     $ (480   $ 35,586     $  85,542  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3


Village Farms International, Inc.

Condensed Consolidated Interim Statements of (Loss) Income and Comprehensive Income

For the Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share data)

(Unaudited)

 

     Three Months Ended June 30,     Six Months Ended June 30,  
     2018     2017     2018     2017  

Sales

   $ 42,039     $ 45,530     $ 71,529     $ 76,807  

Cost of sales

     (41,150     (42,805     (67,053     (70,125

Change in biological asset

     856       (701     197       (1,346

Selling, general and administrative expenses

     (3,688     (3,425     (7,045     (6,608

Stock compensation expense

     (138     (428     (256     (469
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (2,081     (1,829     (2,628     (1,741

Interest expense

     691       695       1,289       1,327  

Foreign exchange loss (gain)

     21       (13     14       1  

Other income

     (26     (15     (44     (41

Share of loss from joint venture

     104       —         341       —    

Gain on sale of assets

     —         (8,572     —         (8,564
  

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income taxes

     (2,871     6,076       (4,228     5,536  

(Recovery of) provision for income taxes

     (589     1,751       (802     1,401  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

   $  (2,282   $ 4,325     $  (3,426   $ 4,135  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic (loss) income per share

   $ (0.05   $ 0.11     $ (0.08   $ 0.11  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (loss) income per share

   $ (0.05   $ 0.11     $ (0.08   $ 0.10  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss) income:

        

Foreign currency translation adjustment

     (34     60       (89     73  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss) income

   $ (2,316   $ 4,385     $ (3,515   $ 4,208  
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

For the Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars)

(Unaudited)

 

     Three Months Ended March 31,     Three Months Ended December 31,  
     2018     2017     2017     2016  

Cash flows used in operating activities:

        

Net loss

   $  (2,282   $ 4,325     $  (3,426   $ 4,135  

Adjustments to reconcile net loss to net cash used in operating activities:

        

Depreciation and amortization

     1,722       1,949       3,523       3,900  

Amortization of deferred charges

     —         18       —         36  

Loss on sale of assets

     —         (8,572     —         (8,564

Share of loss from joint venture

     104       —         341       —    

Interest paid

     691       670       1,289       1,280  

Share-based compensation

     138       428       256       469  

Deferred income taxes

     (604     1,751       (819     1,401  

Change in biological asset

     (856     701       (197     1,346  

Changes in non-cash working capital items

     932       1,269       (6,458     (6,077
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in operating activities

     (155     2,539       (5,491     (2,074
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows used in investing activities:

        

Purchases of property, plant and equipment

     (1,092     (562     (1,440     (993
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (1,092     (562     (1,440     (993
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by financing activities:

        

Proceeds from borrowings

     4,000       1,000       7,000       6,000  

Repayments on borrowings

     (840     (818     (917     (1,656

Interest paid on long-term debt

     (691     (670     (1,289     (1,280

Proceeds from issuance of common stock pursuant to private placement, net

     7,755       —         7,755       —    

Proceeds from exercise of stock options

     94       26       263       26  

Payments on capital lease obligations

     (17     (9     (34     (22
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by financing activities

     10,301       (471     12,778       3,068  
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     10       3       (5     4  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     9,064       1,509       5,842       5  

Cash and cash equivalents, beginning of year

     3,869       3,869       7,091       5,373  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of year

   $  12,933     $ 5,378     $  12,933     $ 5,378  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

        

Income taxes paid

   $ —       $ 286     $ —       $ 1,148  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of non-cash information:

        

Purchases of capital expenditures by financing capital lease

   $ —       $ 126     $ —       $ 126  
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

1

NATURE OF OPERATIONS

Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act . VFF’s principal operating subsidiaries as at June 30, 2018 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc (“VFCE”). The address of the registered office of VFF is 4700 80 th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), which is recorded as Investment in Joint Venture (note 7).

The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also traded in the United States on the OTCQX ® Best Market under the symbol VFFIF.

The Company, through its subsidiaries VFCLP and VFLP, owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. In addition, the Company’s joint venture, Pure Sunfarms, is in the start up stage of becoming a producer and supplier of cannabis products to be sold to wholesalers, distributors and retailers across Canada and internationally.

 

2

BASIS OF PRESENTATION

Statement of Compliance

The Company’s unaudited condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) and its interpretations, as issued by the International Accounting Standards Board (“IASB”). These condensed consolidated interim financial statements are prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting . They do not include all of the information required for full annual financial statement disclosures, and should be read in conjunction with the Company’s audited annual consolidated financial statements for the year ended December 31, 2017, which were prepared in accordance with IFRS.

Basis of Presentation

The condensed consolidated interim financial statements are prepared on a going concern basis. The accounting policies have been applied consistently in all material respects. These condensed consolidated interim financial statements have been prepared by applying the same accounting policies, assessments of estimates and judgments, and methods of computation as compared with the most recent annual consolidated financial statements.

Basis of Measurement

The condensed consolidated interim financial statements (“interim financial statements”) have been prepared on the historical cost basis except for the following material items in the condensed consolidated interim statement of financial position (“interim statement of financial position”):

 

   

biological assets are measured at fair value less costs to sell;

 

   

land is valued at fair market value; and

 

   

available-for-sale financial assets are measured at fair value.

Functional and Presentation Currency

These condensed consolidated interim financial statements are presented in United States dollars (“U.S. dollars”), which is the Company’s primary functional currency. VFCE’s functional currency is Canadian dollars and conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates . All financial information presented in U.S. dollars has been rounded to the nearest thousands, except per share amounts.

 

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

3

CHANGES IN ACCOUNTING POLICIES

The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2018. These changes were made in accordance with the applicable transitional provisions.

IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in de-recognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.

Following the adoption of IFRS 9, the Company could no longer defer and amortize financing fees that resulted from the refinancing of borrowings in periods prior to January 1, 2018. As a result, the Company has restated the beginning balances noted in the table below to properly account for $260 of financing fees in accordance with IFRS 9. The standard was applied retrospectively therefore approximately $260 of deferred financing costs, net of accumulated amortization, remain netted against long-term debt on the consolidated statement of financial position, as at December 31, 2017.

The following tables show the adjustments recognized for each individual line item. Line items that were not affected by the changes have not been included. As a result, the sub-totals and totals disclosed cannot be recalculated from the numbers provided.

 

     December 31, 2017
As originally
presented
     IFRS 9
Adjustments
     January 1, 2018
Restated
 

Statement of Financial Position (extract)

        

Non-current liabilities

        

Long-term debt

   $  35,760      $ 260      $  36,020  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     61,298        260        61,558  
  

 

 

    

 

 

    

 

 

 

Shareholders’ Equity

        

Retained earnings

     39,272        (260      39,012  
  

 

 

    

 

 

    

 

 

 

Total shareholders’ equity

   $ 81,043        (260    $ 80,783  
  

 

 

    

 

 

    

 

 

 

Statements of Income (Loss) and Comprehensive Income (extract)

        

Interest expense

   $ 2,695      $ 260      $ 2,955  
  

 

 

    

 

 

    

 

 

 

Income (loss) before income taxes

     3,960        (260      3,700  

Provision for income taxes

     138        —          138  
  

 

 

    

 

 

    

 

 

 

Net income (loss)

   $ 3,822      $ (260    $ 3,562  
  

 

 

    

 

 

    

 

 

 

Basic income (loss) per share

   $ 0.10      $ (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

Diluted income (loss) per share

   $ 0.10      $ (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.

The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders it receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and its performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.

The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three and six months ended June 30, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.

Accounting Standards Issued and Not Applied

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the Company also applies IFRS 15. Management is currently assessing the impact on the Company’s interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated statement of financial position date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.

 

4

INVENTORIES

 

     June 30, 2018      December 31, 2017  

Deferred crop costs

   $  22,366      $  19,070  

Purchased produce inventory

     644        396  

Biological asset adjustment (note 5)

     (4,530      (2,212

Spare parts inventory

     87        55  
  

 

 

    

 

 

 
   $ 18,567      $ 17,309  
  

 

 

    

 

 

 

The cost of inventories recognized as expense and included in cost of sales for the three months ended June 30, 2018 amounted to $34,375 (2017 - $37,192) and $54,580 for the six months ended June 30, 2018 (2017 - $58,828). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the interim statement of financial position.

 

5

BIOLOGICAL ASSET

Information about the biological asset presented on the consolidated statements of financial position and in the consolidated statements of income (loss) is as follows:

 

     June 30, 2018      December 31, 2017      June 30, 2017  

Estimated sales value–biological asset

   $  12,803      $  7,937      $  14,639  

Less

        

Estimated remaining costs to complete

     5,114        3,043        7,132  

Estimated selling costs

     769        489        751  
  

 

 

    

 

 

    

 

 

 

Fair value of biological asset less costs to sell

     6,920        4,405        6,756  

Less actual costs

     4,530        2,212        6,172  
  

 

 

    

 

 

    

 

 

 

Increase in fair value of biological asset over cost

     2,390        2,193        584  

Fair value over cost of harvested and sold biological asset - beginning of year

     2,193        1,928        1,930  
  

 

 

    

 

 

    

 

 

 

Change in biological asset

   $ 197      $ 265      $  (1,346
  

 

 

    

 

 

    

 

 

 

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

 

6

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of the following:

 

     Land     Leasehold
and land
improve-
ments
    Buildings     Machinery
and
Equipment
    Construction
in process
    Total  

At December 31, 2017

 

Cost

   $  9,112     $ 3,820     $ 77,029     $ 63,237     $ 468     $  153,666  

Accumulated depreciation

     —         (2,223     (33,685     (36,004     —         (71,912
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Six months ended June 30, 2018

 

   

Opening net book value

   $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  

Additions (transfers)

     —         —         —         233       1,417       1,650  

Placed in service

     —         —         —         874       (1,029     (155

Disposals (expense)

     (65     —         —         —         (30     (95

Depreciation expense

     —         (42     (1,333     (2,148     —         (3,523

FX translation adjustment

     —         —         (15     (140     40       (115
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

   $ 9,047     $ 1,555     $ 41,996     $ 26,052     $ 866     $ 79,516  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At June 30, 2018

 

       

Cost

   $ 9,047     $ 3,820     $ 77,007     $ 64,112     $ 866     $ 154,852  

Accumulated depreciation

     —         (2,265     (35,011     (38,060     —         (75,336
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,047     $ 1,555     $ 41,996     $ 26,052     $ 866     $ 79,516  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. As at December 31, 2017, land, greenhouse buildings, and greenhouse equipment at Delta 3 were contributed as the Company’s investment in the joint venture transaction (note 7). The revaluation surplus related to Delta 3 of $1.8 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the condensed consolidated interim statements of loss.

 

7

INVESTMENT IN JOINT VENTURE

On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms Corp. (“Pure Sunfarms”), a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to pursue large-scale cannabis production in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.

As at June 30, 2018 the Investment in Joint Venture of $15.4 million (December 31, 2017 - $15.7 million) is recorded in the condensed consolidated interim statement of financial position. For the three months ended June 30, 2018, the Company’s share of net loss from joint venture totaled $104 (CA$130) (2017 - $nil) and for the six months ended June 30, 2018, the Company’s share of net loss from joint venture totaled $341 (CA$432) (2017 - $nil), which is recorded in the condensed consolidated interim statement of loss.

The Company’s share of the joint venture consists of the following (in $000’s of USD):

 

Balance, January 1, 2018

   $  15,727  

Share of loss

     (341
  

 

 

 

Balance, June 30, 2018

   $ 15,386  
  

 

 

 

 

10


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     June 30, 2018      December 31, 2017  

Current assets

     

Cash and cash equivalents

   $ 791      $ 2,907  

Other current assets

     3,483        475  

Non-current assets

     43,386        23,144  

Current liabilities

     (9,170      (1,171
  

 

 

    

 

 

 

Net assets

   $  38,490      $  25,355  
  

 

 

    

 

 

 

 

     June 30, 2018      December 31, 2017  
Reconciliation of net assets:              

Accumulated deficit

   $  (1,510    $ (645

Contributions from joint venture partners

     40,000        26,000  
  

 

 

    

 

 

 

Net assets

   $  38,490      $  25,355  
  

 

 

    

 

 

 

 

     Three Months
Ended June 30,
2018
     Six Months
Ended June 30,
2018
 

Revenue

   $ —        $ —    

Selling, general and administrative expenses

     (761      (1,315

Change in fair value of bio-asset

     422        422  

Foreign exchange gain

     78        28  
  

 

 

    

 

 

 

Net loss

   $  (261    $ (865
  

 

 

    

 

 

 

 

8

DEBT

 

     June 30, 2018      December 31, 2017  

Long-term debt:

     

Opening balance

   $  38,380      $  45,534  

IFRS adjustment for deferred financing fees (note 3)

     260        —    

Proceeds from long-term debt

     —          306  

Repayment of debt

     (917      (7,320

Foreign currency translation

     (80      120  
  

 

 

    

 

 

 

Closing balance

   $ 37,643      $ 38,640  
  

 

 

    

 

 

 

Current portion

   $ 3,440      $ 2,620  

Non-current portion

     34,203        36,020  

Less: Unamortized deferred transaction costs

     —          (260
  

 

 

    

 

 

 
   $ 37,643      $ 38,380  
  

 

 

    

 

 

 

Credit Facilities

The Company has a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan has a maturity date of May 1, 2021 and a balance of $35,925 as at June 30, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on May 1, 2021. As at June 30, 2018, borrowings under the FCC Loan agreement are subject to an interest rate of 6.85375% (December 31, 2017—5.88483%) which is determined based on the Company’s Debt to EBITDA ratio and the applicable LIBOR rate.

 

11


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 and fixed interest rate of 4.98%. As at June 30, 2018, the balance was US$1,642 (December 31, 2017 - US$1,658). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at June 30, 2018, the balance was US$165                (December 31, 2017 - $192) .

The Company has a line of credit agreement with a Canadian Chartered Bank ( “Operating Loan”). The revolving Operating Loan has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021, and is subject to margin requirements stipulated by the bank. As at June 30, 2018, US$7,000 was drawn on this facility (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling US$261 and CA$38.

The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at June 30, 2018 and December 31, 2017, the Company was in compliance with all covenants on its Credit Facilities.

Accrued interest payable on the credit facilities and loans as at June 30, 2018 was $220 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statement of financial position.

The aggregate annual maturities of long-term debt for the next five years and thereafter are as follows:

 

The remainder of 2018

   $ 1,694  

2019

     3,379  

2020

     3,374  

2021

     28,690  

2022

     345  

Thereafter

     161  
  

 

 

 
     $ 37,643  
  

 

 

 

 

9

FINANCIAL INSTRUMENTS

The following table summarizes the carrying and fair value of the Company’s financial instruments:

 

     June 30, 2018      December 31, 2017  

Cash and cash equivalents

   $  12,933      $ 7,091  

Trade receivables

   $ 14,470      $  11,259  

Other financial assets

   $ 2,353      $ 2,491  

Other financial liabilities

   $ 63,609      $ 56,718  

Interest income, expense and gains and losses from loans, receivables and other financial liabilities are recognized in the condensed consolidated interim statements of loss. The following table summarizes interest income and expense for the three and six months ended June 30:

 

     Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Interest income earned on cash and cash equivalents

   $ 3      $
—  
 
   $ 3      $
—  
 

Interest expense from other financial liabilities

   $  688      $
 695
 
   $  1,286      $  1,327  

Financial assets and liabilities are recognized on the consolidated interim statement of financial position at fair value in a hierarchy that is based on significance of the inputs used in making the measurements. The levels in the hierarchy are:

 

12


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

   

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

   

Level 2 - Inputs other than quoted prices included within level 1 that are observable for the asset or liability either directly (i.e., as prices) or indirectly (i.e., derived from prices)

 

   

Level 3 - Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).

Management of financial risks

The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at June 30, 2018 and December 31, 2017. The Company uses financial instruments only for risk management purposes, not for generating trading profit.

 

  i)

Credit risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables and other receivables. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 11.1% and 10.6% of the balance of trade receivables as at June 30, 2018 (2017 - one customer represented 10.0%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales. The maximum amount of credit risk exposure is limited to the carrying amount of the balances on the interim financial statements.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. As at June 30, 2018, the allowance for doubtful accounts balance was $50 (December 31, 2017 - $50). The Company has not recorded a bad debt expense during the three and six months ended June 30, 2018 (2017 - $nil).

As at June 30, 2018, 93.0% (December 2017 - 89.4%) of trade receivables were outstanding less than 30 days, 5.9% (December 2017 - 7.4%) were outstanding for between 30 and 90 days and the remaining 1.1% (December 2017 - 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

 

  ii)

Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the six months ended June 30, 2018 would have been lower by $95. This represents $95 in increased interest expense (2017 - $107).

 

  iii)

Foreign exchange risk

As at June 30, 2018, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7609 (December 31, 2017 - US$0.7966). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain consolidated statements of financial position items as at June 30, 2018 and December 31, 2017 with the net foreign exchange gain or loss directly impacting net income (loss) for the period.

 

 

13


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Six Months Ended June 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

 

     June 30, 2018      December 31, 2017  

Financial assets

     

Cash and cash equivalents

   $ 92      $ 287  

Trade receivables

     505        349  

Financial liabilities

     

Trade payables and accrued liabilities

     (643      (371

Loan payable

     (216      (232
  

 

 

    

 

 

 

Net foreign exchange (loss) gain

   $ (262    $ 33  
  

 

 

    

 

 

 

 

  iv)

Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at June 30, 2018:

 

Financial liabilities

   Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $ 37,643      $ 3,440      $ 33,528      $ 675      $ —    

Line of credit

     7,000        7,000        —          —          —    

Trade payables

     10,780        10,780        —          —          —    

Accrued liabilities

     6,656        6,656        —          —          —    

Obligation under capital lease

     217        57        160        —          —    

Other liabilities

     1,100        733        367        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 63,396      $ 28,666      $ 34,055      $ 675      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at June 30, 2018, the Company has an operating loan of up to CA$13,000, less an outstanding balance of US$7,000 and outstanding letters of credit totaling US$261 and CA$38.

 

  v)

Fair values

The carrying amount of short-term financial instruments, less provisions for impairment if applicable, is consistent with the fair value of such instruments. The Company’s debt bears a variable interest rate tied to market rates and therefore its carrying value approximates its fair value.

 

10

RELATED PARTY TRANSACTIONS AND BALANCES

As at June 30, 2018, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $891 primarily for consulting services and the reimbursement of expenses which occurred in the year. These amounts were non-interest bearing and were due on demand. These amounts are included in other receivables in the interim statement of financial position.

Included in other assets as at June 30, 2018, is a $67 (December 31, 2017—$70) promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company.

 

14


11

EXPENSES BY NATURE

The following table outlines the Company’s significant expenses by nature:

 

Cost of sales    Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Purchased produce

   $ 11,581      $ 12,548      $ 19,767      $ 22,069  

Raw materials and consumables used

     12,829        13,383        16,265        17,691  

Depreciation and amortization

     1,694        1,916        3,465        3,831  

Transportation and storage

     5,905        5,400        10,441        9,767  

Employee compensation and benefits

     9,141        9,558        17,115        16,767  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 41,150      $ 42,805      $ 67,053      $ 70,125  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Selling, general and administrative expenses    Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Employee benefits – salaries and short-term benefits

   $ 2,294      $ 2,535      $ 4,464      $ 4,650  

Marketing

     92        128        178        212  

Professional services

     659        366        1,070        611  

Office expenses

     449        426        891        800  

Other

     332        398        698        804  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 3,826      $ 3,853      $ 7,301      $ 7,077  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Employee compensation and benefits    Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Salaries and short-term employee benefits

   $ 11,297      $ 11,665      $ 21,323      $ 20,948  

Share-based compensation

     138        428        256        469  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 11,435      $ 12,093      $ 21,579      $ 21,417  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

12

DEFERRED INCOME TAX

Income tax expense is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the six months ended June 30, 2018 was 25%, excluding the change in biological asset as reported on the condensed consolidated interim statements of loss, and 30% for the six months ended June 30, 2017.

 

13

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

     Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Trade receivables

   $ (5,366    $ (5,650    $ (3,219    $ (5,183

Inventories

     (697      3,794        (2,870      1,475  

Inventories reclassified to biological asset

     1,332        (1,173      (921      (3,657

Other receivables

     (58      (182      —          (126

Prepaid expenses and deposits

     267        (402      109        (717

Trade payables

     2,606        2,991        (2,150      396  

Accrued liabilities and taxes

     3,037        1,885        3,081        1,711  

Other assets/other liabilities, net

     (189      6        (488      24  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 932      $ 1,269      $ (6,458    $ (6,077
  

 

 

    

 

 

    

 

 

    

 

 

 


14

SEGMENT AND GEOGRAPHIC INFORMATION

The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer.

The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:

 

     Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Net Sales

           

United States

   $ 32,892      $ 36,861      $ 60,318      $ 65,038  

Canada

     8,693        8,196        10,232        10,810  

Energy - Canada

     454        473        979        959  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 42,039      $ 45,530      $ 71,529      $ 76,807  
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s property, plant and equipment, net of accumulated depreciation, are located as follows:

 

     June 30, 2018      December 31, 2017  

United States

   $ 44,929      $ 46,922  

Canada

     30,632        31,183  

Energy - Canada

     3,955        3,649  
  

 

 

    

 

 

 
   $ 79,516      $ 81,754  
  

 

 

    

 

 

 

Depreciation and amortization charges in the Produce business for the three and six months ended June 30, 2018 were $1,534 (2017 - $1,757) and $3,112 (2017 - $3,522), respectively. Depreciation and amortization charges in the Energy business for the three and six months ended June 30, 2018 were $188 (2017 - $192) and $411 (2017 - $378), respectively.

 

15

LOSS PER SHARE

 

     Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Net (loss) income attributable to owners of the Company

   $ (2,282    $ 4,325      $ (3,426    $ 4,135  

Weighted average number of common shares outstanding (thousands)

     43,336        39,146        42,894        39,146  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic (loss) earnings per share

   $ (0.05    $ 0.11      $ (0.08    $ 0.11  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended June 30,      Six months ended June 30,  
     2018      2017      2018      2017  

Net (loss) income attributable to owners of the Company

   $ (2,282    $ 4,325      $ (3,426    $ 4,135  

Weighted average number of common shares outstanding (thousands)

     43,336        39,146        42,894        39,146  

Adjustment for:

           

Share options (thousands)

     —          811        —          694  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average number of common shares outstanding for diluted earnings per share (thousands)

     43,336        39,957        42,894        39,840  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted (loss) earnings per share

   $ (0.05    $ 0.11      $ (0.08    $ 0.10  
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and six months ended June 30, 2018, there were options to purchase 2,198 (2017 - 2,241) shares of the Company’s common stock that were excluded from the diluted loss per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive during the respective periods.


16

CAPITAL DISCLOSURES

The Company’s capital comprises net debt and equity:

 

     June 30, 2018      December 31, 2017  

Total bank debt

   $ 37,643      $ 38,640  

Less cash and cash equivalents

     (12,933      (7,091
  

 

 

    

 

 

 

Net debt

     24,710        31,549  

Total equity

     85,542        81,043  
  

 

 

    

 

 

 
   $ 110,252      $ 112,592  
  

 

 

    

 

 

 

It is the Company’s intention to meet its obligations through the collection of current accounts receivable and cash. As at June 30, 2018, the Company has an available operating loan up to CA$13,000, less US$7,000 drawn on the loan and US$261 and CA$38 outstanding letters of credit (as at December 31, 2017, $nil was outstanding on the operating loan, and US$333 and CA$38 outstanding on the letters of credit). As at June 30, 2018, the operating loan borrowing base was CA$3,430 based on a percentage of the Company’s outstanding accounts receivable less the issued letters of credit. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

 

17

SHARE-BASED COMPENSATION PLAN

The Company has a share-based compensation plan. The maximum number of common shares that can be earned upon the exercise of earned performance-based restricted share units is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options vest at a rate of 33% per year, beginning one year following the grant date of the options. Performance-based restricted share units are earned based on certain business milestones being achieved prior to a stated date. If the performance does not occur prior to stated date, the restricted share units expire.

As at June 30, 2018 and December 31, 2017, there were 128,000 performance-based restricted share units outstanding with a weighted average grant date fair value of CA$2.82. In June 2018, 979,000 performance-based restricted share units with a weighted average grant date fair value of CA$5.77 were issued to Village Farms employees. All were outstanding as at June 30, 2018.

Share-based compensation expense for the three and six months ended June 30, 2018 of $138 (2017 - $428) and $256 (2017 - $469), respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.

 

18

SUBSEQUENT EVENTS

On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby the Shareholders each contributed CA$5,000 in the form of a demand loan to Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by either Shareholder.

 

17

Exhibit 99.41

Village Farms International, Inc.

Management’s Discussion and Analysis

Three and Six Months Ended June 30, 2018

August 14, 2018


Village Farms International, Inc.

 

 

Management’s Discussion and Analysis

Information is presented in thousands of United States dollars (“U.S. dollars”) unless otherwise noted.

Introduction

This management’s discussion and analysis (“MD&A”) should be read in conjunction with the condensed consolidated interim financial statements and accompanying notes of Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”), for the three and six months ended June 30, 2018 (the “Consolidated Financial Statements”). The information provided in this MD&A is current to August 13, 2018 unless otherwise noted.

VFF is a corporation existing under the Canada Business Corporations Act . The Company’s principal operating subsidiaries at June 30, 2018 were Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”) and VF Clean Energy, Inc. (“VFCE”). On June 6, 2017, VFF entered into a shareholders’ agreement in respect of the operation and governance of Pure Sunfarms Corp. (“Pure Sunfarms”) in which VFF owns a 50% interest.

Basis of Presentation

The annual data included in the MD&A is presented in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.

The preparation of annual financial data requires the use of certain accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the annual financial data, are disclosed in note 3 of the Condensed Consolidated Interim Financial Statements.

Segment Reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the CEO. Based on the aggregation criteria in IFRS 8, Operating Segments , the operating segments of the Company are treated as two reporting segments.

Functional and Presentation Currency

The financial data is presented in U.S. dollars, which is the Company’s functional currency. All financial information presented in U.S. dollars has been rounded to the nearest thousand.

Business Overview

Management believes that the Company is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America. These premium products are grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas. The Company also markets and distributes premium tomatoes, peppers and cucumbers produced under exclusive arrangements with other greenhouse producers. The Company primarily markets and distributes under its Village Farms ® brand name, primarily to retail supermarkets and dedicated fresh food distribution companies throughout the United States and Canada. It currently operates two distribution centres, one located in the United States and one in Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates four main goals – environmental health, economic profitability and social and economic equality. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant from landfill gas that generates electricity and provides thermal heat, in colder months, to one of the Company’s adjacent British Columbia greenhouse facilities and sells electricity to British Columbia Hydro and Power Authority (“BC Hydro”).

 

2


Village Farms International, Inc.

 

 

The Company embraces sustainable agriculture and environmentally-friendly growing practices by:

 

   

utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their products virtually free of chemical agents. The process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies;

 

   

capturing rainwater from various greenhouse roofs for irrigation purposes;

 

   

capturing landfill gas on a long term contract from the City of Vancouver landfill to generate electricity under a long term contract with BC Hydro and thermal heat for an adjacent greenhouse;

 

   

recycling water and nutrients during the production process;

 

   

growing plants in a natural medium, including coconut fibre and rock wool, as opposed to growing in the soil and depleting nutrients; and

 

   

using dedicated environmental control computer systems which monitor and control virtually all aspects of the growing environment, thereby maximizing the efficient use of energy.

The Company’s assets, as of the reporting date, include six operating produce greenhouses providing approximately 849,958 square metres (or approximately 215 acres) of growing space in Canada and the United States. During 2017, the Company granted rights to what was its seventh greenhouse, located in Delta, BC (the “Delta 3 Greenhouse”), to Pure Sunfarms. Pure Sunfarms is in the process of converting the Delta 3 Greenhouse into a facility compliant with Access to Cannabis for Medical Purposes Regulations (“ACMPR”) with the object of seeking to achieve large scale low-cost high quality cannabis production. Pure Sunfarms received a cultivation license on March 2, 2018 and a sales license on July 30, 2018 from Health Canada for the Delta 3 Greenhouse.

All of the Company’s greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company also has marketing agreements with growers in Canada, the United States and Mexico that currently operate approximately 572,800 square metres (or approximately 140 acres) of growing area.

The following table outlines the Company’s greenhouse facilities:

 

     Growing Area       

Greenhouse Facility

   Square Feet      Square
Metres
     Acres     

Products Grown

Marfa, TX (2 greenhouses)

     2,527,312        234,795        60      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Fort Davis, TX (1 greenhouse)

     1,684,874        156,530        40      Specialty tomatoes

Monahans, TX (1 greenhouse) (Permian Basin facility)

     1,272,294        118,200        30      Tomatoes on-the-vine, long English cucumbers

Delta, BC (2 greenhouses)

     3,664,390        340,433        85      Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Pure Sunfarms (1 greenhouse)

     1,077,758        100,127        25      Leased to Pure Sunfarms for cultivation of cannabis
  

 

 

    

 

 

    

 

 

    

Total

     10,226,628        950,085        240     

Marketing

The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed provider to be the sole grower in North America), other speciality tomatoes under exclusive agreements and long English cucumbers at its facilities. The Company also distributes and markets premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.

The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.

 

3


Village Farms International, Inc.

 

 

The Company has distribution capabilities that it believes exceed those of most of its competitors in the North American greenhouse vegetable industry. With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the six months ended June 30, 2018, the Company had an on-time delivery record of approximately 98.3%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.

The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:

 

   

Year-Round Supplier. Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing.

 

   

Quality and Food Safety. Sales are made directly to retailers which ensure control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs ® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs ® .

 

   

Quality Packaging and Presentation. Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf.

 

   

Exclusive Varieties. The Company expands its product profile, to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand.

 

   

Direct Sale to Retail Customers. Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including, Associated Grocers, Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fred Meyer, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, Inc., HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Publix Super Markets, Inc., Roundy’s Supermarkets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, United Supermarkets, Unified Western Grocers, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC.

 

   

Excellence in Customer Service and Logistics. Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres.

Investment in Joint Venture

On June 6, 2017, the Company and Emerald Health Botanicals, Inc. (“Emerald”) formed a new corporation named “Pure Sunfarms Corp.”. The Company and Emerald each own 50% of the shares of Pure Sunfarms. VFF contributed rights to one of its 25-acre greenhouse facilities in Delta, British Colombia as its equity contribution and Emerald agreed to contribute CA$20,000,000 to fund the conversion of the facility, which was fully funded as of April 2018. Pure Sunfarms has commenced the cultivation of cannabis in the licensed portion of the facility and received its sales license for the facility on July 30, 2018 from Health Canada, and has commenced with selling and distributing cannabis. Pure Sunfarms continues the conversion process on the remaining unlicensed portion of the facility, with the expectation that the entire 1.1 million square feet will be converted and licensed by the end of 2018.

On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby the Shareholders agreed to make a demand loan to Pure Sunfarms totaling CA$10,000,000 (CA$5,000,000 from each Shareholder). The loan is evidenced by a promissory notes issued by Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by either Shareholder.

 

4


Village Farms International, Inc.

 

 

Results of Operations

Consolidated Financial Performance

(In thousands of U.S. dollars, except per share amounts)

 

     For the three months
ended June 30,
     For the six months ended June 30,  
     2018      2017      2018      2017  

Sales

   $ 42,039      $ 45,530      $ 71,529      $ 76,807  

Cost of sales

     (41,150      (42,805      (67,053      (70,125

Selling, general and administrative expenses

     (3,688      (3,425      (7,045      (6,608

Stock compensation expense

     (138      (428      (256      (469

Change in biological asset (1)

     856        (701      197        (1,346

(Loss) income from operations

     (2,081      (1,829      (2,628      (1,741

Interest expense, net

     691        695        1,289        1,327  

Other income

     (5      (28      (30      (40

(Gain) loss on sale of assets

     —          (8,572      —          (8,564

Share of (loss) from joint venture

     (104      —          (341      —    

(Recovery of) provision for income taxes

     (589      1,751        (802      1,401  

Net (loss) income

     (2,282      4,325        (3,426      4,135  

EBITDA (2)

     (1,316      1,264        496        4,015  

(Loss) earnings per share - basic

   ($ 0.05    $ 0.11      ($ 0.08    $ 0.11  

(Loss) earnings per share - diluted

   ($ 0.05    $ 0.11      ($ 0.08    $ 0.10  

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s interim consolidated financial statements for the three and six months ended June 30, 2018.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company.

Results of Operations for the Three Months Ended June 30, 2018 compared to the Three Months Ended June 30, 2017

Sales

Sales for the three months ended June 30, 2018 decreased by ($3,491), or (8%), to $42,039 from $45,530 for the three months ended June 30, 2017. The decrease in sales is primarily due to a decrease in production from the Company’s facilities production volume of (13%), of which (8%) is due to the contribution of the Delta 3 greenhouse to Pure Sunfarms. The Company’s Texas facilities produced (8%) less tomatoes, partially offset by and an increase at the remaining two Delta facilities for the three months ended June 30, 2018 versus the same period in 2017. The decrease in the Texas production volume was due to changes in crop cycles between 2018 and 2017, partial weather damage to one facility and some disease pressure.                

The average selling price for tomatoes increased 1% for the three months ended June 30, 2018 versus the three months ended June 30, 2017. Cucumber pricing decreased by (6%) and pepper pricing increased by 4% in the second quarter of 2018 versus the comparable quarter in 2017.    

Cost of Sales

Cost of sales for the three months ended June 30, 2018 decreased by ($1,655), or (4%), to $41,150 from $42,805 for the three months ended June 30, 2017; primarily due a decrease from the Delta 3 facility ($1,524) and a decrease of ($970) in contract sales cost, due to decreased cucumber volumes, partially offset by an increase in freight expense of $571.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended June 30, 2018 increased by $263, or 8%, to $3,688 from $3,425 for the three months ended June 30, 2017. The increase is due to public company costs such as investor relations and listing fees.

 

5


Village Farms International, Inc.

 

 

Stock Compensation Expenses

Stock compensation expense for the three months ended June 30, 2018 was $138 from $428 for the three months ended June 30, 2017.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended June 30, 2018 increased by $1,557 to a gain of $856 from a loss of ($701) for the three months ended June 30, 2017. The increase in the change in value is primarily due to a higher average selling price of the biological asset in July 2018 versus the same period in 2017. The fair value of the biological asset as at June 30, 2018 was $6,920 as compared to $6,756 as at June 30, 2017 due to higher selling prices in July 2018 versus July 2017.

(Loss) from Operations

Loss from operations for the three months ended June 30, 2018 increased ($252) to ($2,081) from ($1,829) for the three months ended June 30, 2017. The decrease is due to a decrease in sales offset by the gain on the change in biological asset $1,557.

Interest Expense, net

Interest expense, net, for the three months ended June 30, 2018 was $691 compared to $695 for the three months ended June 30, 2017.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the three months ended June 30, 2018 was ($104), which consists of salaries and other administrative costs, offset by the Company’s share of the JV’s biological asset of $161, as the joint venture had buds on the plant and dried bud in inventory on June 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on plant and in inventory on June 30, 2018.

Gain on Sale of Assets

No gains were recognized in 2018. The Company recognized for the three month period ended June 30, 2017 a gain of $8,572 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms Corp. in exchange for a 50% equity stake in the corporation. See “Investment in Joint Venture” above.

(Recovery of) Provision for Income Taxes

Income tax recovery for the three month period ended June 30, 2018 was ($589) compared to an income tax provision of $1,751 for the three month period ended June 30, 2017. The change is primarily due to a gain of $8,572 recognized on the contribution of one of the Company’s Delta greenhouse facilities in exchange for its 50% equity interest in Pure Sunfarms 2017.

Net (Loss) Income

Net loss for the three months ended June 30, 2018 was ($2,282) compared to net income of $4,325 for the three months ended June 30, 2017 primarily as a result of the gain recognized in the second quarter of 2017 on the contribution of the Delta facility of $8,572 and the loss from Pure Sunfarms, offset by the gain on the change in biological asset an increase in recovery of income taxes during the second quarter of 2018.

 

6


Village Farms International, Inc.

 

 

EBITDA

EBITDA for the three months ended June 30, 2018 decreased by ($2,580), to ($1,316) from $1,264 for the three months ended June 30, 2017, primarily as a result of a decrease in sales caused by production shortfalls in Texas, share of loss from Pure Sunfarms and an increase in sales and administrative costs. See the EBITDA calculation in “Non-IFRS Measures - Reconciliation of Net Income to EBITDA”.

Results of Operations for the Six Months Ended June 30, 2018 Compared to the Six Months Ended June 30, 2017

Net Sales

Net sales for the six months ended June 30, 2018 decreased ($5,278), or (7%), to $71,529 compared to $76,807 for the six months ended June 30, 2017. The decrease in net sales is due to a decrease in supply partner revenues of (7%) over the comparable period in 2017 and an (11%) decrease in the Company’s production volume. Company’s production volume decrease was caused by a (6%) decrease in the Texas production and the loss of tomato production from the Delta 3 facility, which was contributed to Pure Sunfarms.

The net price for all tomato pounds sold was a decrease of (1%) for the six months ended June 30, 2018 versus the six months ended June 30, 2017. Pepper prices decreased (11%) and pounds increased 13% over the comparable period in 2017, and cucumber prices decreased (4%) and pieces decreased (11%) for the six months ended June 30, 2018 over the comparable period in 2017.

Cost of Sales

Cost of sales for the six months ended June 30, 2018 decreased ($3,072), or (4%), to $67,053 from $70,125 for the six months ended June 30, 2017. The decrease is due to the decrease in supply partner cost of sales of 10% and the removal of the cost of the Delta 3 facility, partially offset by an increase in freight cost of $880. The cost at the Company’s facilities increased 9% per pound, due mostly to the removal of Delta 3 that grew at a lower cost per pound tomato variety.

Change in fair value of biological asset, net

The net change in fair value of biological asset for the six months ended June 30, 2018 increased $1,543 to $197 from ($1,345) for the six months ended June 30, 2017. The increase is due to a higher average selling price of the biological asset in July 2018 versus the same period in 2017.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the six month period ended June 30, 2018 increased ($437), or (7%), to $7,045 from $6,608 for the six month period ended June 30, 2017. The increase is due to public company costs such as investor relations and legal and listing fees.

Stock Compensation Expenses

Stock compensation expenses for the six months ended June 30, 2018 was $256 from $469 for the six months ended June 30, 2017.

(Loss) from Operations

(Loss) from operations for the six months ended June 30, 2018 was ($2,628), which was an increased (loss) of ($887) from a loss of ($1,741) for the six months ended June 30, 2017. The decrease in operating results is due to a decrease in net sales caused mostly by a production shortfall in Texas, and partially offset by a decrease in the cost of sales and an increase in the change in biological asset.

 

7


Village Farms International, Inc.

 

 

Interest Expense, net

Interest expense, net, for the six month period ended June 30, 2018 were relatively unchanged at $1,289 from $1,327 for the six month period ended June 30, 2017.    

Income Taxes (Recovery)

Income tax provision (recovery) for the six month period ended June 30, 2018 was a recovery ($802) compared to $1,401 for the six month period ended June 30, 2017. The income tax provision decrease is due to the gain on sale of assets in 2017 that did not occur in 2018.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the six months ended June 30, 2018 was ($341), which consists of salaries and other administrative costs, offset by the Company’s share of the JV’s biological asset of $161, as the joint venture had buds on the plant and dried bud in inventory on June 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on plant and in inventory on June 30, 2018.

Gain on Sale of Assets

No gains were recognized in 2018. The Company recognized for the six month period ended June 30, 2017 a gain of $8,564 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms in exchange for a 50% equity stake in Pure Sunfarms. See “Investment in Joint Venture” above.

Net Income (Loss)

Net income (loss) for the six month period ended June 30, 2018 decreased to a loss of ($3,426) from $4,135 for the six month period ended June 30, 2017. The decrease is a result of a gain on assets in 2017 of $8,564, a decrease in sales partially offset by an increase in recovery of income taxes and the change in biological asset.

EBITDA

EBITDA for the six month period ended June 30, 2018 decreased ($3,519) to $496 from $4,015 for the six month period ended June 30, 2017, primarily as a result of a decrease in net sales and increase in share of loss from Pure Sunfarms. See the EBITDA calculation in “Non-IFRS Measures - Reconciliation of Net Earnings to EBITDA”.

Selected Statement of Financial Position Data

 

     As at June 30,      As at December 31,  
     2018      2017  

Total assets

   $ 152,944      $ 142,341  

Total liabilities

   $ 67,402      $ 61,298  

Shareholders’ equity

   $ 85,542      $ 81,043  

Non-IFRS Measures

References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

 

8


Village Farms International, Inc.

 

 

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months ended
June 30,
     For the six months ended
June 30,
 
     2018      2017      2018      2017  

Net (loss) income

   ($ 2,282    $ 4,325      ($ 3,426    $ 4,135  

Add:

           

Amortization

     1,722        1,949        3,523        3,900  

Foreign currency exchange loss (gain)

     21        (13      14        1  

Interest expense

     691        695        1,289        1,327  

Income taxes (recovery)

     (589      1,751        (802      1,401  

Stock based compensation

     138        428        256        469  

Change in biological asset

     (856      701        (197      1,346  

Change in biological asset from JV

     (161      —          (161      —    

Gain on disposal of assets

     —          (8,572      —          (8,564
  

 

 

    

 

 

    

 

 

    

 

 

 

EBITDA

   ($ 1,316    $ 1,264        496        4,015  

Liquidity

Cash flows

The Company expects to provide adequate financing to maintain and improve its property, plant and equipment, to fund working capital needs and invest in Pure Sunfarms for the foreseeable future from cash flows from operations, and, if needed, from additional borrowings under the Credit Facilities (as defined below) or other long-term facilities or additional equity financing.

For the three months ended June 30, 2018, cash flows from operating activities before changes in non-cash working capital and change in biological asset totalled ($216) (2017 – $569) and for the six months ended June 30, 2018 totalled $1,164 (2017 - $2,657).

Capital expenditures totalled $1,092 for the three months ended June 30, 2018 (2017 - $562) and $1,440 for the six months ended June 30, 2018 (2017 – $993).

The cash provided by (used in) financing activities for the three months ended June 30, 2018 totalled $10,301 (2017 – ($471)) and for the six months ended June 30, 2017 totalled $12,778 (2017 – $3,068). For the three months ended June 30, 2018, the cash provided by financing activities primarily consisted of issuance of common stock pursuant to a private placement of $7,755, operating loan borrowings of $4,000, proceeds from the exercise of stock options of $94, debt payments of ($840), interest payments of ($691), and payments on capital lease obligations of ($17) (2017 –operating loan borrowings $1,000, proceeds from the exercise of stock options $26, debt payments ($818) interest paid ($670), payments on capital lease obligations ($9)).

For the six months ended June 30, 2018, the cash provided by financing activities primarily consisted of issuance of common stock pursuant to private placement of $7,755, operating loan borrowings of $7,000, proceeds from the exercise of stock options of $263, debt payments of ($917), interest payments of ($1,289), and payments on capital lease obligations of ($34) (2017 –operating loan borrowings $6,000, proceeds from the exercise of stock options $26, debt payments ($1,656) interest paid ($1,280), payments on capital lease obligations ($22)).

 

9


Village Farms International, Inc.

 

 

Capital Resources

 

(in thousands of U.S. dollars unless otherwise noted)    Maximum      Outstanding
June 30, 2018
 

Operating Loan

   CA$ 13,000      $ 7,000  

Term Loan

   $ 35,925      $ 35,925  

VFCE Loan

   CA$ 2,159      CA$ 2,159  

The Company is party to a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). This non-revolving variable rate term loan was amended in March 2016 and now has a maturity date of May 1, 2021 and a balance of $35,925 as at June 30, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on maturity. In December 2017, the Company made a pre-payment on the term loan of $4,000 to release the Delta 2 asset as collateral. The Company was not required to make principal payments from January to March 2018. Monthly principal payments of $253 began in April 2018. As at June 30, 2018, borrowings under the FCC Loan were subject to an interest rate of 6.85375% per annum (December 31, 2017 – 5.88483% per annum). The Company’s interest rate on the FCC Loan is determined based on the Company’s Debt to EBITDA ratio on December 31 of the prior year and the current monthly applicable LIBOR rate.

The Company is also party to a variable rate line of credit agreement with a Canadian chartered bank that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank. As at June 30, 2018, $7,000 was drawn on the Operating Loan (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit of US$261 and CA$38 (or US$29).

The Company’s subsidiary, VFCE, has a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023, a fixed interest rate of 4.98% per annum, and monthly payments of principal and interest of CA$36. In October 2017, VFCE borrowed an additional CA$250 payable at CA$4 per month plus interest of prime plus 2% per annum. As at June 30, 2018, the outstanding balance was CA$2,159 (US$1,642) (December 31, 2017 - US$1,658).

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at June 30, 2018 was $115,325 (December 31, 2017 - $120,815).

As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therefore. The carrying value of the assets pledged as collateral as at June 30, 2018 was $39,734 (December 31, 2017 - $32,883).

The borrowings are subject to certain positive and negative covenants, which include debt coverage ratios. As at June 30, 2018, the Company was in compliance with all of its covenants.

Accrued interest payable on the credit facilities and loans as at June 30, 2018 was $220 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statements of financial position.

 

10


Village Farms International, Inc.

 

 

Contractual Obligations and Commitments

Information regarding the Company’s contractual obligations at June 30, 2018 is set forth in the table below:

 

(in thousands of U.S. dollars)    Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $ 37,643      $ 3,440      $ 33,528      $ 675      $ —    

Line of Credit

     7,000        7,000        —          —          —    

Operating leases

     2,761        1,252        1,024        485        —    

Capital leases

     217        57        160        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 47,621      $ 11,749      $ 34,712      $ 1,160      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Capital Expenditures

During the three and six months ended June 30, 2018, the Company purchased approximately $1,092 and $1,440 of capital assets, respectively. Capital expenditures incurred for 2018 were used for replacements or improvements to existing facilities related mostly to improvements at VFCE, which completed two major engine overhauls.

Management continues to review new capital expenditures to support its strategic plan of achieving cost efficiencies through increased productivity. Management may elect, where appropriate, to sell inefficient or non-strategic assets to produce cash to wholly or partially finance new capital expenditures. The Company will also borrow to maintain, improve and replace capital assets when the return on such investments exceeds targeted thresholds for internal rates of return. There can be no assurance, however, that sources of financing will be available, or will be available on terms favourable to the Company, or that these strategic initiatives will achieve adequate cost reduction in actual implementation or in light of the competitive pressures on the cost of raw materials and other factors of production. Management believes that its recurring capital expenditures will be funded and supported from its ongoing operations.

During the three and six month ended June 30, 2018, the Company incurred $677 and $1,328, respectively, in costs to maintain its capital assets. These expenses are classified as repair and maintenance and are included in cost of sales. Management forecasts approximately $2,500 of annual costs to maintain the Company’s capital assets.

Summary of Quarterly Results

For the three months ended:

 

(in thousands of U.S. Dollars, except per share amounts)    Jun 30,
2018
    Mar 31,
2018
    Dec 31,
2017
    Sept 30,
2017
     Jun 30,
2017
     Mar 31,
2017
    Dec 31,
2016
     Sept 30,
2016
 
Sales    $ 42,039     $ 29,490     $ 36,864     $ 44,735      $ 45,530      $ 31,277     $ 37,308      $ 42,045  
Net income (loss)    ($ 2,282   ($ 1,143   ($ 607   $ 294      $ 4,325      ($ 190   $ 453      ($ 1,425
Basic earnings (loss) per share    ($ 0.05   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04

Diluted earnings (loss) per share

   ($ 0.05   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01      ($ 0.04

The Company’s Canadian vegetable growing operations peak production period is in the summer months, with no production during the winter season. As a result, prices for vegetable products from the Company’s Canadian operations have historically followed a seasonal trend of higher prices at the start and end of its crop year, with lower prices in the summer months when the supply of product is greatest. Conversely, the Company’s U.S. vegetable operations winter production allows it to realize higher prices during the October through March period, due to the reduced supply of greenhouse produce in North America during the winter months. The complementary nature of the growing seasons of the Company’s Canadian and U.S. vegetable operations allows the Company to maintain and service its core vegetable retail accounts year round.

 

11


Village Farms International, Inc.

 

 

Financial Instruments and Risk Management

Risk Management

The Company is exposed to the following risks as a result of holding financial instruments: market risk, credit risk, interest rate risk, foreign exchange risk and liquidity risk. The following is a description of these risks and how they are managed by the Company.

Market Risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market place.

Credit Risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables.

The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 11.1% and 10.6% of the balance of trade receivables as at June 30, 2018 (2017 – one customer represented 10.0%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its vegetable sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At June 30, 2018, the allowance for doubtful accounts balance was $50 (2017 – $50). The Company has not recorded bad debt expense during the three and six months ended June 30, 2018 (2017 – $nil and $nil, respectively).    

At June 30, 2018, 93.0% (December 2017 – 89.4%) of trade receivables were outstanding less than 30 days, 5.9% (December 2017 – 7.4%) were outstanding for between 30 and 90 days and the remaining 1.1% (December 2017 – 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

The Company has used derivative instruments to reduce market exposure to changes in interest rates. The Company has used derivative instruments only for risk management purposes and not for generating trading profits.

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The following are the contractual maturities of financial liabilities as at June 30, 2018:

 

12


Village Farms International, Inc.

 

 

(in thousands of U.S. dollars)

Financial liabilities

   Contractual
cash flows
     0 to 12
months
     12 to 24
months
     After 24
months
 

Accounts payable and accrued liabilities

   $ 17,436      $ 17,436      $ —        $ —    

Bank debt

     37,643        3,440        3,429        30,774  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 55,079      $ 20,876      $ 3,429      $ 30,774  
  

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash. The Company has available lines of credit of up to CA$13,000 (as at June 30, 2018, $7,000 was outstanding and US$261 and CA$38 was utilized in the form of outstanding letters of credit). If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach or default that might otherwise result there from. If the Company defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will continue to agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, and (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its common shares. See also “Risk Factors—Dependence Upon Credit Facilities” in the Company’s current Annual Information Form.

Environmental, Health and Safety Risk

The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate. Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect the Company’s operational results and profitability.

The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.

Overview

The forward-looking statements contained in this section and elsewhere in this MD&A are not historical facts, but rather, reflect the Company’s current expectations regarding future results or events and are based on information currently available to Management. Certain material factors and assumptions were applied in providing these forward-looking statements. See the “Forward-Looking Statements” section of this MD&A.

 

13


Village Farms International, Inc.

 

 

On June 6, 2017, the Company announced an initiative into growing cannabis through a joint venture with an existing licensed producer, pursuant to which the Company would contribute rights to one of its Delta greenhouses and growing knowledge in exchange for a 50% equity position. Emerald has contributed CA$20 million for its 50% equity interest. The joint venture is named “Pure Sunfarms Corp.” Pure Sunfarms received its cultivation license from Health Canada for the Delta 3 Greenhouse on March 2, 2018. Pure Sunfarms received its sales license from Health Canada on July 27, 2018. Pure Sunfarms has been harvesting cannabis since the middle of May and with its sales license has commenced the sales of dried bud to other Licensed Producers. Pure Sunfarms continues to convert the unlicensed sections of the Company’s Delta 3 greenhouse to grow cannabis and meet the required security standards for licensing under the ACMPR. Management believes that Pure Sunfarms will be successful in obtaining a cultivation license for the remainder of the facility by the end of 2018. Once the entire facility is licensed, it will be one the largest commercial cannabis production facilities in Canada. Management believes it will produce cannabis for CA$1 per gram with margins of 50% in late 2019. As such, the Company’s 50% equity interest in Pure Sunfarms is capable of generating substantially higher revenue and profits than prior revenues and profits from the tomato crop currently grown in the facility.

Pure Sunfarms will need incremental capital to complete the full buildout of the Delta 3 Greenhouse as well as for its initial working capital needs. Presently, it is in discussions with the Company’s current lenders to provide traditional term debt to Pure Sunfarms. Depending on the timing and amount of any debt funding’ additional shareholder debt or equity may have be contributed short-term debt to Pure Sunfarms to complete the full build out prior to the end of 2018. In July, each of the PSF Shareholders provided CAD $5.0 million of capital to Pure Sunfarms in the form of demand shareholder loans.

Currently, management has no intention of growing cannabis at its U.S. greenhouse facilities or holding any equity investments in U.S. cannabis cultivation businesses, in each case until it is federally legal to do so.

The Company continues to focus on increasing its produce revenues and profits on its core crops – tomatoes, cucumbers and peppers. The Company also continues to actively explore whether to produce certain higher margin alternative crops at the Company’s continuing produce facilities, such as hemp as well as evaluate other cannabis related business opportunities.

Growth expenditures

The Company expects to spend between $2.5 to $3.0 million on capital expenditures in 2018. These expenditures are to repair and enhance existing growing and pack house systems either due to obsolesces of the system or to improve operational efficiencies.

The Company has made a capital contribution of CAD$5 million to Pure Sunfarms in the form of a shareholder demand loan. Additional equity of cash will likely be required in the next twelve months depending on the final completion timeline for the Delta 3 Greenhouse and whether or not Pure Sunfarms obtains financing.

Disclosure Controls and Procedures

Disclosure controls and procedures have been designed to ensure that information to be disclosed by the Company is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosures. The Chief Executive Officer and Chief Financial Officer have concluded, as of the end of the period covered by the interim and year end filings, that the Company’s disclosure controls and procedures are appropriately designed and operating effectively to provide reasonable assurance that material information relating to the Company is made known to them by others within the Company.

Internal Control over Financial Reporting

Internal control over financial reporting is a process designed to provide reasonable assurance that all assets are safeguarded, transactions are appropriately authorized and to facilitate the preparation of relevant, reliable and timely information. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objective of the control system is met. Management has assessed the effectiveness of the Company’s internal control over financial reporting as defined by National Instrument 52-109, Certification of

 

14


Village Farms International, Inc.

 

 

Disclosure in Issuers’ Annual and Interim Filings. Management has concluded that their internal control over financial reporting was effective as of June 30, 2018. There were no material changes in the Company’s internal control over financial reporting that occurred during the three months ended June 30, 2018 that had materially affected, or is reasonably likely to affect, the Company’s internal control over financial reporting.

Risks and Uncertainties

The Company is subject to various risks and uncertainties which are summarized below, as well as those discussed in this MD&A. Additional details are contained in the Company’s current Annual Information Form dated April 2, 2018 filed on SEDAR, which can be accessed electronically at www.sedar.com .

Risks Relating to the Company

 

   

Product Pricing

 

   

Maintain Profitability

 

   

Risks Inherent in the Agricultural Business

 

   

Covenant Risk

 

   

Natural Catastrophes

 

   

Retail Consolidation

 

   

Dependence Upon Credit Facilities

 

   

Competition

 

   

Transportation Disruptions

 

   

Labour Availability

 

   

Risks Associated with Cross Border Trade

 

   

Governmental Regulations

 

   

Product Liability

 

   

Key Executives

 

   

Uninsured and Underinsured Losses

 

   

Cyber Security

 

   

Vulnerability to Rising Energy Cost

 

   

Risks of Regulatory Change

 

   

Environmental, Health and Safety Risk

 

   

Foreign Exchange Exposure

 

   

Technological Advances

 

   

Accounting Estimates

 

   

Growth

Risks Related to the Joint Venture

 

   

Reliance on Licenses

 

   

Regulatory Risks

 

   

Competition

 

   

Reliance on a Single Facility

 

   

Limited Operating History in the Cannabis Industry

 

   

Risks Inherent in an Agricultural Business

 

   

Conversion of Facility

 

   

Risks Related to the Joint Venture

 

   

Environmental Regulations and Risks

 

   

Failure to Realize Growth Strategy

 

   

Research and Development and Product Obsolescence

 

   

Fluctuating Prices of Raw Materials

 

   

Product Liability

 

   

Product Recalls

 

15


Village Farms International, Inc.

 

 

Risks Related to Tax

 

   

Transfer Pricing

 

   

Potential U.S. Permanent Establishment of VF Canada GP, VFCLP and VFF

 

   

Advances by VF Operations Canada Inc. to U.S. Holdings

 

   

U.S. Real Property Holding Corporation

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

Critical Accounting Estimates

Accounts Receivable

Accounts receivable are measured at amortized cost and due within contractual payment terms and are stated at amounts due from customers net of an allowance for doubtful accounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the bad debt expense.

Inventories

Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year and exclude biological assets (see below). Cost of sales is based upon incurred and estimated costs to be incurred from each crop allocated to both actual and estimated future yields over each crop cycle. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.

Biological Assets

Biological assets consist of the Company’s produce on the vines at the period end. The produce on the vine is measured at fair value less costs to sell and complete, with any change therein recognized in profit or loss. Costs to sell include all costs that would be necessary to sell and complete the assets, including finishing and transportation costs.

Income Taxes

The Company utilizes the assets and liability method of accounting for income taxes under which future income tax assets and liabilities are recognized for the estimated future income tax consequences attributable to differences between the financial statement carrying value amount and the tax basis of assets and liabilities. Management uses judgment and estimates in determining the appropriate rates and amounts in recording future taxes, giving consideration to timing and probability. Actual taxes could significantly vary from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities.

Future income tax assets are recognized to the extent that realization is considered more likely than not. The Company considers past results, current trends and outlooks for future years in assessing realization of income tax assets.

Impairment of Financial and Non-Financial Assets

At the end of each reporting period, the Company reviews the carrying amounts of its long lived assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. The Company estimates the recoverable amounts of the cash-generating unit (“CGU”) to which the asset belongs.

 

16


Village Farms International, Inc.

 

 

Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual CGU’s, or otherwise they are allocated to the smallest group of CGU’s for which a reasonable and consistent allocation basis can be identified. Identifiable cash flows are largely independent of the cash flows of other assets and liabilities. This was determined to be the Canadian and U.S. operations.

Recoverable amount is the higher of the fair value less costs to sell and the value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount of the asset or CGU is reduced to its recoverable amount. An impairment loss is recognized immediately in the statement of income.

Where an impairment loss subsequently reverses for assets with a finite useful life, the carrying amount of the asset or CGU is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset or CGU in prior periods. A reversal of an impairment loss is recognized immediately in the statement of income.

Due to the above-noted considerations, which are based on the Company’s best available information, the Company has not recorded any impairment charge on its non-financial assets during the three months ended June 30, 2018.

Property, Plant and Equipment – Useful Lives

Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.

Land Revaluation

Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016.

Accounting Standards Issued and Not Applied

The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, ie the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the company also applies IFRS 15. Management is currently assessing the impact on the Company’s consolidated interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

 

17


Village Farms International, Inc.

 

 

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated balance sheet date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it re-measures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Accounting Standards Adopted in the Year

The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2018. These changes were made in accordance with the applicable transitional provisions.

IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in de-recognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.

 

18


Village Farms International, Inc.

 

 

The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders it receives from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and its performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.

The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three and six months ended June 30, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the three and six months ended June 30, 2018.

Related Party Transactions

As at June 30, 2018, included in other assets is a $67 promissory note from an employee of the Company in connection with a relocation agreement. The Company has no other commitments as a result of related party transactions during the year.

Outstanding Share Data

The beneficial interests in the Company are currently divided into interests of three classes, described and designated as “Common Shares”, “Special Shares” and “Preferred Shares”, respectively. An unlimited number of Common Shares, Special Shares and Preferred Shares are issuable pursuant to VFF’s constating documents.

On December 21, 2017, VFF issued 2,500,000 Common Shares pursuant to a “bought deal” short form prospectus offering at an issue price of CAD$5.40 per Common Share for gross proceeds of CAD$13,500,000. The offering was conducted by a syndicate of underwriters led by Beacon Securities Limited.

On May 24, 2018, VFF issued 1,886,793 Common Shares pursuant to a private placement offering at an issue price of CAD$5.30 per Common Share for gross proceeds of CAD$10,000,000.

As of the date hereof, VFF has outstanding: (i) 44,472,138 Common Shares carrying the right to one vote at a meeting of voting shareholders of VFF; (ii) nil (0) Special Shares; and (iii) nil (0) Preferred Shares. In conjunction with the formation of Pure Sunfarms Corp., the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Each such warrant entitles the holder to purchase one Common Share at an exercise price of CA$2.07. Each such warrant is exercisable up to June 6, 2020.

For further details on the structure of the Company or the rights attached to each of the above-mentioned securities, please refer to the Company’s current Annual Information Form dated April 2, 2018 which is available electronically at www.sedar.com .

 

19


Village Farms International, Inc.

 

 

Forward-Looking Statements

Certain statements contained in this MD&A constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this MD&A include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable rates when required.

Although the forward-looking statements contained in this MD&A are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this MD&A and the Company’s annual information form.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this MD&A relate only to events or information as of the date on which the statements are made in this MD&A. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Public Securities Filings

You may access other information about the Company, including its current Annual Information Form and other disclosure documents, reports, statements or other information that it files with the Canadian securities regulatory authorities, through SEDAR at www.sedar.com .

 

20

Exhibit 99.42

Village Farms International Announces Appointment of Pure Sunfarms President and CEO

– Mandesh Dosanjh Brings Extensive Consumer Products Experience with

Recent Cannabis Focus at Liquor Control Board of Ontario –

VANCOUVER, August  21, 2018 – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) and Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that Mandesh Dosanjh has been appointed President and Chief Executive Officer of Pure Sunfarms Corp., their 50/50 owned cannabis joint venture, effective on or before October 1, 2018. Mr. Dosanjh joins Pure Sunfarms from his position as Senior Vice President, Supply Chain and Wholesale, at the Liquor Control Board of Ontario (LCBO), where he led LCBO’s supply chain division, and developed and managed its supply chain and wholesale strategy as the LCBO prepared for the legalization of adult-use cannabis.

Mr. Dosanjh commented, “Over the past two years at the LCBO, I became immersed in the Canadian cannabis industry and gained an in-depth knowledge and understanding of its many suppliers. Pure Sunfarms truly stands out in the industry for both the experience and expertise of its team, and the quality of its growing operations, strongly positioning it for leadership in the adult-use market,” said Mr. Dosanjh. “I look forward to the opportunity to leverage my in-depth knowledge of the Canadian cannabis product landscape, as well as my many years managing consumer packaged goods supply chains, to drive the success of Pure Sunfarms as a fully integrated cannabis products business.”

“Mr. Dosanjh will be a tremendous asset to Pure Sunfarms as it moves aggressively to become a vertically integrated cannabis products supplier,” said Michael DeGiglio, CEO, Village Farms. “His deep experience in wholesale distribution and supply for large retailers, and intricate understanding of wholesale distribution in the Canadian cannabis industry, will provide Pure Sunfarms with a significant advantage in the development of its product and distribution strategy, as well as its brand and competitive positioning in the Canadian marketplace. In all respects, we are building this company the right way to drive sustainable value for the long term.”

“Mr. Dosanjh comes to Pure Sunfarms from a unique vantage point in the Canadian cannabis industry, and we expect his insights and relationships to be invaluable in growing the business,” said Mr. Chris Wagner, CEO, Emerald Health Therapeutics. “His broad experience will also be instrumental in driving efficiencies that will benefit bottom line profit.”


Mr. Dosanjh is a seasoned supply chain executive with diverse industry experience. He has extensive experience planning and executing e-commerce, ERP, and logistics strategies focused on effectively and efficiently expanding business operations. His roles leading supply chains have provided him the opportunity to work closely with operations, quality control, IT, regulators, sales and marketing teams. As Senior Vice President, Supply Chain and Wholesale at LCBO, Mr. Dosanjh reported to the President and CEO. He was a member of the LCBO’s Executive Steering Committee for Cannabis, which provided guidance to the LCBO board of directors and Ontario government. Previously, Mr. Dosanjh held increasingly senior executive-level supply and distribution positions with a number of leading retailers, including Longo Brothers, Target Canada, Aritzia and Loblaw Companies.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.

About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group , which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”,


“estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/August2018/21/c6877.html

%SEDAR: 00029410E

For further information : Lawrence Chamberlain, Investor Relations, LodeRock Advisors, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 21-AUG-18

Exhibit 99.43

Village Farms International Announces Amendment to Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to Approximately 420,000 Square Feet

VANCOUVER, August 23, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) and Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its third amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area by 195,000 square feet to approximately 420,000 square feet of the 1.1-million square foot Delta 3 production facility. The newly licensed area will be in commercial production this week, as the Delta 3 nursery has been producing cuttings in anticipation of this expansion.

“We are thrilled with the rapid pace at which the Pure Sunfarms team continues to complete conversion of additional production area, as well as the rapid pace at which it has been able to secure amendments to its cultivation license to steadily expand production,” said Michael DeGiglio, CEO of Village Farms. “It’s a testament to the value of decades of large-scale operational experience combined with an unwavering approach to doing things the right way.”

“We look forward to completing our build-out over the next months,” said Chris Wagner, CEO of Emerald. “As October 17 th quickly approaches, we are prepared for significant sales growth and leveraging the potential of this large, highly optimized growing facility.”

Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted for cannabis production by year end. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms (seven of which are now licensed) optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.


About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group , which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/August2018/23/c1283.html

%SEDAR: 00029410E

For further information: Lawrence Chamberlain, Investor Relations, LodeRock Advisors, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 23-AUG-18

Exhibit 99.44

Village Farms International Announces Amendment to Pure Sunfarms’ Cultivation License, Expanding Cannabis Production Area to 550,000 Square Feet in One of the Single Largest Cannabis Growing Facilities in the World

– Entire First Half of 1.1 Million Square Foot Delta 3 Greenhouse Now Approved for Cultivation and Sale –

VANCOUVER, September 6, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC: VFFIF) and Emerald Health Therapeutics, Inc. (TSXV:EMH; OTCQX:EMHTF) (“Emerald”) today announced that their 50/50 joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada its fourth amendment to the cultivation license for its Delta 3 greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area to 550,000 square feet – half of the 1.1 million square foot Delta 3 production facility. The newly licensed area is expected to be in full production by mid-October of this year.

“It’s a remarkable achievement to now have 550,000 square feet – half of the 1.1 million square foot Delta 3 facility – approved for production just six months since receiving the initial cultivation license,” said Michael DeGiglio, CEO of Village Farms. “I am tremendously proud of the Pure Sunfarms team.”

“Pure Sunfarms is making great strides to achieve high-quality, low-cost cannabis production ahead of the Canadian government’s legalization of adult-use cannabis on October 17,” said Chris Wagner, CEO of Emerald.

In July, Pure Sunfarms received its sales license from Health Canada, permitting it to sell cannabis produced in the Delta 3 greenhouse facility. Pure Sunfarms expects to have the full 1.1 million square foot Delta 3 facility, one of the single largest cannabis growing facilities in the world, converted for cannabis production by year end. The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 17 grow rooms (nine of which are now licensed) optimized for year-round harvesting (more than 85 harvests annually) and an automated process line encompassing harvesting, trimming, drying and packaging.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. With more than 750 years of accumulated master grower experience coupled with advanced proprietary technology and environmentally sustainable growing practices, Village Farms is highly resource efficient. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from its large-scale Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in BC, Ontario, and Mexico.


About Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics (TSXV: EMH; OTCQX: EMHTF; Frankfurt: TBD) is licensed in Canada to produce and sell dried cannabis and cannabis oil for medical purposes. Emerald is preparing to serve the fully legalized Canadian adult-use cannabis market starting October 17, 2018. Emerald owns 50% of Pure Sunfarms, which is converting a licensed existing 1.1 million square foot greenhouse in Delta, BC and is now in commercial production. It owns Agro-Biotech, a Québec-based licensed cannabis grower with a 75,000 square foot indoor facility and is planning to add a 500,000 square foot greenhouse in Metro Vancouver. Emerald’s team is highly experienced in life sciences, product development, large-scale agri-business, and marketing, and is focused on developing value-added cannabis-based products with potential wellness and medical benefits. Emerald is part of the Emerald Health group , which is broadly focused on developing pharmaceutical, botanical, and nutraceutical products that may provide wellness and medical benefits by interacting with the human body’s endocannabinoid system.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/September2018/06/c6601.html

%SEDAR: 00029410E

For further information : Contact Information: Lawrence Chamberlain, Investor Relations, LodeRock Advisors, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 06-SEP-18

Exhibit 99.45

Village Farms International Announces $20 Million Bought

Deal Public Offering of Common Shares

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES OR FOR

DISSEMINATION IN THE UNITED STATES/

Vancouver, BC, September  24, 2018 – Village Farms International, Inc. (“ Village Farms ” or the “ Company ”) (TSX: VFF) (OTCQX: VFFIF) is pleased to announce that it has entered into an agreement with Beacon Securities Limited (“ Beacon ”), as lead underwriter, on its own behalf and on behalf of a syndicate of underwriters (together with Beacon, the “ Underwriters ”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 2,810,000 common shares (the “ Offered Shares ”) in the capital of the Company at a price of $7.13 per Offered Share (the “ Issue Price ”) for aggregate gross proceeds to the Company of $20,035,300 (the “ Offering ”). (All figures are in Canadian dollars unless otherwise stated.)

In addition, the Company has granted the Underwriters an over-allotment option, exercisable, in whole or in part, by Beacon, on behalf of the Underwriters, to purchase up to an additional number of Offered Shares equal to 15% of the Offered Shares sold pursuant to the Offering, at the Issue Price, at any time up to 30 days from the closing of the Offering.

The closing of the Offering is expected to occur on or about October 12, 2018 and is subject to the completion of formal documentation and receipt of regulatory approval, including the approval of the Toronto Stock Exchange. The net proceeds of the Offering will be used by the Company for working capital and general corporate purposes.

The Offered Shares will be offered by way of a short form prospectus to be filed in each of the Provinces of Canada (other than Quebec) and may be offered in the United States to Qualified Institutional Buyers pursuant to exemptions from the registration requirements under rule 144A of the United States Securities Act of 1933, as amended, in a manner that does not require the Offered Shares to be registered in the United States. The Offered Shares may be also sold in such other jurisdictions as the Company and Beacon may agree. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.


Cautionary Language Regarding Forward-Looking Statements

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements concerning: (i) the Offering; and (ii) the use of the proceeds of the Offering. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors” set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2017, and for the three and six months ended June 30, 2018, which are available electronically at www.sedar.com. Actual results may differ materially from any forward-looking statements. Although the Company believes that its forwardlooking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forwardlooking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.

Contact Information

Stephen C. Ruffini

Executive Vice President and Chief Financial Officer

Village Farms International, Inc.

(407) 936-1190, ext. 340

Lawrence Chamberlain

Investor Relations

(416) 519-4196

lawrence.chamberlain@loderockadvisors.com

Exhibit 99.46

FORM 51-102F3

Material Change Report

 

Item 1

Name and Address of Company

Village Farms International, Inc. (“ Village Farms ”)

4700 - 80th Street

Delta, British Columbia

V4K 3N3

 

Item 2

Date of Material Change

September 24, 2018.

 

Item 3

News Release

A news release was issued through CNW Group on September 24, 2018.

 

Item 4

Summary of Material Change

Village Farms announced that it has entered into an agreement with Beacon Securities Limited (“ Beacon ”), as lead underwriter, on its own behalf and on behalf of a syndicate of underwriters (together with Beacon, the “ Underwriters ”), pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 2,810,000 common shares (the “ Offered Shares ”) in the capital of Village Farms at a price of C$7.13 per Offered Share (the “ Issue Price ”) for gross proceeds to Village Farms of C$20,035,300 (the “ Offering ”).

In addition, Village Farms has granted the Underwriters an over-allotment option, exercisable, in whole or in part, by Beacon, on behalf of the Underwriters, to purchase up to an additional number of Offered Shares equal to 15% of the Offered Shares sold pursuant to the Offering, at the Issue Price, at any time up to 30 days from the closing of the Offering (the “Over-Allotment Shares”).

 

Item 5

Full Description of Material Change

5.1 - Full Description of Material Change

Village Farms announced that it has entered into an agreement with Beacon, as lead underwriter, on its own behalf and on behalf of a syndicate of underwriters, pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, the Offered Shares in the capital of Village Farms at a price of C$7.13 per Offered Share for gross proceeds to Village Farms of C$20,035,300.

In addition, Village Farms has granted the Underwriters an over-allotment option, exercisable, in whole or in part, by Beacon, on behalf of the Underwriters, to purchase Over-Allotment Shares, at the Issue Price, at any time up to 30 days from the closing of the Offering.

The closing of the Offering is expected to occur on or about October 12, 2018 and is subject to the completion of formal documentation and receipt of regulatory approval, including the approval of the Toronto Stock Exchange. The net proceeds from the Offering will be used for working capital and general corporate purposes.


The Offered Shares and any Over-Allotment Shares to be issued under the Offering will be offered by way of a short form prospectus to be filed in each of the Provinces of Canada (other than Quebec) and may be offered in the United States to Qualified Institutional Buyers pursuant to exemptions from the registration requirements under rule 144A of the United States Securities Act of 1933, as amended, in a manner that does not require the Offered Shares or any Over-Allotment Shares to be registered in the United States. The Offered Shares and any Over-Allotment Shares may be also sold in such other jurisdictions as Village Farms and Beacon may agree.

5.2 - Disclosure for Restructuring Transactions

Not applicable.

 

Item 6

Reliance on subsection 7.1(2) of National Instrument 51-102

Not applicable.

 

Item 7

Omitted Information

No information has been omitted from this report on the basis that it is confidential information.

 

Item 8

Executive Officer

For further information, please contact Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, at (407) 936-1190, ext. 340.

 

Item 9

Date of Report

September 25, 2018.

Exhibit 99.47

VILLAGE FARMS INTERNATIONAL JOINS INDUSTRY ADVOCATE FOR FULL LEGALIZATION OF HEMP IN THE U.S.

VANCOUVER, September  25, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTC:VFFIF) today announced that it has been accepted as a member of the board of the U.S. Hemp Roundtable ( www.hempsupporter.com ), a coalition of dozens of companies and major national grassroots organizations advocating for the full and permanent legalization of hemp in the United States. Village Farms is one of the first large agricultural companies and the first greenhouse grower to join the U.S. Hemp Roundtable.

Hemp, also known as “industrial hemp”, refers to varieties of the cannabis sativa plant with very low levels of the psychoactive compound, tetrahydrocannabinol (THC) (commonly defined as less than 0.3% concentration of THC) and a key input for the production of a vast array of consumer and industrial products. Hemp is also a source of cannabidiol (CBD), a compound that has become increasingly popular among consumers nationwide to improve their general health and wellness. In the U.S. currently, hemp is a Schedule I controlled substance and cannot be legally cultivated, except under state agricultural pilot programs authorized by the 2014 Farm Bill. The Hemp Farming Act of 2018 is a proposed U.S. law that would permanently remove hemp as a Schedule I controlled substance, legalizing its cultivation and making it an ordinary agricultural commodity.

“Village Farms has been at the leading edge of new agricultural opportunities that can more profitably leverage our decades of experience as a vertically integrated greenhouse grower coupled with the scale and excellence of our North America greenhouse operations,” said Stephen C. Ruffini, CFO of Village Farms International. “We look forward to making a meaningful contribution to the U.S. Hemp Roundtable’s pursuit of establishing hemp as a legal agricultural commodity.”

About the U.S. Hemp Roundtable

Launched in early 2017, the U.S. Hemp Roundtable is a coalition of more than fifty hemp companies – representing every link of the product chain, from seed to sale – and all of the industry’s major national grassroots organizations. Its primary goal is to secure passage of bi-partisan legislation in the U.S. Congress that would establish hemp as an agricultural commodity, and permanently remove it from regulation as a controlled substance. Its efforts include an aggressive, targeted, grass-tops lobbying campaign that brings leading farmers and business executives to Washington to secure final passage of the Hemp Farming Act of 2018.

In order to build political support – and ensure the long-term viability of the industry – the Roundtable’s mission also includes:

 

   

Facilitating information exchange with law enforcement and federal agency officials

 

   

The seeding and infrastructure development of an independent, self-regulatory organization (SRO), including the drafting of regulatory-acceptable specifications and standards.

 

   

Continued long-term legislative advocacy on other major policy issues, remaining vigilant against potential attempts of rival industries to halt hemp’s progress.

For more information, visit: www.hempsupporter.com .


About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook,” “may,” “might,” “will,” “could,” “should,” “would,” “occur,” “expect,” “plan,” “anticipate,” “believe,” “intend,” “estimate,” “predict,” “potential,” “continue,” “likely,” “schedule,” “objectives,” or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/September2018/25/c2492.html

%SEDAR: 00029410E

For further information: Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 25-SEP-18

Execution Version

Exhibit 99.48

UNDERWRITING AGREEMENT

September 27, 2018

Village Farms International, Inc.

4700-80th Street

Delta, British Columbia V4K 3N3

 

Attention:    Michael A. DeGiglio, President and Chief Executive Officer
   Stephen C. Ruffini, Executive Vice President and Chief Financial Officer

Dear Sirs:

Beacon Securities Limited (“ Beacon ”), as lead underwriter and sole bookrunner, and GMP Securities L.P., as underwriters (together with Beacon, the “ Underwriters ”) hereby severally, and not jointly and severally, offer and agree to purchase, on a “bought deal” basis in the Qualifying Jurisdictions (as defined herein) from Village Farms International, Inc. (the “ Company ”), and the Company hereby agrees to issue and sell to the Underwriters an aggregate of 2,810,000 common shares (the “ Initial Shares ”) in the capital of the Company at the purchase price of $7.13 per Initial Share (the “ Issue Price ”), for aggregate gross proceeds of $20,035,300, upon and subject to the terms and conditions contained herein (the “ Offering ”). After a reasonable effort has been made to sell all of the Offered Shares at the Issue Price, the Underwriters may subsequently reduce the selling price to investors from time to time, provided that any such reduction in the Issue Price shall not affect the aggregate gross proceeds less Underwriters’ Fees (as defined herein) payable to the Company.

Upon and subject to the terms and conditions herein set forth and in reliance upon the representations and warranties herein contained, the Company hereby grants to the Underwriters, in the respective percentages set out in Section 38 of this Agreement, an option (the “ Over-Allotment Option ”) to purchase up to 421,500 additional common shares (the “ Additional Shares ”) in the capital of the Company at the Issue Price, that is exercisable on or before 5:00 p.m. (Toronto time) on the date that is thirty (30) days after the Closing Date (as defined below). The Over-Allotment Option may be exercised in whole or in part at any time and from time to time prior to its expiry in accordance with the provisions of this Agreement. The Underwriters shall be under no obligation whatsoever to exercise the Over-Allotment Option in whole or in part.

Delivery of and payment for any Additional Shares will be made at the time and on the date (each an “ Option Closing Date ”) as set out in a written notice of Beacon, on behalf of the Underwriters, referred to below, which Option Closing Date may occur on the Closing Date but will in no event occur earlier than the Closing Date nor later than seven Business Days after the date upon which the Company receives a written notice from Beacon, on behalf of the Underwriters, setting out the number of Additional Shares to be purchased by the Underwriters. Any such notice must be received by the Company not later than 5:00 p.m. (Toronto time) on the date that is thirty (30) days after the Closing Date. Upon the furnishing of such a notice, the Underwriters will be committed to purchase, and the Company will be committed to sell and deliver to the Underwriters, in accordance with and subject to the provisions of this Agreement, the number of Additional Shares indicated in such notice. Unless the context otherwise requires or unless otherwise specifically stated, all references in this Agreement to the “ Offering ” shall be deemed to include the Over-Allotment Option and all references in this Agreement to “ Offered Shares ” shall mean the Initial Shares and the Additional Shares.


In consideration of the Underwriters’ services to be rendered in connection with the Offering, the Company agrees to pay to the Underwriters (i) at the Closing Time (as defined herein) on the Closing Date an aggregate cash fee of $1,202,118, being a fee equal to 6.0% of the aggregate purchase price of the Initial Shares, and (ii) at the Closing Time on each Option Closing Date an aggregate cash fee equal to 6.0% of the aggregate purchase price of the Additional Shares purchased at that time (the fees referred to in (i) and (ii) are collectively the “ Underwriters’ Fees ”). In the event that the Over-Allotment Option is exercised in full, the aggregate Underwriters’ Fee shall be $1,382,435.70.

The Company agrees that each of the Underwriters will be permitted to appoint, at the sole cost and expense of the Underwriter so appointing, other registered dealers (or other dealers duly qualified in their respective jurisdictions) as their agents to assist in the Offering, and that the Underwriters may determine the remuneration payable by the Underwriters to such other dealers appointed by them.

The Offering is conditional upon and subject to the additional terms and conditions set forth below. The following are additional terms and conditions of the Agreement between the Company and the Underwriters:

 

1.

Interpretation

Definitions – In addition to the terms previously defined and terms defined elsewhere in this Agreement (as defined herein), where used in this Agreement or in any amendment hereto, the following terms shall have the following meanings, respectively:

ACMPR ” means the Access to Cannabis for Medical Purposes Regulations (Canada) issued pursuant to the Controlled Drugs and Substances Act;

Agreement ” means this underwriting agreement dated September 27, 2018 between the Company and the Underwriters, as the same may be supplemented, amended and/or restated from time to time;

Ancillary Documents ” means all agreements, indentures, certificates (including the certificates, if any, representing the Offered Shares), officer’s certificates, notices and other documents executed and delivered, or to be executed and delivered, by the Company in connection with the Offering, whether pursuant to Applicable Securities Laws or otherwise;

Applicable Laws ” means all laws and all other statutes, regulations, rules, orders, by-laws, codes, ordinances, decrees, the terms and conditions of any grant of approval, permission, authority or license, or any judgment, order, decision, ruling, award, policy or guideline, of any Governmental Authority, including Applicable Securities Laws and Applicable Regulatory Laws;

Applicable Regulatory Laws ” means collectively, (i) the federal , provincial, state, municipal and local laws which govern agriculture in Canada and the United States, including, without limitation, the Canada Agriculture Products Act, Agriculture Products Marketing Act , Farm Products Marketing Act , and associated order and regulations, the U.S. Food Quality Protection of Act of 1996 , the Perishable Agricultural Commodities Act , and (ii) the laws that govern the cultivation, processing, and sale of cannabis, namely the Controlled Drugs and Substances Act , the Food and Drugs Act and the Cannabis Act (as of October 17, 2018) and their associated regulations including the ACMPR and Food and Drug Regulations and the Narcotic Control Regulations and the Cannabis Regulations (as of October 17, 2018);

 

2


Applicable Securities Laws ” means, collectively, the applicable securities laws of each of the Qualifying Jurisdictions and their respective regulations, rulings, rules, blanket orders, instruments, fee schedules and prescribed forms thereunder, the applicable policy statements issued by the Securities Commissions and the rules and policies of the TSX;

BCSC ” means the British Columbia Securities Commission;

Beneficiaries ” has the meanings ascribed thereto in Section 33(c) of this Agreement;

Bid Letter ” means the letter agreement dated September 23, 2018 and reconfirmed on September 24, 2018, between the Company and Beacon;

Business Day ” means a day, other than a Saturday, a Sunday or a day on which chartered banks are not open for business in Toronto, Ontario;

CDS ” means CDS Clearing and Depository Services Inc.;

Claims ” and “ Claim ” have the meanings ascribed thereto in Section 33(a) of this Agreement;

Closing ” means the closing of the Offering;

Closing Date ” means October 12, 2018 or such other date (not to exceed 42 days from the date of the Final Receipt) as may be agreed to in writing by the Company and the Underwriters, each acting reasonably;

Closing Time ” means 8:30 a.m. (Toronto time) on the Closing Date or Option Closing Date, as the case may be, or such other time on the Closing Date or Option Closing Date as may be agreed to by the Company and Beacon on behalf of the Underwriters;

Common Shares ” means the common shares in the capital of the Company;

Continuing Underwriters ” has the meaning ascribed thereto in Section 38 of this Agreement;

Credit Facilities ” means, collectively, (i) the term facility among the Company and certain affiliates, as guarantors, and Farm Credit Canada entered into on March 28, 2013, as amended from time to time, (ii) the operating credit facility among the Company and a Canadian chartered bank dated August 29, 2013, as amended from time to time, with a maturity date of October 12, 2021, and (iii) the loan agreement between VF Clean Energy, Inc. and a Canadian chartered bank dated July 31, 2014;

Defaulted Shares ” has the meaning ascribed thereto in Section 38 of this Agreement;

Disclosure Record ” means the Company’s prospectuses, annual reports, annual and interim financial statements, annual information forms, business acquisition reports, management discussion and analysis of financial condition and results of operations, information circulars, material change reports, press releases and all other information or documents required to be filed or furnished by the Company under Applicable Securities Laws which have been publicly filed or otherwise publicly disseminated by the Company;

distribution ” means distribution or distribution to the public, as the case may be, for the purposes of Applicable Securities Laws;

 

3


Documents Incorporated by Reference ” means the documents specified in the Preliminary Prospectus or Prospectus, as the case may be, as being incorporated therein by reference or which are deemed to be incorporated therein by reference pursuant to Applicable Securities Laws;

Eligible Issuer ” means an issuer which meets the criteria and has complied with the requirements of NI 44-101 so as to be qualified to offer securities by way of a short form prospectus under Applicable Securities Laws;

Environmental Laws ” has the meaning ascribed thereto in Section 28(ll) of this Agreement;

FDA ” has the meaning ascribed thereto in Section 28(bbb) of this Agreement;

Final Receipt ” means the Passport Receipt for the Prospectus;

Financial Promotion Order ” has the meaning ascribed thereto in Section 24(d) of this Agreement;

Financial Statements ” means, collectively, (i) the audited consolidated financial statements of the Company incorporated by reference in the Offering Documents as at and for the financial year of the Company ended December 31, 2017 (which financial statements include comparative financial information for the financial year of the Company ended December 31, 2016), together with the report of PricewaterhouseCoopers LLP on those financial statements, and including the notes with respect to those financial statements, and (ii) the unaudited condensed consolidated interim financial statements of the Company incorporated by reference in the Offering Documents as at and for the three and six months ended June 30, 2018 (which financial statements include comparative financial information for the three and six months ended June 30, 2017), and including the notes with respect to those financial statements;

FSMA ” has the meaning ascribed thereto in Section 24(d) of this Agreement;

Governmental Authority ” means and includes, without limitation, any national, federal, provincial, state or municipal government or other political subdivision of any of the foregoing, any entity exercising executive, legislative, judicial, regulatory or administrative functions of or pertaining to government and any corporation or other entity owned or controlled (through stock or capital ownership or otherwise) by any of the foregoing;

Governmental Licences ” has the meaning ascribed thereto in Section 28(uu) of this Agreement;

Hazardous Materials ” means any contaminant, pollutant, waste, subject waste, hazardous waste, deleterious substance, industrial waste, toxic matter or any other substance including breakdown products or related substances that when released into the natural environment is likely to cause, at some immediate or future time, material harm or degradation to the natural environment or material risk to human health and, without restricting the generality of the foregoing, includes any contaminant, pollutant, waste, subject waste, deleterious substance, industrial waste, toxic matter, hazardous waste or dangerous goods as defined under any provision of Environmental Laws;

IFRS ” means International Financial Reporting Standards as issued by the International Accounting Standards Board, which were adopted by the Canadian Accounting Standards Board as Canadian generally accepted accounting principles applicable to publicly accountable enterprises;

 

4


Indemnified Parties ” and “Indemnified Party ” have the meanings ascribed thereto in Section 33(a) of this Agreement;

Intellectual Property ” means all domestic and foreign (a) inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto and all patents, patent applications, patent disclosures and industrial designs, together with all re-issuances, continuations, continuations-in-part, revisions, extensions and re-examinations thereof, (b) trademarks, service marks, trade dress, trading styles, logos, trade names and business names, domain names, social media handles, together with all translations, adaptations, derivations and combinations thereof and including all goodwill associated therewith and all applications, registrations and renewals in connection therewith, (c) copyrightable works, copyrights and applications, registrations and renewals in connection therewith, (d) trade secrets and confidential business information (including ideas, research and development, know-how, formulas, algorithms, compositions, manufacturing and production processes and techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals), (e) computer systems, software, data and related documentation, (f) right, title and interest as licensee or authorized user of any of the aforementioned intellectual property, and (g) copies and tangible embodiments thereof in whatever form or medium whether now known or hereafter developed;

Key Properties ” means the property located at 4431—80th Street, Delta, British Columbia;

License ” has the meaning ascribed thereto in Section 28(vv) of this Agreement;

Losses ” has the meaning ascribed thereto in Section 33(a) of this Agreement;

marketing materials ” and “ template version ” shall have their respective meanings ascribed thereto in NI 41-101;

Material Adverse Effect ” means any event, fact, circumstance, development, occurrence or state of affairs that is materially adverse to the business, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, properties, condition (financial or otherwise) or results of operations of the Company and the Subsidiaries, taken as a whole, whether or not arising in the ordinary course of business;

material change ” has the meaning ascribed thereto under Applicable Securities Laws;

material fact ” has the meaning ascribed thereto under Applicable Securities Laws;

Material Subsidiaries ” means (i) Village Farms Canada GP Inc., (ii) Village Farms Canada Limited Partnership, (iii) VF Operations Canada Inc., (iv) VF U.S. Holdings Inc., (v) Agro Power Development Inc., (vi) Village Farms Delaware, L.L.C., (vii) Village Farms, L.P., (viii) VF Clean Energy, Inc., and (ix) Pure Sunfarms, and “ Material Subsidiary ” means any one of them, as the context requires or permits;

misrepresentation ” has the meaning ascribed thereto under Applicable Securities Laws;

NI 44-101 ” means National Instrument 44-101 Short Form Prospectus Distributions of the Canadian Securities Administrators;

NI 51-102 ” means National Instrument 51-102 Continuous Disclosure Obligations of the Canadian Securities Administrators;

 

5


Offering Documents ” means, collectively, the Preliminary Prospectus, the Prospectus and any Supplementary Material;

Option ” means the option of Pure Sunfarms to purchase the common shares and any other shares of Pure Sunfarms Canada Corp. from Emerald Health Botanicals Inc. pursuant to the option agreement among such parties dated October 31, 2017;

Passport Receipt ” means a receipt issued by the BCSC as principal regulator pursuant to the Passport System and which evidences the receipt or the deemed receipt of the Securities Commissions of the Qualifying Jurisdictions for the Preliminary Prospectus or the Prospectus, as the case may be;

Passport System ” means the passport system procedures provided for under National Policy 11-202— Process for Prospectus Reviews in Multiple Jurisdictions of the Canadian Securities Administrators;

person ” means an individual, a firm, a corporation, a syndicate, a partnership, a trust, an association, an unincorporated organization, a joint venture, an investment club, a government or an agency or political subdivision thereof and every other form of legal or business entity of any nature or kind whatsoever;

Preliminary Prospectus ” means the preliminary short form prospectus of the Company dated the date hereof, including all of the Documents Incorporated by Reference therein, relating to the qualification in all of the Qualifying Jurisdictions of the distribution of the Offered Shares under Applicable Securities Laws;

Preliminary Receipt ” means the Passport Receipt for the Preliminary Prospectus;

“Properties” means the Key Properties and the other real property owned or held for use by the Company or any of its Subsidiaries;

Prospectus ” means the (final) short form prospectus of the Company, including all of the Documents Incorporated by Reference therein, to be prepared in connection with the qualification in all of the Qualifying Jurisdictions of the distribution of the Offered Shares under Applicable Securities Laws;

Pure Sunfarms ” means Pure Sunfarms Corp.;

Qualification ” has the meaning ascribed thereto in Section 28(aa) of this Agreement;

Qualifying Jurisdictions ” means all of the Provinces of Canada (other than the Province of Quebec);

Securities Commission ” means the applicable securities commission or regulatory authority in each of the Qualifying Jurisdictions and “ Securities Commissions ” means all of them;

Securityholders Agreement ” means the amended and restated securityholders’ agreement dated December 31, 2009, among the Company, VF Opco and the VF Owners;

SEDAR ” means the System for Electronic Document Analysis and Retrieval;

Selling Firm ” has the meaning ascribed thereto in Section 24(a) of this Agreement;

 

6


Standard Listing Conditions ” has the meaning ascribed thereto in Section 25(a)(iv) of this Agreement;

Subsequent Disclosure Documents ” means any annual and/or interim financial statements, management’s discussion and analysis of financial condition and results of operations, information circulars, annual information forms, material change reports or other documents issued by the Company after the date of this Agreement that are required to be incorporated by reference into the Preliminary Prospectus and/or the Prospectus;

Subsidiary ” means those entities that would be considered a subsidiary of the Company pursuant to Applicable Securities Laws of the Province of Ontario and includes the Material Subsidiaries, and “ Subsidiaries ” means all of them;

Supplementary Material ” means, collectively, any amendment to or amendment and restatement of the Preliminary Prospectus and/or the Prospectus, and any further amendment, amendment and restatement or supplemental prospectus thereto or ancillary materials that may be filed by or on behalf of the Company under Applicable Securities Laws relating to the distribution of the Offered Shares thereunder;

Tax Act ” means the Income Tax Act (Canada), together with all regulations promulgated thereunder, and including all specific proposals to amend the Tax Act publicly announced by or on behalf of the Minister of Finance (Canada) prior to the date hereof;

Taxes ” means all income tax, capital tax, payroll taxes, employer health tax, workers’ compensation payments, excise taxes, property taxes, custom and land transfer taxes, duties, royalties, levies, imposts, assessments, deductions, charges or withholdings and all liabilities with respect thereto, including any penalty, interest or fine payable with respect thereto;

Term Sheet ” means the term sheet dated September 24, 2018, relating to the Offering;

TSX ” means the Toronto Stock Exchange;

VF Opco ” means VF Operations Canada Inc., a corporation incorporated under the laws of Canada; and

VF Owners ” means Michael DeGiglio, Albert Vanzeyst, Kenneth Hollander, Vanzeyst Holdings Company, Hollander Holdings Company, DeGiglio Holdings Company and certain permitted transferees.

Other

 

  (a)

Capitalized terms used but not defined herein have the meanings ascribed to them in the Preliminary Prospectus or, upon filing of the Prospectus, the Prospectus.

 

  (b)

Any reference in this Agreement to a Section shall refer to a section of this Agreement.

 

  (c)

All words and personal pronouns relating thereto shall be read and construed as the number and gender of the party or parties referred to in each case require and the verb shall be construed as agreeing with the required word and/or pronoun.

 

  (d)

Any reference in this Agreement to “$” or to “dollars” shall refer to the lawful currency of Canada, unless otherwise specified.

 

7


  (e)

Where any representation or warranty contained in this Agreement or any Ancillary Document is expressly qualified by reference to the “knowledge” of the Company, or where any other reference is made herein or in any Ancillary Document to the “knowledge” of the Company, it shall be deemed to refer to the actual knowledge of (i) Michael DeGiglio, President and Chief Executive Officer, and (ii) Stephen Ruffini, Executive Vice President and Chief Financial Officer, after having made due enquiry of appropriate and relevant persons and documentation (which for greater certainty shall exclude any due diligence reports or materials prepared by the Underwriters or their counsel).

 

2.

Nature of Transaction

Each purchaser participating in the Offering who is resident in a Qualifying Jurisdiction shall purchase the Offered Shares pursuant to the Prospectus. Each other purchaser participating in the Offering not resident in a Qualifying Jurisdiction, or located outside of a Qualifying Jurisdiction, shall purchase Offered Shares, which have been qualified by the Prospectus in Canada, only on a private placement basis under the applicable securities laws of the jurisdiction in which the purchaser is resident or located, in accordance with such procedures as the Company and the Underwriters may mutually agree, acting reasonably, in order to fully comply with Applicable Laws and the terms of this Agreement. The Company hereby agrees to comply with all Applicable Securities Laws on a timely basis in connection with the distribution of the Offered Shares and the Company shall execute and file with the Securities Commissions all forms, notices and certificates relating to the Offering required to be filed pursuant to Applicable Securities Laws in the Qualifying Jurisdictions within the time required, and in the form prescribed, by Applicable Securities Laws. The Underwriters agree to use commercially reasonable efforts to assist the Company to secure compliance with all regulatory requirements in connection with the Offering, and to offer the Offered Shares for sale only in the Qualifying Jurisdictions and, subject to the consent of the Company, in such jurisdictions outside of the Qualifying Jurisdictions where permitted by and in accordance with Applicable Securities Laws and the applicable securities laws of such other jurisdictions, and provided that in the case of jurisdictions other than the Qualifying Jurisdictions, the Company shall not be required to become registered or file a prospectus or registration statement or similar document in such jurisdictions. The Company also agrees to file within the periods stipulated under Applicable Laws outside of Canada and at the Company’s expense all private placement forms required to be filed by the Company in connection with the Offering and pay all filing fees required to be paid in connection therewith so that the distribution of the Offered Shares outside of Canada may lawfully occur without the necessity of filing a prospectus or any similar document under the Applicable Laws outside of Canada.

 

3.

Filing of Prospectus

 

  (a)

The Company shall:

 

  (i)

not later than 10:00 p.m. (Eastern time) on the date that is four Business Days following September 24, 2018 have prepared and filed the Preliminary Prospectus and other required documents with the Securities Commissions under Applicable Securities Laws, elected to use the Passport System and designated the BCSC as the principal regulator thereunder, and as soon as possible thereafter shall have obtained a Preliminary Receipt from the BCSC under the Passport System which shall evidence that a receipt has been issued or is deemed to have been issued for the Preliminary Prospectus by each of the Securities Commissions; and

 

8


  (ii)

forthwith after any comments with respect to the Preliminary Prospectus have been received from the Securities Commissions but, in any event, not later than 12:00 p.m. (Eastern time) on October 5, 2018 (or such later date as may be agreed to in writing by the Company and Beacon on behalf of the Underwriters), have prepared and filed the Prospectus and other required documents with the Securities Commissions under Applicable Securities Laws, elected to use the Passport System and designated the BCSC as the principal regulator thereunder, and shall have obtained a Final Receipt from the BCSC under the Passport System which shall also evidence that a receipt has been issued or is deemed to have been issued for the Prospectus by each of the Securities Commissions and otherwise fulfilled all legal requirements to qualify the Offered Shares for distribution to the public in the Qualifying Jurisdictions through the Underwriters or any other registered dealer in the applicable Qualifying Jurisdictions.

 

  (b)

During the period of distribution of the Offered Shares, the Company will promptly take, or cause to be taken, any additional steps and proceedings that may from time to time be required under Applicable Securities Laws, or reasonably requested by Beacon on behalf of the Underwriters, to continue to qualify the distribution of the Offered Shares.

 

  (c)

Prior to the filing of the Preliminary Prospectus and the Prospectus and thereafter, during the period of distribution of the Offered Shares, including prior to the filing of any Supplementary Material, the Company shall have allowed the Underwriters to review and comment on such documents and shall have allowed the Underwriters to conduct all due diligence investigations (including through the conduct of oral due diligence sessions at which management of the Company, the chair of the Company’s audit committee, its current auditors, legal counsel and other applicable experts) which they may reasonably require in order to fulfill their obligations as underwriters in order to enable them to execute the certificate required to be executed by them at the end of the Offering Documents.

 

4.

Distribution and Certain Obligations of Underwriters

 

  (a)

The Underwriters shall, and shall require any investment dealer (other than the Underwriters) with which the Underwriters have a contractual relationship in respect of the distribution of the Offered Shares (each, a “ Selling Firm ”) to agree to, comply with Applicable Securities Laws in connection with the distribution thereof and shall offer the Offered Shares for sale to the public directly and through Selling Firms upon the terms and conditions set out in the Prospectus and this Agreement. The Underwriters shall, and shall require any Selling Firm to agree to, offer for sale to the public and sell the Offered Shares only in those jurisdictions where they may be lawfully offered for sale or sold and shall seek the prior consent of the Company, such consent not to be unreasonably withheld, regarding the jurisdictions other than the Qualifying Jurisdictions where the Offered Shares are to be offered and sold. The Underwriters shall: (i) use all commercially reasonable efforts to complete and cause each Selling Firm to complete the distribution of the Offered Shares as soon as reasonably practicable but in any event no later than 42 days after the date of the Final

 

9


  Receipt; and (ii) as soon as practicable after the completion of the distribution of the Offered Shares, and in any event within 30 days after the Closing Date, notify the Company thereof and provide the Company with a breakdown of the number of Offered Shares distributed in the Qualifying Jurisdictions.

 

  (b)

For the purposes of this Section 24, the Underwriters shall be entitled to assume that the Offered Shares are qualified for distribution in any Qualifying Jurisdiction where a Passport Receipt or similar document for the Prospectus shall have been obtained from or deemed issued by the applicable Securities Commission (including a Final Receipt for the Prospectus issued under the Passport System) following the filing of the Prospectus unless otherwise notified in writing.

 

  (c)

During the distribution of the Offered Shares, other than the Offering Documents, the press release announcing the Offering and the Term Sheet (which the Company and the Underwriters agree is a “template version” within the meaning of NI 44-101 of such marketing materials), the Underwriters shall not provide any potential investor with any materials or written communication in relation to the distribution of the Offered Shares. The Company, and the Underwriters (on a several basis), each covenant and agree (i) not to provide any potential investor of Offered Shares with any marketing materials unless a template version of such marketing materials has been filed by the Company with the Securities Commissions on or before the day such marketing materials are first provided to any potential investor of Offered Shares, (ii) not to provide any potential investor in the Qualifying Jurisdictions with any materials or information in relation to the distribution of the Offered Shares or the Company other than (a) such marketing materials that have been approved and filed in accordance with NI 44-101, (b) the Preliminary Prospectus, the Prospectus and any Supplementary Material, and (c) any “standard term sheets” (within the meaning of Applicable Securities Laws) approved in writing by the Company and Beacon on behalf of the Underwriters, and (iii) that any marketing materials approved and filed in accordance with NI 44-101 and any standard term sheets approved in writing by the Company and Beacon on behalf of the Underwriters, shall only be provided to potential investors in the Qualifying Jurisdictions.

 

  (d)

Each of the Company and the Underwriters acknowledge that (i) the Prospectus is for distribution only to persons who (A) are outside of the United Kingdom, (B) are “qualified investors” within the meaning of Section 86(7) of the Financial Services and Markets Act 2000 , as amended (the “ FSMA ”) and either have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “ Financial Promotion Order ”) or fall within Article 49(2)(a) to (d) (“high net worth companies, unincorporated associations etc.”) of the Financial Promotion Order, or (C) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the FSMA) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant person s ”); (ii) the Prospectus is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons; and (iii) any investment or investment activity to which the Prospectus relates is available only to relevant persons and will be engaged in only with relevant persons.

 

10


  (e)

Notwithstanding the foregoing provisions of this Section 24, an Underwriter will not be liable to the Company under this Section 24 with respect to a default under this Section 24 by another Underwriter. However, each Underwriter shall be liable to the Company under this Section 24 with respect to any breach by it of this Section 24.

 

5.

Deliveries on Filing and Related Matters

 

  (a)

The Company shall deliver to each of the Underwriters:

 

  (i)

concurrently with the filing of each of the Preliminary Prospectus and the Prospectus, as the case may be, a copy of each of the Preliminary Prospectus and Prospectus, as the case may be, signed by the Company as required by Applicable Securities Laws;

 

  (ii)

concurrently with the filing thereof, a copy of any Supplementary Material required to be filed by the Company in compliance with Applicable Securities Laws;

 

  (iii)

concurrently with the filing of the Prospectus with the Securities Commissions, a “long form” comfort letter dated the date of the Prospectus, in form and substance satisfactory to the Underwriters, acting reasonably, addressed to the Underwriters and the directors of the Company from the current auditor of the Company with respect to the Financial Statements, and other financial and accounting information relating to the Company contained or incorporated by reference in the Prospectus, which letter shall be based on a review by such auditors within a cut-off date of not more than two Business Days prior to the date of the letter, which letter shall be in addition to any auditors’ consent letters addressed to the Securities Commissions in the Qualifying Jurisdictions;

 

  (iv)

prior to the filing of the Prospectus with the Securities Commissions, copies of correspondence demonstrating that the listing and posting for trading on the TSX of the Offered Shares has been approved subject only to the satisfaction by the Company of such customary and standard post-closing conditions imposed by the TSX in similar circumstances and set forth in a letter of the TSX addressed to the Company (the “ Standard Listing Conditions ”); and

 

  (v)

copies of all other documents resulting or related to the Company taking all other steps and proceedings that may be necessary in order to qualify the Offered Shares for distribution in each of the Qualifying Jurisdictions by the Underwriters and other persons who are registered in a category permitting them to distribute the Offered Shares under Applicable Securities Laws.

 

  (b)

Supplementary Material

If applicable, the Company shall also prepare and deliver promptly to the Underwriters signed copies of all Supplementary Material. Concurrently with the delivery of any Supplementary Material or the incorporation or deemed incorporation by reference in the Prospectus of any Subsequent Disclosure Document, the Company shall deliver to the Underwriters, with respect to such Supplementary Material or Subsequent Disclosure Document, a comfort letter from the Company’s current auditor substantially similar to the letters referred to in Section 25(a)(iii).

 

11


  (c)

Representations as to Prospectus and Supplementary Material

Each delivery to any Underwriter of any Offering Document by the Company shall constitute the representation and warranty of the Company to the Underwriters that:

 

  (i)

all information and statements (except information and statements relating solely to and provided in writing by the Underwriters for inclusion in the Preliminary Prospectus, the Prospectus or any Supplementary Material) contained and incorporated by reference in such Offering Documents, are, at the respective dates, and, if applicable, the respective dates of filing, of such Offering Documents, true and correct in all material respects and contain no misrepresentation and, on the respective dates of such Offering Documents, constitute full, true and plain disclosure of all material facts relating to the Company and the Offered Shares as required by Applicable Securities Laws;

 

  (ii)

no material fact or information (except information and facts or information relating solely to and provided in writing by the Underwriters for inclusion in the Preliminary Prospectus, the Prospectus or any Supplementary Material) has been omitted from any Offering Document which is required to be stated therein or is necessary to make the statements therein not misleading in the light of the circumstances in which they were made; and

 

  (iii)

each of such Offering Document complies with the requirements of Applicable Securities Laws.

Such deliveries shall also constitute the Company’s consent to the Underwriters’ and any Selling Firm’s use of the Offering Document in connection with the distribution of the Offered Shares in compliance with this Agreement.

 

  (d)

Delivery of Prospectus and Related Matters

The Company will cause to be delivered to the Underwriters, at those delivery points as the Underwriters reasonably request, as soon as possible and in any event no later than 12:00 noon (Eastern time) on the next Business Day (or by 12:00 noon (Eastern time) on the second Business Day for deliveries outside of Toronto), in each case following the day on which the Company has obtained (i) the Preliminary Receipt for the Preliminary Prospectus, and (ii) the Final Receipt for the Prospectus, and thereafter from time to time during the distribution of the Offered Shares, as many commercial copies of the Preliminary Prospectus and the Prospectus, as applicable, as the Underwriters may reasonably request. Each delivery of any of the Offering Documents will have constituted or will constitute, as the case may be, consent of the Company to the use by the Underwriters and any Selling Firms of those documents in connection with the distribution and sale of the Offered Shares in all of the Qualifying Jurisdictions.

 

  (e)

Press Releases

Neither the Company, nor the Underwriters, shall make any public announcement in connection with the Offering, except if the other party has consented to such announcement or the announcement is required by applicable laws or stock exchange rules. For greater certainty, during the period commencing on the date hereof and until completion of the distribution of the Offered Shares, the Company will promptly provide to the Underwriters drafts of any press releases of the Company for review and comment by the Underwriters and the Underwriters’ counsel prior to issuance, provided that any such review will be completed in a timely manner, and the Company will incorporate in such press releases all reasonable comments of the Underwriters.

 

12


6.

Material Change

 

  (a)

During the period commencing on the date hereof and ending on the day the Underwriters notify the Company of the completion of the distribution of the Offered Shares in accordance with Section 24(a) hereof, the Company shall promptly inform the Underwriters (and promptly confirm such notification in writing) of the full particulars of:

 

  (i)

any material change whether actual, anticipated, contemplated, threatened or proposed in the Company or any Subsidiary or in any of their respective businesses, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, assets, properties, condition (financial or otherwise) or results of operations or in the Offering;

 

  (ii)

any material fact which has arisen or has been discovered or any new material fact that would have been required to have been stated in the Offering Documents had that fact arisen or been discovered on or prior to the date of any of the Offering Documents; or

 

  (iii)

any change in any material fact (which for the purposes of this Agreement shall be deemed to include the disclosure of any previously undisclosed material fact) contained or incorporated by reference in the Offering Documents or whether any event or state of facts has occurred after the date hereof, which, in any case, is, or may be, of such a nature as to render any of the Offering Documents untrue or misleading in any material respect or to result in any misrepresentation in any of the Offering Documents, including as a result of any of the Offering Documents containing or incorporating by reference therein an untrue statement of a material fact or omitting to state a material fact required to be stated therein or necessary to make any statement therein not false or not misleading in the light of the circumstances in which it was made, or which could result in any of the Offering Documents not complying with Applicable Securities Laws.

 

  (b)

Subject to Section 26(d), the Company will prepare and file promptly (and, in any event, within the time prescribed by Applicable Securities Laws) any Supplementary Material which may be necessary under Applicable Securities Laws, and the Company will prepare and file promptly at the request of the Underwriters any Supplementary Material which, in the opinion of the Underwriters, acting reasonably, may be necessary or advisable, and will otherwise comply with all legal requirements necessary, to continue to qualify the Offered Shares for distribution in each of the Qualifying Jurisdictions.

 

  (c)

During the period commencing on the date hereof until the Underwriters notify the Company of the completion of the distribution of the Offered Shares, the Company will promptly inform the Underwriters in writing of the full particulars of:

 

13


  (i)

any request of any Securities Commission for any amendment to any Offering Document or for any additional information in respect of the Offering or the Company;

 

  (ii)

the receipt by the Company of any material communication, whether written or oral, from any Securities Commission, the TSX or any other competent authority, relating to the Preliminary Prospectus, the Prospectus, the distribution of the Offered Shares or the Company;

 

  (iii)

any notice or other correspondence received by the Company from any Governmental Authority and any requests from any Governmental Authority for information, a meeting or a hearing relating to the Company, any Material Subsidiary, the Offering, the issue and sale of the Offered Shares or any other event or state of affairs that could, individually or in the aggregate, have a Material Adverse Effect; or

 

  (iv)

the issuance by any Securities Commission, the TSX or any other competent authority, including any other Governmental Authority, of any order to cease or suspend trading or distribution of any securities of the Company or of the institution, threat of institution of any proceedings for that purpose or any notice of investigation that could potentially result in an order to cease or suspend trading or distribution of any securities of the Company.

 

  (d)

In addition to the provisions of Sections 26(a), 26(b) and 26(c) hereof, the Company shall in good faith discuss with the Underwriters any circumstance, change, event or fact contemplated in Sections 26(a), 26(b) or 26(c) which is of such a nature that there is or could be reasonable doubt as to whether notice should be given to the Underwriters under Sections 26(a), 26(b) or 26(c) hereof and shall consult with the Underwriters with respect to the form and content of any Supplementary Material proposed to be filed by the Company, it being understood and agreed that no such Supplementary Material shall be filed with any Securities Commission prior to the review and approval thereof by the Underwriters and their counsel, acting reasonably.

 

7.

Regulatory Approvals

 

  (a)

Prior to the filing of the Prospectus with the Securities Commissions, the Company shall file or cause to be filed with the TSX all necessary documents and shall take or cause to be taken all necessary steps to ensure that the Company has obtained all necessary approvals for the Offered Shares to be conditionally listed on the TSX subject only to the Standard Listing Conditions.

 

  (b)

The Company will make all necessary filings and obtain all necessary regulatory consents and approvals (if any), and the Company will pay all filing, exemption and other fees required to be paid in connection with the transactions contemplated in this Agreement.

 

8.

Representations and Warranties of the Company

The Company represents and warrants to the Underwriters, and acknowledges that the Underwriters are relying on such representations and warranties in purchasing the Offered Shares, that:

 

14


  (a)

the Company: (i) has been duly incorporated, amalgamated, continued or organized and is validly existing as a corporation in good standing under the laws of Canada, and has the corporate power, capacity and authority to own, lease and operate its property and assets, to conduct its business as now conducted and as currently proposed to be conducted and to carry out its obligations under this Agreement; and (ii) where required, has been duly qualified as an extra-provincial or foreign corporation for the transaction of business and is in good standing under the laws of each jurisdiction in which it owns or leases property, or conducts any business;

 

  (b)

other than the Material Subsidiaries, the Company has no subsidiary and no investment in any person which in either case is or could be material to the business and affairs of the Company. Other than the Material Subsidiaries, the other Subsidiaries are inactive and do not carry on, and have not carried on, any business or operations. The Company is the direct or indirect registered and beneficial owner of all of the issued and outstanding shares of or other voting securities in each Subsidiary (except Pure Sunfarms, of which it is the registered and beneficial owner of 50% of the voting securities of Pure Sunfarms), free and clear of all encumbrances, liens, mortgages, hypothecations, security interests, charges or adverse interests whatsoever, and no person, firm, corporation or entity has any agreement, option, right or privilege (whether pre-emptive or contractual) capable of becoming an agreement or option, for the purchase from the Company or any Subsidiary of any of the shares or other securities of any Subsidiary;

 

  (c)

each Material Subsidiary: (i) has been duly incorporated, amalgamated, continued or organized and is validly existing as a corporation or limited liability company in good standing under the laws of its jurisdiction of incorporation, amalgamation, continuation or organization and has the corporate power, capacity and authority to own, lease and operate its property and assets, to conduct its business as now conducted and as currently proposed to be conducted and to carry out the provisions hereof; and (ii) where required, has been duly qualified as an extra-provincial or foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases property, or conducts any business, and is not precluded from carrying on business or owning property in such jurisdictions by any other commitment, agreement or document;

 

  (d)

the Company and each Material Subsidiary (i) have each conducted and have each been conducting their business in material compliance with all Applicable Laws of each jurisdiction in which its business is carried on or in which its services are provided and has not received a notice of non-compliance, nor knows of, nor has reasonable grounds to know of, any facts that could give rise to a notice of non-compliance with any such Applicable Laws, (ii) are not in breach or violation of any judgment, order or decree of any Governmental Authority or court having jurisdiction over the Company or any Material Subsidiary, as applicable, and (iii) hold all, and are in substantial compliance with all, Governmental Licences that are material to the conduct of the business of the Company and the Material Subsidiaries and required to carry on their business as now conducted;

 

  (e)

neither the Company nor any Subsidiary has been served with or otherwise received notice of any legal proceeding, action, suit or inquiry or governmental proceedings and there are no legal proceedings, actions, suits, or inquiries or governmental proceedings (whether or not purportedly on behalf of the Company) pending to which the Company

 

15


  or any Subsidiary is a party or of which any property or assets of the Company or any Subsidiary is the subject which is reasonably likely, individually or in the aggregate, to have a Material Adverse Effect, or which might reasonably be expected to materially and adversely affect the consummation by the Company of the transactions contemplated by this Agreement, and, to the knowledge of the Company, no such proceedings, actions, suits or inquiries have been threatened or contemplated by any Governmental Authority or any other persons;

 

  (f)

any real property or building held under lease by the Company or any Subsidiary is held by it under valid and subsisting leases and/or temporary occupations enforceable against the respective lessors and/or owners thereof with the exclusive right to occupy and use such premises, subject to such exceptions as are not material, individually or in the aggregate, to the Company;

 

  (g)

subject to paragraph (f) above, (A) each of the Properties is 100% beneficially owned by the Company or a Material Subsidiary; (B) the Company or a Material Subsidiary holds the Properties under valid, subsisting and enforceable title documents and such title documents permit the Company and the Material Subsidiaries to carry on their business thereon as currently conducted and as proposed to be conducted; (C) except as disclosed in the Prospectus, the Company or a Material Subsidiary has good and marketable freehold title in fee simple to the Properties free and clear of any and all hypothecs, prior claims, mortgages, liens, pledges, charges, security interests, encumbrances, actions, claims or demands of any nature whatsoever or howsoever arising; and (D) the Properties are insured by an owner’s title insurance policy issued by a nationally recognized title insurance company;

 

  (h)

all Taxes and governmental assessments which could be a lien on any of the Key Properties and that are due and owing in respect of any of the Key Properties have been paid;

 

  (i)

there are currently no facts, circumstances, events or conditions which could reasonably be expected to materially and adversely affect or impair the value or permitted use(s) of any of the Key Properties;

 

  (j)

to the Company’s knowledge, the Properties and the buildings constructed and operations on the Properties are in material compliance with all Applicable Laws;

 

  (k)

the Properties and the buildings constructed thereon are insured at insurable replacement value against all loss from damage by hazards or risks normally insured against for properties and buildings of a similar type and usage, with reasonable deductibles;

 

  (l)

the buildings constructed on the Properties were constructed in accordance with building permits properly issued therefor, if required, and in material compliance with all applicable building and zoning by-laws; and there are no material defects in such buildings; neither the Company nor any Subsidiary has received notice of any outstanding work orders or deficiency notices relating to such buildings from or required by any police or fire department, sanitation, health authorities or from any other Governmental Authority and there is currently no matter under discussion with any such departments or authorities relating to work orders; such buildings and all chattels required for the effective operation of such buildings are in good operating condition and are in a state of good repair and maintenance;

 

16


  (m)

except as disclosed in the Offering Documents, no property rights are necessary for the conduct of the business of the Company or the Subsidiaries as currently conducted; none of the Company nor the Subsidiaries is aware of any claim or the basis for any claim that might or could adversely affect the right thereof to use, transfer or otherwise exploit such property rights once acquired; and none of the Company nor any Subsidiary has any responsibility or obligation to pay any commission, royalty, licence fee or similar payment to any person with respect to the property rights thereof;

 

  (n)

any and all of the agreements and other documents and instruments pursuant to which the Company or the Subsidiaries hold the property and assets thereof are valid and subsisting agreements, documents or instruments in full force and effect, enforceable in accordance with the terms thereof (except as may be qualified by the Qualification); neither the Company nor any Subsidiary is in default of any of the material provisions of any such agreements, documents or instruments nor, to the Company’s knowledge, has any such default been alleged, and such properties and assets are in good standing under the applicable statutes and regulations of the jurisdictions in which they are situated; all leases, licences and claims pursuant to which the Company and the Subsidiaries derive the interests thereof in such property and assets are in good standing and there has been no material default under any such lease, licence or claim and all Taxes required to be paid with respect to such properties and assets to the date hereof have been paid;

 

  (o)

any and all operations of the Company and the Subsidiaries, and to the best of the Company’s knowledge, any and all operations by predecessors, on or in respect of the assets and properties of the Company and the Subsidiaries have been conducted substantially in accordance with good industry practices in the jurisdiction of operation and in material compliance with Applicable Laws and orders, judgments, decrees and directions of Governmental Authorities and other competent authorities;

 

  (p)

the Financial Statements:

 

  (i)

have been prepared in accordance with Applicable Securities Laws and IFRS, applied on a consistent basis throughout the periods referred to therein, except as otherwise disclosed therein;

 

  (ii)

present fairly, in all material respects, the financial position and condition of the Company and the Subsidiaries (other than Pure Sunfarms, which is presented and accounted for by the Company using the equity method of accounting) on a consolidated basis as at the respective dates thereof and the results of its operations and the changes in its shareholder’s equity and cash flows for the periods then ended, and do not contain a misrepresentation; and

 

  (iii)

have been audited in the case of the annual financial statements comprising the Financial Statements, and reviewed in the case of the interim financial statements comprising the Financial Statements, by independent public accountants within the meaning of Applicable Securities Laws and the rules of the Chartered Professional Accountants of Canada;

 

17


  (q)

there has not been any “disagreement” or “reportable event” (within the respective meanings of NI 51-102) with the current auditors or any former auditors of the Company during the past five financial years;

 

  (r)

the Company has established and maintains a system of disclosure controls and procedures and internal control over financial reporting, and has: (i) designed such disclosure controls and procedures, or caused them to be designed under management’s supervision, to provide reasonable assurance that material information relating to each of the Company and the Subsidiaries is made known to management by others, particularly during the period in which the financial statements are being prepared; and (ii) designed such internal control over financial reporting, or caused it to be designed under management’s supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with IFRS;

 

  (s)

there are no material liabilities of the Company whether direct, indirect, absolute, contingent or otherwise which are not disclosed or reflected in the Financial Statements;

 

  (t)

the audit committee’s responsibilities and composition comply with National Instrument 52-110— Audit Committees of the Canadian Securities Administrators;

 

  (u)

except as disclosed in the Offering Documents, none of the directors, officers or shareholders who beneficially own, directly or indirectly, or exercise control or direction over, more than 10% of the outstanding Common Shares or any known associate or affiliate of any such person, had or has any material interest, direct or indirect, in any transaction or any proposed transaction (including, without limitation, any loan made to or by any such person) with the Company or any Subsidiary which, as the case may be, materially affects, is material to or will materially affect the Company and its Subsidiaries on a consolidated basis;

 

  (v)

(i) the Company and each Material Subsidiary has duly and on a timely basis filed all foreign, federal, state, provincial and municipal tax returns required to be filed by it, except as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; (ii) the Company and each Subsidiary has paid all Taxes due and payable by the Company and the Subsidiaries, respectively, and has paid all assessments and reassessments and all other Taxes due and payable by it and which are claimed by any Governmental Authority to be due and owing and adequate provision has been made for Taxes payable for any completed fiscal period for which tax returns are not yet required to be filed, except as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; (iii) there are no agreements, waivers or other arrangements providing for an extension of time with respect to the filing of any tax return or payment of any Taxes, governmental charge or deficiency by the Company or by any Subsidiary; (iv) there are no material actions, suits, proceedings, investigations or claims pending or, to the knowledge of the Company, threatened, against the Company or any Subsidiary in respect of Taxes; and (v) there are no matters under discussion with any Governmental Authority relating to Taxes asserted by any such authority, other than matters that are immaterial to the Company and the Subsidiaries taken as a whole;

 

18


  (w)

the Company (i) is a reporting issuer in all of the Provinces of Canada, and (ii) the Company is not in default under Applicable Securities Laws of any of such Qualifying Jurisdictions and is not on the list of defaulting issuers maintained by any Securities Commission;

 

  (x)

the Company is in compliance with its timely and continuous disclosure obligations under Applicable Securities Laws including the policies, rules and regulations of the TSX and, without limiting the generality of the foregoing, there has not occurred any material change (actual, anticipated, contemplated, threatened, financial or otherwise) in the business, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, properties, condition (financial or otherwise), results of operations or control of the Company and the Subsidiaries taken as a whole since December 31, 2017 which has not been set forth in the Offering Documents or otherwise publicly disclosed on a non-confidential basis, and the Company has not filed any confidential material change report which remains confidential as at the date hereof;

 

  (y)

to the knowledge of the Company, no agreement is in force or effect which in any manner affects the voting or control of any of the securities of the Company or any Subsidiary;

 

  (z)

the authorized capital of the Company consists of Common Shares, preferred shares and special voting shares; no preferred shares and no special voting shares are issued and outstanding; the issued Common Shares of the Company is as disclosed in the Preliminary Prospectus and all such issued Common Shares are validly issued and outstanding, and no person, firm or corporation has any right, agreement or option, present or future, contingent or absolute, or any right capable of becoming such a right, agreement or option or privilege (whether pre-emptive or contractual), for the issue or allotment of any unissued shares in the capital of the Company or any Subsidiary or any other security convertible into or exchangeable for any such shares, or to require the Company or any Subsidiary to purchase, redeem or otherwise acquire any of the outstanding securities in the capital of the Company or any Subsidiary, except as disclosed in the Offering Documents in respect of the Company;

 

  (aa)

the execution and delivery of this Agreement and the performance of the transactions contemplated hereby have been duly authorized by all necessary corporate action of the Company and this Agreement has been duly executed and delivered by the Company, and this Agreement constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, provided that enforcement hereof may be limited by laws affecting creditors’ rights generally, that specific performance and other equitable remedies may only be granted in the discretion of a court of competent jurisdiction and that the provisions relating to indemnity, contribution and waiver of contribution may be unenforceable (the “ Qualification ”);

 

  (bb)

the execution and delivery of this Agreement, the fulfillment of the terms hereof by the Company and the issuance, sale and delivery of the Offered Shares to be issued and sold by the Company do not and will not:

 

  (i)

require the consent, approval, authorization, registration or qualification of or with any Governmental Authority, stock exchange, Securities Commission or other third party, except such as have been obtained or will be obtained in a timely manner prior to Closing under Applicable Securities Laws or stock exchange regulations;

 

19


  (ii)

result in a breach of or default under, and do not and will not create a state of facts which, after notice or lapse of time or both, will result in a breach of or default under, and do not and will not conflict with:

 

  A.

any of the terms, conditions or provisions of the articles, by laws or resolutions of the shareholders, directors or any committee of directors of the Company or any Subsidiary;

 

  B.

any indenture, agreement or instrument to which the Company or any Subsidiary is a party or by which it or they are contractually bound, including the Securityholders Agreement and the Credit Facilities; or

 

  C.

any Applicable Laws, including, without limitation, Applicable Securities Laws, or any judgment, order, direction or decree of any Governmental Authority or court having jurisdiction over the Company or any Subsidiary; or

 

  (iii)

affect the rights, duties and obligations of any parties to any indenture, agreement or instrument to which the Company or any Subsidiary is a party, nor give a party the right to terminate any such indenture, agreement or instrument by virtue of the application of terms, provisions or conditions in such indenture, agreement or instrument;

 

  (cc)

the Company has the corporate power, capacity and authority to issue the Offered Shares and to grant the Over-Allotment Option to the Underwriters; the Offered Shares have been duly authorized, allotted and reserved for issuance and, at the applicable Closing Time:

 

  (i)

the Initial Shares and, if applicable, the Additional Shares will be duly and validly issued and outstanding as fully paid and non-assessable shares in the capital of the Company; and

 

  (ii)

the Initial Shares and, if applicable, the Additional Shares will not have been issued in violation of or subject to any pre-emptive or contractual rights to purchase securities issued or granted by the Company, including the Securityholders Agreement;

 

  (dd)

all statements made in the Offering Documents describing the Offered Shares and the attributes thereof are complete and accurate in all material respects;

 

  (ee)

other than as disclosed in the Offering Documents, there is no legislation or governmental regulations in effect or, to the knowledge of the Company, proposed which materially and adversely affect the business, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, properties, condition (financial or otherwise) or results of operations of the Company or any Subsidiary, other than legislation or governmental regulations which the Company is already in material compliance with;

 

20


  (ff)

no order, ruling or determination having the effect of suspending the sale or ceasing the trading of the Offered Shares, the Common Shares or any other security of the Company has been issued or made by any Securities Commission or stock exchange or any other regulatory authority and is continuing in effect and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated or threatened by any such authority or under any Applicable Securities Laws;

 

  (gg)

except for the Underwriters as provided herein, there is no person, firm or corporation acting for the Company entitled to any brokerage or finder’s fee or other similar fee in connection with this Agreement or any of the transactions contemplated hereunder;

 

  (hh)

the Company is an Eligible Issuer and has filed all documents forming the Disclosure Record on a timely basis, except for any failure to file on a timely basis which is not material. As of their respective dates, the documents forming the Disclosure Record complied in all material respects with the requirements of Applicable Securities Laws, and none of the documents forming the Disclosure Record, when filed, contained any misrepresentation, which has not been corrected by the filing of a subsequent document which forms part of the Disclosure Record;

 

  (ii)

the Offered Shares qualify as eligible investments as described in the Preliminary Prospectus under the heading “Eligibility for Investment” and the Company will not take or permit any action within its control which would cause the Offered Shares to cease to be qualified, during the period of distribution of the Offered Shares, as eligible investments to the extent so described in the Prospectus;

 

  (jj)

the minute books and records of each of the Company and the Material Subsidiaries made available to counsel for the Underwriters in connection with its due diligence investigation of the Company and the Material Subsidiaries for the periods from its date of incorporation to the date of examination thereof are all of the minute books and records of the Company and the Material Subsidiaries and contain copies of all material proceedings (or certified copies thereof) of the shareholders, the boards of directors and all committees of the boards of directors of the Company and the Material Subsidiaries to the date of review of such corporate records and minute books and there have been no other meetings, resolutions or proceedings of the shareholders, board of directors or any committees of the board of directors of the Company and the Material Subsidiaries to the date of review of such corporate records and minute books not reflected in such minute books and other records, other than those which are not material to the Company or any Material Subsidiary;

 

  (kk)

the Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts, if any, as are prudent and customary in the businesses in which they are engaged, and the Company has no reason to believe that it will not be able to renew the existing insurance coverage of the Company and the Subsidiaries, if any, as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost as would not have a Material Adverse Effect;

 

21


  (ll)

the Company and the Subsidiaries:

 

  (i)

and the Properties, assets and operations thereof comply, and have complied, in all material respects with all applicable “ Environmental Laws ” (which term means and includes, without limitation, any and all Applicable Laws relating to the environment, occupational health and safety, or any “ Environmental Activity ” (which term means and includes, without limitation, any past, present or future activity, event or circumstance by or in respect of a “ Contaminant ” (which term means and includes, without limitation, any pollutants, hazardous wastes, hazardous materials, hazardous substances or contaminants or any other matter (including any of the foregoing), which is defined or described as such pursuant to any such applicable Environmental Laws), during the time such Properties, assets and operations were under the control of the Company or a Subsidiary, and to the actual knowledge of the Company without inquiry, prior to the time such Properties, assets and operations were under the control of the Company or a Subsidiary, including, without limitation, the storage, use, holding, collection, purchase, accumulation, assessment, generation, manufacture, construction, processing, treatment, stabilization, disposition, handling or transportation thereof, or the release, escape, leaching, dispersal or migration thereof into the natural environment, including the movement through or in the air, soil, surface water or groundwater));

 

  (ii)

have not received any notice of any claim, judicial or administrative proceeding, pending or, to the knowledge of the Company, threatened against, or which may materially adversely affect, the Company, the Subsidiaries or any of the Properties, assets or operations thereof, relating to, or alleging any violation of any Environmental Laws, the Company is not aware of any facts which could give rise to any such claim or judicial or administrative proceeding and, to the Company’s knowledge, neither the Company nor any Subsidiary, nor any of the Properties, assets or operations of either of them, is the subject of any investigation, evaluation, audit or review by any Governmental Authority to determine whether any violation of any Environmental Laws has occurred or is occurring or whether any remedial action is needed in connection with a release of any Contaminant into the environment, except for compliance investigations conducted in the normal course by any Governmental Authority;

 

  (iii)

have not given or filed any notice under any federal, state, provincial or local law with respect to any Environmental Activity, the Company and the Subsidiaries do not, to the Company’s knowledge, have any liability (whether contingent or otherwise) in connection with any Environmental Activity and no notice has been given under any federal, state, provincial or local law or of any liability (whether contingent or otherwise) with respect to any Environmental Activity relating to or affecting either the Company or the Subsidiaries or the Properties, assets, business or operations of any of them;

 

  (iv)

have not stored any hazardous or toxic waste or toxic substance on the Properties and have not disposed of any hazardous or toxic waste, in each case in a manner contrary to any Environmental Laws, and there are no Contaminants on any of the Properties at which the Company or the Subsidiaries carry on business, in each case other than in compliance with Environmental Laws; and

 

22


  (v)

are not subject to any contingent or other liability relating to the restoration or rehabilitation of land, water or any other part of the environment or non-compliance with Environmental Laws;

 

  (mm)

the Company and the Subsidiaries are in compliance with all Applicable Laws respecting employment and employment practices, terms and conditions of employment, pay equity and wages, and human rights, and neither the Company nor any Subsidiary has engaged in any unfair labour practice, except in either case as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect; there is no labour strike, dispute, slowdown, stoppage, complaint or grievance pending or, to the best of the knowledge of the Company after due inquiry, threatened against the Company or a Subsidiary; no union representation question exists respecting the employees of the Company or a Subsidiary and no collective bargaining agreement is in place or currently being negotiated by the Company or a Subsidiary; and all benefit or pension plans of the Company and the Subsidiaries are funded in accordance with Applicable Laws and no past service funding liability exist thereunder, except as would not reasonably be expected to, individually or in the aggregate, have a Material Adverse Effect;

 

  (nn)

each of the Company and the Subsidiaries owns or has the right to use all of the material Intellectual Property owned or used by it as of the date hereof. All registrations, if any, and filings necessary to preserve the rights of the Company and the Subsidiaries in all material Intellectual Property owned by them have been made and are in good standing. Neither the Company nor any Subsidiary has any material pending action or proceeding, nor any material threatened action or proceeding, against any person with respect to the use of the Intellectual Property, and there are no circumstances which cast doubt on the validity or enforceability of any material Intellectual Property owned or used by the Company or the Subsidiaries. The conduct of the Company’s and the Subsidiaries’ business, taken as a whole, does not, to the knowledge of the Company, infringe upon the Intellectual Property rights of any other person. Neither the Company nor any Subsidiary has any pending action or proceeding, nor, to the knowledge of the Company, is there any threatened action or proceeding against it with respect to the Company’s or the Subsidiaries’ use of any material Intellectual Property. No third parties have rights to any Intellectual Property that is owned by the Company or the Subsidiaries, except as disclosed in the Offering Documents or other than rights acquired pursuant to non-exclusive licenses granted by the Company or the Subsidiaries in the ordinary course of business. None of the material Intellectual Property that is owned by the Company or the Subsidiaries comprises an improvement to any material Intellectual Property that would give any third person any rights to any such Intellectual Property, including, without limitation, rights to license any such Intellectual Property;

 

  (oo)

at the time of delivery thereof to the Underwriters:

 

  (i)

the Preliminary Prospectus complied, and the Prospectus and all Supplementary Material, if any, will comply, fully with the requirements of Applicable Securities Laws;

 

  (ii)

the Preliminary Prospectus provided and the Prospectus and all Supplementary Material, if any, will provide, full, true and plain disclosure of all material facts relating to the Company (on a consolidated basis) and the Offered Shares; and

 

23


  (iii)

the Preliminary Prospectus did not, and the Prospectus and all Supplementary Material, if any, will not contain any misrepresentation;

 

  (pp)

Computershare Investor Services Inc., at its principal offices in Toronto, Ontario has been duly appointed as the registrar and transfer agent for the Common Shares;

 

  (qq)

neither the Company nor any Subsidiary, nor, to the knowledge of the Company, any director, officer, employee, consultant, representative or agent of the foregoing, has (i) violated any anti-bribery or anti-corruption laws applicable to the Company or the Subsidiaries, including but not limited to Canada’s Corruption of Foreign Public Officials Act, or (ii) offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to give, or authorized the giving of anything of value, that goes beyond what is reasonable and customary and/or of modest value: (X) to any government official, whether directly or through any other person, for the purpose of influencing any act or decision of a government official in his or her official capacity; inducing a government official to do or omit to do any act in violation of his or her lawful duties or to use his or its influence with a government or instrumentality thereof to affect or influence any act or decision of such government or department, agency, instrumentality or entity thereof; securing any improper advantage; inducing a government official to influence or affect any act or decision of any Governmental Authority; or assisting the Company or the Subsidiaries or any representative thereof in obtaining or retaining business for or with, or directing business to, any person; or (Y) to any person in a manner which would constitute or have the purpose or effect of public or commercial bribery, or the acceptance of or acquiescence in extortion, kickbacks, or other unlawful or improper means of obtaining business or any improper advantage. Neither the Company nor any Subsidiary, nor, to the knowledge of the Company, any director, officer, employee, consultant, representative or agent of foregoing acting upon the request or at the direction of the Company or the Subsidiaries, has (1) conducted or initiated any review, audit, or internal investigation that concluded the Company, the Subsidiaries or any director, officer, employee, consultant, representative or agent of the foregoing violated any such Applicable Laws or committed any wrongdoing, or (2) made a voluntary, directed, or involuntary disclosure to any Governmental Authority responsible for enforcing anti-bribery or anticorruption laws, in each case with respect to any alleged act or omission arising under or relating to non-compliance with any such Applicable Laws, or received any notice, request, or citation from any person alleging non-compliance with any such Applicable Laws;

 

  (rr)

the operations of each of the Company and the Subsidiaries have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements of Applicable Laws relating to anti-money laundering of jurisdictions where each of the Company and the Subsidiaries conduct business, and any related or similar Applicable Laws issued, administered or enforced by any applicable Governmental Authority having jurisdiction over each of the Company and the Subsidiaries (collectively, the “ Anti-Money Laundering Laws ”), and no action, suit or proceeding by or before any court or any arbitrator or Governmental Authority involving any of the Company or the Subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the best knowledge of the Company, threatened or contemplated;

 

24


  (ss)

the business, Properties and assets of the Company and the Subsidiaries conform in all material respects to the descriptions thereof contained or incorporated by reference in the Offering Documents;

 

  (tt)

the Company and each Subsidiary is carrying on its business in material compliance with all Applicable Laws and governmental regulations or ordinances, in whole or in part, and all products provided by the Company or any Subsidiary are provided in material compliance with all Applicable Laws and, in all material respects, meet industry specific standards set by all organizations which pertain to the business of the Company and each Subsidiary;

 

  (uu)

(A) the Company possesses all permits, certificates, licences, approvals, consents and other authorizations and clearances, and supplements and amendments to the foregoing (collectively, the “ Governmental Licences ”) issued by the appropriate Governmental Authority necessary or required to conduct the business as now operated by the Company and proposed to be conducted by the Company (except as otherwise described in the Offering Documents); (B) the Company is in compliance with the terms and conditions of all such Governmental Licences except for instances of noncompliance which would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; (C) all of the Governmental Licences are in good standing, valid and in full force and effect; and (D) the Company has not received any notice relating to the cancellation, revocation, limitation, suspension, or adverse modification of any such Governmental Licences;

 

  (vv)

Pure Sunfarms intends to exercise the Option and amalgamate Pure Sunfarms Canada Corp. with Pure Sunfarms and thereby possess as the exclusive owner thereof an ACMPR licence to produce, sell, possess, ship, transport, deliver and destroy fresh cannabis, dried cannabis, cannabis plants, and cannabis seeds (the “ License ”); the Company confirms that each of the officers and directors of Pure Sunfarms has successfully undergone a security clearance conducted by the Royal Canadian Mounted Police (RCMP) (other than Mandesh Dosanjh, whose appointment as an officer of Pure Sunfarms and RCMP security clearance remain in progress) and obtained a confirmation of security clearance from the applicable Governmental Authorities and such security clearance is valid and in good standing; neither the Company nor, to the knowledge of the Company, Pure Sunfarms has received any communication from a Governmental Authority that the exercise of the Option, the acquisition of control of Pure Sunfarms Canada Corp. by Pure Sunfarms, the change of the shareholder of Pure Sunfarms Canada Corp. or the amalgamation of Pure Sunfarms Canada Corp. and Pure Sunfarms would invalidate, void, nullify or otherwise cancel the License and the Company is not aware of any facts or circumstances which could invalidate, void, nullify or otherwise cancel the License;

 

  (ww)

the Company: (A) has not received any correspondence or notice from any Governmental Authority alleging or asserting material noncompliance with any Applicable Regulatory Laws or any Governmental Licences required by any such Applicable Regulatory Laws; (B) has not received notice of any pending or threatened claim, suit, proceeding, charge, hearing, enforcement, audit, inspection, investigation, arbitration or other action from any Governmental Authority or third party alleging that any operation or activity of the Company, the Material Subsidiaries or any of their directors, officers and/or employees is in material violation of any Applicable Regulatory Laws or Governmental Licences required by any such Applicable

 

25


  Regulatory Laws and has no knowledge or reason to believe that any such Governmental Authority or third party is considering or would have reasonable grounds to consider any such claim, suit, proceeding, charge, hearing, enforcement, audit, inspection, investigation, arbitration or other action; and (C) either directly has, or indirectly on its behalf has, filed, declared, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by Applicable Regulatory Laws or Governmental Licences required by any such Applicable Regulatory Laws in order to keep all Governmental Licences in good standing, valid and in full force (except where the failure to so file, declare, obtain, maintain or submit would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect), and all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct in all material respects on the date filed (or were corrected or supplemented by a subsequent submission);

 

  (xx)

the Company has not received notice of any action pending or recommended by any Governmental Authority to terminate, suspend, limit, withdraw, or forfeit the participation of the Company in any government program, including any food safety programs;

 

  (yy)

no Governmental Authority is presently alleging or asserting, or, to the Company’s knowledge, threatening to allege or assert, noncompliance with any applicable legal requirement or registration in respect of the Company’s products;

 

  (zz)

the Company’s products are currently cultivated, harvested, manufactured, tested, packaged and labeled at facilities which are in compliance with good agricultural practices and good production practices prescribed by Applicable Regulatory Laws and such other regulatory requirements applicable to the Company’s products, including good agricultural practices and good production practices that are acceptable to Health Canada and the FDA;

 

  (aaa)

the business of the Company and each Subsidiary is conducted in compliance with all Applicable Laws related to the development, cultivation, manufacture, production, packaging, labeling, storage, transportation, distribution, purchase, sale or marketing of the Company’s products, in each case, in all material respects. There have been no recalls or withdrawals of any products cultivated, manufactured, produced, packaged, distributed or sold by or on behalf of the Company and/or any Subsidiary, and there have been no claims or other instances of the presence of or exposure to any food contaminants or adulterants, food poisoning, pests, or other Hazardous Materials in any such products, nor any other food-related conditions with respect to the products of the Company and the Subsidiaries that would be reasonably expected to, individually or in the aggregate, have a Material Adverse Effect. Each product of the Company and of each Subsidiary conforms in all material respects to any promises or affirmations of fact made on the container or label for such product or in connection with its distribution or sale (including to the extent that products are being marketed as “non-GMO,” “fresh,” “organic,” “all natural,” “sustainable,” “U.S. grown,” “greenhouse” or similar claims) and the Company and each Subsidiary possesses appropriate certifications or scientifically reliable materials to substantiate such claims;

 

26


  (bbb)

the Company and the Subsidiaries have operated and are currently in material compliance with all applicable rules, regulations, policies and guidances of Health Canada, the Ministry of Agriculture and Agri-Food Canada (“ AAFC ”), the FDA, United States Department of Agriculture (“ USDA ”) and any other Governmental Authority having jurisdiction over the Company or any Subsidiary or their respective activities; all products manufactured, in whole or in part, marketed, or distributed by the Company or any Subsidiary comply in full with and meet industry specific standards set by all relevant organizations, including Health Canada, AAFC, the United States Food and Drug Administration (the “ FDA ”) and the USDA, which pertain to the business of the Company or any Subsidiary and the products of the Company and the Subsidiaries have met and satisfied all product safety standards necessary to permit the sale thereof in each jurisdiction in which such products are sold;

 

  (ccc)

the Company is not in material breach or violation of or default under, and, to the knowledge of the Company, no event or omission has occurred which after notice or lapse of time or both, would constitute a breach or violation of or default under, or would result in the acceleration or maturity of any indebtedness (including the Credit Facilities) or other material liabilities or obligations under any mortgage, hypothec, note, indenture, contract, agreement (written or oral), instrument, lease, or other document to which it is a party or is subject or by which it or its assets or properties are bound;

 

  (ddd)

no VF Owner (other than Michael DeGiglio) has any rights under sections 6.2 and 6.3, or any other provision, of the Securityholders Agreement and, to the knowledge of the Company, no VF Owners (other than Michael DeGiglio) hold any shares or other securities in the Company;

 

  (eee)

all forward-looking information and statements of the Company contained in the Offering Documents and the assumptions underlying such information and statements, subject to any qualifications contained therein, including any forecasts and estimates, expressions of opinion, intention and expectation, as at the time they were or will be made, were or will be made on reasonable grounds after due and proper consideration and were or will be truly and honestly held and fairly based;

 

  (fff)

the statistical, industry and market related data included in the Offering Documents are derived from sources which the Company reasonably believes to be accurate, reasonable and reliable, and such data agrees with the sources from which it was derived; and

 

  (ggg)

(A) the Company has not made any “significant acquisition” as such term is defined in NI 51-102 in its current financial year or prior financial years in respect of which historical and/or pro forma financial statements or other information would be required to be included or incorporated by reference into the Preliminary Prospectus or the Prospectus, and for which a business acquisition report would need to be filed under NI 51-102; (B) the Company has not entered into any agreement or arrangement in respect of a transaction that would be a “significant acquisition” for purposes of Part 8 of NI 51-102; and (C) there are no proposed acquisitions by the Company that have progressed to the state where a reasonable person would believe that the likelihood of the Company completing the acquisition is high and would be a “significant acquisition” for the purposes of Part 8 of NI 51-102, if completed as of the date of the Prospectus.

 

27


9.

Covenants of the Company

The Company covenants and agrees with the Underwriters that the Company:

 

  (a)

will advise the Underwriters, promptly after receiving notice thereof, of the time when the Preliminary Prospectus, the Prospectus and any Supplementary Material has been filed and Passport Receipts have been obtained and will provide evidence satisfactory to the Underwriters of each such filing and copies of such Passport Receipts;

 

  (b)

will advise the Underwriters, promptly after receiving notice or obtaining knowledge of: (i) the issuance by any Securities Commission of any order suspending or preventing the use of the Preliminary Prospectus, the Prospectus or any Supplementary Material or suspending or seeking to suspend the trading of the Offered Shares or the Common Shares; (ii) the suspension of the qualification of the Offered Shares for offering or sale in any of the Qualifying Jurisdictions; (iii) the institution, threatening or contemplation of any proceeding for any of the foregoing purposes; or (iv) any requests made by any Securities Commission for amending or supplementing the Preliminary Prospectus or the Prospectus or any Supplementary Material or for additional information, and will use its commercially reasonable efforts to prevent the issuance of any order or any suspension respectively referred to in (i) or (ii) above and, if any such order is issued, to obtain the withdrawal thereof as promptly as possible or if any such suspension occurs, to promptly remedy such suspension in accordance with this Agreement;

 

  (c)

will use its commercially reasonable efforts to maintain the listing of the Common Shares on the TSX or such other recognized stock exchange or quotation system as Beacon, on behalf of the Underwriters, may approve (acting reasonably), for a period of 12 months following the Closing Date, provided that (i) the foregoing is subject to the obligations of the directors to comply with their fiduciary duties to the Company and (ii) the Company shall not be required to comply with this Section following the completion of a merger, amalgamation, arrangement, business combination or take-over bid pursuant to which the Company ceases to be a “reporting issuer” under Applicable Securities Laws;

 

  (d)

will use its commercially reasonable efforts to ensure that the Offered Shares are, when issued, listed and posted for trading on the TSX upon their date of issuance;

 

  (e)

will apply the net proceeds from the issue and sale of the Offered Shares in accordance with the disclosure set out under the heading “Use of Proceeds” in the Offering Documents;

 

  (f)

will promptly do, make, execute, deliver or cause to be done, made, executed or delivered, all such acts, documents and things as the Underwriters may reasonably require from time to time for the purpose of giving effect to this Agreement and take all such steps as may be reasonably required within its power to implement to the full extent the provisions, and to satisfy the conditions, of this Agreement;

 

  (g)

will on or before the time of filing the Prospectus provide to the Underwriters a copy of the conditional listing approval of the Offered Shares on the TSX;

 

28


  (h)

will forthwith notify the Underwriters of any breach of any covenant of this Agreement or any Ancillary Documents by the Company, or upon it becoming aware that any representation or warranty of the Company contained in this Agreement or any Ancillary Document is or has become untrue or inaccurate in any material respect, or upon the Company becoming aware that it will not be able to satisfy any condition set forth in Section 30;

 

  (i)

will use commercially reasonable efforts to obtain a waiver from Michael DeGiglio of his rights under sections 6.2 and 6.3 of the Securityholders Agreement in connection with the Offering and deliver such waiver as contemplated by Section 30(m);

 

  (j)

will use commercially reasonable efforts to cause the directors and officers of the Company to deliver at the Closing Time on the Closing Date the agreements contemplated by Section 30(o);

 

  (k)

will make available management of the Company for meetings with investors as scheduled by Beacon at the discretion of Beacon, acting reasonably; and

 

  (l)

will direct all inquiries from persons expressing an interest in participating in the Offering to Beacon as long as Beacon is engaged under this Agreement.

 

10.

Conditions of Closing

The obligation of the Underwriters to purchase the Initial Shares at the Closing Time on the Closing Date and to purchase any Additional Shares at the Closing Time on an Option Closing Date shall be subject to the following:

 

  (a)

the Underwriters will receive at the Closing Time a legal opinion addressed to the Underwriters and their counsel dated and delivered on the Closing Date from the Company’s Canadian counsel, Torys LLP, and from local counsel (only in respect of matters governed by laws of the Qualifying Jurisdictions where the Company’s Canadian counsel is not qualified to practice), in each case in form and substance satisfactory to the Underwriters and their counsel, acting reasonably, with respect to the following matters, subject to such reasonable assumptions and qualifications customary with respect to transactions of this nature as may be accepted by Underwriters’ counsel:

 

  (i)

the Company is a “reporting issuer”, or its equivalent, in each of the Qualifying Jurisdictions and it is not listed as being in default of Applicable Securities Laws in any of the Qualifying Jurisdictions which maintain such a list;

 

  (ii)

the Company is a corporation duly incorporated and validly existing under the federal laws of Canada, and has all requisite corporate power, capacity and authority to carry on its business as now conducted and to own, lease and operate its property and assets as described in the Prospectus;

 

  (iii)

as to the authorized, and issued and outstanding, capital of the Company;

 

  (iv)

the rights, privileges, restrictions and conditions attaching to the Offered Shares are accurately summarized in all material respects in the Prospectus;

 

  (v)

the Initial Shares have been duly and validly authorized and issued and are outstanding as fully paid and non-assessable Common Shares;

 

29


  (vi)

the Additional Shares issuable upon the exercise of the Over-Allotment Option have been duly and validly allotted and reserved for issuance by the Company and, upon the valid exercise of the Over-Allotment Option and receipt by the Company of payment in full therefor, the Additional Shares will be duly and validly authorized and issued and will be outstanding as fully paid and non-assessable Common Shares;

 

  (vii)

the Company has all necessary corporate power and capacity: (i) to execute and deliver this Agreement and to perform its obligations under this Agreement; (ii) to offer, issue, sell and deliver the Initial Shares; and (iii) to offer, issue, sell and deliver the Additional Shares issuable upon exercise of the Over-Allotment Option;

 

  (viii)

all necessary corporate action has been taken by the Company to authorize the execution and delivery of each of the Preliminary Prospectus, the Prospectus and any Supplementary Material and the filing thereof in each of the Qualifying Jurisdictions;

 

  (ix)

the Company has duly authorized, executed and delivered, this Agreement and authorized the performance of its obligations hereunder, including the offering, issue, sale and delivery of the Initial Shares, the grant of the Over-Allotment Option, the offering, issue, sale and delivery of the Additional Shares upon the valid exercise of the Over-Allotment Option and receipt by the Company of payment in full therefor, and this Agreement constitutes a legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, subject to: (i) applicable bankruptcy, insolvency, moratorium, reorganization or other laws affecting creditors’ rights generally; (ii) equitable remedies, including the remedies of specific performance and injunctive relief, being available only in the discretion of the applicable court; (iii) the applicable laws regarding limitations of actions; (iv) enforceability of provisions which purport to sever any provision which is prohibited or unenforceable under Applicable Law without affecting the enforceability or validity of the remainder of such document would be determined only in the discretion of the court; (v) enforceability of the provisions exculpating a party from liability or duty otherwise owed by it may be limited under Applicable Law; and (vi) the rights to indemnity, contribution and waiver under the documents which may be limited or unavailable under Applicable Law;

 

  (x)

the execution and delivery of this Agreement and the fulfillment of the terms hereof, the offering, issue, sale and delivery of the Initial Shares, the grant of the Over-Allotment Option, the offering, issue, sale and delivery of the Additional Shares upon the valid exercise of the Over-Allotment Option and receipt by the Company of payment in full therefor, and the consummation of the transactions contemplated by this Agreement, do not result in a breach of (whether after notice or lapse of time or both) or constitute a default under (i) any of the terms, conditions or provisions of the articles of incorporation or amalgamation, as applicable, and by-laws of the Company, (ii) resolutions of the shareholders or the board of directors (or any committee thereof) of the Company, or (iii) the laws of the Province of Ontario and the federal laws of Canada applicable therein;

 

30


  (xi)

Computershare Investor Services Inc. is the duly appointed registrar and transfer agent for the Common Shares;

 

  (xii)

all necessary documents have been filed, all requisite proceedings have been taken, all approvals, permits and consents of the appropriate regulatory authority in each Qualifying Jurisdiction have been obtained, and all necessary legal requirements have been fulfilled, in order to qualify the distribution of the Initial Shares and the Additional Shares in each of the Qualifying Jurisdictions through dealers who are registered under Applicable Securities Laws and who have complied with the relevant provisions of such Applicable Laws;

 

  (xiii)

subject only to the Standard Listing Conditions, the Initial Shares and Additional Shares have been conditionally listed or approved for listing on the TSX;

 

  (xiv)

as to the accuracy of the statements under the heading “Eligibility for Investment” in the Prospectus; and

 

  (xv)

as to all other legal matters reasonably requested by counsel to the Underwriters.

In connection with such opinion, counsel to the Company may rely on the opinions of local counsel in the Qualifying Jurisdictions acceptable to counsel to the Underwriters, acting reasonably, as to the qualification for distribution of the Offered Shares or opinions may be given directly by local counsel of the Company with respect to those items and as to other matters governed by the laws of jurisdictions other than the province or provinces in which the Company’s Canadian counsel are qualified to practice and may rely, to the extent appropriate in the circumstances but only as to matters of fact, on certificates of officers of the Company and others;

 

  (b)

the Underwriters shall have received legal opinions from legal counsel to, and duly qualified to practice law in the jurisdiction of existence of, each wholly-owned Material Subsidiary that is Canadian (other than VF Clean Energy, Inc.) addressed to the Underwriters and legal counsel to the Underwriters and based upon an officer’s certificate for each such Material Subsidiary with respect to: (i) the existence of each such Material Subsidiary; and (ii) the corporate power and capacity of each such Material Subsidiary to carry on its business and activities and to own and lease its property and assets;

 

  (c)

the Underwriters shall have received a certificate dated the Closing Date, signed by the Chief Executive Officer of the Company or any other senior officer(s) of the Company as may be acceptable to the Underwriters, in form and content satisfactory to the Underwriters’ counsel, acting reasonably, with respect to:

 

  (i)

the articles and by laws of the Company;

 

  (ii)

resolutions of the Company’s board of directors relevant to, among other things, the issue and sale of the Offered Shares to be issued and sold by the Company and the authorization of this Agreement and the other agreements and transactions contemplated herein; and

 

  (iii)

the incumbency and signatures of signing officers of the Company;

 

31


  (d)

the Underwriters shall have received a certificate of status or the equivalent dated within one Business Day of the Closing Date and each Option Closing Date, as applicable, in respect of the Company and each Material Subsidiary that is Canadian (other than VF Clean Energy, Inc.);

 

  (e)

the Company shall cause its current auditors to deliver to the Underwriters a “bring down” comfort letter, addressed to the Underwriters and the board of directors of the Company, dated the Closing Date, in form and substance satisfactory to the Underwriters, acting reasonably, bringing forward to a date not more than two Business Days prior to the Closing Date the information contained in the comfort letter referred to in Section 25(a)(iii) hereof;

 

  (f)

the Company shall deliver to the Underwriters, at the Closing Time, certificates dated the Closing Date or the Option Closing Date, as applicable, addressed to the Underwriters and signed by the Chief Executive Officer and the Chief Financial Officer of the Company, or such other senior officer(s) of the Company as may be acceptable to the Underwriters, certifying for and on behalf of the Company and without personal liability, to the effect that:

 

  (i)

the Company has complied in all respects with all the covenants and satisfied all the terms and conditions of this Agreement on its part to be complied with and satisfied at or prior to the Closing Time;

 

  (ii)

the representations and warranties of the Company contained herein are true and correct as at the Closing Time with the same force and effect as if made on and as at the Closing Time after giving effect to the transactions contemplated hereby;

 

  (iii)

the Final Receipt has been issued by the BCSC for the Prospectus pursuant to the Passport System and, to the knowledge of such persons, no order, ruling or determination having the effect of ceasing the trading or suspending the sale of the Common Shares or other securities of the Company, or the Offered Shares to be issued and sold by the Company, has been issued and no proceedings for such purpose have been instituted or are pending or, to the knowledge of such officers, contemplated or threatened;

 

  (iv)

since the respective dates as of which information is given in the Prospectus or any Supplementary Material (A) there has been no material change in the Company, (B) there has been no material and adverse change (financial or otherwise) in the business, assets (including intangible assets), affairs, operations, prospects, liabilities (contingent or otherwise), capital, properties, condition (financial or otherwise) or results of operations of the Company and the Subsidiaries (taken as a whole), and (C) no transaction has been entered into by, and there has been no transaction that affects, the Company or any Subsidiary which is material to the Company and the Subsidiaries (taken as a whole), other than as disclosed in the Prospectus or in any Supplementary Material;

 

  (v)

there has been no change in any material fact (which includes the disclosure of any previously undisclosed material fact) contained in the Prospectus which fact or change is, or may be, of such a nature as to render any statement in the Prospectus misleading or untrue in any material respect or which would result in a misrepresentation in the Prospectus or which would result in the Prospectus not complying with Applicable Securities Laws; and

 

32


  (vi)

such other matters as the Underwriters may reasonably request;

 

  (g)

the Underwriters shall have received copies of correspondence indicating that the Company has obtained the conditional approval of the TSX for the listing of the Offered Shares thereon, subject only to the Standard Listing Conditions;

 

  (h)

the representations and warranties of the Company contained in this Agreement will be true at and as of the Closing Time on the Closing Date and, if applicable, the Option Closing Date, as if such representations and warranties were made at and as of such time and all agreements, covenants and conditions required by this Agreement to be performed, complied with or satisfied by the Company at or prior to the Closing Time on the Closing Date or the Option Closing Date, as applicable, will have been performed, complied with or satisfied at or prior to that time;

 

  (i)

the absence of any misrepresentations in the Offering Documents or undisclosed material change or undisclosed material facts relating to the Company or the Offered Shares;

 

  (j)

the Company shall have received a Preliminary Receipt and a Final Receipt qualifying the Offered Shares for distribution in the Qualifying Jurisdictions, and neither the Preliminary Receipt nor the Final Receipt shall be invalid or have been revoked or rescinded by any Securities Commission;

 

  (k)

the Underwriters shall have received a certificate from Computershare Investor Services Inc. as to the number of Common Shares issued and outstanding as at the date immediately prior to the Closing Date;

 

  (l)

the Underwriters will have received such other certificates, opinions, agreements or closing documents in form and substance reasonably satisfactory to the Underwriters as the Underwriters may reasonably request;

 

  (m)

the Underwriters will have received evidence, satisfactory to the Underwriters, acting reasonably, that Michael DeGiglio has waived his rights under Section 6.3 of the Securityholders Agreement in connection with the Offering;

 

  (n)

the Underwriters shall have received copies of any third-party consents required to complete the Offering and the transactions contemplated in this Agreement in form and substance reasonably satisfactory to the Underwriters as the Underwriters may reasonably request; and

 

  (o)

Michael DeGiglio and all other directors and officers of the Company will have entered into an agreement with and an in form and substance satisfactory to the Underwriters at the Closing Time on the Closing Date pursuant to which they will agree not to, for a period commencing on September 23, 2018 and ending on the date that is 30 days following the Closing Date, directly or indirectly, offer, sell, contract to sell, make any short sale, lend, swap, or otherwise dispose of, transfer, assign, or announce any intention to do so, any Common Shares or any securities convertible into or exchangeable or exercisable for Common Shares, whether now owned or hereafter acquired, directly or indirectly, or under their control or direction, or with respect to

 

33


  which each has beneficial ownership or enter into any transaction or arrangement that has the effect of transferring, in whole or in part, any of the economic consequences of ownership of Common Shares, whether such transaction is settled by the delivery of Common Shares, other securities, cash or otherwise, other than pursuant to a bona fide take-over bid or any other similar transaction made generally to all of the shareholders of the Company, provided that, in the event the change of control or other similar transaction is not completed, such securities shall remain subject to the lock-up agreement.

 

11.

Closing

The closing of the purchase and sale of the Offered Shares shall be completed at the Closing Time on the Closing Date at the Toronto offices of Torys LLP, or at such other place as Beacon, on behalf of the Underwriters, and the Company shall agree upon. At the Closing Time on the Closing Date, the Company will deliver to Beacon, or as Beacon may direct, (i) via electronic deposit, under the non-certificated inventory system, the Offered Shares, in each case registered in the name of “CDS & Co.” or in such other name or names as Beacon may notify the Company in writing prior to the Closing Time, and (ii) all further documentation as may be contemplated in this Agreement or as counsel to the Underwriters may reasonably require; against payment by the Underwriters to the Company (in accordance with their respective entitlements) of the aggregate Issue Price for the Offered Shares being issued and sold under this Agreement, net of the Underwriters’ Fees and the Underwriters’ expenses contemplated in Section 35 of this Agreement, by wire transfer payable to or as directed by the Company not less than 48 hours prior to the Closing Time. At the Closing Time on an Option Closing Date, the obligation of the Underwriters to complete the purchase of any Additional Shares under this Agreement, upon the exercise of the Over-Allotment Option, is subject to the receipt by the Underwriters of those documents contemplated, and the satisfaction of those conditions set forth, in Section 30 as the Underwriters may request.

 

12.

Restrictions on Further Issues or Sales

During the period commencing on September 23, 2018 and ending 90 days following the Closing Date, the Company will not, directly or indirectly, without the prior written consent of Beacon (such consent not to be unreasonably withheld or delayed), issue, sell, offer, grant an option or right in respect of, or otherwise dispose of, or enter into any derivative transaction that has the effect of any of the foregoing, or agree to or announce any intention to issue, sell, offer, grant an option or right in respect of, or otherwise dispose of, or enter into any derivative transaction that has the effect of any of the foregoing, any Common Shares or any securities convertible into or exchangeable or exercisable for Common Shares, other than issuances: (i) of the Initial Shares and Additional Shares pursuant to this Agreement; (ii) under existing director or employee stock options, bonus or purchase plans or similar share compensation arrangements as detailed in the Company’s most recently-filed management discussion and analysis; (iii) under director or employee stock options or bonuses granted subsequently in accordance with regulatory approval and in a manner consistent with the Company’s past practice; (iv) upon the exercise of convertible securities, warrants or options outstanding prior to September 23, 2018; or (v) pursuant to previously scheduled property payments and/or other corporate acquisitions.

 

34


13.

Indemnification by the Company

 

  (a)

The Company shall fully indemnify and save harmless each of the Underwriters and their respective affiliates and their respective directors, officers, employees, shareholders, partners, advisors and agents and each other person, if any, controlling any of the Underwriters or their affiliates (collectively, the “ Indemnified Parties ” and individually an “ Indemnified Party ”) from and against any and all liabilities, claims (including securityholder actions, derivative or otherwise), actions, losses, costs, damages and expenses (including the aggregate amount paid in settlement of any action, suit, proceeding, investigation or claim) and the reasonable fees and expenses of their counsel (collectively, “ Losses ”) that may be incurred in advising with respect to and/or defending any action, suit, proceeding, investigation or claim that may be made or threatened against any Indemnified Party or in enforcing this indemnity (collectively, the “ Claims ” and individually, a “ Claim ”) to which any Indemnified Party may become subject or otherwise involved in any capacity insofar as the Losses and/or Claims relate to, are caused by, result from, arise out of, or are in connection with, directly or indirectly:

 

  (i)

the breach of any representation or warranty of the Company made in any Ancillary Document or the failure of the Company to comply with any of its obligations in any Ancillary Document or any omission or alleged omission to state in any Ancillary Document any fact required to be stated in such document or necessary to make any statement in such document not misleading in light of the circumstances under which it was made;

 

  (ii)

any information or statement (except any information or statement relating solely to the Underwriters or any of them and furnished in writing by the Underwriters to the Company for use therein) in any of the Offering Documents (including, for greater certainty, the Documents Incorporated by Reference and any Subsequent Disclosure Documents) containing or being alleged to contain a misrepresentation or being or being alleged to be untrue, or based upon any omission or alleged omission to state in any of the Offering Documents any material fact required to be stated in those documents or necessary to make any of the statements therein not misleading in light of the circumstances in which they were made;

 

  (iii)

any order made or any inquiry, investigation or proceeding instituted, threatened or announced by any court, securities regulatory authority, stock exchange or by any other competent authority, based upon any untrue statement, omission or misrepresentation or alleged untrue statement, omission or misrepresentation (except a statement, omission or misrepresentation relating solely to the Underwriters or any of them and furnished in writing by the Underwriters to the Company for use therein) contained in any of the Offering Documents or any other document or material filed or delivered on behalf of the Company pursuant to this Agreement, preventing or restricting the trading in or the sale or distribution of the Offered Shares or any other securities of the Company;

 

  (iv)

the non-compliance by the Company with any Applicable Securities Laws or other regulatory requirements or the rules of the TSX including the Company’s non-compliance with any statutory requirement to make any document available for inspection;

 

  (v)

any statement contained in the Disclosure Record which at the time and in the light of the circumstances under which it was made, contained or is alleged to have contained a misrepresentation or untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make any statement therein not misleading in light of the circumstances in which they were made;

 

35


  (vi)

any misrepresentation or alleged misrepresentation by or on behalf of the Company relating to the Offering, whether oral or written and whether made during and in connection with the Offering, where such misrepresentation may give or gives rise to any other liability under any statute in any jurisdiction which is in force on the date of this Agreement;

 

  (vii)

any failure or alleged failure to make timely disclosure of a material change by the Company, where such failure or alleged failure occurs during the Offering or during the period of distribution of the Offered Shares or where such failure relates to the Offering or the Offered Shares, and may give or gives rise to any liability under any statute in any jurisdiction which is in force on the date of this Agreement; or

 

  (viii)

any breach of any representation or warranty of the Company contained herein or the failure of the Company to comply with any of its covenants or other obligations contained herein or to satisfy any conditions contained herein required to be satisfied by the Company.

 

  (b)

If any Claim contemplated by this Section 33 shall be asserted against any of the Indemnified Parties, or if any potential Claim contemplated by this Section 33 shall come to the knowledge of any of the Indemnified Parties, the Indemnified Party concerned shall promptly notify in writing the Company of the nature of such Claim (provided that any failure to so notify in respect of any Claim or potential Claim shall affect the liability of the Company under this Section 33 only if and to the extent that the Company is materially and adversely prejudiced by such failure). The Company shall, subject as hereinafter provided, be entitled (but not required) to assume the defence on behalf of the Indemnified Party of any such Claim; provided that the defence shall be through legal counsel selected by the Company and acceptable to the Indemnified Party, acting reasonably. An Indemnified Party shall have the right to employ separate counsel in any such Claim and participate in the defence thereof but the fees and expenses of such counsel shall be at the expense of the Indemnified Party unless:

 

  (i)

the Company fails to assume the defence of such Claim on behalf of the Indemnified Party within ten days of receiving notice of such suit;

 

  (ii)

the employment of such counsel has been authorized by the Company; or

 

  (iii)

the named parties to any such Claim (including any added or third parties) include the Indemnified Party and the Company and the Indemnified Party shall have been advised by counsel that representation of the Indemnified Party by counsel for the Company is inappropriate as a result of the potential or actual conflicting interests of those represented or that there may be legal defences available to the Indemnified Party or Indemnified Parties which are different from or in addition to those available to the Company or that the subject matter of the Claim may not fall within the foregoing indemnity or that there is a conflict of interest between the Company and the Indemnified Parties;

 

36


in each of cases (i), (ii) or (iii), the Company shall not have the right to assume the defence of such Claim on behalf of the Indemnified Party and the Company shall be liable to pay the reasonable fees and disbursements of counsel for such Indemnified Parties as well as the reasonable costs and out-of-pocket expenses of the Indemnified Party (including an amount to reimburse the Underwriter or Underwriters at their normal per diem rates for time spent by their respective directors, officers, employees or shareholders). Notwithstanding anything set forth herein, in no event shall the Company be liable for the fees or disbursements of more than one firm of legal counsel to an Indemnified Party in a particular jurisdiction in respect of any particular Claim or related set of Claims.

The Company will not, without each affected Indemnified Party’s prior written consent, such consent not to be unreasonably withheld, admit any liability, settle, compromise, consent to the entry of any judgment in or otherwise seek to terminate any action, suit, proceeding, investigation or claim in respect of which indemnification may be sought hereunder unless in connection with any settlement, compromise or consent by the Company, such settlement, compromise or consent (i) includes an unconditional release of each Indemnified Party from any liabilities arising out of such action, suit, proceeding, investigation or claim (if an Indemnified Party is a party to such action) and (ii) does not include a statement as to, or an admission of fault, culpability or a failure to act by or on behalf of an Indemnified Party.

 

  (c)

The Company hereby acknowledges and agrees that, with respect to Sections 33 and 34 hereof, the Underwriters are contracting on their own behalf and as agents for their affiliates, and its and their respective directors, officers, employees, partners, shareholders, advisors, agents and each other person, if any, controlling any of the Underwriters or their affiliates (collectively, the “ Beneficiaries ”). In this regard, each of the Underwriters shall act as trustee for the Beneficiaries of the covenants of the Company under Sections 33 and 34 hereof with respect to the Beneficiaries and accepts these trusts and shall hold and enforce such covenants on behalf of the Beneficiaries.

 

  (d)

The Company agrees to waive any right it may have of first requiring an Indemnified Party to proceed against or enforce any other right, power, remedy or security or claim payment from any other person before claiming under this indemnity. The Company also agrees that no Indemnified Party shall have any liability (whether direct or indirect, in contract or tort or otherwise) to the Company or any person asserting Claims on behalf of or in right of the Company for or in connection with the Offering except to the extent any Losses suffered by the Company are determined by a court of competent jurisdiction in a final judgment that has become non-appealable to have resulted from the negligence, fraud, illegal act or wilful misconduct of such Indemnified Party.

 

  (e)

Notwithstanding anything to the contrary contained herein, the foregoing indemnity shall not apply to the extent that a court of competent jurisdiction in a final judgment that has become non-appealable shall determine that such Losses to which the Indemnified Party may be subject were caused solely by the negligence, fraud, illegal act or wilful misconduct of the Indemnified Party.

 

37


  (f)

The Company agrees that in case any legal proceeding shall be brought against the Company and/or the Underwriters by any governmental commission or regulatory authority or any stock exchange or other entity having regulatory authority, either domestic or foreign, or if any such commission or authority shall investigate the Company and/or the Indemnified Parties and any Indemnified Parties shall be required to testify in connection therewith or shall be required to respond to procedures designed to discover information regarding, in connection with, or by reason of the performance of professional services rendered to the Company by the Underwriters, the Indemnified Parties shall have the right to employ their own counsel in connection therewith, and the reasonable fees and expenses of such counsel as well as the reasonable costs (including an amount to reimburse the Underwriters for time spent by the Indemnified Parties in connection therewith) and out-of-pocket expenses incurred by Indemnified Parties in connection therewith shall be paid by the Company as they occur. The Company agrees to reimburse the Underwriters for the time spent by their personnel in connection with any Claim at their normal per diem rates.

 

  (g)

The rights to indemnification provided in this Section 33 shall be in addition to and not in derogation of any other rights which the Underwriters may have by statute or otherwise at law.

 

14.

Contribution

 

  (a)

In order to provide for just and equitable contribution in circumstances in which the indemnity provided in Section 33 hereof would otherwise be available in accordance with its terms but is, for any reason held to be illegal, unavailable to or unenforceable by the Indemnified Parties or enforceable otherwise than in accordance with its terms, the Company and the Underwriters shall contribute to the aggregate of all Losses of the nature contemplated in Section 33 hereof and suffered or incurred by the Indemnified Parties (i) in such proportion as is appropriate to reflect not only the relative benefits received by the Company, on the one hand, and the Underwriters on the other hand, from the distribution of the Offered Shares, or (ii) if the allocation provided by clause (i) is not permitted by Applicable Law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, in respect of such Losses; provided that the Company shall in any event contribute to the amount paid or payable by the Indemnified Parties as a result of such Claim any excess of such amount over the amount actually received by the Underwriters or any other Indemnified Party under this Agreement and further provided that the Underwriters shall not in any event be liable to contribute, in the aggregate, any amount in excess of such total Underwriters’ Fees or any portion thereof actually received by the Underwriters. However, no party who has engaged in any fraud, fraudulent misrepresentation or wilful misconduct shall be entitled to claim contribution from any person who has not engaged in such fraud, fraudulent misrepresentation or wilful misconduct.

 

  (b)

The relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, shall be deemed to be in the same ratio as the total proceeds from the Offering of the Offered Shares (net of the Underwriters’ Fees payable to the Underwriters but before deducting expenses) received by the Company is to the Underwriters’ Fees actually received by the Underwriters. The relative fault of the Company, on the one hand, and of the Underwriters, on the other hand, shall be determined by reference to, among other things, whether the matters or things referred to in Section 33 which resulted in such Claims and/or Losses relate to information supplied by or steps or actions taken or done or not taken or not done by or on behalf

 

38


  of the Company or to information supplied by or steps or actions taken or done or not taken or not done by or on behalf of the Underwriters and the relative intent, knowledge, access to information and opportunity to correct or prevent such statement, omission or misrepresentation, or other matter or thing referred to in Section 33. The amount paid or payable by an Indemnified Party as a result of the Claims and/or Losses referred to above shall be deemed to include any legal or other expenses reasonably incurred by such Indemnified Party in connection with investigating or defending any such Claims and/or Losses, whether or not resulting in an action, suit, proceeding or claim. The parties to this Agreement agree that it would not be just and equitable if contribution pursuant to this Section 34 were determined by any method of allocation which does not take into account the equitable considerations referred to in this Section 34.

 

  (c)

If the Company may be held to be entitled to contribution from the Underwriters under the provisions of any statute or at law, the Company shall be limited to contribution in an aggregate amount not exceeding the lesser of:

 

  (i)

the portion of the full amount of the Losses giving rise to such contribution for which the Underwriters are responsible, as determined in Section 33(a); and

 

  (ii)

the amount of the aggregate Underwriters’ Fees actually received by the Underwriters from the Company under this Agreement.

 

  (d)

The rights to contribution provided in this Section 34 shall be in addition to and not in derogation of any other right to contribution which the Indemnified Parties may have by statute or otherwise at law.

 

  (e)

If an Indemnified Party has reason to believe that a claim for contribution may arise, the Indemnified Party shall give the Company notice thereof in writing, but failure to so notify shall not relieve the Company of any obligation which it may have to the Indemnified Party under this Section 34 provided that the Company is not materially and adversely prejudiced by such failure, and the right of the Company to assume the defence of such Indemnified Party shall apply as set out in Section 33 hereof, mutatis mutandis .

 

15.

Fees and Expenses

Whether or not the purchase and sale of the Offered Shares shall be completed, all fees and expenses (including GST or HST, if applicable) in connection with the Offering shall be borne by the Company including, without limitation:

 

  (a)

all reasonable expenses of, or incidental to, the creation, issue, sale or distribution of the Offered Shares and the filing and delivery of each of the Preliminary Prospectus, the Prospectus and any Supplementary Material;

 

  (b)

the fees and expenses of the auditors, counsel to the Company and all local counsel (including GST or HST, if and as applicable, on all of the foregoing);

 

  (c)

all costs incurred by the Company in connection with the preparation of documentation relating to the Offering;

 

39


  (d)

the reasonable fees of the Underwriters’ legal counsel (subject to a maximum of $75,000, exclusive of applicable taxes and disbursements, such disbursements not to exceed $1,500); and

 

  (e)

in addition to (d) above, the reasonable out-of-pocket expenses of the Underwriters subject to a maximum $1,500,

with such expenses to be paid by the Company at the Closing Time or at any other time requested by the Underwriters, provided that all fees and expenses incurred by the Underwriters, or on its behalf, pursuant to the Offering shall be payable by the Company immediately upon receiving an invoice therefor from the Underwriters whether or not the Offering is completed unless the Offering is not completed due to the fault of the Underwriters. For greater certainty, any termination of this Agreement by the Underwriters pursuant to Section 36 or 37 shall not be considered to be the non-completion of the Offering due to the fault of the Underwriters. At the option of Beacon, such fees and expenses may be deducted from the gross proceeds otherwise payable to the Company at Closing.

 

16.

All Terms to be Conditions

The Company agrees that the conditions contained in Section 30 will be complied with insofar as the same relate to acts to be performed or caused to be performed by the Company and that it will use its commercially reasonable efforts to cause all such conditions to be complied with. Any breach or failure to comply with or satisfy any of the conditions set out in Section 30 shall entitle the Underwriters to terminate their obligation to purchase the Offered Shares, by written notice to that effect given to the Company at or prior to the Closing Time. It is understood that the Underwriters may waive, in whole or in part, or extend the time for compliance until no later than 42 days from the date of the Final Receipt with, any of such terms and conditions without prejudice to the rights of the Underwriters in respect of any such terms and conditions or any other or subsequent breach or non-compliance, provided that to be binding on the Underwriters any such waiver or extension must be in writing.

 

17.

Termination by Underwriters in Certain Events

 

  (a)

Each Underwriter shall also be entitled to terminate its obligation to purchase the Offered Shares by written notice to that effect given to the Company at or prior to the Closing Time if:

 

  (i)

there shall be any material change in the affairs of the Company and/or its Subsidiaries, or there should be discovered any previously undisclosed material fact or information or circumstance or there should occur a change in any material fact relating to the Company and/or its Subsidiaries, including from that information disseminated by the Company through its periodic and timely disclosure documents publicly filed on the SEDAR, which in any case, in the reasonable opinion of the Underwriters (or any of them), has or would be expected to have a material adverse effect on the market price or value of the Common Shares or any other securities of the Company;

 

  (ii)

(A) any inquiry, action, suit, investigation or other proceeding (whether formal or informal) is commenced, announced or threatened or any order made by any federal, provincial, state, municipal or other governmental department, commission, board, bureau, agency or instrumentality including, without

 

40


  limitation, the TSX or any securities regulatory authority (except for any inquiry, action, suit, proceeding, investigation or order based upon activities of the Underwriters and not upon activities of the Company) or any law or regulation is enacted or changed which in the opinion of any Underwriter, acting reasonably, could operate to prevent or materially restrict the trading of the Common Shares or any other securities of the Company or materially and adversely affects or might be expected to materially and adversely affect the market price or value of the Common Shares or any other securities of the Company or that could be reasonably expected to have a Material Adverse Effect; or (B) if there should develop, occur or come into effect or existence any event, action, state, condition or major financial occurrence of national or international consequence or any law or regulation which in the opinion of the Underwriters, acting reasonably, seriously adversely affects, or involves, or will seriously adversely affect, or involve, the financial markets or the business, operations or affairs of the Company and the Subsidiaries taken as a whole;

 

  (iii)

the Company is in breach of or any term, condition or covenant contained in this Agreement, or any condition herein is not satisfied at Closing or becomes incapable of being satisfied, or any representation or warranty given by the Company in this Agreement becomes or is false or is breached;

 

  (iv)

any order to cease or suspend trading in any securities of the Company or prohibiting or restricting the distribution of any securities of the Company, including the Offered Shares, is made, or proceedings are announced, commenced or threatened for the making of any such order, by any Securities Commission, the TSX or any other competent authority, and has not been rescinded, revoked or withdrawn; or

 

  (v)

any Underwriter and the Company agree in writing to terminate this Agreement in relation to such Underwriter.

 

  (b)

If this Agreement is terminated by any of the Underwriters pursuant to Section 37(a), there shall be no further liability on the part of such Underwriter, or on the part of the Company to such Underwriter except in respect of any liability which may have arisen or may thereafter arise under Sections 33, 34 and 35.

 

  (c)

The right of the Underwriters or any of them to terminate their respective obligations under this Agreement is in addition to such other remedies as they may have in respect of any default, act or failure to act of the Company in respect of any of the matters contemplated by this Agreement. A notice of termination given by one Underwriter under this Section 37 shall not be binding upon the other Underwriter.

 

18.

Obligations of the Underwriters

The obligations of the Underwriters under this Agreement shall be several in all respects and not joint or joint and several. For greater certainty, the obligations of the Underwriters to purchase the Offered Shares shall be several and not joint or joint and several, and shall be limited to the percentages of the aggregate number of Offered Shares to be purchased set out opposite the names of the Underwriters respectively below:

 

Beacon Securities Limited

     —          65

GMP Securities L.P.

     —          35

 

41


If an Underwriter does not complete the purchase and sale of the Offered Shares which that Underwriter has agreed to purchase under this Agreement (other than in accordance with Section 37 of this Agreement) (the “ Defaulted Shares ”), Beacon may delay the Closing Date for not more than three days without the prior written consent of the Company, and the remaining Underwriter (the “ Continuing Underwriter ”) will be entitled, at its option, to purchase all but not less than all of the Defaulted Shares. If the Continuing Underwriter does not elect to purchase the Defaulted Shares:

 

  (a)

the Continuing Underwriter will not be obliged to purchase any of the Offered Shares;

 

  (b)

the Company will not be obliged to sell less than all of the Offered Shares; and

 

  (c)

the Company will be entitled to terminate its obligations under this Agreement, in which event there will be no further liability on the part of the Continuing Underwriter, or on the part of the Company except pursuant to the provisions of Sections 33, 34 and 35 of this Agreement.

 

19.

Over-Allotment

In connection with the distribution of the Offered Shares, the Underwriters may over-allot or effect transactions which stabilize or maintain the market price of the Common Shares at levels above those which might otherwise prevail in the open market, in compliance with Applicable Securities Laws. Those stabilizing transactions, if any, may be discontinued at any time.

 

20.

Notices

Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be delivered to,

in the case of the Company, to:

Village Farms International, Inc.

4700-80th Street

Delta, British Columbia V4K 3N3

Email:                 sruffini@villagefarms.com

Attention:            Stephen Ruffini

with a copy of any such notice (which shall not constitute notice to the Company) to:

Torys LLP

79 Wellington Street West, Suite 3000

Toronto, Ontario M5K 1N2

Email:                 mzackheim@torys.com

Attention:            Michael Zackheim

 

42


in the case of the Underwriters, to:

Beacon Securities Limited

66 Wellington Street West, Suite 4050

TD Tower

Toronto, Ontario M5K 1H1

Email:                 mmaruzzo@beaconsecurities.ca

Attention:            Mario Maruzzo, Managing Director, Investment Banking

GMP Securities L.P.

145 King. Street West, Suite 300

Toronto, Ontario M5H 1J8

Email:                 steveo@gmpsecurities.com

Attention:            Steve Ottaway, Managing Director, Investment Banking

and with a copy of any such notice (which shall not constitute notice to the Underwriters) to:

Fasken Martineau DuMoulin LLP

Suite 2400 - 333 Bay Street

Box 20 Bay Adelaide Centre

Toronto, Ontario M5H 2T6

Fax:                     jsabetti@fasken.com

Attention:            John M. Sabetti

The Company and the Underwriters may change their respective addresses for notice by notice given in the manner aforesaid. Any such notice or other communication shall be in writing, and unless delivered personally to the addressee or to a responsible officer of the addressee, as applicable, shall be given by email and shall be deemed to have been given when: (i) in the case of a notice delivered personally to a responsible officer of the addressee, when so delivered; and (ii) in the case of a notice delivered or given by email prior to 5:00 p.m. (Eastern time), on the date that it is sent, and thereafter, on the first Business Day following the day on which it is sent.

 

21.

Miscellaneous

 

  (a)

Except with respect to Sections 33, 34, 37 and 38, all transactions and notices on behalf of the Underwriters hereunder or contemplated hereby may be carried out or given on behalf of the Underwriters by Beacon and Beacon shall in good faith discuss with the other Underwriter the nature of any such transactions and notices prior to giving effect thereto or the delivery thereof, as the case may be.

 

  (b)

This Agreement shall enure to the benefit of, and shall be binding upon, the Underwriters and the Company and their respective successors and legal representatives, provided that no party may assign this Agreement or any rights or obligations under this Agreement, in whole or in part, without the prior written consent of the other party.

 

43


  (c)

This Agreement, including all schedules to this Agreement, constitutes the entire agreement between the parties relating to its subject matter and supersedes all prior agreements, understandings, negotiations and discussions, whether oral or written, of the parties with respect to such subject matter. This Agreement may only be amended, supplemented, or otherwise modified by written agreement signed by all of the parties.

 

  (d)

The Company acknowledges and agrees that: (i) the purchase and sale of the Offered Shares pursuant to this Agreement is an arm’s-length commercial transaction between the Company, on the one hand, and the several Underwriters, on the other; (ii) in connection therewith and with the process leading to such transaction each Underwriter is acting solely as a principal and not the agent or fiduciary of the Company; (iii) no Underwriter has assumed an advisory or fiduciary responsibility in favour of the Company with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether such Underwriter has advised or is concurrently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth in this Agreement; and (iv) the Company has consulted its own legal and financial advisors to the extent they deemed appropriate. The Company agrees that it will not claim that the Underwriters, or any of them, has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to the Company in connection with such transaction or the process leading thereto.

 

  (e)

In connection with the services described herein, the Underwriters are acting as independent contractors to the Company, and any duties of the Underwriters arising out of this Agreement shall be owed solely to the Company.

 

  (f)

The Company acknowledges that each of the Underwriters is a securities firm that is engaged in securities trading and brokerage activities, as well as providing investment banking and financial advisory services, which may involve services provided to other companies engaged in businesses similar or competitive to the business of the Company and that the Underwriters shall have no obligation to disclose such activities and services to the Company. The Company acknowledges and agrees that in connection with all aspects of the engagement contemplated hereby, and any communications in connection therewith, the Company, on the one hand, and the Underwriters and any of their respective affiliates through which they may be acting, on the other hand, will have a business relationship that does not create, by implication or otherwise, any fiduciary duty on the part of the Underwriters or such affiliates, and each party hereto agrees that no such duty will be deemed to have arisen in connection with any such transactions or communications. The Company acknowledges and agrees that it waives, to the fullest extent permitted by law, any claims the Company and its affiliates may have against any of the Underwriters for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that the Underwriters shall have no liability (whether direct or indirect) to the Company or any of its affiliates in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on behalf of or in right of the Company, including shareholders, employees or creditors of the Company. Information which is held elsewhere within any of the Underwriters, but of which none of the individuals in the investment banking department or division of any of the Underwriters involved in providing the services contemplated by this Agreement actually has knowledge (or without breach of internal procedures can properly obtain) will not for any purpose be taken into account in determining any of the responsibilities of the Underwriters to the Company under this Agreement.

 

44


  (g)

The Company acknowledges that Beacon is a full service securities firm engaged in securities trading and brokerage activities as well as providing investment banking and financial advisory services and that in the ordinary course of its trading and brokerage activities, Beacon and/or any of its affiliates at any time may hold long or short positions, and may trade or otherwise effect transactions, for its own account or the accounts of customers, in debt or equity securities of the Company or any other company that may be involved in a transaction or related derivative securities.

 

  (h)

Neither the Company nor any of Underwriters shall make any public announcement in connection with the Offering, except if the other party has consented to such announcement or the announcement is required by applicable laws or stock exchange rules. In such event, the party proposing to make the announcement will provide the other party with a reasonable opportunity, in the circumstances, to review a draft of the proposed announcement and to provide comments thereon.

 

  (i)

No waiver of any provision of this Agreement will constitute a waiver of any other provision (whether or not similar). No waiver will be binding unless executed in writing by the party to be bound by the waiver. A party’s failure or delay in exercising any right under this Agreement will not operate as a waiver of that right. A single or partial exercise of any right will not preclude a party from any other or further exercise of that right or the exercise of any other right it may have.

 

  (j)

If any provision of this Agreement is determined to be illegal, invalid or unenforceable by an arbitrator or any court of competent jurisdiction from which no appeal exists or is taken, that provision will be severed from this Agreement and the remaining provisions will remain in full force and effect.

 

  (k)

This Agreement shall be governed by and interpreted in accordance with the laws of the Province of Ontario and the federal laws of Canada applicable therein and the parties submit to the non-exclusive jurisdiction of the courts of the Province of Ontario.

 

  (l)

Time shall be of the essence hereof and, following any waiver or indulgence by any party, time shall again be of the essence hereof.

 

  (m)

The words, “hereunder”, “hereof” and similar phrases mean and refer to the Agreement formed as a result of the acceptance by the Company of this offer by the Underwriters to purchase the Offered Shares.

 

  (n)

All warranties, representations, covenants and agreements of the Company herein contained or contained in any Ancillary Document (including those related to indemnification and contribution) shall survive the purchase by the Underwriters of the Offered Shares and shall continue in full force and effect for the benefit of the Underwriters regardless of the Closing of the sale of the Offered Shares, any subsequent disposition of the Offered Shares by the Underwriters or the termination of the Underwriters’ obligations under this Agreement and shall not be limited or prejudiced by any investigation made by or on behalf of the Underwriters in accordance with the preparation of the Preliminary Prospectus, the Prospectus or any Supplementary Material or the distribution of the Offered Shares or otherwise, and the Company agrees that the Underwriters shall not be presumed to know of the existence of a claim against the Company under this Agreement or any Ancillary Document or in connection with the purchase and sale of the Offered Shares as a result of any investigation made by or on behalf of the Underwriters in accordance with the preparation of the Preliminary Prospectus, the Prospectus or any Supplementary Material or the distribution of the Offered Shares or otherwise.

 

45


  (o)

Each of the parties hereto shall be entitled to rely on delivery of a facsimile or portable document format copy of this Agreement and acceptance by each such party of any such facsimile or portable document format copy shall be legally effective to create a valid and binding agreement between the parties hereto in accordance with the terms hereof.

 

  (p)

This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same agreement.

[remainder of page intentionally left blank]

 

46


If this letter accurately reflects the terms of the transactions which we are to enter into and are agreed to by you, please communicate your acceptance by executing the enclosed copies of this letter where indicated and returning them to us.

Yours very truly,

 

  BEACON SECURITIES LIMITED
By:  

<Mario Maruzzo>

Name:

Title:

 

Mario Maruzzo

Managing Director, Investment Banking

 

  GMP SECURITIES L.P.
By:  

<Steve Ottaway>

Name:

Title:

 

Steve Ottaway

Managing Director, Investment Banking


Accepted and agreed to by the undersigned as of the date of this letter first written above.

 

  VILLAGE FARMS INTERNATIONAL, INC.
By:  

<Stephen C. Ruffini>

Name:

Title:

 

Stephen C. Ruffini

Executive Vice President and Chief Financial Officer

Exhibit 99.49

October 4, 2018

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

Ontario Securities Commission

Financial and Consumer Services Commission (New Brunswick)

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Service Newfoundland & Labrador

Office of the Superintendent of Securities, Government of Prince Edward Island

We refer to the short form prospectus of Village Farms International, Inc. (the company) dated October 4, 2018 relating to the sale and issue of 2,810,000 common shares.

We consent to being named in and to the use, through incorporation by reference in the above-mentioned short form prospectus, of our report dated April 2, 2018 to the shareholders of the company on the following consolidated financial statements:

 

   

consolidated statements of financial position as at December 31, 2017 and December 31, 2016;

 

   

consolidated statements of income (loss) and comprehensive income, changes in shareholders’ equity, and cash flows for the years ended December 31, 2017 and December 31, 2016;

 

   

related notes, which comprise a summary of significant accounting policies and other explanatory information.

We report that we have read the short form prospectus and all information specifically incorporated by reference therein and have no reason to believe that there are any misrepresentations in the information contained therein that are derived from the consolidated financial statements on which we have reported or that are within our knowledge as a result of our audit of such financial statements. We have complied with Canadian generally accepted standards for an auditor’s consent to the use of a report of the auditor included in an offering document, which does not constitute an audit or review of the prospectus as these terms are described in the CPA Canada Handbook – Assurance.

(Signed) “PricewaterhouseCoopers LLP”

Chartered Professional Accountants

Vancouver, Canada

Exhibit 99.50

This short form prospectus constitutes a public offering of these securities only in those jurisdictions where they may be lawfully offered for sale and therein only by persons permitted to sell such securities.

No securities regulatory authority has expressed an opinion about these securities and it is an offence to claim otherwise.

These securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the “ U.S. Securities Act ”), or the securities laws of any state of the United States (as such term is defined in Regulation S under the U.S. Securities Act) (the “ United States ”) and may not be offered, sold or delivered, directly or indirectly, in the United States except as permitted by the Underwriting Agreement (as defined below) and pursuant to an exemption from registration under the U.S. Securities Act and applicable U.S. state securities laws. This short form prospectus does not constitute an offer to sell or a solicitation of an offer to buy any of these securities in the United States. See “Plan of Distribution”.

Information has been incorporated by reference in this short form prospectus from documents filed with securities commissions or similar authorities in Canada. Copies of the documents incorporated herein by reference may be obtained on request without charge from the Chief Financial Officer of Village Farms International, Inc., at 4700-80 th Street, Delta, British Columbia, Canada, V4K 3N3 (telephone: (407) 936-1190, ext. 340), and are also available electronically at www.sedar.com.

SHORT FORM PROSPECTUS

 

New Issue

   October 4, 2018

 

LOGO

VILLAGE FARMS INTERNATIONAL, INC.

$20,035,300

2,810,000 Common Shares

This short form prospectus (this “ Prospectus ”) qualifies the distribution to the public (the “ Offering ”) of 2,810,000 common shares (the “ Offered Shares ”) of Village Farms International, Inc. (the “ Company ”) at a price of $7.13 per Offered Share (the “ Offering Price ”).

The Company is a corporation incorporated under the Canada Business Corporations Act (the “ CBCA ”).

The outstanding common shares of the Company (the “ Shares ”) are listed and posted for trading on the Toronto Stock Exchange (the “ TSX ”) under the symbol “VFF” and are also listed on the OTCQX International marketplace (the “ OTCQX ”) under the trading symbol “VFFIF”. On September 21, 2018, the last trading day prior to the public announcement of the Offering, the closing price of the Shares on the TSX and the OTCQX was $7.79 and US$6.1209 per Share, respectively. On October 3, 2018, the last trading day prior to the date of this Prospectus, the closing price of the Shares on the TSX and the OTCQX was $6.65 and US$5.1630 per Share, respectively.

The TSX has conditionally approved the listing of the Offered Shares on the TSX. Listing is subject to the Company fulfilling all of the listing requirements of the TSX on or before December 24, 2018.


 

Price: $7.13 per Offered Share

 

 

 

     Price to the
Public
     Underwriters’
Fee (1)
     Net Proceeds
to the Company (2)
 

Per Offered Share

   $ 7.13      $ 0.4278      $ 6.7022  

Total Offering (3)

   $ 20,035,300      $ 1,202,118      $ 18,833,182  

 

Notes:

 

(1)

Upon closing of the Offering, the Company will pay the Underwriters a cash commission equal to 6% of the gross proceeds of the Offering (the “ Underwriters’ Fee ”) including pursuant to any exercise of the Over-Allotment Option (as defined below). See “Plan of Distribution”.

(2)

Before deducting the expenses of the Offering, estimated to be $235,000, which, together with the Underwriters’ Fee, will be paid from the proceeds of the Offering.

(3)

The Company has granted to the Underwriters an option (the “ Over-Allotment Option ”) exercisable in whole or in part for a period of 30 days from the closing of the Offering to purchase up to 421,500 additional Shares (the “ Over-Allotment Shares ”) (being equal to 15% of the Offered Shares sold pursuant to the Offering) on the same terms as set forth above. If the Over-Allotment Option is exercised in full, the total Price to the Public, Underwriters’ Fee and Net Proceeds to the Company will be $23,040,595, $1,382,435.70 and $21,658,159.30, respectively, before deducting the expenses of the Offering. This Prospectus qualifies the grant of the Over-Allotment Option and the issuance of the Over-Allotment Shares on the exercise of the Over-Allotment Option. A purchaser who acquires Over-Allotment Shares on exercise of the Over-Allotment Option acquires those Over-Allotment Shares under this Prospectus, regardless of whether the over-allocation position is ultimately filled through the exercise of the Over-Allotment Option or secondary market purchases.

Beacon Securities Limited (the “ Lead Underwriter ”), as lead underwriter and sole bookrunner, and GMP Securities L.P. (together with the Lead Underwriter, the “ Underwriters ”) have severally agreed to purchase the Offered Shares from the Company at a price of $7.13 per Offered Share, subject to the terms and conditions of the underwriting agreement described under “Plan of Distribution”. The Offering Price was determined by negotiation between the Company and the Lead Underwriter.

The Underwriters, as principals, conditionally offer the Offered Shares, subject to prior sale, if, as and when issued by the Company and accepted by the Underwriters in accordance with the conditions contained in the underwriting agreement described under “Plan of Distribution” and subject to the approval of certain legal matters on behalf of the Company by Torys LLP and on behalf of the Underwriters by Fasken Martineau DuMoulin LLP.

This Prospectus is only being and may only be distributed to and directed at: (i) persons outside the United Kingdom (the “ UK ”); or (ii) persons in the UK who (a) are “qualified investors” within the meaning of Section 86(7) of the UK Financial Services and Markets Act 2000, as amended (the “ FSMA ”) and fall within the categories of persons referred to in Article 19(5) (investment professionals) or Article 49(2)(a)-(d) (high net worth companies, unincorporated associations, etc.) of the UK Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the “ Financial Promotions Order ”); or (b) are otherwise lawfully permitted to receive it (all such persons together being referred to as “ relevant persons ”). The securities being offered hereunder are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in only with, relevant persons. By accepting a copy of this document and by offering to acquire Offered Shares under the Offering, potential investors in the UK will be deemed to have represented that they satisfy the criteria specified in clause (ii) above to be a relevant person. Any person who is not a relevant person should not act or rely on this Prospectus or any of its contents. This Prospectus is not a prospectus for the purposes of Section 85(1) of the FSMA and contains no offer of transferable securities to the public within the meaning of section 102B of the FSMA, the UK Companies Act 2006 or otherwise. Accordingly, this Prospectus has not been examined or approved as a prospectus by the UK Financial Conduct Authority (the “ FCA ”), under Section 87A of the FSMA and has not been filed with the FCA pursuant to the rules published by the FCA implementing the Prospectus Directive (Directive 2003/71/EC) nor has it been approved by a person authorized under the FSMA for the purposes of Section 21 of the FSMA.

The Company has been advised by the Underwriters that, in connection with the Offering, the Underwriters may effect transactions that stabilize or maintain the market price of the Shares at levels other than those which otherwise might prevail on the open market. Such transactions, if commenced, may be discontinued at any time. The Underwriters may offer the Offered Shares to the public at a price lower than that stated above. Notwithstanding any such reduction by the Underwriters in the Offering Price, the Company will still receive net proceeds of $6.7022 per Offered Share purchased by the Underwriters under the Offering. See “Plan of Distribution”.

Subscriptions will be received subject to rejection or allocation in whole or in part and the Underwriters reserve the right to close the subscription books at any time without notice. Closing of the Offering is expected to occur on or about October 12, 2018 or such other date as the Company and the Underwriters may agree, but in any event not later than 42 days after the date of the receipt for this Prospectus (the “ Closing Date ”). Registrations and transfers of the Offered Shares will be effected electronically through the non-certificated inventory (“ NCI ”) system administered by CDS Clearing and Depository Services Inc. (“ CDS ”). Beneficial owners of Offered Shares will not, except in certain limited circumstances, be entitled to receive physical certificates evidencing their ownership of Offered Shares. See “Plan of Distribution”.

 

ii


The following table sets out the number of Over-Allotment Shares that may be issued pursuant to the Over-Allotment Option:

 

Underwriters’ Position

  Maximum Size or Number of
Securities Available
  Exercise Period   Exercise Price

Over-Allotment Option

  421,500

Over-Allotment
Shares

  30 days from closing of
the Offering
  $7.13 per Over-Allotment
Share

 

An investment in the Offered Shares is subject to a number of risks that should be carefully considered by prospective investors. Prospective investors should carefully review this Prospectus, and specifically the documents incorporated by reference herein, and the risk factors set out herein and in each such document before purchasing Offered Shares. It is important for investors to consider the particular risk factors that may affect the industries in which the Company operates. The risk factors identified under the heading “Risk Factors” in this Prospectus and in the Annual Information Form (as defined herein) should be carefully reviewed and evaluated by prospective investors before making an investment decision. An investment in the Offered Shares is suitable for only those investors who are willing to risk a loss of their entire investment. See “Risk Factors”.

The principal, registered and head office of the Company is located at 4700-80 th Street, Delta, British Columbia, Canada, V4K 3N3.

 

iii


TABLE OF CONTENTS

 

 

     Page  

ABOUT THIS PROSPECTUS

     1  

EXCHANGE RATE INFORMATION

     1  

FORWARD-LOOKING STATEMENTS

     2  

DOCUMENTS INCORPORATED BY REFERENCE

     3  

MARKETING MATERIALS

     4  

ELIGIBILITY FOR INVESTMENT

     4  

THE COMPANY

     4  

RECENT DEVELOPMENTS

     5  

MATERIAL CHANGES TO CONSOLIDATED CAPITALIZATION

     5  

DESCRIPTION OF SHARE CAPITAL

     5  

PLAN OF DISTRIBUTION

     6  

USE OF PROCEEDS

     8  

PRIOR SALES

     8  

PRICE RANGE AND TRADING VOLUME OF THE SHARES

     9  

RISK FACTORS

     10  

LEGAL MATTERS

     11  

AUDITORS AND TRANSFER AGENT AND REGISTRAR

     11  

AGENT FOR SERVICE OF PROCESS

     12  

STATUTORY RIGHTS OF WITHDRAWAL AND RESCISSION

     12  

CERTIFICATE OF THE COMPANY

     C-1  

CERTIFICATE OF THE UNDERWRITERS

     C-2  

 

iv


ABOUT THIS PROSPECTUS

General Advisory

A prospective purchaser of Offered Shares should read this entire Prospectus, including the documents incorporated herein by reference, and consult its own professional advisors to assess the income tax, legal, risks and other aspects of its investment in the Offered Shares. A prospective purchaser of Offered Shares should rely only on the information contained in this Prospectus. The Company and the Underwriters have not authorized anyone to provide prospective purchasers of Offered Shares with additional or different information. The information contained in this Prospectus is accurate only as of the date of this Prospectus, regardless of the time of delivery of this Prospectus or any sale of the Offered Shares. The Company’s business, financial condition, results of operations and prospects may have changed since the date of this Prospectus. Neither the Company nor the Underwriters are making an offer to sell these securities in any jurisdictions where the offer or sale is not permitted. For prospective purchasers of Offered Shares outside Canada, neither the Company nor the Underwriters have done anything that would permit the Offering or possession or distribution of this Prospectus in any jurisdiction where action for that purpose is required, other than in Canada (except Quebec). Prospective purchasers of Offered Shares are required to inform themselves about and to observe any restrictions relating to the Offering and the distribution of the Offered Shares under this Prospectus.

Interpretation

Unless otherwise noted or the context otherwise requires, the term “cannabis” has the meaning given to the term “marihuana” under the Access to Cannabis for Medical Purposes Regulations (the “ ACMPR ”).

Where context requires, all references in this Prospectus to the “Offering” include the Over-Allotment Option and all references in the Prospectus to “Offered Shares” include the Over-Allotment Shares that may be issued pursuant to the Over-Allotment Option.

Market and Industry Data

Unless otherwise indicated, information contained in this Prospectus or in documents incorporated herein by reference concerning the Company’s industry and the markets in which it operates or seeks to operate is based on information from third party sources, industry reports and publications, websites and other publicly available information, and management studies and estimates. Unless otherwise indicated, the Company’s estimates are derived from publicly available information released by third party sources as well as data from the Company’s own internal research, and include assumptions which the Company believes to be reasonable based on management’s knowledge of the Company’s industry and markets. The Company’s internal research and assumptions have not been verified by any independent source, and the Company has not independently verified any third party information. While the Company believes that such third party information to be generally reliable, such information and estimates are inherently imprecise. In addition, projections, assumptions and estimates of the Company’s future performance or the future performance of the industry and markets in which the Company operates are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in this Prospectus and in the Annual Information Form under “Risk Factors”.

Presentation of Financial Information

The financial statements of the Company incorporated by reference in this Prospectus are presented in United States dollars and have been prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board. Certain calculations included in tables and other figures in this Prospectus have been rounded for clarity of presentation.

EXCHANGE RATE INFORMATION

All references to “$”, “C$” or “Canadian dollars” included or incorporated by reference into this Prospectus refer to Canadian dollar values. References to “US$” or “United States dollars” are used to indicate United States dollar values.

The rate of exchange on October 3, 2018 as reported by the Bank of Canada for the conversion of Canadian dollars into United States dollars was C$1.00 equals US$0.7793 and for the conversion of United States dollars into Canadian dollars was US$1.00 equals C$1.2832.

 

1


The following table sets forth, for each of the periods indicated, the high, low and average spot rates for US$1.00 in terms of Canadian dollars, as reported by the Bank of Canada.

 

    
Six months ended
June 30, 2018

(C$)
    
Six months ended
June 30, 2017

(C$)
     Year ended
December 31, 2017
(C$)
     Year ended
December 31, 2016
(C$)
 

High

     1.3310        1.3743        1.3743        1.4589  

Low

     1.2288        1.2977        1.2128        1.2544  

Average

     1.2781        1.3343        1.2986        1.3248  

FORWARD-LOOKING STATEMENTS

Certain statements contained in this Prospectus and the documents incorporated by reference herein constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Offering, the use of proceeds of the Offering, the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this Prospectus and in the documents incorporated by reference herein include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Pure Sunfarms Corp. joint venture for the production of cannabis (the “ Joint Venture ”), including the Joint Venture’s ability to obtain a license under the ACMPR for the full 1.1 million square feet of its Delta 3 greenhouse (the “ Delta 3 Greenhouse ”) and the timing thereof, risks relating to conversion of the Company’s or the Joint Venture’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will become legalized in Canada effective October 17, 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable prices or rates when required.

Although the forward-looking statements contained in this Prospectus and in the documents incorporated by reference herein are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including the Company’s Annual Information Form and management’s discussion and analysis that are incorporate by reference in this Prospectus.

 

2


When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Prospectus and in the documents incorporated by reference herein relate only to events or information as of the date on which the statements are made in this Prospectus or the respective date of the applicable document incorporated by reference herein. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

DOCUMENTS INCORPORATED BY REFERENCE

The following documents filed with the securities commission or similar authority in each of the provinces of Canada are specifically incorporated by reference into, and form an integral part of, this Prospectus:

 

  (a)

the Company’s annual information form for the year ended December 31, 2017 dated April 2, 2018 (the “ Annual Information Form ”);

 

  (b)

the Company’s management information circular dated May 10, 2018 in connection with the annual and special meeting of shareholders held on June 14, 2018;

 

  (c)

the audited consolidated financial statements of the Company for the financial years ended December 31, 2017 and December 31, 2016, and the notes thereto together with the report of the independent auditors thereon;

 

  (d)

management’s discussion and analysis of the Company dated April 2, 2018, for the audited consolidated financial statements referred to in paragraph (c) above;

 

  (e)

the unaudited condensed consolidated interim financial statements of the Company for the three and six months ended June 30, 2018 and June 30, 2017, and the notes thereto;

 

  (f)

management’s discussion and analysis of the Company dated August 14, 2018, for the unaudited condensed consolidated interim financial statements referred to in paragraph (e) above (the “ Q2 MD&A ”);

 

  (g)

the Company’s material change report dated September 25, 2018 in respect of the Offering; and

 

  (h)

the template version of the term sheet for the Offering dated September 24, 2018 (the “ Marketing Materials ”).

Any statement contained in this Prospectus or in a document incorporated or deemed to be incorporated by reference herein will be deemed to be modified or superseded for the purposes of this Prospectus to the extent that a statement contained herein, or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein, modifies or supersedes that prior statement. The modifying or superseding statement need not state that it has modified or superseded a prior statement or include any other information set out in the document or statement that it modifies or supersedes. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this Prospectus. The making of a modifying or superseding statement will not be deemed an admission for any purposes that the modified or superseded statement, when made, constituted a misrepresentation, an untrue statement of a material fact or an omission to state a material fact that is required to be stated or that is necessary to make a statement not misleading in light of the circumstances in which it was made.

Any documents of the type described in Section 11.1 of Form 44-101F1 Short Form Prospectus Distributions filed by the Company with the various securities commissions or similar authorities in each of the provinces of Canada pursuant to the requirements of applicable securities legislation after the date of this Prospectus and prior to the termination of this distribution of Offered Shares are deemed to be incorporated by reference in this Prospectus.

 

3


MARKETING MATERIALS

The Marketing Materials are not part of this Prospectus to the extent that the contents of the Marketing Materials have been modified or superseded by a statement contained in this Prospectus or any amendment. Any “template version” of “marketing materials” (each as defined in National Instrument 41-101 - General Prospectus Requirements ) filed with the securities commission or similar authority in each of the provinces of Canada (except Quebec) in connection with this Offering after the date hereof but prior to the termination of the distribution of the Offered Shares under this Prospectus (including any amendments to, or an amended version of, any marketing materials) is deemed to be incorporated by reference herein.

ELIGIBILITY FOR INVESTMENT

In the opinion of Torys LLP, counsel to the Company, and Fasken Martineau DuMoulin LLP, counsel to the Underwriters, based on the provisions of the Income Tax Act (Canada) (the “ Tax Act ”), the Offered Shares if issued on the date hereof, would be “qualified investments” under the Tax Act for trusts governed by registered retirement savings plans (“ RRSPs ”), registered retirement income funds (“ RRIFs ”), registered education savings plans (“ RESPs ”), deferred profit sharing plans, registered disability savings plans (“ RDSPs ”) and tax-free savings accounts (“ TFSAs ”), provided that the Offered Shares are listed on a “designated stock exchange” (as defined in the Tax Act), which currently includes the TSX.

Notwithstanding that the Offered Shares may be qualified investments for a trust governed by a TFSA, RDSP, RRSP, RRIF or RESP (each a “ Plan ”), a holder of a TFSA or RDSP, an annuitant under an RRSP or RRIF or a subscriber of an RESP (each a “ Plan Holder ”) will be subject to a penalty tax if the Offered Shares are a “prohibited investment” (as defined in subsection 207.01(1) of the Tax Act) for a Plan. The Offered Shares will generally not be a “prohibited investment” for a trust governed by a Plan for purposes of the prohibited investment rules if the Plan Holder deals at arm’s length with the Company for purposes of the Tax Act and does not have a “significant interest” (within the meaning of subsection 207.01(4) of the Tax Act) in the Company. In addition, the Offered Shares will not be a “prohibited investment” for a Plan if the Offered Shares are “excluded property” (as defined in subsection 207.01(1) of the Tax Act) for such Plan. Prospective purchasers who intend to hold the Offered Shares in a Plan should consult their own tax advisors as to whether the Offered Shares will be a “prohibited investment” in their particular circumstances.

THE COMPANY

The Company is a corporation incorporated under the CBCA. The head and registered office of the Company and each of its Canadian subsidiaries is located at 4700-80 th Street, Delta, British Columbia, Canada, V4K 3N3.

The Company is one of the largest and longest-operating vertically integrated greenhouse growers in North America. The Company’s vegetables are grown hydroponically (without the use of soil) in a glass enclosed, high technology environment using sophisticated computer systems to control irrigation, fertilizers, carbon dioxide, light, temperature, ventilation, humidity and other climatic factors. The Company’s tomatoes are produced by plants that have been selected for their taste, quality and other characteristics and are not genetically modified.

The Company owns and currently operates a total of seven greenhouse facilities in British Columbia and Texas.

In June 2017, the Company entered into the Joint Venture with Emerald Health Therapeutics Inc. (“ Emerald ”) for the objective of seeking to achieve large-scale, low-cost, high quality cannabis production. The Joint Venture was formed by way of a corporation named “Pure Sunfarms Corp.”, which is 50% owned by the Company and 50% owned by Emerald, and has the purpose of carrying on the business of the Joint Venture. On September 6, 2018, the Joint Venture’s cannabis cultivation license from Health Canada (the “ License ”) was amended to provide for the production of cannabis on up to 550,000 square feet of the Delta 3 Greenhouse. The Joint Venture expects to have the full 1.1 million square foot area of the Delta 3 Greenhouse converted for cannabis production by the end of 2018.

On December 21, 2017, the Company completed a public offering of 2,500,000 Shares pursuant to a (final) short form prospectus of the Company dated December 15, 2017. The Company utilized the net proceeds from this prior prospectus offering in a manner consistent with that described in the “Use of Proceeds” section of such final prospectus, namely approximately $5.1 million of such net offering proceeds were used to repay a portion of a term loan with a Canadian creditor of the Company and the remainder of such net proceeds were retained by the Company for working capital purposes and, accordingly, were used to finance the Company’s ongoing business operations and growth initiatives.

 

4


Further information regarding the Company and its business is set out in the Annual Information Form, which is incorporated herein by reference.

RECENT DEVELOPMENTS

There have been no material developments in the business of the Company since August 14, 2018, the date of the Company’s unaudited condensed consolidated interim financial statements for the three and six months ended June 30, 2018 and June 30, 2017, which have not been disclosed in this Prospectus or the documents incorporated by reference herein.

On August 21, 2018, the Company announced that Mandesh Dosanjh had been appointed as President and Chief Executive Officer of the Joint Venture, effective on or before October 1, 2018. Mr. Dosanjh previously served as Senior Vice President, Supply Chain and Wholesale, at the Liquor Control Board of Ontario.

On August 23, 2018, the Joint Venture’s License was amended to provide for the production of cannabis on up to approximately 420,000 square feet of the Delta 3 Greenhouse. On September 6, 2018, the License was further amended by Health Canada to provide for the production of cannabis on up to 550,000 square feet of the Delta 3 Greenhouse. For further details, see “The Company”.

On September 25, 2018, the Company announced that it was accepted as a member of the board of the U.S. Hemp Roundtable, a coalition of companies and national grassroots organizations advocating for the full and permanent legalization of hemp in the United States.

MATERIAL CHANGES TO CONSOLIDATED CAPITALIZATION

There have been no material changes in the consolidated capitalization of the Company since June 30, 2018, the date of the Company’s unaudited comparative consolidated interim financial statements for the three and six-month periods ended June 30, 2018, which have not been disclosed in this Prospectus or the documents incorporated by reference herein.

DESCRIPTION OF SHARE CAPITAL

General

The following is a summary of the rights, privileges, restrictions and conditions of or attaching to the Shares. The Company is authorized to issue an unlimited number of Shares, an unlimited number of preferred shares (“ Preferred Shares ”) and an unlimited number of special voting shares (“ Special Shares ”), of which 44,522,138 Shares, no Preferred Shares and no Special Shares were issued and outstanding as of the close of business on October 3, 2018.

Shares

Each Share entitles the holder thereof to receive notice of and to attend all meetings of shareholders of the Company and to one vote per Share at such meetings (other than meetings at which only the holders of another class of shares are entitled to vote separately as a class). The Shares entitle the holders thereof to receive, in any year, dividends on the Shares as and when declared by the board of directors of the Company, provided that payment of such dividends is not prohibited under law and after payment of any applicable amounts to which holders of any Preferred Shares may be entitled. In the event of the liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary, after payment of or other proper provision for all of the liabilities of the Company and the payment of any amounts payable to holders of the Preferred Shares, the holders of the Shares will be entitled to share pro rata in all remaining property or assets of the Company.

The ability of a beneficial owner of Shares to pledge such Shares or otherwise take action with respect to such shareholder’s interest in such Shares (other than through a CDS Participant) may be limited due to the lack of a physical Share certificate. The Company has the option to terminate the registration of the Shares through the book-entry system in which case definitive certificates for the Shares in fully registered form would be issued to beneficial owners of such Shares or their nominees.

 

5


The Company has no current plans to pay dividends as it is growth focused. The amount of any dividends payable by the Company will be at the discretion of the board of directors of the Company and may vary depending on, among other things, the Company’s earnings, financial requirements for the Company’s operations, growth opportunities, debt covenants, the satisfaction of the solvency tests imposed by the CBCA for declaration and payment of dividends and the conditions existing from time to time.

Preferred Shares

The Company’s board of directors will fix the number of Preferred Shares, as well as the designation, rights, privileges, restrictions and conditions for each series of Preferred Shares that may be issued, subject to the Company filing the applicable articles of amendment under the CBCA. Preferred Shares will have preference over Shares with respect to the payment of dividends and in the distribution of assets in the event of the liquidation, dissolution or winding-up of the Company, be it voluntary or involuntary, or any other distribution of the assets of the Company among its shareholders for the purpose of winding-up its affairs. Preferred Shares will have no right to vote on shareholder matters, subject to certain exceptions. No changes to the provisions of the Preferred Shares may be made without the approval of the holders of the Preferred Shares.

Special Shares

The holders of Special Shares are entitled to one vote for each Special Share held at all meetings of shareholders of the Company other than meetings at which only the holders of another class of shares are entitled to vote separately as a class; provided that in no event shall the votes attached to the Special Shares exceed 45% of the votes otherwise attached to the Shares and Special Shares then outstanding. In certain circumstances, the holders of Special Shares will not be entitled to vote separately as a class and will not be entitled to dissent. The holders of Special Shares will not be entitled to share in any distribution of the property or assets of the Company upon the dissolution, liquidation or winding-up of the Company, whether voluntary or involuntary, or in the event of any other distribution of assets of the Company among its shareholders for the purpose of winding-up its affairs. The provisions of the Special Shares cannot be modified by the Company without first obtaining, by separate affirmative vote, two-thirds of the votes cast at a meeting of the holders of the shares of such class.

The holders of Special Shares are not entitled to receive any dividends. The Company has redeemed all of the Special Shares that were previously issued and outstanding.

Further information relating to the Shares, the Preferred Shares and the Special Shares is set out in the Annual Information Form, which is incorporated by reference herein.

PLAN OF DISTRIBUTION

Pursuant to an underwriting agreement dated September 27, 2018 between the Company and the Underwriters (the “ Underwriting Agreement ”), the Company has agreed to sell and the Underwriters have severally agreed to purchase on the Closing Date, an aggregate of 2,810,000 Offered Shares at a purchase price of $7.13 per Offered Share, payable in cash to the Company by the Underwriters against delivery of the Offered Shares for aggregate gross proceeds of $20,035,300. The Underwriters will receive an aggregate fee of $1,202,118 (or 6.0% of the gross proceeds of the Offering), excluding any fees payable pursuant to the Over-Allotment Option. The Offering Price of the Offered Shares was determined by negotiation between the Company and the Lead Underwriter.

In addition, the Company has granted to the Underwriters the Over-Allotment Option exercisable in whole or in part for a period of 30 days from the closing of the Offering to purchase up to 421,500 Over-Allotment Shares on the same terms as set out above. The Underwriting Agreement provides that the Company will pay the Underwriters a fee of $0.4278 per Over-Allotment Share with respect to Over-Allotment Shares issued under the Over-Allotment Option. This Prospectus qualifies the grant of the Over-Allotment Option and the issuance of Over-Allotment Shares on the exercise of the Over-Allotment Option. A purchaser who acquires Over-Allotment Shares on exercise of the Over-Allotment Option acquires those Over-Allotment Shares under this Prospectus, regardless of whether the over-allocation position is ultimately filled through the exercise of the Over-Allotment Option or secondary market purchases. In the event that the Over-Allotment Option is exercised in full, the aggregate Underwriters’ Fee shall be $1,382,435.70.

 

6


The Underwriters propose to offer the Offered Shares initially at the Offering Price. After the Underwriters have made a reasonable effort to sell all of the Offered Shares at the Offering Price, the Offering Price may be decreased and may be further changed from time to time to an amount not greater than the Offering Price, and the compensation realized by the Underwriters will be decreased by the amount that the aggregate price paid by purchasers to the Underwriters for the Offered Shares is less than the price paid by the Underwriters to the Company.

The obligations of the Underwriters under the Underwriting Agreement are several and may be terminated at their discretion pursuant to standard “regulatory out”, “material change out”, “disaster out” and “breach of agreement out” provisions and upon the occurrence of certain other stated events. The Underwriters are, however, severally obligated to take up and pay for all of the Offered Shares that they have agreed to purchase if any of the Offered Shares are purchased under the Underwriting Agreement.

The TSX has conditionally approved the listing of the Offered Shares on the TSX. Listing is subject to the Company fulfilling all of the listing requirements of the TSX on or before December 24, 2018.

Pursuant to the amended and restated securityholders’ agreement dated December 31, 2009, between, among others, the Company and Michael DeGiglio (the “ Securityholders’ Agreement ”), Michael DeGiglio has waived his pre-emptive rights in connection with the Offering. No other person currently holds any pre-emptive rights under the Securityholders’ Agreement or any other agreement with the Company.

Under the Underwriting Agreement, the Company has agreed that it will not, without the prior written consent of the Lead Underwriter, on behalf of the Underwriters, such consent not to be unreasonably withheld or delayed, issue or sell (or agree or announce any such agreement to issue or sell), directly or indirectly (except in certain limited circumstances), any equity securities or other securities convertible into or exchangeable for equity securities, for the period up to and including 90 days after the Closing Date. In addition, under the Underwriting Agreement, each of the directors and officers of the Company has agreed that he or she will not, without the prior written consent of the Lead Underwriter, on behalf of the Underwriters, such consent not to be unreasonably withheld or delayed, sell (or agree or announce any such agreement to sell), directly or indirectly (except in certain limited circumstances), any Shares or other securities convertible into or exchangeable for Shares, for the period up to and including 30 days after the Closing Date, other than pursuant to a bona fide take-over bid or similar transaction made generally to all shareholders of the Company.

The Offered Shares have not been, and will not be, registered under the U.S. Securities Act or the securities laws of any state of the United States and, accordingly, may not be offered, sold or delivered, directly or indirectly, in the United States except in accordance with the Underwriting Agreement and pursuant to an exemption from registration under the U.S. Securities Act and applicable U.S. state securities laws.

In addition, until 40 days after the commencement of the Offering, an offer or sale of the Offered Shares within the United States by any dealer (whether or not participating in the Offering) may violate the registration requirements of the U.S. Securities Act if such offer or sale is made otherwise than in accordance with an exemption from registration under the U.S. Securities Act.

Subscriptions for the Offered Shares will be received subject to rejection or allotment in whole or in part and the right is reserved to close the subscription books at any time without notice. The Offering will be conducted under the NCI system. Offered Shares registered in the name of CDS or its nominee will be deposited electronically with CDS on an NCI basis at closing. A subscriber who purchases Offered Shares will generally only receive a customer confirmation from the registered dealer from or through whom Offered Shares are purchased and who is a CDS participant.

In accordance with rules and policy statements of certain Canadian securities regulators, the Underwriters may not, at any time during the period of distribution, bid for or purchase Shares. The foregoing restriction is, however, subject to exceptions where the bid or purchase is not made for the purpose of creating actual or apparent active trading in, or raising the price of, the Shares. These exceptions include a bid or purchase permitted under the by-laws and rules of applicable regulatory authorities and the TSX, including the Universal Market Integrity Rules for Canadian Marketplaces, relating to

 

7


market stabilization and passive market making activities and a bid or purchase made for and on behalf of a customer where the order was not solicited during the period of distribution. As a result of these activities, the price of the Shares may be higher than the price that otherwise might exist in the open market. If these activities are commenced, they may be discontinued by the Underwriters at any time.

USE OF PROCEEDS

The estimated net proceeds to the Company from the Offering, after deducting the Underwriters’ Fee and the expenses of the Offering (estimated to be $235,000), will be approximately $18.6 million (or approximately $21.4 million if the Over-Allotment Option is exercised in full). The Company intends to use the net proceeds of the Offering for working capital purposes, which may include funding certain future capital needs of Pure Sunfarms as well as other growth opportunities that may arise in respect of the Company’s business over time.

As disclosed in the Q2 MD&A, (i) the Company anticipates that Pure Sunfarms will need incremental capital to complete the full buildout of the Delta 3 Greenhouse as well as for its working capital needs, and (ii) Pure Sunfarms is presently in discussions with the Company’s current lenders to provide traditional term debt to Pure Sunfarms. Depending on the timing and amount of any third-party debt financing for Pure Sunfarms, additional shareholder debt or equity may have be contributed to Pure Sunfarms to complete the build out of the Delta 3 Greenhouse.

In the event that Pure Sunfarms secures third-party debt financing, the Company estimates that it will contribute approximately $5 million to $7 million of working capital to Pure Sunfarms over the next few months in order for Pure Sunfarms to complete the build out of the Delta 3 Greenhouse. In the event that Pure Sunfarms does not secure third-party debt financing, the Company anticipates that it may contribute approximately $15 million to $17 million of working capital to Pure Sunfarms in the next few months in order for Pure Sunfarms to complete the build out of the Delta 3 Greenhouse.

Aside from its investment in Pure Sunfarms, the Company continues to focus on increasing its produce revenues and profits on its core crops – tomatoes, cucumbers and peppers. The Company continues to actively explore whether to produce certain higher margin alternative crops at the Company’s continuing produce facilities, such as hemp as well as evaluate other cannabis related business opportunities. To the extent net proceeds of the Offering are not ultimately used by the Company for the potential Pure Sunfarms purposes described above, the Company intends to use its increased working capital to finance these other business and growth objectives.

For the reasons described above, the Company has not definitively determined how all of the net proceeds of the Offering will be spent as any decisions in respect thereof will be dependent upon, among other things, market conditions and competitive pressures which may evolve and develop in the future. As such, the potential uses of proceeds described above are based on the Company’s best estimates as of the date of this Prospectus and are subject to change. See “Risk Factors – Use of Proceeds”.

PRIOR SALES

The Company has not completed any sales of Shares, or securities convertible or exchangeable into Shares, during the 12-month period preceding the date of this Prospectus, except as described below:

 

8


Date Issued

   Number of
Securities Issued
     Issue/Exercise Price
Per Share
     Nature of Issuance

November 14, 2017

     300,000      $ 3.80      Performance Shares

November 14, 2017

     25,000      $ 0.70      Option Exercise

December 1, 2017

     8,333      $ 0.83      Option Exercise

December 21, 2017

     2,500,000      $ 5.40      Prospectus Financing

December 22, 2017

     210,000      $ 6.00      Performance Shares

December 22, 2017

     155,000      $ 6.00      Options Issuance

January 2, 2018

     10,000      $ 1.10      Option Exercise

January 15, 2018

     33,334      $ 0.80      Option Exercise

January 15, 2018

     8,334      $ 1.43      Option Exercise

January 31, 2018

     50,000      $ 0.70      Option Exercise

February 15, 2018

     3,333      $ 1.24      Option Exercise

February 16, 2018

     100,000      $ 1.24      Option Exercise

April 3, 2018

     30,000      $ 1.24      Option Exercise

April 3, 2018

     8,333      $ 1.43      Option Exercise

May 22, 2018

     99,399      $ 0.70      Option Exercise

May 24, 2018

     1,886,793      $ 5.30      Private Placement

June 5, 2018

     203,000      $ 5.79      Options Issuance

August 15, 2018

     20,000      $ 5.16      Performance Shares

September 7, 2018

     5,000      $ 1.48      Option Exercise

September 12, 2018

     6,667      $ 1.24      Option Exercise

September 12, 2018

     3,333      $ 7.53      Performance Shares

September 18, 2018

     15,000      $ 7.11      Performance Shares

PRICE RANGE AND TRADING VOLUME OF THE SHARES

The Shares of the Company are listed on the TSX under the symbol “VFF”. The following table sets forth the market price ranges and trading volumes of the Shares on the TSX for the 12-month period prior to the date of this Prospectus, as reported by the TSX:

 

     High
($)
     Low
($)
    
Volume
 

2017

        

October

     4.15        2.62        3,089,304  

November

     6.25        3.55        4,309,894  

December

     7.93        5.41        6,190,748  

2018

        

January

     9.80        6.70        15,493,831  

 

9


     High
($)
     Low
($)
    
Volume
 

February

     8.73        6.49        7,019,729  

March

     8.69        5.02        9,836,134  

April

     5.88        4.36        6,685,233  

May

     6.30        4.90        5,528,465  

June

     7.91        5.54        11,705,236  

July

     6.47        4.90        4,845,747  

August

     7.44        4.85        7,532,497  

September

     8.53        6.42        17,151,288  

October 1-3

     7.30        6.57        1,160,891  

RISK FACTORS

An investment in the Offered Shares is subject to a number of risks, including those set forth herein and in the Company’s Annual Information Form and management’s discussion and analysis for the year ended December 31, 2017 and for the three and six months ended June 30, 2018 and June 30, 2017, all of which are incorporated by reference herein. Prospective investors should carefully consider these risks, in addition to information contained in this Prospectus and the information incorporated by reference herein, before purchasing Offered Shares. If any of these or other risks occur, the Company’s business, prospects, financial condition, results of operations and cash flows could be materially and adversely impacted. In that case, the trading price of the Offered Shares could decline and investors could lose all or part of their investment in the Offered Shares. There is no assurance that any risk management steps taken will avoid future loss due to the occurrence of the below described risks or other unforeseen risks. Additional risks and uncertainties not currently known to the Company, or that are currently deemed immaterial, may also materially and adversely affect the Company’s business prospects, financial condition, results of operations or cash flows.

Risks Related to the Offering

Return on Investment is Not Guaranteed

There can be no assurance regarding the amount of income to be generated by the Company. The Offered Shares are equity securities of the Company and are not fixed income securities. Unlike fixed income securities, there is no obligation of the Company to distribute to shareholders a fixed amount or any amount at all, or to return the initial purchase price of a Offered Share on any date in the future. The market value of the Shares may deteriorate if the Company is unable to generate sufficient positive returns, and that deterioration may be significant.

Potential Volatility of Share Price

The market price for Shares may be volatile and subject to wide fluctuations in response to numerous factors, many of which are beyond the Company’s control, including the following: (i) actual or anticipated fluctuations in the Company’s quarterly results of operations; (ii) recommendations by securities research analysts; (iii) changes in the economic performance or market valuations of other issuers that investors deem comparable to the Company; (iv) addition or departure of the Company’s executive officers and other key personnel; (v) release or expiration of lock-up or other transfer restrictions on outstanding Shares; (vi) sales or perceived sales of additional Shares; (vii) significant acquisitions or business combinations, strategic partnerships, joint ventures or capital commitments by or involving the Company or its competitors; and (viii) news reports relating to trends, concerns, technological or competitive developments, regulatory changes and other related issues in the Company’s industry or target markets.

 

10


Financial markets have recently experienced significant price and volume fluctuations that have particularly affected the market prices of equity securities of public entities and that have, in many cases, been unrelated to the operating performance, underlying asset values or prospects of such entities. Accordingly, the market price of the Shares may decline even if the Company’s operating results, underlying asset values or prospects have not changed. Additionally, these factors, as well as other related factors, may cause decreases in asset values that are deemed to be other than temporary, which may result in impairment losses. As well, certain institutional investors may base their investment decisions on consideration of the Company’s environmental, governance and social practices and performance against such institutions’ respective investment guidelines and criteria, and failure to satisfy such criteria may result in limited or no investment in the Shares by those institutions, which could materially adversely affect the trading price of the Shares. There can be no assurance that continuing fluctuations in price and volume will not occur. If such increased levels of volatility and market turmoil continue for a protracted period of time, the Company’s operations and the trading price of the Shares may be materially adversely effected.

Dilution

The number of Shares that the Company is authorized to issue is unlimited. The Company may, in its sole discretion, issue additional Shares from time to time subject to the rules of any applicable stock exchange on which the Shares are then listed and applicable securities law. The issuance of any additional Shares may have a dilutive effect on the interests of holders of Offered Shares. To the extent that any of the net proceeds of the Offering remain un-invested pending their use, or are used to pay down existing indebtedness with a low interest rate, the Offering may result in substantial dilution on a per Share basis to the Company’s net income and certain other financial measures used by the Company.

Market Discount

The price of the Shares will fluctuate with market conditions and other factors. If a holder of Offered Shares sells its Offered Shares, the price received may be more or less than the original investment. The Shares may trade at a discount from their book value. The Offered Shares may trade at a price that is less than the Offering Price. This risk may be greater for investors who sell their Offered Shares relatively shortly after closing of the Offering.

Use of Proceeds

The Company intends to use the net proceeds from the Offering as described under “Use of Proceeds”. However, management will have discretion in the actual application of the proceeds, and may elect to allocate proceeds differently from that described under “Use of Proceeds” if it believes that it would be in the best interests of the Company to do so or if circumstances change. The failure by management to apply these funds effectively could have a material adverse effect on the business of the Company.

LEGAL MATTERS

Certain legal matters in connection with the issue and sale of the Offered Shares offered by this Prospectus will be passed upon at the date of closing of the Offering on behalf of the Company by Torys LLP and on behalf of the Underwriters by Fasken Martineau DuMoulin LLP. As of the date hereof, Torys LLP, as a group, and Fasken Martineau DuMoulin LLP, as a group, respectively beneficially own, directly or indirectly, less than 1% of the outstanding securities of the Company.

AUDITORS AND TRANSFER AGENT AND REGISTRAR

PricewaterhouseCoopers LLP are the auditors of the Company and have confirmed that they are independent with respect to the Company within the meaning of the relevant rules and related interpretations prescribed by the relevant professional bodies in Canada and any applicable legislation or regulation.

The transfer agent and registrar for the Offered Shares is Computershare Investor Services Inc. at its principal offices in Vancouver, British Columbia or Toronto, Ontario.

 

11


AGENT FOR SERVICE OF PROCESS

Michael A. DeGiglio, John P. Henry, David Holewinski, Stephen C. Ruffini and Dr. Roberta Cook (the “ Non-Resident Persons ”) are each directors and/or officers of the Company who reside outside of Canada. Each of the Non-Resident Persons has appointed the Company as their agent for service of process. The Company’s address for service of process is 4700-80 th Street, Delta, British Columbia, Canada, V4K 3N3.

Purchasers are advised that it may not be possible for investors to enforce judgments obtained in Canada against any person or company that is incorporated, continued or otherwise organized under the laws of a foreign jurisdiction or resides outside of Canada, even if the party has appointed an agent for service of process.

STATUTORY RIGHTS OF WITHDRAWAL AND RESCISSION

Securities legislation in certain of the provinces of Canada provides purchasers with the right to withdraw from an agreement to purchase securities. This right may be exercised within two business days after receipt or deemed receipt of a prospectus and any amendment. In several of the provinces, the securities legislation further provides a purchaser with remedies for rescission or, in some jurisdictions, revision of the price or damages if the prospectus and any amendment thereto contains a misrepresentation or is not delivered to the purchaser, provided that the remedies for rescission, revision of the price or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the purchaser’s province. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser’s province for the particulars of these rights or consult with a legal adviser.

 

12


CERTIFICATE OF THE COMPANY

Dated: October 4, 2018

This short form prospectus, together with the documents incorporated by reference, constitutes full, true and plain disclosure of all material facts relating to the securities offered by this short form prospectus as required by the securities legislation of all provinces of Canada, except Quebec.

VILLAGE FARMS INTERNATIONAL, INC.

 

By: (Signed) M ICHAEL A. D E G IGLIO    By: (Signed) S TEPHEN C. R UFFINI
Chief Executive Officer    Chief Financial Officer
On behalf of the Board of Directors
By: (Signed) J OHN R. M C L ERNON    By: (Signed) C HRISTOPHER C. W OODWARD
Director    Director

 

C-1


CERTIFICATE OF THE UNDERWRITERS

Dated: October 4, 2018

To the best of our knowledge, information and belief, this short form prospectus, together with the documents incorporated by reference, constitutes full, true and plain disclosure of all material facts relating to the securities offered by this short form prospectus as required by the securities legislation of all provinces of Canada, except Quebec.

BEACON SECURITIES LIMITED

By: (Signed) M ARIO M ARUZZO

Managing Director, Investment Banking

GMP SECURITIES L.P.

By: (Signed) S TEVE O TTAWAY

Managing Director, Investment Banking

 

C-2

Exhibit 99.51

Village Farms International Completes $22 Million Bought Deal Public Offering of Common Shares

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES OR FOR

DISSEMINATION IN THE UNITED STATES/

VANCOUVER, Oct. 12, 2018 /CNW/ — Village Farms International, Inc. (“ Village Farms ” or the “ Company ”) (TSX: VFF) (OTCQX: VFFIF) announced today that it has completed its previously announced bought deal offering of 3,097,200 common shares (the “ Offered Shares ”) in the capital of the Company at a price of $7.13 per Offered Share (the “ Issue Price ”) for aggregate gross proceeds to the Company of $22,083,036 (the “ Offering ”). The Offering was conducted by a syndicate of underwriters led by Beacon Securities Limited, and including GMP Securities L.P. (collectively, the “ Underwriters ”). The Offering included 287,200 Offered Shares issued pursuant to a partial exercise of the Underwriters’ over-allotment option.

The Company intends to use the net proceeds of the Offering for working capital purposes, which may include funding certain future capital needs of Pure Sunfarms Corp. as well as other growth opportunities that may arise in respect of the Company’s business over time. Further details can be found in the Company’s short form prospectus dated October 4, 2018, which is available on SEDAR at www.sedar.com.

Upon closing of the Offering, there were 47,619,338 issued and outstanding common shares of the Company.

The Offered Shares have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms Corp., one of the single largest cannabis growing operations in the world.

Cautionary Language Regarding Forward-Looking Statements

Certain statements in this press release may constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, statements concerning the intended use of the proceeds of the Offering. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “outlook”, “objective”, “may”, “will”, “expect”, “intend”,


“estimate”, “anticipate”, “believe”, “should”, “plans” or “continue”, or similar expressions suggesting future outcomes or events. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements. Although the Company believes that the expectations reflected in its forward-looking information are reasonable, undue reliance should not be placed on forward-looking information because the Company can give no assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things, the timely receipt of required regulatory approvals. Details of the risk factors relating to the Company and its business are discussed under the heading “Risk Factors” set out in the Company’s annual information form and management’s discussion and analyses for the year ended December 31, 2017, and for the three and six months ended June 30, 2018, which are available electronically at www.sedar.com. Actual results may differ materially from any forward-looking statements. Although the Company believes that its forward-looking statements contained in this press release are based upon reasonable assumptions, you cannot be assured that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this press release, and other than as specifically required by applicable law, the Company does not assume any obligation to update or revise them to reflect new information, events or circumstances.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/October2018/12/c8531.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 08:50e 12-OCT-18

Exhibit 99.52

VILLAGE FARMS INTERNATIONAL FACILITATES APPROVAL OF NOVEL NEW CROP PROTECTANT BY US EPA

Application of New Innoculant at Texas Greenhouse Operations Could Increase Production Yields by 5 to 10%

VANCOUVER, October 15, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTCQX:VFFIF) today announced that it has facilited the approval by both the U.S. Environmental Protection Agency (EPA) of a novel new crop protectant, Pepino mosaic virus, strain CH2, isolate 1906, which the Company facilitated on behalf of its Belgium-based developer, De Ceuster Meststoffen NV (DCM). The new innoculant, branded PMV-01 ® , is a mild form of the Pepino mosaic tomato plant virus (PepMV) and protects greenhouse tomatoes against aggressive forms of that same plant virus through cross-protection, which is a plant defense mechanism against viral infections.

“For nearly two decades, Village Farms has been the North American leader in facilitating the registration of new, better and safer pesticides to meet the unique needs of greenhouse vegetable crop protection, vastly improving the yield and quality not only of our own crops but also those of the entire hydroponic vegetable greenhouse industry,” said Michael DeGiglio, CEO, Village Farms. “We are immensely proud to have led the charge in facilitating well more than 150 greenhouse crop protectant approvals, including virtually every greenhouse crop protectant registrered in the U.S.”

Facilitation of the PMV-01 ® registriation was led by Dr. Michael Bledsoe, Village Farms’ Vice President of Food Safety and Regulatory Affairs, a renowned expert and advocate for the research and registration of greenhouse crop protectants, who, nearly 20 years ago, with the full support of the Company, pioneered the approval and use of pesticides and innoculants through the Inter-Regional Research Project Number 4 (IR-4) Project (a federally funded organization that conducts research necessary for obtaining crop protectant registrations), which works in partnership with the U.S. Department of Agriculture, the EPA and various industry organizations.

The application of PMV-01 ® at the Company’s greenhouse operations in Texas could increase production yields by as much as 5% to 10%.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.


Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/October2018/15/c3528.html

%SEDAR: 00029410E

For further information : Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 07:00e 15-OCT-18

Exhibit 99.53

Village Farms International to Host Third Quarter 2018 Conference Call on Tuesday, November 13, 2018 at 11:00 a.m. ET (8:00 a.m. PT)

VANCOUVER, Nov. 7, 2018 /CNW/ - Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTC: VFFIF) today announced it will host a conference call to discuss its third quarter 2018 financial results, as well as provide an update on its cannabis joint venture, Pure Sunfarms, on Tuesday, November  13, 2018 at 11:00 a.m. ET (8:00 a.m. PT) . Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at https://tinyurl.com/yaxk4ctg .

The Company expects to report its third quarter 2018 financial results via news release after markets close on Monday, November 12, 2018.

Conference Call Archive Access Information

For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859- 2056 and enter the passcode 5589169 followed by the pound key. The telephone replay will be available until Tuesday, November 20, 2018 at midnight (ET). The conference call will also be archived on Village Farm’s web site at http://villagefarms.com/investor-relations/investor-calls.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/November2018/07/c6320.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 13:22e 07-NOV-18

Exhibit 99.54

Village Farms International, Inc.

Condensed Consolidated Interim Financial Statements

Three and Nine Months Ended September 30, 2018 and 2017

(Unaudited)


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Financial Position

(In thousands of United States dollars)

 

     September 30, 2018     December 31, 2017  
     (Unaudited)     (Audited)  

ASSETS

    

Current assets

    

Cash and cash equivalents

   $ 5,851     $ 7,091  

Trade receivables

     11,123       11,259  

Amounts due from joint venture (note 10)

     7,192       411  

Other receivables

     630       1,571  

Inventories (note 4)

     20,641       17,309  

Prepaid expenses and deposits

     1,046       810  

Biological asset (note 5)

     5,119       4,405  
  

 

 

   

 

 

 

Total current assets

     51,602       42,856  
  

 

 

   

 

 

 

Non-current assets

    

Property, plant and equipment (note 6)

     78,943       81,754  

Investment in joint venture (note 7)

     15,358       15,727  

Other assets

     2,065       2,004  
  

 

 

   

 

 

 

Total assets

   $ 147,968     $ 142,341  
  

 

 

   

 

 

 

LIABILITIES

    

Current liabilities

    

Trade payables

   $ 10,726     $ 12,952  

Accrued liabilities

     5,742       3,793  

Line of credit

     7,000       —    

Current maturities of long-term debt (note 8)

     3,450       2,620  

Current maturities of capital lease obligations

     76       72  
  

 

 

   

 

 

 

Total current liabilities

     26,994       19,437  
  

 

 

   

 

 

 

Non-current liabilities

    

Long-term debt (note 8)

     33,365       35,760  

Long-term maturities of capital lease obligations

     130       179  

Deferred tax liability

     2,524       4,825  

Other liabilities

     1,158       1,097  
  

 

 

   

 

 

 

Total liabilities

     64,171       61,298  
  

 

 

   

 

 

 

SHAREHOLDERS’ EQUITY

    

Share capital

     44,145       36,115  

Contributed surplus

     2,173       1,726  

Revaluation surplus (note 6)

     4,321       4,321  

Accumulated other comprehensive loss

     (439     (391

Retained earnings

     33,597       39,272  
  

 

 

   

 

 

 

Total shareholders’ equity

     83,797       81,043  
  

 

 

   

 

 

 

Total liabilities and shareholders’ equity

   $  147,968     $  142,341  
  

 

 

   

 

 

 

Subsequent event (note 18)

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

2


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Changes in Shareholders’ Equity

For the Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except for shares outstanding)

(Unaudited)

 

     Number of                          Accumulated Other           Total  
     Common      Share      Contributed      Revaluation     Comprehensive     Retained     Shareholders’  
     Shares      Capital      Surplus      Surplus     Loss     Earnings     Equity  

Balance at January 1, 2017

     38,882,945      $  24,954      $  1,392      $ 6,132     $ (541   $  35,450       67,387  

Issuance of common stock shares (note 17)

     291,334        469        —          —         —         —         469  

Issuance of warrants for common shares

     —          —          148        —         —         —         148  

Share-based compensation (note 17)

     —          —          117        —         —         —         117  

Cumulative translation adjustment

     —          —          —          —         162       —         162  

Reclassification of previously recorded revaluation gain of land, net of tax (note 6)

     —          —          —          (1,811     —         —         (1,811

Net income

     —          —          —          —         —         4,429       4,429  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2017

     39,174,279        25,423        1,657        4,321       (379     39,879       70,901  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at January 1, 2018 (restated - note 3)

     42,242,612        36,115        1,726        4,321       (391     39,012       80,783  

Issuance of common stock shares (note 17)

     354,400        275        —          —         —         —         275  

Shares issued pursuant to private placement of common stock shares, net of issuance costs

     1,886,793        7,755        —          —         —         —         7,755  

Share-based compensation (note 17)

     —          —          447        —         —         —         447  

Cumulative translation adjustment

     —          —          —          —         (48     —         (48

Net loss

     —          —          —          —         —         (5,415     (5,415
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

Balance at September 30, 2018

     44,483,805      $ 44,145      $ 2,173      $ 4,321     $ (439   $ 33,597     $  83,797  
  

 

 

    

 

 

    

 

 

    

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

3


Village Farms International, Inc.

Condensed Consolidated Interim Statements of (Loss) Income and Comprehensive (Loss) Income

For the Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share data)

(Unaudited)

 

     Three Months Ended September 30,     Nine Months Ended September 30,  
     2018     2017     2018     2017  

Sales (note 14)

   $ 39,684     $ 44,735     $ 111,213     $ 121,542  

Cost of sales (note 11)

     (36,862     (42,400     (103,915     (112,525

Change in biological asset (note 5)

     (1,189     529       (992     (817

Selling, general and administrative expenses (note 11)

     (3,632     (3,358     (10,933     (10,435
  

 

 

   

 

 

   

 

 

   

 

 

 

Loss from operations

     (1,999     (494     (4,627     (2,235

Interest expense, net

     618       689       1,906       2,016  

Foreign exchange loss (gain)

     73       (58     87       (57

Other income

     (17     (55     (61     (96

Share of loss from joint venture (note 7)

     28       220       369       220  

Gain on sale of assets

     —         —         —         (8,564
  

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income taxes

     (2,701     (1,290     (6,928     4,246  

Recovery of income taxes

     (712     (1,584     (1,513     (183
  

 

 

   

 

 

   

 

 

   

 

 

 

Net (loss) income

   $ (1,989   $ 294     $ (5,415   $ 4,429  
  

 

 

   

 

 

   

 

 

   

 

 

 

Basic (loss) earnings per share (note 15)

   $ (0.04   $ 0.01     $ (0.12   $ 0.11  
  

 

 

   

 

 

   

 

 

   

 

 

 

Diluted (loss) earnings per share (note 15)

   $ (0.04   $ 0.01     $ (0.12   $ 0.11  
  

 

 

   

 

 

   

 

 

   

 

 

 

Other comprehensive (loss) income:

        

Foreign currency translation adjustment

   $ 40     $ 89     $ (48   $ 162  
  

 

 

   

 

 

   

 

 

   

 

 

 

Comprehensive (loss) income

   $  (1,949   $ 383     $ (5,463   $ 4,591  
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

4


Village Farms International, Inc.

Condensed Consolidated Interim Statements of Cash Flows

(In thousands of United States dollars)

(Unaudited)

 

     Three Months Ended September 30,     Nine Months Ended September 30,  
     2018     2017     2018     2017  

Cash flows from operating activities:

        

Net (loss) income

   $ (1,989   $ 294     $ (5,415   $ 4,429  

Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities:

        

Depreciation and amortization

     1,748       1,853       5,271       5,753  

Amortization of deferred charges

     —         18       —         54  

Gain on sale of assets

     —         —         —         (8,564

Share of loss from joint venture (note 7)

     28       220       369       220  

Interest paid

     585       676       1,873       1,956  

Share-based compensation (note 17)

     190       91       447       560  

Deferred income taxes

     (1,481     (1,986     (2,301     (585

Change in biological asset (note 5)

     1,189       (529     992       817  

Changes in non-cash working capital items (note 13)

     1,073       2,948       (4,493     (3,075
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash provided by (used in) operating activities

     1,343       3,585       (3,257     1,565  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows used in investing activities:

        

Purchases of property, plant and equipment

     (1,105     (178     (2,546     (1,171

Amounts due from joint venture (note 10)

     (5,890     (96     (6,781     (150
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash used in investing activities

     (6,995     (274     (9,327     (1,321
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows (used in) provided by financing activities:

        

Proceeds from borrowings

     —         113       7,000       7,113  

Repayments on borrowings

     (849     (3,832     (1,766     (6,488

Interest paid on long-term debt

     (585     (676     (1,873     (1,956

Proceeds from the issuance of common stock

     —         —         7,755       —    

Proceeds from exercise of stock options

     12       —         275       26  

Payments on capital lease obligations

     (11     (18     (45     (40
  

 

 

   

 

 

   

 

 

   

 

 

 

Net cash (used in) provided by financing activities

     (1,433     (4,413     11,346       (1,345
  

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     3       9       (2     13  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net decrease in cash and cash equivalents

     (7,082     (1,093     (1,240     (1,088

Cash and cash equivalents, beginning of period

     12,933       5,378       7,091       5,373  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 5,851     $ 4,285     $ 5,851     $ 4,285  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental cash flow information:

        

Income taxes paid

   $ —       $ 286     $ —       $ 36  
  

 

 

   

 

 

   

 

 

   

 

 

 

Supplemental disclosure of non-cash information:

        

Purchases of capital expenditures by financing capital lease

   $ —       $ 126     $ —       $ 191  
  

 

 

   

 

 

   

 

 

   

 

 

 

Issuance of warrants

   $ —       $ —       $ —       $ 148  
  

 

 

   

 

 

   

 

 

   

 

 

 

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

 

5


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

 

1

NATURE OF OPERATIONS

Village Farms International, Inc. (“VFF” the parent company, together with its subsidiaries, the “Company”) is incorporated under the Canada Business Corporation Act . VFF’s principal operating subsidiaries as at September 30, 2018 are Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”), and VF Clean Energy, Inc (“VFCE”). The address of the registered office of VFF is 4700 80 th Street, Delta, British Columbia, Canada, V4K 3N3. VFF owns a 50% equity interest in Pure Sunfarms Corp. (“Pure Sunfarms”), which is recorded as Investment in Joint Venture (note 7).

The Company’s shares are listed on the Toronto Stock Exchange under the symbol VFF and are also traded in the United States on the OTCQX ® Best Market under the symbol VFFIF.

The Company, through its subsidiaries VFCLP and VFLP, owns and operates sophisticated, highly intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells premium-quality tomatoes, bell peppers, and cucumbers. The Company also markets and sells third party produce through its subsidiaries. The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant that generates electricity. In addition, the Company’s joint venture, Pure Sunfarms, is a licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally.

 

2

BASIS OF PRESENTATION

Statement of Compliance

The Company’s unaudited condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standards (“IFRS”) and its interpretations, as issued by the International Accounting Standards Board (“IASB”). These condensed consolidated interim financial statements are prepared in accordance with International Accounting Standard (“IAS”) 34, Interim Financial Reporting . They do not include all of the information required for full annual financial statement disclosures, and should be read in conjunction with the Company’s audited annual consolidated financial statements for the year ended December 31, 2017, which were prepared in accordance with IFRS.

Basis of Presentation

The condensed consolidated interim financial statements are prepared on a going concern basis. The accounting policies have been applied consistently in all material respects. These condensed consolidated interim financial statements have been prepared by applying the same accounting policies, assessments of estimates and judgments, and methods of computation as compared with the most recent annual consolidated financial statements.

Basis of Measurement

The condensed consolidated interim financial statements (“interim financial statements”) have been prepared on the historical cost basis except for the following material items in the condensed consolidated interim statement of financial position (“interim statement of financial position”):

 

   

biological assets are measured at fair value less costs to sell;

 

   

land is valued at fair market value; and

 

   

available-for-sale financial assets are measured at fair value.

Functional and Presentation Currency

These condensed consolidated interim financial statements are presented in United States dollars (“U.S. dollars”), which is the Company’s primary functional currency. VFCE’s functional currency is Canadian dollars and conversion to U.S. dollars is performed in accordance with IAS 21, The Effects of Changes in Foreign Exchange Rates . All financial information presented in U.S. dollars has been rounded to the nearest thousands, except per share amounts.

 

6


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

 

3

CHANGES IN ACCOUNTING POLICIES

The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2018. These changes were made in accordance with the applicable transitional provisions.

IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in de-recognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.

Following the adoption of IFRS 9, the Company could no longer defer and amortize financing fees that resulted from the refinancing of borrowings in periods prior to January 1, 2018. As a result, the Company has restated the beginning balances noted in the table below to properly account for $260 of financing fees in accordance with IFRS 9. The standard was applied retrospectively therefore approximately $260 of deferred financing costs, net of accumulated amortization, remain netted against long-term debt on the consolidated statement of financial position, as at December 31, 2017.

The following tables show the adjustments recognized for each individual line item. Line items that were not affected by the changes have not been included. As a result, the sub-totals and totals disclosed cannot be recalculated from the numbers provided.

 

     December 31, 2017
As originally
presented
     IFRS 9
Adjustments
     January 1, 2018
Restated
 

Statement of Financial Position (extract)

        

Non-current liabilities

        

Long-term debt

   $  35,760      $ 260      $  36,020  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     61,298        260        61,558  
  

 

 

    

 

 

    

 

 

 

Shareholders’ Equity

        

Retained earnings

     39,272        (260      39,012  
  

 

 

    

 

 

    

 

 

 

Total shareholders’ equity

   $ 81,043      $ (260    $ 80,783  
  

 

 

    

 

 

    

 

 

 

Statements of (Loss) Income and

Comprehensive (Loss) Income (extract)

        

Interest expense

   $ 2,695      $ 260      $ 2,955  
  

 

 

    

 

 

    

 

 

 

Income (loss) before income taxes

     3,960        (260      3,700  

Provision for income taxes

     138        —          138  
  

 

 

    

 

 

    

 

 

 

Net income (loss)

   $ 3,822      $  (260    $ 3,562  
  

 

 

    

 

 

    

 

 

 

Basic income (loss) per share

   $ 0.10      $  (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

Diluted income (loss) per share

   $ 0.10      $  (0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

 

7


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.

The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders it receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and its performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.

The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three and nine months ended September 30, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.

Accounting Standards Issued and Not Applied

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the Company also applies IFRS 15. Management is currently assessing the impact on the Company’s interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated statement of financial position date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

 

8


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.

 

4

INVENTORIES

 

     September 30, 2018      December 31, 2017  

Deferred crop costs

   $ 24,217      $ 19,070  

Purchased produce inventory

     279        396  

Biological asset adjustment (note 5)

     (3,918      (2,212

Spare parts inventory

     63        55  
  

 

 

    

 

 

 
   $ 20,641      $ 17,309  
  

 

 

    

 

 

 

The cost of inventories recognized as expense and included in cost of sales for the three months ended September 30, 2018 amounted to $30,769 (2017 - $35,656) and $85,349 for the nine months ended September 30, 2018 (2017 - $94,484). The biological asset adjustment reclassifies actual costs incurred for the biological asset from inventories to biological asset on the interim statement of financial position.

 

5

BIOLOGICAL ASSET

Information about the biological asset presented on the consolidated statements of financial position and in the consolidated statements of (loss) income is as follows:

 

     September 30, 2018      December 31, 2017      September 30, 2017  

Estimated sales value - biological asset

   $  10,550      $  7,937      $  10,684  

Less

        

Estimated remaining costs to complete

     4,862        3,043        4,789  

Estimated selling costs

     569        489        592  
  

 

 

    

 

 

    

 

 

 

Fair value of biological asset less costs to sell

     5,119        4,405        5,303  

Less actual costs

     3,918        2,212        4,192  
  

 

 

    

 

 

    

 

 

 

Increase in fair value of biological asset over cost

     1,201        2,193        1,111  

Fair value over cost of harvested and sold biological asset - beginning of year

     2,193        1,928        1,928  
  

 

 

    

 

 

    

 

 

 

Change in biological asset

   $ (992    $ 265      $ (817
  

 

 

    

 

 

    

 

 

 

 

9


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

6

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consist of the following:

 

     Land     Leasehold
and land
improvements
    Buildings     Machinery
and
Equipment
    Construction
in process
    Total  

At December 31, 2017

 

Cost

   $  9,112     $ 3,820     $ 77,029     $ 63,237     $  468     $  153,666  

Accumulated depreciation

     —         (2,223     (33,685     (36,004     —         (71,912
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Nine months ended September 30, 2018

 

   

Opening net book value

   $ 9,112     $ 1,597     $ 43,344     $ 27,233     $ 468     $ 81,754  

Additions (transfers)

     —         —         —         234       2,524       2,758  

Placed in service

     —         —         —         873       (994     (121

Disposals (expense)

     (65     —         —         (565     (30     (660

Depreciation expense

     —         (64     (1,965     (2,677     —         (4,706

FX translation adjustment

     —         —         (10     (74     2       (82
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Closing net book value

   $ 9,047     $ 1,533     $ 41,369     $ 25,024     $ 1,970     $ 78,943  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

At September 30, 2018

 

       

Cost

   $ 9,047     $ 3,820     $ 77,019     $ 63,705     $ 1,970     $ 155,561  

Accumulated depreciation

     —         (2,287     (35,650     (38,681     —         (76,618
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net book value

   $ 9,047     $ 1,533     $ 41,369     $ 25,024     $ 1,970     $ 78,943  
  

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Depreciation related to the greenhouse facilities and equipment is expensed in cost of sales. Land is the only item of property, plant and equipment that is stated at fair values. As at December 31, 2017, land, greenhouse buildings, and greenhouse equipment at Delta 3 were contributed as the Company’s investment in the joint venture transaction (note 7). The revaluation surplus related to Delta 3 of $1.8 million, net of taxes, that was previously recorded as a component of equity, was reclassified and included as part of the gain on disposal of assets recorded in the condensed consolidated interim statements of loss.

 

7

INVESTMENT IN JOINT VENTURE

On June 6, 2017, the Company entered into an agreement to form Pure Sunfarms Corp. (“Pure Sunfarms”), a B.C. corporation, with Emerald Health Therapeutics Inc. (“Emerald”). The purpose of Pure Sunfarms is to pursue large-scale cannabis production in Canada. Village Farms has a 50% ownership interest in Pure Sunfarms in the form of common shares. The Company has concluded that the agreement constitutes a joint arrangement where joint control is shared with Emerald and therefore has accounted for Pure Sunfarms in accordance with IFRS 11 and IAS 28, using the equity method.

As at September 30, 2018 the Investment in Joint Venture of $15.4 million (December 31, 2017 - $15.7 million) is recorded in the condensed consolidated interim statement of financial position. For the three months ended September 30, 2018, the Company’s share of net loss from joint venture totaled $28 (CA$37) (2017 - $220) and for the nine months ended September 30, 2018, the Company’s share of net loss from joint venture totaled $369 (CA$469) (2017 - $220), which is recorded in the condensed consolidated interim statement of loss.

On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby, as at September 30, 2018, the Shareholders had each contributed CA$8,000 (US$6,110) the form of a demand loan to Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by both Shareholders (see note 10).

 

10


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

The Company’s share of the joint venture consists of the following (in $000’s of USD):

 

Balance, January 1, 2018

   $  15,727  

Share of loss

     (369
  

 

 

 

Balance, September 30, 2018

   $ 15,358  
  

 

 

 

Summarized financial information of Pure Sunfarms (in $000’s of CAD):

 

     September 30, 2018      December 31, 2017  

Current assets

     

Cash and cash equivalents

   $ 1,654      $ 2,907  

Other current assets

     7,256        475  

Non-current assets

     55,105        23,144  

Current liabilities

     (25,599      (1,171
  

 

 

    

 

 

 

Net assets

   $ 38,416      $  25,355  
  

 

 

    

 

 

 

 

     September 30, 2018      December 31, 2017  

Reconciliation of net assets :

     

Accumulated deficit

   $  (1,584    $ (645

Contributions from joint venture partners

     40,000        26,000  
  

 

 

    

 

 

 

Net assets

   $ 38,416      $ 25,355  
  

 

 

    

 

 

 
     Three Months Ended
September 30, 2018
     Nine Months Ended
September 30, 2018
 

Revenue

   $ 247      $ 247  

Cost of sales

     (186      (186

Selling, general and administrative expenses

     (792      (2,107

Change in fair value of bio-asset

     697        1,119  

Foreign exchange gain

     (40      (12
  

 

 

    

 

 

 

Net loss

   $ (74    $ (939
  

 

 

    

 

 

 

 

8

DEBT

 

     September 30, 2018      December 31, 2017  

Long-term debt:

     

Opening balance

   $  38,380      $  45,534  

IFRS adjustment for deferred financing fees (note 3)

     260        —    

Proceeds from long-term debt

     —          306  

Repayment of debt

     (1,832      (7,320

Foreign currency translation

     7        120  
  

 

 

    

 

 

 

Closing balance

   $ 36,815      $ 38,640  
  

 

 

    

 

 

 

Current portion

   $ 3,450      $ 2,620  

Non-current portion

     33,365        36,020  

Less: Unamortized deferred transaction costs

     —          (260
  

 

 

    

 

 

 
   $ 36,815      $ 38,380  
  

 

 

    

 

 

 

 

11


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

Credit Facilities

The Company has a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). The non-revolving variable rate term loan has a maturity date of May 1, 2021 and a balance of $35,155 as at September 30, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on May 1, 2021. As at September 30, 2018, borrowings under the FCC Loan agreement are subject to an interest rate of 6.848% (December 31, 2017 - 5.885%) which is determined based on the Company’s Debt to EBITDA ratio and the applicable LIBOR rate.

The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 and fixed interest rate of 4.98%. As at September 30, 2018, the balance was US$1,597 (December 31, 2017 - US$1,658). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at September 30, 2018, the balance was US$158 (December 31, 2017 - $192).

The Company has a line of credit agreement with a Canadian Chartered Bank ( “Operating Loan”). The revolving Operating Loan has a line of credit up to CA$13,000 and variable interest rates with a maturity date on May 31, 2021, and is subject to margin requirements stipulated by the bank. As at September 30, 2018, US$7,000 was drawn on this facility (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit totaling US$261 and CA$38.

The Company’s borrowings (“Credit Facilities”) are subject to certain positive and negative covenants. As at September 30, 2018 and December 31, 2017, the Company was in compliance with all covenants on its Credit Facilities.

Accrued interest payable on the credit facilities and loans as at September 30, 2018 was $183 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statement of financial position.

The aggregate annual maturities of long-term debt for the next five years and thereafter are as follows:

 

The remainder of 2018

   $ 881  

2019

     3,431  

2020

     3,422  

2021

     28,569  

2022

     348  

Thereafter

     164  
  

 

 

 
   $  36,815  
  

 

 

 

 

9

FINANCIAL INSTRUMENTS

Financial assets and liabilities are recognized on the consolidated interim statement of financial position at fair value in a hierarchy that is based on significance of the inputs used in making the measurements. The levels in the hierarchy are:

 

   

Level 1 - Quoted prices (unadjusted) in active markets for identical assets or liabilities

 

   

Level 2 - Inputs other than quoted prices included within level 1 that are observable for the asset or liability, either directly (i.e., as prices) or indirectly (i.e., derived from prices)

 

   

Level 3 - Inputs for the asset or liability that are not based on observable market data (i.e., unobservable inputs).

 

12


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

The following table summarizes the carrying and fair value of the Company’s financial instruments:

 

     September 30, 2018      December 31, 2017  

Cash and cash equivalents

   $ 5,851      $ 7,091  

Trade receivables

   $  11,123      $  11,259  

Other financial assets

   $ 8,221      $ 2,491  

Other financial liabilities

   $ 61,647      $ 56,718  

All of the Company’s financial assets and liabilities are categorized as Level 1. There were no financial instruments categorized as Level 2 or 3 as at September 30, 2018 and December 31, 2017. There were no transfers of assets or liabilities between levels during the nine month period ended September 30, 2018 and the year ended December 31, 2017.

The financial instruments, excluding loans payable, approximated their carrying value because of the short-term nature of these instruments. The fair value of the loans payable approximated their carrying value as all of the Company’s loans are variable-rate instruments.

Interest income, expense and gains and losses from loans, receivables and other financial liabilities are recognized in the condensed consolidated interim statements of loss. The following table summarizes interest income and expense for the three and nine months ended September 30:

 

     Three months ended      Nine months ended  
     2018      2017      2018      2017  

Interest income earned on cash and cash equivalents

   $ 12      $  —        $ 15      $ —    

Interest expense from other financial liabilities

   $  630      $  689      $  1,921      $  2,016  

Management of financial risks

The Company, through its financial assets and liabilities, is exposed to various risks. The following provides a measurement of some of these risks as at September 30, 2018 and December 31, 2017. The Company uses financial instruments only for risk management purposes, not for generating trading profit.

i) Credit risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, trade receivables and other receivables. The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 12.1% and 10.5% of the balance of trade receivables as at September 30, 2018 (2017 - one customer represented 10.5%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales. The maximum amount of credit risk exposure is limited to the carrying amount of the balances on the interim financial statements.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. As at September 30, 2018, the allowance for doubtful accounts balance was $50 (December 31, 2017 - $50). The Company has not recorded a bad debt expense during the three and nine months ended September 30, 2018 (2017 - $nil).

 

13


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

As at September 30, 2018, 89.2% (December 2017 - 89.4%) of trade receivables were outstanding less than 30 days, 9.5% (December 2017 - 7.4%) were outstanding for between 30 and 90 days and the remaining 1.3% (December 2017 - 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

ii) Interest rate risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt, for which the interest rates charged fluctuate based on the 90-day LIBOR rate. If interest rates had been 50 basis points higher, the net income during the nine months ended September 30, 2018 would have been lower by $138 This represents $138 in increased interest expense (2017 - $160).

iii) Foreign exchange risk

As at September 30, 2018, the Canadian/U.S. foreign exchange rate was CA$1.00 = US$0.7747 (December 31, 2017 - US$0.7966). Assuming that all other variables remain constant, an increase of $0.10 in the Canadian dollar would have the following impact on the ending balances of certain consolidated statements of financial position items as at September 30, 2018 and December 31, 2017 with the net foreign exchange gain or loss directly impacting net income (loss) for the period.

 

     September 30, 2018      December 31, 2017  

Financial assets

     

Cash and cash equivalents

   $ 56      $ 287  

Trade receivables

     364        349  

Financial liabilities

     

Trade payables and accrued liabilities

     (548      (371

Loan payable

     (206      (232
  

 

 

    

 

 

 

Net foreign exchange (loss) gain

   $  (334)      $ 33  
  

 

 

    

 

 

 

iv) Liquidity risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they fall due. The following are the contractual maturities of financial liabilities as at September 30, 2018:

 

Financial liabilities

   Total      1 year      2-3 years      4-5 years      More than
5 years
 

Long-term debt

   $  36,815      $ 3,450      $  32,767      $  598      $  —    

Line of credit

     7,000        7,000        —          —          —    

Trade payables

     10,726        10,726        —          —          —    

Accrued liabilities

     5,742        5,742        —          —          —    

Obligation under capital lease

     206        76        130        —          —    

Other liabilities

     1,158        958        200        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 61,647      $  27,952      $ 33,097      $ 598      $ —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash from sales. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing. In addition, as at September 30, 2018, the Company has an operating loan of up to CA$13,000, less an outstanding balance of US$7,000 and outstanding letters of credit totaling US$261 and CA$38.

 

14


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

v) Fair values

The carrying amount of short-term financial instruments, less provisions for impairment if applicable, is consistent with the fair value of such instruments. The Company’s debt bears a variable interest rate tied to market rates and therefore its carrying value approximates its fair value.    

 

10

RELATED PARTY TRANSACTIONS AND BALANCES

As at September 30, 2018, the Company had amounts due from its joint venture, Pure Sunfarms, totaling $1,002 primarily for consulting services and the reimbursement of expenses which occurred in the year. These amounts were non-interest bearing and were due on demand. On July 5, 2018, the Shareholders entered into a Loan Agreement with Pure Sunfarms, whereby, as at September 30, 2018, the Shareholders had each contributed CA$8,000 (US$6,190) in the form of a demand loan to Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by either Shareholder. These amounts are included in amounts due from joint venture in the interim statement of financial position.

Included in other assets as at September 30, 2018, is a $65 (December 31, 2017 - $70) promissory note that represents the unpaid amount the Company advanced to an employee in connection with a relocation at the request of the Company.

 

11

EXPENSES BY NATURE

The following table outlines the Company’s significant expenses by nature:

 

Cost of sales    Three months ended September 30,      Nine months ended September 30,  
     2018      2017      2018      2017  

Purchased produce

   $  13,104      $  11,148      $ 32,871      $ 33,217  

Raw materials and consumables used

     6,979        14,081        23,244        31,772  

Depreciation and amortization

     1,720        1,817        5,185        5,648  

Transportation and storage

     5,024        5,682        15,465        15,449  

Employee compensation and benefits

     10,035        9,672        27,150        26,439  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 36,862      $ 42,400      $ 103,915      $  112,525  
  

 

 

    

 

 

    

 

 

    

 

 

 
Selling, general and administrative expenses    Three months ended September 30,      Nine months ended September 30,  
     2018      2017      2018      2017  

Employee benefits - salaries and short-term benefits

   $ 2,393      $ 2,221      $ 6,857      $ 6,871  

Marketing

     79        142        257        354  

Professional services

     437        340        1,507        951  

Office expenses

     408        415        1,299        1,215  

Other

     315        240        1,013        1,044  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 3,632      $ 3,358      $ 10,933      $ 10,435  
  

 

 

    

 

 

    

 

 

    

 

 

 
Employee compensation and benefits    Three months ended
September 30,
     Nine months ended
September 30,
 
     2018      2017      2018      2017  

Salaries and short-term employee benefits

   $ 12,238      $ 11,802      $ 33,560      $ 32,750  

Share-based compensation

     190        91        447        560  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 12,428      $ 11,893      $ 34,007      $ 33,310  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

15


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

12

DEFERRED INCOME TAX

Income tax expense is recognized based on management’s best estimate of the weighted average annual income tax rate expected for the full financial year. The estimated average annual rate used for the nine months ended September 30, 2018 was 25%, excluding the change in biological asset as reported on the condensed consolidated interim statements of loss, and 30% for the nine months ended September 30, 2017.

 

13

CHANGES IN NON-CASH WORKING CAPITAL ITEMS

 

     Three months ended September 30,      Nine months ended September 30,  
     2018      2017      2018      2017  

Trade receivables

   $  3,351      $ 2,896      $ 132      $  (2,287

Inventories

     (454      521        (3,324      1,996  

Inventories reclassified to biological asset

     (794      1,986        (1,715      (1,671

Other receivables

     360        (112      360        (238

Prepaid expenses and other current assets

     230        275        340        (388

Trade payables

     (263      (2,278      (2,413      (1,882

Accrued liabilities and taxes

     (937      (243      2,144        1,468  

Other assets/other liabilities, net

     (420      (97      (17      (73
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 1,073      $ 2,948      $  ( 4,493    $  (3,075
  

 

 

    

 

 

    

 

 

    

 

 

 

 

14

SEGMENT AND GEOGRAPHIC INFORMATION

The Company’s two reporting segments include the Produce business and the Energy business. The Produce business produces, markets, and sells the product group which consists of premium quality tomatoes, bell peppers and cucumbers. The Energy business produces power that it sells per a long-term contract to its one customer.

The Company’s primary operations are in the United States and Canada. Net sales by the countries in which its customers are located are as follows:

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2018      2017      2018      2017  

Net Sales

           

United States

   $  32,073      $  35,570      $  92,391      $  100,608  

Canada

     7,139        8,683        17,371        19,493  

Energy - Canada

     472        482        1,451        1,441  
  

 

 

    

 

 

    

 

 

    

 

 

 
     $ 39,684      $ 44,735      $ 111,213      $ 121,542  
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company’s property, plant and equipment, net of accumulated depreciation, are located as follows:

 

     September 30, 2018      December 31, 2017  

United States

   $  44,363      $  46,922  

Canada

     30,788        31,183  

Energy - Canada

     3,792        3,649  
  

 

 

    

 

 

 
   $ 78,943      $ 81,754  
  

 

 

    

 

 

 

Depreciation and amortization charges in the Produce business for the three and nine months ended September 30, 2018 were $1,515 (2017 - $1,647) and $4,627 (2017 - $5,169), respectively. Depreciation and amortization charges in the Energy business for the three and nine months ended September 30, 2018 were $233 (2017 - $206) and $644 (2017 - $584), respectively.

 

16


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

15

(LOSS) EARNINGS PER SHARE

 

     Three months ended
September 30,
     Nine months ended
September 30,
 
     2018      2017      2018      2017  

Net (loss) income attributable to owners of the Company

   $  (1,989    $ 294      $  (5,415    $ 4,429  

Weighted average number of common shares outstanding (thousands)

     44,475        39,174        44,473        39,174  
  

 

 

    

 

 

    

 

 

    

 

 

 

Basic (loss) earnings per share

   $ (0.04    $ 0.01      $ (0.12    $ 0.11  
  

 

 

    

 

 

    

 

 

    

 

 

 
     Three months ended
September 30,
     Nine months ended
September 30,
 
     2018      2017      2018      2017  

Net (loss) income attributable to owners of the Company

   $  (1,989    $ 294      $  (5,415    $ 4,429  

Weighted average number of common shares outstanding (thousands)

     44,475        39,174        44,473        39,174  

Adjustment for:

           

Share options (thousands)

     —          890        —          761  
  

 

 

    

 

 

    

 

 

    

 

 

 

Weighted average number of common shares outstanding for diluted earnings per share (thousands)

     44,475        40,064        44,473        39,935  
  

 

 

    

 

 

    

 

 

    

 

 

 

Diluted (loss) earnings per share

   $ (0.04    $ 0.01      $ (0.12    $ 0.11  
  

 

 

    

 

 

    

 

 

    

 

 

 

For the three and nine months ended September 30, 2018, there were options to purchase 2,186 (2017 - 165) shares of the Company’s common stock that were excluded from the diluted loss per share computation because the impact of the assumed exercise of such stock options would have been anti-dilutive during the respective periods.

 

16

CAPITAL DISCLOSURES

The Company’s capital comprises net debt and equity:

 

     September 30, 2018      December 31, 2017  

Total bank debt

   $ 36,815      $ 38,640  

Less cash and cash equivalents

     (5,851      (7,091
  

 

 

    

 

 

 

Net debt

     30,964        31,549  

Total equity

     83,825        81,043  
  

 

 

    

 

 

 
   $  114,789      $  112,592  
  

 

 

    

 

 

 

It is the Company’s intention to meet its obligations through the collection of current accounts receivable and cash. As at September 30, 2018, the Company has an available operating loan up to CA$13,000, less US$7,000 drawn on the loan and US$261 and CA$38 outstanding letters of credit (as at December 31, 2017, $nil was outstanding on the operating loan, and US$333 and CA$38 outstanding on the letters of credit). As at September 30, 2018, the operating loan borrowing base was CA$9,939 based on a percentage of the Company’s outstanding accounts receivable less the issued letters of credit. If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

 

17

SHARE-BASED COMPENSATION PLAN

The Company has a share-based compensation plan. The maximum number of common shares that can be earned upon the exercise of earned performance-based restricted share units is equal to 10% of the aggregate number of common shares issued and outstanding from time to time. The term during which an option may be exercised is 10 years from the date of the grant. Options vest at a rate of 33% per year, beginning one year following the grant date of the options. Performance-based restricted share units are earned based on certain business milestones being achieved prior to a stated date. If the performance does not occur prior to stated date, the restricted share units expire.

 

 

17


VILLAGE FARMS INTERNATIONAL, INC.

Notes to Condensed Consolidated Interim Financial Statements for the

Three and Nine Months Ended September 30, 2018 and 2017

(In thousands of United States dollars, except per share amounts and unless otherwise noted)

(Unaudited)

 

As at September 30, 2018, there were 1,068,666 performance-based restricted share units outstanding with a weighted average grant date fair value of CA$5.52.

Share-based compensation expense for the three and nine months ended September 30, 2018 of $190 (2017 - $91) and $447 (2017 - $560), respectively, was recorded in selling, general and administrative expenses and the corresponding amount credited to contributed surplus.

 

18

SUBSEQUENT EVENTS

On October 1, 2018 and November 7, 2018, the Shareholders contributed an additional CA$2,000 and CA$3,000 each, respectively, as part of the Loan Agreement (see notes 7 and 10 for additional information).

On October 12, 2018, the Company issued 3,097,200 common shares pursuant to a bought deal public offering at an issue price of CA$7.13 per common share for aggregate gross proceeds to the Company of CA$22,083.

 

18

Exhibit 99.55

Village Farms International, Inc.

Management’s Discussion and Analysis

Three and Nine Months Ended September 30, 2018

November 12, 2018


Village Farms International, Inc.

 

 

Management’s Discussion and Analysis

Information is presented in thousands of United States dollars (“U.S. dollars”) unless otherwise noted.

Introduction

This management’s discussion and analysis (“MD&A”) should be read in conjunction with the condensed consolidated interim financial statements and accompanying notes of Village Farms International, Inc. (“VFF” and, together with its subsidiaries, the “Company”), for the three and nine months ended September 30, 2018 (the “Consolidated Financial Statements”). The information provided in this MD&A is current to November 12, 2018 unless otherwise noted.

VFF is a corporation existing under the Canada Business Corporations Act . The Company’s principal operating subsidiaries at September 30, 2018 were Village Farms Canada Limited Partnership (“VFCLP”), Village Farms, L.P. (“VFLP”) and VF Clean Energy, Inc. (“VFCE”). On June 6, 2017, VFF entered into a shareholders’ agreement in respect of the operation and governance of Pure Sunfarms Corp. (“Pure Sunfarms”) in which VFF owns a 50% interest.

Basis of Presentation

The annual data included in the MD&A is presented in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”), unless otherwise noted.

The preparation of annual financial data requires the use of certain accounting estimates. It also requires management to exercise its judgment in the process of applying the Company’s accounting policies. The areas involving a higher degree of judgment or complexity, or areas where assumptions and estimates are significant to the annual financial data, are disclosed in note 3 of the Consolidated Financial Statements.

Segment Reporting

Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the CEO. Based on the aggregation criteria in IFRS 8, Operating Segments , the operating segments of the Company are treated as two reporting segments.

Functional and Presentation Currency

The financial data is presented in U.S. dollars, which is the Company’s functional currency. All financial information presented in U.S. dollars has been rounded to the nearest thousand.

Business Overview

Management believes that the Company is one of the largest producers, marketers and distributors of premium-quality, greenhouse-grown tomatoes, bell peppers and cucumbers in North America. These premium products are grown in sophisticated, highly intensive agricultural greenhouse facilities located in British Columbia and Texas. The Company also markets and distributes premium tomatoes, peppers and cucumbers produced under exclusive arrangements with other greenhouse producers. The Company primarily markets and distributes under its Village Farms ® brand name, primarily to retail supermarkets and dedicated fresh food distribution companies throughout the United States and Canada. It currently operates two distribution centres, one located in the United States and one in Canada. Since its inception, the Company has been guided by a sustainable agriculture policy which integrates four main goals – environmental health, economic profitability and social and economic equality.

The Company, through its subsidiary VFCE, owns and operates a 7.0 MW power plant from landfill gas that generates electricity and provides thermal heat, in colder months, to one of the Company’s adjacent British Columbia greenhouse facilities and sells electricity to British Columbia Hydro and Power Authority (“BC Hydro”).

 

- 2 -


Village Farms International, Inc.

 

 

In June 2017 the Company established a joint venture, Pure Sunfarms, it is a licensed producer and supplier of cannabis products to be sold to other licensed providers and provincial governments across Canada and internationally.

The Company embraces sustainable agriculture and environmentally-friendly growing practices by:

 

   

utilizing integrated pest management techniques that use “beneficial bugs” to control unwanted pests. The use of natural biological control technology keeps plants and their p products virtually free of chemical agents. The process includes regular monitoring techniques for threat identification, development of appropriate, tailored response strategies and the execution of these strategies;

 

   

capturing rainwater from various greenhouse roofs for irrigation purposes;

 

   

capturing landfill gas on a long term contract from the City of Vancouver landfill to generate electricity under a long term contract with BC Hydro and thermal heat for an adjacent greenhouse;

 

   

recycling water and nutrients during the production process;

 

   

growing plants in a natural medium, including coconut fibre and rock wool, as opposed to growing in the soil and depleting nutrients; and

 

   

using dedicated environmental control computer systems which monitor and control virtually all aspects of the growing environment, thereby maximizing the efficient use of energy.

The Company’s assets, as of the reporting date, include six operating produce greenhouses providing approximately 849,958 square metres (or approximately 215 acres) of growing space in Canada and the United States. During 2017, the Company granted rights to what was its seventh greenhouse, located in Delta, BC (the “Delta 3 Greenhouse”), to Pure Sunfarms. Pure Sunfarms is in the process of converting the Delta 3 Greenhouse into a facility compliant with Access to Cannabis for Medical Purposes Regulations (“ACMPR”), which was merged into the “Cannabis Regulations” on October 17with the object of seeking to achieve large scale low-cost high quality cannabis production. Pure Sunfarms received a cultivation license on March 2, 2018 and a sales license on July 30, 2018 from Health Canada for the Delta 3 Greenhouse.

All of the Company’s greenhouses are constructed of glass, aluminum and steel, and are located on land owned or leased by the Company. The Company also has marketing agreements with growers in Canada, the United States and Mexico that currently operate approximately 808,000 square metres (or approximately 200 acres) of growing area.

The following table outlines the Company’s greenhouse facilities:

 

     Growing Area       

Greenhouse Facility

   Square
Feet
     Square
Metres
     Acres     

Products Grown

Marfa, TX (2 greenhouses)

     2,527,312        234,795        60     

Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Fort Davis, TX (1 greenhouse)

     1,684,874        156,530        40      Specialty tomatoes

Monahans, TX (1 greenhouse)

(Permian Basin facility)

     1,272,294        118,200        30     

Tomatoes on-the-vine, long English cucumbers

Delta, BC (2 greenhouses)

     3,664,390        340,433        85     

Tomatoes on-the-vine, beefsteak tomatoes, specialty tomatoes

Pure Sunfarms (1 greenhouse)

     1,077,758        100,127        25     

Leased to Pure Sunfarms for cultivation of cannabis

  

 

 

    

 

 

    

 

 

    

Total

     10,226,628        950,085        240     

Produce Marketing

The Company is a leading marketer of premium-quality, value-added, branded greenhouse-grown produce in North America, and is a significant producer of tomatoes on-the-vine, beefsteak, cocktail, grape, cherry tomatoes, roma, Mini San Marzano (a tomato variety for which the Company currently has an exclusive agreement with the seed provider to be the sole grower in North America), other speciality tomatoes under exclusive agreements and long English cucumbers at its facilities. The Company also distributes and markets premium tomatoes, bell peppers and cucumbers in the United States and Canada produced by other greenhouse growers located in Canada and Mexico. The Company maintains high standards of food safety and requires the same of its contract growers, while providing on-time, effective and efficient distribution.

 

- 3 -


Village Farms International, Inc.

 

 

The Company strives to continually exceed the expectations of its customers by consistently providing superior product, including adding new product varieties and packaging innovations.

The Company has distribution capabilities that it believes exceed those of most of its competitors in the North American greenhouse vegetable industry. With leased distribution centres in Texas and British Columbia, the Company provides its customers with flexibility in purchasing. For the nine months ended September 30, 2018, the Company had an on-time delivery record of approximately 98.3%, while maintaining competitive freight rates that management of the Company believes to be among the best in the industry.

The Company’s marketing strategy is to strategically position the Company to be the supplier of choice for retailers offering greenhouse produce by focusing on the following:

 

   

Year-Round Supplier. Year-round production capability of the Company enhances customer relationships, resulting in more consistent pricing.

 

   

Quality and Food Safety. Sales are made directly to retailers which ensure control of the product from seed to customer and results in higher levels of food safety, shelf life and quality control. Food safety is an integral part of the Company’s operations, and management believes that it has led, and currently leads, the industry in adopting Good Agricultural Practices. This program is modeled after the U.S. Food and Drug Administration’s Good Manufacturing Practices using the Primus Labs ® format and third party auditors. All of the Company’s packing facilities undergo comprehensive food safety audits by Primus Labs ® .

 

   

Quality Packaging and Presentation. Product is selected at a uniform size and picked at the same stage of vine ripeness. The packaging for the product is “display ready”, ensuring retail customers have a full view of the product on the supermarket shelf.

 

   

Exclusive Varieties. The Company expands its product profile, to create and drive exclusive varietal relationships in North America that enable the Company to present consumers with an enhanced eating experience with the Village Farms brand.

 

   

Direct Sale to Retail Customers. Greenhouse produce (produce grown by the Company plus supply partner produce) is sold directly to supermarket chains, including, Associated Grocers, Associated Wholesale Grocers, BJ’s Wholesale Club Inc., Costco Wholesale, Fred Meyer, The Fresh Market, Inc., Giant Eagle, Harris Teeter Supermarkets, Inc., HEB Grocery Company, The Kroger Co., Loblaw Companies Limited, Publix Super Markets, Inc., Roundy’s Supermarkets, Inc., Safeway Inc., Sobeys Inc., Sam’s Club, Trader Joe’s, United Supermarkets, Unified Western Grocers, Wakefern Food Corp., Wal-Mart Stores, Inc., Whole Foods Market and Winco Foods LLC.

 

   

Excellence in Customer Service and Logistics. Logistics and distribution capability are key factors in ensuring fresh high quality product meets consumer demands. Management of the Company believes it has a competitive advantage through its logistics and distribution networks, which includes strategically located distribution centres.

Investment in Joint Venture

On June 6, 2017, the Company and Emerald Health Botanicals, Inc. (“Emerald”) formed a new corporation named “Pure Sunfarms Corp.”. The Company and Emerald each own 50% of the shares of Pure Sunfarms. VFF contributed rights to one of its 25-acre greenhouse facilities in Delta, British Colombia as its equity contribution and Emerald agreed to contribute CA$20,000,000 to fund the conversion of the facility, which was fully funded as of April 2018. Pure Sunfarms has commenced the cultivation of cannabis in the licensed portion of the facility and received its sales license for the facility on July 30, 2018 from Health Canada, and has commenced with selling and distributing cannabis. Pure Sunfarms continues the conversion process on the remaining unlicensed portion of the facility, with the expectation that the entire 1.1 million square feet will be converted and licensed by the end of 2018.

On July 5, 2018, the Company and Emerald Health Therapeutics Canada Inc. (together, the “Shareholders”) entered into a Shareholder Loan Agreement (the “Loan Agreement”) with Pure Sunfarms, whereby, as at September 30, 2018, the Shareholders had each contributed CA$8,000 (US$6,110) the form of a demand loan to Pure Sunfarms. The loan amounts will initially bear simple interest at the rate of 8% per annum, calculated semi-annually. Interest will accrue and be payable upon demand being made by either Shareholder. On October 1, 2018 and November 7, 2018, the Shareholders contributed an additional CA$2,000 and CA$3,000 each, respectively, as part of the Loan Agreement.

 

- 4 -


Village Farms International, Inc.

 

 

Results of Operations

Consolidated Financial Performance

(In thousands of U.S. dollars, except per share amounts)

 

     For the three months
ended September 30 ,
     For the nine months
ended September 30,
 
     2018      2017      2018      2017  

Sales

   $ 39,684      $ 44,735      $ 111,213      $ 121,542  

Cost of sales

     (36,862      (42,400      (103,915      (112,525

Selling, general and administrative expenses

     (3,442      (3,267      (10,486      (9,875

Stock compensation expense

     (190      (91      (447      (560

Change in biological asset (1)

     (1,189      529        (992      (817

(Loss) income from operations

     (1,999      (494      (4,627      (2,235

Interest expense, net

     618        689        1,906        2,016  

Other income

     (56      113        26        (153

(Gain) loss on sale of assets

     —          —          —          (8,564

Share of (loss) from joint venture

     (28      (220      (369      (220

(Recovery of) provision for income taxes

     (712      (1,584      (1,513      (183

Net (loss) income

     (1,989      294        (5,415      4,429  

Consolidated EBITDA (2)

     897        756        1,394        4,770  

(Loss) earnings per share – basic

   ($ 0.04    $ 0.01      ($ 0.12    $ 0.11  

(Loss) earnings per share – diluted

   ($ 0.04    $ 0.01      ($ 0.12    $ 0.11  

 

(1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s interim consolidated financial statements for the three and nine months ended September 30, 2018.

(2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated EBITDA includes the Company’s 50% share of its joint venture Pure Sunfarms.

Results of Operations for the Three Months Ended September 30, 2018 compared to the Three Months Ended September 30, 2017

Sales

Sales for the three months ended September 30, 2018 decreased by ($5,051), or (11%), to $39,684 from $44,735 for the three months ended September 30, 2017. The decrease in sales is primarily due to the lost production from the Company’s Delta 3 greenhouse which was contributed to Pure Sunfarms and lower production from the Company’s Texas facilities which was primarily caused from a crop cycle change at the Permian Basin facility which did not have tomato production for 10 weeks during the three months ended September 30, 2018 due to a scheduled clean out of the facility after continuous production since early 2012.

The average selling price for tomatoes increased 12% for the three months ended September 30, 2018 versus the three months ended September 30, 2017 as a result of a higher percent of higher priced tomato production in 2018 verse 2017. Cucumber pricing remained flat and pepper pricing decreased by (8%) in the third quarter of 2018 versus the comparable quarter in 2017.    

Cost of Sales

Cost of sales for the three months ended September 30, 2018 decreased by ($5,538), or (13%), to $36,862 from $42,400 for the three months ended September 30, 2017; primarily due to the contribution of the Delta 3 facility ($2,598) and a decrease in costs from the Company’s Texas facilities, due to a scheduled crop change in the Permian Basin facility not having tomato production for 10 weeks for a full cleanout.

 

- 5 -


Village Farms International, Inc.

 

 

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended September 30, 2018 increased by $175, or 5%, to $3,442 from $3,267 for the three months ended September 30, 2017. The increase is due to public company costs such as investor relations and listing fees.

Stock Compensation Expenses

Stock compensation expense for the three months ended September 30, 2018 was $190 from $91 for the three months ended September 30, 2017.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended September 30, 2018 decreased by ($1,718) to ($1,189) from a gain of $529 for the three months ended September 30, 2017. The decrease in the change in value is primarily due to a higher starting fair value at July 1, 2018 versus the same period in 2017 and (7%) less pounds available for sale in September 2018 versus September 2017, due to the loss of production from the Delta 3 facility in 2018 verse 2017. The fair value of the biological asset as at September 30, 2018 was $5,119 as compared to $5,305 as at September 30, 2017.

(Loss) from Operations

Loss from operations for the three months ended September 30, 2018 increased ($1,505) to ($1,999) from ($494) for the three months ended September 30, 2017. The decrease is due to a decrease in the change in biological asset of ($1,718).

Interest Expense, net

Interest expense, net, for the three months ended September 30, 2018 decreased $71 to $618 compared to $689 for the three months ended September 30, 2017, primarily due to lower principal balances.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the three months ended September 30, 2018 was ($28), compared to ($220) for the three months ended September 30, 2017, the loss primarily consists of salaries and other administrative costs, offset by a gross profit from sales of $23 and by the Company’s share of the JV’s change in biological asset of $267, as the joint venture had buds on the plant and dried bud in inventory on September 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on the plant and in inventory on September 30, 2018.

(Recovery of) Provision for Income Taxes

Income tax recovery for the three month period ended September 30, 2018 was ($712) from ($1,584) for the three month period ended September 30, 2017. The income tax recovery decrease is due to the recalculation of gain on sale of assets in 2017.

Net (Loss) Income

Net loss for the three months ended September 30, 2018 was ($1,989) compared to net income of $294 for the three months ended September 30, 2017 primarily due to the change in biological asset decease of ($1,718) and a decrease in recovery of income taxes of ($872) partially offset by a lower share of loss from joint venture of $192.

 

- 6 -


Village Farms International, Inc.

 

 

EBITDA

EBITDA for the three months ended September 30, 2018 increased by $141, to $897 from $756 for the three months ended September 30, 2017. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.

Results of Operations for the Nine Months Ended September 30, 2018 Compared to the Nine Months Ended September 30, 2017

Net Sales

Net sales for the nine months ended September 30, 2018 decreased ($10,329), or (8%), to $111,213 compared to $121,542 for the nine months ended September 30, 2017. The decrease in net sales is due to the loss of tomato production from the Delta 3 facility, which was contributed to Pure Sunfarms in 2017 and the Company’s lower production at its Texas facilities.

The net price for all tomato pounds sold was an increase of 5% for the nine months ended September 30, 2018 versus the nine months ended September 30, 2017 due to a higher percent of higher priced tomato production in 2018 verse 2017. Pepper prices decreased (7%) and pounds increased 30% over the comparable period in 2017, and cucumber prices decreased (3%) and pieces decreased (13%) for the nine months ended September 30, 2018 over the comparable period in 2017.

Cost of Sales

Cost of sales for the nine months ended September 30, 2018 decreased ($8,610), or (8%), to $103,915 from $112,525 for the nine months ended September 30, 2017; primarily due the loss of the Delta 3 facility ($4,598), a decrease in costs in Texas from a decrease on pounds sold from the Texas facilities and a decrease of ($348) in contract sales cost, due to decreased cucumber volumes.

Change in fair value of biological asset, net

The net change in fair value of biological asset for the nine months ended September 30, 2018 decreased ($175) to ($992) from ($817) for the nine months ended September 30, 2017. The decrease is due to lower pounds available for sale in September 2018 versus September 2017 from the loss of the Delta 3 facility.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the nine month period ended September 30, 2018 increased ($611), or (6%), to $10,486 from $9,875 for the nine month period ended September 30, 2017. The increase is due to public company costs such as investor relations, legal and listing fees.

Stock Compensation Expenses

Stock compensation expenses for the nine months ended September 30, 2018 was $447 from $560 for the nine months ended September 30, 2017.

(Loss) from Operations

(Loss) from operations for the nine months ended September 30, 2018 was ($4,627), which was an increased (loss) of ($2,392) from a loss of ($2,235) for the nine months ended September 30, 2017. The decrease in operating results is due to a decrease in net sales caused the loss of the Delta 3 facility and production shortfalls in Texas and partially offset by a decrease in the cost of sales.

 

- 7 -


Village Farms International, Inc.

 

 

Interest Expense, net

Interest expense, net, for the nine month period ended September 30, 2018 decreased ($110) to $1,906 from $2,016 for the nine month period ended September 30, 2017, the decrease is due to interest income of $110 in the nine month period ended September 30, 2018.    

Income Taxes (Recovery)

Income tax provision (recovery) for the nine month period ended September 30, 2018 was a recovery ($1,513) compared to ($183) for the nine month period ended September 30, 2017. The income tax recovery decrease is due to the gain on sale of assets in 2017 that did not occur in 2018.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the nine months ended September 30, 2018 was ($369), compared to ($220) for the nine months ended September 30, 2017. The loss primarily consists of salaries and other administrative costs, offset by a gross profit from sales of $23 and by the Company’s share of the JV’s change in biological asset of $857, as the joint venture had buds on the plant and dried bud in inventory on September 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on plant and in inventory on September 30, 2018.

Gain on Sale of Assets

No gains were recognized in 2018. The Company recognized for the nine month period ended September 30, 2017 a gain of $8,564 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms in exchange for a 50% equity stake in Pure Sunfarms. See “Investment in Joint Venture” above.

Net Income (Loss)

Net income (loss) for the nine month period ended September 30, 2018 decreased to a loss of ($5,415) from income of $4,429 for the nine month period ended September 30, 2017. The decrease is a result of a gain on assets in 2017 of $8,564.

EBITDA

EBITDA for the nine month period ended September 30, 2018 decreased ($3,376) to $1,394 from $4,770 for the nine month period ended September 30, 2017, primarily as a result of a decrease in net sales and an increase in share of loss from Pure Sunfarms of ($1,173). See the EBITDA calculation in “Non-IFRS Measures - Reconciliation of Net Earnings to EBITDA”.

Selected Statement of Financial Position Data

 

     As at September 30,      As at December 31,  
     2018      2017  

Total assets

   $ 147,968      $ 142,341  

Total liabilities

   $ 64,171      $ 61,298  

Shareholders’ equity

   $ 83,797      $ 81,043  

Non-IFRS Measures

References in this MD&A to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized gains on the changes in the value of derivative instruments, unrealized change in biological asset, stock compensation, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

 

- 8 -


Village Farms International, Inc.

 

 

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months
ended September 30,
     For the nine months
ended September 30 ,
 
     2018      2017      2018      2017  

Net (loss) income

   ($ 1,989    $ 294      ($ 5,415    $ 4,429  

Add:

           

Amortization

     1,748        1,853        5,271        5,753  

Foreign currency exchange loss (gain)

     73        (58      87        (57

Interest expense

     618        689        1,906        2,015  

Income taxes (recovery)

     (712      (1,584      (1,513      (183

Stock based compensation

     190        91        447        560  

Change in biological asset

     1,189        (529      992        817  

Change in biological asset from JV

     (267      —          (428      —    

Amortization from JV

     37        —          37        —    

Foreign currency exchange loss (gain) from JV

     10        —          10        —    

Gain on disposal of assets

     —          —          —          (8,564
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated EBITDA

   $ 897      $ 756      $ 1,394      $ 4,770  

EBITDA for JV (50% share)

   ($ 248    ($ 220    ($ 750    ($ 220

Standalone EBITDA

   $ 1,145      $ 976      $ 2,144      $ 4,990  

Liquidity    

Cash flows

The Company expects to provide adequate financing to maintain and improve its property, plant and equipment, to fund working capital needs and invest in Pure Sunfarms for the foreseeable future from cash flows from operations, and, if needed, from additional borrowings under the Credit Facilities (as defined below) or additional equity financing.

For the three months ended September 30, 2018, cash flows from operating activities before changes in non-cash working capital and change in biological asset totalled ($919) (2017 – $1,166) and for the nine months ended September 30, 2018 totalled $244 (2017 - $3,823).

Capital expenditures totalled $1,105 for the three months ended September 30, 2018 (2017 - $178) and $2,546 for the nine months ended September 30, 2018 (2017 – $1,485).

The cash provided by (used in) financing activities for the three months ended September 30, 2018 totalled ($1,433) (2017 – ($4,413)) and for the nine months ended September 30, 2017 totalled $11,346 (2017 – $1,345). For the three months ended September 30, 2018, the cash provided by financing activities primarily consisted of proceeds from the exercise of stock options of $12, debt payments of ($849), interest payments of ($585), and payments on capital lease obligations of ($11) (2017 –operating loan payments ($3,000), debt payments ($832) interest paid ($676), payments on capital lease obligations ($18)).

For the nine months ended September 30, 2018, the cash provided by financing activities primarily consisted of issuance of common stock pursuant to a private placement of $7,755, operating loan borrowings of $7,000, proceeds from the exercise of stock options of $275, debt payments of ($1,766), interest payments of ($1,873), and payments on capital lease obligations of ($45) (2017 – operating loan borrowings $7,113, proceeds from the exercise of stock options $26, debt payments ($6,488) interest paid ($1,956), payments on capital lease obligations ($40)).

 

- 9 -


Village Farms International, Inc.

 

 

Capital Resources    

 

(in thousands of U.S. dollars unless otherwise noted)    Maximum      Outstanding
September 30,
2018
 

Operating Loan

   CA$ 13,000      $ 7,000  

Term Loan

   $ 35,155      $ 35,155  

VFCE Loan

   CA$ 2,028      CA$ 2,028  

The Company is party to a Term Loan financing agreement with a Canadian creditor (“FCC Loan”). This non-revolving variable rate term loan was amended in March 2016 and now has a maturity date of May 1, 2021 and a balance of $35,155 as at September 30, 2018. The outstanding balance is repayable by way of monthly installments of principal and interest based on an amortization period of 15 years, with the balance and any accrued interest to be paid in full on maturity. In December 2017, the Company made a pre-payment on the term loan of $4,000 to release the Delta 2 asset as collateral. The Company was not required to make principal payments from January to March 2018. Monthly principal payments of $253 began in April 2018. As at September 30, 2018, borrowings under the FCC Loan were subject to an interest rate of 6.848% per annum (December 31, 2017 – 5.88483% per annum). The Company’s interest rate on the FCC Loan is determined based on the Company’s Debt to EBITDA ratio on December 31 of the prior year and the current monthly applicable LIBOR rate.

The Company’s subsidiary VFCE has a loan agreement with a Canadian Chartered Bank that includes a non-revolving fixed rate loan of CA$3.0 million with a maturity date of June 2023 and fixed interest rate of 4.98%. As at September 30, 2018, the balance was US$1,597 (December 31, 2017 - US$1,658). The loan agreement also includes an uncommitted, non-revolving credit facility for up to CA$300 to cover Letters of Guarantee issued by the bank on behalf of the Company, with a maximum term of 365 days, renewable annually. The loan agreement also includes an uncommitted credit facility for up to CA$700 to support financing of certain capital expenditures. The Company received an initial advance of CA$250 in October 2017. Each advance is to be repaid on a five-year, straight-line amortization of principal, repaid in monthly installments of principal plus interest at an interest rate of CA$ prime rate plus 200 basis points. As at September 30, 2018, the balance was US$158 (December 31, 2017 - $192).

The Company is also party to a variable rate line of credit agreement with a Canadian chartered bank that has a maturity date of May 31, 2021 (the “Operating Loan” and together with the FCC Loan, the “Credit Facilities”). The Operating Loan is subject to margin requirements stipulated by the bank. As at September 30, 2018, $7,000 was drawn on the Operating Loan (December 31, 2017 - $nil), which is available to a maximum of CA$13,000, less outstanding letters of credit of US$261 and CA$38 (or US$29).

As security for the FCC Loan, the Company has provided promissory notes, a first mortgage on the VFF-owned greenhouse properties (excluding the Delta 3 and Delta 2 greenhouse facilities), and general security agreements over its assets. In addition, the Company has provided full recourse guarantees and has granted security therein. The carrying value of the assets and securities pledged as collateral as at September 30, 2018 was $117,872 (December 31, 2017 – $120,815).

As security for the Operating Loan, the Company has provided promissory notes and a first priority security interest over its accounts receivable and inventory. In addition, the Company has granted full recourse guarantees and security therefore. The carrying value of the assets pledged as collateral as at September 30, 2018 was $36,670 (December 31, 2017 - $32,883).

The borrowings are subject to certain positive and negative covenants, which include debt coverage ratios. As at September 30, 2018, the Company was in compliance with all of its covenants.

Accrued interest payable on the credit facilities and loans as at September 30, 2018 was $183 (December 31, 2017 - $193) and these amounts are included in accrued liabilities in the interim statements of financial position.

 

- 10 -


Village Farms International, Inc.

 

 

Contractual Obligations and Commitments

Information regarding the Company’s contractual obligations at September 30, 2018 is set forth in the table below:

 

(in thousands of U.S. dollars)    Total      1 year      2-3 years      4-5
years
     More than
5 years
 

Long-term debt

   $ 36,815      $ 3,450      $ 32,765      $ 600      $ —    

Line of Credit

     7,000        7 ,000        —          —          —    

Operating leases

     5,54 1        1,289        2,192        1,623        437  

Capital leases

     206        76        130        —          —    
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 49,562      $ 11,815      $ 35,087      $ 2,223      $ 437  
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Capital Expenditures

During the three and nine months ended September 30, 2018, the Company purchased approximately $1,106 and $2,546 of capital assets, respectively. Capital expenditures incurred for 2018 were used for replacements or improvements to existing facilities related mostly to improvements at VFCE, which completed two major engine overhauls.

Management continues to review new capital expenditures to support its strategic plan of achieving cost efficiencies through increased productivity. Management may elect, where appropriate, to sell inefficient or non-strategic assets to produce cash to wholly or partially finance new capital expenditures. The Company will also borrow to maintain, improve and replace capital assets when the return on such investments exceeds targeted thresholds for internal rates of return. There can be no assurance, however, that sources of financing will be available, or will be available on terms favourable to the Company, or that these strategic initiatives will achieve adequate cost reduction in actual implementation or in light of the competitive pressures on the cost of raw materials and other factors of production. Management believes that its recurring capital expenditures will be funded and supported from its ongoing operations.

During the three and nine month ended September 30, 2018, the Company incurred $540 and $1,868, respectively, in costs to maintain its capital assets. These expenses are classified as repair and maintenance and are included in cost of sales. Management forecasts approximately $2,500 of annual costs to maintain the Company’s capital assets.

Summary of Quarterly Results

For the three months ended:

 

(in thousands of U.S. Dollars, except per share amounts)    Sept 30,
2018
    Jun 30,
2018
    Mar 31,
2018
    Dec 31,
2017
    Sept 30,
2017
     Jun 30,
2017
     Mar 31,
2017
    Dec 31,
2016
 

Sales

   $ 39,684     $ 42,039     $ 29,490     $ 36,864     $ 44,735      $ 45,530      $ 31,277     $ 37,308  

Net income (loss)

   ($ 1,989   ($ 2,282   ($ 1,143   ($ 607   $ 294      $ 4,325      ($ 190   $ 453  

Basic earnings (loss) per share

   ($ 0.04   ($ 0.05   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01  

Diluted earnings (loss) per share

   ($ 0.04   ($ 0.05   ($ 0.03   ($ 0.02   $ 0.01      $ 0.11      ($ 0.00   $ 0.01  

The Company’s Canadian vegetable growing operations peak production period is in the summer months, with no production during the winter season. As a result, prices for vegetable products from the Company’s Canadian operations have historically followed a seasonal trend of higher prices at the start and end of its crop year, with lower prices in the summer months when the supply of product is greatest. Conversely, the Company’s U.S. vegetable operations winter production allows it to realize higher prices during the October through March period, due to the reduced supply of greenhouse produce in North America during the winter months. The complementary nature of the growing seasons of the Company’s Canadian and U.S. vegetable operations allows the Company to maintain and service its core vegetable retail accounts year round.

 

- 11 -


Village Farms International, Inc.

 

 

Financial Instruments and Risk Management

Risk Management

The Company is exposed to the following risks as a result of holding financial instruments: market risk, credit risk, interest rate risk, foreign exchange risk and liquidity risk. The following is a description of these risks and how they are managed by the Company.

Market Risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in the market place.

Credit Risk

Credit risk is the risk that the Company will incur a loss due to the failure by its customers or other parties to meet their contractual obligations. Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents and trade receivables.

The Company limits its exposure to credit risk by placing its cash and cash equivalents with high credit quality financial institutions.

The Company’s trade receivables had two customers that represented more than 10% of the balance of trade receivables, representing 12.1% and 10.5% of the balance of trade receivables as at September 30, 2018 (2017 – one customer represented 10.5%). The Company believes that its trade receivables risk is limited due to the high credit quality of its customers and the protection afforded to the Company by the Perishable Agricultural Commodities Act (the “PACA”) for its vegetable sales in the United States, which represent approximately 85% of the Company’s annual sales. The PACA protection gives a claim filed under the PACA first lien on all PACA assets (which include cash and trade receivables). The PACA fosters trading practices in the marketing of fresh and frozen fruits and vegetables in interstate and foreign commerce. It prohibits unfair and fraudulent practices and provides a means of enforcing contracts. Historical write-offs have represented less than one-half of 1% of sales.

Trade receivables for each customer were evaluated for collectability and an allowance for doubtful accounts has been estimated. At September 30, 2018, the allowance for doubtful accounts balance was $50 (2017 – $50). The Company has not recorded bad debt expense during the three and nine months ended September 30, 2018 (2017 – $nil and $nil, respectively).    

At September 30, 2018, 89.2% (December 2017 – 89.4%) of trade receivables were outstanding less than 30 days, 9.5% (December 2017 – 7.4%) were outstanding for between 30 and 90 days and the remaining 1.3% (December 2017 – 3.2%) were outstanding for more than 90 days. Trade receivables are considered past due based on the contract terms agreed to with a customer. Aged receivables that are past due are not considered impaired unless customer specific information indicates otherwise.

Interest Rate Risk

Interest rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates.

The Company has used derivative instruments to reduce market exposure to changes in interest rates. The Company has used derivative instruments only for risk management purposes and not for generating trading profits.

 

- 12 -


Village Farms International, Inc.

 

 

Liquidity Risk

Liquidity risk is the risk that the Company will not be able to meet its obligations as they become due. The following are the contractual maturities of financial liabilities as at September 30, 2018:

 

(in thousands of U.S. dollars)

Financial liabilities

   Contractual
cash flows
     0 to 12
months
     12 to 24
months
     After 24
months
 

Accounts payable and accrued liabilities

   $ 16,468      $ 16,468      $ —        $ —    

Bank debt

     36,815        3,450        3,425        29,940  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 53,283      $ 19,918      $ 3,425      $ 29,940  
  

 

 

    

 

 

    

 

 

    

 

 

 

It is the Company’s intention to meet these obligations through the collection of current accounts receivable and cash. The Company has available lines of credit of up to CA$13,000 (as at September 30, 2018, $7,000 was outstanding and US$261 and CA$38 was utilized in the form of outstanding letters of credit). If the current resources and cash generated from operations are insufficient to satisfy its obligations, the Company may seek to issue additional equity or to arrange debt or other financing.

Under the terms of the Credit Facilities, the Company is subject to a number of covenants, including debt service covenants. These covenants could reduce the Company’s flexibility in conducting the Company’s operations by limiting the Company’s ability to borrow money and may create a risk of default on the Company’s debt (including by a cross-default to other credit agreements) if the Company cannot satisfy or continue to satisfy these covenants. In the event that the Company cannot comply with a debt covenant, or anticipates that it will be unable to comply with a debt covenant in the future, management may seek a waiver and/or amendment from the applicable lenders in respect of any such covenant in order to avoid any breach or default that might otherwise result there from. If the Company defaults under any of the Credit Facilities and the default is not waived by the applicable lenders, the debt extended pursuant to all of its debt instruments could become due and payable prior to its stated due date. The Company cannot give any assurance that (i) its lenders will continue to agree to any covenant amendments or waive any covenant breaches or defaults that may occur under the applicable debt instruments, and (ii) it could pay this debt if it became due prior to its stated due date. Accordingly, any default by the Company under its existing debt that is not waived by the applicable lenders could materially adversely impact the Company’s results of operations and financial results and may have a material adverse effect on the trading price of its common shares. See also “Risk Factors—Dependence Upon Credit Facilities” in the Company’s current Annual Information Form.

Environmental, Health and Safety Risk

The Company’s operations are subject to national, regional and local environmental, health and safety laws and regulations governing, among other things, discharge to air, land and water, the handling and storage of fresh produce, waste disposal, the protection of employee health, safety and the environment. The Company’s greenhouse facilities could experience incidents, malfunctions or other unplanned events that could result in discharges in excess of permitted levels resulting in personal injury, fines, penalties or other sanctions and property damage. The Company must maintain a number of environmental and other permits from various governmental authorities in order to operate. Failure to maintain compliance with these requirements could result in operational interruptions, fines or penalties, or the need to install potentially costly pollution control technology. Compliance with current and future environmental laws and regulations, which are likely to become more stringent over time, including those governing greenhouse gas emissions, may impose additional capital costs and financial expenditures, which could adversely affect the Company’s operational results and profitability.

The Company is committed to protecting the health and safety of employees and the general public, and to sound environmental stewardship. The Company believes that prevention of incidents and injuries, and protection of the environment, benefits everyone and delivers increased value to its shareholders, customers and employees. The Company has health and safety and environmental management and systems and has established policies, programs and practices for conducting safe and environmentally sound operations. Regular reviews and audits are conducted to assess compliance with legislation and Company policy.

 

- 13 -


Village Farms International, Inc.

 

 

Overview

The forward-looking statements contained in this section and elsewhere in this MD&A are not historical facts, but rather, reflect the Company’s current expectations regarding future results or events and are based on information currently available to Management. Certain material factors and assumptions were applied in providing these forward-looking statements. See the “Forward-Looking Statements” section of this MD&A.

On June 6, 2017, the Company announced an initiative into growing cannabis through a joint venture with an existing licensed producer, pursuant to which the Company would contribute rights to one of its Delta greenhouses and growing knowledge in exchange for a 50% equity position. Emerald has contributed CA$20 million for its 50% equity interest. The joint venture is named “Pure Sunfarms Corp.” Pure Sunfarms received its cultivation license from Health Canada for the Delta 3 Greenhouse on March 2, 2018. Pure Sunfarms received its sales license from Health Canada on July 27, 2018. Pure Sunfarms has been harvesting cannabis since the middle of May and with its sales license has commenced the sales of dried bud to other Licensed Producers. Pure Sunfarms continues to convert the unlicensed sections of the Company’s Delta 3 greenhouse to grow cannabis and meet the required security standards for licensing under the ACMPR. Management believes that Pure Sunfarms will be successful in obtaining a cultivation license for the remainder of the facility by the end of 2018 or January 2019. Once the entire facility is licensed, it will be one the largest commercial cannabis production facilities in Canada. Management believes it will produce cannabis for CA$1 per gram with margins of 50% in late 2019. As such, the Company’s 50% equity interest in Pure Sunfarms is capable of generating substantially higher revenue and profits than prior revenues and profits from the tomato crop previously grown in the facility.

Pure Sunfarms will need incremental capital to complete the full buildout of the Delta 3 Greenhouse as well as for its initial working capital needs. Presently, it is in discussions with the Company’s current lenders to provide traditional term debt to Pure Sunfarms. Depending on the timing and amount of any debt funding’ additional shareholder debt or equity may have be contributed short-term debt to Pure Sunfarms to complete the full build out prior to the end of 2018. Since July 2018, each of the PSF Shareholders has provided CAD $13.0 million of capital to Pure Sunfarms in the form of demand shareholder loans.

Currently, management has no intention of growing cannabis at its U.S. greenhouse facilities or holding any equity investments in U.S. cannabis cultivation businesses, in each case until it is federally legal to do so.

The Company continues to focus on increasing its produce revenues and profits on its core crops – tomatoes, cucumbers and peppers. The Company also continues to actively explore whether to produce certain higher margin alternative crops at the Company’s continuing produce facilities, such as hemp as well as evaluate other cannabis related business opportunities.

Growth expenditures

The Company expects to spend between $2.5 to $3.0 million on capital expenditures in 2018. These expenditures are to repair and enhance existing growing and pack house systems either due to obsolesces of the system or to improve operational efficiencies.

The Company has made a capital contribution of CAD$13 million to Pure Sunfarms in the form of a shareholder demand loans. Additional equity of cash will likely be required in the next twelve months depending on the final completion timeline for the Delta 3 Greenhouse and whether or not Pure Sunfarms obtains financing.

Disclosure Controls and Procedures

Disclosure controls and procedures have been designed to ensure that information to be disclosed by the Company is accumulated and communicated to management, as appropriate, to allow timely decisions regarding required disclosures. The Chief Executive Officer and Chief Financial Officer have concluded, as of the end of the period covered by the interim and year end filings, that the Company’s disclosure controls and procedures are appropriately designed and operating effectively to provide reasonable assurance that material information relating to the Company is made known to them by others within the Company.

 

- 14 -


Village Farms International, Inc.

 

 

Internal Control over Financial Reporting

Internal control over financial reporting is a process designed to provide reasonable assurance that all assets are safeguarded, transactions are appropriately authorized and to facilitate the preparation of relevant, reliable and timely information. A control system, no matter how well conceived or operated, can provide only reasonable, not absolute, assurance that the objective of the control system is met. Management has assessed the effectiveness of the Company’s internal control over financial reporting as defined by National Instrument 52-109, Certification of Disclosure in Issuers’ Annual and Interim Filings. Management has concluded that their internal control over financial reporting was effective as of September 30, 2018. There were no material changes in the Company’s internal control over financial reporting that occurred during the three months ended September 30, 2018 that had materially affected, or is reasonably likely to affect, the Company’s internal control over financial reporting.

Risks and Uncertainties

The Company is subject to various risks and uncertainties which are summarized below, as well as those discussed in this MD&A. Additional details are contained in the Company’s current Annual Information Form dated April 2, 2018 filed on SEDAR, which can be accessed electronically at www.sedar.com .

Risks Relating to the Company

 

   

Product Pricing

 

   

Maintain Profitability

 

   

Risks Inherent in the Agricultural Business

 

   

Covenant Risk

 

   

Natural Catastrophes

 

   

Retail Consolidation

 

   

Dependence Upon Credit Facilities

 

   

Competition

 

   

Transportation Disruptions

 

   

Labour Availability

 

   

Risks Associated with Cross Border Trade

 

   

Governmental Regulations

 

   

Product Liability

 

   

Key Executives

 

   

Uninsured and Underinsured Losses

 

   

Cyber Security

 

   

Vulnerability to Rising Energy Cost

 

   

Risks of Regulatory Change

 

   

Environmental, Health and Safety Risk

 

   

Foreign Exchange Exposure

 

   

Technological Advances

 

   

Accounting Estimates

 

   

Growth

Risks Related to the Joint Venture

 

   

Reliance on Licenses

 

   

Regulatory Risks

 

   

Competition

 

   

Reliance on a Single Facility

 

   

Limited Operating History in the Cannabis Industry

 

   

Risks Inherent in an Agricultural Business

 

   

Conversion of Facility

 

   

Risks Related to the Joint Venture

 

   

Environmental Regulations and Risks

 

   

Failure to Realize Growth Strategy

 

- 15 -


Village Farms International, Inc.

 

 

   

Research and Development and Product Obsolescence

 

   

Fluctuating Prices of Raw Materials

 

   

Product Liability

 

   

Product Recalls

Risks Related to Tax

 

   

Transfer Pricing

 

   

Potential U.S. Permanent Establishment of VF Canada GP, VFCLP and VFF

 

   

Advances by VF Operations Canada Inc. to U.S. Holdings

 

   

U.S. Real Property Holding Corporation

Off-Balance Sheet Arrangements

The Company does not have any off-balance sheet arrangements.

Critical Accounting Estimates

Accounts Receivable

Accounts receivable are measured at amortized cost and due within contractual payment terms and are stated at amounts due from customers net of an allowance for doubtful accounts. Credit is extended based on an evaluation of a customer’s financial condition. Accounts outstanding longer than the contractual payment terms are considered past due. The Company determines its allowance by considering a number of factors, including the length of time trade accounts receivable are past due, the Company’s previous loss history and the customer’s current ability to pay its obligation to the Company. The Company writes off accounts receivable when they become uncollectible, and payments subsequently received on such receivables are credited to the bad debt expense.

Inventories

Inventories of Company-grown produce consist of raw materials, labour and overhead costs incurred less costs charged to cost of sales throughout the various crop cycles, which end at various times throughout the year and exclude biological assets (see below). Cost of sales is based upon incurred and estimated costs to be incurred from each crop allocated to both actual and estimated future yields over each crop cycle. The cost of produce inventory purchased from third parties is valued at the lower of cost or net realizable value.

Biological Assets

Biological assets consist of the Company’s produce on the vines at the period end. The produce on the vine is measured at fair value less costs to sell and complete, with any change therein recognized in profit or loss. Costs to sell include all costs that would be necessary to sell and complete the assets, including finishing and transportation costs.

Income Taxes

The Company utilizes the assets and liability method of accounting for income taxes under which future income tax assets and liabilities are recognized for the estimated future income tax consequences attributable to differences between the financial statement carrying value amount and the tax basis of assets and liabilities. Management uses judgment and estimates in determining the appropriate rates and amounts in recording future taxes, giving consideration to timing and probability. Actual taxes could significantly vary from these estimates as a result of future events, including changes in income tax law or the outcome of reviews by tax authorities and related appeals. The resolution of these uncertainties and the associated final taxes may result in adjustment to the Company’s tax assets and tax liabilities.

Future income tax assets are recognized to the extent that realization is considered more likely than not. The Company considers past results, current trends and outlooks for future years in assessing realization of income tax assets.

 

- 16 -


Village Farms International, Inc.

 

 

Impairment of Financial and Non-Financial Assets

At the end of each reporting period, the Company reviews the carrying amounts of its long lived assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss, if any. The Company estimates the recoverable amounts of the cash-generating unit (“CGU”) to which the asset belongs.

Where a reasonable and consistent basis of allocation can be identified, corporate assets are also allocated to individual CGU’s, or otherwise they are allocated to the smallest group of CGU’s for which a reasonable and consistent allocation basis can be identified. Identifiable cash flows are largely independent of the cash flows of other assets and liabilities. This was determined to be the Canadian and U.S. operations.

Recoverable amount is the higher of the fair value less costs to sell and the value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted. If the recoverable amount of an asset or CGU is estimated to be less than its carrying amount, the carrying amount of the asset or CGU is reduced to its recoverable amount. An impairment loss is recognized immediately in the statement of income.

Where an impairment loss subsequently reverses for assets with a finite useful life, the carrying amount of the asset or CGU is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognized for the asset or CGU in prior periods. A reversal of an impairment loss is recognized immediately in the statement of income.

Due to the above-noted considerations, which are based on the Company’s best available information, the Company has not recorded any impairment charge on its non-financial assets during the three months ended September 30, 2018.

Property, Plant and Equipment – Useful Lives

Management estimates the useful lives of property, plant and equipment based on the period during which the assets are expected to be available for use. The amounts and timing of recorded expenses for depreciation of property, plant and equipment for any period are affected by these estimated useful lives. The estimates are reviewed at least annually and are updated if expectations change as a result of physical wear and tear, technical or commercial obsolescence and legal or other limits to use. It is possible that changes in these factors may cause significant changes in the estimated useful lives of the Company’s property, plant and equipment in the future.

Land Revaluation

Management concluded that given significant changes in the fair market value of the Company’s land assets, the revaluation method of accounting for land used in production is a more appropriate accounting policy than historical cost. IAS 8, Accounting Policies, Changes in Accounting Estimates and Errors , allows for prospective application of this policy change and therefore the policy change has been applied to year ended December 31, 2016.

Accounting Standards Issued and Not Applied

The IASB periodically issues new standards and amendments or interpretations to existing standards. The new pronouncements listed below are those policy changes that management considers relevant to the Company now or in the future. This is not intended to be a complete list of new pronouncements made during the year.

IFRS 16, Leases , issued in January 2016, replaces IAS 17, Leases, and related Interpretations. IFRS 16 establishes the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract, i.e. the customer (lessee) and the supplier (lessor). IFRS 16 is effective for annual periods beginning on or after January 1, 2019, with early adoption permitted only if the Company also applies IFRS 15. Management is currently assessing the impact on the Company’s interim financial statements along with the timing of adoption of IFRS 16. Management expects that IFRS 16 will result in the following: a) an increase in assets and liabilities as fewer leases will be expensed as payments are made; b) an increase in depreciation expenses; and c) an increase in cash flow from operating activities as these lease payments will be recorded as financing outflows in the cash flow statements.

 

- 17 -


Village Farms International, Inc.

 

 

IFRS 11, Joint Arrangements , and IAS 28, Investments in Associates and Joint Ventures establishes the criteria for accounting for joint ventures. Investments in joint ventures are accounted for using the equity method. The equity method involves recording the initial investment at cost and subsequently adjusting the carrying value of the investment for the proportionate share of the profit or loss, other comprehensive income or loss and any other changes in the joint venture’s net assets such as dividends. At each consolidated statement of financial position date, the Company will consider whether there is objective evidence of impairment in joint venture. If there is such evidence, the Company will determine the amount of impairment to record, if any, in relation to the joint venture. IFRS is effective for annual periods beginning on or after January 1, 2019.

Amendment to IFRS 3, Business Combinations were issued to clarify that when an entity obtains control of a business that is a joint operation, it remeasures previously held interests in that business. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 12, Income Taxes were issued to clarify that all income tax consequences of dividends (i.e. distribution of profits) should be recognized in profit or loss, regardless of how the tax arises. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Amendments to IAS 23, Borrowing Costs were issued to clarify that if any specific borrowing remains outstanding after the related asset is ready for its intended use or sale, that borrowing becomes part of the funds that an entity borrows generally when calculating the capitalization rate on general borrowings. The amendments are effective for annual periods beginning on or after January 1, 2019. The Company does not anticipate any material impact to the Company’s financial position or results of operations as a result of these amendments.

Further details of new accounting standards and potential impact on the Company can be found in the Company’s consolidated financial statements for the year ended December 31, 2017.

Accounting Standards Adopted in the Year

The Company has adopted the following new and revised standards and changes in accounting policies, along with any consequential amendments as at January 1, 2018. These changes were made in accordance with the applicable transitional provisions.

IFRS 9, Financial Instruments replaced the current IAS 39, Financial Instruments Recognition and Measurement . This standard sets out revised guidance for classifying and measuring financial assets and liabilities, introduces a new expected credit loss model for calculating impairment of financial assets and includes a reformed approach to hedge accounting. The standard also requires that when a financial liability at amortized cost is modified or exchanged, and such modification or exchange does not result in de-recognition, that the adjustment to the amortized cost of the financial liability is recognized in profit or loss. As a result of the Company’s adoption of IFRS 9, effective January 1, 2018, prior year financial statements had to be restated. IFRS 9 was adopted without restating comparative information. The reclassifications arising from the new rules are therefore not reflected in the statement of financial position as at December 31, 2017, but are recognized in the opening statement of financial position on January 1, 2018.

Following the adoption of IFRS 9, the Company could no longer defer and amortize financing fees that resulted from the refinancing of borrowings in periods prior to January 1, 2018. As a result, the Company has restated the beginning balances noted in the table below to properly account for $260 of financing fees in accordance with IFRS 9. The standard was applied retrospectively therefore approximately $260 of deferred financing costs, net of accumulated amortization, remain netted against long-term debt on the consolidated statement of financial position, as at December 31, 2017.

 

- 18 -


Village Farms International, Inc.

 

 

The following tables show the adjustments recognized for each individual line item. Line items that were not affected by the changes have not been included. As a result, the sub-totals and totals disclosed cannot be recalculated from the numbers provided.

 

     December 31,
2017

As originally
presented
     IFRS 9
Adjustments
     January 1,
2018

Restated
 

Statement of Financial Position (extract)

        

Non-current liabilities

        

Long-term debt

   $ 35,760      $ 260      $ 36,020  
  

 

 

    

 

 

    

 

 

 

Total liabilities

     61,298        260        61,558  
  

 

 

    

 

 

    

 

 

 

Shareholders’ Equity

        

Retained earnings

     39,272        (260      39,012  
  

 

 

    

 

 

    

 

 

 

Total shareholders’ equity

   $ 81,043      ($ 260    $ 80,783  
  

 

 

    

 

 

    

 

 

 

Statements of Income (Loss) and Comprehensive Income (extract)

        

Interest expense

   $ 2,695      $ 260      $ 2,955  
  

 

 

    

 

 

    

 

 

 

Income (loss) before income taxes

     3,960        (260      3,700  

Provision for income taxes

  

 

138

 

     —          138  
  

 

 

    

 

 

    

 

 

 

Net income (loss)

   $ 3,822      ($ 260    $ 3,562  
  

 

 

    

 

 

    

 

 

 

Basic income (loss) per share

   $ 0.10      ($ 0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

Diluted income (loss) per share

   $ 0.10      ($ 0.01    $ 0.09  
  

 

 

    

 

 

    

 

 

 

IFRS 15, Revenue from Contracts with Customers , replaces IAS 18, Revenue , and IAS 11, Construction Contracts , and the related Interpretations on revenue recognition. IFRS 15 establishes a single comprehensive model for recognizing revenues from contracts with customers. The standard requires revenue to be recognized in a manner that depicts the transfer of promised goods or services to a customer at an amount that reflects the consideration expected to be received in exchange for transferring those goods and services.

The Company generates its revenue through the sale of produce, with standard shipping terms and discounts, and through the production and sale of power.

The Company’s produce revenue transactions consist of single performance obligations to transfer promised goods. Quantities to be delivered to the customer are determined at a point near the date of delivery through purchase orders it receive from the customer. The Company recognizes revenue when it has fulfilled a performance obligation, which is typically when the customer receives the goods and its performance obligation is complete. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring product. The amount of revenue recognized is reduced for estimated returns and other customer credits, such as discounts and rebates, based on the expected value to be realized. Payment terms are consistent with terms standard to the markets the Company serves. The Company maintains an allowance for doubtful accounts for the loss that would be incurred if a customer was unable to pay amounts due. The Company initially estimates the allowance required at the time of revenue recognition based on historical experience and makes changes to the allowance based on various factors, including changes in the customer’s financial condition or payment patterns.

The Company sells electricity to British Columbia Hydro and Power Authority. Revenues are recognized as the electricity is delivered to/consumed by the customer and is based on contractual usage rates and meter readings that measure electricity consumption.

The Company adopted IFRS 15, as of January 1, 2018, using the modified retrospective transition method, which involves not restating periods prior to the date of initial application. The application of IFRS 15 required no adjustment to the Company’s interim financial statements for the three and nine months ended September 30, 2018, as the amount and timing of substantially all of its revenues is, and will continue to be, recognized at a point in time.

 

- 19 -


Village Farms International, Inc.

 

 

Related Party Transactions

As at September 30, 2018, included in other assets is a $65 promissory note from an employee of the Company in connection with a relocation agreement. The Company has no other commitments as a result of related party transactions during the year.

Outstanding Share Data

The beneficial interests in the Company are currently divided into interests of three classes, described and designated as “Common Shares”, “Special Shares” and “Preferred Shares”, respectively. An unlimited number of Common Shares, Special Shares and Preferred Shares are issuable pursuant to VFF’s constating documents.

On December 21, 2017, VFF issued 2,500,000 Common Shares pursuant to a “bought deal” short form prospectus offering at an issue price of CAD$5.40 per Common Share for gross proceeds of CAD$13,500,000. The offering was conducted by a syndicate of underwriters led by Beacon Securities Limited.

On May 24, 2018, VFF issued 1,886,793 Common Shares pursuant to a private placement offering at an issue price of CAD$5.30 per Common Share for gross proceeds of CAD$10,000,000.

On October 12, 2018VFF issued 3,097,200 Common Shares pursuant to a “bought deal” short form prospectus offering at an issue price of CAD$7.13 per Common Share for gross proceeds of CAD$22,083,036. The offering was conducted by a syndicate of underwriters led by Beacon Securities Limited

As of the date hereof, VFF has outstanding: (i) 47,624,338 Common Shares carrying the right to one vote at a meeting of voting shareholders of VFF; (ii) nil (0) Special Shares; and (iii) nil (0) Preferred Shares. In conjunction with the formation of Pure Sunfarms Corp., the Company issued 300,000 common share purchase warrants to an affiliate of a Canadian financial institution as partial consideration for services provided in respect thereof. Each such warrant entitles the holder to purchase one Common Share at an exercise price of CA$2.07. Each such warrant is exercisable up to June 6, 2020.

For further details on the structure of the Company or the rights attached to each of the above-mentioned securities, please refer to the Company’s current Annual Information Form dated April 2, 2018 which is available electronically at www.sedar.com .

Forward-Looking Statements

Certain statements contained in this MD&A constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this MD&A include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

 

- 20 -


Village Farms International, Inc.

 

 

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt at reasonable rates when required.

Although the forward-looking statements contained in this MD&A are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including this MD&A and the Company’s annual information form.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this MD&A relate only to events or information as of the date on which the statements are made in this MD&A. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Public Securities Filings

You may access other information about the Company, including its current Annual Information Form and other disclosure documents, reports, statements or other information that it files with the Canadian securities regulatory authorities, through SEDAR at www.sedar.com .

 

- 21 -

Exhibit 99.56

VILLAGE FARMS INTERNATIONAL REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS/PURE SUNFARMS EXPANDING CANNABIS PRODUCTION AND SALES

/NOT FOR DISTRIBUTION OVER UNITED STATES WIRE SERVICES/

VANCOUVER, November  12, 2018 /CNW/ – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX: VFF) (OTCQX:VFFIF) today announced its financial results for the third quarter ended September 30, 2018.

(All amounts in U.S. Dollars unless otherwise indicated.)

Highlights for the Third Quarter Ended September 30, 2018

(All comparable figures are for the third quarter ended September 30, 2017)

 

   

Sales of US$39.7 million, a decrease of (11%) from US$44.7 million;

 

   

Net loss of US($2.0) million, or US($0.04) per share, compared with net income of $0.3 million, or US$0.01 per share;

 

   

EBITDA of US$0.9 million compared with US$0.8 million;

 

   

Announced a bought deal offering of 3,097,200 common shares of the Company at a price of $7.13 for aggregate gross proceeds of $22,083,036;

 

   

Village Farms was accepted as a member of the board of the U.S. Hemp Roundtable, as the Company prepares for potential opportunities, independent of its cannabis joint venture in Canada, that could result from the expected federal legalization of hemp cultivation in the U.S.

Highlights for Village Farms’ Cannabis Joint Venture, Pure Sunfarms

 

   

Received its cannabis sales license from Health Canada in late July.

 

   

Commenced regular cannabis sales in September.

 

   

During the third quarter, Pure Sunfarms received from Health Canada the second, third and fourth amendments to the cultivation license for its 1.1 million square foot greenhouse, permitting it to expand its cannabis production area to approximately 225,000 square feet, 420,000 square feet and 550,000 square feet, respectively.

 

   

By October, the entirety of the first half of the 1.1 million square foot greenhouse was in production.

 

   

Appointed Mandesh Dosanjh as Chief Executive Officer, Pure Sunfarms, who joined from his position as Senior Vice President, Supply Chain and Wholesale, at the Liquor Control Board of Ontario (LCBO), where he led LCBO’s supply chain division, and developed and managed its supply chain and wholesale strategy as the LCBO prepared for the legalization of adult-use cannabis. Mr. Dosanjh has substantively advanced supply arrangements with multiple parties, including provincial boards and private retailers, since his appointment.

“Our cannabis joint venture in Canada, Pure Sunfarms, continues to steadily ramp production and remains firmly on track to achieve a full annual production run-rate of 75,000 kilograms in the first half of next year,” said Michael DeGiglio, CEO, Village Farms. “The Pure Sunfarms operation is producing quality, multiple strains with yields in line with our expectations. There is tremendous interest from provincial boards and other licensed producers for its product.


As was expected, the Canadian cannabis market is well short of supply and Pure Sunfarms will be taking advantage of the favourable resulting spot market. At the same time, Pure Sunfarms is building inventory to ensure a consistent supply under its own brand directly to provincial boards, to whom it expects to begin shipping in the coming weeks.”

“As Pure Sunfarms continues to execute on plan toward becoming one of the largest, vertically integrated cannabis suppliers in Canada, independent of our Canadian joint venture Village Farms is now looking to new, higher value crop opportunities in the U.S. and beyond, including the significant potential near-term opportunity around hemp in the U.S., as well as cannabis in Mexico. With one of the largest existing greenhouse footprints in the U.S., strong existing partnerships in Mexico, and a 30-year proven track record as a large-scale, low-cost greenhouse operator, Village Farms has an unmatched platform to capitalize on these new opportunities.”

Financial Highlights

(in thousands of U.S. Dollars unless otherwise indicated)

 

     For the three months
ended September 30 ,
     For the nine months ended
September 30,
 
     2018      2017      2018      2017  

Sales

   $ 39,684      $ 44,735      $ 111,213      $ 121,542  

Cost of sales

     (36,862      (42,400      (103,915      (112,525

Selling, general and administrative expenses

     (3,442      (3,267      (10,486      (9,875

Change in biological asset (1)

     (1,189      529        (992      (817

(Gain) loss on sale of assets

     —                 —          (8,564

Share of (loss) from joint venture

     (28      (220      (369      (220

(Recovery of) provision for income taxes

     (712      (1,584      (1,513      (183

Net (loss) income

     (1,989      294        (5,415      4,429  

Consolidated EBITDA (2)

     897        756        1,394        4,770  

EBITDA Pure Sunfarms – 50%

     (248      (220      (750      (220

(Loss) earnings per share – basic and diluted

   ($ 0.04    $ 0.01      ($ 0.12    $ 0.11  

 

  (1)

Biological assets consist of the Company’s produce on the vines at the period end. Details of the changes are described in note 5 of the Company’s interim consolidated financial statements for the three and nine months ended September 30, 2018.

  (2)

EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. See “Non-IFRS Measures”. Management believes that EBITDA is a useful supplemental measure in evaluating the performance of the Company. Consolidated EBITDA includes the Company’s 50% share of its joint venture Pure Sunfarms.

Results of Operations for the Three Months Ended September 30, 2018 compared to the Three Months Ended September 30, 2017

Sales

Sales for the three months ended September 30, 2018 decreased by ($5,051), or (11%), to $39,684 from $44,735 for the three months ended September 30, 2017. The decrease in sales is primarily due to the lost production from the Company’s Delta 3 greenhouse which was contributed to Pure Sunfarms and lower production from the Company’s Texas facilities which was primarily caused from a crop cycle change at the Permian Basin facility which did not have tomato production for 10 weeks during the three months ended September 30, 2018 due to a scheduled clean out of the facility after continuous production at the facility since early 2012.

The average selling price for tomatoes increased 12% for the three months ended September 30, 2018 versus the three months ended September 30, 2017 as a result of a higher percent of higher priced tomato production in 2018 verse 2017. Cucumber pricing remained flat and pepper pricing decreased by (8%) in the third quarter of 2018 versus the comparable quarter in 2017.


Cost of Sales

Cost of sales for the three months ended September 30, 2018 decreased by ($5,538), or (13%), to $36,862 from $42,400 for the three months ended September 30, 2017; primarily due to the contribution of the Delta 3 facility ($2,598) and a decrease in costs from the Company’s Texas facilities, due to a scheduled crop change in the Permian Basin facility.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended September 30, 2018 increased by $175, or 5%, to $3,442 from $3,267 for the three months ended September 30, 2017. The increase is due to public company costs such as investor relations and listing fees.

Change in Biological Asset

The net change in fair value of the biological asset for the three months ended September 30, 2018 decreased by ($1,718) to ($1,189) from a gain of $529 for the three months ended September 30, 2017. The decrease in the change in value is primarily due to a higher starting fair value at July 1, 2018 versus the same period in 2017 and (7%) less pounds available for sale in September 2018 versus September 2017, due to the loss of production from the Delta 3 facility in 2018 verse 2017. The fair value of the biological asset as at September 30, 2018 was $5,119 as compared to $5,305 as at September 30, 2017.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the three months ended September 30, 2018 was ($28), compared to ($220) for the three months ended September 30, 2017, the loss primarily consists of salaries and other administrative costs, offset by a gross profit from sales of $23 and by the Company’s share of the JV’s change in biological asset of $267, as the joint venture had buds on the plant and dried bud in inventory on September 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on the plant and in inventory on September 30, 2018.

Net (Loss) Income

Net loss for the three months ended September 30, 2018 was ($1,989) compared to net income of $294 for the three months ended September 30, 2017 primarily due to the change in biological asset decease of ($1,718) and a decrease in recovery of income taxes of ($872) partially offset by a lower share of loss from joint venture of $192.

EBITDA

EBITDA for the three months ended September 30, 2018 increased by $141, to $897 from $756 for the three months ended September 30, 2017. See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Income to EBITDA”.

Results of Operations for the Nine Months Ended September 30, 2018 compared to the Nine Months Ended September 30, 2017

Net Sales

Net sales for the nine months ended September 30, 2018 decreased ($10,329), or (8%), to $111,213 compared to $121,542 for the nine months ended September 30, 2017. The decrease in net sales is due to the loss of tomato production from the Delta 3 facility, which was contributed to Pure Sunfarms in 2017 and the Company’s lower production at its Texas facilities.


The net price for all tomato pounds sold was an increase of 5% for the nine months ended September 30, 2018 versus the nine months ended September 30, 2017 due to a higher percent of higher priced tomato production in 2018 verse 2017. Pepper prices decreased (7%) and pounds increased 30% over the comparable period in 2017, and cucumber prices decreased (3%) and pieces decreased (13%) for the nine months ended September 30, 2018 over the comparable period in 2017.

Cost of Sales

Cost of sales for the nine months ended September 30, 2018 decreased ($8,610), or (8%), to $103,915 from $112,525 for the nine months ended September 30, 2017; primarily due the loss of the Delta 3 facility ($4,598), a decrease in costs in Texas from a decrease on pounds sold from the Texas facilities and a decrease of ($348) in contract sales cost, due to decreased cucumber volumes.

Change in fair value of biological asset, net

The net change in fair value of biological asset for the nine months ended September 30, 2018 decreased ($175) to ($992) from ($817) for the nine months ended September 30, 2017. The decrease is due to lower pounds available for sale in September 2018 versus September 2017 from the loss of the Delta 3 facility.

Selling, General and Administrative Expenses

Selling, general and administrative expenses for the nine month period ended September 30, 2018 increased ($611), or (6%), to $10,486 from $9,875 for the nine month period ended September 30, 2017. The increase is due to public company costs such as investor relations, legal and listing fees.

Income Taxes (Recovery)

Income tax provision (recovery) for the nine month period ended September 30, 2018 was a recovery ($1,513) compared to ($183) for the nine month period ended September 30, 2017. The income tax recovery decrease is due to the gain on sale of assets in 2017 that did not occur in 2018.

Share of (Loss) from Joint Venture

The Company’s share of the loss from its joint venture for the nine months ended September 30, 2018 was ($369), compared to ($220) for the nine months ended September 30, 2017. The loss primarily consists of salaries and other administrative costs, offset by a gross profit from sales of $23 and by the Company’s share of the JV’s change in biological asset of $857, as the joint venture had buds on the plant and dried bud in inventory on September 30, 2018. The value of the biological asset is the effective gross margin (revenues in excess of costs of goods) for the buds that existed on plant and in inventory on September 30, 2018.

Gain on Sale of Assets

No gains were recognized in 2018. The Company recognized for the nine month period ended September 30, 2017 a gain of $8,564 on the contribution of the one of the Company’s Delta greenhouse facilities and land to Pure Sunfarms in exchange for a 50% equity stake in Pure Sunfarms. See “Investment in Joint Venture” above.

Net Income (Loss)

Net income (loss) for the nine month period ended September 30, 2018 decreased to a loss of ($5,415) from income of $4,429 for the nine month period ended September 30, 2017. The decrease is a result of a gain on assets in 2017 of $8,564.


EBITDA

EBITDA for the nine month period ended September 30, 2018 decreased ($3,376) to $1,394 from $4,770 for the nine month period ended September 30, 2017, primarily as a result of a decrease in net sales and an increase in share of loss from Pure Sunfarms of ($530). See the EBITDA calculation in “Non-IFRS Measures—Reconciliation of Net Earnings to EBITDA”.

Non-IFRS Measures

References in this press release to “EBITDA” are to earnings before interest, taxes, depreciation, amortization, foreign currency exchange gains and losses on translation of long-term debt, unrealized change in biological asset, stock compensation, share of loss from joint venture, and gains and losses on asset sales. EBITDA is a cash flow measure that is not recognized under IFRS and does not have a standardized meaning prescribed by IFRS. Therefore, EBITDA may not be comparable to similar measures presented by other issuers. Investors are cautioned that EBITDA should not be construed as an alternative to net income or loss determined in accordance with IFRS as an indicator of the Company’s performance or to cash flows from operating, investing and financing activities as measures of liquidity and cash flows. Management believes that EBITDA is an important measure in evaluating the historical performance of the Company.

Reconciliation of Net Income to EBITDA

The following table reflects a reconciliation of net income (loss) to EBITDA, as presented by the Company:

 

(in thousands of U.S. dollars)    For the three months
ended September 30,
     For the nine months
ended September 30,
 
     2018      2017      2018      2017  

Net (loss) income

   ($ 1,989    $ 294      ($ 5,415    $ 4,429  

Add:

           

Amortization

     1,748        1,853        5,271        5,753  

Foreign currency exchange loss (gain)

     73        (58      87        (57

Interest expense

     618        689        1,906        2,015  

Income taxes (recovery)

     (712      (1,584      (1,513      (183

Stock based compensation

     190        91        447        560  

Change in biological asset

     1,189        (529      992        817  

Change in biological asset from JV

     (267      —          (428      —    

Amortization from JV

     37        —          37        —    

Foreign currency exchange loss (gain) from JV

     10        —          10        —    

Gain on disposal of assets

     —          —          —          (8,564
  

 

 

    

 

 

    

 

 

    

 

 

 

Consolidated EBITDA

   $ 897      $ 756      $ 1,394      $ 4,770  

EBITDA for JV (50% share)

   ($ 248    ($ 220    ($ 750    ($ 220

Stand-alone EBITDA

   $ 1,145      $ 976      $ 2,144      $ 4,990  

Conference Call

Village Farms’ management team will host a conference call tomorrow, Tuesday, November 13, 2018, at 11:00 a.m. ET (8:00 a.m. PT) to discuss its third quarter 2018 financial results and provide an update on Pure Sunfarms. Participants can access the conference call by telephone by dialing (647) 427-7450 or (888) 231-8191, or via the Internet at https://tinyurl.com/yaxk4ctg .


For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 849-0833 or (855) 859-2056 and enter the passcode 5589169 followed by the pound key. The telephone replay will be available until Tuesday, November 20, 2018 at midnight (ET). The conference call will also be archived on Village Farms’ website at http://villagefarms.com/investor-relations/investor-calls .

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.

Cautionary Language

Certain statements contained in this press release form constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to: product pricing; maintaining profitability; risks inherent in the agricultural business; natural catastrophes; retail consolidation; covenant risk; dependence upon credit facilities; competition; transportation disruptions; labour; governmental regulations; product liability; key executives; uninsured and underinsured losses; vulnerability to rising energy costs; risks of regulatory change; environmental, health and safety risk, foreign exchange exposure, risks associated with cross-border trade; technological advances; accounting estimates; growth; tax risks; and risks related to the Joint Venture, including the Joint Venture’s ability to obtain licenses under the ACMPR, risks relating to conversion of the Company’s greenhouses to cannabis production, and the ability to cultivate and distribute cannabis.

The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs, including that the Canadian economy will remain stable over the next 12 months, that inflation will remain relatively low, that interest rates will remain stable, that tax laws remain unchanged, that conditions within the greenhouse vegetable and cannabis industries generally will be consistent with the current climate, that recreational cannabis consumption will be approved by the Canadian government during 2018 and that the Canadian capital markets will provide the Company with access to equity and/or debt on reasonable terms when required.


Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Village Farms International, Inc.

View original content: http://www.newswire.ca/en/releases/archive/November2018/12/c3477.html

%SEDAR: 00029410E

For further information: Stephen C. Ruffini, Executive Vice President and Chief Financial Officer, Village Farms International, Inc., (407) 936-1190, ext. 340; Lawrence Chamberlain, Investor Relations, (416) 519-4196, lawrence.chamberlain@loderockadvisors.com

CO: Village Farms International, Inc.

CNW 17:05e 12-NOV-18

Exhibit 99.57

Form 52-109F2

Certification of Interim Filings - Full Certificate

I, Michael A. DeGiglio, the Chief Executive Officer of Village Farms International, Inc., certify the following:

 

  1.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended September 30, 2018.

 

  2.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  3.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  4.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  5.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

 

  5.2:

N/A

 

  5.3

N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2018 and ended on September 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: November 12, 2018

 

    “Michael A. DeGiglio”

Michael A. DeGiglio,
Chief Executive Officer
Village Farms International, Inc.

Exhibit 99.58

Form 52-109F2

Certification of Interim Filings - Full Certificate

I, Stephen C. Ruffini, the Chief Financial Officer of Village Farms International, Inc., certify the following:

 

  1.

Review : I have reviewed the interim financial report and interim MD&A (together, the “interim filings”) of Village Farms International, Inc. (the “issuer”) for the interim period ended September 30, 2018.

 

  2.

No misrepresentations : Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings.

 

  3.

Fair presentation : Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance and cash flows of the issuer, as of the date of and for the periods presented in the interim filings

 

  4.

Responsibility : The issuer’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (DC&P) and internal control over financial reporting (ICFR), as those terms are defined in National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings , for the issuer.

 

  5.

Design : Subject to the limitations, if any, described in paragraphs 5.2 and 5.3, the issuer’s other certifying officer and I have, as at the end of the period covered by the interim filings

 

  (a)

designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that

 

  (i)

material information relating to the issuer is made known to us by others, particularly during the period in which the interim filings are being prepared; and

 

  (ii)

information required to be disclosed by the issuer in its annual filings, interim filings or other reports filed or submitted by it under securities legislation is recorded, processed, summarized and reported within the time periods specified in securities legislation; and

 

  (b)

designed ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with the issuer’s GAAP.

 

  5.1

Control framework : The control framework the issuer’s other certifying officer and I used to design the issuer’s ICFR is the framework set forth in the report of the Treadway Commission’s Committee of Sponsoring Organizations (COSO Framework).

 

  5.2:

N/A

 

  5.3

N/A


  6.

Reporting changes in ICFR : The issuer has disclosed in its interim MD&A any change in the issuer’s ICFR that occurred during the period beginning on July 1, 2018 and ended on September 30, 2018 that has materially affected, or is reasonably likely to materially affect, the issuer’s ICFR.

Date: November 12, 2018

 

     “Stephen C. Ruffini”

Stephen C. Ruffini,
Chief Financial Officer
Village Farms International, Inc.

Exhibit 99.59

 

LOGO       79 Wellington St. W., 30th Floor

Box 270, TD South Tower

Toronto, Ontario M5K 1N2 Canada

P. 416.865.0040 | F. 416.865.7380

 

www.torys.com

December 15, 2017

 

To:   

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

Ontario Securities Commission

Financial and Consumer Services Commission (New Brunswick)

Nova Scotia Securities Commission

Superintendent of Securities, Prince Edward Island

Superintendent of Securities, Newfoundland and Labrador

Dear Sirs/Mesdames:

 

Re:

Village Farms International, Inc.

    

Short Form Prospectus dated December 15, 2017 (the “Prospectus”)

We hereby consent to the reference to our name on the inside cover page and under the heading “Legal Matters” and to the reference to our name and to the use of our opinion under the heading “Eligibility for Investment” in the Prospectus relating to the offering of 2,500,000 Common Shares of Village Farms International, Inc.

We have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained in the Prospectus that are derived from our opinions or that are within our knowledge as a result of services we performed in connection with such opinions.

Yours truly,

“Torys LLP”

Exhibit 99.60

 

LOGO

December 15, 2017

File No.: 290577.00044

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

Ontario Securities Commission

New Brunswick Financial and Consumer Services Commission

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Prince Edward Island

Office of the Superintendent of Securities, Service Newfoundland and Labrador

Dear Sirs/Mesdames:

 

Re:

Village Farms International, Inc. (the “Issuer)”

We refer to the final short form prospectus dated December 15, 2017 (the “ Prospectus ”) of the Issuer.

We hereby consent to the reference to our firm name in the Introduction and under the heading “Legal Matters” and to the reference to our firm name and to the use of our opinion under the heading “Eligibility for Investment” in the Prospectus.

We confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations (as defined in the Securities Act (Ontario)) in the information contained in the Prospectus that is derived from our opinion referred to above or that is within our knowledge as a result of the services we performed in connection with such opinion.

This letter is delivered to the addressees pursuant to the requirements of Section 4.2(a)(vii) of National Instrument 44-101.

Yours truly,

“Fasken Martineau DuMoulin LLP”

Exhibit 99.61

 

LOGO       79 Wellington St. W., 30th Floor

Box 270, TD South Tower

Toronto, Ontario M5K 1N2 Canada

P. 416.865.0040 | F. 416.865.7380

 

www.torys.com

October 4, 2018

 

To:   

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

Ontario Securities Commission

Financial and Consumer Services Commission (New Brunswick)

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Prince Edward Island

Office of the Superintendent of Securities, Newfoundland and Labrador

Dear Sirs/Mesdames:

 

Re:

Village Farms International, Inc.

    

Short Form Prospectus dated October 4, 2018 (the “Prospectus”)

We hereby consent to the reference to our name on the inside cover page and under the heading “Legal Matters” and to the reference to our name and to the use of our opinion under the heading “Eligibility for Investment” in the Prospectus relating to the offering of 2,810,000 Common Shares of Village Farms International, Inc.

We have read the Prospectus and have no reason to believe that there are any misrepresentations in the information contained in the Prospectus that are derived from our opinions or that are within our knowledge as a result of services we performed in connection with such opinions.

Yours truly,

“Torys LLP”

Exhibit 99.62

 

LOGO

October 4, 2018

File No.: 290577.00048

British Columbia Securities Commission

Alberta Securities Commission

Financial and Consumer Affairs Authority of Saskatchewan

The Manitoba Securities Commission

Ontario Securities Commission

New Brunswick Financial and Consumer Services Commission

Nova Scotia Securities Commission

Office of the Superintendent of Securities, Prince Edward Island

Office of the Superintendent of Securities, Service Newfoundland and Labrador

Dear Sirs/Mesdames:

 

Re:

Village Farms International, Inc.

Final Short Form Prospectus

We refer to the final short form prospectus dated October 4, 2018 of Village Farms International, Inc. in relation to the offering of common shares (the “ Prospectus ”).

We hereby consent to the reference to our firm name in the Introduction and under the heading “Legal Matters” and to the reference to our firm name and to the use of our opinion under the heading “Eligibility for Investment” in the Prospectus.

We confirm that we have read the Prospectus and have no reason to believe that there are any misrepresentations (as defined in the Securities Act (Ontario)) in the information contained in the Prospectus that is derived from our opinion referred to above or that is within our knowledge as a result of the services we performed in connection with such opinion.

This letter is delivered to the addressees pursuant to the requirements of Section 4.2(a)(vii) of National Instrument 44-101.

Yours truly,

“FASKEN MARTINEAU DuMOULIN LLP”

Exhibit 99.63

 

LOGO

FOR IMMEDIATE RELEASE

Village Farms International Announces Continued Expansion of Pure

Sunfarms’ Licensed Cannabis Production Area to 687,000 Square Feet, One

of the Largest Production Capacities in Canada

– 1.1 Million Square Foot Pure Sunfarms Facility Continues to Steadily Ramp Production

with Industry-Leading Quality and Yields Firmly in Line with Expectations –

Vancouver, BC, December  10, 2018 – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTCQX: VFFIF) today announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada the fifth amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. This amendment permits Pure Sunfarms to expand its cannabis production area by approximately 137,000 square feet (half of Quadrant 3) to a total of approximately 687,000 square feet. The newly licensed area is expected to be fully planted and in production by the end of this week.

“As strong demand outstrips near-term supply in the Canadian cannabis market, Pure Sunfarms continues to steadily expand its licensed production area, already one of the very largest in the country,” said Michael DeGiglio, CEO of Village Farms. “With the benefit of Village Farms’ three decades of technical and design know-how, its 20-years of site-specific experience at the Delta facility, existing operational and growing teams and existing labour force, Pure Sunfarms’ cannabis facility continues to perform very well, growing multiple strains, with industry-leading quality and yields firmly in line with our expectations. As anticipated, the Canadian industry generally has faced challenges ramping production, however, we are confident in Pure Sunfarms’ ability to achieve its annual run-rate production of 75,000 kilograms in the first half of 2019 and prove itself to be one of the best cannabis production operations in the industry.”

Mr. DeGiglio added, “As Pure Sunfarms ramps production, it continues to take advantage of favourable spot market pricing as it awaits its packaging sales license amendment in order to commence sales to provincial boards. Pure Sunfarms remains poised to be a vertically integrated leader in the rapidly emerging Canadian cannabis industry and Village Farms’ shareholders remain well positioned to reap the rewards.”


Pure Sunfarms has completed conversion of the remainder of Quadrant 3 (approximately 138,000 square feet) and is currently awaiting Health Canada approval of that additional production area. Pure Sunfarms expects to complete conversion of Quadrant 4 (approximately 275,000 square feet) by the end this year and anticipates Health Canada approval of that additional area by the end of January 2019. At a total licensed area of 1.1 million square feet, Pure Sunfarms Delta greenhouse will be one of the single largest cannabis growing facilities in the world.

All supplemental lighting is operational in Quadrants 2 and 3, and is expected to be operational in Quadrant 4 upon start of production, supporting maximum yields during the lower daylight winter months. Supplemental lighting will be installed in Quadrant 1, conversion of which, as per plan, was completed earlier this year without supplemental lighting to be able to commence production immediately during the summer months when supplemental lighting is not required. Quadrant 1 is expected to resume production by the end of February 2019.

The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 16 grow rooms (eleven of which are now licensed) optimized for year-round harvesting (more than 80 harvests annually).

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to closing of the Offering and the intended use of proceeds therefrom.


Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form and management’s discussion and analysis for the year-ended December 31, 2017.

When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

Lawrence Chamberlain

Investor Relations

LodeRock Advisors

(416) 519-4196

lawrence.chamberlain@loderockadvisors.com

Exhibit 99.64

 

LOGO

FOR IMMEDIATE RELEASE

VILLAGE FARMS INTERNATIONAL TO AGGRESSIVELY PURSUE HEMP AND

CBD OPPORTUNITIES FOLLOWING U.S. FEDERAL LEGALIZATION

Village Farms to Leverage Formidable Growing Platform                    

for the “Next Major Nutraceutical Phenomenon”

Vancouver, BC, December  13, 2018 – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTCQX:VFFIF) today announced that, following yesterday’s passage by U.S. Congress of the 2018 Farm Bill, it will aggressively pursue opportunities to become a vertically integrated leader in the legal hemp industry, including significant opportunities in the cannabidiol (CBD) market. The 2018 Farm Bill is still to be signed into law by President Trump, which is expected to occur next week.

The 2018 Farm Bill includes the Hemp Farming Act 2018 which federally legalizes hemp and hemp products in the U.S., including extracts, derivatives and cannabinoids, and permanently removes hemp from the U.S. federal Controlled Substances Act (CSA). CBD has become increasingly popular among consumers seeking to improve their general health and wellness. According to Brightfield Group, with the full federal legalization of hemp-derived CBD in the U.S., the global hemp CBD market is estimated to grow nearly 40-fold in the next four years to US$22 billion in 2022 1 , driven to a large degree by what it believes could be “the next major nutraceutical phenomenon”.

“The full and unambiguous legalization of hemp, and especially hemp-derived CBD products, creates a tremendous global opportunity and Village Farms intends to be a leader in this nascent industry,” said Michael DeGiglio, Chief Executive Officer, Village Farms. “With one of the largest existing greenhouse footprints in the U.S. and a 30-year proven track record as a large-scale, low-cost grower of high-value crops, Village Farms has a formidable platform to capitalize on the hemp and CBD opportunity. In anticipation of the passage of this landmark legislation, over the last several months, we have undertaken broad and extensive foundational work to ensure Village Farms can move quickly, aggressively and profoundly.”

Mr. DeGiglio added, “Village Farms is proud to be a member of the board of the U.S. Hemp Roundtable, who advocated passionately and unremittingly for the passage of this historic legislation, and we congratulate the organization on its success.”


Upon U.S. federal legalization, cultivation of hemp and the sale of hemp and hemp products, including hemp-derived CBD products, remains subject to state law. State governments may impose separate restrictions or requirements on the cultivation and the sale of hemp and hemp products. Village Farms will pursue hemp and CBD opportunities with strict adherence to applicable laws. Village Farms is currently working with lobbyists in Texas to have hemp removed from Texas’ controlled substance list in the upcoming early-2019 legislative session. Management believes early indications for the removal of hemp from Texas’ controlled substance list are favorable. Village Farms is also working with other parties to have hemp removed from the controlled substance lists of other U.S. states to enable the Company to pursue opportunities outside Texas.

“We are optimistic that state authorities will follow the federal government’s lead in permitting the cultivation and sale of hemp and hemp products and, accordingly, Village Farms will continue to advance its current hemp initiatives to ensure we are ready to move quickly and decisively as soon as relevant state laws permit,” said Mr. DeGiglio. “This is a unique and special opportunity for our Company, completely independent of our successful cannabis joint venture in Canada, to create significant, additional, long-term value for our shareholders.”

Village Farms’ potential hemp and CBD business opportunities may include, but are not limited to, the conversion of a portion of its 5.7 million square feet of existing, high-tech greenhouse operations in West Texas (one of the best growing climates for hemp in the U.S.) should the state of Texas remove hemp from its controlled substance list. Village Farms is also pursuing opportunities for both greenhouse and outdoor growing in other states where hemp is expected to be legalized. In addition, the Company believes the development of hemp strains to treat specific ailments, conditions and diseases, as well as an understanding of the health and wellness benefits of individual strains, will be critical to success in this industry and Village Farms also intends to aggressively pursue the advancement of both, independently and through collaborations.

“It is our belief that there will be significant demand for both greenhouse-grown and outdoor-grown hemp to address what is expected to be a vast array of CBD products spanning multiple categories from food and beverage to nutraceuticals to pharmaceuticals, including propagation services,” added Mr. DeGiglio. “Village Farms has a long and proud history of successfully developing large-scale agricultural projects in multiple states across the U.S. and around the world and will pursue both greenhouse and outdoor opportunities. Moreover, our deep experience, extensive relationships, and flawless agricultural product safety record as a vertically integrated grower serving most major food retailers in the U.S. and Canada provide an exceptional foundation to enable Village Farms to play a leading role in the birth and development of this industry.”

No assurance can be given as to whether hemp will ultimately become federally legal in the U.S. and legal in the State of Texas or elsewhere. Accordingly, there can be no assurance that the Company will be able to pursue or implement the hemp-related business initiatives contemplated herein.


Notes

 

1.

Brightfield Group: 2018 Hemp-Derived CBD Study.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms Corp., one of the single largest cannabis growing operations in the world.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis or hemp industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to the U.S. federal and state legalization of hemp and the Company’s potential new business opportunities related thereto.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form dated April 2, 2018 and management’s discussion and analysis for the year-ended December 31, 2017 and for the three- and nine-month periods ended September 30, 2018.


When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

Lawrence Chamberlain

Investor Relations

(416) 519-4196

lawrence.chamberlain@loderockadvisors.com

Exhibit 99.65

Consent of Independent Auditor

We hereby consent to the incorporation by reference in this Registration Statement on Form 40-F of Village Farms International, Inc. (“the Company”) of our report dated April 2, 2018 relating to the consolidated financial statements of the Company as at December 31, 2017 and 2016 and for the years then ended, which appears in the Exhibit 99.11 to the Registration Statement on Form 40-F.

We also consent to the references to us under the heading “Experts” which appears in the Annual Information Form included in Exhibit 99.10 which is incorporated by reference in this Registration Statement on Form 40-F.

/s/ PricewaterhouseCoopers LLP

Chartered Professional Accountants

Vancouver, Canada

January 18, 2019

Exhibit 99.66

 

LOGO

FOR IMMEDIATE RELEASE

VILLAGE FARMS INTERNATIONAL CONTINUES LEADERSHIP IN GREENHOUSE

CROP PROTECTION AND ANNOUNCES PRODUCT INNOVATION AWARD

Vancouver, BC, December  20, 2018 – Village Farms International, Inc. (“Village Farms” or the “Company”) (TSX:VFF) (OTCQX:VFFIF) today announced that it has facilitated the approval by Health Canada’s Pest Management Regulatory Agency (PMRA) of a novel new crop protectant, Pepino mosaic virus, strain CH2, isolate 1906 , branded PMV-01 ® . The new inoculant, branded PMV-01 ® , is a mild form of the Pepino mosaic tomato plant virus (PepMV) and protects greenhouse tomatoes against aggressive forms of that same plant virus through cross-protection, which is a plant defense mechanism against viral infections. As previously announced, the Company also facilitated approval of PMV-01 ® by the U.S. Environmental Protection Agency (EPA) earlier this year. Both approvals were on behalf of its Belgium-based developer of PMV-01 ® , De Ceuster Meststoffen NV (DCM).

“Over our 30-year history in greenhouse growing, Village Farms has proactively taken a leadership role across most facets of our vertically integrated greenhouse produce business – from innovation in greenhouse design and technologies, to improved cultivation techniques to enhance quality and yield, to the development exclusive produce varieties, as well as advancement of food safety programs, sustainability practices, and, as this latest pesticide registration further demonstrates, crop protection,” said Michael DeGiglio, Chief Executive Officer, Village Farms. “Throughout our history, we have welcomed the opportunity to work closely and collaboratively with key government agencies and regulators, including the EPA, the US Department of Agriculture, the US Food and Drug Administration, and Health Canada, to drive innovation and best practices that have benefited not only our Company but the entire industry.”

“We plan to bring the same leadership, passion and expertise that have underpinned our success as a vertically integrated operator in the produce sector to the cannabis and hemp-derived CBD industries as we aggressively pursue those opportunities in the U.S., Canada and globally,” added Mr. DeGiglio.

Facilitation of the PMV-01 ® registration was led by Dr. Michael Bledsoe, Village Farms’ Vice President of Food Safety and Regulatory Affairs, a renowned expert and advocate for the research and registration of greenhouse crop protectants. Nearly 20 years ago, Dr. Bledsoe, with the full support of the Company, pioneered the approval and use of pesticides and inoculants through the Inter-Regional Research Project Number 4 (IR-4) Project (a federally funded organization that conducts research necessary for obtaining crop protectant registrations) U.S. Department and the EPA. When Village Farms expanded into the greenhouse vegetable industry in Canada in 2006, the Company and Dr. Bledsoe brought their extensive greenhouse vegetable protectant experience and leadership in the U.S. to Agriculture and Agri-Food Canada’s Pest Management Centre (PMC), where they have been significant contributors, including to the alignment of the approval processes in both countries.


Village Farms Wins Top Product Innovation Award at New York Produce Show

Village Farms also announced that its Stackable Snackables™ series of exclusive specialty tomatoes in new top-seal packaging received the Joe Nucci Award for Product Innovation at this year’s New York Produce Show last week.

Mr. DeGiglio commented, “We are proud to once again be recognized as a leading innovator in the produce industry, this year taking the top overall award for industry innovation.”

Last year, Village Farms’ was one of ten winners of the inaugural Innovation Awards from Produce Business Magazine at the New York Produce Show for its exclusive Lorabella Blossom TM tomato variety.

About Village Farms International, Inc.

Village Farms International, Inc. is one of the largest and longest-operating vertically integrated greenhouse growers in North America and the only publicly traded greenhouse produce company in Canada. Village Farms produces and distributes fresh, premium-quality produce with consistency 365-days a year to national grocers in the U.S. and Canada from more than nine million square feet of Controlled Environment Agriculture (CEA) greenhouses in British Columbia and Texas, as well as from its partner greenhouses in British Columbia, Ontario, and Mexico. The Company is now leveraging its 30 years of experience as a vertically integrated grower for the rapidly emerging global cannabis opportunity through a 50% ownership of British Columbia-based Pure Sunfarms, Corp., one of the single largest cannabis growing operations in the world. The Company also intends to pursue opportunities to become a vertically integrated leader in the hemp-derived CBD market, subject to applicable state and federal law.

Cautionary Language

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws (“ forward-looking statements ”). Forward-looking statements may relate to the Company’s future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, Pure Sunfarms, the greenhouse vegetable industry or the cannabis or hemp industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as “outlook”, “may”, “might”, “will”, “could”, “should”, “would”, “occur”, “expect”, “plan”, “anticipate”, “believe”, “intend”, “estimate”, “predict”, “potential”, “continue”, “likely”, “schedule”, “objectives”, or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. Some of the specific forward-looking statements in this press release include, but are not limited to, statements with respect to the U.S. federal and state legalization of hemp and the Company’s potential new business opportunities related thereto.

Although the forward-looking statements contained in this press release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company’s control, that may cause the Company’s or the industry’s actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company’s filings with securities regulators, including as detailed in the Company’s annual information form dated April 2, 2018 and management’s discussion and analysis for the year-ended December 31, 2017 and for the three- and nine-month periods ended September 30, 2018.


When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this press release only relate to events or information as of the date on which the statements are made in this press release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

Lawrence Chamberlain

Investor Relations

(416) 519-4196

lawrence.chamberlain@loderockadvisors.com